{"title": "anticuerpo anti igg: Topics by WorldWideScience.org", "author": null, "url": null, "hostname": null, "description": null, "sitename": null, "date": "1995-03-01", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "[Anticuerpos IgG anti-toxoplasma gondii en pacientes con s\u00edntomas atribu\u00edbles a toxoplasmosis](http://www.revistabiomedica.org/index.php/biomedica/article/view/2070) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJorge E. Collazo\n1993-12-01\nFull Text Available Se evaluaron 6.520 pacientes con s\u00edntomas atribu\u00edbles a toxoplasmosis por la presencia de anticuerpos IgG anti - Toxoplasma gondii mediante la t\u00e9cnica de inmunofluorescencia indirecta. El 51,27% de los evaluados resultaron positivos.El 60,85% de los pacientes con trastornos oculares son seropositivos a IgG anti - T. gondii; seguidos del 56,25 y 48,10% para aquellos con trastornos generales y gineco-obst\u00e9tricos. Los s\u00edntomas o manifestaciones que evidenciaron mayor porcentaje de positividad fueron: astenia, coriorretinitis, trastornos menstruales, cefaleas y uve\u00edtis.\n[Rabbit IgG antibodies against Phospholipase A2 from Crotalus durissus terrificus neutralize the lethal activity of the venom Los anticuerpos IgG de conejos anti-fosfolipasa A2 de Crotalus durissus terrificus neutralizan la actividad letal del veneno](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802006000600003) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJuan P. Rodr\u00edguez\n2006-12-01\nFull Text Available Crotalus durissus terrificus (C.d.t. (South American rattlesnake venom possesses myotoxic and neurotoxic activities, both of which are also expressed by crotoxin, the principal toxin of this venom. Crotoxin contains a basic phospholipase A2 (PLA2 and a non toxic acidic protein, crotapotin. We have produced and investigated the ability of IgG antibodies raised in rabbits against PLA2 to neutralize the lethality of the whole venom. PLA2 was isolated by gel filtration chromatography (Sephadex G-75. Specific antibodies were obtained by subcutaneous and intramuscular inoculation of PLA2 (700 \u00b5g with Freund adjuvant. Groups of six mice (20 + 2 g were inoculated with 0.5 ml i.p. of C. d. t. venom (4 \u00b5g or a mixture of venom that had been preincubated with the desired volume of IgG antibodies. Mortality, recorded 24 and 48 h after inoculation, showed that IgG anti-PLA2 were more effective than anticrotalic serum in neutralizing the lethal activity. These results demonstrate that it could be possible to obtain an anti-venom made by specific antibodies with a high level of protection against the lethal component of C.d.t. venom, and/or the inclusion of these antibodies as a supplement in heterologous anti-venoms.El veneno de Crotalus durissus terrificus (C.d.t. (Cascabel de Sud Am\u00e9rica posee actividad miot\u00f3xica y neurot\u00f3xica, actividades que tambi\u00e9n exhibe el complejo crotoxina, principal componente t\u00f3xico de este veneno. El complejo crotoxina est\u00e1 constituido por una fosfolipasa A2 b\u00e1sica (PLA2 y una prote\u00edna ac\u00eddica no t\u00f3xica, el crotapot\u00edn. En este trabajo se estudi\u00f3 la capacidad neutralizante de anticuerpos IgG anti-PLA2 sobre la letalidad inducida por el veneno entero. El ant\u00edgeno PLA2, fue aislado por cromatograf\u00eda de filtraci\u00f3n en gel (Sephadex G-75. Se inocularon conejos machos por v\u00eda subcut\u00e1nea e intramuscular, con 700 \u00b5g de PLA2 y adyuvante para la obtenci\u00f3n de anticuerpos espec\u00edficos. La capacidad neutralizante del\n[Determinaci\u00f3n de anticuerpos anti-\u03b22glicoprote\u00edna I en pacientes con s\u00edndrome antifosfol\u00edpido Anti- \u03b22 glycoprotein antibodies in patients with antiphospholipid syndrome](http://www.iatreia.udea.edu.co/index.php/iatreia/article/view/235) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nOscar Uribe Uribe\n2004-09-01\nFull Text Available EL objetivo de este estudio fue comparar la presencia de anticuerpos anti-\u03b22glicoprote\u00edna I (anti- \u03b22GPI con las pruebas convencionales de laboratorio de anticuerpos anticardiolipina (aCL y anticoagulante l\u00fapico, y con las manifestaciones cl\u00ednicas del s\u00edndrome antifosfol\u00edpido (SAF. Se incluyeron en el estudio 80 mujeres con SAF; 35 de ellas de la consulta de Reumatolog\u00eda y las otras 45 con historia de aborto recurrente espont\u00e1neo (ARE; 5 mujeres de la consulta de Reumatolog\u00eda sin SAF, 27 mujeres con ARE, sin SAF y un grupo control de 20 mujeres sanas en edad reproductiva. Se investigaron la presencia de anticuerpos IgG e IgM anticardiolipina (aCL e IgG anti- \u03b22GPI por la t\u00e9cnica de ELISA, y el anticoagulante l\u00fapico por la determinaci\u00f3n del tiempo parcial de tromboplastina activado. Adicionalmente, se registraron las manifestaciones cl\u00ednicas asociadas al SAF. De las pacientes con SAF, 25.7% del grupo de Reumatolog\u00eda (9/35 y 4.4% de las pacientes con ARE (2/45 fueron positivas para anticuerpos anti-\u03b22GPI, mientras que ninguna de las mujeres sin SAF, ni de las mujeres del grupo control, fue positiva. La asociaci\u00f3n entre la presencia de anti- \u03b22GPI y los anticuerpos IgG e IgM aCL mostr\u00f3 una diferencia significativa en los t\u00edtulos de 3+ (altamente positivos en contraste con los individuos negativos para anti- \u03b22GPI. La positividad del anticoagulante l\u00fapico tambi\u00e9n se correlacion\u00f3 con la presencia de anticuerpos anti- \u03b22GPI. No hubo diferencia significativa entre las diversas manifestaciones cl\u00ednicas del SAF y la presencia de dichos anticuerpos. En conclusi\u00f3n, la determinaci\u00f3n de anticuerpos anti- \u03b22GPI tiene una alta especificidad en pacientes con SAF pero no se asoci\u00f3 con ninguna manifestaci\u00f3n cl\u00ednica en particular. The objective of this study was to compare the presence of anti-\u03b22glycoprotein (anti- \u03b22GPI antibodies with the conventional laboratory tests of anticardiolipin antibodies (aCL and lupus anticoagulant\n[Preparaci\u00f3n de un conjugado peroxidasa-anti IgG humana (cadena en conejo Preparation of a peroxidase-anti human IgG conjugate (chain g in rabbit](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-02892001000200008) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJulio C Merl\u00edn Linares\n2001-08-01\nFull Text Available Se prepar\u00f3 un conjugado con peroxidasa a partir de los anticuerpos espec\u00edficos aislados de un suero de conejo anti cadenas g de la IgG humana. Los anticuerpos espec\u00edficos se aislaron por cromatograf\u00eda de afinidad, y el conjugado se prepar\u00f3 por el m\u00e9todo de oxidaci\u00f3n con peryodato. El conjugado obtenido present\u00f3 una relaci\u00f3n molar IgG/peroxidasa de 1,07, un valor de RZ de 0,33 y result\u00f3 evaluado satisfactoriamente en cuanto a su especificidad y reactividad en los ensayos inmunoenzim\u00e1ticos realizadosA peroxidase conjugate was prepared starting from the specific antibodies isolated from an anti-chain rabbit serum and from human IgG. The specific antibodies were isolated by affinity chromatography and the conjugate was prepared by the method of oxidation with periodate. The conjugate obtained presented a molar IgG/peroxidase relation of 1.07, a RZ value of 0.33 and it was satisfactorily evaluated as regards its specificity and reactivity in the immunoenzimatic assays carried out\n[Asociaci\u00f3n entre la presencia de anticuerpos anti-Ras y anti-VPH16 E4/E7 y lesiones intraepiteliales del c\u00e9rvix](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0036-36342003000500002) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nV\u00e1zquez-Corzo Sara\n2003-01-01\nFull Text Available OBJETIVO: Determinar si anticuerpos s\u00e9ricos contra E4, E7 y Ras pueden ser utilizados como marcadores de lesiones tempranas del c\u00e9rvix uterino asociadas al virus del papiloma humano. MATERIAL Y M\u00c9TODOS: Entre marzo de 1999 y abril de 2000 se realiz\u00f3 un estudio sero-epidemiol\u00f3gico de casos y controles en la cl\u00ednica de displasias del Hospital General Doctor Gea Gonz\u00e1lez, en la Ciudad de M\u00e9xico, en 116 muestras de suero para evaluar la presencia de anticuerpos anti-E4, E7 y Ras utilizando un ELISA de captura. Se estimaron razones de momios e intervalos de confianza de 95% RESULTADOS: Anticuerpos anti-E7 se asociaron a mujeres con lesiones NIC III, mientras que anticuerpos anti-E4 y anti-Ras fueron m\u00e1s frecuentes en lesiones NIC I-II. Al evaluar el perfil de anticuerpos que presentaron las mujeres, encontramos que a anticuerpos contra dos prote\u00ednas predicen la existencia de una lesi\u00f3n NIC I-II, y b la presencia de tres anticuerpos predicen una lesi\u00f3n NIC III. CONCLUSIONES: La detecci\u00f3n de anticuerpos s\u00e9ricos contra E4, E7 y Ras en combinaci\u00f3n con otras t\u00e9cnicas de diagn\u00f3stico, podr\u00edan ser de utilidad para detectar oportunamente a mujeres con lesiones tempranas asociadas al Virus del Papiloma Humano y en riesgo de desarrollar c\u00e1ncer.\n[Concentraci\u00f3n de anticuerpos contra prote\u00ednas de las gl\u00e1ndulas salivales de Aedes aegypti e historia de la exposici\u00f3n al virus del dengue en residentes de una zona end\u00e9mica colombiana](http://www.revistabiomedica.org/index.php/biomedica/article/view/2530) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nBerlin Londo\u00f1o-Renter\u00eda\n2015-12-01\nFull Text Available Introducci\u00f3n. Las prote\u00ednas salivales de los mosquitos son capaces de inducir la producci\u00f3n de anticuerpos, lo que a su vez refleja el grado de contacto hombre-vector. Adem\u00e1s, los anticuerpos IgG contra el virus del dengue son indicadores de una exposici\u00f3n previa a este virus. El riesgo de transmisi\u00f3n del virus del dengue est\u00e1 asociado no solo con factores relacionados con la biolog\u00eda del mosquito, o factores virales, sino tambi\u00e9n, con factores socioecon\u00f3micos, como la disponibilidad de agua en el hogar, que pueden desempe\u00f1ar un papel importante durante la temporada epid\u00e9mica. Objetivo. Determinar el efecto de la presencia de mosquitos Aedes aegypti en las casas y la exposici\u00f3n previa al virus del dengue, sobre los niveles de anticuerpos contra mosquitos en el contacto humano-vector en habitantes de un \u00e1rea end\u00e9mica de Colombia. Materiales y m\u00e9todos. Se hizo un estudio piloto de 58 casas y 55 participantes en Norte de Santander, Colombia. Se emple\u00f3 un cuestionario para recopilar la informaci\u00f3n sobre los factores socioecon\u00f3micos y se examinaron las casas para detectar la presencia de sitios de cr\u00eda de Ae. aegypti. Se recolect\u00f3 una muestra de sangre humana total en papel de filtro y se estableci\u00f3 el nivel de anticuerpos IgG contra el virus del dengue, adem\u00e1s del de los anticuerpos IgG e IgM anti-Ae. aegypti de extracto de gl\u00e1ndula salival mediante ELISA. Resultados. Los resultados revelaron un mayor nivel de anticuerpos IgG de extracto de gl\u00e1ndula salival en sujetos que viv\u00edan en casas con presencia de mosquitos Ae. aegypti en la fase acu\u00e1tica. Asimismo, se encontr\u00f3 una mayor concentraci\u00f3n de anticuerpos IgG de extracto de gl\u00e1ndula salival en personas previamente expuestas al virus del dengue. Los resultados evidenciaron una correlaci\u00f3n positiva significativa entre los niveles de IgM de extracto de gl\u00e1ndula salival y los de IgG anti-virus del dengue de extracto de gl\u00e1ndula salival, y una correlaci\u00f3n negativa con\n[Detecci\u00f3n de Anticuerpos IgG Espec\u00edficos para Sarampi\u00f3n mediante la T\u00e9cnica de Inmunofluorescencia Indirecta](http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1726-46342000000100007&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nM\u00f3nica Nieto Z\n2000-01-01\nFull Text Available La t\u00e9cnica de \u00ednmunofluorescencia indirecta para detectar anticuerpos IgG espec\u00edficos a sarampi\u00f3n (IFI-IgG fue evaluada con la prueba de neutralizaci\u00f3n por reducci\u00f3n de placas (PRN con 128 muestras de suero de personas con edades entre 0 y 15 a\u00f1os, 64 con antecedente de vacunaci\u00f3n y 64 sin \u00e9ste antecedente. El IFI-IgG alcanz\u00f3 una sensibilidad de 80,4% y una especificidad de 100,0%, mostrando ser una prueba sencilla, reproducible, y tener correlaci\u00f3n con PRN, aunque menos sensible que \u00e9sta \u00faltima, especialmente cuando la PRN estim\u00f3 t\u00edtulos bajos de anticuerpos. Se concluye que la t\u00e9cnica IFI-IgG puede ser usada como m\u00e9todo de rutina para la confirmaci\u00f3n de sarampi\u00f3n en muestras de fase aguda y convalesciente de la enfermedad (sueros pareados, as\u00ed como para estudios de prevalencia de anticuerpos en la comunidad, aunque no reemplazar\u00eda a la PRN.\n[Antisperm autoantibodies and infertility Anticuerpos antiespermatozoides e infertilidad](http://www.iatreia.udea.edu.co/index.php/iatreia/article/view/432) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJorge Eli\u00e9cer Ossa Londo\u00f1o\n1997-02-01\nFull Text Available Fourteen human infertile couples were studied along with seven fertile control couples in order to determine the presence of antisperm au. toantibodies and to correlate results with their clinical reproductive status, spermogram parameters and the quality of cervical mucus. Immunoglobulins of IgG and IgA isotypes were evaluated on spermatozoa by the direct immunobead technique and in serum and cervical mucus by the indirect method. The following differences were found: Nine of 14 male patients but only 1 of 7 male controls had IgG on spermatozoa (p= 0.042 and OR= 10.8. Seven out of 14 male patiens and 1 of 7 controls were positive for IgA on spermatozoa (p= 0.12. Infertile males had a higher frequency of abnormal spermogram parameters as compared to controls (p= 0.0029 and OR= 3.32. Interestingly, the presence of only IgG in serum appeared to be a \"protective factor\" against IgG on sperm; only one out of the 16 positive males contradicted this observation. Para determinar la presencia de anticuerpos antiespermatozoides y correlacionarla con la situaci\u00f3n reproductiva, el espermograma y la calidad del moco cervical, se estudiaron 7 parejas sanas, con hijos, y 14 inf\u00e9rtiles. Se determinaron por las t\u00e9cnicas directa e indirecta de inmunoesferas los anticuerpos de los isotipos IgG e IgA en espermatozoides, suero y moco cervical. En 9 de los 14 hombres inf\u00e9rtiles y en 1 de los 7 f\u00e9rtiles se encontraron anticuerpos IgG en la superficie de los espermatozoides (p= 0.042 y una Raz\u00f3n de disparidad [RD] = 10.8 y 8 de \u00e9stos tambi\u00e9n tuvieron IgA en los espermatozoides. El n\u00famero de pruebas alteradas en el espermograma de los hombres inf\u00e9rtiles fue significativamente mayor (p= 0.0029 y RD = 3.32. Tanto en los hombres inf\u00e9rtiles como en los f\u00e9rtiles la presencia de s\u00f3lo IgG en el suero parece ser un \"factor de protecci\u00f3n\" contra IgG en los espermatozoides; de los 16 hombres que presentaron anticuerpos, fuera en el suero o en los espermatozoides, s\n[Presencia de anticuerpos IgG del virus de la rub\u00e9ola, virus herpes simple y citomegalovirus en embarazadas residentes en Ciudad de La Habana](http://www.revistabiomedica.org/index.php/biomedica/article/view/1103) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nCarmen Acosta\n2001-06-01\nFull Text Available Se realiz\u00f3 un estudio seroepidemiol\u00f3gico con 207 gestantes, residentes en el municipio Marianao de Ciudad de la Habana, con la finalidad de conocer la presencia de anticuerpos IgG anti-rub\u00e9ola, anti-citomegalovirus y anti-herpes simple (1 y 2; el nivel de positividad se expres\u00f3 como la relaci\u00f3n de la fluorescencia de la muestra con respecto a la del control positivo, para un nivel de corte de 0,3 para rub\u00e9ola, 0,2 para citomegalovirus y 0,185 para herpes simple. Las seroconversiones se expresaron como el incremento de esta relaci\u00f3n con respecto a la determinaci\u00f3n realizada en el primer trimestre de embarazo. El 91,3% de las gestantes resultaron positivas para rub\u00e9ola, el 92,7% para citomegalovirus y el 98,1% para herpes simple. Se sugiere la valoraci\u00f3n de aspectos fundamentales relacionados con estas infecciones dentro del Programa Nacional de Atenci\u00f3n a las Embarazadas.\n[Prevalencia de anticuerpos antifosfol\u00edpidos en pacientes con conectivopat\u00edas](http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1025-55832011000300006&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\n\u00d3scar Emilio Ruiz-Franco\n2011-07-01\nFull Text Available Objetivos: Determinar la prevalencia de anticuerpos antifosfol\u00edpidos en pacientes con conectivopat\u00edas. Dise\u00f1o: Estudio descriptivo transversal. Instituci\u00f3n: Hospital Dos de Mayo e Instituto de Investigaciones Cl\u00ednicas de la UNMSM, Lima, Per\u00fa. Participantes: Pacientes con diagn\u00f3stico de colagenopat\u00eda y sujetos sanos. Intervenciones: En 100 pacientes con diagn\u00f3stico de colagenopat\u00eda y 50 sujetos sanos, todos provenientes de Lima Metropolitana y atendidos entre enero y noviembre de 2008, se determin\u00f3 fibrin\u00f3geno, tiempo de protrombina, tiempo parcial de tromboplastina activada, anticuerpos anticardiolipina y anticoagulante l\u00fapico. Principales medidas de resultados: Presencia de anticuerpos anticardiolipina y anticoagulante l\u00fapico. Resultados: Los pacientes con conectivopat\u00edas presentaron anticuerpos antifosfol\u00edpidos en 17%, anticoagulante l\u00fapico en 13% y anticardiolipina IgG 4%. Al dividir el grupo por conectivopat\u00edas, en los 70 pacientes con lupus eritematoso sist\u00e9mico 10 resultaron positivos para anticoagulante l\u00fapico y 3 tuvieron anticardiolipina IgG; de los 30 pacientes con artritis reumatoide, 3 tuvieron anticoagulante l\u00fapico positivo y 1 present\u00f3 anticardiolipina IgG. En el grupo de 50 personas sanas, solo se encontr\u00f3 un caso positivo para anticoagulante l\u00fapico. Conclusiones: La prevalencia de anticuerpos antifosfol\u00edpidos en pacientes con conectivopat\u00edas fue 17%. La conectivopat\u00eda estudiada m\u00e1s frecuente fue el lupus eritematoso sist\u00e9mico. El anticuerpo antifosfol\u00edpido m\u00e1s frecuente fue el anticoagulante l\u00fapico.\n[Asociaci\u00f3n entre la presencia de anticuerpos anti-Ras y anti-VPH16 E4/E7 y lesiones intraepiteliales del c\u00e9rvix Association between anti-Ras and anti-HPV16 E4/E7 antibodies with cervical intraepithelial lesions](http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342003000500002) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nSara V\u00e1zquez-Corzo\n2003-10-01\nFull Text Available OBJETIVO: Determinar si anticuerpos s\u00e9ricos contra E4, E7 y Ras pueden ser utilizados como marcadores de lesiones tempranas del c\u00e9rvix uterino asociadas al virus del papiloma humano. MATERIAL Y M\u00c9TODOS: Entre marzo de 1999 y abril de 2000 se realiz\u00f3 un estudio sero-epidemiol\u00f3gico de casos y controles en la cl\u00ednica de displasias del Hospital General Doctor Gea Gonz\u00e1lez, en la Ciudad de M\u00e9xico, en 116 muestras de suero para evaluar la presencia de anticuerpos anti-E4, E7 y Ras utilizando un ELISA de captura. Se estimaron razones de momios e intervalos de confianza de 95% RESULTADOS: Anticuerpos anti-E7 se asociaron a mujeres con lesiones NIC III, mientras que anticuerpos anti-E4 y anti-Ras fueron m\u00e1s frecuentes en lesiones NIC I-II. Al evaluar el perfil de anticuerpos que presentaron las mujeres, encontramos que a anticuerpos contra dos prote\u00ednas predicen la existencia de una lesi\u00f3n NIC I-II, y b la presencia de tres anticuerpos predicen una lesi\u00f3n NIC III. CONCLUSIONES: La detecci\u00f3n de anticuerpos s\u00e9ricos contra E4, E7 y Ras en combinaci\u00f3n con otras t\u00e9cnicas de diagn\u00f3stico, podr\u00edan ser de utilidad para detectar oportunamente a mujeres con lesiones tempranas asociadas al Virus del Papiloma Humano y en riesgo de desarrollar c\u00e1ncer.OBJECTIVE: To evaluate whether serum antibodies anti-E4, E7 and Ras could be used as markers for early cervical lesions associated with HPV (human papillomavirus. MATERIAL AND METHODS: A seroepidemiological case-control study was conducted between March 1999 and April 2000 at the dysplasia clinic of Hospital General Doctor Gea Gonzalez, in Mexico City, to evaluate the presence of antibodies anti-E4, E7, and Ras through a sandwich ELISA. Analysis was done using odds ratios and 95% confidence intervals. RESULTS: Anti-E7 antibodies were associated to women with CIN III lesions, while anti-E4 and Ras antibodies were strongly associated with CIN I-II lesions. The antibody profile of women with different\n[Obtenci\u00f3n de anticuerpos monoclonales de rat\u00f3n contra proteasa de ciste\u00edna 5 recombinante de Entamoeba histolytica](http://revistas.unicordoba.edu.co/revistamvz/mvz-172/V17N2A9.pdf) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJuanita Trejos S.\n2012-08-01\nFull Text Available Objetivo. Obtener anticuerpos monoclonales de rat\u00f3n contra la proteasas de ciste\u00edna 5 (EhCP5 de Entamoeba histolytica. Materiales y m\u00e9todos. Se inmunizaron ratones BALB/c por v\u00eda intraperitoneal con adyuvante de Freund completo e incompleto con la prote\u00edna recombinante EhCP5 obtenida a partir del cultivo de E.coli DH5\u03b1 trasfectada con el vector recombinante pJC45 que expresa dicha prote\u00edna. Se seleccion\u00f3 el animal con mejor respuesta de anticuerpos. Al cual se le extrajo su bazo como fuente de linfocitos B, los cuales se fusionaron utilizando PEG con c\u00e9lulas de mieloma de rat\u00f3n SP2-0/Ag14. Se procedi\u00f3 a selecci\u00f3n de los hibridomas y a la evaluaci\u00f3n de los sobrenadantes de las colonias que crecieron a los 7 d\u00edas mediante ELISA. Los hibridomas con valores m\u00e1s altos de anticuerpos espec\u00edficos contra la prote\u00edna EhCP5r se seleccionaron, y los clones obtenidos por diluciones limitantes fueron expandidos. Resultados. A partir de un clon secretor estable se purifico el anticuerpo monoclonal anti EhCP5r del isotipo IgG1 por cromatograf\u00eda de afinidad con prote\u00edna G. Los clones fueron expandidos in vivo e in vitro. Con el anticuerpo purificado se dise\u00f1aron tres sistemas de captura para evaluar la aplicabilidad del anticuerpo monoclonal anti EhCP5r como m\u00e9todo inmunodiagn\u00f3stico. Conclusiones. Se logro la producci\u00f3n de un anticuerpo monoclonal espec\u00edfico contra EhCP5r que permite diferenciar Entamoeba histolytica de Entamoeba dispar.\n[Prevalencia de anticuerpos neutralizantes contra los serotipos del virus dengue en universitarios de Tabasco, M\u00e9xico Prevalence of neutralizing antibodies to dengue virus serotypes in university students from Tabasco, Mexico](http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342008000500008) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nGilma Guadalupe S\u00e1nchez-Burgos\n2008-10-01\nFull Text Available OBJETIVO: Determinar la seroprevalencia de anticuerpos neutralizantes de los serotipos del virus dengue en estudiantes universitarios de Tabasco, M\u00e9xico, durante los meses de septiembre a noviembre del a\u00f1o 2005. MATERIAL Y M\u00c9TODOS: Se determin\u00f3 la presencia de IgG contra el virus en el suero de estudiantes que acudieron al centro cl\u00ednico de la universidad; en los sueros positivos se determinaron los anticuerpos neutralizantes mediante el ensayo de reducci\u00f3n de placa l\u00edtica. RESULTADOS: La prevalencia de IgG contra el dengue fue de 9.1%; de esta proporci\u00f3n, los anticuerpos neutralizantes fueron DENV-1 (20%, DENV-2 (100%, DENV-3 (4% y DENV-4 (68%. CONCLUSIONES: Este estudio muestra que el serotipo transmitido con mayor frecuencia en el estado de Tabasco es el DENV-2, aunque no ha sido el aislado con m\u00e1s frecuencia. La elevada prevalencia de anticuerpos neutralizantes contra el DENV-4, al parecer de reacci\u00f3n cruzada, podr\u00eda explicar la baja circulaci\u00f3n de este serotipo en Tabasco.OBJECTIVE: Determine the seroprevalence of neutralizing antibodies to dengue virus in students from the state university of Tabasco, Mexico. MATERIAL AND METHODS: A transversal study was conducted of serum collected from students between September and November, 2005. The sera were screened for anti-dengue IgG and those that had evidence of dengue antibodies were analyzed by a plaque reduction neutralization test. RESULTS: Prevalence of anti-dengue IgG was 9.1%. The frequency of neutralizing antibodies was 100% for DENV-2, 68% for DENV-4, 20% for DENV-1, and 4 % for DENV-3. CONCLUSIONS: We found that in this population, DENV-2 circulates more than DENV-3 despite the fact that DENV-3 is more frequently isolated. Unexpectedly, neutralizing antibodies against DENV-4 were frequently found even though this serotype is almost extinct; thus, it is probable that cross-immunity could suppress DEN-4 transmission, as has been suggested.\n[Asociaci\u00f3n entre enfermedad cardiovascular y anticuerpos contra Chlamydia pneumoniae](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0036-36342002000300008) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nGarc\u00eda-Elorriaga Guadalupe de los A\n2002-01-01\nFull Text Available Objetivo. Precisar si existe asociaci\u00f3n entre enfermedad cardiovascular (ECV y anticuerpos contra Chlamydia en poblaci\u00f3n mexicana. Material y m\u00e9todos. Estudio transversal, realizado en la Unidad de Investigaci\u00f3n en Inmunolog\u00eda e Infectolog\u00eda -Hospital de Infectolog\u00eda del Centro M\u00e9dico Nacional La Raza (CMNR- y en el Servicio de Cirug\u00eda Cardiovascular y Asistencia Circulatoria, del Hospital General del CMNR, Instituto Mexicano del Seguro Social (IMSS, de agosto de 1998 a abril de 2000. Se determinaron anticuerpos IgG e IgM contra C. psittaci, C. trachomatis y C. pneumoniae mediante microinmunofluorescencia, en suero de 70 pacientes con ECV hospitalizados en el CMNR, mayores de 30 a\u00f1os, de uno u otro sexo, y se compararon con 140 sanos, pareados por edad y sexo. Se utilizaron muestras aleatorias simples, con un tama\u00f1o poblacional de 110, una prevalencia de 50% y un nivel de confianza de 99%. Para establecer la diferencia entre las proporciones de los t\u00edtulos se utiliz\u00f3 ji cuadrada y se calcul\u00f3 la raz\u00f3n de momios. Resultados. El 94.3% (66/70 de los pacientes present\u00f3 IgG en contra de C. pneumoniae vs 37% (52/140 de los individuos sanos (p<0.001. Conclusiones. Existe una fuerte asociaci\u00f3n entre anticuerpos IgG hacia C. pneumoniae y ECV.\n[Serological blind spots for variants of human IgG3 and IgG4 by a commonly used anti-immunoglobulin reagent.](https://www.ncbi.nlm.nih.gov/pubmed/27632931)\nHowie, Heather L; Delaney, Meghan; Wang, Xiaohong; Er, Lay See; Vidarsson, Gestur; Stegmann, Tamara C; Kapp, Linda; Lebedev, Jenna N; Wu, Yanyun; AuBuchon, James P; Zimring, James C\n2016-12-01\nHuman immunoglobulin G (IgG) includes four different subtypes (IgG1, IgG2, IgG3, and IgG4), and it is also now appreciated that there are genetic variations within IgG subtypes (called isoallotypes). Twenty-nine different isoallotypes have been described, with 7, 4, 15, and 3 isoallotypes described for IgG1, IgG2, IgG3, and IgG4, respectively. The reactivity of anti-IgG with different isoallotypes has not been characterized. A novel monoclonal anti-K antibody (PugetSound Monoclonal Antibody 1 [PUMA1]) was isolated and sequenced, and a panel of PUMA1 variants was expressed, consisting of the 29 known IgG isoallotypes. The resulting panel of antibodies was preincubated with K-positive red blood cells (RBCs) and then subjected to testing with currently approved anti-IgG by flow cytometry, solid phase systems, gel cards, and tube testing. A US Food and Drug Administration (FDA)-approved monoclonal anti-IgG (gamma-clone) failed to recognize 2 of 15 IgG3 isoallotypes (IgG3-03 and IgG3-13) and 3 of 3 IgG4 isoallotypes (IgG4-01, IgG4-02, and IgG4-03). In contrast, an FDA-approved rabbit polyclonal anti-IgG recognized each of the known human IgG isoallotypes. These findings demonstrate \"blind spots\" in isoalloantibody detection by a monoclonal anti-IgG. If a patient has anti-RBC antibodies predominantly of an IgG3 subtype (the IgG3-03 and/or IgG3-13 variety), then it is possible that a clinically significant alloantibody would be missed. IgG-03 and IgG-13 have an estimated frequency of 1% to 3% in Caucasian populations and 20% to 30% in certain African populations. Nonreactivity with IgG4 is a known characteristic of this monoclonal anti-IgG, but IgG4 isoallotypes have not been previously reported. \u00a9 2016 AABB.\n[Anti-HBc testing for blood donations in areas with intermediate hepatitis B endemicity Detecci\u00f3n de anticuerpos anti-HBc en sangre donada en lugares donde la hepatitis B tiene endemicidad intermedia](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49891999000600018) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nCelina Maria Turchi Martelli\n1999-07-01\nFull Text Available En otros estudios se ha evaluado el menor riesgo de infecciones transmitidas por transfusi\u00f3n sangu\u00ednea que acarrea el tamizaje de anticuerpos contra los ant\u00edgenos nucleares de la hepatitis B (anti-HBc, sumado a la prueba detectora de ant\u00edgenos de superficie (HbsAg. No obstante, la mayor\u00eda de estos estudios se basaron en datos procedentes de zonas con baja endemicidad por hepatitis B o de bancos de sangre de pa\u00edses desarrollados, donde la mayor\u00eda de la sangre proviene de personas que han donado previamente. A fin de examinar los pros y los contras del tamizaje de anticuerpos anti-HBc en el Brasil, los autores describen los antecedentes y la interpretaci\u00f3n de las pruebas de tamizaje para prevenir la hepatitis postransfusi\u00f3n. Tambi\u00e9n presentan los datos sobre el tamizaje de la hepatitis B en todas las regiones del Brasil. No hay pruebas suficientes para suspender el tamizaje de los anticuerpos anti-HBc en el pa\u00eds. Debe darse alta prioridad a comparar el costo-efectividad de un marcador basado en la biolog\u00eda molecular con el de la actual prueba detectora de anticuerpos anti-HBc aplicada com\u00fanmente, a fin de mejorar las medidas de tamizaje que garantizan la inocuidad de la sangre.\n[Sensibilidad y especificidad de los ex\u00e1menes de anticuerpos antigliadina y antiendomisio](https://www.openaire.eu/search/publication?articleId=od_______615::52a083a2b18f5d5c56245c2510ac2485)\nLOZANO, WINSTON; M\u00e9NDEZ, VIRGINIA; FERREIRA, MAR\u00edA IN\u00e9S; GUTI\u00e9RREZ, CARMEN\n2002-01-01\nLa enfermedad cel\u00edaca se presenta con una gran heterogeneidad: formas sintom\u00e1ticas, silentes y latentes. La determinaci\u00f3n de anticuerpos antigliadina y antiendomisio es \u00fatil para definir a qu\u00e9 pacientes realizar biopsia de intestino delgado y para el seguimiento de los cel\u00edacos ya conocidos. Estas t\u00e9cnicas fueron incorporadas en 1994 en el Centro Hospitalario Pereira Rossell. Objetivo: conocer la sensibilidad y especificidad de los anticuerpos antigliadina (IgG) y antiendomisio (IgA) para el ...\n[Patr\u00f3n de immunoblotting y niveles de anticuerpos anti-Toxoplasma gondii en suero y humor acuoso de pacientes con lesiones de toxoplasmosis ocular](http://erevistas.saber.ula.ve/index.php/biomedicina/article/view/4282) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMorella Bouchard Pereira\n2014-07-01\nFull Text Available El objetivo de este estudio fue evaluar en muestras de suero y humor acuoso los niveles de anticuerpos anti-toxoplasma a trav\u00e9s del Coeficiente de Goldmann y Witmer (CGW y el patr\u00f3n de reconocimiento antig\u00e9nico a trav\u00e9s del immunoblotting (IB, en pacientes con serolog\u00eda positiva con y sin lesiones de toxoplasmosis ocular. Se recogieron simult\u00e1neamente muestras de suero y humor acuoso de 26 pacientes: un grupo de casos que pose\u00edan lesiones retinales de toxoplasmosis ocular en fase activa e inactiva (n=17 y un grupo control que requer\u00eda cirug\u00eda ocular por presencia de cataratas (n=9. Las determinaci\u00f3n de IgM e IgG espec\u00edficas se realiz\u00f3 por ELISA de inmunocaptura e indirecto, respectivamente. Se utiliz\u00f3 la inmunodifusi\u00f3n radial para la cuantificaci\u00f3n de la IgG total. El CGW result\u00f3 >2, indicativo de producci\u00f3n local de anticuerpos espec\u00edficos en 12/17 de los casos, mientras que en los controles no se observ\u00f3, esto evidenci\u00f3 una sensibilidad del 71% y una especificidad de 100%. En IB, la aparici\u00f3n de bandas diferentes en humor acuoso, indicativo de producci\u00f3n local de anticuerpos espec\u00edficos se observaron en 11/17 de los casos y 1/9 de los controles, reflejando una sensibilidad de 65% y una especificidad de 89%. Al considerar las dos pruebas la sensibilidad se increment\u00f3 a un 73%, pero la especificidad disminuy\u00f3 a 89%. En conclusi\u00f3n el IB es \u00fatil como prueba confirmatoria para diagn\u00f3stico de toxoplasmosis ocular, pero s\u00f3lo como un complemento del coeficiente de GW especialmente en pacientes con lesiones at\u00edpicas donde el diagn\u00f3stico cl\u00ednico es dif\u00edcil. Aqueous humor and serum immunoblotting profiles and anti\u2013toxoplasma gondii antibodies in patients with toxoplasmosis-induced retinal lesions Abstract The purpose of this study was to analize the anti-Toxoplasma gondii antibodies levels in serum and aqueous humor samples in patients with ocular toxoplasmosis by using Goldman and Witmer Coefficient (GWC and the\n[Fc-Glycosylation in Human IgG1 and IgG3 Is Similar for Both Total and Anti-Red-Blood Cell Anti-K Antibodies](http://journal.frontiersin.org/article/10.3389/fimmu.2018.00129/full) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMyrthe E. Sonneveld\n2018-01-01\nFull Text Available After albumin, immunoglobulin G (IgG are the most abundant proteins in human serum, with IgG1 and IgG3 being the most abundant subclasses directed against protein antigens. The quality of the IgG-Fc-glycosylation has important functional consequences, which have been found to be skewed toward low fucosylation in some antigen-specific immune responses. This increases the affinity to IgG1-Fc-receptor (Fc\u03b3RIIIa/b and thereby directly affects downstream effector functions and disease severity. To date, antigen-specific IgG-glycosylation have not been analyzed for IgG3. Here, we analyzed 30 pregnant women with anti-K alloantibodies from a prospective screening cohort and compared the type of Fc-tail glycosylation of total serum- and antigen-specific IgG1 and IgG3 using mass spectrometry. Total serum IgG1 and IgG3 Fc-glycoprofiles were highly similar. Fc glycosylation of antigen-specific IgG varied greatly between individuals, but correlated significantly with each other for IgG1 and IgG3, except for bisection. However, although the magnitude of changes in fucosylation and galactosylation were similar for both subclasses, this was not the case for sialylation levels, which were significantly higher for both total and anti-K IgG3. We found that the combination of relative IgG1 and IgG3 Fc-glycosylation levels did not improve the prediction of anti-K mediated disease over IgG1 alone. In conclusion, Fc-glycosylation profiles of serum- and antigen-specific IgG1 and IgG3 are highly similar.\n[Determinaci\u00f3n de anticuerpos anti Neospora caninum en vacas de la provincia de Sugamuxi, Colombia](http://www.redalyc.org/articulo.oa?id=265628982002) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMart\u00edn Orlando Pulido Medell\u00edn\n2013-01-01\nFull Text Available El objetivo fue determinar la presencia de anticuerpos anti Neospora caninum en vacas mediante la t\u00e9cnica de ELISA indirecta en el valle de Sugamuxi, Colombia, identificando las variables que influyen en la susceptibilidad de los bovinos al protozoo. Se tomaron muestras de sangre a 400 hembras bovinas y fueron evaluadas por medio de ELISA indirecta. Se determin\u00f3 una seroprevalencia de Neospora caninum del 57.5 %; no se hall\u00f3 relaci\u00f3n entre las hembras en gestaci\u00f3n y la presencia del par\u00e1sito; para la presencia de celo se encontr\u00f3 que el 27.7 % de vacas infectadas por el par\u00e1sito presentaron repetici\u00f3n de \u00e9ste. La presencia del par\u00e1sito fue del 100 % en hembras con historial de cinco partos. Los resultados de este estudio muestran la presencia de anticuerpos anti Neospora caninum en los animales pertenecientes a fincas lecheras de la provincia de Sugamuxi, y la alta prevalencia muestra el riesgo potencial para este tipo de explotaciones.\n[Neuromielitis \u00f3ptica con alta expresi\u00f3n de acuaporina-4 y anticuerpos anti-acuaporina-4 positivos en suero](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802012000200007&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAlejandra B\u00e1ez\n2012-04-01\nFull Text Available La presencia de anticuerpos IgG en suero, con blanco en los canales de acuaporina-4, es espec\u00edfica de la neuromielitis \u00f3ptica (NMO. El 60% de los pacientes con NMO presentan lesiones cerebrales en la resonancia magn\u00e9tica (RM; en un 8% (mayor\u00eda ni\u00f1os estas lesiones se consideraron \"at\u00edpicas\". Presentamos dos pacientes con NMO y lesiones en el SNC de alta expresi\u00f3n de acuaporina-4. Caso 1: var\u00f3n de 50 a\u00f1os, que comenz\u00f3 con p\u00e9rdida de visi\u00f3n en ojo derecho (OD. Recibi\u00f3 tratamiento emp\u00edrico con metilprednisolona 1 g/d x 3 d\u00edas. Al mes present\u00f3 dolor generalizado y hemiparesia derecha; nuevamente recibi\u00f3 metilprednisolona 1 g/d x 5 d\u00edas e IgG IV 400 mg/kg/d \u00d7 5 d\u00edas. Recuper\u00f3 la deambulaci\u00f3n persistiendo el dolor y fen\u00f3menos parox\u00edsticos en los 4 miembros. Potenciales evocados visuales: P100, ojo izquierdo (OI 123 mseg. OD sin respuesta. La RM de cerebro (FLAIR mostr\u00f3 hiperintensidad en nervio \u00f3ptico derecho, hipot\u00e1lamo y comisura blanca anterior. RM cervical: lesi\u00f3n medular extensa (5 cuerpos vertebrales. Caso 2: mujer de 53 a\u00f1os, con disminuci\u00f3n de la agudeza visual en ambos ojos y parestesias en miembros inferiores que remitieron espont\u00e1neamente. Evolucion\u00f3 al mes con cuadriparesia e incontinencia esfinteriana. Recibi\u00f3 metilprednisolona 1 g/d x 5 d\u00edas, sin mejor\u00eda. Potenciales evocados visuales: P100 OI 124 mseg. OD 128 mseg. RM cerebro: (FLAIR hiperintensidad hipotal\u00e1mica y periacueductal. RM cervical: lesi\u00f3n medular extensa (7 cuerpos vertebrales. Anticuerpos anti-acuaporina-4 positivos en ambos pacientes (inmunofluorescencia indirecta. Las lesiones consideradas \"at\u00edpicas\", como aqu\u00ed, en sitios con alta densidad de prote\u00ednas canales de agua AQP4 deber\u00e1n considerarse para el diagn\u00f3stico diferencial.\n[Kinetics of IgG antibody to cytomegalovirus (CMV) after birth and seroprevalence of anti-CMV IgG in Chinese children.](https://www.ncbi.nlm.nih.gov/pubmed/23228149)\nChen, Jie; Hu, Lingqing; Wu, Meiling; Zhong, Tianying; Zhou, Yi-Hua; Hu, Yali\n2012-12-10\nPrevalence of cytomegalovirus (CMV) infection is 90-100% in developing countries; however, the kinetics of anti-CMV IgG in infants remains elusive. Sera from 112 mother-newborn pairs and longitudinal samples from 41 infants up to 2-year old were tested for anti-CMV IgG and IgM. Additionally, samples from 837 healthy children were included. Of 112 mothers, 108 (96.4%) were anti-CMV IgG positive; their 108 newborns were also seropositive. In a 2-year follow-up among 40 infants of positive mothers, anti-CMV IgG level in 8 individuals decreased with time and became undetectable by age of 3.5-8 months, and that in 32 others decreased at 1- and 3.5-month old, and then increased. Based on the positive IgM, rising IgG levels, and low anti-CMV IgG avidity index, 76.7% of the primary infections were demonstrated to occur during 1-3.5 months of age. The overall seroprevalence of anti-CMV in 837 children was 82.4%, which was generally constant from 2 to 8 years old (\u03c72 = 3.150, p = 0.790). The maternally acquired anti-CMV IgG in infants disappears before 8-month old. Primary CMV infection in Chinese children mostly occurs during 1-3.5 months of age. Whether the relatively lower seroprevalence of anti-CMV in Chinese children found in this survey may reflect the positive rate in child-bearing age women in the future remains to be further studied.\n[Kinetics of IgG antibody to cytomegalovirus (CMV after birth and seroprevalence of anti-CMV IgG in Chinese children](http://www.virologyj.com/content/9/1/304) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nChen Jie\n2012-12-01\nFull Text Available Abstract Background Prevalence of cytomegalovirus (CMV infection is 90\u2013100% in developing countries; however, the kinetics of anti-CMV IgG in infants remains elusive. Methods Sera from 112 mother-newborn pairs and longitudinal samples from 41 infants up to 2-year old were tested for anti-CMV IgG and IgM. Additionally, samples from 837 healthy children were included. Results Of 112 mothers, 108 (96.4% were anti-CMV IgG positive; their 108 newborns were also seropositive. In a 2-year follow-up among 40 infants of positive mothers, anti-CMV IgG level in 8 individuals decreased with time and became undetectable by age of 3.5\u20138 months, and that in 32 others decreased at 1- and 3.5-month old, and then increased. Based on the positive IgM, rising IgG levels, and low anti-CMV IgG avidity index, 76.7% of the primary infections were demonstrated to occur during 1\u20133.5 months of age. The overall seroprevalence of anti-CMV in 837 children was 82.4%, which was generally constant from 2 to 8 years old (\u03c72 = 3.150, p = 0.790. Conclusions The maternally acquired anti-CMV IgG in infants disappears before 8-month old. Primary CMV infection in Chinese children mostly occurs during 1\u20133.5 months of age. Whether the relatively lower seroprevalence of anti-CMV in Chinese children found in this survey may reflect the positive rate in child-bearing age women in the future remains to be further studied.\n[Evaluaci\u00f3n de la respuesta de anticuerpos hacia ant\u00edgenos de Pseudomonas aeruginosa.](http://scielo.sld.cu/pdf/vac/v16n1/vac02107.pdf) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAniel Moya\n2007-04-01\nFull Text Available Pseudomonas aeruginosa es un pat\u00f3geno extracelular que genera una respuesta de anticuerpos espec\u00edficos con utilidad para el diagn\u00f3stico y vacunas. En el presente estudio nos propusimos evaluar en suero humano los niveles de anticuerpos contra ant\u00edgenos relevantes de P. aeruginosa. Realizamos la determinaci\u00f3n de anticuerpos IgG contra tres exoenzimas, consideradas como factores de virulencia de mayor importancia en infecciones. Este resultado dio paso a la evaluaci\u00f3n del reconocimiento de IgG e IgA hacia ant\u00edgenos de la envoltura celular bacteriana por ELISA de c\u00e9lulas enteras. Todos los sueros evaluados mostraron t\u00edtulos de IgG e IgA superiores a los individuos sanos, con excepci\u00f3n de dos muestras de pacientes que no mostraron alto t\u00edtulo. Este ensayo permiti\u00f3 analizar el nivel de reconocimiento hacia los ant\u00edgenos m\u00e1s expuestos de la bacteria que incluyen principalmente LPS y prote\u00ednas de membrana externa. Se encontr\u00f3 diferencias entre los valores de densidad \u00f3ptica a 450 nm de individuos sanos y enfermos. El m\u00e9todo usado permiti\u00f3 seleccionar dos sueros de pacientes de diferentes tipos de infecciones que fueron comparados por Western blot. Se observ\u00f3 que aunque los sueros ten\u00edan reacci\u00f3n hacia distintos serotipos de P. aeruginosa, la intensidad del reconocimiento variaba seg\u00fan el tipo de infecci\u00f3n.\n[Auto-anticorpos anti-\u03b22-glicoprote\u00edna I e s\u00edndrome metab\u00f3lica Anticuerpos anti-\u03b22-glicoprote\u00edna I y s\u00edndrome metab\u00f3lico Anti-beta2-glycoprotein I autoantibodies and metabolic syndrome](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2011000400003) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nRodrigo B. Kr\u00e1s Borges\n2011-04-01\nFull Text Available FUNDAMENTO: A s\u00edndrome metab\u00f3lica (SM \u00e9 uma entidade pr\u00f3-aterog\u00eanica. Autoanticorpos tais como \u03b22-glicoprote\u00edna I (\u03b22-gpI podem influenciar o aparecimento de ateromas. Estudos anteriores confirmaram uma associa\u00e7\u00e3o entre anticorpos IgA anti-\u03b22-gpI e isquemia cerebral, infarto do mioc\u00e1rdio, doen\u00e7a arterial perif\u00e9rica e doen\u00e7a da car\u00f3tida. OBJETIVO: O objetivo desse estudo de caso-controle foi avaliar uma poss\u00edvel associa\u00e7\u00e3o entre anticorpos anti-\u03b22-gpI e anticardiolipina (aCL com SM n\u00e3o-complicada. M\u00c9TODOS: Pacientes com SM sem hist\u00f3rico de eventos vasculares e indiv\u00edduos-controle, consistindo em pacientes da Enfermaria de Ortopedia admitidos devido a doen\u00e7as musculoesquel\u00e9ticas foram inclu\u00eddos no estudo. Idade, sexo, etnia, hist\u00f3rico de hipertens\u00e3o, tabagismo, hipercolesterolemia e diabetes mellitus foram avaliados como fatores de risco em ambos os grupos. Anticorpos IgG, IgM, e IgA anti-\u03b22-gpI e aCL foram detectados atrav\u00e9s de imunoensaios enzim\u00e1ticos. RESULTADOS: Um total de 68 pacientes com SM e 82 controles foram estudados. Os pacientes com SM tinham m\u00e9dia de idade superior \u00e0 dos controles (P = 0,001, enquanto homens (P = 0,003; OR 0,31; IC95%: 0,15-0,16 e etnia caucasiana (P = 0,004; OR 0,25; IC95%:0,10-0,60 eram predominantes nos controles. Hist\u00f3rico de hipertens\u00e3o, hipercolesterolemia e diabetes mellitus foi mais prevalente nos pacientes com SM do que nos controles (P FUNDAMENTO: El s\u00edndrome metab\u00f3lico (SM es una entidad pro-aterog\u00e9nica. Autoanticuerpos tales como \u03b22-glicoprote\u00edna I (\u03b22-GPI pueden influir en la aparici\u00f3n de ateromas. Estudios previos han confirmado una asociaci\u00f3n entre anticuerpos IgA anti-\u03b22-GPI y la isquemia cerebral, infarto de miocardio, enfermedad arterial perif\u00e9rica y enfermedad carotidea. OBJETIVO: El objetivo de este estudio de caso-control fue evaluar una posible asociaci\u00f3n entre los anticuerpos anti-\u03b22-GPI y anticardiolipina (aCL con SM complicada. M\u00c9TODOS: Se\n[Kinetics of IgG antibody to cytomegalovirus (CMV) after birth and seroprevalence of anti-CMV IgG in Chinese children](https://www.openaire.eu/search/publication?articleId=dedup_wf_001::3612f80d59bde955697dc80f0bf5300f)\nChen, Jie; Hu, Lingqing; Wu, Meiling; Zhong, Tianying; Zhou, Yi-Hua; Hu, Yali\n2012-01-01\nAbstract Background Prevalence of cytomegalovirus (CMV) infection is 90\u2013100% in developing countries; however, the kinetics of anti-CMV IgG in infants remains elusive. Methods Sera from 112 mother-newborn pairs and longitudinal samples from 41 infants up to 2-year old were tested for anti-CMV IgG and IgM. Additionally, samples from 837 healthy children were included. Results Of 112 mothers, 108 (96.4%) were anti-CMV IgG positive; their 108 newborns were also seropositive. In a 2-year follow-u...\n[Asociaci\u00f3n del anticuerpo anti-C1q con las manifestaciones cl\u00ednicas, hematol\u00f3gicas e inmunol\u00f3gicas en el Lupus Eritematoso Sist\u00e9mico : Estudio observacional retrospectivo de 135 casos.](https://www.openaire.eu/search/publication?articleId=od______1404::3275170fdd830f23aae3cf86adb62970)\nC\u00f3rica, Mar\u00eda Emilia\n2012-01-01\n: Las concentraciones de anticuerpo anti-C1q est\u00e1n elevadas en los pacientes afectados de LES. Seg\u00fan algunos estudios la presencia de este anticuerpo est\u00e1 asociada a la nefropat\u00eda l\u00fapica, sin embargo en otros estudios esta relaci\u00f3n no se comprob\u00f3. En nuestro trabajo relacionamos la positividad del anticuerpo anti-C1q con las manifestaciones cl\u00ednicas, hematol\u00f3gicas e inmunol\u00f3gicas de la enfermedad. A diferencia de estudios previos s\u00f3lo pudimos establecer una relaci\u00f3n estad\u00edsticamente significa...\n[Frecuencia de anticuerpos anti Trypanozoma cruzi en pacientes portadores de marcapasos de la Clinica San Pedro Claver de Bogot\u00e1](http://www.revistabiomedica.org/index.php/biomedica/article/view/122) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nGuillermo Mora\n2007-12-01\nConclusiones. La prevalencia de anticuerpos anti-T. cruzi en pacientes portadores de marcapaso es alta. La implantaci\u00f3n de marcapasos se present\u00f3 m\u00e1s tempranamente en el grupo seropositivo. No hay adecuada sospecha cl\u00ednica ni informaci\u00f3n al paciente sobre el diagn\u00f3stico de la enfermedad de Chagas.\n[Prevalencia de anticuerpos antirrub\u00e9ola y antiparvovirus B19 en embarazadas de la ciudad de C\u00f3rdoba y en mujeres en edad f\u00e9rtil de la ciudad de Villa Mercedes, San Luis Prevalence of anti-rubella and anti-parvovirus B19 antibodies in pregnant women in the city of C\u00f3rdoba, and in women of fertile age in the city of Villa Mercedes, province of San Luis](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0325-75412007000100012) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nM. S. Pedranti\n2007-03-01\nFull Text Available Se determin\u00f3 la prevalencia de anticuerpos contra virus rub\u00e9ola en 100 muestras de suero de mujeres embarazadas que concurr\u00edan a chequeos de rutina en una instituci\u00f3n privada de la ciudad de C\u00f3rdoba y en 100 muestras de suero de mujeres en edad f\u00e9rtil (42 de ellas embarazadas que concurr\u00edan a dispensarios de la ciudad de Villa Mercedes, provincia de San Luis. En las muestras tomadas en la ciudad de C\u00f3rdoba tambi\u00e9n se determinaron anticuerpos IgG contra parvovirus B19. Por inhibici\u00f3n de la hemoaglutinaci\u00f3n, los resultados de los sueros de C\u00f3rdoba mostraron una prevalencia de anticuerpos antirrub\u00e9ola del 98%; en las muestras de Villa Mercedes se observ\u00f3 una prevalencia del 96%. La prevalencia de anticuerpos antiparvovirus B19 en los sueros de C\u00f3rdoba fue del 66%. Estos datos se asemejan a los de la bibliograf\u00eda mundial y fundamentan el inter\u00e9s en continuar estudios de este tipo para monitorear el plan de inmunizaci\u00f3n para rub\u00e9ola, que en Argentina se lleva a cabo desde 1997, como as\u00ed tambi\u00e9n la relevancia de la determinaci\u00f3n de IgM antiparvovirus B19 en aquellas embarazadas sintom\u00e1ticas con resultado negativo para rub\u00e9ola, a fin de elaborar un diagn\u00f3stico diferencial.We determined the prevalence of anti-rubella antibodies in 100 serum samples from pregnant women who attended routine examination at a private institution in the city of C\u00f3rdoba, and in 100 serum samples from women of gestational age, 42 of whom were pregnant, attending health centres in the city of Villa Mercedes, province of San Luis. IgG antibodies against parvovirus B19 were also determined in the serum samples from C\u00f3rdoba. Using the hemmagglutination inhibition test, we found a 98 % prevalence of anti-rubella antibodies among pregnant women in C\u00f3rdoba and of 96 % among the women in Villa Mercedes, whereas the prevalence of anti-parvovirus B19 was 66% in the serum samples from C\u00f3rdoba. These results coincide with those reported for other cities in the\n[Low anti-streptokinase IgG concentrations following streptokinase-streptodornase treatment of leg ulcer patients](http://www.forskningsdatabasen.dk/en/catalog/2270631557) [DEFF Research Database (Denmark)](http://forskningsbasen.deff.dk/?lang=eng)\nMunkvad, S; Breuning, L; Tvedskov, Jesper\n1994-01-01\nWe have evaluated whether neutralising anti-streptokinase IgG antibodies are produced following streptokinase-streptodornase therapy of leg ulcer patients. Serum anti-streptokinase IgG concentrations in 10 leg ulcer patients were determined before, and 1 week, 2 weeks, and 3 weeks following the t...... the treatment. We observed only a negligible increase in neutralizing anti-streptokinase IgG concentrations during the observation period, which was probably of no therapeutical significance....\n[Descripci\u00f3n de un inmunoensayo enzim\u00e1tico que reconoce anticuerpos anti-factor VIII/von Willebrand obtenidos a partir de hibridomas m\u00faridos Description of an enzime immunoassay that recognizes anti-factor VIII/von Willebrand antibodies obtained from murine hybridomas](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-02891999000100007) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nRen\u00e9e Gonz\u00e1lez Sampedro\n1999-04-01\nFull Text Available Se describe un inmunoensayo enzim\u00e1tico (ELISA que detecta anticuerpos anti-Factor-VIII/von Willebrand (FVIII/vW, con una relaci\u00f3n de enlace > 5, que permite reconocer dichos anticuerpos tempranamente en los cultivos de hibridomas m\u00faridos. Para la adsorci\u00f3n de las placas del inmunoensayo se utilizaron preparados semipurificados de FVIII/vW obtenidos en Cuba. Se inmunizaron ratones Balb/c con la finalidad de generar los anticuerpos monoclonales detectados por este ELISA. Se obtuvo un clon con crecimiento estable y varios subclones positivos por el ELISA con actividad biol\u00f3gica espec\u00edfica de anticuerpos inhibidores de FVIIIAn enzime immunoassay (ELISA that detects anti-Factor VIII/von Willebrand (FVIII/vw antibodies with a binding relationship > 5 that allows the early recognition of such antibodies in the cultures of murine hybridomas is described. Semipurified preparations of FVIII/vw obtained in Cuba were used for the adsorption of the immunoassay plates. Balb/c mice were immunized in order to generate the monoclonal antibodies detected by this ELISA. A clone with stable growth and several positive subclones were obtained by ELISA with specific biological activity of FVIII-inhibiting antibodies\n[Marcadores inflamat\u00f3rios e anticorpos anti-chlamydia em pacientes com s\u00edndrome metab\u00f3lica Marcadores inflamatorios y anticuerpos anti-chlamydia en pacientes con s\u00edndrome metab\u00f3lico Inflammatory markers and antichlamydial antibodies in patients with metabolic syndrome](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2011000200008) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nRosecler Riethmuller Franco\n2011-02-01\n\u00e3o mostraram diferen\u00e7a significativa em pacientes com SM, com e sem eventos.FUNDAMENTO: El s\u00edndrome metab\u00f3lico est\u00e1 asociado al aumento de riesgo de eventos cardiovasculares. Marcadores inflamatorios y anticuerpos anti-Chlamydia han sido relacionados al desarrollo y a la progresi\u00f3n de la aterosclerosis y de los eventos cardiovasculares. OBJETIVO: Evaluar los marcadores inflamatorios interleucina-6 (IL-6 y factor de necrosis tumoral-alfa (TNF-\u03b1 y los anticuerpos anti-Chlamydia pneumoniae en pacientes con s\u00edndrome metab\u00f3lico (SM, con y sin eventos cardiovasculares. M\u00c9TODOS: Estudio transversal constituido por 147 individuos. De estos, 100 (68% con SM y sin eventos cardiovasculares; y 47 (32% con SM y con eventos cardiovasculares. De los individuos que hab\u00edan sufrido eventos cardiovasculares, 13 (6,11% presentan infarto agudo de miocardio (IAM, y diez (4,7%, accidente cerebro vascular (ACV. El diagn\u00f3stico del SM fue determinado por los criterios del NCEP-ATPIII. RESULTADOS: La media de edad de los sujetos con eventos cardiovasculares fue de 61,26 \u00b1 8,5 y de 59,32 \u00b1 9,9 en los individuos sin esos eventos (p=0,279, habiendo predominio del sexo femenino. El grupo con SM y sin evento present\u00f3 mayor peso, altura, IMC y circunferencia abdominal. Para los individuos con eventos cardiovasculares (p=0,001, los marcadores inflamatorios IL-6 y TNF-\u03b1 y la enfermedad vascular perif\u00e9rica fueron significativamente mayores. Se obtuvieron niveles elevados de anticuerpos IgG para Chlamydia pneumoniae en el grupo SM, sin eventos y de IgA en el grupo con eventos cuando fueron comparados los dos grupos. Con relaci\u00f3n al IAM y al ACV, los anticuerpos anti-Chlamydia pneumoniae no demostraron significaci\u00f3n estad\u00edstica, comparados al grupo sin eventos cardiovasculares. Asociaci\u00f3n fue observada con el uso de estatinas, hipoglicemiantes orales, inyectables y antiinflamatorios no esteroides en el grupo con esos eventos. CONCLUSI\u00d3N: Marcadores inflamatorios se encuentran\n[Anti-metallothionein IgG and levels of metallothionein in autistic children with GI disease](http://www.dovepress.com/anti-metallothionein-igg-and-levels-of-metallothionein-in-autistic-chi-a2771) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nA J Russo\n2009-01-01\nFull Text Available A J RussoMount Saint Mary\u2019s University, Emmitsburg, MD, USAAim: To assess both serum concentration of metallotionein (MT and anti-metallothionein (anti-MT immunoglobulin G (IgG in autistic children with gastrointestinal (GI symptoms and controls, and to test the hypothesis that there is an association between the presence of MT, anti-MT IgG, and inflammatory GI disease seen in many children with autistic spectrum disorder (ASD.Subjects and methods: ELISAs were used to measure serum MT and anti-MT IgG in 41 autistic children with chronic digestive disease (many with ileo-colonic lymphoid nodular hyperplasia [LNH] and inflammation of the colorectum, small bowel, and/or stomach, and 33 controls (17 age-matched autistic children with no GI disease and 16 age-matched children without autism or GI disease.Results: Ten of 41 autistic children with chronic digestive disease had high serum concentration of MT compared to only one of the 33 controls (p < 0.01. Thirteen of the 41 autistic children with chronic digestive disease had anti-MT IgG compared to only four of 33 controls (p < 0.01. Nine of 10 (90% of autistic children with GI disease with high MT levels had a regressive onset (compared to the expected 25 of 41, or 61%, in this group (p < 0.05, whereas only nine of 13 of the autistic children with GI disease and anti-MT IgG had a regressive onset (70% which was not significantly higher than the expected. We didn\u2019t find any correlation between severity of GI disease and MT concentration or anti-MT IgG.Discussion: These results suggest a relationship between MT, anti-MT IgG and GI disease seen in many ASD individuals.Keywords: autism, metallothionein, anti-metallothionein, GI disease\n[The Pathogenicity of Anti-\u03b22GP1-IgG Autoantibodies Depends on Fc Glycosylation](http://dx.doi.org/10.1155/2015/638129) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nChristoph Fickentscher\n2015-01-01\nFull Text Available To analyze the glycosylation of anti-\u03b22GP1, we investigated purified IgG from healthy children, patients with APS, and asymptomatic adult carriers of antiphospholipid antibodies. We observed that in the sera of healthy children and of patients with APS, IgG3 and IgG2 were predominant, respectively. The potentially protective anti-\u03b22GP1-IgM was lower in the sera of healthy children. Although anti-\u03b22GP1-associated C1q did not differ between children and patients with antiphospholipid syndrome, the associated C3c was significantly higher in the sera of healthy children. This indicates a more efficient clearance of anti-\u03b22GP1 immune complexes in the healthy children. This clearance is not accompanied by inflammation or coagulatory events. It is likely that the most important pathogenic factor of the anti-\u03b22GP1-IgG is related to the different glycosylation observed in healthy and diseased individuals. We detected a significantly higher sialylation of anti-\u03b22GP1-IgG isolated from the sera of healthy children and asymptomatic adults when compared with that of patients with clinically apparent antiphospholipid syndrome. Low sialylated IgG reportedly ameliorates inflammation and inflammation promotes hyposialylation. Thus, both reactions create a vicious circle that precipitates the pathology of the antiphospholipid syndrome including thrombus-formation. We conclude that the increased sialylation of anti-\u03b22GP1-IgG of sera of healthy individuals limits their pathogenicity.\n[Dose-dependent platelet stimulation and inhibition induced by anti-PIA1 IgG](https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=22008682) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nRyu, T.; Davis, J.M.; Schwartz, K.A.\n1990-01-01\nThe PIA1 antibody produces several clinically distinct and severe thrombocytopenias. Investigations have demonstrated divergent effects on platelet function; prior reports demonstrated inhibition, while a conflicting publication showed platelet activation. We have resolved this conflict using anti-PIA1 IgG produced by a patient with posttransfusion purpura. Relatively low concentrations stimulated platelet aggregation and release of adenosine triphosphate (ATP) whereas high concentrations inhibited platelet function, producing a thrombasthenia-like state. The number of molecules of platelet-associated IgG necessary to initiate aggregation and ATP release (2,086 +/- 556) or produce maximum aggregation (23,420 +/- 3,706) or complete inhibition (63,582 +/- 2654) were measured with a quantitative radiometric assay for bound anti-PIA1. Preincubation of platelets with high concentrations of PIA1 antibody inhibited platelet aggregation with 10 mumol/L adenosine diphosphate and blocked 125I-labeled fibrinogen platelet binding. Platelet activation with nonfibrinogen dependent agonist, 1 U/ml thrombin, was not inhibited by this high concentration of PIA1 IgG. In conclusion, anti-PIAI IgG produces (1) stimulation of platelet aggregation and ATP release that is initiated with 2000 molecules IgG per platelet and is associated with an increase of 125I-fibrinogen binding; (2) conversely, inhibition of platelet aggregation is observed with maximum antibody binding, 63,000 molecules IgG per platelet, and is mediated via a blockade of fibrinogen binding\n[Anticuerpos policlonales contra la prote\u00edna recombinante NS3 del virus del dengue](http://www.revistabiomedica.org/index.php/biomedica/article/view/3249) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nLiliana Morales\n2017-01-01\nResultados. Los anticuerpos producidos fueron \u00fatiles en ensayos de Western blot e inmunofluorescencia y se report\u00f3 por primera vez un anticuerpo policlonal anti-NS3 que permiti\u00f3 la inmunoprecipitaci\u00f3n de la prote\u00edna viral y la detecta con Western blot sin necesidad de inducir sobreexpresi\u00f3n de NS3 o de usar extractos de c\u00e9lulas marcados metab\u00f3licamente con radiois\u00f3topos. Conclusi\u00f3n. Las prote\u00ednas recombinantes expresadas y los anticuerpos producidos constituyen herramientas valiosas para estudiar procesos infecciosos del DENV que involucren a la prote\u00edna NS3 y evaluar pruebas dirigidas a interferir las funciones de esta prote\u00edna.\n[Maternal IgG Anti-A and Anti-B Titer Levels Screening in Predicting ABO Hemolytic Disease of the Newborn: A Meta-Analysis.](https://www.ncbi.nlm.nih.gov/pubmed/26359685)\nLi, Ping; Pang, Li-Hong; Liang, Hai-Feng; Chen, Hong-Yan; Fan, Xiao-Jing\n2015-01-01\nMaternal IgG anti-A/B titers have been considered as a susceptible factor to the risk of ABO hemolytic disease in newborn (ABO-HDN). However, the results remain controversial. This meta-analysis aimed to estimate the association between maternal IgG anti-A/B titers and the risk of ABO-HDN. Trials on the relationship between maternal IgG anti-A/B titers and the risk of ABO-HDN were collected by searching Embase, PubMed, and Cochrane Central Register of Controlled Trials (CENTRAL) electronic databases. The inclusion criteria were maternal IgG anti-A/B titers screening and the evaluation of clinical outcomes in relation to ABO-HDN. Stata 12.0 was used to analyze the data. A total of 23 trials were eligible for inclusion, of which four trials with 5,246 participants were suitable for this meta-analysis. Meta-analysis results suggested that maternal IgG anti-A/B titers were significantly associated with the risk of ABO-HDN [OR = 2.86, 95% CI = 2.50-3.28; OR = 4.67, 95% CI = 3.92-5.55; OR = 1.61, 95% CI = 1.36-1.91 in titers (128 to 256) vs. titers (64 or lower), titers (512 or higher) vs. titers (64 or lower), and titers (512 or higher) vs. titers (128-256), respectively]. Our meta-analysis suggests that maternal IgG anti-A/B titers are significantly associated with the risk of ABO-HDN. They contribute to the prediction of risk of ABO-HDN, in addition to the need for invasive treatment for antibody titers \u2265512.\n[Anticuerpo anticitrulina y manifestaciones extra articulares en artritis reumatoidea](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802013000100004&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMar\u00eda Jezabel Haye Salinas\n2013-02-01\nFull Text Available Los pacientes con artritis reumatidea (AR pueden desarrollar manifestaciones extra articulares (MExA, relacionadas a su morbi-mortalidad. Los anticuerpos anti-p\u00e9ptidos citrulinados c\u00edclicos (ACCP son espec\u00edficos para la AR y estan relacionados con el da\u00f1o articular; y podr\u00edan tener rol patog\u00e9nico en las MExA. Nuestro objetivo fue determinar la relaci\u00f3n entre los anticuerpos ACCP y MExA en pacientes con AR. Se incluyeron 74 pacientes con diagn\u00f3stico de AR (ACR 1987 mayores de 18 a\u00f1os, de m\u00e1s de 6 meses de evoluci\u00f3n, con MExA, y un control apareado por sexo y edad sin MExA por cada paciente. Las variables demogr\u00e1ficas, cl\u00ednicas y de laboratorio se compararon con test t, chi cuadrado o Mann-Whitney. Se realiz\u00f3 an\u00e1lisis multivariado; p \u2264 0.05. Los pacientes con MExA presentaron mayor t\u00edtulo de anticuerpo ACCP (116 vs. 34, p < 0.01 y de factor reumatoideo (FR (108 vs. 34.5, p < 0.01. En el an\u00e1lisis multivariado hubo asociaci\u00f3n entre la presencia de MExA y tabaquismo activo (p = 0.02, OR: 3.78, IC 95%: 1.17-12.2, FR positivo (p = 0.04, OR: 3.23, IC95%: 1.04-11.8 y anticuerpo ACCP positivo (p = 0.04, OR: 3.23, IC 95%: 1.04-10. Presentaron mayor t\u00edtulo de anticuerpo ACCP que los controles los pacientes con xerostom\u00eda (109 vs. 34, p = 0.04, xeroftalmia (150 vs. 34, p < 0.01, n\u00f3dulos sub-cut\u00e1neos (NSC (141 vs. 34, p < 0.01 y fibrosis pulmonar (158 vs. 34, p = 0.04. En conclusi\u00f3n, el anticuerpo ACCP positivo, el FR positivo y el tabaquismo activo fueron factores de riesgo independientes para el desarrollo de MExA.\n[Anti Helicobacter pylori IgG and IgA response in patients with gastric cancer and chronic gastritis.](https://www.ncbi.nlm.nih.gov/pubmed/18613460)\nManojlovic, Nebojsa; Babic, Dragana; Filipovic-Ljeshovic, Ivana; Pilcevic, Dijana\n2008-01-01\nImmune response against Helicobacter pylori is important for the course and outcome of infection. We conducted study looking for the difference in anti H. pylori IgG and IgA between patients with intestinal type of gastric cancer, superficial and atrophic gastritis. For this study, 133 patients infected with H. pylori were enrolled: 50 with superficial gastritis, 42 with atrophic gastritis and 41 with gastric cancer. Anti H. pylori IgG and IgA ELISA tests were performed. The difference in antibody titers of IgG and IgA, frequency of IgA > IgG ratio and combination of low IgG and IgA > IgG ratio were analyzed. The patients with gastritis had higher titer of IgG that the patients with gastric cancer (p gastritis had higher titer of IgA than the patients with gastric cancer (p IgG ratio is more frequent in patients with gastric cancer than in the patients with superficial gastritis (p IgG is more frequent in the patients with gastric cancer than in the patients with gastritis (p cancer elicit different anti H. pylori IgG and IgA response than the patients with superficial and atrophic gastritis. Low IgG and IgA predominance seems characteristic for gastric cancer.\n[Los niveles de anticuerpos anti factor plaquetario 4-heparina y el \u00edndice 4T para trombocitopenia inducida por heparina](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802012000100005&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMarta E. Martinuzzo\n2012-02-01\nFull Text Available La trombocitopenia inducida por heparina (HIT es un efecto adverso del tratamiento con heparina, mediada por anticuerpos anti complejo factor plaquetario 4 (PF4-heparina (HPIA. La HIT es frecuentemente moderada pero pueden desarrollarse complicaciones tromb\u00f3ticas. El diagn\u00f3stico precoz es importante. La detecci\u00f3n de HPIA por ELISA tiene alta sensibilidad pero baja especificidad (t\u00edtulos bajos sin significaci\u00f3n cl\u00ednica. El \u00edndice de las 4T (\u00edndice 4T puede detectar pacientes con alto riesgo de HIT. El prop\u00f3sito del estudio fue correlacionar los niveles de HPIA y el \u00edndice 4T de un grupo de pacientes derivados a nuestro centro. Evaluamos 84 pacientes, 34 de ellos desarrollaron trombosis. Cada m\u00e9dico complet\u00f3 un cuestionario cl\u00ednico que fue remitido con la muestra a nuestro centro. Los cuestionarios fueron analizados por un investigador externo y el \u00edndice 4T se calcul\u00f3 previamente al ensayo. Los HPIA se determinaron por un ELISA (Asserachrom HPIA que detecta los 3 isotipos, IgG, IgM e IgA, \u00fanico reactivo disponible en Argentina. Los resultados se expresaron como porcentaje de absorbancia (%ABS. La correlaci\u00f3n del \u00edndice 4T con los HPIA fue 0.472 (rho spearman, p < 0.001. Los pacientes con \u00edndice 4T \u2265 6 presentaban %ABS mayores que los \u2264 5 (67 vs. 39, p < 0.001. Aqu\u00e9llos con trombosis presentaron t\u00edtulos mayores que los que no la desarrollaron (%ABS 59 vs. 39, p = 0.017. En conclusi\u00f3n: Los t\u00edtulos altos de HPIA medidos por ELISA, que detecta los 3 isotipos, correlacionaron claramente con el \u00edndice 4T \u2265 6 y fueron m\u00e1s frecuentes en los pacientes con trombosis, coincidiendo con lo ya descripto para ensayos de ELISA espec\u00edficos para isotipo IgG.\n[Estudio de la enfermedad cel\u00edaca mediante el desarrollo de un ensayo inmunocromatogr\u00e1fico para la determinaci\u00f3n de anticuerpos antitransglutaminasa](https://www.openaire.eu/search/publication?articleId=od______2008::22ca84354c29c39b3f3d5cb83a7a1406)\nGalv\u00e1n Cabrera, Jos\u00e9 Armando\n2012-01-01\nEn el presente trabajo se muestran los resultados del desarrollo y la evaluaci\u00f3n de un sistema inmunocromatogr\u00e1fico r\u00e1pido y sencillo para la detecci\u00f3n de anticuerpos antitransglutaminasa, que es un importante marcador serol\u00f3gico en el diagn\u00f3stico de la enfermedad cel\u00edaca (EC). Con este sistema se pueden detectar en una misma prueba tanto anticuerpos de tipo IgA como IgG. Se obtuvieron niveles de sensibilidad, especificidad y concordancia elevados cuando se compararon con la biopsia de yeyuno...\n[Preferential decrease in IgG4 anti-citrullinated protein antibodies during treatment with tumour necrosis factor blocking agents in patients with rheumatoid arthritis](https://www.narcis.nl/publication/RecordID/oai%3Apure.amc.nl%3Apublications%2F48a483d2-20f5-41a4-bdbc-e0050cb2260f/uquery/IGG4/id/11/Language/EN)\nBos, W. H.; Bartelds, G. M.; Vis, M.; van der Horst, A. R.; Wolbink, G. J.; van de Stadt, R. J.; van Schaardenburg, D.; Dijkmans, B. A. C.; Lems, W. F.; Nurmohamed, M. T.; Aarden, L.; Hamann, D.\n2009-01-01\nTo investigate the dynamics of IgG1 and IgG4 anti-citrullinated protein antibody (ACPA) subclasses during anti-tumour necrosis factor (TNF) treatment in patients with rheumatoid arthritis (RA). IgG, IgG1 and IgG4 ACPA levels were determined by ELISA on anti-citrullinated fibrinogen (ACF) and IgG1 :\n[Association of anti-herpes simplex virus IgG in tears and serum with clinical presentation in patients with presumed herpetic simplex keratitis.](https://www.ncbi.nlm.nih.gov/pubmed/22262223)\nBorderie, Vincent M; Gineys, Raquel; Goldschmidt, Pablo; Batellier, Laurence; Laroche, Laurent; Chaumeil, Christine\n2012-11-01\nTo assess the clinical relevance of tear anti-herpes simplex virus (HSV) antibody measurement for the diagnosis of herpes simplex keratitis. Records of 364 patients clinically suspect of HSV-related keratitis who had tear anti-HSV IgG assessment (tear-quantified anti-HSV IgG/filtrated IgG ratio) in our institution between January 2000 and August 2008 were retrospectively analyzed. Patients were classified into 4 groups as follows: group 1, anti-HSV IgG negative in serum and tears; group 2, anti-HSV IgG negative in tears and positive in serum; group 3, anti-HSV IgG nonsignificantly positive in tears and positive in serum; and group 4, anti-HSV IgG significantly positive in serum and tears. Randomly selected patient charts from each group were reviewed for clinical data. The prevalence of anti-HSV IgG in blood increased with age from >70% before 20 years to 95% after 70 years. The prevalence of anti-HSV IgG in tears increased with age from 20% before 20 years to >50% after 70 years. The presence (either significant or not) of anti-HSV IgG in tears was significantly associated with decreased corneal sensation, presence of stromal opacities, and with neurotrophic keratitis. Logistic regression showed no significant association between age and clinical signs except for herpetic ulcers and herpetic necrotizing keratitis. Tear production of anti-HSV IgG increases with age, and it is associated with sequelae of herpes simplex keratitis. Conversely, it is poorly associated with clinical signs of acute herpes simplex keratitis.\n[Preferential decrease in IgG4 anti-citrullinated protein antibodies during treatment with tumour necrosis factor blocking agents in patients with rheumatoid arthritis](https://www.narcis.nl/publication/RecordID/oai%3Adare.uva.nl%3Apublications%2F3837baea-3cdc-4e16-bca8-b1a34dbb2dd1/uquery/IGG4/id/14/Language/EN)\nBos, W.H.; Bartelds, G.M.; Vis, M.; van der Horst, A.R.; Wolbink, G.J.; van de Stadt, R.J.; van Schaardenburg, D.; Dijkmans, B.A.C.; Lems, W.F.; Nurmohamed, M.T.; Aarden, L.; Hamann, D.\n2009-01-01\nObjective: To investigate the dynamics of IgG1 and IgG4 anti-citrullinated protein antibody ( ACPA) subclasses during anti-tumour necrosis factor (TNF) treatment in patients with rheumatoid arthritis ( RA). Methods: IgG, IgG1 and IgG4 ACPA levels were determined by ELISA on anti-citrullinated\n[Preferential decrease in IgG4 anti-citrullinated protein antibodies during treatment with tumour necrosis factor blocking agents in patients with rheumatoid arthritis](https://www.narcis.nl/publication/RecordID/oai%3Aresearch.vu.nl%3Apublications%2Fb459fa62-5e69-4def-ae46-031d7c7ae690/uquery/IGG4/id/12/Language/EN)\nBos, W.H.; Bartelds, G.M.; Vis, M.; Horst, A.; Wolbink, G.; van de Stadt, R.J.; van Schaardenburg, D.; Dijkmans, B.A.C.; Lems, W.F.; Nurmohamed, M.T.; Aarden, L.; Hamann, D.\n2009-01-01\nObjective: To investigate the dynamics of IgG1 and IgG4 anti-citrullinated protein antibody (ACPA) subclasses during anti-tumour necrosis factor (TNF) treatment in patients with rheumatoid arthritis (RA). Methods: IgG, IgG1 and IgG4 ACPA levels were determined by ELISA on anti-citrullinated\n[Prevalencia de anticuerpos contra HTLV-1 en una poblaci\u00f3n negra de Colombia](http://www.revistabiomedica.org/index.php/biomedica/article/view/855) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMar\u00eda C. Navas\n1995-03-01\nFull Text Available El virus linfotr\u00f3pico humano 1 (HTLV-1 ha sido asociado con la leucemia de c\u00e9lulas T del adulto (ATL y la paraparesia esp\u00e1stica tropical (PET o mielopat\u00eda asociada con HTLV-1 (HAM. Aunque la prevalencia de anticuerpos contra el HTLV-1 ha sido descrita en diversos pa\u00edses, especialmente en Jap\u00f3n, poco se conoce acerca de este marcador de contacto viral en nuestra poblaci\u00f3n. En este art\u00edculo describimos la ausencia de niveles de anticuerpos anti-HTLV-1 en el suero, medidos por la prueba de ELISA, en una poblaci\u00f3n negra de la costa atl\u00e1ntica de Colombia. Nuestros hallazgos sugieren que: a este grupo descendiente de \u00c1frica no se ha expuesto al virus; b puede ser que algunos de los individuos incluidos en el estudio est\u00e9n en per\u00edodo de incubaci\u00f3n y, que debido a su juventud, no fue posible demostrar una respuesta humoral contra el virus; y, c como ha sido descrito en otros estudios, la prevalencia de anticuerpos anti-HTLV- 1 var\u00eda entre las diferentes regiones de Colombia.\n[Anti-pituitary antibodies against corticotrophs in IgG4-related hypophysitis.](https://www.ncbi.nlm.nih.gov/pubmed/27896569)\nIwata, Naoko; Iwama, Shintaro; Sugimura, Yoshihisa; Yasuda, Yoshinori; Nakashima, Kohtaro; Takeuchi, Seiji; Hagiwara, Daisuke; Ito, Yoshihiro; Suga, Hidetaka; Goto, Motomitsu; Banno, Ryoichi; Caturegli, Patrizio; Koike, Teruhiko; Oshida, Yoshiharu; Arima, Hiroshi\n2017-06-01\nIgG4-related disease is a systemic inflammatory disease characterized by infiltration of IgG4-positive plasma cells into multiple organs, including the pituitary gland. Autoimmunity is thought to be involved in the pathogenesis of IgG4-related disease. The diagnosis of IgG4-related hypophysitis (IgG4-RH) is difficult because its clinical features, such as pituitary swelling and hypopituitarism, are similar to those of other pituitary diseases, including lymphocytic hypophysitis and sellar/suprasellar tumors. The presence and significance of anti-pituitary antibodies (APA) in IgG4-RH is unclear. In this case-control study, we used single indirect immunofluorescence on human pituitary substrates to assess the prevalence of serum APA in 17 patients with IgG4-RH, 8 control patients with other pituitary diseases (lymphocytic infundibulo-neurohypophysitis, 3; craniopharyngioma, 2; germinoma, 3), and 9 healthy subjects. We further analyzed the endocrine cells targeted by the antibodies using double indirect immunofluorescence. APA were found in 5 of 17 patients with IgG4-RH (29%), and in none of the pituitary controls or healthy subjects. The endocrine cells targeted by the antibodies in the 5 IgG4-RH cases were exclusively corticotrophs. Antibodies were of the IgG1 subclass, rather than IgG4, in all 5 cases, suggesting that IgG4 is not directly involved in the pathogenesis. Finally, antibodies recognized pro-opiomelanocortin in 2 of the cases. Our study suggests that autoimmunity is involved in the pathogenesis of IgG4-RH and that corticotrophs are the main antigenic target, highlighting a possible new diagnostic marker for this condition.\n[Diagn\u00f3stico diferencial en la encefalitis por anticuerpos contra el receptor NMDA](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3101880)\nGonz\u00e1lez-Valc\u00e1rcel, J.; Rosenfeld, M.R.; Dalmau, J.\n2011-01-01\nResumen Introducci\u00f3n La encefalitis por anticuerpos contra el receptor de NMDA (NMDAR) suele desarrollarse como un s\u00edndrome caracter\u00edstico de evoluci\u00f3n multif\u00e1sica y diagn\u00f3stico diferencial amplio. Pacientes Presentamos a 2 pacientes diagnosticadas de encefalitis por anticuerpos NMDAR con un cuadro cl\u00ednico t\u00edpico, pero que inicialmente se\u00f1al\u00f3 otras etiolog\u00edas. Discusi\u00f3n La afectaci\u00f3n frecuente de pacientes j\u00f3venes con manifestaciones psiqui\u00e1tricas prominentes indica frecuentemente otras consideraciones diagn\u00f3sticas; las m\u00e1s frecuentes son las encefalitis virales, los procesos psiqui\u00e1tricos y el s\u00edndrome neurol\u00e9ptico maligno. Varios s\u00edndromes previamente definidos de manera parcial o descriptiva en adultos y pacientes pedi\u00e1tricos probablemente eran casos de encefalitis anti-NMDAR. Conclusiones La encefalitis anti-NMDAR debe considerarse en pacientes j\u00f3venes con manifestaciones psiqui\u00e1tricas subagudas, movimientos anormales y alteraciones auton\u00f3micas. La caracterizaci\u00f3n cl\u00ednica e inmunol\u00f3gica de esta enfermedad ha llevado a la identificaci\u00f3n de nuevos anticuerpos que afectan a procesos de memoria, aprendizaje, conducta y psicosis. PMID:20964986\n[Oriented immobilized anti-hIgG via F(c) fragment-imprinted PHEMA cryogel for IgG purification.](https://www.ncbi.nlm.nih.gov/pubmed/23070898)\nBereli, Nilay; Ert\u00fcrk, Gizem; T\u00fcmer, M A\u015fkin; Say, Ridvan; Denizli, Adil\n2013-05-01\nAntibodies are used in many applications, especially as diagnostic and therapeutic agents. Among the various techniques used for the purification of antibodies, immunoaffinity chromatography is by far the most common. For this purpose, oriented immobilization of antibodies is an important step for the efficiency of purification step. In this study, F(c) fragment-imprinted poly(hydroxyethyl methacrylate) cryogel (MIP) was prepared for the oriented immobilization of anti-hIgG for IgG purification from human plasma. Non-imprinted poly(hydroxyethyl methacrylate) cryogel (NIP) was also prepared for random immobilization of anti-hIgG to compare the adsorption capacities of oriented (MIP/anti-hIgG) and random (NIP/anti-hIgG) cryogel columns. The amount of immobilized anti-hIgG was 19.8 mg/g for the NIP column and 23.7 mg/g for the MIP column. Although the amount of immobilized anti-hIgG was almost the same for the NIP and MIP columns, IgG adsorption capacity was found to be three times higher than the NIP/anti-hIgG column (29.7 mg/g) for the MIP/anti-hIgG column (86.9 mg/g). Higher IgG adsorption capacity was observed from human plasma (up to 106.4 mg/g) with the MIP/anti-hIgG cryogel column. Adsorbed IgG was eluted using 1.0 M NaCl with a purity of 96.7%. The results obtained here are very encouraging and showed the usability of MIP/anti-hIgG cryogel prepared via imprinting of Fc fragments as an alternative to conventional immunoaffinity techniques for IgG purification. Copyright \u00a9 2012 John Wiley & Sons, Ltd.\n[Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange](https://www.narcis.nl/publication/RecordID/oai%3Apure.amc.nl%3Apublications%2Ff03cd7ea-1870-4be3-a9f1-c8ec0eb4b84b/uquery/fab/id/6/Language/EN)\nvan der Neut Kolfschoten, Marijn; Schuurman, Janine; Losen, Mario; Bleeker, Wim K.; Mart\u00ednez-Mart\u00ednez, Pilar; Vermeulen, Ellen; den Bleker, Tamara H.; Wiegman, Luus; Vink, Tom; Aarden, Lucien A.; de Baets, Marc H.; van de Winkel, Jan G. J.; Aalberse, Rob C.; Parren, Paul W. H. I.\n2007-01-01\nAntibodies play a central role in immunity by forming an interface with the innate immune system and, typically, mediate proinflammatory activity. We describe a novel posttranslational modification that leads to anti-inflammatory activity of antibodies of immunoglobulin G, isotype 4 (IgG4). IgG4\n[Pertussis serology: assessment of IgG anti-PT ELISA for replacement of the CHO cell assay*](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3003908)\nDALBY, TINE; S\u00d8RENSEN, CHARLOTTE; PETERSEN, JESPER WESTPHAL; KROGFELT, KAREN ANGELIKI\n2010-01-01\nDalby T, S\u00f8rensen C, Petersen JW, Krogfelt KA. Pertussis serology: assessment of IgG anti-PT ELISA for replacement of the CHO cell assay. APMIS 2010; 118: 968\u201372. Two types of serological assays are commonly used for the assessment of pertussis vaccine-induced antibodies; the Chinese hamster ovary cell (CHO cell) assay and the immunoglobulin G (IgG) anti pertussis toxin (PT) enzyme-linked immunosorbent assay (IgG anti-PT ELISA). Recently, both the techniques have been modified to improve performance with sera with interfering activity (CHO cell assay) or with heat-treated sera (IgG anti-PT ELISA). These two improved techniques were compared by the analysis of 100 individual serum samples from a previous clinical trial and 213 sera from a longitudinal serum collection from 20 Danish adults recently vaccinated with the Danish acellular pertussis vaccine. The comparison showed a significant linear correlation between the results of the two assays with a p-value of ELISA can be used as a replacement for the often troublesome and time-consuming CHO cell assay for the measurement of vaccine-induced human antibodies to PT. PMID:21091778\n[Serum levels of IgG and IgG4 in Hashimoto thyroiditis.](https://www.ncbi.nlm.nih.gov/pubmed/23695895)\nKawashima, Sachiko-Tsukamoto; Tagami, Tetsuya; Nakao, Kanako; Nanba, Kazutaka; Tamanaha, Tamiko; Usui, Takeshi; Naruse, Mitsuhide; Minamiguchi, Sachiko; Mori, Yusuke; Tsuji, Jun; Tanaka, Issei; Shimatsu, Akira\n2014-03-01\nAlthough IgG4-related disease is characterized by extensive infiltration of IgG4-positive plasma cells and lymphocytes of various organs, the details of this systemic disease are still unclear. We screened serum total IgG levels in the patients with Hashimoto thyroiditis (HT) to illustrate the prevalence of IgG4-related thyroiditis in HT. Twenty-four of 94 patients with HT (25.5%) had elevated serum IgG levels and their serum IgG4 was measured. Five of the 24 cases had more than 135 mg/dL of IgG4, which is the serum criterion of IgG4-related disease. One was a female patient who was initially treated as Graves' disease and rapidly developed a firm goiter and hypothyroidism. The biopsy of her thyroid gland revealed that follicular cells were atrophic with squamous metaplasia, replaced with fibrosis, which was compatible with the fibrous variant of HT. Immunohistochemical examination revealed diffuse infiltration of IgG4-positive plasma cells, and the serum IgG4 level was 179 mg/dL. The levels of IgG and IgG4 were positively correlated with the titers of anti-thyroglobulin antibody or anti-thyroid peroxidase antibody. In conclusion, at least a small portion of patients with HT with high titers of anti-thyroid antibodies may overlap the IgG4-related thyroiditis.\n[Serological analysis of human IgG and IgE anti-insulin antibodies by solid-phase radioimmunoassays](https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=12605221) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nHamilton, R.G.; Rendell, M.; Adkinson, N.F. Jr.\n1980-01-01\nA single solid-phase assay system which is useful for quantitative measurement of both IgG and IgE anti-insulin antibodies in human serum has been developed. Insulin-specific immunoglobulins are absorbed from human serum by excess quantities of insulin-agarose. After washes to remove unbound immunoglobulins, radioiodinated Staph A or rabbit anti-human IgE is added to detect bound IgG or IgE anbitodies, respectively\n[Production of double antibody for radioimmunoassay (sheep anti-rabbit IgG antiserum)](http://www.iaea.org/inis/collection/NCLCollectionStore/_Public/26/040/26040665.pdf?r=1) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nSilva, S.R. da.\n1993-01-01\nA second antibody (sheep anti-rabbit IgG antiserum) to be used in RIAs in which the first antibody is raised in rabbits was produced. For this production, initially the IgG was isolated from rabbit serum and purified by sodium sulphate precipitation followed by ion exchange chromatography on DEAE-cellulose. Four sheep were immunized with 500 u g of purified rabbit IgG, emulsified in Freund Complete Adjuvant and administered by multisite subcutaneous injections. These injections were repeated at 20-days intervals and blood samples (40 ml) were taken from the jugular vein 10 days after the boosts for the evaluation of the antisera title. After each four boosts a great bleeding was done by the same route. Approximately 500 ml of serum were obtained in each bleeding per animal. The antisera were evaluated by the human thyrotropin RIA developed at IPEN laboratories employing reagents provided by NIDDKD, USA. These evaluations referred to the determination of the antisera title and of the ideal concentration of carrier IgG, to the study of the kinetic of precipitation and to the confirmation of the inexistent cross-reactivity with human IgG, in comparison with a reference antiserum of know precipitation characteristics supplied by the Radioassay System Laboratories. Approximately 3,6 l of antiserum (sheep anti-rabbit IgG serum) were produced from the four sheep, which presented title and precipitation characteristics very similar to those exhibited by the imported commercial product, even presenting higher titles. The results obtained in this work indicated that it was created enough experience for the production of this biological reagent for RIA, that could be done integrally in the country in greater scale, and at a very reduced cost. (author). 81 refs, 36 figs, 33 tabs\n[Concurrent IgG4-related tubulointerstitial nephritis and IgG4 myeloperoxidase-anti-neutrophil cytoplasmic antibody positive crescentic glomerulonephritis: A case report.](https://www.ncbi.nlm.nih.gov/pubmed/28514287)\nSu, Tao; Yang, Li; Cui, Zhao; Wang, Su-Xia; Zhao, Ming-Hui\n2017-05-01\nIgG4-related disease (IgG4-RD) is a newly recognized systemic disease. The typical pathological finding in the kidney is abundant IgG4-positive plasma cell infiltration with characteristic storiform fibrosis in the interstitium. Antibodies of the IgG4 subclass have been linked to certain autoimmune diseases including antiproteinase 3 (PR3) anti-neutrophil cytoplasmic antibody (ANCA) of the IgG4 subclass. Here, we report a rare case of kidney injury with concurrent typical IgG4-related tubulointerstitial nephritis and IgG4 subclass of myeloperoxidase (MPO) ANCA-positive necrotizing crescentic glomerulonephritis. A 42-year-old Chinese man presented with repeated epigastric pain, sausage-shaped pancreas observed morphologically in computed tomography, effectiveness of prednisone therapy and was diagnosed with autoimmune pancreatitis. He subsequently developed acute kidney injury. The patient had an elevated serum IgG4, eosinophilia, and positive MPO-ANCA of IgG4-dominant subclass. Renal biopsy revealed necrotizing crescentic nephritis and typical IgG4-related tubulointerstitial nephritis. The patient was treated with a combination of corticosteroids and cyclophosphamide, and a course of rituximab was later added to deplete peripheral B cells. The patient responded well and his renal function improved. This is the first case report of an IgG4-RD with concurrent IgG4-related tubulointerstitial nephritis and IgG4 MPO-ANCA-associated necrotizing crescentic glomerulonephritis. It raises the difficulty in differentiation diagnosis of the two separate diseases that is worthy of further study.\n[Higher Anti-CMV IgG Concentrations are Associated with Worse Neurocognitive Performance During Suppressive Antiretroviral Therapy.](https://www.ncbi.nlm.nih.gov/pubmed/29506084)\nLetendre, Scott; Bharti, Ajay; Perez-Valero, Ignacio; Hanson, Barbara; Franklin, Donald; Woods, Steven Paul; Gianella, Sara; de Oliveira, Michelli Faria; Heaton, Robert K; Grant, Igor; Landay, Alan L; Lurain, Nell\n2018-03-01\nTo determine the association of CMV infection with neurocognitive performance in HIV+ adults. Cross-sectional, observational, exploratory study. Anti-CMV IgG concentrations in blood and CMV DNA copies in blood and cerebrospinal fluid (CSF) were measured in stored specimens of 80 HIV+ adults who were previously assessed with a standardized, comprehensive neurocognitive test battery. Thirty-eight were taking suppressive antiretroviral therapy (ART, HIV RNA \u2264 50 copies/mL) and 42 were not taking ART. A panel of 7 soluble biomarkers were also measured by immunoassay in CSF. Anti-CMV IgG concentrations ranged from 5.2 to 46.1 U/mL. CMV DNA was detected in 7 (8.8%) blood plasma but in none of the CSF specimens. Higher anti-CMV IgG levels were associated with older age (p=0.0017), lower nadir CD4+ T-cell count (pperformance overall (p=0.059). This correlation was present in those taking suppressive ART (p=0.0049) but not in those who were not taking ART (p=0.92). Worse neurocognitive performance remained associated with higher anti-CMV IgG levels after accounting for other covariates in multivariate models (Model p=0.0038). Detectable plasma CMV DNA was associated with AIDS (p=0.05) but not with neurocognitive performance. CMV may influence neurocognitive performance in HIV+ adults taking suppressive ART. Future clinical trials of anti-CMV therapy should help determine whether the observed relationships are causal.\n[Increased levels of anti-non-Gal IgG following pig-to-baboon bone marrow transplantation correlate with failure of engraftment](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3848062)\nLiang, Fan; Wamala, Isaac; Scalea, Joseph; Tena, Aseda; Cormack, Taylor; Pratts, Shannon; Struuck, Raimon Duran; Elias, Nahel; Hertl, Martin; Huang, Christene A.; Sachs, David H.\n2013-01-01\nBackground The development of genetically modified pigs which lack the expression of alpha 1\u20133 galactosyl transferase, (GalT-KO pigs) has facilitated the xenogeneic transplantation of porcine organs and tissues into primates by avoiding hyperacute rejection due to pre-existing antibodies against the Gal epitope. However, antibodies against other antigens (anti-non-Gal antibodies), are found at varying levels in the pre-transplant sera of most primates. We have previously found that baboons with high levels of pre-transplant anti-non-Gal IgG, conditioned with a non-myeloablative conditioning regimen, failed to engraft following pig-to-baboon bone marrow transplantation [8]. Two baboons with low levels of pre-transplant anti-non-Gal IgG, conditioned with the same regimen, showed porcine bone marrow progenitors at 28 days following transplantation, suggesting engraftment. These baboons also showed evidence of donor-specific hypo-responsiveness. This observation led us to investigate the hypothesis that selecting for baboon recipients with low pre-transplant anti-non-Gal IgG levels might improve engraftment levels following GalT-KO pig-to-baboon bone marrow transplantation. Methods Five baboons, with low pre-transplant anti-non-Gal IgG levels, received transplantation of bone marrow cells (1\u20135 \u00d7 10^9/kg of recipient weight) from GalT-KO pigs. They received a non-myeloablative conditioning regimen consisting of low-dose total body irradiation (150cGy), thymic irradiation (700cGy), anti-thymocyte globulin (ATG) and tacrolimus. In addition, two baboons received Rituximab and Bortezomib (Velcade) treatment as well as extra-corporeal immunoadsorption using GalT-KO pig livers. Bone marrow engraftment was assessed by porcine-specific PCR on colony forming units (CFU) of day 28 bone marrow aspirates. Anti-non-Gal antibody levels were assessed by serum binding towards GalT-KO PBMC using flow cytometry (FACS). Peripheral macro-chimerism was measured by FACS using pig and\n[Comparison of Salivary Anti Helicobacter pylori IgG with Serum IgG and Bacteriological Tests in Detecting Helicobacter pylori Infections](http://journals.mui.ac.ir/jrms/article/view/342) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nH Ghasemian safaei\n2005-01-01\nFull Text Available Background: This study was conducted to compare the efficacy of enzyme-linked immunosorbent assay (ELISA for detecting anti-Helicobacter pylori (H. pylori specific IgG antibodies in specimens of oral fluid and serum with bacteriological tests. Methods: Antral biopsy specimens, as well as serum and oral fluid samples were collected from 97 patients who underwent upper gastrointestinal endoscopy. The presence or absence of current H. pylori infection was determined by culture, histology and urease detection. Anti-H. pylori specific IgG was detected in serum and oral fluid, using an established lab-made, and a commercial ELISA kit. The obtained data were compared with results of bacteriological tests. Results: In all, 62 (64% of 97 patients were positive for H. pylori by one or more of the gold standard tests (culture, histology and urease detection. Lab-made enzyme-linked immunoassay of oral fluid had a sensitivity and specificity of 92% and 83% respectively. A sensitivity and specificity of 87% and 83%, respectively, was obtained with the commercial kit. Lab-made enzyme-linked immunoassay of serum samples had a sensitivity and specificity of 90% and 88%, respectively. A sensitivity of 86% and specificity of 86% was obtained with the commercial kit. Conclusion: Detection of anti-H. pylori specific IgG in oral fluid by ELISA is comparable in sensitivity and specificity with serum based methods. Oral fluid based ELISA could provide a reliable, non-invasive method for the diagnosis of H. pylori infection. Saliva testing may have a role in epidemiological studies. Keywords: Helicobacter pylori, ELISA, Oral fluid\n[Preparation of 99''m technitium labelled erythrocytes coated with anti-rhesus-D immunoglobulin (anti-Rho-D IgG) for defective spleen diagnosis](https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=30043931) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nNanny Kartini, H.; Karnama, S.; Ahmad Muhtadi; Karna Awangga\n1999-01-01\nPreparation of 99m technetium-red blood cells coated with anti-rhesus-D IgG has been carried out and evaluated. Some factors such as the concentration of Sn(II) and incubation time which can influence the labelling yield are discussed. A labelling efficiency of greater than 90% (93.1 \u00b11.4% ) was obtained. Biological studies in normal human volunteers, showed that 99m Tc-red blood cell coated with anti-rhesus-D IgG accumulated in the spleen and may become a spleen imaging agent. (author)\n[Thyroid autoantibodies in autoimmune diseases Anticuerpos antitiroideos en enfermedades autoinmunes](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802004000300006) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nRegina M. Innocencio\n2004-06-01\nFull Text Available Abnormalities in the thyroid function and thyroid autoantibodies have been frequently described in patients with autoimmune diseases but seldom in antiphospholipid syndrome patients. In order to determine the prevalence of thyroid function and autoimmune abnormalities, we compared serum thyrotropin (TSH, serum free thyroxine (T4 levels, thyroid antithyroglobulin (TgAb and antithyroperoxidase (TPOAb levels of 25 patients with systemic sclerosis, 25 patients with rheumatoid arthritis and 13 patients with antiphospholipid syndrome to a control group of 113 healthy individuals. Evaluation included a thorough clinical examination with particular attention to thyroid disease and a serologic immune profile including rheumatoid factor, antinuclear and anticardiolipin antibody measurements. Subclinical hypothyroidism (4.2Ciertas anormalidades en la funci\u00f3n tiroidea y anticuerpos antitiroideos han sido frecuentemente descriptos en pacientes con enfermedades autoinmunes, y m\u00e1s raramente en pacientes con el s\u00edndrome antifosfolip\u00eddico. Para determinar la prevalenc\u00eda de anormalidades en la funci\u00f3n tiroidea y de autoinmunidad, comparamos los niveles s\u00e9ricos de tirotropina (TSH tiroxina libre en suero (T4 anticuerpos antitiroglobulina (TgAb y antitiroperoxidasa (TPOAb en 25 pacientes con esclerosis sist\u00e9mica, 25 pacientes con artritis reumatoidea y 13 pacientes con el s\u00edndrome antifosfolip\u00eddico con un grupo control de 113 individuos aparentemente sanos. La evaluaci\u00f3n incluy\u00f3 un completo examen cl\u00ednico con particular atenci\u00f3n para las enfermedades de la tiroides y una evaluaci\u00f3n inmunol\u00f3gica incluyendo dosaje del factor reumatoideo, anticuerpos antinucleares y anticardiolipina. Hipotiroidismo subcl\u00ednico (4.2\n[Seroprevalence of anti-rubella and anti-measles IgG antibodies in pregnant women in Shiraz, Southern Iran: outcomes of a nationwide measles-rubella mass vaccination campaign.](http://europepmc.org/articles/PMC3561451?pdf=render) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nBehnam Honarvar\nFull Text Available OBJECTIVE: Nonimmune pregnant women are at risk of developing congenital rubella syndrome and measles complications. We aimed to identify pregnant women susceptible to rubella or measles in order to determine the need for immunity screening and supplemental immunization in women of childbearing age. METHOD: This seroprevalence survey was conducted by convenience sampling in obstetric hospitals affiliated with Shiraz University of Medical Sciences (southern Iran. Serum IgG levels were measured by ELISA. RESULT: Mean age of the 175 pregnant women was 27.3\u00b15.3 (range 16 to 42 years. The geometric mean concentration of anti-rubella IgG was 14.9 IU/mL (CI 95%,14.1-15.5, and that of anti-measles IgG was 13.8 IU/mL (CI 95%, 13-14.5. One hundred sixty-eight women (96% had a protective serologic level (>11 IU/mL of IgG against rubella, and 143 (81.7% had a protective level against measles. Except for a significant inverse correlation that was showed by univariate analysis between anti-rubella IgG and the women's age (P = 0.01, immunity did not correlate with demographic or obstetric characteristics or medical history. There was no significant correlation between anti-rubella and anti-measles IgG levels (P = 0.25. CONCLUSION: Nearly a decade after Iran's nationwide measles-rubella vaccination campaign for the population aged 5-25 years, most pregnant women up to 34 years of age had humoral immunity against rubella. We recommend rubella immunity screening or catch-up immunization for women older than 35 years who wish to become pregnant, and measles immunity screening and appropriate vaccination for all women of childbearing age.\n[Changes in the seroprevalence of IgG anti-hepatitis A virus between 2001 and 2013: experience at a single center in Korea](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4099331)\nChung, Sung Jun; Kim, Sun Min; Roh, Min; Yu, Mi Yeon; Lee, Jung Hoon; Oh, ChangKyo; Lee, Eun Young; Lee, Seung; Jeon, Yong Cheol; Yoo, Kyo-Sang; Sohn, Joo Hyun\n2014-01-01\nBackground/Aims The incidence of symptomatic hepatitis A reportedly increased among 20- to 40-year-old Korean during the late 2000s. Vaccination against hepatitis A was commenced in the late 1990s and was extended to children aged <10 years. In the present study we analyzed the changes in the seroprevalence of IgG anti-hepatitis A virus (HAV) over the past 13 years. Methods Overall, 4903 subjects who visited our hospital between January 2001 and December 2013 were studied. The seroprevalence of IgG anti-HAV was analyzed according to age and sex. In addition, the seroprevalence of IgG anti-HAV was compared among 12 age groups and among the following time periods: early 2000s (2001-2003), mid-to-late 2000s (2006-2008), and early 2010s (2011-2013). The chi-square test for trend was used for statistical analysis. Results The seroprevalence of IgG anti-HAV did not differ significantly between the sexes. Furthermore, compared to the seroprevalence of IgG anti-HAV in the early 2000s and mid-to-late 2000s, that in the early 2010s was markedly increased among individuals aged 1-14 years and decreased among those aged 25-44 years (P<0.01). We also found that the seroprevalence of IgG anti-HAV in individuals aged 25-44 years in the early 2010s was lower than that in the early 2000s and mid-to-late 2000s. Conclusions The number of symptomatic HAV infection cases in Korea is decreasing, but the seroprevalence of IgG anti-HAV is low in the active population. PMID:25032182\n[Changes in the seroprevalence of IgG anti-hepatitis A virus between 2001 and 2013: experience at a single center in Korea](http://e-cmh.org/upload/pdf/cmh-20-162.pdf) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nSung Jun Chung\n2014-06-01\nFull Text Available Background/AimsThe incidence of symptomatic hepatitis A reportedly increased among 20- to 40-year-old Korean during the late 2000s. Vaccination against hepatitis A was commenced in the late 1990s and was extended to children aged <10 years. In the present study we analyzed the changes in the seroprevalence of IgG anti-hepatitis A virus (HAV over the past 13 years.MethodsOverall, 4903 subjects who visited our hospital between January 2001 and December 2013 were studied. The seroprevalence of IgG anti-HAV was analyzed according to age and sex. In addition, the seroprevalence of IgG anti-HAV was compared among 12 age groups and among the following time periods: early 2000s (2001-2003, mid-to-late 2000s (2006-2008, and early 2010s (2011-2013. The chi-square test for trend was used for statistical analysis.ResultsThe seroprevalence of IgG anti-HAV did not differ significantly between the sexes. Furthermore, compared to the seroprevalence of IgG anti-HAV in the early 2000s and mid-to-late 2000s, that in the early 2010s was markedly increased among individuals aged 1-14 years and decreased among those aged 25-44 years (P<0.01. We also found that the seroprevalence of IgG anti-HAV in individuals aged 25-44 years in the early 2010s was lower than that in the early 2000s and mid-to-late 2000s.ConclusionsThe number of symptomatic HAV infection cases in Korea is decreasing, but the seroprevalence of IgG anti-HAV is low in the active population.\n[Survey of malaria and anti-dengue virus IgG among febrile HIV-infected patients attending a tertiary hospital in Abuja, Nigeria.](https://www.ncbi.nlm.nih.gov/pubmed/28721101)\nMustapha, Jelili Olaide; Emeribe, Anthony Uchenna; Nasir, Idris Abdullahi\n2017-01-01\nDengue and malaria are infections, of great public health concern, especially in sub-Saharan Africa where the burden of HIV infection is high. This study was conducted to determine the seroprevalence of dengue virus IgG antibodies and dengue/malaria coinfection among febrile HIV-infected patients attending the University of Abuja Teaching Hospital, Gwagwalada, Abuja. In this cross-sectional study, blood samples from 178 consenting HIV-infected patients receiving antiretroviral therapy were collected and tested for plasmodiasis and anti-Dengue virus IgG using malaria microscopy and ELISA, respectively. Interviewer-based questionnaires were used to assess subjects' sociodemographic variables and dengue risk factors. Of the 178 screened participants, 44.4% were seropositive for dengue virus IgG antibody, whereas 29.2% were positive for Plasmodium falciparum. About 44.2% were positive for both dengue virus and P. falciparum . There was a statistical association between anti-dengue IgG and occupation ( p =0.03) but not with age, residential area, educational level and patients' gender ( p >0.05). Seroprevalence of anti-dengue specific IgG was relatively higher in participants who adopted protective measures. There was a statistical association between seroprevalence of anti-dengue IgG and adoption of preventive measures ( p <0.05). The high prevalence of malaria and dengue virus IgG indicates the need to strengthen vector control and dengue surveillance programs.\n[Anti-CagA IgG Antibody is Independent from Helicobacter pylori vacA and cagA Genotypes](http://jmb.tums.ac.ir/index.php/jmb/article/view/113) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nHashem Fakhre Yaseri\n2015-12-01\nFull Text Available Background: Helicobacter pylori strains have two classical virulence genes, the cytotoxinassociated A (cagA gene and the vacuolating cytotoxin A (vacA gene, which are located in thecag pathogenicity island (cagPAI. Serum immunoglobulin G (IgG antibodies to H. pylori,especially, the CagA antigen may be a reliable marker for selection of dyspeptic patients for upperendoscopy.Methods: Serum sample of 129 dyspeptic patients with positive H. pylori, were tested for serumIgG Anti-CagA antibody by ELISA. The presence of the cagA and vacA genotypes weredetermined using polymerase chain reaction (PCR on biopsy samples taken via endoscopy.Results: Positive serum IgG anti-CagA antibodies in patients with cagA+/vacA+ and cagA+/vacA- genotypes were 22/23 (95.6% and 18/19 (94.7%, respectively. In addition, serum IgG anti-CagAantibodies in patients with cagA-/vacA+ and cagA-/vacA- genotypes were 22/47 (46.8% and 33/40(82.5%, respectively.Conclusions: It can be concluded that the serum IgG anti-CagA antibody alone could selectpatients with dyspepsia following upper endoscopy. The assessment of vacuolating cytotoxinactivity of H. Pylori is, therefore, not required, even when vacA gene is positive. This hypothesisneeds to be studied in a large number of patients with dyspepsia.\n[Canakinumab: un anticuerpo monoclonal prometedor en el tratamiento de enfermedades cardiovasculares](http://www.sciencedirect.com/science/article/pii/S0120563313700226) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nFernando Manzur, MD., FACC\n2013-01-01\nFull Text Available El canakinumab es un anticuerpo monoclonal anti-IL-1\u03b2 totalmente humano desarrollado por Novartis, cuyo mecanismo de acci\u00f3n se basa en la neutralizaci\u00f3n de la se\u00f1alizaci\u00f3n IL-1\u03b2, lo cual conduce a la supresi\u00f3n de la inflamaci\u00f3n en pacientes con trastornos de origen autoinmune. La IL-1\u03b2 act\u00faa como un mediador de la respuesta inmune perif\u00e9rica durante la infecci\u00f3n y la inflamaci\u00f3n. Mediante la uni\u00f3n ant\u00edgeno-anticuerpo el canakinumab inhibe la acci\u00f3n de la IL1-\u03b2 evitando sus efectos pro-inflamatorios. En la actualidad, est\u00e1 en evaluaci\u00f3n como un nuevo posible agente dirigido frente a la IL-1\u03b2, con el objetivo de reducir la tasa de eventos cardiovasculares y la diabetes de aparici\u00f3n reciente (estudio CANTOS.\n[Seroprevalencia de Helicobacter pylori en la poblaci\u00f3n infantil ecuatoriana](https://www.openaire.eu/search/publication?articleId=od_______619::61023da14b4f2a8c5ae1017a254ceac1)\nG\u00f3mez, N\u00e9stor A; Salvador, Alexandra; Vargas, Paola E; Zapatier, Jorge A; \u00c1lvarez, Jos\u00e9\n2004-01-01\nObjetivo: Determinar la prevalencia de anticuerpos IgG contra el Helicobacter pylori (anti-Hp) en la poblaci\u00f3n infantil ecuatoriana y si existe relaci\u00f3n con la presencia de sintomatolog\u00eda gastrointestinal recurrente. Materiales y M\u00e9todos: Se incluyeron ni\u00f1os de manera aleatoria de las diferentes \u00e1reas geogr\u00e1ficas, y se investig\u00f3 la presencia de anticuerpos s\u00e9ricos utilizando una prueba de ELISA. Asimismo, se relacion\u00f3 la sintomatolog\u00eda gastrointestinal entre los pacientes con y sin anticuerpo...\n[Producci\u00f3n y caracterizaci\u00f3n de un anticuerpo policlonal dirigido contra la fosfoprote\u00edna del virus de la rabia](http://www.revistabiomedica.org/index.php/biomedica/article/view/221) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nNadia Yadira Casta\u00f1eda\n2007-06-01\nMateriales y m\u00e9todos. El gen P que codifica para la prote\u00edna P del virus de la rabia, fue amplificado por reacci\u00f3n en cadena de la polimerasa de transcriptasa reversa y clonado en el vector de expresi\u00f3n PinPointTM Xa-1 T (PROMEGA. La prote\u00edna recombinante P fue expresada en E. coli purificada por cromatograf\u00eda de afinidad y usada para la producci\u00f3n del anticuerpo policlonal anti-P. El anticuerpo obtenido fue purificado y caracterizado por inmunocitoqu\u00edmica con un sistema enzim\u00e1tico, inmunofluorescencia, Cell-ELISA fluorom\u00e9trica y Western blotting. Resultados. La prote\u00edna recombinante se expres\u00f3 eficientemente como una prote\u00edna de fusi\u00f3n biotinilada de aproximadamente 50 kd, que corresponde a la forma completa de la prote\u00edna P del virus de la rabia. El anticuerpo policlonal anti-P detect\u00f3 con alta especificidad la prote\u00edna P en cultivos de neuronas sensoriales infectados con el virus de la rabia. Conclusi\u00f3n. La prote\u00edna P recombinante expresada en E. coli se constituy\u00f3 en un ant\u00edgeno espec\u00edfico para producir un anticuerpo policlonal que reconoce la prote\u00edna P nativa en c\u00e9lulas infectadas con el virus de la rabia.\n[\u00bfEs necesario investigar anticuerpos IgM contra el virus de la hepatitis A cuando el enzimograma hep\u00e1tico es normal?](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0325-75412007000300010&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nC. Coitinho\nFull Text Available La hepatitis por virus A (VHA es la m\u00e1s frecuente de las hepatitis virales en el mundo, especialmente en los pa\u00edses subdesarrollados. Donde esta enfermedad es end\u00e9mica, se suelen realizar un gran n\u00famero de estudios de laboratorio para confirmarla. El objetivo del presente trabajo fue evaluar la utilidad de investigar anticuerpos IgM anti hepatitis A (IgM anti-VHA para el diagn\u00f3stico de la VHA en pacientes con niveles s\u00e9ricos normales de aspartato y alanina aminotransferasas (AST/ALT. Todos los pacientes que concurrieron al laboratorio con solicitud de enzimograma hep\u00e1tico y anticuerpos IgM anti-VHA durante el per\u00edodo octubre 2005-marzo 2006 fueron evaluados en este estudio. Los datos cl\u00ednicos m\u00e1s frecuentes fueron presunci\u00f3n de hepatitis e ictericia (27,5 y 12,7%. La determinaci\u00f3n de IgM anti-VHA se realiz\u00f3 por ensayo inmunoenzim\u00e1tico de micropart\u00edculas (MEIA; la de enzimas hep\u00e1ticas en un multianalizador. De los 158 pacientes estudiados, 84 ten\u00edan valores elevados de AST/ALT; dentro de este grupo, el 82% fue reactivo para IgM anti-VHA. Los 74 pacientes restantes mostraron niveles normales de AST/ALT y solo 7 de ellos, bajo control de evoluci\u00f3n por VHA ya confirmada, fueron reactivos para IgM anti-VHA. El 49% de los pacientes IgM anti-VHA reactivos correspondi\u00f3 a menores de 10 a\u00f1os. De acuerdo con estas observaciones, sugerimos que los estudios de laboratorio para confirmar infecci\u00f3n aguda por VHA deber\u00edan realizarse en forma secuencial, ya que es innecesaria la determinaci\u00f3n de anticuerpos IgM anti-VHA cuando las aminotransferasas s\u00e9ricas son normales.\n[Evaluation of anti-Schistosoma mansoni igG antibodies in patients with chronic schistosomiasis mansoni before and after specific treatment Avalia\u00e7\u00e3o da presen\u00e7a de anticorpos IgG anti-Schistosoma mansoni no soro de pacientes com esquistossomose mans\u00f4nica cr\u00f4nica, antes e ap\u00f3s tratamento espec\u00edfico](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0036-46652001000300007) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nC\u00e9lia Maria V. VENDRAME\n2001-06-01\nFull Text Available The circumoval precipitin test (COPT, enzyme-linked immunosorbent assay (ELISA and the immunoblotting anti-adult worm antigen (AWA and soluble egg antigen (SEA tests were applied to 17 chronically schistosome-infected patients for the detection of anti-Schistosoma mansoni antibodies before and on four occasions after oxamniquine administration over a period of six months. Compared to a control group, schistosomiasis patients showed high levels of IgG antibodies in AWA and SEA-ELISA. A decrease in IgG levels was observed six months after treatment, although negative reactions were not obtained. Significant decreases in IgG1, IgG3 and, mainly, IgG4, but not anti-SEA IgG2 levels were observed six months after treatment, again without negativity. Analysis of anti-AWA IgG antibodies by immunoblotting before treatment showed a 31 kDa strand in 14 patients (82% which disappeared in three cases up to six months after treatment; furthermore, anti-SEA IgG antibodies showed the same band in nine patients (53% before treatment, which disappeared in only four cases up to six months after treatment.Em 17 pacientes com infec\u00e7\u00e3o cr\u00f4nica por Schistosoma mansoni utilizaram-se os testes de rea\u00e7\u00e3o periovular, imunoenzim\u00e1tico (ELISA e imunoblotting, empregando-se ant\u00edgenos obtidos a partir de vermes adultos (AWA ou de ovos de S. mansoni (SEA, para detec\u00e7\u00e3o de anticorpos anti-S. mansoni, antes e em quatro ocasi\u00f5es ap\u00f3s tratamento com oxamniquine. Quando cotejados a grupo controle os pacientes esquistossom\u00f3ticos revelaram altos n\u00edveis s\u00e9ricos de anticorpos IgG nos testes ELISA (anti-AWA e anti-SEA, n\u00e3o se observando, por\u00e9m, negativa\u00e7\u00e3o at\u00e9 seis meses ap\u00f3s tratamento espec\u00edfico. Encontrou-se, entretanto, decr\u00e9scimo significativo, sem negativa\u00e7\u00e3o, dos n\u00edveis de IgG1, IgG3 e, principalmente, IgG4, quando se utilizou ant\u00edgeno sol\u00favel obtido a partir de ovos de S. mansoni (SEA, seis meses ap\u00f3s administra\u00e7\u00e3o de oxamniquine. O mesmo n\u00e3o foi\n[Correlation between the Amount of Anti-D Antibodies and IgG Subclasses with Severity of Haemolytic Disease of Foetus and Newborn](http://www.id-press.eu/mjms/article/view/321) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nEmilija Velkova\n2015-05-01\nCONCLUSIONS: The titers of the pregnant women serum those are lower than 32 and those higher than 1000 can well predict HDFN. The titers of anti-D antibodies between 64 and 512 have no exact predictive value. IgG1 and IgG3 subclasses of anti-D have no predictive value by themselves, and cannot foresee the outcome of HDFN. The research study results suggest that IgG1 and IgG3 should be included in a multi \u2013 parameter protocol for evaluation of the HDFN intensity. They can give a real assessment of the expected HDFN intensity in combination with the titer hight and the significance of the antibodies.\n[[Comparison of recent IgG anti-HAV prevalence between two hospitals in Seoul and Gyeonggi area].](https://www.ncbi.nlm.nih.gov/pubmed/17898552)\nKim, Tae Yeob; Sohn, Joo Hyun; Ahn, Sang Bong; Son, Byoung Kwan; Lee, Hang Lak; Eun, Chang Soo; Jeon, Yong Cheol; Han, Dong Soo\n2007-09-01\nRecently, the incidence of acute hepatitis A has increased nationwide and is related to the low rate of IgG anti-HAV. This study compared the prevalence of IgG anti-HAV in two university hospitals located in a large city and in a small city including a rural region according to age, gender, and the year of diagnosis. IgG anti-HAV was measured in a total of 4299 patients, who visited Seoul or Guri Hanyang University Hospital between January 2002 and December 2006. The positive rates of the antibody in Seoul and Guri hospitals were 52.7% vs 57.1% in under the age of 1, 40.7% vs 42.2% in age of 1 to 4, 31.8% vs 30.3% in age of 5 to 9, 24.8% vs 27.1% in age of 10 to 14, 11.6% vs 18.2% in age of 15 to 19, 23.0% vs 20.3% in age of 20 to 24, 40.5% vs 42.9% in age of 25 to 29, 67.5% vs 75.0% in age of 30 to 34, 86.5% vs 88.1% in age of 35 to 39, 95.3% vs 93.6% in age of 40 to 44, 97.0% vs 98.7% in age of 45 to 49, and 98.5% vs 98.6% in patients who were more than 50, respectively. The positive rates of the antibody were not significantly different between two sites according to each age group and gender. The results confirmed the low rates of IgG anti-HAV, particularly in the ages of 10-24 that match the age group of recently increased incidence of acute hepatitis A nationwide. Therefore, measurement of the antibody and vaccination should be considered in this age group.\n[A three-layer immunoradiometric assay for determination of IgG subclass antibodies in Human Sera (''IgG subclass RAST'')](https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=15030919) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nDjurup, R.; Soendergaard, I.; Weeke, B.; University of Copenhagen, Denmark); Magnusson, C.G.M.\n1984-01-01\nWe report the development of a three-layer immunoradiometric assay (TIRA) for measurement of IgG antibodies of all four subclasses in human sera. The first layer consists of diluted human serum, the second layer is monoclonal mouse antibodies to human IgG subclasses, and the third layer is 125 I-labelled rabbit anti-mouse IgG. Monoclonal anti-IgGI, anti-IgG3 and anti-IgG4 reacted only with their complementary IgG subclass, whereas the anti-IgG2 showed slight cross-reactivity to immunoglobins of other subclasses and classes and to light chain proteins. The observed cross-reactivity was found to be without importance, when the TIRA was applied to measurement of IgG subclass antibodies. Equipotency was established by use of appropriate dilutions of the monoclonal antibodies, and the assay was calibrated by use of human reference serum. The TIRA therefore permits reliable inter-individual and intra-individual comparisons of the IgG antibody response in all four subclasses. Non-specific binding obtained with pooled normal human serum was below 0.33%. Inter-assay coefficient of variation was between 18 and 27%. The TIRA was applied to measurement of IgG subclass antibodies to timothy grass pollen in sera from grass pollen allergies undergoing immunotherapy. (author)\n[Pneumococcal polysaccharide vaccination elicits IgG anti-AB blood group antibodies in healthy individuals and patients with Type I diabetes mellitus](http://journal.frontiersin.org/Journal/10.3389/fimmu.2016.00493/full) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nWendelin Wolfram\n2016-11-01\nFull Text Available Hypothesis: Blood group antibodies are natural antibodies that develop early in life in response to cross-reactive environmental antigens in the absence of antigen encounter. Even later in life structural similarities in saccharide composition between environmental antigens such as bacterial polysaccharides and blood group A/B antigens could lead to changes in serum levels, IgM/IgG isotype and affinity maturation of blood group anti-A/B antibodies. We adressed the question whether immunization with pneumococcal polysaccharide (PnP vaccine (PPV Pneumovax\u00ae23 could have such an effect in patients with with type I diabetes mellitus (DM I, an autoimmune disease where an aberrant immune response to microbial antigens likely plays a role.Methods: Anti-PnP IgM and IgG responses were determined by ELISA and the Diamed-ID Micro Typing System was used to screen anti-A/B antibody titer before and after Pneumovax\u00ae23 immunization in 28 healthy individuals and 16 patients with DM I. In addition, surface plasmon resonance (SPR technology using the Biacore\u00ae device and a synthetic blood group A/B trisaccharide as the antigen was applied to investigate IgM and IgG anti-A/B antibodies and to measure antibody binding dynamics. Results: All healthy individuals and DM I patients responded with anti-PnP IgM and IgG antibody production four to six weeks after Pneumovax\u00ae23 (Pn23 immunization, while no increase in blood group anti-A/B antibody titer was observed when measured by the Diamed-ID Micro Typing System. Interestingly, isotype-specific testing by SPR-technology revealed an increase in blood group anti-A/B IgG, but not IgM, following Pn23 immunization in both patients and controls. No change in binding characteristics of blood group anti-A/B antibodies could be detected following Pn23 vaccination, supporting the assumption of an increase in IgG antibody titer with no or very little affinity maturation.Conclusion: The study provides evidence for epitope sharing\n[Development of a polyclonal anti-dugong immunoglobulin G (IgG) antibody with evaluation of total plasma IgG in a living dugong (Dugong dugon) population.](https://www.ncbi.nlm.nih.gov/pubmed/29776608)\nWong, Arthur; Lanyon, Janet M; McKee, Sara J; Linedale, Richard; Woolford, Lucy; Long, Trevor; Leggatt, Graham R\n2018-06-01\nSpecies-specific antibodies (Ab) for the measurement of immunoglobulins (Ig) are valuable tools for determining the humoral immune status of threatened and endangered wildlife species such as dugongs. However, no studies have reported antibody reagents against dugong immunoglobulin. The object of this study was to develop an Ab with specificity for dugong IgG and apply this tool to survey total IgG levels in plasma samples from a live wild population of dugongs in southern Queensland, Australia. Dugong IgG was isolated from plasma by protein A/G column chromatography and a polyclonal antiserum was successfully raised against the dugong IgG through immunization of mice. The anti-dugong antiserum was reactive with dugong serum but not immunoglobulin from other species such as rats and humans. When tested against a panel of dugong plasma samples, relative IgG levels from dugongs (n = 116) showed biologically relevant relationships with pregnancy status and a principal component of Body Mass Index (BMI)/globulin/fecal glucocorticosteroid (chronic stress) levels combined, which together accounted for 9.2% of the variation in total Ig levels. Together these data suggest that dugongs show variation in total IgG and that this correlates with some physiological parameters of dugong health. Copyright \u00a9 2018 Elsevier B.V. All rights reserved.\n[Determinaci\u00f3n de anticuerpos contra Cryptococcus neoformans en un grupo de colomb\u00f3filos](http://www.revistabiomedica.org/index.php/biomedica/article/view/1941) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nCarmen Sof\u00eda Corrales\n1987-12-01\nFull Text Available Se evalu\u00f3 la respuesta humoral, medida como anticuerpos espec\u00edficos anti-Criptococcus neoformans, en 69 sueros de un grupo de colomb\u00f3filos de Bogot\u00e1; grupo considerado como de alto riesgo dado el frecuente contacto con el material contaminado con el microorganismo. Adem\u00e1s se estudiaron 65 sueros de un grupo control constitu\u00eddo por personas dedicadas a actividades diferentes. En las pruebas de inmunofluorescencia indirecta y aglutinaci\u00f3n en tubo, no se evidenci\u00f3 diferencia entre los niveles de anticuerpos de ambos grupos. Se estudiaron adicionalmente 15 palomares con el objeto de aislar el microorganismo lo que se logr\u00f3 en el 66,7% de ellos. En 8 de los aislamientos se hizo serotipificaci\u00f3n del hongo encontr\u00e1ndose que la totalidad correspond\u00eda a C. neoformans var. neoformans.\n[Anticuerpos aviares: alternativa en producci\u00f3n y diagn\u00f3stico](http://www.revistabiomedica.org/index.php/biomedica/article/view/1077) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nCarmen E. Alarc\u00f3n\n2000-12-01\nFull Text Available El uso de anticuerpos para investigaci\u00f3n y diagn\u00f3stico se realiza desde hace varias d\u00e9cadas en todo el mundo. Normalmente, estos anticuerpos se obtienen a partir del suero de mam\u00edferos (roedores, caprinos, equinos, etc.. De acuerdo con el tama\u00f1o del hu\u00e9sped, se pueden producir peque\u00f1as o grandes cantidades de suero, haciendo siempre sangr\u00edas regulares para su recolecci\u00f3n. En los \u00faltimos anos, se han utilizado cada vez con mayor frecuencia anticuerpos purificados a partir de huevos de gallinas inmunizadas, los cuales presentan diferencias con los anticuerpos producidos en mamiferos en su estructura y caracteristicas fisicoqu\u00edmicas, pero, adem\u00e1s, son una alternativa que disminuye el estr\u00e9s e injuria al hu\u00e9sped y tiene alta productividad y facilidad para su recolecci\u00f3n. Se ha informado el uso de estos anticuerpos aviares en ensayos inmunoqu\u00edmicos, producci\u00f3n de conjugados y en terap\u00e9utica con un \u00e9xito similar al de los anticuerpos en mamiferos y a un costo menor. En este trabajo, se hace una revisi\u00f3n del tema y se plantean sus posibles usos tanto en investigaci\u00f3n y diagn\u00f3stico, como en terapia.\n[Anticuerpos antinucleares, im\u00e1genes y caracter\u00edsticas obtenidas por inmunofluorescencia: Importancia de los isotipos IgA, IgM e IgG Antinuclear antibodies, patterns and characteristics obtained by immunofluorescence: The importance of the IgA, IgM and IgG isotypes](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802009000600002) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMiriam Arcavi\n2009-10-01\nFull Text Available La t\u00e9cnica de elecci\u00f3n para el screening de anticuerpos antinucleares (ANA es la inmunofluorescencia indirecta que utiliza como sustrato una l\u00ednea de c\u00e9lulas epiteliales de carcinoma de laringe humano (IFI-HEp2, y como antisuero, anti-IgG o anti-Ig totales. Los ANA-IgG son los m\u00e1s importantes para el diagn\u00f3stico y monitoreo de las enfermedades del tejido conectivo (ETC, mientras los ANA-IgM son de menor relevancia cl\u00ednica en estos pacientes. Sin embargo, poco se sabe de los ANA-IgA ya que estos Ac han sido menos investigados. El objetivo de este trabajo fue estudiar la prevalencia de los diferentes isotipos de inmunoglobulinas de anticuerpos antinucleares en los pacientes con ETC y evaluar la conveniencia de utilizar conjugados monovalentes o polivalentes. Se procesaron 100 sueros de pacientes con diversas ETC empleando IFI-HEp2, en los cuales se detect\u00f3 38% de ANA-IgA (t\u00edtulos \u2265 1:80 y 12% de ANA-IgM (t\u00edtulos \u2264 1:160. En 29 casos se detect\u00f3 IgA en ausencia de IgM, en 3 casos IgM en ausencia de IgA. En todos los casos los ANA-IgG estuvieron presentes. En 6 sueros se observ\u00f3 un cambio de imagen con conjugado anti-IgA y en 3 con conjugado anti-IgM. Debido a la alta prevalencia de ANA-IgA detectada por IFI-HEp2, se destaca la conveniencia de utilizar conjugado anti-Ig totales en lugar de anti-IgG, mientras se desconozca la relevancia de los ANA-IgA en el diagn\u00f3stico, pron\u00f3stico y seguimiento de las enfermedades reum\u00e1ticas sist\u00e9micas.The indirect immunofluorescence with epitelial cell line from human laryngeal carcinoma as substrate (IIF-HEp2 and anti-IgG or anti-total Ig as antisera, is the technique currently used for the detection of antinuclear antibodies. The most important antibodies for the diagnosis and follow-up of connective tissue diseases (CTD are the IgG-ANA, while the IgM-ANA have no clinical relevance. However the IgA-ANA have not been thoroughly investigated so far. The aim of this work was to study the prevalence\n[Human anti-rhesus D IgG1 antibody produced in transgenic plants](http://www.forskningsdatabasen.dk/en/catalog/5787441) [DEFF Research Database (Denmark)](http://forskningsbasen.deff.dk/?lang=eng)\nBouquin, Thomas; Thomsen, Mads; Nielsen, Leif Kofoed\n2002-01-01\nantigen, which is responsible for alloimmunization of RhD- mothers carrying an RhD+ fetus. Anti-RhD extracted from plants specifically reacted with RhD+ cells in antiglobulin technique, and elicited a respiratory burst in human peripheral blood mononuclear cells. Plant-derived antibody had equivalent......Transgenic plants represent an alternative to cell culture systems for producing cheap and safe antibodies for diagnostic and therapeutic use. To evaluate the functional properties of a 'plantibody', we generated transgenic Arabidopsis plants expressing full-length human IgG1 against the Rhesus D...... properties to CHO cell-produced anti-RhD antibody, indicating its potential usefulness in diagnostic and therapeutic programs....\n[Performance Evaluation of the VIDAS\u00ae Measles IgG Assay and Its Diagnostic Value for Measuring IgG Antibody Avidity in Measles Virus Infection](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4997596)\nDina, Julia; Creveuil, Christian; Gouarin, Stephanie; Viron, Florent; Hebert, Amelie; Freymuth, Francois; Vabret, Astrid\n2016-01-01\nThe objective of this study is primarily to compare the performance of the VIDAS\u00ae Measles immunoglobulin (Ig)G assay to that of two other serological assays using an immunoassay technique, Enzygnost\u00ae Anti-measles Virus/IgG (Siemens) and Measles IgG CAPTURE EIA\u00ae (Microimmune). The sensitivity and the agreement of the VIDAS\u00ae Measles IgG assay compared to the Enzygnost\u00ae Anti-measles Virus/IgG assay and the Measles IgG CAPTURE EIA\u00ae assay are 100%, 97.2% and 99.0%, 98.4%, respectively. The very low number of negative sera for IgG antibodies does not allow calculation of specificity. As a secondary objective, we have evaluated the ability of the VIDAS\u00ae Measles IgG assay to measure anti-measles virus IgG antibody avidity with the help of the VIDAS\u00ae CMV IgG Avidity reagent, using 76 sera from subjects with measles and 238 other sera. Different groups of populations were analyzed. In the primary infection measles group, the mean IgG avidity index was 0.16 (range of 0.07 to 0.93) compared to 0.79 (range of 0.25 to 1) in the serum group positive for IgG antibodies and negative for IgM. These data allow to define a weak anti-measles virus IgG antibody avidity as an avidity index (AI) 0.6. The VIDAS\u00ae Measles IgG assay has a performance equivalent to that of other available products. Its use, individual and quick, is well adapted to testing for anti-measles immunity in exposed subjects. PMID:27556477\n[IgG and IgG subclasses antibody responses to rK39 in Leishmania donovani infections](http://www.iaea.org/inis/collection/NCLCollectionStore/_Public/30/018/30018792.pdf?r=1) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nDaifalla, N.S.; El Hassan, A.M.\n1998-01-01\nLeishmania donovani infection cause a wide spectrum of human diseases ranging from self-healing subclinical infections to severe visceral leishmaniasis, post kal-azar dermal leishmaiasis, and mucosal leishmaiasis. The infection associated with high levels of anti-leishmania antibodies which offer a potential parameter for the serological diagnosis of L. donovani infection replacing the invasive parasitological methods. rK39, a cloned antigen of L. chagasis was reported to have high levels of anti-leishmania antibodies in Sudanese and American visceral leishmaniasis patients. In an assessment of rK39-ELISA in detecting L. donovani infection we found that the antigen detected visceral leishmaniasis, post kala-azar dermal leishmaniasis, and mucosal leismaniasis with the sensitives of 96.6%, 95.91% and 90.91% respectively. The test has the specificity of 96.7%. Further investigation of 25 visceral leishmaniasis patients showed elevated anti-rK39 antibody responses of IgG subclasses with IgG1 and IgG3 significantly higher than IgG4. igG3 showed the highest sensitivity (84.00%) whereas IgG1 showed the highest sensitivity (100%). The dynamics of the serological reactivity to rK39 in l.donovani infections will be discussed in relation to exposure, infection, cure and relapse.(Author)\n[Correlation between the Amount of Anti-D Antibodies and IgG Subclasses with Severity of Haemolytic Disease of Foetus and Newborn.](https://www.ncbi.nlm.nih.gov/pubmed/27275238)\nVelkova, Emilija\n2015-06-15\nThe aim of this study was to investigate the influence of subclasses to IgG anti-D on the intensity of hemolytic disease of fetus and newborn (HDFN) at 45 fetuses/newborns with symptoms of mild and severe HDFN in Republic of Macedonia. In retrospective and prospective studies, in a period of 10 years, from 2004 to 2014, there have been immunohemathology tests performed on 22 009 samples on serums of pregnant women. At 37.78% of the total number of tested patients, IgG1 and IgG3 was the reason for severe HDFN. At 17.77% of the total number of tested patients, which had only IgG1detected, was the reason for serious intensity of HDFN. The correlation of the titer to anti-D antibodies in the mother's serum and the intensity of HDFN were researched in 48 newborns. The titers between 1:8 and 1:32 resulted in 3 cases of HDFN with symptoms of severe disease and in 4 cases there were no signs of HDFN. At 12 women that had a titre between 1:32 and 1:512, five of the newborns developed severe HDFN, and seven had symptoms of mild and weak intensity form. In 3 cases the titer was higher than 512, and out of them one newborn had weak symptoms of HDFN, one developed severe HDFN and one ended with foetal death. Only in one case the titer reached a value higher than 1000, and it ended with a fetal death. The titers of the pregnant women serum those are lower than 32 and those higher than 1000 can well predict HDFN. The titers of anti-D antibodies between 64 and 512 have no exact predictive value. IgG1 and IgG3 subclasses of anti-D have no predictive value by themselves, and cannot foresee the outcome of HDFN. The research study results suggest that IgG1 and IgG3 should be included in a multi - parameter protocol for evaluation of the HDFN intensity. They can give a real assessment of the expected HDFN intensity in combination with the titer hight and the significance of the antibodies.\n[Production and characterization of anti-human IgG F(ab')2 antibody fragment.](https://www.ncbi.nlm.nih.gov/pubmed/29689714)\nValedkarimi, Zahra; Nasiri, Hadi; Aghebati-Maleki, Leili; Abdolalizadeh, Jalal; Esparvarinha, Mojghan; Majidi, Jafar\n2018-04-10\nIn present study an optimized protocol for the separation of antibodies into antigen-binding fragments F(ab')2 using pepsin digestion was investigated. The production of these fragments is a consequential step in the development of medical research, treatment and diagnosis. For production of polyclonal antibody rabbit received antigen in four steps. The rabbit serum at 1/128000 dilution showed high absorbance in reaction with human IgG at the designed ELISA method. Rabbit IgG was purified by Ion-Exchange Chromatography (IEC) method. Purity was assessed by SDS-PAGE method. In non-reduced condition only one band was seen in about 150 kDa MW position and in reduced form, two bands were seen in 50 and 25 kDa MW positions. Rabbit IgG was digested by pepsin enzyme. The antibody fragments solution was applied to Gel filtration column to isolate the F(ab')2. Non-reduced SDS-PAGE for determining the purity of F(ab')2 fragment resulted in one band in 100 kDa corresponds to F(ab')2 fragment and a band in 150 kDa MW position corresponds to undigested IgG antibodies. The activities of FITC conjugated F(ab')2 fragment and commercial ones were compared using flowcytometry method. The activity results implied that the FITC conjugated- anti human F(ab')2 fragment worked as efficiently as the commercial one.\n[Anticuerpos anti-HLA y rechazo agudo del injerto renal en los ni\u00f1os](https://www.openaire.eu/search/publication?articleId=od_______612::4450a66f555dc64f379f8e241722c40b)\nGaleas, Rub\u00e9n Arturo; Gomezchico-Velasco, Rebeca; Valverde, Sa\u00fal; Ram\u00f3n-Garc\u00eda, Guillermo; Vel\u00e1squez-Jones, Luis; Romero-Navarro, Benjam\u00edn; Hern\u00e1ndez, Ana Mar\u00eda; Vargas, Arindal; Leo, Claudia de; Medeiros, Mara\n2010-01-01\nIntroducci\u00f3n. A pesar de que las nuevas terapias inmunosupresoras han mejorado notablemente la evoluci\u00f3n cl\u00ednica de los trasplantes renales, los rechazos agudo y cr\u00f3nico siguen limitando la sobrevida a largo plazo del injerto. En base a lo anterior, el objetivo de este estudio fue determinar la presencia de anticuerpos s\u00e9ricos contra ant\u00edgenos de histocompatibilidad (HLA) clase I y clase II en ni\u00f1os con rechazo agudo del injerto renal. M\u00e9todos. Se realiz\u00f3 un estudio cl\u00ednico prospectivo en pac...\n[IgG subclass reactivity to Trypanosoma cruzi in chronic chagasic patients.](https://www.ncbi.nlm.nih.gov/pubmed/11665655)\nHern\u00e1ndez-Becerril, N; Nava, A; Reyes, P A; Monte\u00f3n, V M\n2001-01-01\nThe anti-Trypanosoma cruzi antibodies isotype profile in Chagas' disease has been studied in relation to different clinical manifestations. A high titer of IgG anti-T. cruzi antibodies is found in patients with cardiac involvement, while a high titer of IgA anti-T. cruzi antibodies is associated with digestive forms. The aim of this work was to analyze the IgG subclass reactivity of anti-T. cruzi antibodies in patients with chronic Chagasic cardiomyopathy. Twelve consecutive chagasic patients were analyzed for IgG subclass reactivity to a T. cruzi antigenic extract. They had a complete clinical evaluation, peripheral EKG, echocardiography, left ventriculogram, and coronariography. All patients came from rural areas of Mexico and had lived in endemic zones for over seven years. They presented left ventricular endsystolic dimension above 42 mm in 58% (7/12) and ejection fraction below 50% in 58% (7/12). We found that IgG1 and IgG2 anti-T. cruzi antibodies showed higher titer than IgG3 antibodies, with consistently low titer of IgG4 antibodies. Expression of the four IgG subclasses of anti-T. cruzi antibodies suggest a mixed Th1/Th2-like immune response under a probably continuous chronic antigenic stimulation. On the other hand, high levels of IgG2 anti-T. cruzi antibodies showed a tendency to be associated with severe cardiomegaly. Our results suggest that a mixed Th1/Th2-like immune response may take place in chronic chagasic patients under a chronic antigenic stimulation.\n[Prevalencia de anticuerpos contra Leptospira en personas asintom\u00e1ticos y en perros de Chancay, Lima 2001](http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1726-46342007000400004&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nManuel C\u00e9spedes\n2007-10-01\nFull Text Available Objetivos. Determinar la prevalencia de anticuerpos contra Leptospiras en personas asintom\u00e1ticas dedicadas a la agricultura, pesca y comercio y en perros dom\u00e9sticos de localidades de Chancay (Huaral, Lima. Material y m\u00e9todos. Estudio transversal anal\u00edtico, se tom\u00f3 muestras de suero de 268 pobladores de tres localidades, en quienes se evalu\u00f3 la presencia de anticuerpos totales contra Leptospiras por el m\u00e9todo de ELISA IgG y la prueba de microaglutinaci\u00f3n (MAT. Se buscaron los factores asociados con la positividad a Leptospiras calculando el OR con su intervalo de confianza al 95%. De la misma manera, se tom\u00f3 muestras de suero de 241 perros a los que se realiz\u00f3 la prueba de MAT. Resultados. La prevalencia de anticuerpos contra Leptospira en poblaci\u00f3n asintom\u00e1tica fue de 10,1% (IC95%: 6,3-13,9, la cual estuvo asociada con el abastecimiento de agua para consumo en quebrada o pozo (OR: 3,48, IC95%: 1,39-8,74, con el antecedente de nadar en el r\u00edo o acequia (OR: 4,75, IC95%: 1,51-14,92 y con tener una edad entre 21-40 a\u00f1os (OR: 2,47, IC95%: 1,10-5,52. Los serovares m\u00e1s frecuentes fueron Icterohaemorrhagiae y Canicola seg\u00fan MAT. En canes, 27,8% (67/241 tuvieron serolog\u00eda positiva a leptospiras. Conclusiones. Existe una mediana prevalencia de serolog\u00eda positiva para Leptospiras en la poblaci\u00f3n general asintom\u00e1tica y condiciones favorables para la presencia de Leptospiras en las localidades estudiadas. En estas zonas se recomienda realizar actividades educativas preventivas frecuentes, tomando en cuenta los resultados de este estudio y el personal de salud debe sospechar de la leptospirosis como una causa de enfermedad febril.\n[Detecting fish parvalbumin with commercial mouse monoclonal anti-frog parvalbumin IgG.](https://www.ncbi.nlm.nih.gov/pubmed/16848548)\nChen, Lingyun; Hefle, Sue L; Taylor, Steve L; Swoboda, Ines; Goodman, Richard E\n2006-07-26\nParvalbumin is a calcium-binding muscle protein that is highly conserved across fish species and amphibians. It is the major cross-reactive allergen associated with both fish and frog allergy. We used two-dimensional electrophoretic and immunoblotting techniques to investigate the utility of a commercial monoclonal anti-frog parvalbumin IgG for detecting parvalbumin present in some commonly consumed fish species. The 2D electrophoresis and immunoblots revealed species-specific differences in proteins that appear to represent various numbers of isoforms of parvalbumin in carp (5), catfish (3), cod (1) and tilapia (2). No parvalbumin was detected in yellowfin tuna. Based on minor differences in relative intensities of protein staining and immunodetection, parvalbumin isoforms may have slight differences in the epitope region recognized by the anti-frog parvalbumin antibody. These results suggest that the frog anti-parvalbumin antibody can be used as a valuable tool to detect parvalbumins from the fish tested in this study, except yellowfin tuna.\n[Goat anti-rabbit IgG conjugated fluorescent dye-doped silica nanoparticles for human breast carcinoma cell recognition.](https://www.ncbi.nlm.nih.gov/pubmed/24179992)\nChen, Min-Yan; Chen, Ze-Zhong; Wu, Ling-Ling; Tang, Hong-Wu; Pang, Dai-Wen\n2013-11-12\nWe report an indirect method for cancer cell recognition using photostable fluorescent silica nanoprobes as biological labels. The dye-doped fluorescent silica nanoparticles were synthesized using the water-in-oil (W/O) reverse microemulsion method. The silica matrix was produced by the controlled hydrolysis of tetraethylorthosilicate (TEOS) in water nanodroplets with the initiation of ammonia (NH3\u00b7H2O). Fluorescein isothiocyanate (FITC) or rhodamine B isothiocyanate conjugated with dextran (RBITC-Dextran) was doped in silica nanoparticles (NPs) with a size of 60 \u00b1 5 nm as a fluorescent signal element by covalent bonding and steric hindrance, respectively. The secondary antibody, goat anti-rabbit IgG, was conjugated on the surface of the PEG-terminated modified FITC-doped or RBITC-Dextran-doped silica nanoparticles (PFSiNPs or PBSiNPs) by covalent binding to the PEG linkers using the cyanogen bromide method. The concentrations of goat anti-rabbit IgG covering the nanoprobes were quantified via the Bradford method. In the proof-of-concept experiment, an epithelial cell adhesion molecule (EpCAM) on the human breast cancer SK-Br-3 cell surface was used as the tumor marker, and the nanoparticle functionalized with rabbit anti-EpCAM antibody was employed as the nanoprobe for cancer cell recognition. Compared with fluorescent dye labeled IgG (FITC-IgG and RBITC-IgG), the designed nanoprobes display dramatically increased stability of fluorescence as well as photostability under continuous irradiation.\n[Clearance of red cells by monoclonal IgG3 anti-D in vivo is affected by the VF polymorphism of Fcgamma RIIIa (CD16)](https://www.narcis.nl/publication/RecordID/oai%3Apure.amc.nl%3Apublications%2F87c26126-c5e9-4525-ad23-1f452ebb923c/uquery/Anti%20AND%20D/id/15/Language/EN)\nKumpel, B. M.; de Haas, M.; Koene, H. R.; van de Winkel, J. G. J.; Goodrick, M. J.\n2003-01-01\nHuman red cells (RBC) coated with IgG anti-D are cleared from the circulation to the spleen by macrophages which express IgG receptors (Fcgamma R). Polymorphisms of Fcgamma RIIa and Fcgamma RIIIa affect IgG binding in vitro, and may alter the efficiency of clearance of immune complexes in vivo. In a\n[Asociaci\u00f3n entre enfermedad cardiovascular y anticuerpos contra Chlamydia pneumoniae Association between cardiovascular disease and antibodies against Chlamydia pneumoniae](http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342002000300008) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nGuadalupe de los A Garc\u00eda-Elorriaga\n2002-06-01\nFull Text Available Objetivo. Precisar si existe asociaci\u00f3n entre enfermedad cardiovascular (ECV y anticuerpos contra Chlamydia en poblaci\u00f3n mexicana. Material y m\u00e9todos. Estudio transversal, realizado en la Unidad de Investigaci\u00f3n en Inmunolog\u00eda e Infectolog\u00eda -Hospital de Infectolog\u00eda del Centro M\u00e9dico Nacional La Raza (CMNR- y en el Servicio de Cirug\u00eda Cardiovascular y Asistencia Circulatoria, del Hospital General del CMNR, Instituto Mexicano del Seguro Social (IMSS, de agosto de 1998 a abril de 2000. Se determinaron anticuerpos IgG e IgM contra C. psittaci, C. trachomatis y C. pneumoniae mediante microinmunofluorescencia, en suero de 70 pacientes con ECV hospitalizados en el CMNR, mayores de 30 a\u00f1os, de uno u otro sexo, y se compararon con 140 sanos, pareados por edad y sexo. Se utilizaron muestras aleatorias simples, con un tama\u00f1o poblacional de 110, una prevalencia de 50% y un nivel de confianza de 99%. Para establecer la diferencia entre las proporciones de los t\u00edtulos se utiliz\u00f3 ji cuadrada y se calcul\u00f3 la raz\u00f3n de momios. Resultados. El 94.3% (66/70 de los pacientes present\u00f3 IgG en contra de C. pneumoniae vs 37% (52/140 de los individuos sanos (pObjective. To evaluate the association between cardiovascular disease (CVD and antibodies against Chlamydia in Mexican population. Material and Methods. A cross-sectional study was conducted from August 1988 to April 2000, at the Immunology and Infectology Research Unit of Hospital de Infectolog\u00eda, Centro M\u00e9dico Nacional La Raza (CMNR- and at the Cardiovascular Surgery and Circulatory Care, Hospital General CMNR, Instituto Mexicano del Seguro Social (IMSS. Study subjects were 70 CVD hospitalized patients, older than 30 years, from both genders. Serum IgG and IgM antibodies against C. psitaccii, C. trachomatis and C. pneumoniae were determined by microimmunofluorescence in study subjects and compared with those from 140 healthy individuals, matched by age and sex. Simple random sampling was used\n[Production of double antibody for radioimmunoassay (sheep anti-rabbit IgG antiserum); Producao de duplo anticorpo para radioimunoensaio (antissoro de carneiro anti-IgG de coelho)](https://www.osti.gov/etdeweb/biblio/38160) [Energy Technology Data Exchange (ETDEWEB)](https://www.etde.org/etdeweb/fieldedsearch.jsp)\nSilva, S.R. da\n1994-12-31\nA second antibody (sheep anti-rabbit IgG antiserum) to be used in RIAs in which the first antibody is raised in rabbits was produced. For this production, initially the IgG was isolated from rabbit serum and purified by sodium sulphate precipitation followed by ion exchange chromatography on DEAE-cellulose. Four sheep were immunized with 500 u g of purified rabbit IgG, emulsified in Freund Complete Adjuvant and administered by multisite subcutaneous injections. These injections were repeated at 20-days intervals and blood samples (40 ml) were taken from the jugular vein 10 days after the boosts for the evaluation of the antisera title. After each four boosts a great bleeding was done by the same route. Approximately 500 ml of serum were obtained in each bleeding per animal. The antisera were evaluated by the human thyrotropin RIA developed at IPEN laboratories employing reagents provided by NIDDKD, USA. These evaluations referred to the determination of the antisera title and of the ideal concentration of carrier IgG, to the study of the kinetic of precipitation and to the confirmation of the inexistent cross-reactivity with human IgG, in comparison with a reference antiserum of know precipitation characteristics supplied by the Radioassay System Laboratories. Approximately 3,6 l of antiserum (sheep anti-rabbit IgG serum) were produced from the four sheep, which presented title and precipitation characteristics very similar to those exhibited by the imported commercial product, even presenting higher titles. The results obtained in this work indicated that it was created enough experience for the production of this biological reagent for RIA, that could be done integrally in the country in greater scale, and at a very reduced cost. (author). 81 refs, 36 figs, 33 tabs.\n[Asma y deficiencia de subclases de IgG Asthma and IgG subclases deficiency](http://www.iatreia.udea.edu.co/index.php/iatreia/article/view/474) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nLuc\u00eda Santamar\u00eda Ortiz\n1995-04-01\nFull Text Available\nSe estudiaron 45 pacientes asm\u00e1ticos adultos de dif\u00edcil manejo, de m\u00e1s de 5 a\u00f1os de evoluci\u00f3n, 37 de ellos esteroide dependientes y 8 no dependientes, con asma al\u00e9rgica o intr\u00ednseca y algunos con Infecciones respiratorias recurrentes de predominio viral. Por nefelometr\u00eda se midieron los niveles s\u00e9ricos de las IgsG, M y A, y por ELISA se determin\u00f3 la IgE total. Se encontraron 4 pacientes con deficiencia de IgG total, en el grupo de los esteroide dependientes. Mediante ELISA tipo sandwich y con anticuerpos monoclonales espec\u00edficos para las sub clases de IgG se investigaron los niveles s\u00e9 ricos de IgG1, 2, 3 y 4. En el 55.6% de los enfermos se encontraron una O m\u00e1s deficiencias de sub clases. No hubo diferencias significativas entre los grupos esteroide y no esteroide dependientes, ni entre los asm\u00e1ticos al\u00e9rgicos e intr\u00ednsecos, ni entre los con infecci\u00f3n recurrente o sin ella. predomin\u00f3 la deficiencia de IgG1; en total el 46.7% de los pacientes ten\u00edan deficiencia aislada o combinada de IgG1, el 31.1% de IgG2, el 24.4% de IgG3 y el 17.8% de Igd4. La alta incidencia de deficiencia de sub clases podr\u00eda deberse a la acci\u00f3n de los esteroides o a una alteraci\u00f3n en la regulaci\u00f3n de la s\u00edntesis de Igs producida por un defecto Inmune primario. Esta deficiencia ser\u00eda la responsable del comportamiento agresivo de la enfermedad.\nWe studied 45 adult asthmatic patients with difficult to care disease and who had more than five years of evolution; they suffered from elther allergic or intrinsic asthma and some had experienced recurrent respiratory tract infections. predominantly of viral etiology. Serum levels of IgA, IgG and IgM were measured by nephelometry and total lgE was determined by an Enzyme-Linked immunosorbent Assay (ELISA. Total lg\n[Clearance of red cells by monoclonal IgG3 anti-D in vivo is affected by the VF polymorphism of Fc gamma RIIIa (CD16)](https://www.narcis.nl/publication/RecordID/oai%3Apure.rug.nl%3Apublications%2F7c0cedcf-64d0-4052-b30a-f29b12972020/uquery/Anti%20AND%20D/id/10/Language/EN)\nKumpel, BM; De Haas, M; Koene, HR; Van de Winkel, JGJ; Goodrick, MJ\nHuman red cells (RBC) coated with IgG anti-D are cleared from the circulation to the spleen by macrophages which express IgG receptors (Fcgamma R). Polymorphisms of Fcgamma RIIa and Fcgamma RIIIa affect IgG binding in vitro , and may alter the efficiency of clearance of immune complexes in vivo. In\n[Identifying anti-Toxocara IgG antibodies in horses of Mexico](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-09352018000100001&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nR. Heredia\nFull Text Available ABSTRACT Both the presence of owned dogs and stray dogs allows the spread of Toxocara, a parasite whose eggs can be found in soil, water and food. Animals, including horses, serve as definitive and paratenic hosts. In M\u00e9xico, where consumption of horse meat is common, Toxocara is a zoonotic parasite. The aim of this study was to identify the presence of anti-Toxocara antibodies in work horses and horses intended for human consumption by ELISA. ELISA was chosen for analysis as paratenic hosts do not shed Toxocara eggs in their feces. Blood samples were collected from a total of 188 horses, 94 of which were work horses and 94 horses from the slaughter house. Samples were analyzed by ELISA, and the general equine seroprevalence was found to be 44.6% (n = 188. Adult horses for slaughter had a 61.7% greater presence of anti-Toxocara antibodies (p = 0.006. Toxocara IgG antibodies were found in horses, confirming that horses are paratenic hosts and possible sources of infection for other animals and people.\n[Antimalaric antiobodies in school children in El Bagre, Colombia Detecci\u00f3n de anticuerpos antimal\u00e1ricos en un grupo de escolares del municipio de El Bagre, Antioquia](http://www.iatreia.udea.edu.co/index.php/iatreia/article/view/416) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nIsabel Polanco\n1998-01-01\nFull Text Available A cases and controls study was carried out in 1996 in El Bagre, Colombia, endemic zone for malaria, in order to determine the relationship between nutritional situation and immune response to malaria in 51 children with malaria and 49 without it; IgG and IgM antibodies were determined by means of indirect inmunofluorescence .against P. falciparum antigens (Strain FCB2. Nutritional situation was evaluated according to USA National Center for Health Statistics. No child was found positive for IGM antibodies; concerning IgG response, it was positive in 29 (56.9% malaric children but only in 4 (8.2% of the non-malaric ones (p<0.00001 . Difference was also signjficant (p<0.00001 for malarja antecedents in the previous year (70.6% in malaric children vs 10.2% jn the nonmalaric ones. Of the 29 malaric seropositive children 20 (69% were malnourished (p<0.01 . En 1996, en el municipio de El Bagre (Antioquia-Colombia, zona end\u00e9mica para malaria y con altos niveles de desnutrici\u00f3n, se realiz\u00f3 un estudio de casos y controles con el objeto de determinar la relaci\u00f3n entre el estado nutricional y la respuesta inmune humoral de ni\u00f1os con y sin malaria. Se trabaj\u00f3 con un grupo de 100 ni\u00f1os entre 4 y 9 a\u00f1os de edad, 51 con malaria y 49 sin ella, al cual se le determinaron los niveles de anticuerpos antimal\u00e1ricos IgG e IgM por la t\u00e9cnica de inmunofluorescencia indirecta (IFI, empleando antigenos de P. falciparum cepa FCB 2 mantenida en cultivo continuo. El estado nutricional se evalu\u00f3 por comparaci\u00f3n de las medidas antropom\u00e9tricas con la referencia de crecimiento del National Center for Health Statistics (NCHS de los Estados Unidos. Los resultados mostraron diferencias en la tasa de positividad de anticuerpos IgG entre los ni\u00f1os mal\u00e1ricos y los no mal\u00e1ricos. En efecto: Veintinueve ni\u00f1os mal\u00e1ricos (56.9% y s\u00f3lo 4 de los no mal\u00e1ricos (8.2% ten\u00edan dichos anticuerpos (P<0.00001 ; la diferencia tambi\u00e9n fue significativa para el antecedente de\n[Seroprevalence of hepatitis B e antigen (HBe antigen and B core antibodies (IgG anti-HBcore and IgM anti-HBcore among hepatitis B surface antigen positive blood donors at a Tertiary Centre in Nigeria](http://www.biomedcentral.com/1756-0500/5/167) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAkinbami Akinsegun A\n2012-03-01\nFull Text Available Abstract Background Hepatitis B virus (HBV is a common cause of liver disease throughout the world. HBV is transmitted through blood and other body fluids, including semen and saliva. Chronic replication of HBV virons is characterized by persistence circulation of HBsAg, HBeAg and HBV DNA; usually with anti-HBc and occasionally with anti-HBs. Aim: To determine the prevalence of HBeAg, IgG anti-HBcore and IgM anti-HBcore amongst HBsAg positive blood donors. These parameters are reflective of transmissibility and active hepatitis B infection. A cross sectional study was carried out at the blood donor clinics of Lagos State University Teaching Hospital Ikeja and Lagos University Teaching Hospital Idiaraba. A total of 267 donors were recruited to determine HBe antigen, IgG and IgM anti-HBcore antibodies amongst hepatitis BsAg positive donors. Five milliliters of blood was collected from those who tested positive to HBsAg screen during donation. The sera were subjected to enzyme linked immunosorbent assay (ELISA. Pearson chi-squared test was used for the analytical assessment. Findings A total number of 267 HBsAg positive blood donors were studied. A seroprevalence of 8.2% (22 of 267 HBeAg was obtained, 4 of 267 (1.5% were indeterminate while 241 (90.3% tested negative. Only 27 out of 267 donors (10.1% tested positive to IgM anti-HBcore, 234(87.6% tested negative, while 6(2.2% were indeterminate. A higher percentage of 60.7% (162 of 267 tested positive to IgG anti-HBcore, while 39.3% (105 of 267 tested negative. Conclusion There is a low seroprevalence rate of HBeAg-positive chronic hepatitis and relatively high IgG anti-HBcore and IgM anti-HBcore rates in South West Nigeria.\n[Study of chronic hemolytic anaemia patients in Rio de Janeiro: prevalence of anti-human parvovirus B19 IgG antibodies and the developement aplastic crises](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0036-46652002000400002) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nSANT'ANNA Anadayr L.M.\n2002-01-01\nFull Text Available The prevalence of anti-human parvovirus B19 IgG antibodies was determined in sera from 165 chronic hemolytic anemia patients, receiving medical care at Instituto Estadual de Hematologia (IEHE, Rio de Janeiro, during the year of 1994. This sample represents around 10% of the chronic hemolytic anemia patients attending at IEHE. Most of these patients (140 have sickle cell disease. Anti-B19 IgG antibodies were detected in 32.1% of patients. No statistically significant difference (p > 0.05 was seen between IgG antibody prevalence in male (27.8% and female (35.5% patients. Anti-B19 IgG antibodies were more frequent in older (37.6% than younger (28.2% than 20 years old patients, although this difference had no statistical significance (p > 0.05. Anti-B19 IgG antibody prevalence showed that 67.9% of patients enrolled in the study were susceptible to B19 acute infection. With the aim to detect acute B19 infection, patients follow up continued until February 1996. During this period four patients presented transient aplastic crisis due to human parvovirus B19 as confirmed by the detection of specific IgM antibodies. All four patients were younger than 20 years old, and 3 were younger than 10 years old. Three of them were sickle cell disease patients. Three of the four acute B19 infection occurred during 1994 springtime.\n[Detec\u00e7\u00e3o de imunoglobulinas IgG, IgM e IgA anti-Toxoplasma gondii no soro, l\u00edquor e saliva de pacientes com s\u00edndrome da imunodefici\u00eancia adquirida e neurotoxoplasmose Detection of anti-Toxoplasma gondii IgG, IgM and IgA immunoglobulins in the serum, cerebrospinal fluid and saliva of patients with acquired immunodeficiency syndrome and neurotoxoplasmosis](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2004000600019) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAercio Sebasti\u00e3o Borges\n2004-12-01\nFull Text Available Estudamos 55 pacientes com sindrome da imunodefici\u00eancia adquirida (SIDA e neurotoxoplasmose (grupo 1; 37 pacientes com SIDA e comprometimento neurol\u00f3gico por outra etiologia (grupo 2 e 18 indiv\u00edduos anti-HIV negativos com manifesta\u00e7\u00f5es neurol\u00f3gicas (grupo 3, pesquisando IgG, IgA e IgM anti-Toxoplasma gondii, no soro, l\u00edquor e saliva, utilizando teste ELISA, para fins diagn\u00f3sticos. O valor preditivo negativo do teste para o encontro de IgG no soro foi 100% e no l\u00edquor, 92,4%. N\u00e3o houve diferen\u00e7a entre os tr\u00eas grupos quanto aos anticorpos IgA neste material. Para IgA, no l\u00edquor, o teste alcan\u00e7ou 72,7% de especificidade (pWe studied 55 patients with acquired immunodeficiency syndrome (AIDS and neurotoxoplasmosis (group 1, 37 patients with AIDS and neurological involvement due to another etiology (group 2 and 18 anti-HIV-negative individuals with neurological manifestations, by searching for anti-T. gondii IgG, IgA and IgM immunoglobulins in serum, cerebrospinal fluid (CSFand saliva, using ELISA. The negative predictive value of the test for IgG in serum was 100% and in CSF, 92.4%. There was no difference among the three groups studied regarding IgA in serum. For IgA, in CSF the test reached 72.7% specificity (p<0.05. In saliva, only the detection of IgG was found to be correlated with a diagnosis of neurotoxoplasmosis. We emphasize that the absence of anti-T. gondii IgG antibodies in serum and CSF strongly indicates the absence of a diagnosis of neurotoxoplasmosis and that specific IgA immunoglobulins in CSF and IgG in saliva may represent two auxiliary markers for the differential diagnosis of toxoplasmic encephalitis in AIDS.\n[Perfil de isotipos de imunoglobulinas e subclasses de IgG na leishmaniose tegumentar americana Immunoglobulin isotype and IgG subclass profiles in american tegumentary leishmaniasis](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822005000200002) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMaria Aparecida de Souza\n2005-04-01\nFull Text Available O presente trabalho avaliou o perfil de anticorpos em amostras de soro de 37 pacientes com diagn\u00f3stico cl\u00ednico confirmado ou compat\u00edvel com leishmaniose tegumentar americana atendidos no Hospital de Cl\u00ednicas da Universidade Federal de Uberl\u00e2ndia, MG. Os perfis das classes de imunoglobulinas e subclasses de IgG foram analisados pelo teste ELISA indireto, utilizando-se ant\u00edgeno sol\u00favel de Leishmania (Leishmania amazonensis. A avidez dos anticorpos foi determinada pelo tratamento com ur\u00e9ia a 6 M, ap\u00f3s incuba\u00e7\u00e3o dos soros com o ant\u00edgeno. Observou-se que 97%, 94,6%, 57,5 e 21,5% das amostras testadas apresentaram anticorpos anti-Leishmania das classes IgE, IgG, IgA e IgM, respectivamente e, os perfis das subclasses de IgG demonstraram, IgG1>IgG3>IgG2>IgG4. Os anticorpos IgE anti-Leishmania de alta avidez corresponderam a 44,4%. Por outro lado, IgG e IgA anti-Leishmania foram em sua maioria (62,8 e 47,8%, respectivamente, de m\u00e9dia avidez. A varia\u00e7\u00e3o do perfil de isotipos, bem como a avidez das imunoglobulinas refletiu a complexidade da resposta imune humoral contra a leishmaniose tegumentar americana.The present work investigated the serum antibody profiles in 37 patients with American tegumentary leishmaniasis, who were attended at Hospital de Clinicas - Universidade Federal de Uberlandia, MG, Brazil. The immunoglobulin class and IgG subclass profiles were analyzed by indirect ELISA using Leishmania (Leishmania amazonensis soluble antigen. The antibody avidity was determined by 6 M urea treatment after incubation with immunoenzymatic conjugate. It was observed that 97% of the serum samples presented anti-Leishmania antibodies for IgE class, 94.6% IgG, 57.5% IgA and 21.5% IgM class. For IgG subclasses the profiles were in the following order of frequency: IgG1>IgG3>IgG2>IgG4. High avidity of anti-Leishmania IgE antibodies was found in 44.4% of the samples. On the other hand, moderate avidity of specific IgG and IgA was observed in 62\n[Anti-Transforming Growth Factor \u03b2 IgG Elicits a Dual Effect on Calcium Oxalate Crystallization and Progressive Nephrocalcinosis-Related Chronic Kidney Disease.](https://www.ncbi.nlm.nih.gov/pubmed/29651290)\nSteiger, Stefanie; Grill, Julia Felicitas; Ma, Qiuyue; B\u00e4uerle, Tobias; Jordan, Jutta; Smolle, Michaela; B\u00f6hland, Claudia; Lech, Maciej; Anders, Hans-Joachim\n2018-01-01\nCrystallopathies are a heterogeneous group of diseases caused by intrinsic or environmental microparticles or crystals, promoting tissue inflammation and scarring. Certain proteins interfere with crystal formation and growth, e.g., with intrarenal calcium oxalate (CaOx) crystal formation, a common cause of kidney stone disease or nephrocalcinosis-related chronic kidney disease (CKD). We hypothesized that immunoglobulins can modulate CaOx microcrystal formation and crystal growth and that therefore, biological IgG-based drugs designed to specifically target disease modifying proteins would elicit a dual effect on the outcome of CaOx-related crystallopathies. Indeed, both the anti-transforming growth factor (TGF)\u03b2 IgG and control IgG1 antibody impaired CaOx crystallization in vitro , and decreased intrarenal CaOx crystal deposition and subsequent CKD in mice on an oxalate-rich diet compared to oxalate-fed control mice. However, the TGF\u03b2-specific IgG antibody showed nephroprotective effects beyond those of control IgG1 and substantially reduced interstitial fibrosis as indicated by magnetic resonance imaging, silver and \u03b1-smooth muscle actin staining, RT-qPCR, and flow cytometry for pro-fibrotic macrophages. Suppressing interstitial fibrosis slowed the decline of glomerular filtration rate (GFR) compared to treatment with control IgG1 [slope of m = -8.9 vs. m = -14.5 \u03bcl/min/100 g body weight (BW)/day, \u0394 = 38.3%], an increased GFR at the end of the study (120.4 vs. 42.6 \u03bcl/min/100 g BW, \u0394 = 64.6%), and prolonged end stage renal disease (ESRD)-free renal survival by 10 days (\u0394 = 38.5%). Delayed onset of anti-TGF\u03b2 IgG from day 7 was no longer effective. Our results suggest that biological drugs can elicit dual therapeutic effects on intrinsic crystallopathies, such as anti-TGF\u03b2 IgG antibody treatment inhibits CaOx crystallization as well as interstitial fibrosis in nephrocalcinosis-related CKD.\n[Anti-Transforming Growth Factor \u03b2 IgG Elicits a Dual Effect on Calcium Oxalate Crystallization and Progressive Nephrocalcinosis-Related Chronic Kidney Disease](http://journal.frontiersin.org/article/10.3389/fimmu.2018.00619/full) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nStefanie Steiger\n2018-03-01\nFull Text Available Crystallopathies are a heterogeneous group of diseases caused by intrinsic or environmental microparticles or crystals, promoting tissue inflammation and scarring. Certain proteins interfere with crystal formation and growth, e.g., with intrarenal calcium oxalate (CaOx crystal formation, a common cause of kidney stone disease or nephrocalcinosis-related chronic kidney disease (CKD. We hypothesized that immunoglobulins can modulate CaOx microcrystal formation and crystal growth and that therefore, biological IgG-based drugs designed to specifically target disease modifying proteins would elicit a dual effect on the outcome of CaOx-related crystallopathies. Indeed, both the anti-transforming growth factor (TGF\u03b2 IgG and control IgG1 antibody impaired CaOx crystallization in vitro, and decreased intrarenal CaOx crystal deposition and subsequent CKD in mice on an oxalate-rich diet compared to oxalate-fed control mice. However, the TGF\u03b2-specific IgG antibody showed nephroprotective effects beyond those of control IgG1 and substantially reduced interstitial fibrosis as indicated by magnetic resonance imaging, silver and \u03b1-smooth muscle actin staining, RT-qPCR, and flow cytometry for pro-fibrotic macrophages. Suppressing interstitial fibrosis slowed the decline of glomerular filtration rate (GFR compared to treatment with control IgG1 [slope of m = \u22128.9 vs. m = \u221214.5 \u03bcl/min/100 g body weight (BW/day, \u0394 = 38.3%], an increased GFR at the end of the study (120.4 vs. 42.6 \u03bcl/min/100 g BW, \u0394 = 64.6%, and prolonged end stage renal disease (ESRD-free renal survival by 10 days (\u0394 = 38.5%. Delayed onset of anti-TGF\u03b2 IgG from day 7 was no longer effective. Our results suggest that biological drugs can elicit dual therapeutic effects on intrinsic crystallopathies, such as anti-TGF\u03b2 IgG antibody treatment inhibits CaOx crystallization as well as interstitial fibrosis in nephrocalcinosis-related CKD.\n[Determinaci\u00f3n de anticuerpos contra Cryptococcus neoformans en un grupo de colomb\u00f3filos](https://www.openaire.eu/search/publication?articleId=doajarticles::d3bf614135a7f7442b07d75548a47a39)\nCarmen Sof\u00eda Corrales; Nelly Ord\u00f3\u00f1ez; Luisa Marcela Londo\u00f1o; Elizabeth Casta\u00f1eda\n1987-01-01\nSe evalu\u00f3 la respuesta humoral, medida como anticuerpos espec\u00edficos anti-Criptococcus neoformans, en 69 sueros de un grupo de colomb\u00f3filos de Bogot\u00e1; grupo considerado como de alto riesgo dado el frecuente contacto con el material contaminado con el microorganismo. Adem\u00e1s se estudiaron 65 sueros de un grupo control constitu\u00eddo por personas dedicadas a actividades diferentes. En las pruebas de inmunofluorescencia indirecta y aglutinaci\u00f3n en tubo, no se evidenci\u00f3 diferencia entre los niveles de...\n[Mitochondrial-dependent Autoimmunity in Membranous Nephropathy of IgG4-related Disease](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4485911)\nBuelli, Simona; Perico, Luca; Galbusera, Miriam; Abbate, Mauro; Morigi, Marina; Novelli, Rubina; Gagliardini, Elena; Tentori, Chiara; Rottoli, Daniela; Sabadini, Ettore; Saito, Takao; Kawano, Mitsuhiro; Saeki, Takako; Zoja, Carlamaria; Remuzzi, Giuseppe; Benigni, Ariela\n2015-01-01\nThe pathophysiology of glomerular lesions of membranous nephropathy (MN), including seldom-reported IgG4-related disease, is still elusive. Unlike in idiopathic MN where IgG4 prevails, in this patient IgG3 was predominant in glomerular deposits in the absence of circulating anti-phospholipase A2 receptor antibodies, suggesting a distinct pathologic process. Here we documented that IgG4 retrieved from the serum of our propositus reacted against carbonic anhydrase II (CAII) at the podocyte surface. In patient's biopsy, glomerular CAII staining increased and co-localized with subepithelial IgG4 deposits along the capillary walls. Patient's IgG4 caused a drop in cell pH followed by mitochondrial dysfunction, excessive ROS production and cytoskeletal reorganization in cultured podocytes. These events promoted mitochondrial superoxide-dismutase-2 (SOD2) externalization on the plasma membrane, becoming recognizable by complement-binding IgG3 anti-SOD2. Among patients with IgG4-related disease only sera of those with IgG4 anti-CAII antibodies caused low intracellular pH and mitochondrial alterations underlying SOD2 externalization. Circulating IgG4 anti-CAII can cause podocyte injury through processes of intracellular acidification, mitochondrial oxidative stress and neoantigen induction in patients with IgG4 related disease. The onset of MN in a subset of patients could be due to IgG4 antibodies recognizing CAII with consequent exposure of mitochondrial neoantigen in the context of multifactorial pathogenesis of disease. PMID:26137589\n[Prevalencia de anticuerpos contra Trypanosoma cruzi en donadores de sangre del IMSS, Orizaba, Veracruz, M\u00e9xico](https://www.openaire.eu/search/publication?articleId=doajarticles::f9d4081bcecc5ee2b2eb8e294952e14b)\nRamos-Ligonio Angel; Ram\u00edrez-S\u00e1nchez Micha\u00eda Eli\u00e1n; Gonz\u00e1lez-Hern\u00e1ndez Juan Carlos; Rosales-Encina Jos\u00e9 Luis; L\u00f3pez-Monteon Aracely\n2006-01-01\nOBJETIVO: Determinar la prevalencia de anticuerpos contra Trypanosoma cruzi en donadores del Hospital General Regional del Instituto Mexicano del Seguro Social (IMSS) en la ciudad de Orizaba, Veracruz. MATERIAL Y M\u00c9TODOS: Se examinaron muestras de donadores del banco de sangre del Hospital General Regional (HGRO) del IMSS para la b\u00fasqueda de antiT. cruzi por ELISA, Western blot e IFI, utilizando una prote\u00edna recombinante (MBP::Hsp70) y un extracto crudo de epimastigotes. Las muestras fueron o...\n[Absence of hemolytic disease of fetus and newborn despite maternal high-titer IgG anti-Ku.](https://www.ncbi.nlm.nih.gov/pubmed/21214298)\nKakaiya, R M; Whaley, A; Howard-Menk, C; Rami, J; Papari, M; Campbell-Lee, S; Malecki, Z\n2010-01-01\nAnti-Ku seen in K(o) (Kell-null) individuals has previously been shown to cause severe hemolytic transfusion reactions. Maternal anti-Ku can cause none or moderate to severe hemolytic disease of the fetus and newborn (HDFN). In two of four previously described HDFN cases, intrauterine transfusions were required because of severe anemia. We report a case in which maternal anti-Ku did not cause HDFN. Standard serologic methods were used for RBC antibody screening and identification, adsorption and elution of RBC antibodies, and antigen typing. A gravida 3, para 3 (G3P3) woman was first evaluated in 2006 and was found to have an IgG RBC antibody that reacted against all panel RBCs in the anti-human globulin phase. A panel of RBCs treated with DTT did not react with the antibody. The antibody failed to react with one example of K(o) RBCs. The patient\u2019s RBCs typed negative for the following Kell blood group antigens: KEL1, KEL2, KEL3, KEL4, KEL6, KEL7, KEL11, KEL13, and KEL18. These results established the presence of anti-Ku in maternal serum. The newborn was group A, D+ and required phototherapy for hyperbilirubinemia, but did not require transfusion. The woman was seen again in January 2010 during the third trimester (G4P3). At this time, anti-Ku titer was 256. She delivered a healthy group O, D+ baby boy at 37 weeks' gestation. Cord RBCs were 4+ for IgG by DAT. An eluate reacted with all RBCs tested, but did not react when tested against a panel of DTT-treated RBCs. K(o) phenotype is rare to begin with, and the maternal anti-Ku formation may require more than one pregnancy. Therefore, cases that can be evaluated for anti-Ku\u2013related HDFN are rare. Our case contributes to serologic and clinical aspects of such rare cases.\n[PROTEINA BLANCO DE LOS AUTO-ANTICUERPOS ANTI-P ASOCIADOS A LUPUS NEUROPSIQUATRICO: FUNCION Y MECANISMOS PATOGENICOS](https://www.openaire.eu/search/publication?articleId=od______3056::b03ef0f759c9125d7ce04f0845b57faf)\nsegovia miranda, fabian josue\n2012-01-01\nEl potencial patog\u00e9nico de los auto-anticuerpos en las disfunciones del sistema nervioso central ha atra\u00eddo gran inter\u00e9s en los \u00faltimos a\u00f1os. La identificaci\u00f3n de autoanticuerpos neuropatog\u00e9nicos dirigidos contra componentes de la superficie neuronal ayuda a entender la influencia que el sistema inmune puede ejercer sobre procesos que involucran memoria, cognici\u00f3n y comportamiento. Tambi\u00e9n provee herramientas para entender mejor la funci\u00f3n de componentes ya conocidos, o de nuevos com...\n[Neuromyelitis optica IgG in the cerebrospinal fluid induces astrocytopathy in optic nerve](http://www.forskningsdatabasen.dk/en/catalog/2290412631) [DEFF Research Database (Denmark)](http://forskningsbasen.deff.dk/?lang=eng)\nSoelberg, Kerstin; Lillevang, S\u00f8ren Thue; M\u00f8rch, Marlene\n(anti-CD59a). A total of five mice received AQP4-IgG + C + anti-CD59a, four mice received normal-IgG + C + anti-CD59a, four mice received AQP4-IgG+ C and one normal-IgG + C. Mice were killed four days later. The optic nerves were isolated and fixed in paraformaldehyde. Paraffin embedded optic nerves...... was coincident with deposition of complement. Histopathological lesions were markedly enhanced with extensive/long-segment astrocytopathy of optic nerve and optic chiasm involvement in AQP4- IgG+ C + anti-CD59a treated mice. Such pathology was not seen in mice receiving normal human IgG, C and anti-CD59a...\n[A rare case of Addison's disease, hepatitis, thyreoiditis, positive IgG anti-tissue transglutaminase antibodies and partial IgA deficiency.](https://www.ncbi.nlm.nih.gov/pubmed/27536208)\nBaleva, Marta P; Mihaylova, Snejina; Yankova, Petja; Atanasova, Iliana; Nikolova-Vlahova, Milena; Naumova, Elissaveta\n2016-01-01\nSelective IgA deficiency (IgAD) is the most prevalent type of primary immune deficiencies, but partial IgA deficiency is even more common. Addison's disease is a rare condition associated with primary adrenal insufficiency due to infection or autoimmune destruction of the adrenals. The association between IgA deficiency and Addison's disease is very rare. We observed a 22-year-old male patient with marked darkening of the skin, especially on the palms and areolae, jaundice on the skin and sclera, astheno-adynamia, hypotension (80/50 mm Hg), and pain in the right hypochondrium. The laboratory investigations revealed increased serum levels of total and indirect bilirubin, AST, ALT, GGT and LDH, negative HBsAg, anti-HBc IgM, anti-HCV and anti-HAV IgM, very low serum IgA levels (0.16 g/l) with normal IgG and IgM, negative ANA, ANCA, AMA, LKM-1, anti-GAD-60, anti-IA-2, anti-thyroglobulin antibodies, a mild increase in anti-TPO antibodies titer, a marked increase in IgG anti-tissue transglutaminase antibodies, with no typical changes in cellular immunity, negative T-SPOT-TB test, HLA - A*01; B*08; DRB1*03; DQB1*02, karyotype - 46, XY. We present a rare case of partial IgA deficiency with Addison's disease, hepatitis, thyroiditis and positive anti-tissue transglutaminase antibodies. IgAD and some autoimmune disorders share several predisposing HLA genes, thus explaining the increased prevalence of IgAD in certain patient groups.\n[Anticuerpos anti 21 hidroxilasa s\u00e9ricos en pacientes con anticuerpos antifracci\u00f3n microsomal: S\u00edndrome poliendocrino autoinmune Seric 21- hydroxilase antibodies in patients with anti-microsomal fraction antibodies: Autoimmune polyendocrine syndrome](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802007000200006) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nSilvia Botta\n2007-04-01\nFull Text Available El s\u00edndrome poliendocrino autoinmune (SPA es la asociaci\u00f3n de enfermedades endocrinas autoinmunes con otros des\u00f3rdenes autoinmunes no endocrinos. Los tipos 1, 2 y 4 presentan adrenalitis autoinmune, esto indica la presencia de autoanticuerpos, y su marcador serol\u00f3gico espec\u00edfico es el anti 21 hidroxilasa (a21-OH. El SPA tipo 2 es la asociaci\u00f3n de adrenalitis, enfermedad tiroidea y/o diabetes mellitus inducidas por autoanticuerpos. Como componentes menores, pueden estar asociados entre otros, vitiligo, alopecia y miastenia. Nuestros objetivos fueron: establecer la prevalencia de a21-OH s\u00e9ricos en pacientes con anticuerpos anti fracci\u00f3n microsomal (AFM positivos, enfermedad tiroidea autoinmune y/o afecciones endocrinas y no endocrinas autoinmunes; diagnosticar formas incompletas de SPA y estudiar individuos con probable riesgo de progresi\u00f3n a un SPA completo. Estudiamos 72 pacientes AFM positivos y 60 sujetos tomados como grupo control, AFM negativos. Hallamos a21-OH elevados en dos pacientes: A= 47 U/ml, hipotiroidismo autoinmune y miastenia; y B= 8.75 U/ml, hipotiroidismo autoinmune y vitiligo; ambos con ausencia de insuficiencia adrenal. La prevalencia de a21-OH encontrada fue del 2.8%. Las pacientes A y B corresponden a un SPA tipo 2 incompleto y latente en relaci\u00f3n al componente adrenal. Considerando a los a21-OH marcadores de enfermedad autoinmune latente, el eventual riesgo de evoluci\u00f3n hacia la afecci\u00f3n cl\u00ednica sugiere la necesidad de estrechos controles cl\u00ednicos y bioqu\u00edmicos peri\u00f3dicos.Autoimmune polyendocrine syndrome (APS is the association of autoimmune endocrine diseases, with other autoimmune nonendocrine disorders. APS types 1, 2 and 4 include autoimmune adrenalitis; this suggests the presence of autoantibodies. A specific serological marker for these is the anti 21- hydroxilase autoantibody (a21-OH. APS type 2 is the association of autoimmune adrenalitis, to autoimmune thyroid disease and/or diabetes mellitus, all\n[NY-BR-1 Antigen Expression and anti-NY-BR-1 IgG in Egyptian Breast Cancer Patients: Clinicopathological and Prognostic Significance.](https://www.ncbi.nlm.nih.gov/pubmed/26415367)\nAbu El-Nazar, Salma Y; Ghazy, Amany A; Ghoneim, Hossam E; Zoheir, Malak; Ahmed, Ahmed S; Sorour, Sally S; Abouelella, Amira M\n2015-01-01\nBreast cancer is the most common gynecological malignancy in the world. In Egypt, it ranks the first among female malignancies with incidence of 37.7%. Over the last decades, the integration of prognostic and predictive markers in treatment decisions has led to more individualized and optimized therapy. NY-BR-1 antigen has been shown to be frequently expressed in breast cancers. The study aimed to assess the tissue expression of NY-BR-1 antigen and serum IgG antibody to this antigen in Egyptian breast cancer females. The study was conducted on 60 females (10 healthy, 10 having benign breast lesions, 40 with malignant breast cancer). NY-BR-1 Ag expression was evaluated by immunohistochemistry and anti-NY-BR-1 IgG was assessed by ELISA. Results revealed a significant difference in NY-BR-1 Ag expression between benign and malignant breast cancer patients. There was a significant correlation between NY-BR-1 antigen expression and estrogen receptor's status (P = 0.019), stage of the disease (P = 0.008), menopausal status (P = 0.008), lymph node involvement (P = 0.022) and anti-NY-BR-1 IgG (P = 0.032) among the studied individuals. In addition, there was a statistically significant increase in anti-NY-BR-1 IgG O.D. results among malignant breast cancer group. It is correlated with tumor type (P < 0.001) and progesterone receptor status (P = 0.038). In conclusion, our work may represent a step towards identification of a new prognostic marker specific for breast cancer.\n[Determination of anti-canine IgG using a continuous filtration/dissolution system based on the formation of a high-molecular size immunocomplex.](https://www.ncbi.nlm.nih.gov/pubmed/18968430)\nReyes, F D; Arce, C; Moreno, A; Fern\u00e1ndez Romero, J M; Luque de Castro, M D\n2001-10-31\nA method for the determination of monoclonal antibody anti-canine-IgG based on a continuous filtration/dissolution system is presented as prototype for further developments. The basis of the system is the continuous formation of a high-molecular immunocomplex, which is temporally retained on a microfilter located prior to the detector. The immunochemical method consists of the development of a sandwich type heterogeneous non-competitive reaction to yield a high molecular immunocomplex, as a result of the affinity interaction between streptavidin and biotincanine IgG and the immunoreaction between canine IgG and mAb anti-canine IgG, which occurs in solution. Goat anti-mouse IgG labelled with peroxidase is used as tracer. The extension of the immunoreaction is monitored fluorimetrically via the condensation product between 4-hydroxyphenylacetic acid and hydrogen peroxide in the presence of the peroxidase retained on the filter. The method provides a dynamic range from 10(-4) to 500 mug l(-1) with an IC(50) of 0.554 mug 1(-1) (for a biotin-IgG dilution of 1:250, chi(2)=0.6085, r(2)=0.9991, n=14) and a precision, expressed as R.S.D.%, lower than 4.7%. After modifications, the method here proposed can be extended for monitoring analytes of interest in the agrochemical, food and environmental areas, as far as permitted by the availability to produce the corresponding monoclonal antibody.\n[Occurrence of anti-Neospora caninum and anti-Toxoplasma gondii IgG antibodies in goats and sheep in western Maranh\u00e3o, Brazil Ocorr\u00eancia de anticorpos IgG anti-Neospora caninum e anti-Toxoplasma gondii em caprinos e ovinos do oeste do Maranh\u00e3o, Brasil](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-29612011000400010) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nLarissa Martins de Brito Moraes\n2011-12-01\nFull Text Available Neosporosis and toxoplasmosis are parasitic diseases which can cause reproductive problems in goats and sheep. The current study aimed to determine the occurrence of anti-Neospora caninum and anti-Toxoplasma gondii IgG antibodies in goats and sheep from the districts of Amarante do Maranh\u00e3o and Buritirana, Imperatriz microregion, western area of Maranh\u00e3o State, northeastern Brazil, and to assess factors associated to infection by these etiologic agents. Blood samples from 110 animals (46 goats and 64 sheep from five herds were collected, and indirect immunofluorescence assay was used for serological testing. Of 46 goat samples, 17.39% (n = 8 showed anti-N. caninum antibodies and 4.35% (n = 2 anti-T. gondii, while of 64 sheep samples 4.69% (n = 3 and 18.75% (n = 12 showed anti-N. caninum and anti-T. gondii antibodies, respectively. No significant difference regarding the presence of domestic cats and/or dogs on the property and veterinary care was seen for both etiologic agents studied. However, food supplementation and animal reproductive failure were significantly (p A neosporose e a toxoplasmose s\u00e3o doen\u00e7as parasit\u00e1rias que podem causar problemas reprodutivos em caprinos e ovinos. O objetivo deste estudo foi determinar a ocorr\u00eancia de anticorpos IgG anti-Neospora caninum e anti-Toxoplasma gondii em caprinos e ovinos dos munic\u00edpios de Amarante do Maranh\u00e3o e Buritirana, microrregi\u00e3o de Imperatriz, Oeste maranhense, Nordeste do Brasil, bem como avaliar fatores associados \u00e0 infec\u00e7\u00e3o por esses agentes etiol\u00f3gicos. Amostras de sangue de 110 animais (46 caprinos e 64 ovinos, provenientes de cinco propriedades, foram coletadas, e a rea\u00e7\u00e3o de imunofluoresc\u00eancia indireta utilizada para o diagn\u00f3stico sorol\u00f3gico. Das 46 amostras de caprinos, 17,39% (n = 8 apresentaram anticorpos anti-N. caninum e 4,35% (n = 2 anti-T. gondii, enquanto das 64 amostras de ovinos, 4,69% (n = 3 e 18,75% (n = 12 apresentaram anticorpos anti-N. caninum e anti\n[Anti-HIV activity in cervical-vaginal secretions from HIV-positive and -negative women correlate with innate antimicrobial levels and IgG antibodies.](http://europepmc.org/articles/PMC2894072?pdf=render) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMimi Ghosh\n2010-06-01\nFull Text Available We investigated the impact of antimicrobials in cervicovaginal lavage (CVL from HIV(+ and HIV(- women on target cell infection with HIV. Since female reproductive tract (FRT secretions contain a spectrum of antimicrobials, we hypothesized that CVL from healthy HIV(+ and (- women inhibit HIV infection.CVL from 32 HIV(+ healthy women with high CD4 counts and 15 healthy HIV(- women were collected by gently washing the cervicovaginal area with 10 ml of sterile normal saline. Following centrifugation, anti-HIV activity in CVL was determined by incubating CVL with HIV prior to addition to TZM-bl cells. Antimicrobials and anti-gp160 HIV IgG antibodies were measured by ELISA. When CXCR4 and CCR5 tropic HIV-1 were incubated with CVL from HIV(+ women prior to addition to TZM-bl cells, anti-HIV activity in CVL ranged from none to 100% inhibition depending on the viral strains used. CVL from HIV(- controls showed comparable anti-HIV activity. Analysis of CH077.c (clone of an R5-tropic, mucosally-transmitted founder virus viral inhibition by CVL was comparable to laboratory strains. Measurement of CVL for antimicrobials HBD2, trappin-2/elafin, SLPI and MIP3alpha indicated that each was present in CVL from HIV(+ and HIV(- women. HBD2 and MIP3alpha correlated with anti-HIV activity as did anti-gp160 HIV IgG antibodies in CVL from HIV(+ women.These findings indicate that CVL from healthy HIV(+ and HIV(- women contain innate and adaptive defense mechanisms that inhibit HIV infection. Our data suggest that innate endogenous antimicrobials and HIV-specific IgG in the FRT can act in concert to contribute toward the anti-HIV activity of the CVL and may play a role in inhibition of HIV transmission to women.\n[Detection of anti-HIV-1 IgG antibodies in whole saliva by GACELISA and Western blot assays.](https://www.ncbi.nlm.nih.gov/pubmed/8756029)\nMatee, M I; Lyamuya, E F; Simon, E; Mbena, E C; Kagoma, C; Samaranayake, L P; Scheutz, F\n1996-05-01\nThe present study, based on 158 HIV seropositives and 167 HIV seronegatives, demonstrates that saliva collected with the Omni-SAL device and tested with GACELISA (an IgG antibody capture ELISA) is an effective non-invasive alternative to serum for anti-HIV IgG antibody screening. The study also shows that a conventional serum Western blot kit can be used, with slight modifications, for confirmatory testing of saliva specimens. Collecting saliva with the Omni-SAL device had a very good acceptance rate among Tanzanian subjects, and although this diagnostic method is not yet known by the general public, 65% of the study participants preferred to give saliva instead of blood for HIV testing.\n[Re-examination of immune response and estimation of anti-Vi IgG protective threshold against typhoid fever-based on the efficacy trial of Vi conjugate in young children.](https://www.ncbi.nlm.nih.gov/pubmed/24630869)\nSzu, Shousun C; Klugman, Keith P; Hunt, Steven\n2014-04-25\nThe capsular polysaccharide of Salmonella enterica serovar Typhi, Vi antigen, is an essential virulence factor and a protective antigen. Similar to other polysaccharide vaccines, the protective action of Vi, both to the polysaccharide alone or when presented as a conjugate, is mediated by serum IgG Vi antibodies. The evaluation of Vi capsular polysaccharide based vaccines to prevent typhoid fever would be significantly facilitated by the identification of a \"protective level\" of serum antibodies to Vi antigen. The protective level of anti-Vi IgG against typhoid fever was derived from the protective efficacy and immune response of a Vi-rEPA conjugate vaccine efficacy trial. The estimation was derived by two methods: correlation of the percent efficacy and the antibody distribution profile in the vaccine group at a given period of observation, and use of the relative ratio of anti-Vi IgG levels between the vaccine and placebo groups greater or equal to the Relative Risk of typhoid fever used in the efficacy determination. Both methods predicted a similar range of a minimum protective level of anti-Vi IgG between 1.4 and 2.0\u03bcg/ml (short term threshold). When applying a protective threshold of 10\u03bcg/ml at 6 months post immunization, an IgG level in excess of 1.4\u03bcg/ml was achieved by 90% of children at 46 months post immunization, consistent with an 89% level of protection over the duration of the study. We thus suggest that the proportion of children with Vi IgG>10\u03bcg/ml (long term threshold) 6 months after immunization may reflect the proportion protected over at least a 4 year period. The current assignment of an anti-Vi IgG protective level may be of value when evaluating vaccine performance of future Vi conjugate vaccines. Published by Elsevier Ltd.\n[Asociaci\u00f3n entre variables reproductivas y anticuerpos anti Neospora caninum en bovinos lecheros de un municipio de Colombia](http://cienciaspecuarias.inifap.gob.mx/index.php/Pecuarias/article/view/4439/3731) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMart\u00edn Orlando Pulido Medell\u00edn\n2017-04-01\nFull Text Available El objetivo fue determinar el porcentaje de vacas seropositivas a Neospora caninum y la identificaci\u00f3n de las variables reproductivas que se encuentran relacionadas con la presencia de anticuerpos contra este protozoo. Se tomaron 1,000 muestras de sangre a hembras bovinas del municipio de Sotaquir\u00e1, Boyac\u00e1, las cuales fueron evaluadas por medio de ELISA indirecta. Se determin\u00f3 una seroprevalencia de Neospora caninum del 45 %; las variables reproductivas asociadas con la positividad de N. caninum fueron: la presencia de distocia en el parto, el intervalo de edad (3-4 a\u00f1os y la raza de los bovinos (Holstein, mientras que las variables de presencia de aborto, inseminaci\u00f3n artificial, muerte embrionaria, repetici\u00f3n de celo, presentaci\u00f3n de terneros d\u00e9biles al nacer y monta directa con toro, no presentaron relaci\u00f3n con la positividad de los bovinos. Los resultados de este estudio muestran la presencia de anticuerpos contra Neospora caninum en animales de producci\u00f3n lechera, siendo esta prevalencia encontrada una muestra del riesgo potencial que representa esta enfermedad sobre el estado reproductivo dentro de los hatos.\n[Anti-EBOV GP IgGs Lacking \u03b11-3-Galactose and Neu5Gc Prolong Survival and Decrease Blood Viral Load in EBOV-Infected Guinea Pigs.](http://europepmc.org/articles/PMC4900587?pdf=render) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nOlivier Reynard\nFull Text Available Polyclonal xenogenic IgGs, although having been used in the prevention and cure of severe infectious diseases, are highly immunogenic, which may restrict their usage in new applications such as Ebola hemorrhagic fever. IgG glycans display powerful xenogeneic antigens in humans, for example \u03b11-3 Galactose and the glycolyl form of neuraminic acid Neu5Gc, and IgGs deprived of these key sugar epitopes may represent an advantage for passive immunotherapy. In this paper, we explored whether low immunogenicity IgGs had a protective effect on a guinea pig model of Ebola virus (EBOV infection. For this purpose, a double knock-out pig lacking \u03b11-3 Galactose and Neu5Gc was immunized against virus-like particles displaying surface EBOV glycoprotein GP. Following purification from serum, hyper-immune polyclonal IgGs were obtained, exhibiting an anti-EBOV GP titer of 1:100,000 and a virus neutralizing titer of 1:100. Guinea pigs were injected intramuscularly with purified IgGs on day 0 and day 3 post-EBOV infection. Compared to control animals treated with IgGs from non-immunized double KO pigs, the anti-EBOV IgGs-treated animals exhibited a significantly prolonged survival and a decreased virus load in blood on day 3. The data obtained indicated that IgGs lacking \u03b11-3 Galactose and Neu5Gc, two highly immunogenic epitopes in humans, have a protective effect upon EBOV infection.\n[Anti-EBOV GP IgGs Lacking \u03b11-3-Galactose and Neu5Gc Prolong Survival and Decrease Blood Viral Load in EBOV-Infected Guinea Pigs](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4900587)\nReynard, Olivier; Jacquot, Fr\u00e9d\u00e9ric; Evanno, Gw\u00e9na\u00eblle; Mai, Hoa Le; Martinet, Bernard; Duvaux, Odile; Bach, Jean-Marie; Conchon, Sophie; Judor, Jean-Paul; Perota, Andrea; Lagutina, Irina; Duchi, Roberto; Lazzari, Giovanna; Le Berre, Ludmilla; Perreault, H\u00e9l\u00e8ne; Lheriteau, Elsa; Raoul, Herv\u00e9; Volchkov, Viktor; Galli, Cesare; Soulillou, Jean-Paul\n2016-01-01\nPolyclonal xenogenic IgGs, although having been used in the prevention and cure of severe infectious diseases, are highly immunogenic, which may restrict their usage in new applications such as Ebola hemorrhagic fever. IgG glycans display powerful xenogeneic antigens in humans, for example \u03b11\u20133 Galactose and the glycolyl form of neuraminic acid Neu5Gc, and IgGs deprived of these key sugar epitopes may represent an advantage for passive immunotherapy. In this paper, we explored whether low immunogenicity IgGs had a protective effect on a guinea pig model of Ebola virus (EBOV) infection. For this purpose, a double knock-out pig lacking \u03b11\u20133 Galactose and Neu5Gc was immunized against virus-like particles displaying surface EBOV glycoprotein GP. Following purification from serum, hyper-immune polyclonal IgGs were obtained, exhibiting an anti-EBOV GP titer of 1:100,000 and a virus neutralizing titer of 1:100. Guinea pigs were injected intramuscularly with purified IgGs on day 0 and day 3 post-EBOV infection. Compared to control animals treated with IgGs from non-immunized double KO pigs, the anti-EBOV IgGs-treated animals exhibited a significantly prolonged survival and a decreased virus load in blood on day 3. The data obtained indicated that IgGs lacking \u03b11\u20133 Galactose and Neu5Gc, two highly immunogenic epitopes in humans, have a protective effect upon EBOV infection. PMID:27280712\n[Bajo \u00edndice de sospecha para deficiencia de anticuerpos en ni\u00f1os sometidos a procedimientos quir\u00fargicos de Otorrinolaringolog\u00eda](http://ojs.actapediatrica.org.mx/index.php/APM/article/view/1206) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAB Ram\u00edrez-L\u00f3pez\n2016-06-01\nFull Text Available INTRODUCCI\u00d3N: las inmunodeficiencias primarias est\u00e1n subdiagnosticadas en todo el mundo, aun en centros de tercer nivel de atenci\u00f3n. Los defectos de anticuerpos constituyen el grupo m\u00e1s prevalente y suelen manifestarse cl\u00ednicamente despu\u00e9s de los 6 meses de edad como infecciones respiratorias recurrentes causadas por bacterias encapsuladas. Algunas cirug\u00edas de o\u00eddo-nariz y garganta se indican en pacientes con infecciones respiratorias recurrentes o complicadas que no han respondido adecuadamente al tratamiento m\u00e9dico. Estos ni\u00f1os sometidos a procedimientos quir\u00fargicos luego de una historia de infecciones respiratorias recurrentes pueden constituir un grupo de alto riesgo para inmunodeficiencias primarias. OBJETIVO: indagar qu\u00e9 tan frecuentes son los defectos de anticuerpos en ni\u00f1os sometidos a cualquiera de tres cirug\u00edas de otorrinolaringolog\u00eda. MATERIALES Y M\u00c9TODOS: revisamos los expedientes electr\u00f3nicos de ni\u00f1os que hubieran sido sometidos a adenoamigdalectom\u00eda (ATT, drenaje endosc\u00f3pico de senos paranasales (ESD y colocaci\u00f3n de tubos timp\u00e1nicos de ventilaci\u00f3n (TVT en nuestro instituto durante 2011-2012, en busca de niveles s\u00e9ricos de inmunoglobulinas (IgE, IgG, IgA, IgM. RESULTADOS: encontramos 112 procedimientos quir\u00fargicos en 87 pacientes, de los cuales la indicaci\u00f3n para cirug\u00eda fue infecciosa en 37 (21 varones, 1 muerto, edad media 7.3 a\u00f1os, m\u00e1s frecuentemente rinosinusitis (19/37 y amigdalitis (9/37 cr\u00f3nicas. Los procedimientos incluyeron: 24 adenoamigdalectom\u00edas, 13 drenajes endosc\u00f3picos de senos paranasales y 6 colocaciones de tubos timp\u00e1nicos de ventilaci\u00f3n, para un total de 43; ocho pacientes (21.6% fueron sometidos a m\u00e1s de una cirug\u00eda. La IgE s\u00e9rica se encontr\u00f3 en el expediente de 27 pacientes (72.9%, y \u201cal menos IgG\u201d en 18 (48.6%. S\u00f3lo 70% de las pruebas fueron ordenadas antes de la cirug\u00eda. Los resultados anormales incluyeron: IgE elevada en 10/27, IgG\n[\u00bfEs necesario investigar anticuerpos IgM contra el virus de la hepatitis A cuando el enzimograma hep\u00e1tico es normal? Is it necessary to investigate anti-hepatitis A virus (HAV IgM antibodies when the hepatic enzymogram is normal?](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0325-75412007000300010) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nC. Coitinho\n2007-09-01\nFull Text Available La hepatitis por virus A (VHA es la m\u00e1s frecuente de las hepatitis virales en el mundo, especialmente en los pa\u00edses subdesarrollados. Donde esta enfermedad es end\u00e9mica, se suelen realizar un gran n\u00famero de estudios de laboratorio para confirmarla. El objetivo del presente trabajo fue evaluar la utilidad de investigar anticuerpos IgM anti hepatitis A (IgM anti-VHA para el diagn\u00f3stico de la VHA en pacientes con niveles s\u00e9ricos normales de aspartato y alanina aminotransferasas (AST/ALT. Todos los pacientes que concurrieron al laboratorio con solicitud de enzimograma hep\u00e1tico y anticuerpos IgM anti-VHA durante el per\u00edodo octubre 2005-marzo 2006 fueron evaluados en este estudio. Los datos cl\u00ednicos m\u00e1s frecuentes fueron presunci\u00f3n de hepatitis e ictericia (27,5 y 12,7%. La determinaci\u00f3n de IgM anti-VHA se realiz\u00f3 por ensayo inmunoenzim\u00e1tico de micropart\u00edculas (MEIA; la de enzimas hep\u00e1ticas en un multianalizador. De los 158 pacientes estudiados, 84 ten\u00edan valores elevados de AST/ALT; dentro de este grupo, el 82% fue reactivo para IgM anti-VHA. Los 74 pacientes restantes mostraron niveles normales de AST/ALT y solo 7 de ellos, bajo control de evoluci\u00f3n por VHA ya confirmada, fueron reactivos para IgM anti-VHA. El 49% de los pacientes IgM anti-VHA reactivos correspondi\u00f3 a menores de 10 a\u00f1os. De acuerdo con estas observaciones, sugerimos que los estudios de laboratorio para confirmar infecci\u00f3n aguda por VHA deber\u00edan realizarse en forma secuencial, ya que es innecesaria la determinaci\u00f3n de anticuerpos IgM anti-VHA cuando las aminotransferasas s\u00e9ricas son normales.Type A viral Hepatitis (HAV is the most frequent viral hepatitis around the world, especially in low income countries. In order to confirm this disease, a lot of laboratory tests are annually carried out where HAV is endemic. Our objective was to establish the utility of investigating anti-hepatitis A virus (HAV IgM antibodies for HAV diagnosis in patients with normal\n[Neuromielitis \u00f3ptica con alta expresi\u00f3n de acuaporina-4 y anticuerpos anti-acuaporina-4 positivos en suero Neuromyelitis optica with high aquaporin-4 expression and positive serum aquaporin-4 autoantibodies](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802012000200007) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAlejandra B\u00e1ez\n2012-04-01\nFull Text Available La presencia de anticuerpos IgG en suero, con blanco en los canales de acuaporina-4, es espec\u00edfica de la neuromielitis \u00f3ptica (NMO. El 60% de los pacientes con NMO presentan lesiones cerebrales en la resonancia magn\u00e9tica (RM; en un 8% (mayor\u00eda ni\u00f1os estas lesiones se consideraron \"at\u00edpicas\". Presentamos dos pacientes con NMO y lesiones en el SNC de alta expresi\u00f3n de acuaporina-4. Caso 1: var\u00f3n de 50 a\u00f1os, que comenz\u00f3 con p\u00e9rdida de visi\u00f3n en ojo derecho (OD. Recibi\u00f3 tratamiento emp\u00edrico con metilprednisolona 1 g/d x 3 d\u00edas. Al mes present\u00f3 dolor generalizado y hemiparesia derecha; nuevamente recibi\u00f3 metilprednisolona 1 g/d x 5 d\u00edas e IgG IV 400 mg/kg/d \u00d7 5 d\u00edas. Recuper\u00f3 la deambulaci\u00f3n persistiendo el dolor y fen\u00f3menos parox\u00edsticos en los 4 miembros. Potenciales evocados visuales: P100, ojo izquierdo (OI 123 mseg. OD sin respuesta. La RM de cerebro (FLAIR mostr\u00f3 hiperintensidad en nervio \u00f3ptico derecho, hipot\u00e1lamo y comisura blanca anterior. RM cervical: lesi\u00f3n medular extensa (5 cuerpos vertebrales. Caso 2: mujer de 53 a\u00f1os, con disminuci\u00f3n de la agudeza visual en ambos ojos y parestesias en miembros inferiores que remitieron espont\u00e1neamente. Evolucion\u00f3 al mes con cuadriparesia e incontinencia esfinteriana. Recibi\u00f3 metilprednisolona 1 g/d x 5 d\u00edas, sin mejor\u00eda. Potenciales evocados visuales: P100 OI 124 mseg. OD 128 mseg. RM cerebro: (FLAIR hiperintensidad hipotal\u00e1mica y periacueductal. RM cervical: lesi\u00f3n medular extensa (7 cuerpos vertebrales. Anticuerpos anti-acuaporina-4 positivos en ambos pacientes (inmunofluorescencia indirecta. Las lesiones consideradas \"at\u00edpicas\", como aqu\u00ed, en sitios con alta densidad de prote\u00ednas canales de agua AQP4 deber\u00e1n considerarse para el diagn\u00f3stico diferencial.Disease-specific aquaporin-4 antibodies (NMO-IgG are the main effector of lesions in neuromyelitis optica (NMO patients. Brain MRI lesions are detected in 60% of them, with 8% (almost infants at sites of high\n[Anticuerpos monoclonales contra la gonadotropina cori\u00f3nica humana (hCG para su uso en la detecci\u00f3n de embarazo Monoclonal antibodies against human chorionic gonadotropin (HCG for their use in pregnancy detection](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-29532004000300002) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nBertha V. Rodr\u00edguez Pend\u00e1s\n2004-12-01\nFull Text Available Se reporta la generaci\u00f3n de 2 anticuerpos monoclonales (AcM de rat\u00f3n dirigidos contra la hormona gonadotropina cori\u00f3nica humana (hCG, a partir de la inmunizaci\u00f3n de ratones BALB/c con hCG humana, purificada en el Instituto Nacional de Endocrinolog\u00eda (INEN. Los AcM obtenidos son de la clase IgG y fueron purificados a partir de l\u00edquido asc\u00edtico, mediante cromatograf\u00eda de afinidad en prote\u00edna G Sepharosa. El estudio de afinidad y especificidad demostr\u00f3 que estos anticuerpos pod\u00edan ser \u00fatiles en ensayos inmunoenzim\u00e1ticos, con el uso de uno de ellos en el sistema microELISA, de nuestra instituci\u00f3n, para la detecci\u00f3n cualitativa de embarazo en orina.The generation of 2 mouse monoclonal antibodies directed against the human chorionic gonadotropin hormone (CGh, starting from the immunization of BALB/c mice with human CGh purified at the National Institute of Endocrinology (NIEN is reported. IgG monoclonal antibodies were obtained. They were purified starting from the ascitic fluid by affinity chromatography in protein G Sepharose. The affinity and specificity study showed that these antibodies could be useful in immunoenzimatic assays, using one of them in the microELISA system of our institution for the qualitative detection of pregnancy in urine.\n[Modelo de detecci\u00f3n de anticuerpos neutralizantes contra IFN-\u03b2 mediante citometr\u00eda de flujo](http://www.revistabiomedica.org/index.php/biomedica/article/view/637) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJuan Carlos Villa-Camacho\n2012-12-01\nFull Text Available Introducci\u00f3n. El interfer\u00f3n beta (IFN-\u03b2 se usa para tratar la forma reca\u00edda-remisi\u00f3n de la esclerosis m\u00faltiple. Sin embargo, el uso de prote\u00ednas recombinantes como medicamentos puede generar la producci\u00f3n de anticuerpos, disminuyendo as\u00ed la efectividad del tratamiento. Objetivo. Estandarizar una t\u00e9cnica de detecci\u00f3n de anticuerpos neutralizantes contra IFN-\u03b2, mediante citometr\u00eda de flujo. Materiales y m\u00e9todos. Se cultivaron dos l\u00edneas tumorales humanas (U937 y K562 con IFN-\u03b21a humano recombinante y mediante citometr\u00eda de flujo se determin\u00f3 la expresi\u00f3n de la prote\u00edna ISG15 intracelular. Los sueros se obtuvieron de un conejo Nueva Zelanda antes y despu\u00e9s de la inmunizaci\u00f3n con 100.000 UI de IFN-\u03b21a en adyuvante de Freund. Para la detecci\u00f3n de anticuerpos neutralizantes, se estimularon c\u00e9lulas K562 con IFN-\u03b21a preincubado con sueros de conejos a una diluci\u00f3n 1:20. Despu\u00e9s de 24 horas de incubaci\u00f3n se determin\u00f3 la expresi\u00f3n de la prote\u00edna ISG15. Resultados. La expresi\u00f3n de ISG15 fue mayor en c\u00e9lulas K562 estimuladas. La intensidad media de fluorescencia para la ISG-15 entre c\u00e9lulas en ausencia IFN-\u03b21a, mostr\u00f3 una mediana de 198 unidades arbitrarias (UA (p25-75= 173-231 UA y, en presencia de IFN-\u03b21a, 430 UA (p25-75 =316-611,5, con una diferencia estad\u00edsticamente significativa (p=0,008. La presencia de anticuerpos anti-IFN-\u03b21a en el suero del conejo inmunizado, hizo disminuir de forma acentuada la expresi\u00f3n de la ISG15 en c\u00e9lulas K562 cultivadas con IFN-\u03b21a, en comparaci\u00f3n con el control (mediana=3,040 UA Vs. 43,644 UA, respectivamente. Conclusiones. Este trabajo muestra la detecci\u00f3n de anticuerpos neutralizantes contra IFN-\u03b2 en conejos, utilizando la expresi\u00f3n de la prote\u00edna ISG15 por citometr\u00eda de flujo. doi: http://dx.doi.org/10.7705/biomedica.v32i4.637\n[Anti-dog IgG secondary antibody successfully detects IgG in a variety of aquatic mammals](https://pubs.er.usgs.gov/publication/70188105)\nRoehl, Katherine; Jankowski, Mark D.; Hofmeister, Erik K.\n2016-01-01\nSerological tests play an important role in the detection of wildlife diseases. However, while there are many commercial assays and reagents available for domestic species, there is a need to develop efficient serological assays for wildlife. In recent years, marine mammals have represented a wildlife group with emerging infectious diseases, such as influenza, brucellosis, and leptospirosis. However, with the exception of disease-agent-specific assays or functional assays, few reports describe the use of antibody detection assays in marine mammals. In an indirect enzyme-linked immunoassay (EIA) or an immunofluorescence assay, antibody is detected using an antitarget species secondary conjugated antibody. The sensitivity of the assay depends on the avidity of the binding reaction between the bound antibody and the detection antibody. A commercial polyclonal antidog IgG conjugated antibody was tested in an EIA for its ability to sensitively detect the IgG of seven marine mammals including sea otter (Enhydra lutris), polar bear (Ursus maritimus), grey seal (Halichoerus grypus), harbor seal (Phoca vitulina), northern elephant seal (Mirounga angustirostris), California sea lion (Zalophus californianus), Pacific walrus (Odobenus rosmarus) and one freshwater mammal: Asian small-clawed otter (Aonyx cinerea). With the exception of Asian small-clawed sea otters, the detection of IgG in these marine mammals either exceeded or was nearly equal to detection of dog IgG. The use of the tested commercial antidog IgG antibody may be a valid approach to the detection of antibody response to disease in sea mammals.\n[IgG4-related sialadenitis and Sj\u00f6gren's syndrome.](https://www.ncbi.nlm.nih.gov/pubmed/27318181)\nFragoulis, G E; Zampeli, E; Moutsopoulos, H M\n2017-03-01\nIgG4-related disease (IgG4-RD) has emerged as a new entity in the last decade. It comprises numerous conditions previously thought to be unrelated. Macroscopically, these diseases cause diffuse organ swelling and formation of pseudotumorous masses. Histopathologically, they are characterized by a lymphoplasmacytic infiltrate with increased IgG4+ plasma cells and storiform fibrosis. Despite rapid progress within the last years, our knowledge on these conditions is still fragmented. To date, more than forty organs have been reported to be included in IgG4-RD, and salivary gland involvement is amongst the most common organs affected [IgG4-related sialadenitis (IgG4-RS)]. Interestingly, IgG4-RS shares commonalities with Sj\u00f6gren's syndrome (SS), like glandular enlargement, sicca symptoms, arthralgias, hypergammaglobulinemia, hypocomplementemia, and circulating antinuclear antibodies. Nonetheless, they differ in that the incidence of anti-Ro and anti-La reactivity is not frequently found in patients with IgG4-RS, their salivary glands are infiltrated by a large number of IgG4+ plasma cells and IgG4-RS symptoms respond promptly to steroids. The aim of this review was to describe the clinical, serological, histopathological and pathophysiological aspects of IgG4-RS in the context of IgG4-RD and highlight the differences between IgG4-RS and SS. \u00a9 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.\n[Prevalencia de anticuerpos IgG al toxoide tet\u00e1nico en trabajadores sanitarios](http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0465-546X2014000300002&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nB. P\u00e9rez Berm\u00fadez\n2014-09-01\nFull Text Available Introducci\u00f3n: En el a\u00f1o 2009 el Ministerio de Sanidad y Consumo de Espa\u00f1a publica una nueva gu\u00eda para la vacunaci\u00f3n de la Difteria y T\u00e9tanos. Existen discrepancias con los tiempos de inoculaci\u00f3n de las dosis de recuerdo con otros pa\u00edses y sociedades m\u00e9dicas. Material y m\u00e9todos: Estudio descriptivo. Las variables analizadas fueron: IgG-Toxoide Tet\u00e1nico, tiempo \u00faltima dosis de vacunaci\u00f3n, dosis totales, edad, sexo, hospital, habito tab\u00e1quico e \u00edndice de masa corporal. Se construy\u00f3 un modelo de Regresi\u00f3n Log\u00edstica. Con el fin de determinar los puntos de corte m\u00e1s sensibles y espec\u00edficos para las variables temporales (tiempo desde la \u00faltima dosis y edad se calcularon las curvas R.O.C Resultados: Las variables, edad O,R= 17,56 (1,840 - 167,760, dosis de vacuna inoculadas al trabajador, O,R= 0,064 (0,006 - 0,908 y tiempo de la \u00faltima dosis de vacunaci\u00f3n, O,R= 1,03 (1,017 - 1,047, son las variables significativas en el an\u00e1lisis multivariante. Los puntos de cortes, para la edad son 54 a\u00f1os (Sensibilidad S= 0,72, Especificidad SP=0,77 y 15 a\u00f1os tras la \u00faltima dosis a\u00f1os (S= 0,88, SP=0,86, por encima de este corte la probabilidad de no tener anticuerpos al T\u00e9tanos es alta. Conclusiones: Ante un trabajador que refiere o documenta que hace m\u00e1s de 15 a\u00f1os de la ultima dosis deber\u00edamos plantearnos la revacunaci\u00f3n, si adem\u00e1s este trabajador refiere no tener m\u00e1s de 5 dosis inoculadas y tiene m\u00e1s de 54 a\u00f1os la revacunaci\u00f3n ser\u00eda muy recomendable.\n[Desarrollo de improntas para el diagn\u00f3stico del virus Epstein-Barr por inmunofluorescencia indirecta Development of slides for Epstein-Barr virus diagnosis by indirect immunofluorescence](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802005000400006) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nGerm\u00e1n R. P\u00e9rez\n2005-08-01\nFull Text Available El virus de Epstein-Barr (VEB es el principal agente oncog\u00e9nico linfotr\u00f3pico dentro de la familia Herpesviridae y se encuentra mundialmente distribuido. La primoinfecci\u00f3n se produce en adultos j\u00f3venes y se manifiesta como mononucleosis infecciosa. La detecci\u00f3n de anticuerpos anti-viral capside antigen (VCA indica infecci\u00f3n previa o presente con VEB. Adem\u00e1s, se observan t\u00edtulos elevados de anticuerpos anti-VCA en las enfermedades neopl\u00e1sicas asociadas al VEB como los linfomas, en individuos HIV-positivos. El objetivo de este estudio fue el desarrollo y puesta a punto de improntas de c\u00e9lulas P3HR1 para la detecci\u00f3n serol\u00f3gica del VEB por t\u00e9cnicas de inmunofluorescencia indirecta (IFI. Se estimularon cultivos de c\u00e9lulas P3HR1 en crecimiento exponencial con phorbol-12-mirystoil-13-acetato, y se recolectaron al\u00edcuotas a distintos tiempos para realizar improntas. Se realiz\u00f3 una IFI con cada impronta usando como anticuerpo primario un suero VEB-positivo. Se observ\u00f3 un aumento del 11% en la expresi\u00f3n del VCA a las 40 horas post-estimulaci\u00f3n, decayendo al 3.5% a las 48 horas. Estos datos fueron corroborados por ensayo de western blot con inmunodetecci\u00f3n. La precisi\u00f3n intra- e inter-lote de las improntas fue evaluada para anticuerpos IgM e IgG, con sueros probados previamente por equipos para esta determinaci\u00f3n disponibles en el mercado para el VEB y con sueros reactivos para otros miembros de la familia Herpesviridae. No se obtuvieron resultados falsos-negativos ni falsos-positivos para el VEB ni se observ\u00f3 reactividad cruzada con otros herpesvirus. Las improntas desarrolladas constituyen un instrumento para el diagn\u00f3stico de la primoinfecci\u00f3n del VEB y la detecci\u00f3n serol\u00f3gica de anticuerpos IgG anti-VCA de neoplasias asociadas al VEB.Epstein-Barr virus (EBV is the main oncogenic lymphotropic agent of the Herpesviridae family and is globally distributed. EBV acute infection occurs in young adults producing infectious\n[IgG4 anti-phospholipase A2 receptor might activate lectin and alternative complement pathway meanwhile in idiopathic membranous nephropathy: an inspiration from a cross-sectional study.](https://www.ncbi.nlm.nih.gov/pubmed/26837241)\nYang, Yang; Wang, Chao; Jin, Liping; He, Fagui; Li, Changchun; Gao, Qingman; Chen, Guanglei; He, Zhijun; Song, Minghui; Zhou, Zhuliang; Shan, Fujun; Qi, Ka; Ma, Lu\n2016-08-01\nThe deposition of IgG4 of antibodies against phospholipase A2 receptor (anti-PLA2R) is predominating in the kidneys of patients with idiopathic membranous nephropathy, while its predictive value has not been determined. It was a retrospective study, and 438 patients were included. Serum samples of two time points [before intervention (baseline) and after 1.5-year treatment (endpoint)] were detected for total and IgG4 anti-PLA2R. IgG4 IgG4 subclass and the achievement of CR; (3) bi-negativity of IgG4 has a high accuracy of predicting CR compared with total antibodies; (4) in patients of bi-positivity, those achieving CR showed lower MASP-1/2, MBL, C3a, C5a, FB, Ba and Bb than patients failing to achieve CR; (5) the titers of endpoint and decrease in Ba and Bb were associated with improvement of 24 h-UP in those of bi-positivity; and (6) the decrease in Ba was a significant factor for achieving CR in those of bi-positivity. Continuous IgG4 negativity was a useful tool to predict the achievement of CR; however, in patients of continuous IgG4 positivity, those with lower activation of lectin and alternative pathways would still more probably achieve CR.\n[Inmunofluorescencia con Crithidia luciliae para la detecci\u00f3n de anticuerpos anti-ADN: Im\u00e1genes at\u00edpicas y su relaci\u00f3n con enfermedad de Chagas y leishmaniasis Immunofluorescence assay with Crithidia luciliae for the detection of anti-DNA antibodies: Atypical images and their relationship with Chagas\u2019 disease and leishmaniasis](https://www.openaire.eu/search/publication?articleId=doajarticles::44d691368bbcc6a8f4eda7e7887fe263)\nGloria Griemberg; Nidia F. Ferrarotti; Graciela Svibel; Maria R. Ravelli; N\u00e9stor J. Taranto; Emilio L. Malchiodi; Mar\u00eda C. Pizzimenti\n2006-01-01\nLos anticuerpos anti-ADN nativo pueden detectarse por inmunofluorescencia indirecta con Crithidia luciliae, observ\u00e1ndose tinci\u00f3n fluorescente anular del kinetoplasto que contiene ADN de doble cadena. En algunos casos pueden observarse im\u00e1genes fluorescentes en flagelo, membrana y corp\u00fasculo basal, consideradas at\u00edpicas. Como C. luciliae pertenece a la familia Trypanosomatidae, que incluye pat\u00f3genos para el hombre como Trypanosoma cruzi y Leishmaniaspp., se consider\u00f3 que las im\u00e1genes at\u00edpicas ...\n[Vasculitis asociadas a anticuerpos anti-citoplasma de neutr\u00f3filos: Cl\u00ednica y tratamiento](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802013000200004&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMar\u00eda Virginia Paolini\n2013-04-01\nFull Text Available Las vasculitis asociadas a anticuerpos anti-citoplasma de neutr\u00f3filos (ANCA comprenden a un grupo de enfermedades caracterizadas por la inflamaci\u00f3n de la pared de peque\u00f1os vasos. Analizamos las caracter\u00edsticas epidemiol\u00f3gicas y cl\u00ednicas en una serie de 47 pacientes: 23 (49% granulomatosis de Wegener (GW, 15 (32% poliange\u00edtis microsc\u00f3pica (PAM y nueve (19% vasculitis limitada al ri\u00f1\u00f3n (VLR. La edad media al inicio de los s\u00edntomas fue de 50.7 \u00b1 14.9 a\u00f1os. La manifestaci\u00f3n cl\u00ednica m\u00e1s frecuente fue el compromiso renal en 41 (87% pacientes, seguido por el pulmonar en 26 (55% y el otorrinolaringol\u00f3gico en 17 (36%. En 26 (55% se asoci\u00f3 compromiso renal y pulmonar. La forma cl\u00ednica m\u00e1s frecuente fue la generalizada en 23 (49%, seguida por la grave en 18 (38%. El 89% presentaron determinaciones de ANCA positivas. Cuatro (8% no recibieron tratamiento inmunosupresor de inicio. De los 43 que recibieron tratamiento de inicio, 29 (67% tuvieron remisi\u00f3n completa, con un tiempo de remisi\u00f3n promedio de 35.3 meses. Once (26% presentaron reca\u00eddas, diez (91% reca\u00eddas mayores y uno (9% menor. Doce (28% fallecieron, siete en forma temprana y cinco durante la evoluci\u00f3n de la enfermedad. Quince (31% evolucionaron a insuficiencia renal cr\u00f3nica. Los 26 pacientes en seguimiento tuvieron respuesta al tratamiento y 20 (77% de ellos estaban en remisi\u00f3n al finalizar el estudio. Las vasculitis asociadas a ANCA contin\u00faan siendo enfermedades de alta morbilidad y mortalidad, a pesar de las mejor\u00edas logradas con los tratamientos inmunosupresores.\n[ELISA Ureasa para selecci\u00f3n primaria y monitoreo de anticuerpos monoclonales](http://www.revistabiomedica.org/index.php/biomedica/article/view/1994) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nGladys Thal\u00eda Cortes\n1990-12-01\nFull Text Available Se emple\u00f3 el m\u00e9todo de Elisa Ureasa indirecto para detectar anticuerpos monoclonales obtenidos a partir de ratones inmunizados con merozo\u00edtos libres de Plasmodium falciparum. Se seleccionaron los anticuerpos monoclonales que mostraron ser muy estables en posteriores ensayos de caracterizaci\u00f3n. Los anticuerpos obtenidos no fueron espec\u00edfiCos contra ant\u00edgeno de Plasmodium falciparum pero permitieron identificar la prote\u00edna Espectrina del citoesqueleto de eritrocito humano. En el ensayo fue empleado un ant\u00edgeno de esquizontes concentrados y solubilizados. Se obtuvo la determinaci\u00f3n del punto final de la reacci\u00f3n a trav\u00e9s de lectura visual semicuantitativa. A partir de la enzima Ureasa de alta pureza que se encuentra disponible comercialmente y, empleando m\u00e9todos muy sencillos se prepararon los reactivos utilizados en el ensayo.\n[Prevalencia de anticuerpos anti-Chlamydia trachomatis y anti-Neisseria gonorrhoeae en grupos de individuos de la poblaci\u00f3n mexicana Prevalence of antibodies against Chlamydia trachomatis and Neisseria gonorrhoeae in Mexican populations](http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342003001100014) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMar\u00eda del Carmen Cravioto\n2003-01-01\nFull Text Available OBJETIVO: Estimar la prevalencia de infecci\u00f3n por Chlamydia trachomatis (CT y Neisseria gonorrhoeae (NG en grupos de individuos con diferente riesgo para infecciones de transmisi\u00f3n sexual. MATERIAL Y M\u00c9TODOS: Estudio transversal multic\u00e9ntrico efectuado en el Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, de la Ciudad de M\u00e9xico, de enero de 1992 a diciembre de 1993, en el que se estudiaron 945 individuos en edad reproductiva, 585 mujeres y 360 hombres. Seg\u00fan su riesgo para infecciones de transmisi\u00f3n sexual se clasificaron en grupos de alto y bajo riesgo. Los de alto riesgo incluyeron mujeres inf\u00e9rtiles con da\u00f1o tubario, mujeres con embarazo ect\u00f3pico o aborto, hombres inf\u00e9rtiles, pacientes con VIH/SIDA, hombres homo o bisexuales y trabajadoras del sexo comercial (TSC. Los de bajo riesgo: mujeres primigestas, hombres f\u00e9rtiles y mujeres inf\u00e9rtiles sin da\u00f1o tubario. Se determin\u00f3 en duplicado IgG e IgA anti-NG y anti-CT en suero, por an\u00e1lisis inmunoenzim\u00e1tico, utilizando como ant\u00edgeno el pili de NG y la fracci\u00f3n L1 de CT. Se calcularon porcentajes. RESULTADOS: En mujeres la prevalencia para NG fue IgG 13.7% e IgA 14.3%, y para CT fue IgG 11.4% e IgA 4.4%. En hombres, NG 3.3% y 13.3%, respectivamente, y para CT 7.2% y 5.5%, respectivamente. En TSC se encontr\u00f3 NG en 31.2 % y 28.4%, respectivamente, y para CT 25.0% y 5.7%, respectivamente. En mujeres con infertilidad por da\u00f1o tubario, NG 5.6% y 9.8%, respectivamente, y CT 8.4% y 1.4%, respectivamente. En 110 primigestas j\u00f3venes, NG 4.5% y 10.0%, respectivamente, y CT 3.6% y 9.1%, respectivamente. CONCLUSIONES: Estos datos confirman la prevalencia elevada de Neisseria gonorrhoeae y Chlamydia trachomatis en trabajadoras del sexo comercial y en hombres homo/bisexuales, pero no en otros grupos de alto riesgo como las mujeres inf\u00e9rtiles, con aborto o embarazo ect\u00f3pico.OBJECTIVE: To estimate the prevalence of Chlamydia trachomatis (CT and Neisseria gonorrhoeae\n[Producci\u00f3n de anticuerpos policlonales IgG contra la proteina iduronato-2-sulfato sulfatasa y desarrollo de un sistema de detecci\u00f3n para IDS humana recombinante.](http://www.revistabiomedica.org/index.php/biomedica/article/view/1340) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nOlga Pe\u00f1a\n2005-06-01\nFull Text Available Introducci\u00f3n. La enfermedad de Hunter es un trastorno lisos\u00f3mico caracterizado por la deficiencia de la enzima iduronato-2-sulfato sulfatasa (IDS (EC 3.1.6.13. Esta enfermedad, al igual que muchos trastornos metab\u00f3licos, son patolog\u00edas intratables mediante la terap\u00e9utica convencional; sin embargo, existe la posibilidad de ser tratada alternativamente mediante terapia g\u00e9nica o terapia de reemplazo enzim\u00e1tico. Objetivo. El Instituto de Errores Innatos del Metabolismo (IEIM ha desarrollado un sistema de expresi\u00f3n de sulfatasas para producir IDS humana recombinante (IDShr en Escherichia coli y Pichia pastoris, con resultados favorables. El objetivo principal de este trabajo fue desarrollar un sistema de detecci\u00f3n de IDS humana recombinante. Materiales y m\u00e9todos. Para el efecto, se inmunizaron con IDS comercial de TKT (Cambridge, MA dos conejos de raza Nueva Zelanda blanca y los anticuerpos purificados a partir del suero se utilizaron en el desarrollo de una t\u00e9cnica semicuantitativa por dot-blot. Diferentes muestras de extractos crudos de fermentaciones con P. pastoris y E. coli se procesaron con el fin de poder determinar la presencia de la enzima. Resultados. Se demostr\u00f3 que los anticuerpos eran espec\u00edficos en el reconocimiento de la IDS sin presentar reactividad cruzada con prote\u00ednas contaminantes de los extractos crudos. Conclusi\u00f3n. Por consiguiente, los anticuerpos se podr\u00e1n usar en el desarrollo de una t\u00e9cnica ELISA tipo sandwich como m\u00e9todo de detecci\u00f3n y cuantificaci\u00f3n de la enzima y en procesos de purificaci\u00f3n de la misma mediante cromatograf\u00eda de afinidad.\n[IgA, IgE e subclasses de IgG anti-Candida albicans no soro e lavado vaginal de pacientes com candid\u00edase vulvovaginal IgA, IgE and IgG subclasses to Candida albicans in serum and vaginal fluid from patients with vulvovaginal candidiasis](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302003000400037) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nRicardo Jos\u00e9 Victal de Carvalho\n2003-01-01\nFull Text Available OBJETIVO: Determinar n\u00edveis de anticorpos IgA, IgE, IgG e subclasses (IgG1, IgG4 espec\u00edficos a C. albicans no soro e lavado vaginal de mulheres com ou sem candid\u00edase vulvovaginal para avaliar o papel destes anticorpos na imunopatog\u00eanese desta doen\u00e7a. M\u00c9TODOS: Foram selecionadas 30 mulheres com sintomas cl\u00ednicos de candid\u00edase vulvovaginal (15 com cultura de secre\u00e7\u00e3o vaginal positiva para C. albicans, 11 com cultura negativa e quatro com cultura positiva para Candida n\u00e3o-albicans e 12 mulheres controles assintom\u00e1ticas (nove com cultura negativa. Amostras de soro e lavado vaginal foram obtidas para a detec\u00e7\u00e3o de anticorpos anti-C. albicans por ELISA. RESULTADOS: Pacientes sintom\u00e1ticas com cultura positiva apresentaram n\u00edveis de IgA espec\u00edficas significativamente maiores no lavado vaginal e menores no soro do que aquelas com cultura negativa. N\u00edveis s\u00e9ricos de IgE espec\u00edfica foram extremamente baixos em rela\u00e7\u00e3o ao lavado vaginal. Altos n\u00edveis de IgG total espec\u00edfica foram encontrados no soro e lavado vaginal em ambos os grupos, independente da presen\u00e7a do fungo. N\u00edveis de IgG1 e IgG4 espec\u00edficas foram significativamente maiores somente no lavado vaginal de mulheres sintom\u00e1ticas e cultura positiva, com rela\u00e7\u00e3o IgG1/IgG4 ligeiramente maior, indicando que a resposta de anticorpos IgG1 possa estar predominantemente envolvida na resolu\u00e7\u00e3o da infec\u00e7\u00e3o f\u00fangica. CONCLUS\u00d5ES: Nossos resultados indicam resposta acentuada de IgA, IgG1 e IgG4 anti-C. albicans no lavado vaginal de mulheres sintom\u00e1ticas com cultura positiva, sugerindo importante papel destes anticorpos na resposta imune local estimulada pela presen\u00e7a do fungo.PURPOSE: To determine the levels of IgA, IgE, IgG and subclasses (IgG1, IgG4 antibodies specific to C. albicans in serum and vaginal washes from women with or without vulvovaginal candidiasis in order to evaluate the role of these antibodies in the immunopathogenesis of the disease. METHODS: Thirty women\n[Seroprevalencia de anticuerpos contra Toxocara canis y factores de riesgo en ni\u00f1os, Ciudad Bol\u00edvar, Bogot\u00e1, D.C., 2000](http://www.revistabiomedica.org/index.php/biomedica/article/view/1116) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMyriam Acero\n2001-09-01\nFull Text Available La toxocariasis humana es una zoonosis causada por larvas de los nem\u00e1todos Toxocara canis y Toxocara cati, cuyo h\u00e1bitat es el intestino de perros y gatos, respectivamente. Para estimar la prevalencia de anticuerpos contra T: canis y su relaci\u00f3n con algunos factores de riesgo, se estudiaron 193 ni\u00f1os entre 4 y 14 a\u00f1os de edad procedentes de establecimientos oficiales de educaci\u00f3n b\u00e1sica primaria de la localidad de Ciudad Bol\u00edvar en Bogot\u00e1 durante el a\u00f1o 2000. Asimismo, para determinar la proporci\u00f3n de cachorros positivos al par\u00e1sito T: canis, se estudiaron las muestras fecales de 21 perros que conviv\u00edan con los ni\u00f1os en el momento del estudio. Se determin\u00f3 la seropositividad de anticuerpos IgG por el m\u00e9todo de ELlSA y la prevalencia de infecci\u00f3n por T canis en heces de cachorros por el m\u00e9todo modificado de McMaster. La prevalencia de seropositividad observada fue de 7,3%, con una mayor proporci\u00f3n en ni\u00f1os menores de 5 a\u00f1os; sin embargo, el promedio de t\u00edtulos aument\u00f3 con la edad. La prevalencia de infecci\u00f3n en cachorros fue de 66,7%. El factor de riesgo para la presencia de t\u00edtulos de anticuerpos positivos contra T: canis que result\u00f3 estad\u00edsticamente significativo, fue el de no lavarse las manos antes de comer (RR=9,91; IC 95%=1,27-77,21. Sin embargo, condiciones como la edad, el sexo, la geofagia y el incremento de la densidad poblacional canina pueden favorecer la transmisi\u00f3n de esta zoonosis en la localidad.\n[Comparison of semi-automatized assays for anti-T. gondii IgG detection in low-reactivity serum samples: importance of the results in patient counseling Compara\u00e7\u00e3o de ensaios semi-automatizados para pesquisa de IgG anti-T. gondii em amostras de soros de baixa reatividade: import\u00e2ncia dos resultados no aconselhamento do paciente](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1676-24442003000200003) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nPaulo Guilherme Leser\n2003-06-01\nFull Text Available Toxoplasmosis is a disease which can cause severe congenital infection and is normally diagnosed by the detection of T. gondii specific antibodies in the serum of infected patients. Several different tests allow to distinguish recent from past infections and to quantify anti-T. gondii specific IgG, and the results can be used as markers for immunity. In the present study, we compare the performance of two different methodologies, the Elfa (bioM\u00e9rieux S.A and the Meia (Abbott Laboratories in detecting T. gondii specific IgG in low-reactivity sera. Of 76 analyzed samples, three presented discrepant results, being positive in the Abbott AxSYM Toxo IgG assay, and negative in the bioM\u00e9rieux Vidas Toxo IgG II assay. By using other tests, the three sera were confirmed to be negative. The results are discussed in the context of their importance for patient management, especially during pregnancy.Toxoplasmose, doen\u00e7a conhecida por sua severidade na infec\u00e7\u00e3o cong\u00eanita \u00e9 geralmente diagnosticada pela demonstra\u00e7\u00e3o de anticorpos espec\u00edficos contra ant\u00edgenos de T. gondii, presentes no soro de indiv\u00edduos infectados. Diferentes testes s\u00e3o dispon\u00edveis para diferenciar infec\u00e7\u00e3o recente de infec\u00e7\u00e3o pregressa, para quantificar anticorpos IgG anti-T. gondii nos soros dos pacientes e utilizar os resultados como marcadores de imunidade. Neste trabalho apresentamos os resultados do estudo comparativo de duas tecnologias, Elfa (bioM\u00e9rieux S.A. e Meia (Abbott Laboratories, para pesquisa de anticorpos IgG anti-T. gondii em amostras de soros de baixa reatividade. De 76 amostras processadas, tr\u00eas apresentaram resultados discrepantes, reagentes para AxSYM Toxo IgG e n\u00e3o-reagentes para Vidas Toxo IgG II. A confirma\u00e7\u00e3o dos resultados, feita por bateria de testes, mostrou que todas as tr\u00eas amostras eram n\u00e3o-reagentes. Os resultados s\u00e3o discutidos em sua import\u00e2ncia e orienta\u00e7\u00e3o cl\u00ednica, principalmente para a paciente gestante.\n[Asociaci\u00f3n entre variables reproductivas y anticuerpos anti Neospora caninum en bovinos lecheros de un municipio de Colombia](https://www.openaire.eu/search/publication?articleId=doajarticles::ae92c86cab8f4fc5b2100e8cd33b961b)\nMart\u00edn Orlando Pulido Medell\u00edn; Adriana Mar\u00eda D\u00edaz Anaya; Roy Jos\u00e9 Andrade Becerra\n2017-01-01\nEl objetivo fue determinar el porcentaje de vacas seropositivas a Neospora caninum y la identificaci\u00f3n de las variables reproductivas que se encuentran relacionadas con la presencia de anticuerpos contra este protozoo. Se tomaron 1,000 muestras de sangre a hembras bovinas del municipio de Sotaquir\u00e1, Boyac\u00e1, las cuales fueron evaluadas por medio de ELISA indirecta. Se determin\u00f3 una seroprevalencia de Neospora caninum del 45 %; las variables reproductivas asociadas con la positividad de N. cani...\n[Antigen-Specific IgG ameliorates allergic airway inflammation via Fc\u03b3 receptor IIB on dendritic cells](http://respiratory-research.com/content/12/1/42) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nKarasuyama Hajime\n2011-04-01\nFull Text Available Abstract Background There have been few reports on the role of Fc receptors (FcRs and immunoglobulin G (IgG in asthma. The purpose of this study is to clarify the role of inhibitory FcRs and antigen presenting cells (APCs in pathogenesis of asthma and to evaluate antigen-transporting and presenting capacity by APCs in the tracheobronchial mucosa. Methods In Fc\u03b3RIIB deficient (KO and C57BL/6 (WT mice, the effects of intratracheal instillation of antigen-specific IgG were analysed using the model with sensitization and airborne challenge with ovalbumin (OVA. Thoracic lymph nodes instilled with fluorescein-conjugated OVA were analysed by fluorescence microscopy. Moreover, we analysed the CD11c+ MHC class II+ cells which intaken fluorescein-conjugated OVA in thoracic lymph nodes by flow cytometry. Also, lung-derived CD11c+ APCs were analysed by flow cytometry. Effects of anti-OVA IgG1 on bone marrow dendritic cells (BMDCs in vitro were also analysed. Moreover, in Fc\u03b3RIIB KO mice intravenously transplanted dendritic cells (DCs differentiated from BMDCs of WT mice, the effects of intratracheal instillation of anti-OVA IgG were evaluated by bronchoalveolar lavage (BAL. Results In WT mice, total cells and eosinophils in BAL fluid reduced after instillation with anti-OVA IgG1. Anti-OVA IgG1 suppressed airway inflammation in hyperresponsiveness and histology. In addition, the number of the fluorescein-conjugated OVA in CD11c+ MHC class II+ cells of thoracic lymph nodes with anti-OVA IgG1 instillation decreased compared with PBS. Also, MHC class II expression on lung-derived CD11c+ APCs with anti-OVA IgG1 instillation reduced. Moreover, in vitro, we showed that BMDCs with anti-OVA IgG1 significantly decreased the T cell proliferation. Finally, we demonstrated that the lacking effects of anti-OVA IgG1 on airway inflammation on Fc\u03b3RIIB KO mice were restored with WT-derived BMDCs transplanted intravenously. Conclusion Antigen-specific IgG ameliorates\n[Prevalencia de anticuerpos contra dengue y leptospira en la poblaci\u00f3n de J\u00e1ltipan, Veracruz Prevalence of dengue and leptospira antibodies in the state of Veracruz, Mexico](http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342006000300006) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJoel Navarrete-Espinosa\n2006-06-01\nFull Text Available OBJETIVO: Conocer la prevalencia de anticuerpos contra dengue y leptospira en J\u00e1ltipan, Veracruz, M\u00e9xico MATERIAL Y M\u00c9TODOS: Estudio transversal en 500 habitantes de J\u00e1ltipan, Veracruz, mediante un muestreo por hogares, aplicaci\u00f3n de cuestionario y toma de muestras sangu\u00edneas. Se buscaron anticuerpos IgG y se evaluaron factores asociados a sus seroprevalencias mediante regresi\u00f3n log\u00edstica RESULTADOS: La seroprevalencia global para denguevirus fue 79.6% (IC95% 76-81; los principales factores vinculados con la infecci\u00f3n fueron la edad (pOBJECTIVE: To discover the prevalence of antibodies against denguevirus and leptospira. MATERIAL AND METHODS: A cross-sectional study was carried out in 500 inhabitants of Veracruz, Mexico through household sampling, administration of a questionnaire and collection of blood samples. The presence of IgG antibodies was determined and factors associated with seroprevalence were evaluated using a logistic regression model. RESULTS: Total denguevirus seroprevalence was 79.6% (IC95% 76-81. The main factors associated with infection were age and residence in neighborhoods with higher vectorial indices (RMP=2.94, IC95% 1.46-6.1. Overall seroprevalence against leptospira was 4% (IC95% 2-6. Prevalence was higher in the 25 to 44 years age group (35%, IC95% 15-59. Seroprevalence in individuals who referred to living with dogs, pigs, cows and rats was 25% (IC95% 0.63-80. Eighty-five percent of individuals who were leptospira positive were also dengue positive. CONCLUSIONS: The prevalence of denguevirus antibodies suggests the risk of serious dengue hemorrhagic outbreaks. Although leptospirosis prevalence was low, the coexistence of both agents was confirmed.\n[Multiple nuclear dots and rim-like/membranous IgG isotypes in primary biliary cirrhosis.](https://www.ncbi.nlm.nih.gov/pubmed/19301204)\nMuratori, Paolo; Granito, Alessandro; Ferri, Silvia; Pappas, Georgios; Volta, Umberto; Menichella, Rita; Bianchi, Francesco B; Lenzi, Marco; Muratori, Luigi\n2009-03-01\nAnti nuclear (ANA) immunomorphological patterns such as multiple nuclear dots (MND) and rim-like/membranous (RL/M) are considered highly specific but little sensitive for primary biliary cirrhosis (PBC) diagnosis. To evaluate frequency and clinical significance of MND and RL/M in PBC patients when investigated at the level of immunoglobulin G isotypes. MND and RL/M pattern have been tested in 141 PBC sera and 230 pathological controls using HEp-2 cells as substrate and anti- total IgG and individual IgG subclasses (IgG1, IgG2, IgG3, IgG4) as specific antisera. One hundred and fourteen of 141 (80%) PBC patients had RL/M or MND pattern when IgG subclasses were used as revealing reagents (vs. 34% when anti total IgG were used, p < 0.0001). The prevalent isotype was IgG1 for RL/M, and IgG2 for MND pattern. None of controls was positive. No clinical differences in terms of severity and outcome of disease have been observed in PBC patients positive for MND and RL/M when investigated with IgG isotypes. The research for RL/M and MND pattern at level of IgG isotype determines a wide gain in terms of sensitivity without a loss of specificity. In Italian PBC patients MND and RL/M pattern did not seem to characterize any subgroup of patients with a poorer prognosis.\n[Flexibility and conformational change of IgG molecule](http://www.iaea.org/inis/collection/NCLCollectionStore/_Public/14/760/14760433.pdf?r=1) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nAlpert, Y.; Ostanevich, Yu.M.\n1982-12-01\nThe dynamic behaviour of pig anti-Dnp-immunoglobulin (IgG) investigated by the neutron spin echo technique gave evidence of internal motion of a biological macromolecule. It is suggested that this motion belongs to the wobbling of the Fab parts of the investigated IgG molecule around its so called hinge region. (author)\n[High prevalence of human anti-bovine IgG antibodies as the major cause of false positive reactions in two-site immunoassays based on monoclonal antibodies](http://www.forskningsdatabasen.dk/en/catalog/37483831) [DEFF Research Database (Denmark)](http://forskningsbasen.deff.dk/?lang=eng)\nAndersen, Ditte C; Koch, Claus; Jensen, Charlotte H\n2004-01-01\nwere purified by protein G affinity chromatography from culture supernatant containing 10% (v/v) fetal calf serum (FCS). Human anti-animal IgG (bovine, mouse, horse, and swine) antibodies and human anti-bovine serum albumin antibodies were measured using an ELISA design, with direct bridging...... of the solid phase and biotinylated antigens. The false positive reactions were abolished by addition of 1% (v/v) bovine serum to the dilution buffer (DB). Human anti-bovine IgG antibodies (HABIA) were detected in 99 out of 104 sera from blood donors (50 females; 54 males). HABIA levels in male sera (n = 54......) were positively correlated to the false positive signals in the PP14 ELISA (r = 0.923; p detected in the donor sera, but levels and frequencies were lower compared to that of HABIA. Furthermore, HABIA were...\n[Human IgG4: a structural perspective.](https://www.ncbi.nlm.nih.gov/pubmed/26497518)\nDavies, Anna M; Sutton, Brian J\n2015-11-01\nIgG4, the least represented human IgG subclass in serum, is an intriguing antibody with unique biological properties, such as the ability to undergo Fab-arm exchange and limit immune complex formation. The lack of effector functions, such as antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity, is desirable for therapeutic purposes. IgG4 plays a protective role in allergy by acting as a blocking antibody, and inhibiting mast cell degranulation, but a deleterious role in malignant melanoma, by impeding IgG1-mediated anti-tumor immunity. These findings highlight the importance of understanding the interaction between IgG4 and Fc\u03b3 receptors. Despite a wealth of structural information for the IgG1 subclass, including complexes with Fc\u03b3 receptors, and structures for intact antibodies, high-resolution crystal structures were not reported for IgG4-Fc until recently. Here, we highlight some of the biological properties of human IgG4, and review the recent crystal structures of IgG4-Fc. We discuss the unexpected conformations adopted by functionally important C\u03b32 domain loops, and speculate about potential implications for the interaction between IgG4 and Fc\u03b3Rs. \u00a9 2015 The Authors. Immunological Reviews Published by John Wiley & Sons Ltd.\n[Obtenci\u00f3n, purificaci\u00f3n y caracterizaci\u00f3n de anticuerpos policlonales IgY desarrollados en gallina, dirigidos contra aislamientos colombianos de Giardia duodenalis.](http://www.revistabiomedica.org/index.php/biomedica/article/view/1372) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nDabeiba Adriana Garc\u00eda\n2005-12-01\nFull Text Available Introducci\u00f3n. El desarrollo de anticuerpos policlonales requiere de animales de laboratorio, generalmente, el conejo, que deben sangrarse para su obtenci\u00f3n. Como alternativa, se han utilizado las gallinas. Objetivo. Desarrollar anticuerpos policlonales IgY anti-Giardia duodenalis y evaluar diferentes m\u00e9todos para su purificaci\u00f3n a partir de yema de huevo. Materiales y m\u00e9todos. Se inmunizaron tres gallinas intramuscularmente con trofozo\u00edtos del par\u00e1sito: las inmunizaciones se realizaron a los 0, 15, 30, 45, 60, 90 y 120 d\u00edas. Se recolectaron huevos en cada etapa de la inmunizaci\u00f3n y se purific\u00f3 la IgY por deslipidaci\u00f3n (D y precipitaci\u00f3n (P mediante cinco protocolos diferentes: M1: (P: sulfato de amonio/D: dextr\u00e1n sulfato-cloruro de calcio, M2: (D: dextr\u00e1n sulfato-cloruro de calcio/P: sulfato de amonio, M3: (D: cloroformo/ P: sulfato de amonio 50%, M4: (D: soluci\u00f3n A/P:soluci\u00f3n B y M5: (D: cloroformo/P: sulfato de amonio 30%. Se realiz\u00f3 evaluaci\u00f3n inmunoqu\u00edmica de la IgY anti-Giardia duodenalis mediante inmunodifusi\u00f3n, contrainmunoelectroforesis e inmunoelectrotransferencia (Western blot; la pureza de IgY por SDS-PAGE en presencia y ausencia de reductor y la concentraci\u00f3n de la inmunoglobulina (mg/mL por espectrofotometr\u00eda y densitometr\u00eda. Resultados. La IgY anti-G. duodenalis mediante evaluaci\u00f3n inmunoqu\u00edmica present\u00f3 t\u00edtulos hasta de 1:32. La inmunoglobulina en ausencia de reductor mostr\u00f3 una banda de 180 kd y en su presencia bandas de 30 y 68 kd, caracter\u00edsticas de sus cadenas liviana y pesada, respectivamente. Las mayores concentraciones de inmunoglobulina se recuperaron con el m\u00e9todo dos (M2, 4,6 mg de IgY por mL de yema de partida. Conclusiones. Por su facilidad y econom\u00eda de producci\u00f3n en gallinas, los anticuerpos policlonales IgY anti-Giardia as\u00ed obtenidos podr\u00e1n utilizarse para desarrollar inmunoensayos que detecten el par\u00e1sito en elu\u00eddos de heces.\n[Diagn\u00f3stico r\u00e1pido de citomegalovirus (CMV en pacientes inmunocomprometidos mediante anticuerpos monoclonales que reconocen proteinas precoces virales Rapid diagnosis of cytomegalovirus infection in immunocompromised patients by using monoclonal antibodies against early viral antigens](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02761989000200017) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMaritza Alvarez\n1989-06-01\nFull Text Available Se aplic\u00f3 la t\u00e9cnica de detecci\u00f3n de antigenos precoces fluorescentes (DAPF usando el anticuerpo monoclonal E-13 McAb, mediante el cual se lograron detectar 15 casos positivos a CMV de 75 muestras de orina o sangre (\"buffy coat\" tomadas de 52 pacientes inmunocomprometidos ingresados en el Instituto de Nefrolog\u00eda de ciudad Habana. Aplicando las t\u00e9cnicas cl\u00e1sicas de aislamiento en fibroblastos humanos diploides (MRC-5, se lograron aislar 12 cepas de CMV de casos previamente positivos por DAPF; logr\u00e1ndose adem\u00e1s un aislamiento en una muestra reportada negativa por fluorescencia. Se observ\u00f3 una coincidencia de un 80% entre ambas t\u00e9cnicas. Se detect\u00f3 la presencia de anticuerpos IgG contra CMV en todos los casos estudiados, utilizando para ello la t\u00e9cnica ELISA.A technique was applied to detect early fluorescent antigens (DEFA of cytomegalovirus (CMV using the E13 monoclonal antibodies in 52 immunocompromised patients hospitalized in the Nephrology Institute of Havana. Of the 75 urine or blood (buffy coat samples taken, 15 were found positive to CMV. Using classical diploide human fibroblast isolation technique, 12 CMV strains were isloation of previously detected positive samples by DEFA. In addition, CMV was isolated from one sample reported to be negative by DEFA. A coincidence of 80% was found between both techniques. With the ELISA test, all the sample studied have IgG antibodies to CMV.\n[IgG4 autoantibodies are inhibitory in the autoimmune disease bullous pemphigoid.](https://www.ncbi.nlm.nih.gov/pubmed/27377454)\nZuo, Yagang; Evangelista, Flor; Culton, Donna; Guilabert, Antonio; Lin, Lin; Li, Ning; Diaz, Luis; Liu, Zhi\n2016-09-01\nThe IgG4 subclass of antibodies exhibits unique characteristics that suggest it may function in an immunoregulatory capacity. The inhibitory function of IgG4 has been well documented in allergic disease by the demonstration of IgG4 blocking antibodies, but similar functions have not been explored in autoimmune disease. Bullous pemphigoid (BP) is a subepidermal autoimmune blistering disease characterized by autoantibodies directed against BP180 and an inflammatory infiltrate including eosinophils and neutrophils. Animal models have revealed that the NC16A region within BP180 harbors the critical epitopes necessary for autoantibody mediated disease induction. BP180 NC16A-specific IgG belong to the IgG1, IgG3, and IgG4 subclasses. The purpose of this study was to determine effector functions of different IgG subclasses of NC16A-specific autoantibodies in BP. We find that IgG4 anti-NC16A autoantibodies inhibit the binding of IgG1 and IgG3 autoantibodies to the NC16A region. Moreover, IgG4 anti-NC16A blocks IgG1 and IgG3 induced complement fixation, neutrophil infiltration, and blister formation clinically and histologically in a dose-dependent manner following passive transfer to humanized BP180-NC16A mice. These findings highlight the inhibitory role of IgG4 in autoimmune disease and have important implications for the treatment of BP as well as other antibody mediated inflammatory and autoimmune diseases. Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.\n[Obtenci\u00f3n de anticuerpos policlonales IgY antiparvovirus canino y evaluaci\u00f3n en un sistema de aglutinaci\u00f3n con l\u00e1tex](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2015000300001&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJannet Gonz\u00e1lez-Figueredo\n2015-12-01\nFull Text Available La parvovirosis canina es una de las principales infecciones que provoca gastroenteritis, fundamentalmente en cachorros, con altos \u00edndices de morbiletalidad. Los diagnosticadores m\u00e1s utilizados se basan en la detecci\u00f3n de part\u00edculas virales excretadas durante la fase aguda de la enfermedad. Algunos requieren equipos especializados, lo que aumenta los costos y el tiempo de diagn\u00f3stico. Por esto, la simplificaci\u00f3n de estos m\u00e9todos con alta sensibilidad y especificidad es prioritaria. En Cuba solo se logra un diagn\u00f3stico presuntivo sin la completa confirmaci\u00f3n de la enfermedad, principalmente por la escasez o ausencia de un medio diagn\u00f3stico en toda la red de consultorios y cl\u00ednicas veterinarias, r\u00e1pido, eficaz y ajustable a nuestras condiciones. Este trabajo tuvo como objetivo obtener anticuerpos policlonales IgY a partir de yema de huevo de gallina y evaluarlos mediante un sistema de l\u00e1tex-aglutinaci\u00f3n, para su posible uso como terapia y principalmente en el diagn\u00f3stico. Se inmunizaron por v\u00eda intramuscular dos gallinas de raza Leghorn con una cepa atenuada de parvovirus canino (PVC tipo 2. Se aplicaron 8 inoculaciones por ave cada 15 d\u00edas. Se cosecharon los huevos y se purificaron los anticuerpos por el m\u00e9todo de sulfato de dextrana/sulfato de sodio. Se determin\u00f3 el t\u00edtulo de IgY anti-PVC por el m\u00e9todo de Inhibici\u00f3n de la Hemoaglutinaci\u00f3n (IH y con ant\u00edgeno de PVC acoplado a part\u00edculas de l\u00e1tex de poliestireno. Por IH se obtuvo un t\u00edtulo de IgY anti-PVC de 1:1024. Las mezclas de anticuerpos con t\u00edtulos alto y medio de ambas gallinas aglutinaron con los reactivos preparados con 230 y 460 \u00b5g/mL de ant\u00edgeno. La mayor intensidad de la reacci\u00f3n y la mejor detectabilidad correspondieron a los reactivos elaborados con los anticuerpos de mayor t\u00edtulo.\n[Prevalencia de anticuerpos antimal\u00e1ricos en donantes del banco de sangre del Hospital Universitario San Vicente de Pa\u00fal de Medell\u00edn, Colombia](http://www.revistabiomedica.org/index.php/biomedica/article/view/1035) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJhon M. Ort\u00edz\n1999-12-01\nFull Text Available Se determin\u00f3 la prevalencia de anticuerpos antimal\u00e1ricos, tipo IgG, mediante la t\u00e9cnica de inmunofluorescencia indirecta (IFI, en 392 sueros de donantes voluntarios de sangre del Hospital Universitario San Vicente de Pa\u00fal, recolectados durante los meses de septiembre y octubre del a\u00f1o 1995 y mantenidos en congelaci\u00f3n a -70 \"\"C durante 36 meses. La prevalencia de seropositividad fue de 1,8% (7 donantes, de los cuales, tres ten\u00edan el antecedente de haber vivido en zona end\u00e9mica para malaria; de \u00e9stos, dos hab\u00edan sufrido malaria, por lo menos, una vez en la vida; los cuatro donantes restantes no hab\u00edan vivido en zona end\u00e9mica para malaria ni ten\u00edan antecedentes de haberla padecido. Todos los donantes tuvieron gotas gruesas negativas para Plasmodium. Para tratar de reducir el riesgo de malaria transfusional, se recomienda informar en forma clara a los donantes sobre las\u00e1reas end\u00e9micas para malaria en el departamento, complementar la encuesta que realizan los bancos de sangre con gota gruesa en todas las unidades de sangre que se vayan a transfundir y determinar anticuerpos antimal\u00e1ricos en todos los donantes de riesgo con encuestas sospechosas y que puedan ser transmisores potenciales de Plasmodium.\n[Enhancement of retroviral infection in vitro by anti-Le(y) IgG: reversal by humanization of monoclonal mouse antibody](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=7902106&query_hl=17) [DEFF Research Database (Denmark)](http://forskningsbasen.deff.dk/?lang=eng)\nHansen, J E; S\u00f8rensen, A M; Arendrup, M\n1993-01-01\nMonoclonal mouse IgG3 antibody (ABL 364) against the carbohydrate Le(y) antigen enhanced infection in vitro with HTLV-1 and with HIV-1 when propagated in both transformed and normal lymphocytes. Enhancement was independent of complement, occurred with both lymphocytes and monocytes as target cells...... with no indication of any alternative pathway of infection, as evidenced by abrogation of enhancement by anti-CD4 MAb or soluble recombinant CD4, and also the inability of anti-Le(y) MAb to mediate HIV infection of HSB-2 cells in which HTLV-1/HIV pseudovirus infection was enhanced. While F(ab)2 fragments of ABL 364...\n[Immunoradiometric assay for cytomegalovirus-specific IgG antibodies](https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=21090354) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nKlapper, P.E.; Cleator, G.M.; Prinja-Wolks, D.; Morris, D.J.\n1990-01-01\nAn immunoradiometric assay (radio-immunosorbent test; RIST) for the detection of IgG antibodies to human herpesvirus 4 [human cytomegalovirus (CMV)] has been developed. The technique utilizes CMV antigen passively adsorbed to a polyvinyl microtitration plate and a radiolabelled murine monoclonal anti-human IgG antibody to detect binding of human antibody to the 'solid phase' reagent. The assay was optimized, and its specifity confirmed by testing paired acute and convalescent sera from patients with acute CMV or other human herpesvirus infections. To determine the assay's sensitivity 1433 blood donor sera were examined. The RIST was more sensitive than a standard complement fixation (CFT). Use of a monoclonal anti-human IgG antibody in the RIST reduced non-specific binding to the control uninfected cell antigen such that blood donor sera could be tested in the assay using only a CMV antigen without generating an unacceptable false positive rate. (author). 23 refs.; 1 tab\n[Prevalence of Anti Human Herpes Virus-6 IgG and its Receptor in Acute Leukemia (Membrane Cofactor Protein: MCP, CD46)](https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=41019450) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nAssem, M.M; El-Sharkawy, N.M.; Tarek, H.; Kamel, A.M.; Gad, W.H.; El-Rouby, M.N.; Ghaleb, F.M.\n2005-01-01\nCD46 is a membrane cofactor protein, which acts as a cofactor for factor I proteolytic cleavage of C3, so it protects the cells expressing it on their surface from autologous complement attack. It has been recently described as a receptor for HHV-6. Also, it has been shown to be highly expressed on malignant cells as compared to normal cells, thus playing a major role by which these cells, either cells of haematological malignancy or cells of other body cancers, can protect themselves against complement attack so they can survive and metastasize. Patients and methods: This study has been done to detect the sero prevalence of HHV-6 among 47 Egyptian adult cases of acute leukemia using the anti-HHV-6 IgG ELISA serological technique. CD46 receptor expression and immuno phenotyping technique were performed using FCM. Twenty nine of the cases were ANLL, while 18 were ALL cases. Sixteen age- and sex-matched control cases were also studied for both anti-HHV-6 IgG and CD46 receptor expression. HHV-6 IgG antibodies were encountered in 29 (100%), 14 (77.8%) and 12 (75%) of the ANLL, ALL and the control group, cases, respectively. CD46 expression was encountered in 21 (72.4%) of the ANLL cases and in 10 (55.6%) of the ALL cases. Concordance between HHV6 sero positivity and CD46 expression was encountered in 31 cases (29 positive and 2 negative). Dis concordance was encountered in 16 cases with 14 showing HHV-6 IgG sero positivity with no CD46 expression and 2 showing the reverse. The lack of significant correlation between CD46 expression and sero positivity would exclude CD46 expression as a cause of contracting HHV-6 infection in leukemic patients\n[Analyses of the peripheral immunome following multiple administrations of avelumab, a human IgG1 anti-PD-L1 monoclonal antibody](https://www.openaire.eu/search/publication?articleId=od_______908::13dff595dd525dd45a41f85372234426)\nDonahue, Renee N.; Lepone, Lauren M.; Grenga, Italia; Jochems, Caroline; Fantini, Massimo; Madan, Ravi A.; Heery, Christopher R.; Gulley, James L.; Schlom, Jeffrey\n2017-01-01\nBackground Multiple anti-PD-L1/PD-1 checkpoint monoclonal antibodies (MAb) have shown clear evidence of clinical benefit. All except one have been designed or engineered to omit the possibility to mediate antibody-dependent cell-mediated cytotoxicity (ADCC) as a second potential mode of anti-tumor activity; the reason for this is the concern of lysis of PD-L1 positive immune cells. Avelumab is a fully human IgG1 MAb which has been shown in prior in vitro studies to mediate ADCC versus a range...\n[A Unique Report: Development of Super Anti-Human IgG Monoclone with Optical Density Over Than 3](http://journals.tbzmed.ac.ir/PDF/APB/Manuscript/APB-3-333.pdf) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nLeili Aghebati Maleki\n2013-08-01\nFull Text Available Purpose: Monoclonal antibodies and related conjugates are key reagents used in biomedical researches as well as, in treatment, purification and diagnosis of infectious and non- infectious diseases. Methods: Balb/c mice were immunized with purified human IgG. Spleen cells of the most immune mouse were fused with SP2/0 in the presence of Poly Ethylene Glycol (PEG. Supernatant of hybridoma cells was screened for detection of antibody by ELISA. Then, the sample was assessed for cross-reactivity with IgM & IgA by ELISA and confirmed by immunoblotting. The subclasses of the selected mAbs were determined. The best clone was injected intraperitoneally to some pristane-injected mice. Anti-IgG mAb was purified from the animals' ascitic fluid by Ion exchange chromatography and then, mAb was conjugated with HRP. Results: In the present study, over than 50 clones were obtained that 1 clone had optical density over than 3. We named this clone as supermonoclone which was selected for limiting dilution. The result of the immunoblotting, showed sharp band in IgG position and did not show any band in IgM&IgA position. Conclusion: Based on the findings of this study, the conjugated monoclonal antibody could have application in diagnosis of infectious diseases like Toxoplasmosis, Rubella and IgG class of other infectious and non- infectious diseases.\n[A Unique Report: Development of Super Anti-Human IgG Monoclone with Optical Density Over Than 3](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3848219)\nAghebati Maleki, Leili; Baradaran, Behzad; Abdolalizadeh, Jalal; Ezzatifar, Fatemeh; Majidi, Jafar\n2013-01-01\nPurpose: Monoclonal antibodies and related conjugates are key reagents used in biomedical researches as well as, in treatment, purification and diagnosis of infectious and non- infectious diseases. Methods: Balb/c mice were immunized with purified human IgG. Spleen cells of the most immune mouse were fused with SP2/0 in the presence of Poly Ethylene Glycol (PEG). Supernatant of hybridoma cells was screened for detection of antibody by ELISA. Then, the sample was assessed for cross-reactivity with IgM & IgA by ELISA and confirmed by immunoblotting. The subclasses of the selected mAbs were determined. The best clone was injected intraperitoneally to some pristane-injected mice. Anti-IgG mAb was purified from the animals' ascitic fluid by Ion exchange chromatography and then, mAb was conjugated with HRP. Results: In the present study, over than 50 clones were obtained that 1 clone had optical density over than 3. We named this clone as supermonoclone which was selected for limiting dilution. The result of the immunoblotting, showed sharp band in IgG position and did not show any band in IgM&IgA position. Conclusion: Based on the findings of this study, the conjugated monoclonal antibody could have application in diagnosis of infectious diseases like Toxoplasmosis, Rubella and IgG class of other infectious and non- infectious diseases. PMID:24312857\n[ANTICUERPOS DIRIGIDOS A PEQUE\u00d1AS MOL\u00c9CULAS DE NEUROTRANSMISORES Y P\u00c9PTIDOS: PRODUCCI\u00d3N Y APLICACI\u00d3N DE ANTICUERPOS A DOPAMINA, SEROTONINA, GABA, VASOPRESINA, P\u00c9PTIDO VASOACTIVO INTESTINAL, NEUROP\u00c9PTIDO Y, SOMATOSTATINA Y SUSTANCIA P](http://www.redalyc.org/articulo.oa?id=43211940006) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nRuud M. Buijs\n2009-01-01\nFull Text Available En el presente trabajo se describe un procedimiento por medio del cual pueden ser obtenidos anticuerpos a partir de mol\u00e9culas peque\u00f1as de neurotransmisores usando glutaraldehido como agente acoplador. Este procedimiento fue desarrollado bajo la condici\u00f3n de que el inmun\u00f3geno usado para la preparaci\u00f3n del anticuerpo fuera, hasta donde fuese posible, de la misma identidad que la mol\u00e9cula transmisora fijada al tejido. Con el de fin de lograr mayor \u00e9xito, los p\u00e9ptidos, aminas o amino\u00e1cidos1 fueron conjugados a una prote\u00edna acarreadora usando glutaraldehido. Los anticuerpos obtenidos fueron usados en estudios de inmunohistoqu\u00edmica permitiendo la detecci\u00f3n de estos transmisores despu\u00e9s de un proceso de fijaci\u00f3n con glutaraldehido o paraformaldehido para los p\u00e9ptidos.\n[Genetic and infectious profiles influence cerebrospinal fluid IgG abnormality in Japanese multiple sclerosis patients.](http://europepmc.org/articles/PMC3988235?pdf=render) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nSatoshi Yoshimura\nFull Text Available BACKGROUND: Abnormal intrathecal synthesis of IgG, reflected by cerebrospinal fluid (CSF oligoclonal IgG bands (OBs and increased IgG index, is much less frequently observed in Japanese multiple sclerosis (MS cohorts compared with Western cohorts. We aimed to clarify whether genetic and common infectious backgrounds influence CSF IgG abnormality in Japanese MS patients. METHODOLOGY: We analyzed HLA-DRB1 alleles, and IgG antibodies against Chlamydia pneumoniae, Helicobacter pylori, Epstein-Barr virus nuclear antigen (EBNA, and varicella zoster virus (VZV in 94 patients with MS and 367 unrelated healthy controls (HCs. We defined CSF IgG abnormality as the presence of CSF OBs and/or increased IgG index (>0.658. PRINCIPAL FINDINGS: CSF IgG abnormality was found in 59 of 94 (62.8% MS patients. CSF IgG abnormality-positive patients had a significantly higher frequency of brain MRI lesions meeting the Barkhof criteria compared with abnormality-negative patients. Compared with HCs, CSF IgG abnormality-positive MS patients showed a significantly higher frequency of DRB1 1501, whereas CSF IgG abnormality-negative patients had a significantly higher frequency of DRB1 0405. CSF IgG abnormality-positive MS patients had a significantly higher frequency of anti-C. pneumoniae IgG antibodies compared with CSF IgG abnormality-negative MS patients, although there was no difference in the frequency of anti-C. pneumoniae IgG antibodies between HCs and total MS patients. Compared with HCs, anti-H. pylori IgG antibodies were detected significantly less frequently in the total MS patients, especially in CSF IgG abnormality-negative MS patients. The frequencies of antibodies against EBNA and VZV did not differ significantly among the groups. CONCLUSIONS: CSF IgG abnormality is associated with Western MS-like brain MRI features. DRB1 1501 and C. pneumoniae infection confer CSF IgG abnormality, while DRB1 0405 and H. pylori infection are positively and negatively\n[Quantitation of parasite-specific human IgG and IgE in sera: evaluation of solid-phase RIA and ELISA methodology](https://www.osti.gov/etdeweb/biblio/6015448) [Energy Technology Data Exchange (ETDEWEB)](https://www.etde.org/etdeweb/fieldedsearch.jsp)\nHamilton, R G [Johns Hopkins Univ., Baltimore, MD (USA). Dept. of Medicine; Hussain, R; Ottesen, E A [National Inst. of Allergy and Infectious Diseases, Bethesda, MD (USA); Adkinson, Jr, N F [Johns Hopkins Univ., Baltimore, MD (USA). School of Medicine\n1981-07-17\nThe authors have developed a non-competitive solid-phase radioimmunoassay (SPRIA) to quantitate both human IgE and IgG antibodies against soluble adult antigens of Brugia malayi (B.m.), a filarial parasite causing extensive infection throughout the tropics. Previously enzyme-linked immunosorbent assays (ELISA) had been used to detect ..mu..g/ml levels of IgG anti-B.m., but IgE antibodies were difficult to detect in this system. Since the SPRIA successfully quantitates both IgG and IgE anti-B.m., they sought to examine the reasons for the SPRIA's apparent superiority in detecting IgE anti-B.m. by extracting specific IgG from sera with high levels of IgE and IgG anti-B.m. antibodies. IgE anti-B.m. was then quantitated in these sera using both the SPRIA and ELISA methods. Results indicate that IgG anti-B.m. does not interfere with detection of specific IgE antibody in the SPRIA but does interfere in the ELISA. While ELISA permits detection of IgE anti-B.m. in the absence of competing IgG anti-B.m., as levels of specific IgG increase, the IgE is no longer detectable. These differences between SPRIA and ELISA can be explained by the SPRIA's antigen excess conditions which assure that there are sufficient antigens both to detect all anti-B.m. antibodies present in the serum and to adequately represent all antigen specificities in the crude B.m. extract. Their findings commend the use of SPRIA methods over ELISA in assessment of B.m.-specific IgE antibody in filariasis and indicate a potential role for SPRIA methods in absolute quantitation of specific serum antibodies.\n[Immunization of chickens with an agonistic monoclonal anti-chicken CD40 antibody-hapten complex: rapid and robust IgG response induced by a single subcutaneous injection.](https://www.ncbi.nlm.nih.gov/pubmed/22366632)\nChen, Chang-Hsin; Abi-Ghanem, Daad; Waghela, Suryakant D; Chou, Wen-Ko; Farnell, Morgan B; Mwangi, Waithaka; Berghman, Luc R\n2012-04-30\nProducing diagnostic antibodies in chicken egg yolk represents an alternate animal system that offers many advantages including high productivity at low cost. Despite being an excellent counterpart to mammalian antibodies, chicken IgG from yolk still represents an underused resource. The potential of agonistic monoclonal anti-CD40 antibodies (mAb) as a powerful immunological adjuvant has been demonstrated in mammals, but not in chickens. We recently reported an agonistic anti-chicken CD40 mAb (designated mAb 2C5) and showed that it may have potential as an immunological adjuvant. In this study, we examined the efficacy of targeting a short peptide to chicken CD40 [expressed by the antigen-presenting cells (APCs)] in enhancing an effective IgG response in chickens. For this purpose, an immune complex consisting of one streptavidin molecule, two directionally biotinylated mAb 2C5 molecules, and two biotinylated peptide molecules was produced. Chickens were immunized subcutaneously with doses of this complex ranging from 10 to 90 \u03bcg per injection once, and relative quantification of the peptide-specific IgG response showed that the mAb 2C5-based complex was able to elicit a strong IgG response as early as four days post-immunization. This demonstrates that CD40-targeting antigen to chicken APCs can significantly enhance antibody responses and induce immunoglobulin isotype-switching. This immunization strategy holds promise for rapid production of hapten-specific IgG in chickens. Copyright \u00a9 2012 Elsevier B.V. All rights reserved.\n[Duration of detection of anti-BmR1 IgG4 antibodies after mass-drug administration (MDA) in Sarawak, Malaysia.](https://www.ncbi.nlm.nih.gov/pubmed/22543621)\nNoordin, R; Muhi, J; Md Idris, Z; Arifin, N; Kiyu, A\n2012-03-01\nThe detection rates of brugian filariasis in three regions of Sarawak namely Central, North and South after three courses of mass drug administration (MDA) from year 2004 to 2006 was investigated. A recombinant BmR1 antigen-based IgG4 detection test, named Brugia Rapid and night blood smear for microfilaria (mf) detection were used. All three regions recorded a sharp fall in mf positive rates after a year post-MDA. Meanwhile Brugia Rapid positive rates declined more gradually to 3.8% and 5.6% of the pre-MDA levels in the Central and North regions, respectively. This study showed that in filariasis endemic areas in Sarawak, anti-filarial IgG4 antibodies to BmR1, as detected by the Brugia Rapid test, were positive for one to two years after mf disappearance.\n[Anticuerpos monoclonales: desarrollo f\u00edsico y perspectivas terap\u00e9uticas Monoclonal antibodies: physical development and therapeutic perspectives](http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0123-93922006000300006) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nNINA PATRICIA MACHADO\n2006-09-01\nFull Text Available Los anticuerpos monoclonales son glucoprote\u00ednas especializadas que hacen parte del sistema inmune, producidas por las c\u00e9lulas B, con la capacidad de reconocer mol\u00e9culas espec\u00edficas (ant\u00edgenos. Los anticuerpos monoclonales son herramientas esenciales en el \u00e1mbito cl\u00ednico y biotecnol\u00f3gico, y han probado ser \u00fatiles en el diagn\u00f3stico y tratamiento de enfermedades infecciosas, inmunol\u00f3gicas y neopl\u00e1sicas, as\u00ed como tambi\u00e9n en el estudio de las interacciones pat\u00f3geno-hospedero y la marcaci\u00f3n, detecci\u00f3n y cuantificaci\u00f3n de diversas mol\u00e9culas. Actualmente, la incorporaci\u00f3n de las t\u00e9cnicas de biolog\u00eda molecular e ingenier\u00eda gen\u00e9tica y proteica han permitido ampliar el horizonte de la generaci\u00f3n de anticuerpos monoclonales y sus usos, y se han encontrado t\u00e9cnicas como la hibridaci\u00f3n, la quimerizaci\u00f3n, la humanizaci\u00f3n y la producci\u00f3n de anticuerpos monoclonales totalmente humanos. Es una de las \u00e1reas de mayor crecimiento en la industria biotecnol\u00f3gica y farmac\u00e9utica; en el mercado se encuentran cerca de 29 anticuerpos monoclonales aprobados por la Food and Drug Administration (FDA de los Estados Unidos para uso en humanos.\n[Obtenci\u00f3n de anticuerpos monoclonales dirigidos contra ant\u00edgenos solubles de P. Falciparum](http://www.revistabiomedica.org/index.php/biomedica/article/view/1990) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nZuleima Rubio\n1990-12-01\nFull Text Available En este trabajo, se describe la producci\u00f3n de los anticuerpos monoclonales dirigidos contra prote\u00ednas solubles de P. falciparum (FCB-1. Uno de los anticuerpos identificados como M-45 detect\u00f3 una prote\u00edna de 72 Kd y dos m\u00e1s de menor peso molecular de 30 y 26 Kd, y el otro, identificado como G-172, detect\u00f3 una prote\u00edna de 120 Kd, cuando se enfrentaron a un extracto de esquizontes por inmunoelectrotransferencia. Estos anticuerpos monoclonales mostraron patrones de fluorescencia diferente en eritrocitos infectados con esquizontes; M-45 (isotipo M produjo una fluorescencia uniforme y generalizada, mientras que el G-172 (isotipo G2a mostr\u00f3 regiones con parches de mayor intensidad. Posteriormente, los monoclonales se utilizaron en una prueba de ELlSA sandwich, como anticuerpos de captura para antigenos solubles de P. falciparum, en sobrenadantes de cultivo y en cinco sueros de pacientes con infecci\u00f3n mal\u00e1rica aguda. Los resultados mostraron un 100% de sensibilidad y especificidad para la diluci\u00f3n 1/20 de los sueros y un 80% de sensibilidad para la diluci\u00f3n 1/40. Teniendo en cuenta estos resultados preliminares se abre la posibilidad de utilizar estos monoclonales en una prueba de ELlSA que permita el seguimiento de una infecci\u00f3n mal\u00e1rica.\n[Presencia del virus del oeste del Nilo en el noreste de M\u00e9xico Presence of west Nile virus in northeast Mexico](http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342007000300006) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nIldefonso Fern\u00e1ndez-Salas\n2007-06-01\nFull Text Available OBJETIVO: Detectar la presencia del virus del oeste del Nilo (VON en aves, equinos y seres humanos en el noreste de M\u00e9xico. MATERIAL Y M\u00c9TODOS: Se busc\u00f3 en diferentes localidades del noreste de M\u00e9xico la presencia de anticuerpos antivirus del oeste del Nilo (anti-VON en suero de 33 aves, 24 caballos y 237 personas mediante pruebas de ELISA durante el periodo de julio de 2003 a julio de 2006. En los sueros humanos se busc\u00f3 tambi\u00e9n el RNA-VON mediante RT-PCR. RESULTADOS: Se encontraron tres aves seropositivas y 15 equinos. En el hombre, 40% de los sueros fue positivo para anticuerpos IgG y ninguno para anticuerpos IgM. CONCLUSIONES: El VON se encuentra activo en M\u00e9xico y se suma a otras enfermedades emergentes transmitidas por vectores que representan un reto a la investigaci\u00f3n y a los programas de prevenci\u00f3n.OBJECTIVE: To investigate the presence of WNV in birds, horses and humans in northeast Mexico. MATERIAL AND METHODS: Serum samples from 33 birds, 24 horses and 237 humans were screened by ELISA for Anti-WNV antibodies. Human serum samples were also screened for WNV RNA using an RT-PCR assay. RESULTS: Positive sera were found in three birds and 15 horses. Forty percent of the human serum samples were positive for IgG antibodies and 0% for IgM antibodies and viral RNA. CONCLUSIONS: The results of this study show that WNV is present in northeast Mexico and it is a new emergent infectious agent that represents a challenge for research and prevention programs in Mexico.\n[Chlamydia trachomatis IgG3 seropositivity is a predictor of reproductive outcomes in infertile women with patent fallopian tubes](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4663111)\nSteiner, Anne Z.; Diamond, Michael P.; Legro, Richard S.; Schlaff, William D.; Barnhart, Kurt T.; Casson, Peter R.; Christman, Gregory M.; Alvero, Ruben; Hansen, Karl R.; Geisler, William M.; Thomas, Tracey; Santoro, Nanette; Zhang, Heping; Eisenberg, Esther\n2015-01-01\nObjective To determine if Chlamydia trachomatis (Ct) seropositivity as detected by the Ct elementary body (EB)-based enzyme linked immunosorbent assay (Ct EB ELISA) predicts pregnancy and pregnancy outcome among infertile women with documented tubal patency. Design Cohort study Setting Outpatient clinics participating in the reproductive medicine network Patients 1250 infertile women with documented tubal patency enrolled in one of two randomized controlled trials: PPCOSII and AMIGOS Intervention Sera were analyzed for anti-Ct IgG1 and IgG3 antibodies using a research Ct EB ELISA. OD405 readings \u22650.35 and \u22650.1 were considered positive for IgG1 and IgG3, respectively. Main Outcome Measures Primary outcomes included pregnancy, live birth, and ectopic pregnancy. Log linear regression was used to determine the relative risk after adjusting for age, race, treatment medication, smoking status, and current alcohol use. Results 243 (19%) women were seropositive for anti-Ct IgG3. They tended to be non-White and smokers. Anti-Ct IgG3 seropositive women were significantly less likely to conceive (RR 0.65, 95% CI 0.52-0.83) or to have a live birth (RR 0.59, 95% 0.43-0.80); these associations were weakened after adjusting for number of HSG-documented patent tubes (RR 0.73, 95% CI 0.56-0.97) and (0.73, 95% CI: 0.50-1.04), respectively. Anti-Ct IgG3 seropositive women who conceived had 2.7 (95% CI: 1.40-5.34) times the risk of ectopic pregnancy. Conclusions Even in the presence of tubal patency, anti-Ct IgG3 seropositivity is associated with lower likelihood of pregnancy. Anti-Ct IgG3 seropositive women have up to 3 times the risk of ectopic pregnancy. PMID:26413816\n[The quantitation of parasite-specific human IgG and IgE in sera: evaluation of solid-phase RIA and ELISA methodology](https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=12635302) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nHamilton, R.G.; Adkinson, N.F. Jr.\n1981-01-01\nThe authors have developed a non-competitive solid-phase radioimmunoassay (SPRIA) to quantitate both human IgE and IgG antibodies against soluble adult antigens of Brugia malayi (B.m.), a filarial parasite causing extensive infection throughout the tropics. Previously enzyme-linked immunosorbent assays (ELISA) had been used to detect \u03bcg/ml levels of IgG anti-B.m., but IgE antibodies were difficult to detect in this system. Since the SPRIA successfully quantitates both IgG and IgE anti-B.m., they sought to examine the reasons for the SPRIA's apparent superiority in detecting IgE anti-B.m. by extracting specific IgG from sera with high levels of IgE and IgG anti-B.m. antibodies. IgE anti-B.m. was then quantitated in these sera using both the SPRIA and ELISA methods. Results indicate that IgG anti-B.m. does not interfere with detection of specific IgE antibody in the SPRIA but does interfere in the ELISA. While ELISA permits detection of IgE anti-B.m. in the absence of competing IgG anti-B.m., as levels of specific IgG increase, the IgE is no longer detectable. These differences between SPRIA and ELISA can be explained by the SPRIA's antigen excess conditions which assure that there are sufficient antigens both to detect all anti-B.m. antibodies present in the serum and to adequately represent all antigen specificities in the crude B.m. extract. Their findings commend the use of SPRIA methods over ELISA in assessment of B.m.-specific IgE antibody in filariasis and indicate a potential role for SPRIA methods in absolute quantitation of specific serum antibodies. (Auth.)\n[Fc receptors for mouse IgG1 on human monocytes: polymorphism and role in antibody-induced T cell proliferation.](https://www.ncbi.nlm.nih.gov/pubmed/6235283)\nTax, W J; Hermes, F F; Willems, R W; Capel, P J; Koene, R A\n1984-09-01\nIn previous studies, it was shown that there is polymorphism in the mitogenic effect of mouse IgG1 monoclonal antibodies against the T3 antigen of human T cells. This polymorphism implies that IgG1 anti-T3 antibodies are not mitogenic for T cells from 30% of healthy individuals. The present results demonstrate that this polymorphism is caused by polymorphism of an Fc receptor for mouse IgG1, present on human monocytes. The Fc receptor for murine IgG1 could be detected by a newly developed rosetting assay on monocytes from all individuals responsive to the mitogenic effect of IgG1 anti-T3 antibodies. This Fc receptor was not detectable on monocytes from those individuals exhibiting no mitogenic responses to IgG1 anti-T3 monoclonal antibodies. Cross-linking of T3 antigens appears to be essential for antibody-induced mitosis of T cells, because mononuclear cells that did not proliferate in response to WT 31 (an IgG1 antibody against T3 antigen) showed a proliferative response to Sepharose beads coated with WT 31. The Fc receptor--if functionally present--may be involved in the cross-linking of T3 antigens through anti-T3 antibodies. Further evidence for the involvement of this Fc receptor in antibody-induced T cell proliferation was provided by inhibition studies. Immune complexes containing IgG1 antibodies were able to inhibit the proliferative response to IgG1 anti-T3 antibodies. This inhibition by immune complexes appears to be mediated through the monocyte Fc receptor for mouse IgG1. These findings are important for the interpretation of previously described inhibitory effects of anti-T cell monoclonal antibodies on T cell proliferation, and show that such inhibitory effects may be monocyte-mediated (via immune complexes) rather than caused by a direct involvement of the respective T cell antigens in T cell mitosis. The Fc receptor for mouse IgG1 plays a role in antibody-induced T cell proliferation. Its polymorphism may have important implications for the\n[Anticuerpos s\u00e9ricos contra la enfermedad de Newcastle e Influenza Aviar en aves rapaces de Chile.](http://revistas.unicordoba.edu.co/revistamvz/mvz-173/V17N3A4.pdf) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nDaniel Gonz\u00e1lez-Acu\u00f1a\n2012-12-01\nFull Text Available Objetivo. Detectar la presencia de anticuerpos s\u00e9ricos sangu\u00edneos contra los virus de la Enfermedad de Newcastle (ENC e Influenza aviar (IA, para comprender la contribuci\u00f3n de las aves silvestres en la transmisi\u00f3n de estos virus en Chile. Materiales y m\u00e9todos. Se analizaron 63 aves pertenecientes a los \u00f3rdenes Falconiformes y Strigiformes desde centros de rehabilitaci\u00f3n de aves de las zonas central y sur de Chile. Se realizaron las pruebas de inhibici\u00f3n de la hemoaglutinaci\u00f3n (IHA para detectar anticuerpos contra el virus ENC e inmunodifusi\u00f3n en gel agar (IDGA y ELISA para IA. Resultados. Se detectaron 14 aves positivas (22.2% para anticuerpos s\u00e9ricos contra el virus de la ENC. En cambio, no se registraron anticuerpos s\u00e9ricos sangu\u00edneos para el virus de la IA. Conclusiones. La presencia de aves rapaces positivas en los centros de rescate a los anticuerpos s\u00e9ricos contra el virus de la ENC puede ser explicada por el consumo de carne de pollos que han sido vacunados contra ENC o consumo de aves que han adquirido directamente el virus vacunal a trav\u00e9s de los distintos procedimientos de administraci\u00f3n (aerosoles, bebederos de la vacuna o por el ingreso a los centros de rescate de aves rapaces migratorias, las que podr\u00edan facilitar la diseminaci\u00f3n de la infecci\u00f3n desde los pa\u00edses de origen, hecho que debe ser investigado.\n[First report of real-time monitoring of coagulation function potential and IgG subtype of anti-FVIII autoantibodies in a child with acquired hemophilia A associated with streptococcal infection and amoxicillin.](https://www.ncbi.nlm.nih.gov/pubmed/28597369)\nTakeyama, Masahiro; Nogami, Keiji; Kajimoto, Takahiro; Ogiwara, Kenichi; Matsumoto, Tomoko; Shima, Midori\n2018-01-01\nWe describe an 8-year-old boy with acquired hemophilia A (AHA) associated with streptococcal infection and amoxicillin. Laboratory data revealed low factor VIII activity (FVIII:C, 1.5 IU/dl), and FVIII inhibitor (15.9 BU/ml). Comprehensive coagulation function assays, including rotation thromboelastometry (ROTEM \u00ae ), revealed a markedly prolonged clotting time. Thrombin and plasmin generation (TG/PG) appeared to be moderately impaired. The inhibitor epitope of his anti-FVIII autoantibody recognized light and heavy chains. He was treated with Novoseven \u00ae and prednisolone, resulting in rapid improvement. ROTEM showed the return of coagulation time to normal level on day 20, and TG gradually improved. PG was moderately reduced in the clinical early phase, but improved at day 20. The patient's IgG subtype was IgG 4 at onset. IgG 1 was transiently positive on day 20, but negative on day 46. FVIII inhibitor gradually decreased and was completely absent after day 46, along with the elevated FVIII:C. IgG4 was again elevated on day 83, followed by a rapid decrease, indicative of the presence of non-neutralizing antibody, which remains currently undetected. We for the first time report changes in comprehensive coagulation function and IgG subtype of anti-FVIII antibody in a rare pediatric case of AHA.\n[Vacunaci\u00f3n antineumococo en pacientes con lupus eritematoso sist\u00e9mico](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802003000500004) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nC. Pisoni\n2003-10-01\nFull Text Available Se evalu\u00f3 la respuesta de anticuerpos espec\u00edficos, aparici\u00f3n de autoanticuerpos y actividad de la enfermedad en pacientes con lupus eritematoso sist\u00e9mico (LES luego de la inmunizaci\u00f3n con vacuna polivalente para neumococo. Se inocul\u00f3, con vacuna 23 valente para neumococo, a 37 pacientes con diagn\u00f3stico de LES; previamente y a las 12 semanas post vacunaci\u00f3n se determin\u00f3 los autoanticuerpos, el nivel de complemento s\u00e9rico y la actividad de la enfermedad aplicando el \u00edndice SLEDAI y la respuesta de los anticuerpos IgG contra ant\u00edgenos polisac\u00e1ridos capsulares. En 30 pacientes (85.7% los anticuerpos duplicaron el valor basal alcanzando de esta manera, el nivel estimado protector. No hubo diferencias estad\u00edsticamente significativas en los \u00edndices de actividad post vacunaci\u00f3n. En conclusi\u00f3n: en esta serie de pacientes l\u00fapicos, la inmunizaci\u00f3n con vacuna 23 valente no provoc\u00f3 reactivaci\u00f3n de la enfermedad, e indujo una adecuada respuesta de anticuerpos en el 85% del grupo. No se registraron efectos adversos generales o locales que motivaran alguna medicaci\u00f3n o internaci\u00f3n de ning\u00fan paciente.The objective of the study was to evaluate antibody response, autoantibodies induction and disease activity in systemic lupus erythematosus (SLE patients after polyvalent pneumococcal vaccination. SLE patients (n 37 were vaccinated with 23 valent pneumococcal vaccine. Systemic lupus erythematosus disease activity index (SLEDAI and specific IgG antibodies against pneumococcus were measured before and after vaccination. After inoculation 30 patients (85.7% duplicated IgG anti pneumococcus baseline value, reaching protective levels of antibodies. We did not find significant differences in disease activity up to three months after vaccination. In conclusion: after vaccination of this lupus population an 85.0% antibody response was obtained, without temporal associated disease flare or any serious adverse event.\n[Overview of IgG4-Related Tubulointerstitial Nephritis and Its Mimickers](http://www.jpatholtm.org/upload/pdf/jptm-2015-11-09.pdf) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nHyeon Joo Jeong\n2016-01-01\nFull Text Available Tubulointerstitial nephritis (TIN is the most common form of renal involvement in IgG4-related disease. It is characterized by a dominant infiltrate of IgG4-positive plasma cells in the interstitium and storiform fibrosis. Demonstration of IgG4-positive plasma cells is essential for diagnosis, but the number of IgG4-positive cells and the ratio of IgG4-positive/IgG-positive plasma cells may vary from case to case and depending on the methods of tissue sampling even in the same case. IgG4-positive plasma cells can be seen in TIN associated with systemic lupus erythematosus, Sj\u00f6gren syndrome, or anti-neutrophil cytoplasmic antibody\u2013associated vasculitis, which further add diagnostic confusion and difficulties. To have a more clear view of IgG4-TIN and to delineate differential points from other TIN with IgG4-positive plasma cell infiltrates, clinical and histological features of IgG4-TIN and its mimickers were reviewed. In the rear part, cases suggesting overlap of IgG4-TIN and its mimickers and glomerulonephritis associated with IgG4-TIN were briefly described.\n[OBTENCI\u00d3N DE ANTICUERPOS POLICLONALES IgY ANTIPARVOVIRUS CANINO A PARTIR DE YEMA DE HUEVO DE GALLINA](https://docs.google.com/folder/d/0B_IdlsctkRrxU0kxWVFQa05MNEU/edit?usp=sharing&pli=1&docId=0B_IdlsctkRrxb1BnVTZCdWoxRUE) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nPinto, J.\n2005-06-01\nFull Text Available Inmunizando un grupo de diez gallinas de postura raza Lohmann de 16 semanas de edad con parvovirus canino (CPV cepa vacunal, se obtuvieron anticuerpos IgY policlonales contra CPV en yema de huevo.En la extracci\u00f3n de los anticuerpos de la yema se requirieron dos pasos, el primero para la remoci\u00f3n de l\u00edpidos y el segundo para la precipitaci\u00f3n de prote\u00ednas. Para la remoci\u00f3n de l\u00edpidos se us\u00f3 el m\u00e9todo PBS:Cloroformo y para la precipitaci\u00f3n de los anticuerpos solubles (Inmunoglobulinas-IgY se us\u00f3 el m\u00e9todo de salting-out con sulfato de amonio ((NH42SO4. La evaluaci\u00f3n del proceso se efectu\u00f3 empleando el m\u00e9todo comercial est\u00e1ndar \u201cEGGstract IgY Purification System\u00ae\u201d de PROMEGA.La metodolog\u00eda empleada permiti\u00f3 la obtenci\u00f3n de anticuerpos IgY policlonales contra CPV a partir de yema de huevo de gallina en concentraciones altas por mililitro de yema, con una pureza aceptable y t\u00edtulos altos; los resultados fueron comparables con el m\u00e9todo comercial.\n[Cloning of pCDNA3-IgG4 and pQE-2-IgG4 human hinge region ...](https://www.ajol.info/index.php/ajb/article/viewFile/98691/87955) [African Journals Online (AJOL)](http://www.ajol.info/index.php)\nGREGORY\n2011-12-16\nDec 16, 2011 ... diseases and in allergy-related immunoassays, thus, anti-hIgG4 antibody is of interest in the development of ... pQE-2-. IgG4 will be used for protein expression in M15 prokaryotic .... Solution conformation of wild-type and ...\n[Prevalencia de anticuerpos anti-Leptospira spp. en personas con exposici\u00f3n laboral en el departamento del Tolima / Prevalence of anti-Leptospira spp. antibodies among people with occupational exposure in Tolima Department](http://aprendeenlinea.udea.edu.co/revistas/index.php/fnsp/article/view/22372) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nBlanca L. Guzm\u00e1n-Barrag\u00e1n\n2016-05-01\nFull Text Available Resumen Objetivo: estimar la prevalencia de anticuerpos IgM contra Leptospira spp., mediante el Ensayo de Inmunoabsorci\u00f3n Ligado a Enzimas (elisa, en la poblaci\u00f3n de riesgo laboral de 8 municipios del Tolima. Metodolog\u00eda: se obtuvieron muestras de sangre de 261 empleados, las cuales fueron analizadas mediante la t\u00e9cnica de elisa para la detecci\u00f3n de anticuerpos IgM anti-Leptospira spp., seguido de mat y serotipificaci\u00f3n. Resultado: se estim\u00f3 una seroprevalencia del 25,29%, con una seroreactividad mayor en trabajadores de plantas de beneficio animal (34,2%, recolecci\u00f3n de residuos s\u00f3lidos (27,1% y trabajadores de acueducto y alcantarillado (14,8%. La actividad en plantas de beneficio animal se identific\u00f3 como factor de riesgo de Leptospira spp. (OR=1,86. Los serovares identificados fueron L. Bratislava (16, Ballum (5, Tarassovi (3, Hebdomadis (2, Sejroe (2 y Icterhemorragiae (1. El municipio de Libano presento el mayor porcentaje de positividad (36,96%, seguido de Espinal y Guamo con 28,57% cada uno. Discusi\u00f3n: la evaluaci\u00f3n del sistema de vigilancia indic\u00f3 deficiencia en recursos y debilidades de los profesionales de la salud al desconocer los procedimientos, investigaci\u00f3n, diagn\u00f3stico y notificaci\u00f3n de la enfermedad. Conclusiones: la leptospirosis est\u00e1 presente en poblaciones de riesgo laboral en el Tolima y se hace necesario abordar esta problem\u00e1tica en la poblaci\u00f3n de otros municipios y los animales transmisores de la enfermedad. / Abstract Objective: to estimate the prevalence of IgM antibodies against Leptospira spp. Using the enzyme-linked immunosorbent assay (elisa in a population at occupational risk from 8 municipalities of the Tolima department, Colombia. Methodology: blood samples were collected from 261 employees and analyzed with the elisa technique to detect IgM and anti-Leptospira spp. antibodies. This was followed by mat and serotyping. Results: a seroprevalence of 25.29% was estimated, with higher\n[Canakinumab: un anticuerpo monoclonal prometedor en el tratamiento de enfermedades cardiovasculares Canakinumab: a promising monoclonal antibody in the treatment of cardiovascular diseases](http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0120-56332013000100007) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nFernando Manzur\n2013-02-01\nFull Text Available El canakinumab es un anticuerpo monoclonal anti-IL-1\u03b2 totalmente humano desarrollado por Novartis, cuyo mecanismo de acci\u00f3n se basa en la neutralizaci\u00f3n de la se\u00f1alizaci\u00f3n IL-1\u03b2, lo cual conduce a la supresi\u00f3n de la inflamaci\u00f3n en pacientes con trastornos de origen autoinmune. La IL-1\u03b2 act\u00faa como un mediador de la respuesta inmune perif\u00e9rica durante la infecci\u00f3n y la inflamaci\u00f3n. Mediante la uni\u00f3n ant\u00edgeno-anticuerpo el canakinumab inhibe la acci\u00f3n de la IL1-\u03b2 evitando sus efectos pro-inflamatorios. En la actualidad, est\u00e1 en evaluaci\u00f3n como un nuevo posible agente dirigido frente a la IL-1\u03b2, con el objetivo de reducir la tasa de eventos cardiovasculares y la diabetes de aparici\u00f3n reciente (estudio CANTOS.Canakinumab is a totally human monoclonal antibody anti-IL-1\u03b2 developed by Novartis, whose mode of action is based on the neutralization of IL-1\u03b2 signaling, which leads to suppression of inflammation in patients with autoimmune disorders. The IL-1\u03b2 acts as a mediator of the peripheral immune response during infection and inflammation. By the antigen-antibody binding, canakinumab inhibits the action of IL1-\u03b2 avoiding its pro-inflammatory effects. Currently, it is being evaluated as a new possible agent directed against IL-1\u03b2, with the goal of reducing the rate of cardiovascular events and new onset diabetes (study CANTOS.\n[Identification of anti-HPA-1a allo-antibodies using IgG platelet antibody detection and crossmatch system assay with Galileo Echo.](https://www.ncbi.nlm.nih.gov/pubmed/25101933)\nDi Cristofaro, Julie; Frassati, Coralie; Montagnie, Rolande; Basire, Agnes; Merieux, Yves; Picard, Christophe\n2015-01-01\nFetal/neonatal allo-immune thrombocytopenia is the most frequent and the most dangerous clinical condition involving anti-human platelet antigens (HPA)-1a allo-antibodies. Anti-HPA-1a allo-immunization requires rapid and accurate diagnosis to determine appropriate treatment. The Capture-P Ready-Screen assay (C-PRS) is a new qualitative immunoassay to detect IgG anti-human leukocyte antigen (HLA) and anti-HPA allo-antibodies. The aim of this study is to assess the identification of anti-HPA-1a allo-antibodies using the C-PRS assay, associated with HLA class I stripping reagents, on the automated benchtop analyzer Galileo Echo. Forty-nine sera were analyzed: without anti-HLA class I or anti-HPA allo-antibodies, with anti-HLA class I allo-antibodies, with anti-HPA-1a allo-antibodies, among which with anti-HLA class I allo-antibodies. None of the samples without allo-antibodies were reactive. Only anti-HLA antibodies, detected by cytotoxicity-dependent complement and not by Luminex, remained positive before and after stripping reagents. Of the 13 samples, anti-HPA-1a allo-antibodies that were correctly identified before and after incubation with HLA assassin reagent were 70% and 85%, respectively. Anti-glycoprotein auto-antibodies and anti-HLA allo-antibodies do not interfere with the detection of anti-HPA-1a antibodies. This preliminary study indicates that further improvement of the test will be helpful in developing a clinically useful assay in the future.\n[Highly sensitive electrochemical immunoassay for human IgG using double-encoded magnetic redox-active nanoparticles](http://dx.doi.org/10.1007/s00604-010-0442-x) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nTang, D.; Tang, J.; Su, B.; Chen, H.; Chen, G.; Huang, J.\n2010-01-01\nA new sandwich-type electrochemical immunoassay was developed for the detection of human IgG using doubly-encoded and magnetic redox-active nanoparticles as recognition elements on the surface of a glassy carbon electrode modified with anti-IgG on nanogold particles. The recognition elements were synthesized by coating magnetic Fe3O4 nanoparticles with Prussian blue nanoparticles and then covered with peroxidase-labeled anti-IgG antibodies (POx-anti-IgG) on Prussian blue nanoparticles. The immunoelectrode displays very good electrochemical properties towards detection of IgG via using double-encoded magnetic redox-active nanoparticles as trace and hydrogen peroxide as enzyme substrate. Its limit of detection (10 pmol.L -1 ) is 10-fold better than that of using plain POx-anti-IgG secondary antibodies. The method was applied to the detection of IgG in serum samples, and an excellent correspondence with the reference values was found. (author)\n[Serum IgG2 and tissue IgG2 plasma cell elevation in orbital IgG4-related disease (IgG4-RD): Potential use in IgG4-RD assessment.](https://www.ncbi.nlm.nih.gov/pubmed/28351925)\nChan, Anita S Y; Mudhar, Hardeep; Shen, Sunny Yu; Lang, Stephanie S; Fernando, Malee; Hilmy, Maryam Hazly; Guppy, Naomi Jayne; Rennie, Ian; Dunkley, Lisa; Al Jajeh, Issam\n2017-11-01\nTo determine the role of serum and tissue IgG2 in orbital biopsies with the histological features of IgG4-related disease (IgG4-RD) in comparison with non-IgG4-related orbital inflammatory disorders (OID), including autoimmune disorders. This is an international (Sheffield, UK, and Singapore) collaborative, retrospective case review of 69 patients (38 from Singapore National Eye Centre and 31 from Royal Hallamshire Hospital, Sheffield) with orbital inflammatory biopsies between 2002 and 2016. Clinical information and histology were reviewed and cases were classified into three groups: Group 1: IgG4-RD orbital inflammation (n=43); Group 2: idiopathic OID (n=12) and Group 3: autoimmune OID (n=14). Serum IgG1, IgG2, IgG3 and IgG4 levels were collated where available and immunohistochemistry (IHC) for tissue IgG2 plasma cells was performed. Dual IHC showed IgG2 plasma cells as a distinct population from IgG4 plasma cells. Significant (twofold) serum IgG2 elevation was noted among IgG4-RD (group 1), idiopathic (group 2) and autoimmune OID (group 3). Similarly, significant elevation of tissue IgG2 plasma cells was also seen among IgG4-RD (group 1), idiopathic and autoimmune OID (groups 2 and 3). Significant elevations of serum IgG2 and tissue IgG2 plasma cells are present in orbital IgG4-RD in comparison with non-IgG4 orbital inflammation (idiopathic and autoimmune OID), suggesting that IgG2 may play a role in IgG4-RD. A serum IgG2 cut-off >5.3 g/L was found to be 80% sensitive and 91.7% specific for orbital IgG4-RD, with an accuracy of 0.90. Tissue IgG2 and IgG4 subclass reporting may provide additional insight regarding the 'IgG4-RD' pathogenesis. \u00a9 Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.\n[Study on immobilizations of ovine anti-human IgG and MCAb against EHF on radiation-modified silicone films](https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=22083446) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nGuo Jinhui; Ha Hongfei; Zhang Yuhua\n1990-01-01\nFilms of silicone (silastic) were grafted by monomer acrylamide vis \u03b3-radiation technology and then the ovine anti-human IgG, Epidemic hemorrhagic fever (EHF)-MCAb were immobilized on the silastic-AAM films with different grafting yields passthrough associate reactions. Measruements of relationships between grafting yields. Contents of immobilized antibodies and immunoactivities for immobilized silastic-AAM films were performed by using 125 I method ELISA method was used to measure the immunoactivities for the immobilized monoantibody. The results showed that the antibodies used can be immobilized on radiation-grafted silicone films and this immobilization method has its potential significance in clinical practice\n[Study on immobilizations of ovine anti-human IgG and MCAb against EHF on radiation-modified silicone films](https://www.osti.gov/etdeweb/biblio/6151459) [Energy Technology Data Exchange (ETDEWEB)](https://www.etde.org/etdeweb/fieldedsearch.jsp)\nJinhui, Guo; Hongfei, Ha; Yuhua, Zhang [Beijing Univ., BJ (China). Dept. of Technical Physics\n1990-08-01\nFilms of silicone (silastic) were grafted by monomer acrylamide vis {gamma}-radiation technology and then the ovine anti-human IgG, Epidemic hemorrhagic fever (EHF)-MCAb were immobilized on the silastic-AAM films with different grafting yields passthrough associate reactions. Measruements of relationships between grafting yields. Contents of immobilized antibodies and immunoactivities for immobilized silastic-AAM films were performed by using {sup 125}I method ELISA method was used to measure the immunoactivities for the immobilized monoantibody. The results showed that the antibodies used can be immobilized on radiation-grafted silicone films and this immobilization method has its potential significance in clinical practice.\n[Sistema inmune y gen\u00e9tica: un abordaje diferente a la diversidad de anticuerpos.](https://www.openaire.eu/search/publication?articleId=dedup_wf_001::4d5fda784fc5e06c9e2cbd6f95d27536)\nMatta Camacho, Nubia Estela\n2011-01-01\nRESUMEN Es com\u00fan encontrar en los libros de inmunolog\u00eda o de gen\u00e9tica un cap\u00edtulo con el t\u00edtulo de \u201csistema inmune y gen\u00e9tica\u201d, sin embargo su asociaci\u00f3n se centra en c\u00f3mo la generaci\u00f3n de anticuerpos rompi\u00f3 el paradigma \u201cun gen, una prote\u00edna\u201d, pues en el caso de la producci\u00f3n de anticuerpos, un gen produce millones de prote\u00ednas. El sistema inmune tiene muchos v\u00ednculos con la gen\u00e9tica y la herencia; esta asociaci\u00f3n se da porque cualquier sustancia o compuesto que produzca un organi...\n[Salivary IgG assay to detect Helicobacter pylori infection in an Indian adult population](http://www.ijdr.in/article.asp?issn=0970-9290;year=2012;volume=23;issue=5;spage=694;epage=695;aulast=Krishnaswamy) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nRamya Thirumala Krishnaswamy\n2012-01-01\nConclusion: EIAgen H. pylori IgG assay is a noninvasive, moderately accurate, and sensitive method for the detection of H. pylori infection in saliva. Salivary anti H. pylori IgG test prior to endoscopy is a useful screening test for seroepidemiological studies.\n[CERTIFICATION REPORT The certification of the mass concentration of immunoglobulin G proteinase 3 anti-neutrophil cytoplasmic autoantibodies (IgG PR3 ANCA) in human serum: ERM\u00ae - DA483/IFCC](https://www.openaire.eu/search/publication?articleId=od______1739::212bba95176d5b7bc815ccd4e2cd2691)\nMONOGIOUDI EVANTHIA; HUTU DANA PETRONELA; CHAROUD-GOT JEAN; SHELDON JOANNA; SCHIMMEL HEINZ; TRAPMANN STEFANIE; MERONI PIERLUIGI; EMONS HENDRIK; ZEGERS INGRID\n2017-01-01\nThis report describes the production and certification of ERM-DA483/IFCC, a serum protein reference material intended for the standardisation of measurements of immunoglobulin G proteinase 3 anti-neutrophil cytoplasmic autoantibodies (IgG PR3 ANCA). The material was produced according to ISO Guide 34:2009 [ ] and is certified in accordance with ISO Guide 35:2006. The raw material used to prepare ERM-DA483/IFCC was a plasmapheresis material containing a high concentration of IgG PR3 ANCA. A...\n[Inducci\u00f3n de IgA e IgG anti-omp48 en conejos inmunizados intrag\u00e1stricamente con una fracci\u00f3n extracelular de Aeromonas veronii](http://www.redalyc.org/articulo.oa?id=265619698008) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nEduardo Ruiz-Bustos\n2011-01-01\nFull Text Available Una prote\u00edna de membrana externa de 48 kDa (omp48 de Aeromonas veronii (A. veronii, que tiene afinidad por secreciones de la mucosa (tal como mucina, lactoferrina, inmunoglobulinas o col\u00e1geno, induce una respuesta inmune estad\u00edsticamente significativa al ser administrada intrag\u00e1stricamente a conejos blancos de Nueva Zelanda. Estudios posteriores mostraron una correlaci\u00f3n positiva entre las inmunoglobulinas y la respuesta de c\u00e9lulas productoras de anticuerpo (CPA. La administraci\u00f3n intrag\u00e1strica del ant\u00edgeno induce una respuesta vigorosa, tanto local como sist\u00e9mica, principalmente de inmunoglobulinas A y G contra la omp48 de A. veronii. Estas se evidenciaron por la presencia de (i c\u00e9lulas productoras de anticuerpos contra omp48 en el tracto gastrointestinal, bazo y sangre, y (ii elevados niveles de anticuerpos circulantes.La estimulaci\u00f3n del sistema inmune de mucosa mediante ant\u00edgenos bacterianos inmunog\u00e9nicos, puede ser una importante alternativa para el control y prevenci\u00f3n de enfermedades asociadas a Aeromonas.\n[IgM but not IgG monoclonal anti-Nocardia brasiliensis antibodies confer protection against experimental actinomycetoma in BALB/c mice.](https://www.ncbi.nlm.nih.gov/pubmed/19624737)\nGonzalez-Suarez, Maria L; Salinas-Carmona, Mario C; P\u00e9rez-Rivera, Isabel\n2009-10-01\nNocardia brasiliensis is a facultative intracellular microorganism that produces a human chronic infection known as actinomycetoma. Human and mouse anti-N. brasiliensis antibody response identify P24, P26 and P61 immunodominant antigens. In this work, we generated immunoglobulin M (IgM) and IgG monoclonal antibodies (mAbs) specific to immunodominant P61 antigen. The monoclonal IgM (NbM1) and IgG2a (NbG1) antibodies were assessed for their in vitro bactericidal activity, in vivo protective effect and ability to block catalase activity. These mAbs specifically recognized P61, but they did not inhibit its enzyme activity. The in vitro bactericidal effect of NbG1 was higher than the killing ability of the IgM mAb. In vivo experiments with a murine model of experimental infection with N. brasiliensis injected into rear footpads was used to test the effect of NbM1 and NbG1. The negative untreated group developed a chronic actinomycetoma within 4 weeks. IgM mAbs conferred protection to BALB/c mice infected with N. brasiliensis. IgG mAb lacked this protective effect. IgM mAb showed a dose-response correlation between antibody concentration and lesion size. These results demonstrate that humoral immune response mediated by antigen-specific IgM antibody protects against an intracellular bacterial infection.\n[Serodiagn\u00f3stico de giardiosis: identificaci\u00f3n de inmunoglobulina G anti-Giardia duodenalis en suero mediante ELISA](http://www.revistabiomedica.org/index.php/biomedica/article/view/1112) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nSof\u00eda Duque\n2001-09-01\nFull Text Available El diagn\u00f3stico de la infecci\u00f3n por Giardia duodenalis se basa en la identificaci\u00f3n de quistes o trofozo\u00edtos en materia fecal, alcanzando una sensibilidad m\u00e1xima de 85% en muestras seriadas, debido a la excreci\u00f3n intermitente de quistes. Aunque la determinaci\u00f3n de anticuerpos no permite diferenciar entre una infecci\u00f3n pasada y una reciente, si podr\u00eda ayudar en el diagn\u00f3stico diferencial. El presente estudio tuvo como objetivos estandarizar y evaluar una prueba inmunoenzim\u00e1tica (ELISA para la detecci\u00f3n de anticuerpos tipo IgG anti-Giardia duodenalis en sueros de pacientes con la infecci\u00f3n. La preparaci\u00f3n del antigeno se hizo a partir de trofozoitos cultivados que, inicialmente, fueron obtenidos del intestino de gerbils (Meriones unguiculatus infectados experimentalmente con quistes purificados a partir de muestras positivas de materia fecal humana. Para la estandarizaci\u00f3n y evaluaci\u00f3n de la prueba, se emplearon 60 sueros de pacientes con giardiosis comprobada parasitol\u00f3gicamente (muestras positivas y 47 sueros de cord\u00f3n umbilical reci\u00e9n cortado (muestras negativas. Como conjugado, se utiliz\u00f3 anti-lgG humana ligada a fosfatasa alcalina. La concentraci\u00f3n \u00f3ptima de ant\u00edgeno de trofozo\u00edto de G. duodenalis fue de 15 ug/ml y las diluciones \u00f3ptimas de suero y conjugado fueron 1:25 y 1:400, respectivamente. El valor del punto de corte (absorbancia fue 0,300. Los par\u00e1metros de la prueba fueron: sensibilidad, 98,3% (intervalo de confianza de 95% (lC 95%: 89,9%-99,974; especificidad, 957% (IC 95%:84,3%-99,3%; valor predictivo positivo, 96,7% (IC 95%: 87,6%-99,4%, y valor predictivo negativo, 97,8% (IC 95%: 87,0%-99,9%. La prueba ELlSA descrita contribuir\u00e1 a mejorar el diagn\u00f3stico de giardiosis y podr\u00e1 ser empleada para estudios epidemiol\u00f3gicos de seroprevalencia.\n[Evaluation of Anti-TBGL Antibody in the Diagnosis of Tuberculosis Patients in China](http://dx.doi.org/10.1155/2015/834749) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJingge Zhao\n2015-01-01\nFull Text Available Tuberculous glycolipid (TBGL is a component of the Mycobacterium tuberculosis cell wall, and anti-TBGL antibodies are used for serodiagnosis of tuberculosis. Anti-TBGL IgG and IgA levels were measured in 45 pulmonary TB patients (PTB, 26 extra-pulmonary TB patients (ETB, 16 AIDS-TB patients, and 58 healthy controls (HC including 39 health care workers (HW and 19 newly enrolled students (ST. Anti-TBGL IgG measurements yielded 68.9% and 46.2% sensitivity in PTB and ETB, respectively, and 81.0% specificity. However, anti-TBGL IgA measurements were significantly less sensitive in detecting ETB than PTB (15.4% versus 46.7% sensitivity but showed up to 89.7% specificity. Samples from AIDS-TB patients exhibited low reaction of anti-TBGL IgG and IgA with 6.3% and 12.5% sensitivity, respectively. Unlike anti-lipoarabinomannan (LAM IgG that was found to elevate in sputum smearpositive subjects, anti-TBGL IgG and IgA elevated in those with cavitation and bronchiectasis, respectively. Anti-TBGL IgG in cavitary TB yielded 78.2% sensitivity compared to 57.1% in those otherwise. Meanwhile, higher anti-TBGL IgA titers were observed in HW than in ST, and increasing anti-TBGL IgG titers were observed in HW on follow-up. Therefore, higher anti-TBGL antibody titers are present in patients presenting cavities and bronchiectasis and subjects under TB exposure risk.\n[The immunological properties of haptens coupled to thymus-independent carrier molecules. IV. The IgG response to dinitrophenylated Ficoll.](https://www.ncbi.nlm.nih.gov/pubmed/1086786)\nKlaus, G G; Phillips, J M; Humphrey, J H; Dresser, D W; Cross, A M\n1976-06-01\nDinitrophenylated polysucrose (DNP-Ficoll) elicits T cell-independent IgM anti-DNP antibody formation in mice. This antigen also elicits a heterogeneous IgG1 and IgG2 anti-DNP response, which is operationally as T-independent as the IgM response. However, a concomitant graft-versus-host reaction markedly enhances the IgG response (allogeneic effect). These results confirm those of others, indicating that a certain proportion of the precursors of IgG-producing cells can be triggered by some T-independent antigens. However, our results suggest that even with such antigens optimal triggering of IgG precursors requires T cell help.\n[Aplicaci\u00f3n de una biblioteca de anticuerpos lineales humanos frente al polisac\u00e1rido capsular de Neisseria meningitidis serogrupo B](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2013000300006&lng=es&nrm=iso) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nEmigdio Le\u00f3n-Toirac\n2013-12-01\nFull Text Available Neisseria meningitidis serogrupo B produce a\u00fan morbimortalidad significativa. Su polisac\u00e1rido capsular muestra similitud estructural con prote\u00ednas humanas y pobre inmunogenicidad, obstaculizando as\u00ed el desarrollo de vacunas y anticuerpos monoclonales (AcM y policlonales contra esta bacteria. Recientemente se han creado bibliotecas artificiales de anticuerpos humanos expresados en bacteri\u00f3fagos que reconocen espec\u00edficamente a mol\u00e9culas diana existentes, con la ventaja sobre los AcM convencionales por su r\u00e1pida obtenci\u00f3n, sin utilizaci\u00f3n de animales de laboratorio, lo que emerge como alternativa atractiva para la producci\u00f3n de AcM contra ant\u00edgenos peculiares o complejos. Se realiz\u00f3 un trabajo de investigaci\u00f3n b\u00e1sica, utilizando una biblioteca de fagos filamentosos que expresan constitutivamente regiones variables de anticuerpos humanos, que se enfrent\u00f3 al polisac\u00e1rido capsular de N. meningitidis serogrupo B. Los resultados que se obtuvieron mediante ELISA policlonal sugieren la existencia de anticuerpos humanos expresados en fagos que lo reconocen.\n[The Emerging Importance of IgG Fab Glycosylation in Immunity.](https://www.ncbi.nlm.nih.gov/pubmed/26851295)\nvan de Bovenkamp, Fleur S; Hafkenscheid, Lise; Rispens, Theo; Rombouts, Yoann\n2016-02-15\nHuman IgG is the most abundant glycoprotein in serum and is crucial for protective immunity. In addition to conserved IgG Fc glycans, \u223c15-25% of serum IgG contains glycans within the variable domains. These so-called \"Fab glycans\" are primarily highly processed complex-type biantennary N-glycans linked to N-glycosylation sites that emerge during somatic hypermutation. Specific patterns of Fab glycosylation are concurrent with physiological and pathological conditions, such as pregnancy and rheumatoid arthritis. With respect to function, Fab glycosylation can significantly affect stability, half-life, and binding characteristics of Abs and BCRs. Moreover, Fab glycans are associated with the anti-inflammatory activity of IVIgs. Consequently, IgG Fab glycosylation appears to be an important, yet poorly understood, process that modulates immunity. Copyright \u00a9 2016 by The American Association of Immunologists, Inc.\n[Diagnosis and Treatment of IgG4-Related Disease.](https://www.ncbi.nlm.nih.gov/pubmed/28197739)\nKamisawa, Terumi; Okazaki, Kazuichi\n2017-01-01\nIt is critical to differentiate IgG4-related disease (IgG4-RD) from malignant tumor and similar disease of the affected organ to apply appropriate therapy and avoid unnecessary surgery. IgG4-RD is diagnosed on combination of typical radiological findings; elevation of serum IgG4 levels; histopathological findings of abundant infiltration of IgG4-positive plasma cells and lymphocytes, storiform fibrosis , and obliterative phlebitis ; association with other IgG4-related diseases; and response to steroids. Histopathological approach is particularly recommended. Systemic glucocorticoids are currently the first-line approach for IgG4-RD, and the indications are symptoms. The initial recommended dose of oral prednisolone for induction of remission is 0.6 mg/kg/day, administered for 2-4 weeks. This dose is gradually tapered to a maintenance dose of 2.5-5 mg/day over a period of 2-3 months. As IgG4-RD sometimes relapses after steroids, maintenance therapy is usually performed in Japan. However, as IgG4-RD patients are typically elderly and are at high risk of developing steroid-related complications, cessation of the medication should be attempted at least within 3 years. For relapsed IgG4-RD, re-administration or dose up of steroid is effective, but the addition of immunomodulatory drugs such as azathioprine has been considered to be appropriate. B cell depletion with rituximab (an anti-CD20 antibody) is effective, even in many patients in whom treatment with immunomodulatory drugs was unsuccessful. The short-term clinical, morphological, and functional outcomes of most IgG4-RD patients treated with steroid therapy are good, but the long-term outcomes are less clear due to several unknown factors such as relapse, developed fibrosis, and associated malignancy.\n[Conversion of a Mouse Fab into a Whole Humanized IgG Antibody for Detecting Botulinum Toxin](https://fsl-bsf.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1LSwMxEB7EIurJJz5hbp5WY7rdbKEUat1VD4rFFr2VPGVBs2C3oB787Sa7qyteekuGIWRgMjP5mAdAm56S4J9NkIwJTWJm2lEou0oyFZ-HJnLaxKQLMjwsOZm0k6fwbuRLY35qxGovEDRQRpkKxf-0T_IunhH29eDbbrtw3-l6azBK0vt1WLVvsuKvchtLC5luwFYzxhadKZ_7xSYsabsN2dDnepdAFeYGOd66_7fGlAvMbJE7wqMfW4slwp59aoU3z1c4sEUmcvWBLs7ES-3Rf-d3sCf6F3nhE8rnr70z0feEcf6eWb_ZgZM0GQ-vg99LTmspq_7W01owRndh2eZW7wESE0sXr1AWRyaMuIo7HcWpCIUgXU4p2QdcdNrBYpZDWGtwhiNoGfcO9DGsmNlLIGbmG3lDjUI) [National Research Council Canada - National Science Library](http://science-libraries.canada.ca/eng/national-science-library/)\nPalys, Thomas J; Schmid, Kara E; Scherer, John M; Schoepp, Randal J\n2006-01-01\n.... Therefore we sought to convert a murine Fab into a whole humanized IgG. The variable regions from an anti-botulinum Fab were cloned into human IgG heavy and light chain vectors and produced in myeloma cells...\n[Comunicaci\u00f3n preliminar sobre la presencia de Trypanosoma cruzi en departamentos del norte y nororiente del Per\u00fa](http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1025-55832012000100008&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nHilda Sol\u00eds\n2012-01-01\nFull Text Available Objetivo: Realizar un estudio epidemiol\u00f3gico de la zona norte y nororiental del Per\u00fa sobre la presencia de enfermedad de Chagas y sus vectores. Dise\u00f1o: Estudio descriptivo, transversal. Instituci\u00f3n: Instituto de Medicina Tropical Daniel A. Carri\u00f3n, Facultad de Medicina, Universidad Nacional Mayor de San Marcos, Lima, Per\u00fa. Material biol\u00f3gico: Triatominos positivos a Trypanosoma cruzi Chagas 1909, ratones machos Swiss-Webster de un mes de edad. Intervenciones: En septiembre de 2008, se visit\u00f3 las localidades de Chilete, Paredones, en la Provincia de Contumaz\u00e1, Cajamarca, y las localidades de Pampa Larca, La Puerta, Guitarras y Suyo en la provincia de Ayabaca, Piura, colect\u00e1ndose 10 espec\u00edmenes de Panstrongylus chinai (Del Ponte, 1929 en Piura y 12 espec\u00edmenes de Panstrongylus herreri (Wygodzinsky, 1948, en Chilete, Cajamarca. Se aisl\u00f3 las cepas de Trypanosoma en ratones blancos, machos, de un mes de edad, cepa Swiss webster, siendo estos mantenidos en el laboratorio por traspasos sucesivos. Se hizo la curva de parasitemia y el estudio morfom\u00e9trico de los tripomastigotes sangu\u00edneos. Los ratones infectados fueron sacrificados a los 30 d\u00edas de inoculados, se separ\u00f3 las v\u00edsceras y en estas se hizo el estudio anatomopatol\u00f3gico. Se tom\u00f3 59 muestras de sangre a los habitantes de las zonas en estudio, de pulpa digital, en papel filtro, para b\u00fasqueda de anticuerpos IgG anti-T. cruzi por ELISA y reacci\u00f3n de inmunofluorescencia indirecta (IFI. Principales medidas de resultados: Identificaci\u00f3n de los triatominos y determinar su infecci\u00f3n por Trypanosoma cruzi; presencia de anticuerpos IgG anti- T. cruzi en los pobladores. Resultados: De los espec\u00edmenes de triatominos colectados, se encontr\u00f3 dos espec\u00edmenes de P. chinai y uno de P. herreri positivos a Trypanosoma cruzi. El pico m\u00e1ximo de la curva de parasitemia, ocurri\u00f3 a los 20 d\u00edas y se hall\u00f3 nidos de amastigotes de T. cruzi en miocardio y m\u00fasculo esquel\u00e9tico de los ratones\n[Role of polymorphic Fc receptor Fc gammaRIIa in cytokine release and adverse effects of murine IgG1 anti-CD3/T cell receptor antibody (WT31).](https://www.ncbi.nlm.nih.gov/pubmed/9000670)\nTax, W J; Tamboer, W P; Jacobs, C W; Frenken, L A; Koene, R A\n1997-01-15\nAnti-CD3 monoclonal antibody (mAb) OKT3 is immunosuppressive, but causes severe adverse effects during the first administration (\"first-dose reaction\"). These adverse effects are presumably caused by cytokine release that results from T-cell activation. In vitro, T-cell activation by anti-CD3 mAb requires interaction with monocyte Fc receptors. The Fc receptor for murine IgG1, Fc gammaRIIa, is polymorphic. In some individuals, murine IgG1 anti-CD3 mAb causes T-cell proliferation and cytokine release in vitro (high responders [HR]), whereas in individuals with the low-responder (LR) phenotype it does not. We have now investigated the role of this Fc gammaRIIa polymorphism in the release of cytokines in vivo and the occurrence of adverse effects after the administration of WT31, a murine IgG1 anti-CD3/T cell receptor mAb. WT31 caused an increase of plasma tumor necrosis factor-alpha in all four HR patients and none of the five LR patients. In all HR patients except one, plasma gamma-interferon and interleukin 6 also increased, and a first-dose response was observed, whereas no cytokine release or adverse effects occurred in any of the LR patients. WT31 caused lymphopenia in all HR and none of the LR patients. FACS analysis demonstrated that in HR patients, after the initial disappearance of CD3+ cells from peripheral blood, modulation of CD3 occurred, whereas in LR patients a high degree of coating of the lymphocytes was observed. Surprisingly, WT31 also induced a marked granulocytopenia, as well as a decrease of thrombocytes, in three of the four HR patients (and in none of the LR patients). These data provide direct clinical evidence that Fc receptor interaction determines the release of cytokines and the occurrence of adverse effects after administration of anti-CD3/T cell receptor mAb. Furthermore, these data suggest that tumor necrosis factor-alpha by itself is not sufficient to induce the first-dose reaction.\n[Fibrosis pulmonar asociada a vasculitis con anticuerpos anticitoplasm\u00e1ticos positivos Pulmonary fibrosis associated with anti-neutrophil cytoplasmic antibody-positive vasculitis](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802012000400012) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMarcelo Fern\u00e1ndez Casares\n2012-08-01\nFull Text Available Las complicaciones pulmonares m\u00e1s conocidas de las vasculitis con anticuerpos anticitoplasm\u00e1ticos de los neutr\u00f3filos (ANCA positivos (VAA, son la hemorragia alveolar, los granulomas y la estenosis de la v\u00eda a\u00e9rea. En los \u00faltimos a\u00f1os han aparecido algunos informes aislados que muestran la asociaci\u00f3n con fibrosis pulmonar (FP, sugiriendo que \u00e9sta ser\u00eda otra complicaci\u00f3n de las VAA. En este trabajo informamos dos casos con dicha asociaci\u00f3n describiendo sus caracter\u00edsticas cl\u00ednicas, tomogr\u00e1ficas e inmunol\u00f3gicas. Dado que en la asociaci\u00f3n de FP y VAA notificada en los \u00faltimos a\u00f1os, la FP puede ser su primera manifestaci\u00f3n, podr\u00eda ser necesaria la b\u00fasqueda de ANCA en pacientes con FP, como causa de la misma y por el posible desarrollo posterior de vasculitis.The most frequently observed pulmonary complications of vasculitis (AAV with anti-neutrophil cytoplasmic positive antibodies (ANCA are alveolar hemorrhage, granulomas and airway stenosis. In recent years, some reports have been published that show the association of vasculitis with pulmonary fibrosis (PF, suggesting that it may be another complication of AAV. We report and describe here two cases with such association, and their clinical, tomographic and immunological characteristics. Given that in the association between PF and AAV, as reported in the last years, PF could be the first manifestation of AAV, the search for ANCA in patients with PF may be necessary, as a cause of it and for the possible subsequent development of vasculitis.\n[Pathogenicity of IgG in patients with IgG4-related disease.](https://www.ncbi.nlm.nih.gov/pubmed/26964842)\nShiokawa, Masahiro; Kodama, Yuzo; Kuriyama, Katsutoshi; Yoshimura, Kenichi; Tomono, Teruko; Morita, Toshihiro; Kakiuchi, Nobuyuki; Matsumori, Tomoaki; Mima, Atsushi; Nishikawa, Yoshihiro; Ueda, Tatsuki; Tsuda, Motoyuki; Yamauchi, Yuki; Minami, Ryuki; Sakuma, Yojiro; Ota, Yuji; Maruno, Takahisa; Kurita, Akira; Sawai, Yugo; Tsuji, Yoshihisa; Uza, Norimitsu; Matsumura, Kazuyoshi; Watanabe, Tomohiro; Notohara, Kenji; Tsuruyama, Tatsuaki; Seno, Hiroshi; Chiba, Tsutomu\n2016-08-01\nIgG4-related disease (IgG4-RD) is a systemic disease characterised by elevated serum IgG4 and IgG4-positive lymphoplasmacytic infiltration in the affected tissues. The pathogenic role of IgGs, including IgG4, in patients with IgG4-RD, however, is unknown. We examined the pathogenic activity of circulating IgGs in patients with IgG4-RD by injecting their IgGs into neonatal male Balb/c mice. Binding of patient IgGs to pancreatic tissue was also analysed in an ex vivo mouse organ culture model and in tissue samples from patients with autoimmune pancreatitis (AIP). Subcutaneous injection of patient IgG, but not control IgG, resulted in pancreatic and salivary gland injuries. Pancreatic injury was also induced by injecting patient IgG1 or IgG4, with more destructive changes induced by IgG1 than by IgG4. The potent pathogenic activity of patient IgG1 was significantly inhibited by simultaneous injection of patient IgG4. Binding of patient IgG, especially IgG1 and IgG4, to pancreatic tissue was confirmed in both the mouse model and AIP tissue samples. IgG1 and IgG4 from patients with IgG4-RD have pathogenic activities through binding affected tissues in neonatal mice. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/\n[Prophylactic anti-D preparations display variable decreases in Fc-fucosylation of anti-D.](https://www.ncbi.nlm.nih.gov/pubmed/25234110)\nKapur, Rick; Della Valle, Luciana; Verhagen, Onno J H M; Hipgrave Ederveen, Agnes; Ligthart, Peter; de Haas, Masja; Kumpel, Belinda; Wuhrer, Manfred; van der Schoot, C Ellen; Vidarsson, Gestur\n2015-03-01\nRhIG is obtained from hyperimmunized healthy anti-D donors (HIDs) boosted with D+ red blood cells (RBCs). One hypothesis for its mechanism of action is fast clearance of opsonized D+ RBCs through Fc\u03b3 receptor (Fc\u03b3R)III. Levels of immunoglobulin (Ig)G Fc-fucosylation influence interactions with Fc\u03b3RIII, with less Fc-fucosylation strengthening the interaction. Anti-D IgG1 Fc-glycosylation patterns in 93 plasma samples from 28 male and 28 female Dutch HIDs and RhIG were analyzed with mass spectrometry. The Fc-glycosylation profiles of HIDs were evaluated with regard to their immunization history. HID sera demonstrated clearly lowered anti-D Fc-fucosylation compared to normal IgG fucosylation (93%); this was more pronounced for female than for male HIDs (47% vs. 65%, p = 0.001). RhIG preparations from seven manufacturers varied greatly in the level of Fc-fucosylation (56%-91%). The level of fucosylation slightly increased upon repeated immunization, although it remained fairly constant over time. The RhIG from the different manufacturers all demonstrated increased Fc-galactosylation (64%-82%) compared to total IgG (38%-51%). RhIG preparations vary in Fc-fucosylation and all demonstrate increased galactosylation. Despite not knowing the exact working mechanism, immunoprophylaxis could perhaps be optimized by selection of donors whose anti-D have low amounts of Fc-fucose, to increase the clearance activity of anti-D preparations, as well as high amounts of galactosylation, for anti-inflammatory effects. Implementing a biologic assay in the standardization of RhIG preparations might be considered. \u00a9 2014 AABB.\n[Seroprevalence of diphtheria toxoid IgG antibodies in children, adolescents and adults in Poland.](https://www.ncbi.nlm.nih.gov/pubmed/24252165)\nZasada, Aleksandra A; Rastawicki, Waldemar; Rokosz, Natalia; Jagielski, Marek\n2013-11-19\nRecommendations for diphtheria immunization are to apply an effective primary immunization in infancy and to maintain immunity throughout life. Immunity against diphtheria depends primarily on antibody to the diphtheria toxin. This study evaluated the seroprevalence of IgG diphtheria antitoxin in sera of healthy children, adolescents and adults in Poland. A total of 1387 serum samples collected between 2010 and 2012 from individuals with ages ranging from 1 month to 85 years were investigated. Antibody concentrations were measured with an enzyme-linked immunosorbent assay (Anti-Diphtheria Toxoid ELISA IgG, Euroimmun, Germany). The results showed that among 1387 individuals examined, 547 (39.4%) had anti-diphtheria toxoid IgG antibody levels below 0.1 IU/ml (36.9% \u2264 18 years and 40.5% >18 years old, respectively). The 212 (50.8%) children and 542 (55.9%) adults showed only basic protection (0.1-1.0 IU/ml) and need immediate booster. High levels of anti-diphtheria toxoid IgG antibodies (>1.0 IU/ml) were found more often in children and adolescent (12.2%) than in adults (3.6%) and this was statistically significant (P 60 years old. Characteristically, in individuals > 40 years old high levels of anti-diphtheria toxoid IgG antibodies (>1.0 IU/ml) were not seen. There were no statistically significant differences in results in relation to gender. The present study showed inadequate immunity levels to diphtheria amongst the Polish population, especially in adults > 40 years old and children \u2264 2 years old. To prevent reemergence of diphtheria an information campaign reminding people about recommendations concerning diphtheria booster vaccination in adults should be conducted. Moreover, the immunogenicity of the DTP vaccine used in Poland should be verified.\n[Control externo de la calidad del diagn\u00f3stico serol\u00f3gico del dengue en laboratorios de pa\u00edses de las Am\u00e9ricas, 1996-2001](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892003001100001&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMar\u00eda G. Guzm\u00e1n\n2003-12-01\nFull Text Available OBJETIVO: Dar a conocer los resultados de cuatro controles externos de la calidad del diagn\u00f3stico serol\u00f3gico del dengue realizados en la Regi\u00f3n de las Am\u00e9ricas en el per\u00edodo de 1996- 2001 y presentar los resultados obtenidos por los laboratorios participantes. M\u00c9TODOS: Se realizaron controles externos de la calidad del diagn\u00f3stico serol\u00f3gico del dengue en 1996-1997, 1998-1999, 1999-2000 y 2000-2001. Paneles compuestos por 20 sueros (12 de estos positivos a anticuerpos IgM contra el dengue fueron enviados a laboratorios de la Regi\u00f3n para que participaran en los controles realizados. Los sueros de los paneles eran negativos a anticuerpos contra el virus de la inmunodeficiencia humana y el virus de la hepatitis C, as\u00ed como al ant\u00edgeno de superficie de la hepatitis B, y fueron almacenados a -20 \u00b0C hasta su env\u00edo en refrigeraci\u00f3n a los laboratorios participantes. La presencia de anticuerpos IgM se determin\u00f3 mediante un ensayo inmunoenzim\u00e1tico (ELISA de captura, mientras que el t\u00edtulo de anticuerpos IgG se determin\u00f3 por inhibici\u00f3n de la hemoaglutinaci\u00f3n o ELISA de IgG. Los resultados de la determinaci\u00f3n de anticuerpos IgM contra el dengue que no coincid\u00edan con los del centro de referencia se consideraron discordantes. El t\u00edtulo de anticuerpos IgG se consider\u00f3 discordante cuando los resultados difirieron en dos diluciones o m\u00e1s con respecto al resultado del centro de referencia. RESULTADOS: Un total de 27 laboratorios recibi\u00f3 59 paneles de sueros de 1996 a 2001, y se recibieron los resultados del an\u00e1lisis de 54 de esos paneles (91,5%. De 1 080 sueros (20 X 54, 95,6% coincidieron con el laboratorio de referencia en cuanto a los resultados de la detecci\u00f3n de anticuerpos IgM contra el dengue. Adem\u00e1s, en 47 paneles (87% la coincidencia con el laboratorio de referencia se observ\u00f3 en 90% de las muestras del panel o m\u00e1s. De los 27 paneles para los cuales se recibieron los resultados de los t\u00edtulos de anticuerpos IgG contra el\n[Analyses of the peripheral immunome following multiple administrations of avelumab, a human IgG1 anti-PD-L1 monoclonal antibody.](https://www.ncbi.nlm.nih.gov/pubmed/28239472)\nDonahue, Renee N; Lepone, Lauren M; Grenga, Italia; Jochems, Caroline; Fantini, Massimo; Madan, Ravi A; Heery, Christopher R; Gulley, James L; Schlom, Jeffrey\n2017-01-01\nMultiple anti-PD-L1/PD-1 checkpoint monoclonal antibodies (MAb) have shown clear evidence of clinical benefit. All except one have been designed or engineered to omit the possibility to mediate antibody-dependent cell-mediated cytotoxicity (ADCC) as a second potential mode of anti-tumor activity; the reason for this is the concern of lysis of PD-L1 positive immune cells. Avelumab is a fully human IgG1 MAb which has been shown in prior in vitro studies to mediate ADCC versus a range of human tumor cells, and clinical studies have demonstrated anti-tumor activity versus a range of human cancers. This study was designed to investigate the effect on immune cell subsets in the peripheral blood of cancer patients prior to and following multiple administrations of avelumab. One hundred twenty-three distinct immune cell subsets in the peripheral blood of cancer patients ( n = 28) in a phase I trial were analyzed by flow cytometry prior to and following one, three, and nine cycles of avelumab. Changes in soluble (s) CD27 and sCD40L in plasma were also evaluated. In vitro studies were also performed to determine if avelumab would mediate ADCC of PBMC. No statistically significant changes in any of the 123 immune cell subsets analyzed were observed at any dose level, or number of doses, of avelumab. Increases in the ratio of sCD27:sCD40L were observed, suggesting potential immune activation. Controlled in vitro studies also showed lysis of tumor cells by avelumab versus no lysis of PBMC from five donors. These studies demonstrate the lack of any significant effect on multiple immune cell subsets, even those expressing PD-L1, following multiple cycles of avelumab. These results complement prior studies showing anti-tumor effects of avelumab and comparable levels of adverse events with avelumab versus other anti-PD-1/PD-L1 MAbs. These studies provide the rationale to further exploit the potential ADCC mechanism of action of avelumab as well as other human IgG1 checkpoint\n[Reactivation of the Chagasic Infection in Wistar Rats in Gestation](https://www.openaire.eu/search/publication?articleId=od_______621::7e1633db2080f63743041c74da64c51d)\nMoreno B, Elio; M\u00e9ndez I, Maid\u00e9; Alarc\u00f3n M, Maritza; Araujo A, Sonia; Lugo de Yarbuh, Ana\n2005-01-01\nEn este trabajo investigamos en ratas Wistar cr\u00f3nicamente infectadas con Trypanosoma cruzi, la reactivaci\u00f3n de la infecci\u00f3n durante la gestaci\u00f3n y despu\u00e9s del parto, mediante un estudio parasitol\u00f3gico, inmunol\u00f3gico, histopatol\u00f3gico e inmunohistoqu\u00edmico. Los resultados mostraron un control de las parasitemias patentes y/o subpatentes; t\u00edtulos elevados de anticuerpos espec\u00edficos anti-T. cruzi, detect\u00e1ndose en las ratas gestantes una disminuci\u00f3n en los niveles de IgG y un incremento significativ...\n[Infectious Mononucleosis Triggers Generation of IgG Auto-Antibodies against Native Myelin Oligodendrocyte Glycoprotein.](https://www.ncbi.nlm.nih.gov/pubmed/26907324)\nKakalacheva, Kristina; Regenass, Stephan; Wiesmayr, Silke; Azzi, Tarik; Berger, Christoph; Dale, Russell C; Brilot, Fabienne; M\u00fcnz, Christian; Rostasy, Kevin; Nadal, David; L\u00fcnemann, Jan D\n2016-02-12\nA history of infectious mononucleosis (IM), symptomatic primary infection with the Epstein Barr virus, is associated with the development of autoimmune diseases and increases the risk to develop multiple sclerosis. Here, we hypothesized that immune activation during IM triggers autoreactive immune responses. Antibody responses towards cellular antigens using a HEp-2 based indirect immunofluorescence assay and native myelin oligodendrocyte glycoprotein (MOG) using a flow cytometry-based assay were determined in 35 patients with IM and in 23 control subjects. We detected frequent immunoglobulin M (IgM) reactivity to vimentin, a major constituent of the intermediate filament family of proteins, in IM patients (27/35; 77%) but rarely in control subjects (2/23; 9%). IgG autoantibodies binding to HEp-2 cells were absent in both groups. In contrast, IgG responses to native MOG, present in up to 40% of children with inflammatory demyelinating diseases of the central nervous system (CNS), were detectable in 7/35 (20%) patients with IM but not in control subjects. Normalization of anti-vimentin IgM levels to increased total IgM concentrations during IM resulted in loss of significant differences for anti-vimentin IgM titers. Anti-MOG specific IgG responses were still detectable in a subset of three out of 35 patients with IM (9%), even after normalization to increased total IgG levels. Vimentin-specific IgM and MOG-specific IgG responses decreased following clinical resolution of acute IM symptoms. We conclude from our data that MOG-specific memory B cells are activated in subset of patients with IM.\n[Comparative study of the second antibody for radioimmunoassay totally produced in the country to a similar imported one (sheep serum anti-rabbit IgG)](https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=23078827) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nSilva, S.R. da; Borghi, V.C.; Wajchenberg, B.L.\n1992-01-01\nThis work compares a second antibody for radioimmunoassay (RIA) produced at IPEN-CNEN/SP with a commercial one of known quality, produced by Radioassay Systems Laboratories, U.S.A.. This antiserum, sheep serum anti-rabbit IgG produced in its totality in the country, presented title and precipitation characteristics similar to those exhibited by the commercial product, being as suitable for the RIA separation as its imported similar. (author)\n[Histopathology of IgG4-Related Autoimmune Hepatitis and IgG4-Related Hepatopathy in IgG4-Related Disease.](https://www.ncbi.nlm.nih.gov/pubmed/27466793)\nNakanuma, Yasuni; Ishizu, Yoji; Zen, Yoh; Harada, Kenichi; Umemura, Takeji\n2016-08-01\nImmunoglobulin G4-related disease (IgG4-RD) is a systemic disease involving many organs; it includes IgG4-related sclerosing cholangitis and inflammatory pseudotumor in the hepatobiliary system. Two types of hepatic parenchymal involvement have been reported in IgG4-RD: IgG4-related autoimmune hepatitis (AIH) and IgG4-hepatopathy. Moreover, only three cases of IgG4-related AIH have been reported. Immunoglobulin G4-related AIH is clinicopathologically similar to AIH, except for an elevated serum IgG4 level and heavy infiltration of IgG4-positive plasma cells in the liver tissue. Interestingly, IgG4-related AIH can be complicated by well-known IgG4-RD(s). Immunoglobulin G4-hepatopathy, which includes various histopathological lesions encountered in the liver of patients with type I autoimmune pancreatitis, is classified into five histological categories: portal inflammation, large bile duct damage, portal sclerosis, lobular hepatitis, and cholestasis. Immunoglobulin G4-hepatopathy is currently a collective term covering hepatic lesions primarily or secondarily related to IgG4-related sclerosing cholangitis and type 1 autoimmune pancreatitis. In conclusion, the liver is not immune to IgG4-RD, and at least two types of hepatic involvement in IgG4-RD have been reported: IgG4-related AIH and IgG4-hepatopathy. Additional studies are required to clarify their precise clinical significance with respect to IgG4-RD and inherent liver diseases. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.\n[A soluble form of IL-13 receptor alpha 1 promotes IgG2a and IgG2b production by murine germinal center B cells.](https://www.ncbi.nlm.nih.gov/pubmed/10415009)\nPoudrier, J; Graber, P; Herren, S; Gretener, D; Elson, G; Berney, C; Gauchat, J F; Kosco-Vilbois, M H\n1999-08-01\nA functional IL-13R involves at least two cell surface proteins, the IL-13R alpha 1 and IL-4R alpha. Using a soluble form of the murine IL-13R alpha 1 (sIL-13R), we reveal several novel features of this system. The sIL-13R promotes proliferation and augmentation of Ag-specific IgM, IgG2a, and IgG2b production by murine germinal center (GC) B cells in vitro. These effects were enhanced by CD40 signaling and were not inhibited by an anti-IL4R alpha mAb, a result suggesting other ligands. In GC cell cultures, sIL-13R also promoted IL-6 production, and interestingly, sIL-13R-induced IgG2a and IgG2b augmentation was absent in GC cells isolated from IL-6-deficient mice. Furthermore, the effects of the sIL-13R molecule were inhibited in the presence of an anti-IL-13 mAb, and preincubation of GC cells with IL-13 enhanced the sIL-13R-mediated effects. When sIL-13R was injected into mice, it served as an adjuvant-promoting production to varying degrees of IgM and IgG isotypes. We thus propose that IL-13R alpha 1 is a molecule involved in B cell differentiation, using a mechanism that may involve regulation of IL-6-responsive elements. Taken together, our data reveal previously unknown activities as well as suggest that the ligand for the sIL-13R might be a component of the IL-13R complex or a counterstructure yet to be defined.\n[Characteristics of primary Sj\u00f6gren's syndrome patients with IgG4 positive plasma cells infiltration in the labial salivary glands.](https://www.ncbi.nlm.nih.gov/pubmed/27864697)\nLiu, Chang; Zhang, Huayong; Yao, Genhong; Hu, Yunxia; Qi, Jingjing; Wang, Yan; Chen, Weiwei; Tang, Xiaojun; Li, Wenchao; Lu, Liwei; Gu, Luo; Sun, Lingyun\n2017-01-01\nThe purpose of this study was to investigate the characteristics of primary Sj\u00f6gren's syndrome (pSS) patients with IgG4 positive (IgG4 + ) plasma cell infiltration in labial salivary glands (LSGs). Paraffin sections of LSGs from 336 pSS patients were stained with IgG4 and IgG monoclonal antibodies. According to the infiltration of IgG4 + plasma cells, patients were divided and clinical and serological characteristics were analyzed and compared. Based on the infiltration of IgG4 + plasma cells in the LSGs, patients were divided into three subgroups, low IgG4, moderate IgG4, and high IgG4 groups. A negative association between the number of infiltrated IgG4 + plasma cells and the disease characteristics was observed. We found that the higher the IgG4 + expression in plasma cells, the lower the positive rates of serum anti-SSA antibodies, anti-SSB antibodies, antinuclear antibodies (ANA), and rheumatoid factor (RF). Besides, patients from the high IgG4 group had the highest frequency of interstitial lung disease (ILD, 30.6%) and tubulointerstitial nephritis (TIN, 13.9%), but the lowest frequency of leucopenia (13.9%), thrombocytopenia (11.1%), and abnormal thyroidal function (0%). PSS patients with different IgG4 + plasma cells infiltration in the LSGs had distinctive clinical and laboratory characteristics. It may help us to further understand the role of IgG4 + plasma cells in pSS.\n[A Label-Free Immunosensor for IgG Based on an Extended-Gate Type Organic Field Effect Transistor](http://www.mdpi.com/1996-1944/7/9/6843) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nTsukuru Minamiki\n2014-09-01\nFull Text Available A novel biosensor for immunoglobulin G (IgG detection based on an extended-gate type organic field effect transistor (OFET has been developed that possesses an anti-IgG antibody on its extended-gate electrode and can be operated below 3 V. The titration results from the target IgG in the presence of a bovine serum albumin interferent, clearly exhibiting a negative shift in the OFET transfer curve with increasing IgG concentration. This is presumed to be due an interaction between target IgG and the immobilized anti-IgG antibody on the extended-gate electrode. As a result, a linear range from 0 to 10 \u00b5g/mL was achieved with a relatively low detection limit of 0.62 \u00b5g/mL (=4 nM. We believe that these results open up opportunities for applying extended-gate-type OFETs to immunosensing.\n[Serum total IgG and IgG4 levels in thyroid eye disease](https://www.dovepress.com/serum-total-igg-and-igg4-levels-in-thyroid-eye-disease-peer-reviewed-article-IMCRJ) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nSy A\n2016-10-01\nFull Text Available Aileen Sy, Rona Z Silkiss Department of Ophthalmology, California Pacific Medical Center, San Francisco, CA, USA Purpose: To investigate the relationship between immunoglobulin G (IgG4-related disease (IgG4-RD and thyroid eye disease (TED with respect to IgG levels. Patients and methods: A retrospective review of total IgG, IgG subclass, and thyroid stimulating immunoglobulin (TSI levels in 24 patients with TED. Results: Five patients (20.8% demonstrated serum IgG4 levels consistent with IgG4-RD without any additional systemic disease. Total IgG and IgG subclass levels were found to be an inadequate proxy for TSI elevation. Conclusion: There may be a subtype of TED patients with elevated IgG4 in the absence of IgG4-RD systemic findings. Keywords: thyroid eye disease, IgG subclass, IgG4, Graves\u2019 disease, Graves\u2019 ophthalmopathy, IgG4-RD\n[[IgG4-related disease - a case report].](https://www.ncbi.nlm.nih.gov/pubmed/28987046)\nMilczarek-Banach, Justyna; Brodzi\u0144ska, Kinga; Jankowska, Anna; Ambroziak, Urszula; Szczepankiewicz, Benedykt; Na\u0142\u0119cz-Janik, Jolanta; Mi\u015bkiewicz, Piotr\n2017-09-29\nImmunoglobulin G4-related disease (IgG4-RD) is a comparatively new condition that may involve more than one organ. The lack of characteristic, pathognomonic clinical symptoms may delay the diagnosis of this disease. The diagnosis is based upon clinical manifestation, elevated serum levels of IgG4 and histopathologic examination with immunohistochemical staining to reveal infiltration of IgG4-positive plasma cells. The first line treatment is oral glucocorticoids. 38-year-old woman with Hashimoto disease, chronic sinusitis and chronic hepatitis of unknown etiology was admitted to the Department of Endocrinology because of moderate eyelids swelling accompanied by redness for 3 years. Graves' orbitopathy and systemic vasculitis were suspected, however both were excluded (negative antibodies results: anty-TSHR, ANCA, ANA). Serologic investigation of Sj\u00f6gren's syndrome was also negative. In Magnetic Resonance Imaging (MRI) of orbits there were described bilateral mild extension of lateral rectus muscles, normal signal of adipose tissue and bilateral lacrimal glands enlargement. Moreover, increased IgG4 serum levels were detected. The material derived from perinasal sinuses surgery was analyzed in histopathology examination with immunohistochemical staining, which revealed characteristic features of chronic inflammatory process and increased numbers of IgG4 - positive plasma cells (>50 in a large field of view). The diagnosis of IgG4-RD was established. Because of non-effective oral methylprednisolone therapy in the past, the patient was referred to Clinic of Rheumatology for further treatment. After the therapy with methylprednisolone and azathioprine there were observed the significant reduction of symptoms. Because of lack of characteristic symptoms of IgG4- RD, it should be always considered in differential diagnosis of chronic inflammatory diseases of various organs.\n[ORIGINAL ARTICLE RUBELLA IgG ANTIBODY AMONG NIGERIAN ...](https://www.ajol.info/index.php/ajcem/article/download/83865/73873) [African Journals Online (AJOL)](http://www.ajol.info/index.php)\nboaz\ncapable of causing a spectrum of birth defects described as congenital rubella syndrome (CRS). Despite the availability of safe and effective ... designed to determine the prevalence of anti- rubella IgG among pregnant women in order to ..... Vyse A.J., Gay N.J., White J.M., Ramsay. M.E., Brown D.W., Cohen B.J. Evolution.\n[Enhanced opsonisation of Rhesus D-positive human red blood cells by recombinant polymeric immunoglobulin G anti-G antibodies.](https://www.ncbi.nlm.nih.gov/pubmed/28686149)\nD\u00edaz-Solano, Dylana; Fuenmayor, Jaheli; Monta\u00f1o, Ramon F\n2018-02-01\nAnti-RhD antibodies (anti-D) are important in the prophylaxis of haemolytic disease of the foetus and newborn (HDFN) due to RhD incompatibility. Current preparations of anti-D are sourced from hyperimmune human plasma, so its production carries a risk of disease and is dependent on donor availability. Despite the efforts to develop a monoclonal preparation with similar prophylactic properties to the plasma-derived anti-D, no such antibody is yet available. Here we studied the agglutinating, opsonic and haemolytic activities of two recombinant polymeric immunoglobulins (Ig) against the G antigen of the Rh complex. Recombinant polymeric anti-G IgG1 (IgG1\u03bctp) and IgG3 (IgG3\u03bctp) were produced in vitro, purified by protein G-affinity chromatography, and analysed by gel electrophoresis. Their agglutinating, opsonic and haemolytic activities were evaluated using haemagglutination, erythrophagocytosis, and complement activation assays. The recombinant IgG1\u03bctp and IgG3\u03bctp anti-G antibodies ranged from 150,000 to 1,000,000 Da in molecular weight, indicating the formation of polymeric IgG. No complement activation or haemolytic activity was detected upon incubation of RhD-positive red-blood cells with the polymeric anti-G IgG. Both polymers were better opsonins than a prophylactic preparation of plasma-derived anti-D. The enhanced opsonic properties of the polymeric anti-G IgG1\u03bctp and IgG3\u03bctp could allow them to mediate the clearance of RhD-positive red blood cells from circulation more efficiently than natural or other synthetic prophylactic anti-D options. Their inability to induce complement-mediated haemolysis would be prophylactically convenient and is comparable in vitro to that of the available plasma-derived polyclonal anti-D preparations. The described properties suggest that polymeric antibodies like these (but with anti-D specificity) may be testable candidates for prophylaxis of HDFN caused by anti-D.\n[[The diagnostic value of anti-CMV and anti-HPV-B19 antiviral antibodies in studies on causes of recurrent abortions].](https://www.ncbi.nlm.nih.gov/pubmed/9463082)\nSzkaradkiewicz, A; Pieta, P; Tu\u0142ecka, T; Breborowicz, G; S\u0142omko, Z; Strzyzowski, P\n1997-04-01\nPresence of serum anti-cytomegalovirus (CMV) and anti-parvovirus B19 (HPV-B19) antibodies was studied in 11 women within the first day after consecutive spontaneous abortion in the second trimester of pregnancy and in the control group, consisting of 15 women in the second trimester of a normal pregnancy. Most of studied women manifested presence of serum IgG class anti-CMV antibodies (IgG-anti-CMV) and levels of the antibodies proved significantly higher in women following spontaneous abortions. The patients frequently demonstrated in parallel presence of serum IgG class anti-HPV-B19 antibodies. In one patient a generalised nonimmunological hydrops fetalis was disclosed and her serum contained IgM and IgG class antibodies against CMV as well as against HPV-B19. The results suggest that in majority of the studied women the spontaneous abortion might have resulted from fetal infection due to reactivation of chronic CMV infection in the course of pregnancy.\n[Clinical significance of anti-domain 1 \u03b22-glycoprotein I antibodies in antiphospholipid syndrome.](https://www.ncbi.nlm.nih.gov/pubmed/28363116)\nIwaniec, Teresa; Kaczor, Marcin P; Celi\u0144ska-L\u00f6wenhoff, Magdalena; Pola\u0144ski, Stanis\u0142aw; Musia\u0142, Jacek\n2017-05-01\nAntiphospholipid syndrome (APS) is characterized by the presence of circulating antiphospholipid antibodies (aPL) in patients with thrombosis and/or pregnancy morbidity. In APS patients anti-domain 1 \u03b22-glycoprotein I (anti-D1 \u03b22GPI) IgG antibodies correlate strongly with thrombosis and to the lesser extent, with pregnancy complications. The aim of this study was to assess clinical utility of the anti-D1 \u03b22GPI antibodies in the diagnosis and risk stratification of antiphospholipid syndrome. In this retrospective study 202 autoimmune patients were studied (primary APS - 58, secondary - 45 SLE - 99). Anticardiolipin (aCL) and anti-\u03b2 2 GPI (a\u03b2 2 GPI antibodies) (IgG and IgM class) together with anti-D1 IgG were tested with QUANTA Flash chemiluminescent immunoassay and lupus anticoagulant (LA) with coagulometric methods. The highest anti-D1 values were observed in triple positive patients as compared to patients with other antiphospholipid antibody profiles. A strong correlation was found between levels of anti-D1 IgG and a \u03b22GPI IgG antibodies for all patients analyzed (Spearman's \u03c1=0.87; p<0.0001). Anti-D1 IgG antibodies increase specificity resulting from classic aPL positivity but at the expense of sensitivity. Anti-D1 test does not add accuracy in predicting APS thrombotic complications on the top of accuracy offered by classic aPL tests and their profiles. Anti-D1 IgG antibodies did not add diagnostic power to the standard laboratory aPL tests as assessed by this retrospective study. A true clinical significance of anti-D1 antibodies in thrombotic risk stratification of aPL positive patients will require a properly designed clinical prospective trials. Copyright \u00a9 2017 Elsevier Ltd. All rights reserved.\n[Sialylated Autoantigen-Reactive IgG Antibodies Attenuate Disease Development in Autoimmune Mouse Models of Lupus Nephritis and Rheumatoid Arthritis](https://www.frontiersin.org/article/10.3389/fimmu.2018.01183/full) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nYannic C. Bartsch\n2018-06-01\nFull Text Available Pro- and anti-inflammatory effector functions of IgG antibodies (Abs depend on their subclass and Fc glycosylation pattern. Accumulation of non-galactosylated (agalactosylated; G0 IgG Abs in the serum of rheumatoid arthritis and systemic lupus erythematosus (SLE patients reflects severity of the diseases. In contrast, sialylated IgG Abs are responsible for anti-inflammatory effects of the intravenous immunoglobulin (pooled human serum IgG from healthy donors, administered in high doses (2 g/kg to treat autoimmune patients. However, whether low amounts of sialylated autoantigen-reactive IgG Abs can also inhibit autoimmune diseases is hardly investigated. Here, we explore whether sialylated autoantigen-reactive IgG Abs can inhibit autoimmune pathology in different mouse models. We found that sialylated IgG auto-Abs fail to induce inflammation and lupus nephritis in a B cell receptor (BCR transgenic lupus model, but instead are associated with lower frequencies of pathogenic Th1, Th17 and B cell responses. In accordance, the transfer of small amounts of immune complexes containing sialylated IgG Abs was sufficient to attenuate the development of nephritis. We further showed that administration of sialylated collagen type II (Col II-specific IgG Abs attenuated the disease symptoms in a model of Col II-induced arthritis and reduced pathogenic Th17 cell and autoantigen-specific IgG Ab responses. We conclude that sialylated autoantigen-specific IgG Abs may represent a promising tool for treating pathogenic T and B cell immune responses in autoimmune diseases.\n[The Salivary Anti-A and Anti-B Isoantibody System in Group O Males.](http://www.dtic.mil/docs/citations/AD0729303)\nagglutinins increased significantly in two individuals and anti-B in four, and parotid saliva anti-A agglutinins in one and anti-B in three. Both whole...and parotid saliva agglutinating activity were demonstrated to be primarily due to secretory IgA, both pre- and postimmunization. IgG coating activity\n[A simple solid-phase radioimmunoassay for the measurement of IgG secreted in vitro by human lymphocytes](https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=11505226) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nRomagnani, S.; Prete, G.F. del; Giudizi, G.M.; Almerigogna, F.; Ricci, M.\n1979-01-01\nA radioimmunoassay is described for measuring IgG, based on the ability of immunoglobulins of this class to inhibit the binding of radioiodinated staphylococcal protein A to IgG linked to a solid phase. The solid phase is represented by ox erythrocytes coated with anti-ox erthrocyte rabbit IgG, a reagent used for detecting cells equipped with receptors for the Fc fragment of IgG. By this assay the IgG secreted in vitro by human peripheral blood lymphocytes stimulated with PWM and those present in samples of very diluted human sera were measured. It was found that the assay is a very rapid, simple and and reproducible procedure for the detection of IgG immunoglobulin at the nanogram level. (Auth.)\n[Clinical significance of isolated anti-HBc positivity in cases of chronic liver disease in New Delhi, India](http://www.jgid.org/article.asp?issn=0974-777X;year=2009;volume=1;issue=1;spage=29;epage=32;aulast=Jain) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nManisha Jain\n2009-01-01\nFull Text Available Background: The presence of anti-HBc IgG in the absence of HBsAg is usually indicative of a past self-limiting HBV infection. But it is frequently associated with co-infection with HCV which can worsen the existing status of chronic liver disease (CLD. Objectives: The present study was planned to evaluate the significance of isolated HBc IgG positivity in patients of CLD and look for the presence of HCV co-infection in such patients. Methods: Clinical profiles and biochemical tests were done for all the 77 CLD cases included in the study. Blood samples were taken from these patients and tested by the commercially available EIA for the presence of HBsAg, anti-HBc IgG, anti-HBs and anti-HCV. HBV DNA was detected by amplifying the surface region in all the cases. Results: Isolated anti-HBc IgG positivity defined as the presence of anti-HBc IgG in absence of any other serological markers of HBV infection was detected in 28 patients . Out of 64 patients positive for anti-HBc IgG 36 had the markers of HBV, either HBsAg, HBV DNA or anti-HBs alone or in combination. There was a significant association between isolated anti-HBc IgG positivity and HCV co-infection. Conclusion: Anti-HBc IgG should be tested in all patients with CLD as it is frequently the only marker of HBV infection in such patients and they should be monitored closely as such patients can develop CLD. Presence of co-infection with HCV should be actively searched for in such patients.\n[Estudio de inmunogenicidad de la vacuna antitifo\u00eddica cubana de polisac\u00e1rido Vi vax-TyVi\u00ae en ratones](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2006000200001&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJuan Carlos Ram\u00edrez\n2006-08-01\nFull Text Available Salmonella enterica serovar Typhi es un microorganismo que provoca m\u00e1s de 16 millones de casos de fiebre tifoidea con aproximadamente 600 000 muertes al a\u00f1o en todo el mundo. Dentro de las vacunas antitifo\u00eddicas la de polisac\u00e1rido capsular Vi ha encontrado, gracias a sus incuestionables ventajas, una gran aceptaci\u00f3n entre productores y consumidores. El presente trabajo aborda el estudio de inmunogenicidad de la vacuna antitifo\u00eddica cubana de polisac\u00e1rido Vi vax-TyVi\u00e2 en ratones. El estudio estuvo conformado por un grupo control no inoculado y un segundo grupo que recibi\u00f3 0,05 mL de la vacuna por v\u00eda intramuscular. Se tomaron muestras de sangre a los -3, 7, 14, 21, 28, 42, 56 y 84 d\u00edas. La actividad de anticuerpos IgG antipolisac\u00e1rido Vi de los sueros individuales fue determinada por ELISA. Los datos fueron analizados por grupo y por sexo y se calcul\u00f3 el porcentaje de seroconversi\u00f3n, consider\u00e1ndose respondedor aquel animal que al menos aumentara en cuatro veces su t\u00edtulo inicial. La respuesta de anticuerpos inducida por la vacuna mostr\u00f3 un aumento notable de los t\u00edtulos de IgG antipolisac\u00e1rido Vi en el grupo vacunado (100% de seroconversi\u00f3n, mientras que el grupo control no increment\u00f3 sus niveles m\u00ednimos iniciales (0% de respondedores. Aunque m\u00e1s dispersa, la respuesta de anticuerpos antiVi fue significativamente mayor en las hembras que en los machos.\n[Cutoff Values of Serum IgG4 and Histopathological IgG4+ Plasma Cells for Diagnosis of Patients with IgG4-Related Disease](http://dx.doi.org/10.1155/2012/580814) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nYasufumi Masaki\n2012-01-01\nFull Text Available IgG4-related disease is a new disease classification established in Japan in the 21st century. Patients with IgG4-related disease display hyper-IgG4-gammaglobulinemia, massive infiltration of IgG4+ plasma cells into tissue, and good response to glucocorticoids. Since IgG4 overexpression is also observed in other disorders, it is necessary to diagnose IgG4-related disease carefully and correctly. We therefore sought to determine cutoff values for serum IgG4 and IgG4/IgG and for IgG4+/IgG+ plasma cells in tissue diagnostic of IgG4-related disease. Patients and Methods. We retrospectively analyzed serum IgG4 concentrations and IgG4/IgG ratio and IgG4+/IgG+ plasma cell ratio in tissues of 132 patients with IgG4-related disease and 48 patients with other disorders. Result. Serum IgG4 >135 mg/dl demonstrated a sensitivity of 97.0% and a specificity of 79.6% in diagnosing IgG4-related disease, and serum IgG4/IgG ratios >8% had a sensitivity and specificity of 95.5% and 87.5%, respectively. IgG4+cell/IgG+ cell ratio in tissues >40% had a sensitivity and specificity of 94.4% and 85.7%, respectively. However, the number of IgG4+ cells was reduced in severely fibrotic parts of tissues. Conclusion. Although a recent unanimous consensus of all relevant researchers in Japan recently established the diagnostic criteria for IgG4-related disease, findings such as ours indicate that further discussion is needed.\n[The S228P mutation prevents in vivo and in vitro IgG4 Fab-arm exchange as demonstrated using a combination of novel quantitative immunoassays and physiological matrix preparation.](https://www.ncbi.nlm.nih.gov/pubmed/25568323)\nSilva, John-Paul; Vetterlein, Olivia; Jose, Joby; Peters, Shirley; Kirby, Hishani\n2015-02-27\nHuman immunoglobulin G isotype 4 (IgG4) antibodies (Abs) are potential candidates for immunotherapy when reduced effector functions are desirable. IgG4 Abs are dynamic molecules able to undergo a process known as Fab arm exchange (FAE). This results in functionally monovalent, bispecific antibodies (bsAbs) with unknown specificity and hence, potentially, reduced therapeutic efficacy. IgG4 FAE is suggested to be an important biological mechanism that provides the basis for the anti-inflammatory activity attributed to IgG4 Abs. To date, the mechanism of FAE is not entirely understood and studies measuring FAE in ex vivo matrices have been hampered by the presence and abundance of endogenous IgG4 wild-type (WT) Abs. Using representative humanized WT IgG4 monoclonal Abs, namely, anti-IL-6 and anti-TNF, and a core-hinge stabilized serine 228 to proline (S228P) anti-IL-6 IgG4 mutant, it is demonstrated for the first time how anti-IgG4 affinity chromatography can be used to prepare physiologically relevant matrices for assessing and quantifying FAE. A novel method for quantifying FAE using a single MSD immunoassay is also reported and confirms previous findings that, dependent on the redox conditions, the S228P mutation can prevent IgG4 FAE to undetectable levels both in vitro and in vivo. Together, the findings and novel methodologies will allow researchers to monitor and quantify FAE of their own IgG4 molecules in physiologically relevant matrices. \u00a9 2015 by The American Society for Biochemistry and Molecular Biology, Inc.\n[Cubeta para la incubaci\u00f3n y lavado de anticuerpos](https://www.openaire.eu/search/publication?articleId=dedup_wf_001::b4ea5f20b024ce1dfdc886c43b84f379)\nRevilla Novella, Yolanda; Nogal Par\u00eds, Mar\u00eda Luisa\n2008-01-01\nCubeta para la incubaci\u00f3n y lavado de anticuerpos. La cubeta comprende un cuerpo (1) lavable, inerte y no poroso, que est\u00e1 dotado de unos pocillos (2) ubicados en su interior, cuyo n\u00famero y tama\u00f1o puede variar en funci\u00f3n del requerimiento experimental. En dichos pocillos (2) se introducen preferiblemente fragmentos o tiras (3) de nitrocelulosa, que contienen prote\u00ednas que han sido previamente transferidas desde un gel de poliacrilamida utilizando un campo el\u00e9ctrico. Esta cubeta ti...\n[Human IgG4 binds to IgG4 and conformationally altered IgG1 via Fc-Fc interactions](https://www.narcis.nl/publication/RecordID/oai%3Apure.amc.nl%3Apublications%2F1973c654-54d7-4cfe-99d0-cb51a458d45b/uquery/IGG4/id/1/Language/EN)\nRispens, Theo; Ooievaar-de Heer, Pleuni; Vermeulen, Ellen; Schuurman, Janine; van der Neut Kolfschoten, Marijn; Aalberse, Rob C.\n2009-01-01\nThe Fc fragment of IgG4 can interact with the Fc fragment of another IgG molecule. This interaction is a confounding factor when measuring IgG4 rheumatoid factor levels. Recently, we demonstrated that half-molecules of IgG4 can exchange to form a bispecific Ab. We expected these two phenomena to be\n[Evaluation of cysticercus-specific IgG (total and subclasses and IgE antibody responses in cerebrospinal fluid samples from patients with neurocysticercosis showing intrathecal production of specific IgG antibodies Avalia\u00e7\u00e3o das respostas de anticorpos anti-cisticercos IgG (total e subclasses e IgE em amostras de l\u00edquido cefalorraquidiano de pacientes com neurocisticercose apresentando produ\u00e7\u00e3o intratecal de anticorpos espec\u00edficos IgG](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2013005000002) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nLisandra Akemi Suzuki\n2013-01-01\nFull Text Available In the present study, an enzyme-linked immunosorbent assay (ELISA standardized with vesicular fluid of Taenia solium cysticerci was used to screen for IgG (total and subclasses and IgE antibodies in cerebrospinal fluid (CSF samples from patients with neurocysticercosis showing intrathecal production of specific IgG antibodies and patients with other neurological disorders. The following results were obtained: IgG-ELISA: 100% sensitivity (median of the ELISA absorbances (MEA=1.17 and 100% specificity; IgG1-ELISA: 72.7% sensitivity (MEA=0.49 and 100% specificity; IgG2-ELISA: 81.8% sensitivity (MEA=0.46 and 100% specificity; IgG3-ELISA: 63.6% sensitivity (MEA=0.12 and 100% specificity; IgG4-ELISA: 90.9% sensitivity (MEA=0.85 and 100% specificity; IgE-ELISA 93.8% sensitivity (MEA=0.60 and 100% specificity. There were no significant differences between the sensitivities and specificities in the detection of IgG-ELISA and IgE-ELISA, although in CSF samples from patients with neurocysticercosis the MEA of the IgG-ELISA was significantly higher than that of the IgE-ELISA. The sensitivity and MEA values of the IgG4-ELISA were higher than the corresponding values for the other IgG subclasses. Future studies should address the contribution of IgG4 and IgE antibodies to the physiopathology of neurocysticercosis.No presente estudo, uma rea\u00e7\u00e3o imunoenzim\u00e1tica (ELISA padronizada com o fluido vesicular de cisticercos de Taenia solium foi utilizada para avaliar as respostas de anticorpos anti-cisticercos IgG (total e subclasses e IgE em amostras de l\u00edquido cefalorraquidiano (LCR de pacientes com neurocisticercose apresentando produ\u00e7\u00e3o intratecal de anticorpos espec\u00edficos IgG e pacientes com outras desordens neurol\u00f3gicas. Os seguintes resultados foram obtidos: ELISA-IgG: 100% de sensibilidade (mediana das absorb\u00e2ncias das rea\u00e7\u00f5es ELISA (MAE=1,17 e especificidade 100%; ELISA-IgG1: sensibilidade 72,7% (MAE=0,49 e especificidade 100%; ELISA-IgG2\n[Elevated plasma surfactant protein D (SP-D) levels and a direct correlation with anti-severe acute respiratory syndrome coronavirus-specific IgG antibody in SARS patients](http://www.forskningsdatabasen.dk/en/catalog/19729781) [DEFF Research Database (Denmark)](http://forskningsbasen.deff.dk/?lang=eng)\nWu, Y P; Liu, Z H; Wei, R\n2009-01-01\nPulmonary SP-D is a defence lectin promoting clearance of viral infections. SP-D is recognized to bind the S protein of SARS-CoV and enhance phagocytosis. Moreover, systemic SP-D is widely used as a biomarker of alveolar integrity. We investigated the relation between plasma SP-D, SARS-type pneum......Pulmonary SP-D is a defence lectin promoting clearance of viral infections. SP-D is recognized to bind the S protein of SARS-CoV and enhance phagocytosis. Moreover, systemic SP-D is widely used as a biomarker of alveolar integrity. We investigated the relation between plasma SP-D, SARS......-type pneumonia and the SARS-specific IgG response. Sixteen patients with SARS, 19 patients with community-acquired pneumonia (CAP) (Streptococcus pneumonia) and 16 healthy control subjects were enrolled in the study. Plasma SP-D and anti-SARS-CoV N protein IgG were measured using ELISA. SP-D was significantly...... elevated in SARS-type pneumonia [median (95% CI), 453 (379-963) ng/ml versus controls 218 (160-362) ng/ml, P protein IgG (r(2) = 0.5995, P = 0.02). The possible re-emergence of SARS or SARS-like infections suggests a need...\n[Combined roles of human IgG subclass, alternative complement pathway activation, and epitope density in the bactericidal activity of antibodies to meningococcal factor h binding protein.](https://www.ncbi.nlm.nih.gov/pubmed/22064712)\nGiuntini, Serena; Reason, Donald C; Granoff, Dan M\n2012-01-01\nMeningococcal vaccines containing factor H binding protein (fHbp) are in clinical development. fHbp binds human fH, which enables the meningococcus to resist complement-mediated bacteriolysis. Previously, we found that chimeric human IgG1 mouse anti-fHbp monoclonal antibodies (MAbs) had human complement-mediated bactericidal activity only if the MAb inhibited fH binding. Since IgG subclasses differ in their ability to activate complement, we investigated the role of human IgG subclasses on antibody functional activity. We constructed chimeric MAbs in which three different murine fHbp-specific binding domains were each paired with human IgG1, IgG2, or IgG3. Against a wild-type group B isolate, all three IgG3 MAbs, irrespective of their ability to inhibit fH binding, had bactericidal activity that was >5-fold higher than the respective IgG1 MAbs, while the IgG2 MAbs had the least activity. Against a mutant with increased fHbp expression, the anti-fHbp MAbs elicited greater C4b deposition (classical pathway) and greater bactericidal activity than against the wild-type strain, and the IgG1 MAbs had similar or greater activity than the respective IgG3 MAbs. The bactericidal activity against both wild-type and mutant strains also was dependent, in part, on activation of the alternative complement pathway. Thus, at lower epitope density in the wild-type strain, the IgG3 anti-fHbp MAbs had the greatest bactericidal activity. At a higher epitope density in the mutant, the IgG1 MAbs had similar or greater bactericidal activity than the IgG3 MAbs, and the activity was less dependent on the inhibition of fH binding than at a lower epitope density.\n[A Secondary Antibody-Detecting Molecular Weight Marker with Mouse and Rabbit IgG Fc Linear Epitopes for Western Blot Analysis.](https://www.ncbi.nlm.nih.gov/pubmed/27494183)\nLin, Wen-Wei; Chen, I-Ju; Cheng, Ta-Chun; Tung, Yi-Ching; Chu, Pei-Yu; Chuang, Chih-Hung; Hsieh, Yuan-Chin; Huang, Chien-Chiao; Wang, Yeng-Tseng; Kao, Chien-Han; Roffler, Steve R; Cheng, Tian-Lu\n2016-01-01\nMolecular weight markers that can tolerate denaturing conditions and be auto-detected by secondary antibodies offer great efficacy and convenience for Western Blotting. Here, we describe M&R LE protein markers which contain linear epitopes derived from the heavy chain constant regions of mouse and rabbit immunoglobulin G (IgG Fc LE). These markers can be directly recognized and stained by a wide range of anti-mouse and anti-rabbit secondary antibodies. We selected three mouse (M1, M2 and M3) linear IgG1 and three rabbit (R1, R2 and R3) linear IgG heavy chain epitope candidates based on their respective crystal structures. Western blot analysis indicated that M2 and R2 linear epitopes are effectively recognized by anti-mouse and anti-rabbit secondary antibodies, respectively. We fused the M2 and R2 epitopes (M&R LE) and incorporated the polypeptide in a range of 15-120 kDa auto-detecting markers (M&R LE protein marker). The M&R LE protein marker can be auto-detected by anti-mouse and anti-rabbit IgG secondary antibodies in standard immunoblots. Linear regression analysis of the M&R LE protein marker plotted as gel mobility versus the log of the marker molecular weights revealed good linearity with a correlation coefficient R2 value of 0.9965, indicating that the M&R LE protein marker displays high accuracy for determining protein molecular weights. This accurate, regular and auto-detected M&R LE protein marker may provide a simple, efficient and economical tool for protein analysis.\n[Prevalencia de hepatitis viral A y B y factores de riesgo asociados a su infecci\u00f3n en la poblaci\u00f3n escolar de un distrito de Hu\u00e1nuco - Per\u00fa](http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1726-46342002000100002&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nC Heriberto Hidalgo\n2002-01-01\nFull Text Available Objetivo: Determinar la prevalencia de marcadores serol\u00f3gicos para la infecci\u00f3n por el virus de la hepatitis A y B en la poblaci\u00f3n escolar del distrito de Hu\u00e1nuco e identificar los factores asociados a dichas infecciones. Materiales y m\u00e9todos: en este estudio transversal anal\u00edtico se seleccion\u00f3 una muestra aleatoria y estratificada de 270 del total de escolares registrados en los diferentes centros educativos del distrito de Hu\u00e1nuco, Departamento de Hu\u00e1nuco-Per\u00fa, de abril a diciembre del 2000, en quienes se evalu\u00f3 la presencia de HBsAg y anticuerpos anti-HAV, anticuerpos totales, anticuerpos IgM anti-HBcAg, anti-HDV y ant\u00edgeno \"e\" en sangre (Estos \u00faltimos tres s\u00f3lo a los HBsAg reactivos. La presencia de factores de riesgo para la infecci\u00f3n por estos dos virus fue evaluada por una encuesta epidemiol\u00f3gica. Resultados: 257 (95,2% escolares tuvieron Anticuerpos anti-HAV, 8 (3,0% resultaron ser portadores de HBsAg, 62 (23,0% tuvieron anticuerpos anti- HBcAg y ninguno de los 8 portadores de HBsAg tuvieron anticuerpos anti-HDV, anticuerpos IgM anti-HBcAg, ni ant\u00edgeno \"e\" (HBeAg. La edad mayor a 11 a\u00f1os estuvo asociada a la presencia de anti-HAV (OR=14,3, p<0,001. El tener vivienda de adobe estuvo asociado a la reactividad al HBsAg (OR=5,1, p=0,045 y el tener relaciones sexuales estuvo asociado a la presencia de anticuerpos anti-HBcAg (OR=6,49, p=0,003. Conclusiones: el distrito de Hu\u00e1nuco tiene una alta endemicidad para HAV y endemicidad intermedia para el HBV. La edad mayor de 11 a\u00f1os estuvo asociada a una mayor infecci\u00f3n por HAV y el tener vivienda precaria y relaciones sexuales a una mayor infecci\u00f3n por HBV.\n[Anti-proteinase 3 anti-neutrophil cytoplasm autoantibodies recapitulate systemic vasculitis in mice with a humanized immune system.](http://europepmc.org/articles/PMC3256135?pdf=render) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMark A Little\nFull Text Available Evidence is lacking for direct pathogenicity of human anti-proteinase-3 (PR3 antibodies in development of systemic vasculitis and granulomatosis with polyangiitis (GPA, Wegener's granulomatosis. Progress in study of these antibodies in rodents has been hampered by lack of PR3 expression on murine neutrophils, and by different Fc-receptor affinities for IgG across species. Therefore, we tested whether human anti-PR3 antibodies can induce acute vasculitis in mice with a human immune system. Chimeric mice were generated by injecting human haematopoietic stem cells into irradiated NOD-scid-IL2R\u03b3\u207b/\u207b mice. Matched chimera mice were treated with human IgG from patients with: anti-PR3 positive renal and lung vasculitis; patients with non-vasculitic renal disease; or healthy controls. Six-days later, 39% of anti-PR3 treated mice had haematuria, compared with none of controls. There was punctate bleeding on the surface of lungs of anti-PR3 treated animals, with histological evidence of vasculitis and haemorrhage. Anti-PR3 treated mice had mild pauci-immune proliferative glomerulonephritis, with infiltration of human and mouse leukocytes. In 3 mice (17% more severe glomerular injury was present. There were no glomerular changes in controls. Human IgG from patients with anti-PR3 autoantibodies is therefore pathogenic. This model of anti-PR3 antibody-mediated vasculitis may be useful in dissecting mechanisms of microvascular injury.\n[Anti-proteinase 3 anti-neutrophil cytoplasm autoantibodies recapitulate systemic vasculitis in mice with a humanized immune system.](http://www.lenus.ie/hse/handle/10147/237978) [LENUS (Irish Health Repository)](http://www.lenus.ie/hse/)\nLittle, Mark A\n2012-01-01\nEvidence is lacking for direct pathogenicity of human anti-proteinase-3 (PR3) antibodies in development of systemic vasculitis and granulomatosis with polyangiitis (GPA, Wegener\\\\'s granulomatosis). Progress in study of these antibodies in rodents has been hampered by lack of PR3 expression on murine neutrophils, and by different Fc-receptor affinities for IgG across species. Therefore, we tested whether human anti-PR3 antibodies can induce acute vasculitis in mice with a human immune system. Chimeric mice were generated by injecting human haematopoietic stem cells into irradiated NOD-scid-IL2R\u03b3\u207b\\\\/\u207b mice. Matched chimera mice were treated with human IgG from patients with: anti-PR3 positive renal and lung vasculitis; patients with non-vasculitic renal disease; or healthy controls. Six-days later, 39% of anti-PR3 treated mice had haematuria, compared with none of controls. There was punctate bleeding on the surface of lungs of anti-PR3 treated animals, with histological evidence of vasculitis and haemorrhage. Anti-PR3 treated mice had mild pauci-immune proliferative glomerulonephritis, with infiltration of human and mouse leukocytes. In 3 mice (17%) more severe glomerular injury was present. There were no glomerular changes in controls. Human IgG from patients with anti-PR3 autoantibodies is therefore pathogenic. This model of anti-PR3 antibody-mediated vasculitis may be useful in dissecting mechanisms of microvascular injury.\n[Primary cytomegalovirus infection in pregnant Egyptian women confirmed by cytomegalovirus IgG avidity testing.](https://www.ncbi.nlm.nih.gov/pubmed/24052007)\nKamel, N; Metwally, L; Gomaa, N; Sayed Ahmed, W A; Lotfi, M; Younis, S\n2014-01-01\nTo determine the frequency of primary cytomegalovirus (CMV) infection in pregnant Egyptian women using CMV IgG avidity testing. A cross-sectional study was conducted at Suez Canal University Hospital, Ismailia, Egypt. A total of 546 pregnant women, presenting for routine antenatal screening, were tested for CMV IgG and IgM using a commercially available enzyme-linked immunosorbent assay (ELISA). Sera from CMV IgM-positive women were tested by CMV IgG avidity assay. All the 546 pregnant women were seropositive for anti-CMV IgG. Of the 546 women, 40 (7.3%) were positive or equivocal for IgM antibodies. All sera from the 40 women (IgG+/IgM+) showed a high or intermediate CMV IgG avidity index. Of the 40 women, 23 (57.5%) were in the second or third trimesters of pregnancy and had their first-trimester blood retrieved, and the tested CMV IgG avidity assay showed a high avidity index. Women who were IgM positive had no primary CMV infection in the index pregnancy as evidenced by the high CMV IgG avidity testing. \u00a9 2013 S. Karger AG, Basel.\n[Anti-coagulation effect of Fc fragment against anti-\u03b22-GP1 antibodies in mouse models with APS.](https://www.ncbi.nlm.nih.gov/pubmed/21078423)\nXie, Weidong; Zhang, Yaou; Bu, Cunya; Sun, Shijing; Hu, Shaoliang; Cai, Guoping\n2011-01-01\nAnti-beta (2)-glycoprotein I (anti-\u03b22-GP1) is one of the important pathogenesis factors responsible for thrombosis formation in patients with antiphospholipid syndrome (APS). Administration of intravenous immunoglobulin (IVIg) is a common method used to inhibit the abnormal antibody levels and decrease the mortality of APS in emergency situations. We hypothesize that the Fc fragment of IgG is the molecular structure responsible for these effects. The present study investigates the beneficial effects of both recombinant and natural human Fc fragments of heterogeneous IgG against human anti-\u03b22-GP1 antibodies in mouse models with APS. Results showed that both recombinant and natural human Fc fragments moderately but significantly decreased the levels of serum anti-\u03b22-GP1 antibodies and had anti-coagulation effects in human \u03b22-GP1-immunized mice. Furthermore, both recombinant and natural human Fc fragments inhibited thrombosis formation and decreased mortality in mouse models infused intravenously with human anti-\u03b22GP1 antibodies from patients with APS. Findings suggest that the Fc fragment might be one of the active structural units of heterogeneous IgG. Thus, recombinant human Fc fragment administration may be a useful treatment for individuals with APS. Copyright \u00c2\u00a9 2010 Elsevier B.V. All rights reserved.\n[Papel de los anticuerpos beta2-glicoprote\u00edna I circulantes en pacientes con enfermedad arterial perif\u00e9rica en la modulaci\u00f3n de un genotipo endotelial pro-aterog\u00e9nico](https://www.openaire.eu/search/publication?articleId=dedup_wf_001::b07c5dbd73c0494ecf79b52780895500)\nVarela Casariego, C\u00e9sar\n2015-01-01\nTesis in\u00e9dita presentada en la Universidad Europea de Madrid. Facultad de Ciencias Biom\u00e9dicas. Programa de Doctorado en Biomedicina y Ciencias de la Salud La enfermedad arterial perif\u00e9rica (EAP) es una enfermedad arterial inflamatoria cr\u00f3nica que se inicia con la p\u00e9rdida de las funciones homeost\u00e1ticas del endotelio. Esta disfunci\u00f3n endotelial se ha asociado con una disminuci\u00f3n de la bioactividad del \u00f3xido n\u00edtrico (NO). En este contexto, los anticuerpos anti-beta2-glicoprote\u00edna I (ABGPI) se...\n[Biotin-avidin sandwich elisa with specific human isotypes IgG1 and IgG4 for Culicidae mosquito blood meal identification from an epizootic yellow fever area in Brazil](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1678-91992009000400008) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAM Marass\u00e1\n2009-01-01\nFull Text Available With a view toward investigating the feeding behavior of Culicidae mosquitoes from an area of epizootic yellow fever transmission in the municipalities of Garruchos and Santo Ant\u00f4nio das Miss\u00f5es, Rio Grande do Sul State, Brazil, specimens were collected by aspiration from September 2005 to April 2007. The engorged females were submitted to blood meal identification by enzyme-linked immunosorbent assay (ELISA. A total of 142 blood-engorged samples were examined for human or monkey blood through species-specific IgG. Additional tests for specificity utilizing isotypes IgG1 and IgG4 of human monoclonal antibodies showed that only anti-human IgG1 was effective in recognizing blood meals of human origin. The results indicated a significant difference (p = 0.027 in detection patterns in samples of Haemagogus leucocelaenus recorded from human blood meals at Santo Ant\u00f4nio das Miss\u00f5es, which suggests some degree of exposure, since it was an area where epizootic outbreaks have been reported.\n[A novel antibody engineering strategy for making monovalent bispecific heterodimeric IgG antibodies by electrostatic steering mechanism.](https://www.ncbi.nlm.nih.gov/pubmed/25583986)\nLiu, Zhi; Leng, Esther C; Gunasekaran, Kannan; Pentony, Martin; Shen, Min; Howard, Monique; Stoops, Janelle; Manchulenko, Kathy; Razinkov, Vladimir; Liu, Hua; Fanslow, William; Hu, Zhonghua; Sun, Nancy; Hasegawa, Haruki; Clark, Rutilio; Foltz, Ian N; Yan, Wei\n2015-03-20\nProducing pure and well behaved bispecific antibodies (bsAbs) on a large scale for preclinical and clinical testing is a challenging task. Here, we describe a new strategy for making monovalent bispecific heterodimeric IgG antibodies in mammalian cells. We applied an electrostatic steering mechanism to engineer antibody light chain-heavy chain (LC-HC) interface residues in such a way that each LC strongly favors its cognate HC when two different HCs and two different LCs are co-expressed in the same cell to assemble a functional bispecific antibody. We produced heterodimeric IgGs from transiently and stably transfected mammalian cells. The engineered heterodimeric IgG molecules maintain the overall IgG structure with correct LC-HC pairings, bind to two different antigens with comparable affinity when compared with their parental antibodies, and retain the functionality of parental antibodies in biological assays. In addition, the bispecific heterodimeric IgG derived from anti-HER2 and anti-EGF receptor (EGFR) antibody was shown to induce a higher level of receptor internalization than the combination of two parental antibodies. Mouse xenograft BxPC-3, Panc-1, and Calu-3 human tumor models showed that the heterodimeric IgGs strongly inhibited tumor growth. The described approach can be used to generate tools from two pre-existent antibodies and explore the potential of bispecific antibodies. The asymmetrically engineered Fc variants for antibody-dependent cellular cytotoxicity enhancement could be embedded in monovalent bispecific heterodimeric IgG to make best-in-class therapeutic antibodies. \u00a9 2015 by The American Society for Biochemistry and Molecular Biology, Inc.\n[Isolation and purification of rabbit imunoglobulin (IgG) for the production of a second antibody for radioimunoassay](http://www.iaea.org/inis/collection/NCLCollectionStore/_Public/21/079/21079400.pdf?r=1) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nSilva, S.R. da; Borghi, V.C.\n1990-03-01\nImmunoglobulin (IgG) from rabbit serum was isolated and purified by sodium sulphate precipitation followed by ion exchange chromatography on DEAE-cellulose. The efficiency of the procedure was followed by total protein determination during all purification steps. The purity of the final product was verified through immunoelectroforesis of IgG with sheep serum anti-rabbit whole serum. Were obtained 850 mg of pure IgG, enough for the immunization of several sheeps to be used in the production of a second antibody for radioimmunoassay. (author) [pt\n[Granulocyte-associated IgG in neutropenic disorders](https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=14750542) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nCines, D.B.; Passero, F.; Guerry, D.; Bina, M.; Dusak, B.; Schreiber, A.D.\n1982-01-01\nWe applied a radiolabeled antiglobulin test to a study of patients with a variety of neutropenic disorders. After defining the nature of the interaction of radiolabeled anti-IgG with the neutrophil, we studied 16 patients with neutropenia of uncertain etiology and adequate bone marrow granulocyte precursors. Twelve of these 16 patients had increased neutrophil-associated IgG (PMN-IgG). Patients with the highest levels of PMN-IgG had the lowest neutrophil counts. The majority of patients with neutropenia and increased PMN-IgG had an underlying immunologic disorder that included immune thrombocytopenic purpura in 5 patients and autoimmune hemolytic anemia in 1 patient. In some patients, elevated PMN-IgG preceded other evidence for immunologic disease. The direct antiglobulin test helped to distinguish neutropenic patients with increased PMN-IgG both from patients with neutropenia due to a known nonimmune disorder and from nonneutropenic patients with rheumatoid arthritis or systemic lupus erythematosis. Each of four patients with increased neutrophil-associated IgG treated with systemic corticosteroids responded clinically with an associated fall in neutrophil IgG and a rise in the circulating neutrophil count. The radiolabeled antiglobulin test appears useful in defining a subpopulation of patients with neutropenia due to an underlying immunologic disorder\n[Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nYoh Zen\n2012-01-01\nFull Text Available IgG4 cholangiopathy can involve any level of the biliary tree which exhibits sclerosing cholangitis or pseudotumorous hilar lesions. Most cases are associated with autoimmune pancreatitis, an important diagnostic clue. Without autoimmune pancreatitis, however, the diagnosis of IgG4-cholangiopathy is challenging. Indeed such cases have been treated surgically. IgG4-cholangiopathy should be diagnosed based on serological examinations including serum IgG4 concentrations, radiological features, and histological evidence of IgG4+ plasma cell infiltration. Steroid therapy is very effective even at disease relapse. A Th2-dominant immune response or the activation of regulatory T cells seems to be involved in the underlying immune reaction. It is still unknown why IgG4 levels are specifically elevated in patients with this disease. IgG4 might be secondarily overexpressed by Th2 or regulatory cytokines given the lack of evidence that IgG4 is an autoantibody.\n[Prohibitin Is Involved in Patients with IgG4 Related Disease.](http://europepmc.org/articles/PMC4416882?pdf=render) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nHongwu Du\nFull Text Available IgG4-related disease (IgG4-RD is a chronic systemic disease involved in many organs and tissues. As only limited autoantigens have been found since the beginning of this century, the aim of this study was to reveal new candidate autoantigens of IgG4-RD.Multiple cell lines including HT-29, EA.hy926, HEK 293 and HepG2 were used to test the binding ability of circulating autoantibodies from IgG4-RD sera. The amino-acid sequence was then analyzed by matrix-assisted laser desorption/ionization time-of-flight tandem (MALDI-TOF/TOF mass spectrometry. After the cloning and expression of recombinant putative autoantigen in a bacterial expression system, the corresponding immuno assay was set up and utilized to observe the prevalence of serum autoantibodies in a large set of confirmed clinical samples.One positive autoantigen was identified as prohibitin. ELISA analysis showed that a majority of patients with IgG4-RD have antibodies against prohibitin. Anti-prohibitin antibodies were present in the sera of patients with definite autoimmune pancreatitis (25/34; 73.5%, Mikulicz's disease (8/15; 53.3%, retroperitoneal fibrosis (6/11; 54.5%, other probable IgG4-RD (26/29; 89.7% and Sj\u00f6gren's syndrome (4/30; 13.3% but not in apparently healthy donors (1/70; 1.4%.An association between prohibitin and patients with some IgG4-RD was observed, although the results were quite heterogeneous among different individuals within autoimmune pancreatitis, Mikulicz's disease and retroperitoneal fibrosis.\n[Serum IgG antibody levels to periodontal microbiota are associated with incident Alzheimer disease.](https://www.ncbi.nlm.nih.gov/pubmed/25522313)\nNoble, James M; Scarmeas, Nikolaos; Celenti, Romanita S; Elkind, Mitchell S V; Wright, Clinton B; Schupf, Nicole; Papapanou, Panos N\n2014-01-01\nPeriodontitis and Alzheimer disease (AD) are associated with systemic inflammation. This research studied serum IgG to periodontal microbiota as possible predictors of incident AD. Using a case-cohort study design, 219 subjects (110 incident AD cases and 109 controls without incident cognitive impairment at last follow-up), matched on race-ethnicity, were drawn from the Washington Heights-Inwood Columbia Aging Project (WHICAP), a cohort of longitudinally followed northern Manhattan residents aged >65 years. Mean follow-up was five years (SD 2.6). In baseline sera, serum IgG levels were determined for bacteria known to be positively or negatively associated with periodontitis (Porphyromonas gingivalis, Tannerella forsythia, Actinobacillus actinomycetemcomitans Y4, Treponema denticola, Campylobacter rectus, Eubacterium nodatum, and Actinomyces naeslundii genospecies-2). In all analyses, we used antibody threshold levels shown to correlate with presence of moderate-severe periodontitis. Mean age was 72 years (SD 6.9) for controls, and 79 years (SD 4.6) for cases (pthe sample. In a model adjusting for baseline age, sex, education, diabetes mellitus, hypertension, smoking, prior history of stroke, and apolipoprotein E genotype, high anti-A. naeslundii titer (>640 ng/ml, present in 10% of subjects) was associated with increased risk of AD (HR = 2.0, 95%CI: 1.1-3.8). This association was stronger after adjusting for other significant titers (HR = 3.1, 95%CI: 1.5-6.4). In this model, high anti-E. nodatum IgG (>1755 ng/ml; 19% of subjects) was associated with lower risk of AD (HR = 0.5, 95%CI: 0.2-0.9). Serum IgG levels to common periodontal microbiota are associated with risk for developing incident AD.\n[Papel de los anticuerpos en la protecci\u00f3n contra micobacterium tuberculosis](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2006000300004&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nNesty Olivares\n2006-12-01\nFull Text Available Convencionalmente se asume que la defensa del hospedero contra Mycobacterium tuberculosis se basa en los mecanismos de inmunidad celular exclusivamente y se descarta el papel de los anticuerpos en la protecci\u00f3n. En este trabajo se analizan evidencias recientes que retan este dogma y sugieren la importancia de considerar la manipulaci\u00f3n de la respuesta inmune humoral como una alternativa en la investigaci\u00f3n de vacunas contra la tuberculosis.\n[Hemolytic disease of the fetus and newborn caused by anti-E](https://www.openaire.eu/search/publication?articleId=dedup_wf_001::71df4eb03637b7a393f035af520d2ce6)\nUsman, Adiyyatu Sa?idu; Mustaffa, Rapiaah; Ramli, Noraida; Diggi, Sirajo A.\n2013-01-01\nObjective: Maternal allo-antibody production is stimulated when fetal red blood cells are positive for an antigen absent on the mother\u2032s red cells. The maternal IgG antibodies produced will pass through the placenta and attack fetal red cells carrying the corresponding antigen. Allo-immune hemolytic disease of the fetus and newborn caused by anti-E rarely occurs. Case summary: We report two cases of anti-E hemolytic diseases in neonates. One of the neonates had severe hemolysis presenting wit...\n[Immunoradiometric assay for cytomegalovirus-specific IgG antibodies; Assay development and evaluation in blood transfusion practice](http://www.etde.org/etdeweb/details.jsp?query_id=1&page=0&osti_id=6444152) [Energy Technology Data Exchange (ETDEWEB)](https://www.etde.org/etdeweb/fieldedsearch.jsp)\nKlapper, P.E.; Cleator, G.M.; Prinja-Wolks, D.; Morris, D.J. (Medical School, Manchester (United Kingdom). Department of Medical microbiology, Virology Unit); Morell, G. (Regional Blood Transfusion Centre, manchester (United Kingdom))\n1990-03-01\nAn immunoradiometric assay (radio-immunosorbent test; RIST) for the detection of IgG antibodies to human herpesvirus 4 (human cytomegalovirus (CMV)) has been developed. The technique utilizes CMV antigen passively adsorbed to a polyvinyl microtitration plate and a radiolabelled murine monoclonal anti-human IgG antibody to detect binding of human antibody to the 'solid phase' reagent. The assay was optimized, and its specifity confirmed by testing paired acute and convalescent sera from patients with acute CMV or other human herpesvirus infections. To determine the assay's sensitivity 1433 blood donor sera were examined. The RIST was more sensitive than a standard complement fixation (CFT). Use of a monoclonal anti-human IgG antibody in the RIST reduced non-specific binding to the control uninfected cell antigen such that blood donor sera could be tested in the assay using only a CMV antigen without generating an unacceptable false positive rate. (author). 23 refs.; 1 tab.\n[Quantification of anti-Leishmania antibodies in saliva of dogs.](https://www.ncbi.nlm.nih.gov/pubmed/28606325)\nCantos-Barreda, Ana; Escribano, Dami\u00e1n; Bernal, Luis J; Cer\u00f3n, Jos\u00e9 J; Mart\u00ednez-Subiela, Silvia\n2017-08-15\nDetection of serum anti-Leishmania antibodies by quantitative or qualitative techniques has been the most used method to diagnose Canine Leishmaniosis (CanL). Nevertheless, saliva may represent an alternative to blood because it is easy to collect, painless and non-invasive in comparison with serum. In this study, two time-resolved immunofluorometric assays (TR-IFMAs) for quantification of anti-Leishmania IgG2 and IgA antibodies in saliva were developed and validated and their ability to distinguish Leishmania-seronegative from seropositive dogs was evaluated. The analytical study was performed by evaluation of assay precision, sensitivity and accuracy. In addition, serum from 48 dogs (21 Leishmania-seropositive and 27 Leishmania-seronegative) were analyzed by TR-IFMAs. The assays were precise, with an intra- and inter-assay coefficients of variation lower than 11%, and showed high level of accuracy, as determined by linearity under dilution (R 2 =0.99) and recovery tests (>88.60%). Anti-Leishmania IgG2 antibodies in saliva were significantly higher in the seropositive group compared with the seronegative (pLeishmania IgA antibodies between both groups were observed. Furthermore, TR-IFMA for quantification of anti-Leishmania IgG2 antibodies in saliva showed higher differences between seropositive and seronegative dogs than the commercial assay used in serum. In conclusion, TR-IFMAs developed may be used to quantify anti-Leishmania IgG2 and IgA antibodies in canine saliva with an adequate precision, analytical sensitivity and accuracy. Quantification of anti-Leishmania IgG2 antibodies in saliva could be potentially used to evaluate the humoral response in CanL. However, IgA in saliva seemed not to have diagnostic value for this disease. For future studies, it would be desirable to evaluate the ability of the IgG2 assay to detect dogs with subclinical disease or with low antibody titers in serum and also to study the antibodies behaviour in saliva during the\n[Preparation of goat and rabbit anti-camel immunoglobulin G whole molecule labeled with horseradish peroxidase](http://www.veterinaryworld.org/Vol.10/January-2017/15.pdf) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nEman Hussein Abdel-Rahman\n2017-01-01\nFull Text Available Aim: As the labeled anti-camel immunoglobulins (Igs with enzymes for enzyme-linked immunosorbent assay (ELISA are unavailable in the Egyptian market, the present investigation was directed for developing local labeled anti-camel IgG with horseradish peroxidase (HRP to save hard curacy. Materials and Methods: For purification of camel IgG whole molecule, camel sera was preliminary precipitated with 50% saturated ammonium sulfate and dialyzed against 15 mM phosphate-buffered saline pH 7.2 then concentrated. This preparation was further purified by protein A sepharose affinity column chromatography. The purity of the eluted camel IgG was tested by sodium dodecyl sulfate polyacrylamide gel electrophoresi. Anti-camel IgG was prepared by immunization of goats and rabbits separately, with purified camel IgG. The anti-camel IgG was purified by protein A sepharose affinity column chromatography. Whole molecule anti-camel IgG was conjugated with HRP using glutraldehyde based assay. Sensitivity and specificity of prepared conjugated secondary antibodies were detected using positive and negative camel serum samples reacted with different antigens in ELISA, respectively. The potency of prepared conjugated antibodies was evaluated compared with protein A HRP. The stability of the conjugate at \u221220\u00b0C during 1 year was assessed by ELISA. Results: The electrophoretic profile of camel IgG showed four bands of molecular weight 63, 52, 40 and 33 kDa. The recorded sensitivity and specificity of the product are 100%. Its potency is also 100% compared to 58-75% of commercial protein A HRP. The conjugates are stable for 1 year at \u221220\u00b0C as proved by ELISA. Conclusion: Collectively, this study introduces goat and rabbit anti-camel IgG whole molecules with simple, inexpensive method, with 100% sensitivity, 100% specificity and stability up to 1 year at \u221220\u00b0C. The important facet of the current study is saving hard curacy. Future investigations are necessary for\n[A methodological approach for production and purification of polyclonal antibody against dog IgG.](https://www.ncbi.nlm.nih.gov/pubmed/29719659)\nSadeghi, Somayeh; Aghebati-Maleki, Leili; Nozari, Samira; Majidi, Jafar\n2018-01-01\nAntibodies are a class of biomolecules that has an important role in the immune system and lots of applications in biotechnological methods and in pharmaceutics. Production and purification of antibodies in laboratory animals is one of the first ways to manufacture of these prominent tools. The obtained antibodies from these process could be used in various types of bioassay techniques such as enzyme linked immunosorbent assay (ELISA), radioimmunoassay, etc. Also, antibodies employed in diagnostics applications in humans and other animals in order to detect specific antigens. In this study, we aimed to produce and purify anti-dog IgG via immunizing rabbits with dog IgG in combination with Freund's adjuvant. Polyclonal IgG were purified by ion exchange chromatography and then the purified antibody was labeled with horse radish peroxidase (HPR). Direct ELISA was used to determine the optimum titer and cross-reactivity of HRP conjugated IgG. The purity of various IgG preparations and the optimum dilution of prepared HRP conjugated IgG, respectively, was about 95.00% and 1:8000. This study showed that efficiency ion-exchange chromatography could be an appropriate method for purification of IgG antibodies. This antibody could be a useful tool for future dog immune diagnosis tests. This product characterization shown here sets the foundations for future work on dog IgGs.\n[Anti-neuronal anti-bodies in patients with early psychosis.](https://www.ncbi.nlm.nih.gov/pubmed/28461116)\nMantere, O; Saarela, M; Kiesepp\u00e4, T; Raij, T; M\u00e4ntyl\u00e4, T; Lindgren, M; Rikandi, E; Stoecker, W; Teegen, B; Suvisaari, J\n2018-02-01\nIt may be challenging to distinguish autoimmune encephalitis associated with anti-neuronal autoantibodies from primary psychiatric disorders. Here, serum was drawn from patients with a first-episode psychosis (n=70) or a clinical high-risk for psychosis (n=6) and controls (n=34). We investigated the serum prevalence of 24 anti-neuronal autoantibodies: IgG antibodies for anti-N-methyl-d-aspartate-type glutamate receptor (anti-NMDAR), glutamate and \u03b3-aminobutyric acid alpha and beta receptors (GABA-a, GABA-b), alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPA), glycine receptor (GlyR), metabotropic glutamate receptor 1 and 5 (mGluR1, mGluR5), anti-Tr/Delta/notch-like epidermal growth factor-related receptor (DNER), contactin-associated protein-like 2 (CASPR2), myelin oligodendrocyte glycoprotein (MOG), glutamic acid decarboxylase-65 (GAD65), collapsin response mediator protein 5/crossveinless-2 (CV2), aquaporin-4 (AQP4), anti-dipeptidyl-peptidase-like protein-6 (DPPX), type 1 anti-neuronal nuclear antibody (ANNA-1, Hu), Ri, Yo, IgLON5, Ma2, zinc finger protein 4 (ZIC4), Rho GTPase-activating protein 26, amphiphysin, and recoverin, as well as IgA and IgM for dopamine-2-receptor (DRD2). Anti-NMDA IgG antibodies were positive with serum titer 1:320 in one patient with a clinical high risk for psychosis. He did not receive a diagnosis of encephalitis after comprehensive neurological evaluation. All other antineuronal autoantibodies were negative and there were no additional findings with immunohistochemistry of brain issues. Copyright \u00a9 2017 Elsevier B.V. All rights reserved.\n[IgG4-related prostatitis progressed from localized IgG4-related lymphadenopathy.](https://www.ncbi.nlm.nih.gov/pubmed/26617921)\nLi, Dujuan; Kan, Yunzhen; Fu, Fangfang; Wang, Shuhuan; Shi, Ligang; Liu, Jie; Kong, Lingfei\n2015-01-01\nImmunoglobulin G4-related disease (IgG4-RD) is a recently described inflammatory disease involving multiple organs. Prostate involvement with IgG4-RD is very rare. In this report, we describe a case of IgG4-related prostatitis progressed from localized IgG4-related lymphadenopathy. This patient was present with urine retention symptoms. MRI and CT examination revealed the prostatic enlargement and the multiple lymphadenopathy. Serum IgG4 levels were elevated. Prostatic tissue samples resected both this time and less than 1 year earlier showed the same histological type of prostatitis with histopathologic and immunohistochemical findings characteristic of IgG4-RD. The right submandibular lymph nodes excised 2 years earlier were eventually proven to be follicular hyperplasia-type IgG4-related lymphadenopathy. This is the first case of IgG4-RD that began as localized IgG4-related lymphadenopathy and progressed into a systemic disease involving prostate and multiple lymph nodes. This patient showed a good response to steroid therapy. This leads us to advocate a novel pathogenesis of prostatitis, and a novel therapeutic approach against prostatitis. Pathologists and urologists should consider this disease entity in the patients with elevated serum IgG4 levels and the symptoms of prostatic hyperplasia to avoid ineffective medical or unnecessary surgical treatment.\n[Toxoplasmose em gestantes de Araraquara/SP: an\u00e1lise da utiliza\u00e7\u00e3o do teste de avidez de IgG anti-Toxoplasma na rotina do pr\u00e9-natal = Toxoplasmosis in pregnant women from Araraquara/SP: analysis of Toxoplasma-specific IgG avidity test utilization in the prenatal care routine](http://revistaseletronicas.pucrs.br/ojs/index.php/scientiamedica/article/viewFile/1636/1899) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nIsabel, Thais F.\n2007-01-01\nConclus\u00f5es: O tratamento antiparasit\u00e1rio foi prescrito para algumas gestantes mesmo na presen\u00e7a de uma taxa de avidez de IgG anti-T. gondii alta no primeiro trimestre da gesta\u00e7\u00e3o, mostrando que o teste de avidez n\u00e3o foi corretamente interpretado e utilizado na pr\u00e1tica cl\u00ednica\n[Human IgG1 antibodies suppress angiogenesis in a target-independent manner](http://www.narcis.nl/publication/RecordID/oai%3Adspace.library.uu.nl%3A1874%2F341294/uquery/Omalizumab/id/16/Language/EN)\nBogdanovich, Sasha; Kim, Younghee; Mizutani, Takeshi; Yasuma, Reo; Tudisco, Laura; Cicatiello, Valeria; Bastos-Carvalho, Ana; Kerur, Nagaraj; Hirano, Yoshio; Baffi, Judit Z; Tarallo, Valeria; Li, Shengjian; Yasuma, Tetsuhiro; Arpitha, Parthasarathy; Fowler, Benjamin J; Wright, Charles B; Apicella, Ivana; Greco, Adelaide; Brunetti, Arturo; Ruvo, Menotti; Sandomenico, Annamaria; Nozaki, Miho; Ijima, Ryo; Kaneko, Hiroki; Ogura, Yuichiro; Terasaki, Hiroko; Ambati, Balamurali K; Leusen, Jeanette HW; Langdon, Wallace Y; Clark, Michael R; Armour, Kathryn L; Bruhns, Pierre; Verbeek, J Sjef; Gelfand, Bradley D; De Falco, Sandro; Ambati, Jayakrishna\n2016-01-01\nAberrant angiogenesis is implicated in diseases affecting nearly 10% of the world's population. The most widely used anti-angiogenic drug is bevacizumab, a humanized IgG1 monoclonal antibody that targets human VEGFA. Although bevacizumab does not recognize mouse Vegfa, it inhibits angiogenesis in\n[Detecci\u00f3n de anticuerpos anti-Brucella spp. en cerdos mediante t\u00e9cnicas de aglutinaci\u00f3n y ELISA indirecto en las provincias de Buenos Aires y La Pampa: Argentina Detection of anti-Brucella spp. antibodies in swine by agglutination techniques and indirect ELISA in the Buenos Aires and La Pampa provinces: Argentina](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0325-75412006000200007) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nH.A. Castro\n2006-04-01\nFull Text Available En nuestro pa\u00eds no existe un programa de control sobre brucelosis porcina y su verdadera situaci\u00f3n epidemiol\u00f3gica es desconocida. El objetivo de nuestro trabajo fue detectar la presencia de anticuerpos anti-Brucella spp. en porcinos provenientes de criaderos del sudoeste de la provincia de Buenos Aires y del este de la provincia de La Pampa. La toma de muestras de sangre se realiz\u00f3 en el momento del faenado de los animales. La detecci\u00f3n de anticuerpos se efectu\u00f3 mediante las t\u00e9cnicas de aglutinaci\u00f3n con ant\u00edgeno tamponado en placa (BPA, seroaglutinaci\u00f3n en tubo (SAT, aglutinaci\u00f3n con 2-ME (2-ME y ELISA indirecto, con dos ant\u00edgenos diferentes: el ant\u00edgeno CYT (fracci\u00f3n citoplasm\u00e1tica de B. abortus S19 y el ant\u00edgeno CP (extracto citoplasm\u00e1tico libre de lipopolisac\u00e1rido. Del total de las muestras analizadas (n=325, el 17,8% fue positivo para BPA, el 13,8% fue positivo para SAT y s\u00f3lo el 8,0% fue positivo para 2-ME. Mediante ELISA-CYT, este porcentaje se elev\u00f3 a 21,0%, mientras que a trav\u00e9s del ELISA-CP s\u00f3lo se hall\u00f3 un 10,0% de muestras reactivas. Estos resultados son compatibles con los informados en los escasos reportes previos para todo el pa\u00eds y sugieren la necesidad de extender los estudios a otras zonas, donde sea habitual la cr\u00eda de cerdos.Porcine brucellosis is one of the most important zoonoses in this country. Currently, there is no control program for porcine brucellosis in Argentina and the epidemiological situation is still unknown. The purpose of our study was to detect anti-Brucella spp. antibodies in swine in the southwest of the Buenos Aires province and the east of the La Pampa province. Blood samples were obtained when animals were slaughtered. The presence of anti-brucella antibodies was studied by the buffered plate agglutination test (BPA, the tube agglutination test (SAT, the 2-mercaptoethanol (2-ME agglutination test and indirect ELISA tests, using the cytosolic fraction from Brucella abortus S19\n[Necrotizing RPGN with linear anti IgG deposits in a patient with history of granulomatosis with polyangiitis: a case report](http://www.dovepress.com/necrotizing-rpgn-with-linear-anti-igg-deposits-in-a-patient-with-histo-peer-reviewed-article-IJNRD) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nParekh N\n2014-11-01\nFull Text Available Ninad Parekh, Edward Epstein, Suzanne El-Sayegh Department of Medicine, Division of Nephrology, Staten Island University Hospital, Staten Island, NY, USA Introduction: Diagnosing the etiology of a rapidly progressive glomerulonephritis is of vital importance to guide appropriate therapeutic management. This case highlights the complexity involved in establishing diagnosis when presentation is atypical. In certain cases diagnosis cannot be established based on clinical presentation or biopsy findings alone, and critical analysis of biopsy findings in context of clinical presentation is crucial to guide the clinical decision-making process.Case presentation: A 47-year-old Hispanic male with history of granulomatosis with polyangiitis (GPA in remission on azathioprine, presented with fatigue and lethargy. Physical examination was unremarkable. Laboratory data revealed elevated creatinine and otherwise normal electrolytes. Urinalysis showed numerous dysmorphic red blood cells with few red cell casts. His serologic results were all negative except anti-proteinase-3 antibody at very low titers. Kidney biopsy showed necrotizing crescentic glomerulonephritis with linear immunoglobulin G staining along the basement membrane.Conclusion: This case presented conflicting serologic and histopathologic findings. The presence of anti-proteinase-3 antibody supported diagnosis of recurrence of GPA. However, linear staining of immunoglobulin G (IgG on immunofluorescence (IF staining of renal biopsy supported anti-glomerular basement membrane (GBM disease. The treatment of anti-GBM disease and GPA both involve immunosuppression with prednisone and cyclophosphamide. However, patients with anti-GBM disease are also treated with plasmapheresis early in the disease presentation to prevent further damage. The patient with GPA, on the other hand, was shown to benefit from plasmapheresis only in the case of severe renal disease (serum creatinine level more than 5 mg/dL or\n[Measurement of anti-double-stranded DNA antibodies in major immunoglobulin classes](https://www.osti.gov/etdeweb/biblio/5733965) [Energy Technology Data Exchange (ETDEWEB)](https://www.etde.org/etdeweb/fieldedsearch.jsp)\nAotsuka, S; Okawa, M; Ikebe, K; Yokohari, R [Division of Clinical Immunology, Clinical Research Institute, National Medical Center Hospital, Shinjuku-ku, Tokyo, Japan\n1979-07-10\nA solid-phase radioimmunoassay for quantitating anti-double-stranded deoxyribonucleic acid antibodies (anti-dsDNA) in IgG, IgM and IgA classes has been devised. A distinct feature of the method is an application of polystyrene tubes coated with poly-L-lysine, through which dsDNA could be bound firmly to a solid phase. Studies on patients sera as well as normal sera revealed that anti-dsDNA was not qualitatively but quantitatively characteristic of systematic lupus erythematosus (SLE) and that IgG anti-dsDNA levels correlated well with the disease activity.\n[IgG4 related sclerosing mastitis: expanding the morphological spectrum of IgG4 related diseases.](https://www.ncbi.nlm.nih.gov/pubmed/25474510)\nChougule, Abhijit; Bal, Amanjit; Das, Ashim; Singh, Gurpreet\n2015-01-01\nIgG4 related disease (IgG4RD) is a recently recognised condition characterised by mass forming lesions associated with storiform fibrosis, obliterative phlebitis, lymphoplasmacytic infiltrate rich in IgG4 positive plasma cells and elevated serum IgG4 levels. Although rare, mammary involvement has been reported as IgG4 related sclerosing mastitis, the morphological counterpart of a growing family of IgG4 related diseases. A total of 17 cases belonging to mass forming benign inflammatory breast lesions such as plasma cell mastitis, granulomatous lobular mastitis, non-specific mastitis and inflammatory pseudotumour were investigated as a possible member of IgG4 related sclerosing mastitis. Clinical, radiological, histopathological and immunohistochemistry findings were noted in all cases. Cases diagnosed as inflammatory pseudotumour showed all the histopathological features of IgG4RD along with increased number of IgG4 positive plasma cells and IgG4/IgG ratio >40%. However, only a few IgG4 positive cells were seen in plasma cell mastitis, granulomatous lobular mastitis and non-specific mastitis cases. These cases also did not fulfill the morphological criteria for the diagnosis of IgG4 related diseases. IgG4RD should be excluded in plasma cell rich lesions diagnosed on core biopsies by IgG4 immunostaining. This can avoid unnecessary surgery as IgG4 related diseases respond to simple and effective steroid treatment.\n[New radioimmunoassay for IgM and IgG rheumatoid factors, based on a double antibody method](http://www.etde.org/etdeweb/details.jsp?query_id=1&page=0&osti_id=5503835) [Energy Technology Data Exchange (ETDEWEB)](https://www.etde.org/etdeweb/fieldedsearch.jsp)\nNordfang, O. (Rigshospitalet, Copenhagen (Denmark)); Hoeier-Madsen, M.; Lieberkind, J. (Statens Seruminstitut, Copenhagen (Denmark)); Halberg, P. (Medical Department, Division of Rheumatology, Hvidovre Hospital, Hvidovre, Denmark)\n1981-11-30\nA new radioimmunoassay has been developed for measuring IgM and IgG rheumatoid factors. Diluted sera from donors and patients were incubated with immunoprecipitates prepared from sheep serum and rabbit anti-sheep IgG antiserum. The precipitates were washed, and radioiodinated rabbit F(ab')/sub 2/ fragments specific for human IgM or IgG were added. The precipitates were isolated by filtration and measured in a gamma counter. With this assay IgM rheumatoid factors were detected in sera from all patients with seropositive rheumatoid arthritis and in sera from 40% of patients with seronegative rheumatoid arthritis. IgG rheumatoid factors were found in sera from 68% of the seropositive and 40% of the seronegative patients. Gel filtration experiments demonstrated that it is possible to detect monomeric IgG rheumatoid factors and IgM rheumatoid factors of molecular weight smaller than pentameric IgM. Furthermore it has been shown that IgG rheumatoid factor activity is still present after reduction of IgM rheumatoid factors with dithiotreitol.\n[Cetuximab in combination with anti-human IgG antibodies efficiently down-regulates the EGF receptor by macropinocytosis](http://dx.doi.org/10.1016/j.yexcr.2012.09.001) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nBerger, Christian; Madshus, Inger Helene; Stang, Espen\n2012-01-01\nThe monoclonal antibody C225 (Cetuximab) blocks binding of ligand to the epidermal growth factor receptor (EGFR). In addition, it is known that incubation with C225 induces endocytosis of the EGFR. This endocytosis has previously been shown to be increased when C225 is combined with an additional monoclonal anti-EGFR antibody. However, the effects of antibody combinations on EGFR activation, endocytosis, trafficking and degradation have been unclear. By binding a secondary antibody to the C225-EGFR complex, we here demonstrate that a combination of antibodies can efficiently internalize and degrade the EGFR. Although the combination of antibodies activated the EGFR kinase and induced ubiquitination of the EGFR, the kinase activity was not required for internalization of the EGFR. In contrast to EGF-induced EGFR down-regulation, the antibody combination efficiently degraded the EGFR without initiating downstream proliferative signaling. The antibody-induced internalization of EGFR was found not to depend on clathrin and/or dynamin, but depended on actin polymerization, suggesting induction of macropinocytosis. Macropinocytosis may cause internalization of large membrane areas, and this could explain the highly efficient internalization of the EGFR induced by combination of antibodies. -- Highlight: \u25ba Cetuximab induced endocytosis of EGFR increases upon combination with anti-human IgG. \u25ba Antibody combination causes internalization of EGFR by macropinocytosis. \u25ba Antibody-induced internalization of EGFR is independent of EGFR kinase activity. \u25ba Antibody combination may have a zipper effect and cross-link EGFRs on neighboring cells.\n[Normalizaci\u00f3n y validaci\u00f3n de ensayos inmunoenzim\u00e1ticos para cuantificar IgG humana antileptospira serovares canicola canicola, icterohaemorrhagiae copenhageni y pomona mozdok.](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2001000300003&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nXenia Ferriol\n2001-06-01\nFull Text Available Con el objetivo de evaluar la respuesta inmune inducida por la vacuna cubana vax-SPIRAL se desarrollaron tres ELISAs de tipo indirecto para la cuantificaci\u00f3n de IgG humana antileptospira, en el cual se emplearon como ant\u00edgenos de captura las c\u00e9lulas enteras de Leptospira interrogans de los serovares canicola canicola, icterohaemorrhagiae copenhageni y pomona mozdok, inactivadas con formaldeh\u00eddo y posteriormente desecadas a 33 \u00b0C durante 16-20 h en placas para ELISA. Para la cuantificaci\u00f3n se emple\u00f3 un suero est\u00e1ndar al que se le asignaron unidades arbitrarias, correspondientes al rec\u00edproco del t\u00edtulo obtenido por microaglutinaci\u00f3n (MAT. Estos fueron 31, 12 y 58 U/mL respectivamente para los tres serovares se\u00f1alados que se incluyen en el preparado vacunal. Se utiliz\u00f3 un conjugado anti IgG humana-peroxidasa, el cual se une a los anticuerpos espec\u00edficos contra cada serovar, la reacci\u00f3n se evidencia por la acci\u00f3n de la enzima sobre la mezcla sustratocrom\u00f3geno (ortofenilendiamina que genera color. El m\u00e9todo normalizado se valid\u00f3 para los tres serovares; la precisi\u00f3n intra e interensayos fueron excelentes, con coeficientes de variaci\u00f3n inferiores al 10%. Las desviaciones de la recuperaci\u00f3n y linealidad fueron tambi\u00e9n inferiores al 10%. El suero control se ubicaron para los tres serovares en la zona de mayor inter\u00e9s para las muestras. Los ELISAs mostraron un 100% de sensibilidad para los tres serovares y se obtuvieron valores de 93,33% de especificidad para los serovares canicola canicola e icterohaemorrhagiae copenagheni y de 100% para el serovar pomona mozdok. El l\u00edmite de detecci\u00f3n para cada uno de los serovares fue de 0,478; 0,127 y 0,632 U/mL respectivamente.\n[Frecuencia de anticuerpos contra el virus C de la hepatitis en pacientes con cirrosis hep\u00e1tica en Yucat\u00e1n, M\u00e9xico](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0036-36342003000500003) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nG\u00f3ngora-Biachi Ren\u00e1n A\n2003-01-01\nFull Text Available OBJETIVO: En este estudio reportamos la prevalencia de anticuerpos contra el virus C de la hepatitis (Ac-VCH en un grupo de pacientes con cirrosis hep\u00e1tica (CH. MATERIAL Y M\u00c9TODOS: Se hizo un estudio prospectivo, transversal y descriptivo, de marzo de 1998 a mayo de 1999. Se estudiaron a 153 pacientes (117 (76% hombres y 36 (24% mujeres con diagn\u00f3stico de CH, que eran atendidos en el Hospital General Agust\u00edn O' Horan y en el Centro de Investigaciones Regionales Doctor Hideyo Noguchi, en la ciudad de M\u00e9rida, Yucat\u00e1n, M\u00e9xico. Se aplic\u00f3 un cuestionario con datos cl\u00ednico-epidemiol\u00f3gicos y se determin\u00f3 la presencia de Ac-VCH (ELISA de 2\u00aa generaci\u00f3n y RIBA-2 para confirmar el diagn\u00f3stico a cada paciente. Se determin\u00f3 tambi\u00e9n el ant\u00edgeno de superficie de la hepatitis B (AgsHB y anticuerpos contra el ant\u00edgeno central de la hepatitis B (Anti-HBc mediante el m\u00e9todo de ELISA. La presencia de Ac-VCH fue relacionada con las variables epidemiol\u00f3gicas de los sujetos. La prevalencia de anti-HCV y la frecuencia de caracter\u00edsticas se compararon entre los pacientes positivos y negativos con las pruebas de c\u00b2 y exacta de Fisher. RESULTADOS: El 32% de los pacientes con CH (35/117 (30% hombres y 14/36 (39% mujeres fueron positivos para los Ac-VCH. El alcoholismo estuvo presente en todos los hombres serorreactivos y en ninguna de las mujeres positivas (p< 0.001. Ninguna de las variables epidemiol\u00f3gicas analizadas estuvo asociada con la seropositividad. Los anti-HBc se encontraron en 16% de los pacientes positivos para Ac-VCH y en 12% de los seronegativos (p=0.69. CONCLUSIONES: La prevalencia encontrada fue mayor a los reportes previos realizados en poblaci\u00f3n general de la Pen\u00ednsula de Yucat\u00e1n (1.3%. La alta prevalencia de Ac-VCH en este grupo de pacientes sugiere que la CH est\u00e1 m\u00e1s frecuentemente asociada con el VCH en Yucat\u00e1n, M\u00e9xico, que con el virus B de la hepatitis. El alcoholismo probablemente act\u00faa como un cofactor en el\n[Evaluaci\u00f3n serol\u00f3gica de una prote\u00edna recombinante a partir de una cepa aislada del virus de la fiebre amarilla en el Per\u00fa: un estudio piloto](http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1726-46342003000400004&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nCarlos Y\u00e1bar V\n2003-10-01\nFull Text Available Objetivo: Evaluar serol\u00f3gicamente una prote\u00edna recombinante de 66 kDa (Er66 de una cepa del virus de la fiebre amarilla aislada en el Per\u00fa usando anticuerpos inmunoreactivos. Material y m\u00e9todos: La prote\u00edna Er66 fue expresada in vitro en la bacteria Escherichia coli y enfrentada a t\u00edtulos de 1/100, 1/50 y 1/25 de anticuerpos monoclonales, y a sueros con anticuerpos IgM e IgG inmunoreactivos contra el virus de la fiebre amarilla mediante ensayos de Western blot (WB. Asimismo, se evaluaron prote\u00ednas totales de las cepas de referencia del virus dengue (DEN y fiebre amarilla como controles de antigenicidad. Resultados: La prote\u00edna recombinante Er66 present\u00f3 antigenicidad contra t\u00edtulos de 1/50 y 1/25 de anticuerpo monoclonal (MAB8701; sin embargo, no se observ\u00f3 inmunoreactividad en sueros positivos para fiebre amarilla y dengue. Los ensayos con extractos crudos de la cepa de fiebre amarilla Asibi 17D (PTFA revelaron que la antigenicidad de las prote\u00ednas virales comprendidas entre 60 y 80 kDa fue afectada negativamente a temperaturas desnaturalizantes de 100\u00b0C. En cambio, tratamientos con \u00df-mercaptoetanol sin calor gener\u00f3 un aumento de la antigenicidad de dichas prote\u00ednas. Siguiendo este mismo principio, la prote\u00edna Er66 fue sometida a tratamientos desnaturalizantes con \u00df-mercaptoetanol sin incluir calor y fue enfrentada nuevamente a los sueros reactivos. El resultado final revel\u00f3 que la prote\u00edna Er66 gener\u00f3 inmunoreactividad frente a sueros con altos t\u00edtulos de anticuerpos IgM e IgG para fiebre amarilla mientras que en otras muestras se observ\u00f3 una d\u00e9bil se\u00f1al. Conclusiones: Los datos obtenidos en este trabajo demuestran que la Er66 pudo ser reconocida por anticuerpos IgM e IgG espec\u00edficos para fiebre amarilla presentes en sueros de pacientes infectados. Los datos presentados en este art\u00edculo sugieren el uso de prote\u00ednas recombinantes como posibles candidatas de valor diagn\u00f3stico para la FA.\n[PCSK-9: papel en las hipercolesterolemias y anticuerpos monoclonales espec\u00edficos inhibitorios](http://www.sciencedirect.com/science/article/pii/S0120563317301936) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\n\u00c1lvaro J. Ruiz\n2017-11-01\nLos anticuerpos monoclonales contra PCSK9, evolocumab y alirocumab, son una novedosa herramienta terap\u00e9utica de gran utilidad en los casos de hipercolesterolemia familiar heterocigota, en algunos casos de hipercolesterolemia familiar homocigota y de personas con alto riesgo cardiovascular, cuyos niveles de cLDL no pueden ser controlados con dosis m\u00e1ximas toleradas de las estatinas de mayor efectividad, adem\u00e1s de ezetimibe y cambios en el estilo de vida.\n[M\u00e9todo fosfatasa alcalina anti-fosfatasa alcalina para el diagn\u00f3stico de inmunodeficiencias celulares Alkaline phosphatase-anti-alkaline phosphatase method for the diagnosis of cell immunodeficiencies](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-02892001000300008) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nBerta B Socarr\u00e1s Ferrer\n2001-12-01\nFull Text Available Para el estudio de 25 pacientes con infecciones recurrentes y un grupo control de 25 individuos supuestamente sanos, se aplic\u00f3, en nuestro laboratorio, el m\u00e9todo inmunocitoqu\u00edmico de fosfatasa alcalina anti-fosfatasa alcalina, para la cuantificaci\u00f3n de las principales subpoblaciones de linfocitos T identificados con los anticuerpos monoclonales: anti-CD3, anti-CD4 y anti-CD8. Se obtuvieron diferencias significativas para las subpoblaciones TCD3 y CD4 positivos (p For the study of 25 patients with recurrent infections and a control group of 25 supposedly healthy individuals, our Laboratory applied the immunocytochemical method of alkaline phosphatase - anti-alkaline phosphatase for the quantitation of the main T-lymphocyte subgroups identified with monoclonal antibodies:antiCD3, anti-CD4 and anti-CD8. There were significant differences in positive TCD3 and CD4 subsets (p<0,05. Because this is a low cost and quick method, it may be applied by other immunodiagnosis labs throughout the country\n[Mechanisms of anti-D action in the prevention of hemolytic disease of the fetus and newborn.](https://www.ncbi.nlm.nih.gov/pubmed/20008198)\nBrinc, Davor; Lazarus, Alan H\n2009-01-01\nAnti-D is routinely and effectively used to prevent hemolytic disease of the fetus and newborn (HDFN) caused by the antibody response to the D antigen on fetal RBCs. Anti-D is a polyclonal IgG product purified from the plasma of D-alloimmunized individuals. The mechanism of anti-D has not been fully elucidated. Antigenic epitopes are not fully masked by anti-D and are available for immune system recognition. However, a correlation has frequently been observed between anti-D-mediated RBC clearance and prevention of the antibody response, suggesting that anti-D may be able to destroy RBCs without triggering the adaptive immune response. Anti-D-opsonized RBCs may also elicit inhibitory FcgammaRIIB signaling in B cells and prevent B cell activation. The ability of antigen-specific IgG to inhibit antibody responses has also been observed in a variety of animal models immunized with a vast array of different antigens, such as sheep RBCs (SRBC). This effect has been referred to as antibody-mediated immune suppression (AMIS). In animal models, IgG inhibits the antibody response, but the T-cell response and memory may still be intact. IgG does not mask all epitopes, and IgG-mediated RBC clearance or FcgammaRIIB-mediated B-cell inhibition do not appear to mediate the AMIS effect. Instead, IgG appears to selectively disrupt B cell priming, although the exact mechanism remains obscure. While the applicability of animal models of AMIS to understanding the true mechanism of anti-D remains uncertain, the models have nevertheless provided us with insights into the possible IgG effects on the immune response.\n[Recombinant IgG1 Fc hexamers block cytotoxicity and pathological changes in experimental in vitro and rat models of neuromyelitis optica.](https://www.ncbi.nlm.nih.gov/pubmed/29428821)\nTradtrantip, Lukmanee; Felix, Christian M; Spirig, Rolf; Morelli, Adriana Baz; Verkman, A S\n2018-05-01\nIntravenous human immunoglobulin G (IVIG) may have therapeutic benefit in neuromyelitis optica spectrum disorders (herein called NMO), in part because of the anti-inflammatory properties of the IgG Fc region. Here, we evaluated recombinant Fc hexamers consisting of the IgM \u03bc-tailpiece fused with the Fc region of human IgG1. In vitro, the Fc hexamers prevented cytotoxicity in aquaporin-4 (AQP4) expressing cells and in rat spinal cord slice cultures exposed to NMO anti-AQP4 autoantibody (AQP4-IgG) and complement, with >500-fold greater potency than IVIG or monomeric Fc fragments. Fc hexamers at low concentration also prevented antibody-dependent cellular cytotoxicity produced by AQP4-IgG and natural killer cells. Serum from rats administered a single intravenous dose of Fc hexamers at 50 mg/kg taken at 8 h did not produce complement-dependent cytotoxicity when added to AQP4-IgG-treated AQP4-expressing cell cultures. In an experimental rat model of NMO produced by intracerebral injection of AQP4-IgG, Fc hexamers at 50 mg/kg administered before and at 12 h after AQP4-IgG fully prevented astrocyte injury, complement activation, inflammation and demyelination. These results support the potential therapeutic utility of recombinant IgG1 Fc hexamers in AQP4-IgG seropositive NMO. Copyright \u00a9 2018 Elsevier Ltd. All rights reserved.\n[IgG4-Related Tubulointerstitial Nephritis.](https://www.ncbi.nlm.nih.gov/pubmed/28284385)\nZhang, Pingchuan; Cornell, Lynn D\n2017-03-01\nImmunoglobulin G4 (IgG4)-related disease (IgG4-RD) is a fibroinflammatory disorder that can involve nearly any organ. The disorder has increasingly become known as a distinct clinical entity during the last decade. IgG4-related tubulointerstitial nephritis (IgG4-TIN) is the most common manifestation of IgG4-RD in the kidney. Many patients with IgG4-TIN are diagnosed after IgG4-RD has been recognized in other organ systems, but the kidney may also be the first or only site involved. The presenting clinical features of IgG4-TIN are most commonly kidney insufficiency, kidney mass lesion(s), or both. On biopsy, IgG4-TIN shows a dense lymphoplasmacytic infiltrate, increased IgG4+ plasma cells, storiform fibrosis, and often tubular basement membrane immune complex deposits. Elevation of serum IgG4 often accompanies IgG4-RD; however, it is not specific in reaching the diagnosis. Like IgG4-RD in other organs, IgG4-TIN characteristically responds promptly to steroids, although there is a high relapse rate on discontinuation of immunosuppression. The pathogenesis of IgG4-RD is not understood. Copyright \u00a9 2016 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.\n[Prevalencia de anticuerpos IgG espec\u00edficos dirigidos a Mycobacterium avium en caprinos y ovinos en el sur de la Guajira y norte del Cesar](https://www.journalhealthsciences.com/index.php/UDES/article/view/80) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMar\u00eda Fernanda Cepeda\n2016-06-01\nenviados para su procesamiento al Laboratorio de Investigaciones Biom\u00e9dicas y Biotecnol\u00f3gicas (LIBB del programa de Bacteriolog\u00eda y Laboratorio Cl\u00ednico de la Universidad de Santander UDES Bucaramanga. Los resultados del procesamiento de las pruebas de ELISA ser\u00e1n ingresados en una base de datos proporcionada por la instituci\u00f3n responsable del control de calidad de pruebas, Laboratorios VECOL, para su posterior an\u00e1lisis. El an\u00e1lisis estad\u00edstico ser\u00e1 realizado mediante la aplicaci\u00f3n del paquete estad\u00edstico Graphpad Prism (La Jolla, CA, USA. Resultados: Como resultado de este trabajo se plantea la determinaci\u00f3n de la prevalencia de anticuerpos espec\u00edficos de tipo IgG dirigidos a M. avium en caprinos y ovinos, informaci\u00f3n que aportar\u00e1 herramientas encaminadas a la construcci\u00f3n de un perfil sanitario en los municipios del sur de la Guajira y el Norte del Cesar. Conclusiones: El conocimiento de la prevalencia de M. avium en ovinos y caprinos de la regi\u00f3n del sur de la Guajira y el norte del Cesar, se concibe como un aspecto de importancia epidemiol\u00f3gica al ser considerada una infecci\u00f3n de notificaci\u00f3n obligatoria seg\u00fan la Organizaci\u00f3n Mundial de Sanidad Animal (OIE seg\u00fan su sigla en ingl\u00e9s dado que estos departamentos encabezan el listado de las regiones con mayor actividad econ\u00f3mica basada en la producci\u00f3n y consumo de estos animales y sus productos, adicionalmente, los ovinos y caprinos tienen la capacidad de ser reservorios para este agente infeccioso, llegando a convertirse en potencial causa del desarrollo de enfermedades en estas poblaciones espec\u00edficas, as\u00ed como, la importancia que pueden representar desde el punto de vista de su potencial zoon\u00f3tico.\n[Hemolytic disease of the newborn due to anti-U Doen\u00e7a hemol\u00edtica do rec\u00e9m-nascido devido a anti-U](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0041-87812003000600006) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMarcia Cristina Zago Novaretti\n2003-01-01\nFull Text Available Anti-U is a rare red blood cell alloantibody that has been found exclusively in blacks. It can cause hemolytic disease of the newborn and hemolytic transfusion reactions. We describe the case of a female newborn presenting a strongly positive direct antiglobulin test due to an IgG antibody in cord blood. Anti-U was recovered from cord blood using acid eluate technique. Her mother presented positive screening of antibodies with anti-U identified at delivery. It was of IgG1 and IgG3 subclasses and showed a titer of 32. Monocyte monolayer assay showed moderate interaction of Fc receptors with maternal serum with a positive result (3.1%. The newborn was treated only with 48 hours of phototherapy for mild hemolytic disease. She recovered well and was discharged on the 4th day of life. We conclude that whenever an antibody against a high frequency erythrocyte antigen is identified in brown and black pregnant women, anti-U must be investigated.Anti-U \u00e9 um aloanticorpo eritrocit\u00e1rio raro detectado exclusivamente em negros, que pode causar doen\u00e7a hemol\u00edtica do rec\u00e9m-nascido e rea\u00e7\u00f5es transfusionais hemol\u00edticas. Relatamos o caso de um rec\u00e9m-nascido, de sexo feminino, que apresentou teste de antiglobulina direto fortemente positivo, dirigido a um anticorpo IgG em sangue de cord\u00e3o umbilical. Anti-U foi identificado por t\u00e9cnica de elui\u00e7\u00e3o \u00e1cida. A m\u00e3e apresentava pesquisa de anticorpos irregulares positiva com anticorpo anti-U, de subclasses IgG1 e IgG3, t\u00edtulo 32, identificado ao nascimento. O ensaio de monocamada de mon\u00f3citos apresentou resultado positivo (3.1%, mostrando uma intera\u00e7\u00e3o moderada de receptores Fc com soro materno. O rec\u00e9m-nascido foi tratado somente por fototerapia durante 48 horas para uma doen\u00e7a hemol\u00edtica leve. A crian\u00e7a recuperou-se bem e teve alta m\u00e9dica no quarto dia de vida. Conclu\u00edmos que quando um anticorpo contra um ant\u00edgeno eritrocit\u00e1rio de alta freq\u00fc\u00eancia for identificado em gestantes negras e pardas\n[DEFF Research Database (Denmark)](http://forskningsbasen.deff.dk/?lang=eng)\nDetlefsen, S\u00f6nke; Kl\u00f6ppel, G\u00fcnter\n2018-01-01\ndisease (IgG4-RD). The histologic key findings are lymphoplasmacytic infiltration rich in IgG4-positive plasma cells combined with storiform fibrosis and obliterative phlebitis. Among the organs mainly affected by IgG4-RD are the pancreas and the extrahepatic bile ducts. The pancreatic and biliary...... alterations have been described under the terms autoimmune pancreatitis (AIP) and sclerosing cholangitis, respectively. These diseases are currently more precisely called IgG4-related pancreatitis (or type 1 AIP to distinguish it from type 2 AIP that is unrelated to IgG4-RD) and IgG4-related sclerosing...... cholangitis (IgG4-related SC). Clinically and grossly, both diseases commonly imitate pancreatic and biliary adenocarcinoma, tumors that are well known for their dismal prognosis. As IgG4-RD responds to steroid treatment, making a resection of a suspected tumor unnecessary, a biopsy is often required...\n[Indices of anti-dengue immunoglobulin G subclasses in adult Mexican patients with febrile and hemorrhagic dengue in the acute phase.](https://www.ncbi.nlm.nih.gov/pubmed/28881485)\nPosadas-Mondrag\u00f3n, Araceli; Aguilar-Faisal, Jos\u00e9 Leopoldo; Ch\u00e1vez-Negrete, Adolfo; Guill\u00e9n-Salom\u00f3n, Edith; Alc\u00e1ntara-Farf\u00e1n, Ver\u00f3nica; Luna-Rojas, Lucero; \u00c1vila-Trejo, Amanda Marineth; Del Carmen Pacheco-Y\u00e9pez, Judith\n2017-10-01\nHeterologous secondary infections are at increased risk of developing dengue hemorrhagic fever (DHF) because of antibody-dependent enhancement (ADE). IgG subclasses can fix and activate complement and bind to Fc\u0263 receptors. These factors may also play an important role in the development of ADE and thus in the pathogenesis of DHF. The aim of this study was to analyze the indices of anti-dengue IgG subclasses in adult patients with febrile and hemorrhagic dengue in the acute phase. In 2013, 129 patients with dengue fever (DF) and 57 with DHF in Veracruz, Mexico were recruited for this study and anti-dengue IgM and IgG determined by capture ELISA. Anti-dengue IgG subclasses were detected by indirect ELISA. Anti-dengue IgG2 and IgG3 subclasses were detected in patients with dengue. IgG1 increased significantly in the sera of patients with both primary and secondary infections and DHF, but was higher in patients with secondary infections. The IgG4 subclass index was significantly higher in the sera of patients with DHF than in that of those with DF, who were in the early and late acute phase of both primary and secondary infection. In conclusion, indices of subclasses IgG1 and IgG4 were higher in patients with DHF. \u00a9 2017 The Societies and John Wiley & Sons Australia, Ltd.\n[Postoperative change of anti-Thomsen-Friedenreich and Tn IgG level: the follow-up study of gastrointestinal cancer patients.](https://www.ncbi.nlm.nih.gov/pubmed/18666325)\nSmorodin, Eugeniy-P; Kurtenkov, Oleg-A; Sergeyev, Boris-L; Kodar, Kristel-E; Chuzmarov, Valentin-I; Afanasyev, Vladimir-P\n2008-07-21\nTo study the influence of tumor removal on the serum level of IgG antibodies to tumor-associated Thomsen-Friedenreich (TF), Tn carbohydrate epitopes and xenogeneic alphaGal, and to elucidate on the change of the level during the follow-up as well as its association with the stage and morphology of the tumor and the values of blood parameters in gastrointestinal cancer. Sixty patients with gastric cancer and 34 patients with colorectal cancer in stages I-IV without distant metastases were subjected to follow-up. The level of antibodies in serum was determined by the enzyme-linked immunosorbent assay (ELISA) using synthetic polyacrylamide (PAA) glycoconjugates. Biochemical and haematological analyses were performed using automated equipment. In gastrointestinal cancer, the TF antibody level was found to have elevated significantly after the removal of G3 tumors as compared with the preoperative level (u = 278.5, P gastric cancer patients (sign test, 20 vs 8, P cancer, the elevated postoperative level of TF, Tn and alphaGal antibodies was noted in most patients with G3 tumors (sign test, 22 vs 5, P stage I, whose mean anti-TF IgG level remained above the cut-off value (1.26), was significantly higher than that of patients with the cancer in stages III-IV (c2 = 4.71, gastric cancer; c2 = 4.11, gastrointestinal cancer; P stage but remains low in its terminal stages. The stage- and morphology-dependent immunosuppression affects the TF-antibody response and may be one of the reasons for unresponsiveness to the immunization with TF-antigens.\n[A condition closely mimicking IgG4-related disease despite the absence of serum IgG4 elevation and IgG4-positive plasma cell infiltration.](https://www.ncbi.nlm.nih.gov/pubmed/24884481)\nHara, Satoshi; Kawano, Mitsuhiro; Mizushima, Ichiro; Yamada, Kazunori; Fujita, Kentaro; Harada, Kenichi; Matsumura, Masami; Yamagishi, Masakazu; Sato, Yasuharu; Yamaguchi, Yutaka; Nakanuma, Yasuni; Nagata, Michio\n2016-09-01\nWe describe a 74-year-old Japanese man with systemic fibroinflammatory conditions closely resembling those of immunoglobulin G4-related disease (IgG4-RD). Radiology and histology showed characteristics of IgG4-related tubulointerstitial nephritis, despite normal serum IgG4 value and scanty IgG4-positive plasma cell infiltration in each organ. This case suggests that a condition closely mimicking IgG4-RD may develop without IgG4-positive plasma cells and those exceptional cases should also be taken into account in the differential diagnosis of IgG4-RD.\n[Comparative analysis of upper gastrointestinal endoscopy, double-contrast upper gastrointestinal barium X-ray radiography, and the titer of serum anti-Helicobacter pylori IgG focusing on the diagnosis of atrophic gastritis.](https://www.ncbi.nlm.nih.gov/pubmed/26223472)\nYamamichi, Nobutake; Hirano, Chigaya; Takahashi, Yu; Minatsuki, Chihiro; Nakayama, Chiemi; Matsuda, Rie; Shimamoto, Takeshi; Takeuchi, Chihiro; Kodashima, Shinya; Ono, Satoshi; Tsuji, Yosuke; Fujishiro, Mitsuhiro; Wada, Ryoichi; Mitsushima, Toru; Koike, Kazuhiko\n2016-04-01\nUpper gastrointestinal endoscopy (UGI-ES) and double-contrast upper gastrointestinal barium X-ray radiography (UGI-XR) are two major image-based methods to diagnose atrophic gastritis, which is mostly induced by Helicobacter pylori infection. However, there have been few studies directly comparing them. Atrophic gastritis was evaluated using the data of 962 healthy subjects who underwent UGI-ES and UGI-XR within 1 year. Based on UGI-ES and UGI-XR, 602 subjects did not have atrophic gastritis and 254 subjects did have it. Considering UGI-ES-based atrophic gastritis as the standard, sensitivity and specificity of UGI-XR-based atrophic gastritis were 92.0 % (254/276) and 92.8 % (602/649), respectively. The seven-grade Kimura-Takemoto classification of UGI-ES-based atrophic gastritis showed a strong and significant association with the four-grade UGI-XR-based atrophic gastritis. Sensitivity and specificity of serum anti-Helicobacter pylori IgG to detect UGI-ES/UGI-XR-based atrophic gastritis were 89.4 % (227/254) and 99.8 % (601/602), indicating that atrophic gastritis can be overlooked according to serum anti-Helicobacter pylori IgG alone.\nQuattrocchio, Giacomo; Roccatello, Dario\n2016-08-01\nIgG4-related disease (IgG4-RD) is a recently recognized disorder, often with multiple organ involvement, characterized by dense tissue infiltration of IgG4-positive plasma cells, storiform fibrosis, obliterative phlebitis and frequently elevated serum IgG4 concentration. The kidney can be involved either directly or indirectly. The most frequent direct renal manifestations of IgG4-RD are IgG4-related tubulointerstitial nephritis (TIN) and membranous glomerulonephropathy. Retroperitoneal fibrosis (RPF) is another condition that is frequently IgG4-related and that can indirectly affect the kidney causing ureteral obstruction and hydronephrosis. Contrast-enhanced computerized tomography, magnetic resonance imaging and (18)F-fluorodeoxyglucose positron emission tomography/computed tomography show different imaging findings and are useful tools for monitoring therapeutic response. Steroid treatment is the first line of therapy, but relapsing or refractory forms of the disease are frequently observed and require more aggressive therapeutic approaches. At our centre, we treated three cases of aggressive IgG4-related TIN and two cases of IgG4-related RPF with an intensified, immune suppressive protocol, obtaining good results without severe adverse effects.\n[Seroprevalence of dengue virus antibodies in asymptomatic Costa Rican children, 2002-2003: a pilot study La seroprevalencia de anticuerpos contra el virus del dengue en ni\u00f1os costarricenses asintom\u00e1ticos, 2002-2003: estudio piloto](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892006000700005) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nRoberto Iturrino-Monge\n2006-07-01\nFull Text Available OBJECTIVES: Since 1993 dengue has become more frequent in Costa Rica. Adults have been the most affected population, while children have remained virtually unharmed. So far no studies have investigated how many asymptomatic children have been affected by this virus. This pilot study documents the seroprevalence, measured as the presence of IgG antibodies, of dengue virus in asymptomatic children from two different geographical areas. METHODS: This descriptive, prospective epidemiologic study compared the presence of antibodies in children who live in a coastal region of a tropical country where dengue is endemic, and an inland area where dengue is not endemic. An enzyme-linked immunosorbent assay was used to test the serum for dengue virus IgG antibodies. None of the children had a prior history of dengue, fever, immunosuppressive therapy or underlying disease. RESULTS: During the period from July 2002 to July 2003, 103 children were recruited from each area. In the costal region we found a seroprevalence of 36.9%. In the inland area seroprevalence was 2.9% CONCLUSIONS: We found a substantial number of asymptomatic infections in Costa Rican children. This greatly increases the risk of dengue hemorrhagic fever or dengue shock syndrome in these children, in whom previous dengue infection had gone undetected. Preventive efforts should be targeted at the costal region due to the higher prevalence in this area.OBJETIVOS: Desde 1993, la frecuencia de dengue en Costa Rica ha venido aumentando. La poblaci\u00f3n de adultos ha sido la m\u00e1s afectada, mientras que en los ni\u00f1os apenas se han presentado casos. Hasta el momento no se han realizado estudios para determinar cu\u00e1ntos ni\u00f1os asintom\u00e1ticos se han visto afectados por el virus de la enfermedad. Este estudio piloto documenta la seroprevalencia de anticuerpos de tipo IgG contra el virus del dengue en ni\u00f1os asintom\u00e1ticos procedentes de dos zonas geogr\u00e1ficas distintas. M\u00c9TODOS: En este estudio\n[Fibrosis pulmonar asociada a vasculitis con anticuerpos anticitoplasm\u00e1ticos positivos](https://www.openaire.eu/search/publication?articleId=dedup_wf_001::1673f4284151b71a02e4b2ae2806ae97)\nMarcelo Fern\u00e1ndez Casares; Alejandra Gonz\u00e1lez; Flavia Caputo; Yanina Bottinelli; Patricia Nastavi; Marcelo Zamboni\n2012-01-01\nLas complicaciones pulmonares m\u00e1s conocidas de las vasculitis con anticuerpos anticitoplasm\u00e1ticos de los neutr\u00f3filos (ANCA) positivos (VAA), son la hemorragia alveolar, los granulomas y la estenosis de la v\u00eda a\u00e9rea. En los \u00faltimos a\u00f1os han aparecido algunos informes aislados que muestran la asociaci\u00f3n con fibrosis pulmonar (FP), sugiriendo que \u00e9sta ser\u00eda otra complicaci\u00f3n de las VAA. En este trabajo informamos dos casos con dicha asociaci\u00f3n describiendo sus caracter\u00edsticas cl\u00ednicas, tomogr\u00e1fi...\n[IgG4 plasma cell myeloma: new insights into the pathogenesis of IgG4-related disease.](https://www.ncbi.nlm.nih.gov/pubmed/24030741)\nGeyer, Julia T; Niesvizky, Ruben; Jayabalan, David S; Mathew, Susan; Subramaniyam, Shivakumar; Geyer, Alexander I; Orazi, Attilio; Ely, Scott A\n2014-03-01\nIgG4-related disease is a newly described systemic fibroinflammatory process, characterized by increase in IgG4-positive plasma cells. Its pathogenesis, including the role of IgG4, remains poorly understood. Plasma cell myeloma is typically associated with a large monoclonal serum spike, which is frequently of IgG isotype. We sought to identify and characterize a subset of IgG4-secreting myeloma, as it may provide a biological model of disease with high serum levels of IgG4. Six out of 158 bone marrow biopsies (4%) from patients with IgG myeloma expressed IgG4. Four patients were men and two were women, with a mean age of 64 (range 53-87) years. Imaging showed fullness of pancreatic head (1), small non-metabolic lymphadenopathy (1), and bone lytic lesions (6). Two patients developed necrotizing fasciitis. All had elevated serum M-protein (mean 2.4, range 0.5-4.2 g/dl), and none had definite signs or symptoms of IgG4-related disease. Four myelomas had plasmablastic morphology. Four had kappa and two had lambda light chain expression. Three cases expressed CD56. Two patients had a complex karyotype. In conclusion, the frequency of IgG4 myeloma correlates with the normal distribution of IgG4 isoform. The patients with IgG4 myeloma appear to have a high rate of plasmablastic morphology and could be predisposed to necrotizing fasciitis. Despite high serum levels of IgG4, none had evidence of IgG4-related disease. These findings suggest that the increased number of IgG4-positive plasma cells is not the primary etiologic agent in IgG4-related disease. Elevated serum levels of IgG4 is not sufficient to produce the typical disease presentation and should not be considered diagnostic of IgG4-related disease.\n[Serum anti-Helicobacter pylori immunoglobulin G titer correlates with grade of histological gastritis, mucosal bacterial density, and levels of serum biomarkers.](https://www.ncbi.nlm.nih.gov/pubmed/24329006)\nTu, Huakang; Sun, Liping; Dong, Xiao; Gong, Yuehua; Xu, Qian; Jing, Jingjing; Yuan, Yuan\n2014-03-01\nOBJECTIVE. Clinical implications of serum anti-Helicobacter pylori immunoglobulin G (IgG) titer were unclear. This study investigated the associations of serum anti-H. pylori IgG titer with grade of histological gastritis, mucosal bacterial density and levels of serum biomarkers, including pepsinogen (PG) I, PGII, PGI/II ratio and gastrin-17. MATERIAL AND METHODS. Study participants were from a screening program in northern China. Serum anti-H. pylori IgG measurements were available for 5922 patients with superficial gastritis. Serum anti-H. pylori IgG titer and serum biomarkers were measured using ELISA, and gastric biopsies were evaluated using standardized criteria. RESULTS. In patients with mild, moderate or severe superficial gastritis, the mean serum anti-H. pylori IgG titers were 17.3, 33.4 and 54.4 EIU (p for trend histological gastritis, mucosal bacterial density and concentrations of serum PGI, PGII and gastrin-17, and negatively with PGI/II ratio.\n[Pattern of pre-existing IgG subclass responses to a panel of asexual stage malaria antigens reported during the lengthy dry season in Daraweesh, Sudan](http://www.forskningsdatabasen.dk/en/catalog/185167140) [DEFF Research Database (Denmark)](http://forskningsbasen.deff.dk/?lang=eng)\nNasr, A; Iriemenam, N C; Troye-Blomberg, M\n2011-01-01\nThe anti-malarial IgG immune response during the lengthy and dry season in areas of low malaria transmission as in Eastern Sudan is largely unknown. In this study, ELISA was used for the measurement of pre-existing total IgG and IgG subclasses to a panel of malaria antigens, MSP2-3D7, MSP2-FC27, ...\n[Avalia\u00e7\u00e3o das subclasses IgG1 e IgG3 na doen\u00e7a hemol\u00edtica perinatal Assessment of IgG1 and IgG3 subclasses in perinatal hemolytic disease](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842003000400004) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMaria A. Ara\u00fajo\n2003-01-01\nFull Text Available A doen\u00e7a hemol\u00edtica perinatal (DHPN ainda \u00e9 um problema cl\u00ednico. Nenhum teste isolado prediz, com seguran\u00e7a, a gravidade do quadro hemol\u00edtico. O objetivo do presente estudo foi determinar as subclasses de anticorpos IgG1 e IgG3 por citometria de fluxo no soro de 42 gestantes isoimunizadas e correlacionar os dados obtidos com a gravidade da DHPN. A distribui\u00e7\u00e3o dos fetos ou neonatos segundo a gravidade do quadro hemol\u00edtico evidenciou 13 casos com doen\u00e7a leve, 16 casos com doen\u00e7a moderada e 13 com doen\u00e7a grave. As subclasses foram detectadas em 33/42 (79% amostras. A subclasse IgG1, isoladamente, foi evidenciada em 14/33 (42,4% casos. Na rela\u00e7\u00e3o entre gravidade da doen\u00e7a e subclasses de IgG, observou-se que IgG1 isolada foi encontrada em todos os grupos, e os valores da mediana de intensidade de fluoresc\u00eancia (MIF foram significativamente mais altos nas formas mais graves da DHPN (pThe hemolytic disease of the newborn (HDN continues to be a clinical problem in spite of prophylaxis. To date, none of the available tests, developed to predict the severity of HDN, has provided complete reliability. The objective of the present study was to determine the IgG1 and IgG3 subclasses in 42 isoimmunized pregnant women, and to correlate them with clinical severity of hemolytic disease. The IgG subclasses were determined employing flow cytometry. According to the clinical severity of HDN, fetuses and newborn babies were classified as 13 mild, 16 moderate and 13 severe cases. The IgG subclasses were detected in 33 of the 42 pregnant women. Of these, IgG1 was predominant in 72.7% of the cases; either isolated (42.4% or in association with IgG3 (30.3%. IgG1 was present in all the three clinical severity categories, however, its values were significantly higher in cases with greater clinical severity of HDN (p<0.01. On the other hand, the distribution of IgG3 values within each group was not statistically significant (p=0.11. IgG3 seems to be more\n[Highly sensitive detection of human IgG using a novel bio-barcode assay combined with DNA chip technology](http://www.etde.org/etdeweb/details.jsp?query_id=1&page=0&osti_id=22209429) [Energy Technology Data Exchange (ETDEWEB)](https://www.etde.org/etdeweb/fieldedsearch.jsp)\nLiu, Zhenbao [Central South University, School of Pharmaceutical Sciences (China); Zhou, Bo, E-mail: zhoubo1771@163.com [The Affiliated Zhongda Hospital of Southeast University, Department of Gerontology (China); Wang, Haiqing; Lu, Feng; Liu, Tianjun; Song, Cunxian; Leng, Xigang, E-mail: lengxigyky@163.com [Institute of Biomedical Engineering, Chinese Academy of Medical Sciences and Peking Union Medical College (China)\n2013-09-15\nA simple and ultrasensitive detection of human IgG based on signal amplification using a novel bio-barcode assay and DNA chip technology was developed. The sensing platform was a sandwich system made up of antibody-modified magnetic microparticles (Ab-MMPs)/human IgG/Cy3-labeled single-stranded DNA and antibody-modified gold nanoparticles (Cy3-ssDNA-Ab-AuNPs). The MMPs (2.5 {mu}m in diameter) modified with mouse anti-human IgG monoclonal-antibodies could capture human IgG and further be separated and enriched via a magnetic field. The AuNPs (13 nm in diameter) conjugated with goat anti-human IgG polyclonal-antibodies and Cy3-ssDNA could further combine with the human IgG/Ab-MMP complex. The Cy3-ssDNA on AuNPs was then released by TCEP to hybridize with the DNA chip, thus generating a detectable signal by the fluorescence intensity of Cy3. In order to improve detection sensitivity, a three-level cascaded signal amplification was developed: (1) The MMP enrichment as the first-level; (2) Large quantities of Cy3-ssDNA on AuNPs as the second-level; (3) The Cy3-ssDNA conjugate with DNA chip as the third-level. The highly sensitive technique showed an increased response of the fluorescence intensity to the increased concentration of human IgG through a detection range from 1 pg mL{sup -1} to 10 ng mL{sup -1}. This sensing technique could not only improve the detection sensitivity for the low concentration of human IgG but also present a robust and efficient signal amplification model. The detection method has good stability, specificity, and reproducibility and could be applied in the detection of human IgG in the real samples.\n[Highly sensitive detection of human IgG using a novel bio-barcode assay combined with DNA chip technology](http://adsabs.harvard.edu/abs/2013JNR....15.1964L)\nLiu, Zhenbao; Zhou, Bo; Wang, Haiqing; Lu, Feng; Liu, Tianjun; Song, Cunxian; Leng, Xigang\n2013-09-01\nA simple and ultrasensitive detection of human IgG based on signal amplification using a novel bio-barcode assay and DNA chip technology was developed. The sensing platform was a sandwich system made up of antibody-modified magnetic microparticles (Ab-MMPs)/human IgG/Cy3-labeled single-stranded DNA and antibody-modified gold nanoparticles (Cy3-ssDNA-Ab-AuNPs). The MMPs (2.5 \u03bcm in diameter) modified with mouse anti-human IgG monoclonal-antibodies could capture human IgG and further be separated and enriched via a magnetic field. The AuNPs (13 nm in diameter) conjugated with goat anti-human IgG polyclonal-antibodies and Cy3-ssDNA could further combine with the human IgG/Ab-MMP complex. The Cy3-ssDNA on AuNPs was then released by TCEP to hybridize with the DNA chip, thus generating a detectable signal by the fluorescence intensity of Cy3. In order to improve detection sensitivity, a three-level cascaded signal amplification was developed: (1) The MMP enrichment as the first-level; (2) Large quantities of Cy3-ssDNA on AuNPs as the second-level; (3) The Cy3-ssDNA conjugate with DNA chip as the third-level. The highly sensitive technique showed an increased response of the fluorescence intensity to the increased concentration of human IgG through a detection range from 1 pg mL-1 to 10 ng mL-1. This sensing technique could not only improve the detection sensitivity for the low concentration of human IgG but also present a robust and efficient signal amplification model. The detection method has good stability, specificity, and reproducibility and could be applied in the detection of human IgG in the real samples.\n[Highly sensitive detection of human IgG using a novel bio-barcode assay combined with DNA chip technology](http://dx.doi.org/10.1007/s11051-013-1964-z) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nLiu, Zhenbao; Zhou, Bo; Wang, Haiqing; Lu, Feng; Liu, Tianjun; Song, Cunxian; Leng, Xigang\n2013-01-01\nA simple and ultrasensitive detection of human IgG based on signal amplification using a novel bio-barcode assay and DNA chip technology was developed. The sensing platform was a sandwich system made up of antibody-modified magnetic microparticles (Ab-MMPs)/human IgG/Cy3-labeled single-stranded DNA and antibody-modified gold nanoparticles (Cy3-ssDNA-Ab-AuNPs). The MMPs (2.5 \u03bcm in diameter) modified with mouse anti-human IgG monoclonal-antibodies could capture human IgG and further be separated and enriched via a magnetic field. The AuNPs (13 nm in diameter) conjugated with goat anti-human IgG polyclonal-antibodies and Cy3-ssDNA could further combine with the human IgG/Ab-MMP complex. The Cy3-ssDNA on AuNPs was then released by TCEP to hybridize with the DNA chip, thus generating a detectable signal by the fluorescence intensity of Cy3. In order to improve detection sensitivity, a three-level cascaded signal amplification was developed: (1) The MMP enrichment as the first-level; (2) Large quantities of Cy3-ssDNA on AuNPs as the second-level; (3) The Cy3-ssDNA conjugate with DNA chip as the third-level. The highly sensitive technique showed an increased response of the fluorescence intensity to the increased concentration of human IgG through a detection range from 1 pg mL \u22121 to 10 ng mL \u22121 . This sensing technique could not only improve the detection sensitivity for the low concentration of human IgG but also present a robust and efficient signal amplification model. The detection method has good stability, specificity, and reproducibility and could be applied in the detection of human IgG in the real samples\n[A toolbox of anti\u2013mouse and anti\u2013rabbit IgG secondary nanobodies](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=5839796)\n2018-01-01\nPolyclonal anti\u2013immunoglobulin G (anti-IgG) secondary antibodies are essential tools for many molecular biology techniques and diagnostic tests. Their animal-based production is, however, a major ethical problem. Here, we introduce a sustainable alternative, namely nanobodies against all mouse IgG subclasses and rabbit IgG. They can be produced at large scale in Escherichia coli and could thus make secondary antibody production in animals obsolete. Their recombinant nature allows fusion with affinity tags or reporter enzymes as well as efficient maleimide chemistry for fluorophore coupling. We demonstrate their superior performance in Western blotting, in both peroxidase- and fluorophore-linked form. Their site-specific labeling with multiple fluorophores creates bright imaging reagents for confocal and superresolution microscopy with much smaller label displacement than traditional secondary antibodies. They also enable simpler and faster immunostaining protocols, and allow multitarget localization with primary IgGs from the same species and of the same class. PMID:29263082\n[IL4 gene polymorphism and previous malaria experiences manipulate anti-Plasmodium falciparum antibody isotype profiles in complicated and uncomplicated malaria](http://www.malariajournal.com/content/8/1/286) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nKalambaheti Thareerat\n2009-12-01\nFull Text Available Abstract Background The IL4-590 gene polymorphism has been shown to be associated with elevated levels of anti-Plasmodium falciparum IgG antibodies and parasite intensity in the malaria protected Fulani of West Africa. This study aimed to investigate the possible impact of IL4-590C/T polymorphism on anti-P. falciparum IgG subclasses and IgE antibodies levels and the alteration of malaria severity in complicated and uncomplicated malaria patients with or without previous malaria experiences. Methods Anti-P.falciparum IgG subclasses and IgE antibodies in plasma of complicated and uncomplicated malaria patients with or without previous malaria experiences were analysed using ELISA. IL4-590 polymorphisms were genotyped using RFLP-PCR. Statistical analyses of the IgG subclass levels were done by Oneway ANOVA. Genotype differences were tested by Chi-squared test. Results The IL4-590T allele was significantly associated with anti-P. falciparum IgG3 antibody levels in patients with complicated (P = 0.031, but not with uncomplicated malaria (P = 0.622. Complicated malaria patients with previous malaria experiences carrying IL4-590TT genotype had significantly lower levels of anti-P. falciparum IgG3 (P = 0.0156, while uncomplicated malaria patients with previous malaria experiences carrying the same genotype had significantly higher levels (P = 0.0206 compared to their IL4-590 counterparts. The different anti-P. falciparum IgG1 and IgG3 levels among IL4 genotypes were observed. Complicated malaria patients with previous malaria experiences tended to have lower IgG3 levels in individuals carrying TT when compared to CT genotypes (P = 0.075. In contrast, complicated malaria patients without previous malaria experiences carrying CC genotype had significantly higher anti-P. falciparum IgG1 than those carrying either CT or TT genotypes (P = 0.004, P = 0.002, respectively. Conclusion The results suggest that IL4-590C or T alleles participated differently in the\n[Limitations of a hemolytic plaque assay for IgG-anti-IgG rheumatoid factor-producing cells.](https://www.ncbi.nlm.nih.gov/pubmed/3309063)\nVenn, A J; Dresser, D W\n1987-09-24\nAn attempt has been made to develop a hemolytic plaque assay capable of detecting homophile IgG rheumatoid factor (RF)-producing cells. Anti-immunoglobulin allotype-developing reagents were used to distinguish between target and effector IgG. The hemolytic assay has been used to demonstrate an apparently high level of homophile IgM and IgG RF-producing cells in the spleens and lymph nodes of mice stimulated by LPS. However, it appears that a large proportion of the plaques obtained in these assays are due to an artefact resulting from cross-linking of target and effector molecules by the developing reagents. In the case of IgM RF the artefact depends on the presence of a small contamination of the target IgG by IgM, allowing cross-linking of target and effector IgM by the anti-mu-specific developing reagent. With the IgG RF, cross-reactivity of the rabbit anti-Ighb allotype-developing serum for the 'wrong' (Igha) allotype, normally undetectable, becomes sufficient to be biologically relevant when the developing antibody is complexed by being bound to its target (Ighb) allotype. Nevertheless anti-allotype reagents may afford an accurate means of detecting homophile IgG RF producing cells using other assay systems.\n[Cetuximab in combination with anti-human IgG antibodies efficiently down-regulates the EGF receptor by macropinocytosis](http://www.etde.org/etdeweb/details.jsp?query_id=1&page=0&osti_id=22212621) [Energy Technology Data Exchange (ETDEWEB)](https://www.etde.org/etdeweb/fieldedsearch.jsp)\nBerger, Christian [Department of Pathology, Oslo University Hospital, Rikshospitalet, Post box 4950 Nydalen, 0424 Oslo (Norway); Madshus, Inger Helene [Institute of Pathology, University of Oslo, Rikshospitalet, 0027 Oslo (Norway); Department of Pathology, Oslo University Hospital, Rikshospitalet, Post box 4950 Nydalen, 0424 Oslo (Norway); Stang, Espen, E-mail: espsta@rr-research.no [Department of Pathology, Oslo University Hospital, Rikshospitalet, Post box 4950 Nydalen, 0424 Oslo (Norway)\n2012-12-10\nThe monoclonal antibody C225 (Cetuximab) blocks binding of ligand to the epidermal growth factor receptor (EGFR). In addition, it is known that incubation with C225 induces endocytosis of the EGFR. This endocytosis has previously been shown to be increased when C225 is combined with an additional monoclonal anti-EGFR antibody. However, the effects of antibody combinations on EGFR activation, endocytosis, trafficking and degradation have been unclear. By binding a secondary antibody to the C225-EGFR complex, we here demonstrate that a combination of antibodies can efficiently internalize and degrade the EGFR. Although the combination of antibodies activated the EGFR kinase and induced ubiquitination of the EGFR, the kinase activity was not required for internalization of the EGFR. In contrast to EGF-induced EGFR down-regulation, the antibody combination efficiently degraded the EGFR without initiating downstream proliferative signaling. The antibody-induced internalization of EGFR was found not to depend on clathrin and/or dynamin, but depended on actin polymerization, suggesting induction of macropinocytosis. Macropinocytosis may cause internalization of large membrane areas, and this could explain the highly efficient internalization of the EGFR induced by combination of antibodies. -- Highlight: Black-Right-Pointing-Pointer Cetuximab induced endocytosis of EGFR increases upon combination with anti-human IgG. Black-Right-Pointing-Pointer Antibody combination causes internalization of EGFR by macropinocytosis. Black-Right-Pointing-Pointer Antibody-induced internalization of EGFR is independent of EGFR kinase activity. Black-Right-Pointing-Pointer Antibody combination may have a zipper effect and cross-link EGFRs on neighboring cells.\n[Immunohistochemical analysis of IgA expression differentiates IgG4-related disease from plasma cell-type Castleman disease.](https://www.ncbi.nlm.nih.gov/pubmed/27438709)\nManabe, Akihiro; Igawa, Takuro; Takeuchi, Mai; Gion, Yuka; Yoshino, Tadashi; Sato, Yasuharu\n2017-03-01\nPlasma cell-type Castleman disease (PCD) is often encountered when differentiating IgG4-related disease (IgG4-RD). Given that serum IgA is often elevated in Castleman disease, we investigated whether IgA expression levels in histological specimens can be used to differentiate between the two diseases. Lymph node lesions obtained from 12 IgG4-RD and 11 PCD patients were analysed by immunohistochemistry with anti-IgG, -IgG4, and -IgA antibodies. In addition to all 12 cases of IgG4-RD, 8/11 cases (72.7 %) of PCD also met the diagnostic criteria of IgG4-RD (serum IgG4 \u2265135 mg/dl and IgG4/IgG-positive cells \u226540 %). IgA-positive cells were sparsely and densely distributed in IgG4-RD and PCD cases, respectively. The median number of IgA-positive cells \u00b1 SD in all 12 cases of IgG4-RD was 31 \u00b1 37 cells per three high-powered fields (3HPFs) (range 4-118 cells/3HPFs). In contrast, the median number of IgA-positive cells, which was significantly higher in all 11 cases of PCD, was 303 \u00b1 238 cells/3HPFs (range 74-737 cells/3HPFs) (P IgG4-RD.\n[Serum IgG antibody levels to periodontal microbiota are associated with incident Alzheimer disease.](http://europepmc.org/articles/PMC4270775?pdf=render) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJames M Noble\nFull Text Available Periodontitis and Alzheimer disease (AD are associated with systemic inflammation. This research studied serum IgG to periodontal microbiota as possible predictors of incident AD.Using a case-cohort study design, 219 subjects (110 incident AD cases and 109 controls without incident cognitive impairment at last follow-up, matched on race-ethnicity, were drawn from the Washington Heights-Inwood Columbia Aging Project (WHICAP, a cohort of longitudinally followed northern Manhattan residents aged >65 years. Mean follow-up was five years (SD 2.6. In baseline sera, serum IgG levels were determined for bacteria known to be positively or negatively associated with periodontitis (Porphyromonas gingivalis, Tannerella forsythia, Actinobacillus actinomycetemcomitans Y4, Treponema denticola, Campylobacter rectus, Eubacterium nodatum, and Actinomyces naeslundii genospecies-2. In all analyses, we used antibody threshold levels shown to correlate with presence of moderate-severe periodontitis.Mean age was 72 years (SD 6.9 for controls, and 79 years (SD 4.6 for cases (p640 ng/ml, present in 10% of subjects was associated with increased risk of AD (HR = 2.0, 95%CI: 1.1-3.8. This association was stronger after adjusting for other significant titers (HR = 3.1, 95%CI: 1.5-6.4. In this model, high anti-E. nodatum IgG (>1755 ng/ml; 19% of subjects was associated with lower risk of AD (HR = 0.5, 95%CI: 0.2-0.9.Serum IgG levels to common periodontal microbiota are associated with risk for developing incident AD.\n[Soluci\u00f3n adyuvante CM-95 tratada magn\u00e9ticamente en comparaci\u00f3n con el adyuvante de Freund para la obtenci\u00f3n del suero de Coombs en conejo](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2009000300002&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nClara Mart\u00ednez\n2009-12-01\nFull Text Available En este trabajo se evalu\u00f3 la aplicaci\u00f3n de la soluci\u00f3n CM-95 tratada magn\u00e9ticamente como adyuvante inmunol\u00f3gico, en comparaci\u00f3n con el adyuvante de Freund, para la obtenci\u00f3n del suero de Coombs en conejos, de gran demanda en bancos de sangre y hospitales, para el diagn\u00f3stico cl\u00ednico de conflictos Rh y la enfermedad hemol\u00edtica del reci\u00e9n nacido, entre otras. Conejos Nueva Zelanda Blancos se inocularon por la v\u00eda subcut\u00e1nea con suero humano obtenido de 30 donantes O+, unido con la soluci\u00f3n CM-95 tratada magn\u00e9ticamente como adyuvante inmunol\u00f3gico. Se emple\u00f3 un esquema de inmunizaci\u00f3n de 40 d\u00edas, donde se evalu\u00f3 la din\u00e1mica en el t\u00edtulo de anticuerpos anti IgG humano por la t\u00e9cnica de hemoaglutinaci\u00f3n en tubos. Al antisuero se le determin\u00f3 la calidad inmunol\u00f3gica por el t\u00edtulo de heteroaglutininas de los grupos sangu\u00edneos A, B y O, de anticuerpos anticomplemento C3b, C3d y C4b y anti IgG, antes y despu\u00e9s de su purificaci\u00f3n. El suero de Coombs con la soluci\u00f3n adyuvante CM-95 tratada magn\u00e9ticamente mostr\u00f3 valores similares a los obtenidos con el adyuvante de Freund. En el mismo se cumpli\u00f3 con los requisitos establecidos por el Centro Estatal para el Control de la Calidad de los Medicamentos, seg\u00fan las normativas de la FDA para este diagnosticador. Estos resultados abren nuevas perspectivas para el uso de la soluci\u00f3n adyuvante en la obtenci\u00f3n del suero de Coombs.\n[Anti-NMDA receptor encephalitis and nonencephalitic HSV-1 infection.](https://www.ncbi.nlm.nih.gov/pubmed/29629396)\nSalovin, Amy; Glanzman, Jason; Roslin, Kylie; Armangue, Thais; Lynch, David R; Panzer, Jessica A\n2018-07-01\nTo determine whether there is an association between nonencephalitic herpes simplex virus 1 (HSV-1) infection and anti-NMDA receptor encephalitis (anti-NMDARE). Antibody testing was performed using samples from 2 cohorts in a case-control observational study. The cohort \"Philadelphia\" included 16 serum samples of pediatric anti-NMDARE cases and 42 age-matched controls with other neuroinflammatory disorders studied at the Children's Hospital of Philadelphia and University of Pennsylvania. The cohort \"Barcelona\" contained 23 anti-NMDARE patient samples and 26 age-matched participants with other neuroinflammatory disorders studied at IDIBAPS-Hospital Clinic, University of Barcelona. The presence of HSV-1 IgG antibodies was examined by ELISA. As an additional control, IgG antibodies to cytomegalovirus (CMV) and Epstein-Barr virus viral capsid antigen (EBV-VCA) were determined. In each cohort, more participants with anti-NMDARE than controls had anti-HSV-1 IgG antibodies. In the Philadelphia cohort (58 participants), 44% of anti-NMDARE cases had antibodies to HSV-1 compared with 14% controls (OR 4.67, 95% CI 1.3-17.3, p = 0.031). In the Barcelona cohort (49 participants), 52% of participants with anti-NMDARE had antibodies to HSV-1 compared with 31% of controls (OR 2.45, 95% CI 0.7-7.9, p = 0.155). Overall, 49% of anti-NMDARE cases have antibodies to HSV-1 in these 2 combined cohorts compared with 21% of controls (Mantel-Haenszel OR 3.21, 95% CI 1.3-7.7, p = 0.007). Past HSV-1 infection was found in significantly more anti-NMDARE cases than controls. This suggests a meaningful association between nonencephalitic HSV-1 infection and development of anti-NMDARE.\n[Detection of Serum IgG4 Levels in Patients with IgG4-Related Disease and Other Disorders](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4401680)\nWang, Chenqiong; Wu, Xuefen; Miao, Ye; Xiong, Hui; Bai, Lin; Dong, Lingli\n2015-01-01\nObjective Elevated serum IgG4 levels are an important hallmark for diagnosing IgG4-related disease (IgG4-RD), but can also be observed in other diseases. This study aimed to compare two different testing methods for IgG4: ELISA and nephelometric assay. Both assays were used to measure serum IgG4 concentrations, and to assess the prevalence of high serum IgG4 levels in both IgG4-RD and non-IgG4-RD diseases. Methods A total of 80 serum samples were tested using the nephelometric assay and ELISA method that we established. Serum IgG4 concentrations were determined by ELISA for 957 patients with distinct diseases, including 12 cases of IgG4-RD and 945 cases of non-IgG4-RD. Results IgG4 levels from 80 selected serum samples examined by ELISA were in agreement with those detected using the nephelometry assay. Meanwhile, the serum IgG4 concentrations measured by ELISA were also consistent with the clinical diagnoses of patients with IgG4-RD during the course of disease. The Elevated levels of serum IgG4 (>1.35 g/L) were detected in all IgG4-RD (12/12) patients, and the prevalence of high IgG4 serum levels was 3.39% in non-IgG4-RD cases. Among them, the positive rates of serum IgG4 were 2.06% in patients with carcinoma and 6.3% in patients with other non-IgG4 autoimmune diseases. Conclusion Our established ELISA method is a reliable and convenient technique, which could be extensively used in the clinic to measure serum IgG4 levels. High levels of IgG4 were observed in IgG4-RD. However, this phenomenon could also be observed in other diseases, such as carcinomas and other autoimmune diseases. Thus, a diagnosis of IgG4 disease cannot only be dependent on the detection of elevated serum IgG4 levels. PMID:25885536\n[Antiradiation Antitoxin IgG : Immunological neutralization of Radiation Toxins at Acute Radiation Syndromes.](http://adsabs.harvard.edu/abs/2010cosp...38.3536P)\nPopov, Dmitri; Maliev, Slava\nIntroduction: High doses of radiation induce apoptotic necrosis of radio-sensitive cells. Mild doses of radiation induce apoptosis or controlled programmed death of radio-sensitive cells with-out development of inflammation and formation of Radiation Toxins. Cell apoptotic necrosis initiates Radiation Toxins (RT)formation. Radiation Toxins play an important role as a trig-ger mechanism for inflammation development and cell lysis. If an immunotherapy approach to treatment of the acute radiation syndromes (ARS) were to be developed, a consideration could be given to neutralization of radiation toxins (Specific Radiation Determinants-SRD) by specific antiradiation antibodies. Therapeutic neutralization effects of the blocking anti-radiation antibodies on the circulated RT had been studied. Radiation Toxins were isolated from the central lymph of irradiated animals with Cerebrovascular(Cv ARS),Cardiovascular (Cr ARS),Gastrointestinal(Gi ARS) and Haemopoietic (Hp ARS) forms of ARS. To accomplish this objective, irradiated animals were injected with a preparation of anti-radiation immunoglobulin G (IgG) obtained from hyperimmune donors. Radiation-induced toxins that we call Specific Radiation Determinants (SRD) possess toxic (neurotoxic, haemotoxic) characteristics as well as specific antigenic properties. Depending on direct physiochemical radiation damage, they can induce development of many of the pathological processes associated with ARS. We have tested several specific hyperimmune IgG preparations against these radiation toxins and ob-served that their toxic properties were neutralized by the specific antiradiation IgGs. Material and Methods: A scheme of experiments was following: 1.Isolation of radiation toxins (RT) from the central lymph of irradiated animals with different form of ARS. 2.Transformation of a toxic form of the RT to a toxoid form of the RT. 3.Immunization of radiation naive animals. Four groups of rabbits were inoculated with a toxoid form of SRD\n[Early diagnosis of congenital toxoplasmosis in newborn infants using IgG subclasses against two Toxoplasma gondii recombinant proteins](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762012000300008&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nCarlos Henryque de Souza e Silva\n2012-05-01\nFull Text Available The aim of this work was to evaluate the utility of ELISA-based testing of total IgG (IgGt antibodies and its subclasses (IgG1, IgG2, IgG3 and IgG4 against soluble (STAg and recombinant (rSAG1 and rMIC3 antigens of Toxoplasma gondii for diagnosing congenital toxoplasmosis. Sera from 217 newborns initially testing positive for specific IgM in filter paper dried blood spots were tested for specific IgM and IgG by ELFA-VIDAS\u00ae. Congenital toxoplasmosis was confirmed in 175 and ruled out in 42 infants. The validity of the ELISA tests was determined using the persistence of IgG antibodies (ELFA-VIDAS\u00ae kit at the end of 12 months, which is considered the reference test for the diagnosis of congenital toxoplasmosis. The frequency of positivity with IgGt against STAg, rSAG1 and rMIC3 was found in 97.2%, 96.3% and 80.2%, respectively, of the newborns with confirmed congenital toxoplasmosis. IgG1 reacted with all three antigens, while IgG3 and IgG4 reacted preferentially with rMIC3. Higher mean values of reactivity (sample optical density/cut-off were found for all subclasses when using rMIC3. All of the antigens showed high sensitivity and low specificity in detecting anti-T. gondii IgGt and IgG1 and low sensitivity and high specificity in detecting IgG3 and IgG4. In conclusion, the combined detection of IgG antibody subclasses against recombinant toxoplasmic antigens may be useful for the early diagnosis of congenital toxoplasmosis.\n[ELISA indireto para detec\u00e7\u00e3o de IgG antiv\u00edrus da doen\u00e7a de Newcastle em soro de codorna Indirect ELISA for the detection of IgG specific to Newcastle disease virus in quail serum](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-09352007000500040) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nD.D. Oliveira\n2007-10-01\nFull Text Available An indirect ELISA for the detection of japanese quail IgG specific to Newcastle disease virus (NDV was developed. The secondary anti-quail IgG was produced in Balb/c mice, by inoculating Freund's complete adjuvant emulsified japanese quail-IgG extract. The purification of IgG was achieved using the caprilic acid method. The ELISA was compared to the haemagglutination-inhibition (HI test for antibodies to NDV. ELISA cut-off point was established through TG-ROC analysis. Total correlation was observed between the ELISA and the HI, being the ELISA efficient in the identification of positive and negative sera, with high sensitivity and specificity (100%. These results validate the use of the indirect ELISA as an alternative for the detection of NDV-specific IgG in japanese quail sera, with the advantage of high sensitivity and automation.\n[Diagnostic Performance of Serum IgG4 Levels in Patients With IgG4-Related Disease](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4616795)\nYu, Kuang-Hui; Chan, Tien-Ming; Tsai, Ping-Han; Chen, Ching-Hui; Chang, Pi-Yueh\n2015-01-01\nAbstract The aim of this study is to study the clinical features and diagnostic performance of IgG4 in Chinese populations with IgG4-related diseases (IgG4-RDs). The medical records of 2901 adult subjects who underwent serum IgG4 level tests conducted between December 2007 and May 2014 were reviewed. Serum concentrations of IgG4 were measured in 2901 cases, including 161 (5.6%) patients with IgG4-RD and 2740 (94.4%) patients without IgG4-RD (non-IgG4-RD group). The mean age of the IgG4-RD patients was 58.4 \u00b1 16.1 years (range: 21\u201387), and 48 (29.8%) were women. The mean serum IgG4 level was significantly much higher in IgG4-RD patients than in non-IgG4-RD (1062.6 vs 104.3 mg/dL, P IgG4 >135 mg/dL, the sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), likelihood ratio (LR)+, and LR\u2212 were 86%, 77%, 18%, 99%, 3.70, and 0.19, respectively. When the upper limit of normal was doubled for an IgG4 >270 mg/dL, the corresponding data were 75%, 94%, 43%, 98%, 12.79, and 0.26, respectively. For IgG4 >405 mg/dL (tripling the upper limit of normal), the corresponding data were 62%, 98%, 68%, 98%, 37.00, and 0.39, respectively. When calculated according to the manufacturer's package insert cutoff (>201 mg/dL) for the diagnosis of IgG4-RD, the corresponding sensitivity, specificity, PPV, NPV, LR+, and LR\u2212 were 80%, 89%, 29%, 99%, 7.00, and 0.23, respectively. For IgG4 >402 mg/dL (>2\u00d7 the upper limit of the normal range), the corresponding data were 62%, 98%, 68%, 98%, 36.21, and 0.39, respectively. For IgG4 >603 mg/dL (>3\u00d7 the upper limit of the normal range), the corresponding data were 50%, 99%, 84%, 97%, 90.77 and 0.51, respectively. The optimal cutoff value of serum IgG4 (measured by nephelometry using a Siemens BN ProSpec instrument and Siemens reagent) for the diagnosis of IgG4-RD was 248 mg/dL, the sensitivity and specificity were 77.6% and 92.8%, respectively. The present study demonstrated that 2 or\n[Falsely low immunoglobulin (Ig)G4 in routine analysis: how not to miss IgG4 disease.](https://www.ncbi.nlm.nih.gov/pubmed/27125474)\nEgner, W; Swallow, K; Lock, R J; Patel, D\n2016-10-01\nImmunoglobulin (Ig)G4 disease can have apparently 'normal' levels of IgG4 due to antigen excess conditions. IgG4 measurement therefore appears falsely low. UK National External Quality Assurance Scheme (UK NEQAS) data and other reports have suggested that this problem occurred despite pre-existing antigen excess detection steps. To determine the clinical relevance of the problem, we examined the prevalence and characteristics of prozoning in our laboratory and patient cohorts. We establish that the prevalence of raised IgG4 in routine IgG4 analysis is low (IgG4 samples in our patients. This may explain the previous reports of low sensitivity of raised IgG4 for IgG4RD, and predictive values should be re-evaluated in this disease using modified prozone-resistant protocols. All laboratories providing IgG4 measurements should verify that their assays are fit for the clinical quality requirement of detection raised IgG4 levels and must verify the upper limit of their reference ranges and freedom from prozoning. \u00a9 2016 British Society for Immunology.\n[[Serum immunoglobulin IgG subclass distribution of antibody responses to pertussis toxin and filamentous hemagglutinin of Bordetella pertussis in patients with whooping cough].](https://www.ncbi.nlm.nih.gov/pubmed/24730215)\nRastawicki, Waldemar; Smieta\u0144ska, Karolina; Rokosz-Chudziak, Natalia; Jagielski, Marek\n2013-01-01\nThe present study was aimed at determining the IgG subclass distribution against pertussis toxin (PT) and filamentous hemagglutinin (FHA) of Bordetella pertussis in patients with whooping cough. The total number of 222 serum samples obtained from patients suspected in clinical investigation for pertussis were tested separately by in-house ELISA for the presence of IgG antibodies to pertussis toxin and filamentous hemagglutinin. The percentage distribution of specific anti-PT and anti-FHA IgG subclass response was calculated only on the basis of group of sera confirmed in the present study as positive for total IgG antibodies (183 sera to PT antigen and 129 to FHA antigen). Paired serum specimens were obtained from 36 patients. Based on the results of determining the level of antibodies in the sera of 40 blood donors, the cut-off limit of serum antibodies for each subclass was set at arithmetic mean plus two standard deviations. Antibodies of IgG1 to pertussis toxin and filamentous hemagglutinin were diagnosed in 151 (82.5%) and 99 (76.7%), IgG2 in 72 (39.0%) and 50 (38.8%), IgG3 in 17 (9.3%) and 43 (33.3%), IgG4 in 55 (30.1%) and 53 (41.1%) serum samples, respectively. There were no significant differences in percentage of sera with IgG1, IgG2 and IgG3 in relation to age of the patients. However, the frequency of occurrence of IgG4 antibodies was highest in the group of the youngest children to the age of 6 years old (61.8% for PT and 68.0% for FHA), and decrease with age, reaching the minimum in the group of patients above 40 years old (13.2% and 4.2% for PT and FHA, respectively). We also found significantly higher frequency of IgG4 to PT and FHA antigens in men than in women. Statistically significant, essential changes in the pattern of IgG subclass during the course of infection were not found. In conclusion, this study showed that all four subclasses of IgG antibodies to pertussis toxin and filamentous hemagglutinin are produced during whooping cough.\n[Increased levels of anti-glycan antibodies in patients with cystic fibrosis](http://www.eurjmedres.com/content/16/9/385) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nHirche TO\n2011-09-01\nFull Text Available Abstract Background The prevalence of Crohn's disease (CD is increased in patients with cystic fibrosis (CF. Anti-Saccharomyces cerevisiae antibodies (ASCA have been suggested as a screening tool to detect CD in CF. Recently, several new anti-glycan antibodies have been reported in CD. Materials and methods The sera of 119 CF patients of various age groups were prospectively screened for ASCA type IgG (gASCA, anti-laminaribioside carbohydrate IgG antibodies (ALCA, anti-chitobioside carbohydrate IgA antibodies (ACCA, and anti-mannobioside carbohydrate IgG antibodies (AMCA. The frequency of these anti-glycan antibodies was then compared in patients with CD, ulcerative colitis, rheumatoid arthritis and healthy volunteers. Results A significant number of CF patients were positive for gASCA (51.3% [41.6-60.6] and up to three other anti-glycan antibodies concurrently. Serum levels of anti-glycan antibodies in CF and CD were not related to parameters of inflammation. Despite the well-documented difference in clinical course between male and female CF patients no gender difference of anti-glycan antibodies was found. In contrast, there was a significant positive correlation between anti-glycan markers and age in CF patients. Conclusions Our findings demonstrate for the first time the increased frequency of a panel of anti-glycan antibodies in CF and provide a link between the presence of these serological biomarkers and patient's age. Anti-glycan antibody profiling may therefore become a valuable tool in the care of patients with CF.\nBozzalla Cassione, Emanuele; Stone, John H\n2017-05-01\nRemarkable insights have been gleaned recently with regard to the pathophysiology of IgG4-related disease (IgG4-RD). These findings have direct implications for the development of targeted strategies for the treatment of this condition. Oligoclonal expansions of cells of both the B and T lymphocyte lineages are present in the blood of patients with IgG4-RD. Oligoclonal expansions of plasmablasts are a good biomarker for disease activity. An oligoclonally expanded population of CD4+ cytotoxic T lymphocytes is found not only in the peripheral blood but also at tissue sites of active disease. This cell elaborates cytokines that may drive the fibrosis characteristic of IgG4-RD. T follicular helper cells (Tfhc), particularly the Tfhc2 subset, appear to play a major role in driving the class switch to IgG4 that typifies this disease. The relationship between malignancy and IgG4-RD remains an area of interest. Advances in understanding the pathophysiology of IgG4-RD have proceeded swiftly, leading to the identification of a number of potential targeted treatment strategies. The completion of classification criteria for IgG4-RD, an effort supported jointly by the American College of Rheumatology and the European League Against Rheumatism, will further facilitate studies on this disease.\n[Radioimmunoassay of IgG and IgM rheumatoid factors reacting with human IgG](https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=8346974) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nCarson, D.A.; Lawrance, S.; Catalano, M.A.; Vaughan, J.H.; Abraham, G.\n1977-01-01\nAlthough IgG rheumatoid factor may play a central role in the pathogenesis of rheumatoid arthritis, previously there have been no precise methods for its specific measurement in serum and synovial fluid. This paper describes a solid phase radioimmunoassay for the independent quantification of IgM and IgG rheumatoid factor reacting with the Fc fragment of human IgG. As measured by this assay, serum IgG rheumatoid factor levels differed significantly between patients with seropositive and seronegative rheumatoid arthritis and normal control subjects. In addition, several sera and joint fluids from patients with seropositive rheumatoid arthritis, even without vasculitis, were shown by gel chromatography to have acid-dissociable complexes of IgG rheumatoid factor suggestive of IgG-IgG dimer or trimer formation\n[Induction of IgG3 to LPS via Toll-like receptor 4 co-stimulation.](http://europepmc.org/articles/PMC2566810?pdf=render) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nFrancisco J Quintana\nFull Text Available B-cells integrate antigen-specific signals transduced via the B-cell receptor (BCR and antigen non-specific co-stimulatory signals provided by cytokines and CD40 ligation in order to produce IgG antibodies. Toll-like receptors (TLRs also provide co-stimulation, but the requirement for TLRs to generate T-cell independent and T-cell dependent antigen specific antibody responses is debated. Little is known about the role of B-cell expressed TLRs in inducing antigen-specific antibodies to antigens that also activate TLR signaling. We found that mice lacking functional TLR4 or its adaptor molecule MyD88 harbored significantly less IgG3 natural antibodies to LPS, and required higher amounts of LPS to induce anti-LPS IgG3. In vitro, BCR and TLR4 signaling synergized, lowering the threshold for production of T-cell independent IgG3 and IL-10. Moreover, BCR and TLR4 directly associate through the transmembrane domain of TLR4. Thus, in vivo, BCR/TLR synergism could facilitate the induction of IgG3 antibodies against microbial antigens that engage both innate and adaptive B-cell receptors. Vaccines might exploit BCR/TLR synergism to rapidly induce antigen-specific antibodies before significant T-cell responses arise.\n[La criptosporidiosis en la regi\u00f3n andina de Colombia: seroprevalencia y reconocimiento de ant\u00edgenos](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892000001100001) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nVergara Castiblanco Claudia\n2000-01-01\nFull Text Available El objetivo de este estudio fue investigar, por primera vez, la seroprevalencia de la criptosporidiosis en habitantes urbanos y rurales de distintos departamentos de la regi\u00f3n andina de Colombia. Se estudi\u00f3 tambi\u00e9n el reconocimiento de ant\u00edgenos de Cryptosporidium parvum por los sueros. Entre junio de 1996 y octubre de 1998 se recogieron 1 778 muestras s\u00e9ricas de personas seleccionadas mediante un muestreo \"de conveniencia\". La detecci\u00f3n de anticuerpos (IgM, IgA e IgG anti-C. parvum se realiz\u00f3 mediante la t\u00e9cnica de ELISA y el reconocimiento de ant\u00edgenos, por una t\u00e9cnica de inmunoelectrotransferencia. Se hall\u00f3 una prevalencia de 83,3%, mientras que los porcentajes de anticuerpos fueron 72,2% de IgM; 27,7% de IgA y 27,6% de IgG. Los porcentajes de seropositividad m\u00e1s altos se obtuvieron en mujeres, menores de 30 a\u00f1os de edad y personas de procedencia rural. Se observ\u00f3 que la seroprevalencia de IgM disminuye a medida que aumenta la edad, mientras que las de IgG e IgA aumentan al par que la edad. Estos tres isotipos reconocieron con mayor frecuencia los ant\u00edgenos de 51 a 69 kDa, que pueden considerarse inmunodominantes. Se destac\u00f3 la inmunorreactividad de IgM e IgA a fracciones prote\u00ednicas de 12 a 14 kDa y de 42 a 48 kDa, respectivamente, lo que podr\u00eda indicar exposici\u00f3n al par\u00e1sito. Estos resultados parecen indicar que la criptosporidiosis es end\u00e9mica en esa regi\u00f3n de Colombia, por lo que es posible atribuir muchos casos de s\u00edndrome diarreico a C. parvum.\n[IgG4-producing lymphoma arising in a patient with IgG4-related disease.](https://www.ncbi.nlm.nih.gov/pubmed/27068526)\nIgawa, Takuro; Hayashi, Toshiaki; Ishiguro, Kazuya; Maruyama, Yumiko; Takeuchi, Mai; Takata, Katsuyoshi; Yoshino, Tadashi; Sato, Yasuharu\n2016-12-01\nWe herein report a case in which an IgG4-producing lymphoma arose in a patient with a previous diagnosis consistent with an IgG4-related disease. A 43-year-old man presented with enlarged cervical lymph nodes and was treated with steroids and radiation for what was initially assumed to be Kimura's disease, although the lesions were later histologically re-diagnosed as IgG4-related lymphadenopathy. Fourteen years later, when the patient was 58-years-old, he presented with retroperitoneal fibrosis and swollen lymph nodes. The suspicious lesions were not histologically examined as the patient did not give consent. However, the serum IgG4 concentration was high (1400 mg/dL) and he was clinically diagnosed with systemic IgG4-related disease. Although steroid administration reduced the size of the lesions, tapering the dose finally resulted in systemic, prominently enlarged lymph nodes. Analysis of the biopsy specimen revealed that these multiple lymph node lesions were marginal zone B cell lymphomas that themselves expressed IgG4. Complete remission was achieved after a total of six courses of chemotherapy including rituximab. This case suggests that the infiltrating IgG4-expressing cells observed in IgG4-related disease can clonally expand to malignant lymphomas.\n[Assessment of IgG Antibodies Against HSV1, HSV2, CMV and EBV in Patients with Pemphigus Vulgaris versus Healthy People](http://jdt.tums.ac.ir/index.php/jdt/article/view/1177) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nParichehr Ghalayani\n2016-08-01\nFull Text Available Objectives: Regarding the implication of viruses particularly herpes in pemphigus vulgaris, we sought to assess and compare the level of immunoglobulin G (IgG antibodies against herpes simplex virus types 1 and 2 (HSV1 and HSV2, cytomegalovirus (CMV and Epstein-Barr virus (EBV in patients with pemphigus vulgaris and healthy people. Materials and Methods: In this cross-sectional study, 25 patients with pemphigus vulgaris and 27 healthy individuals comprised the experimental and control groups, respectively. Serum samples were taken from both groups; the levels of IgG antibodies against HSV1, HSV2, CMV and EBV were measured using ELISA. Results: Immunoglobulin G titer was higher for all four viruses in the patient group in comparison to the control group. This difference was significant for anti-EBV (P= 0.005, anti-CMV (P=0.0001 and anti-HSV2 (P=0.001 but not significant for anti-HSV1 (P= 0.36.Conclusion: Viruses including EBV, CMV, and HSV2 probably play a role in the pathogenesis of pemphigus in addition to the effects of genetics, toxins and other predisposing factors. In this study, no statistically significant relationship was observed between HSV1 and pemphigus vulgaris, which was probably due to the high titer of anti-HSV1 IgG in healthy individuals in the community. More studies must be done in this regard.\n[Membranous glomerulonephritis in a patient with anti-u1 ribonucleoprotein (RNP antibody-positive mixed connective tissue disease: A case report](http://www.sciencedirect.com/science/article/pii/S2214330017300809) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nNaoya Toriu\n2018-03-01\nFull Text Available We report a 33-year-old Japanese man diagnosed with mixed connective tissue disease (MCTD who developed nephrotic proteinuria. Both speckled antinuclear antibody (ANA and anti-U1 ribonucleoprotein (RNP antibody were positive, but anti-double-stranded DNA (dsDNA antibody and anti-Smith (Sm antibody were negative, while complement levels were normal. Renal biopsy revealed membranous glomerulonephritis (MGN with diffuse thickening of the glomerular basement membrane (GBM plus spike and bubble formation. Immunofluorescence demonstrated granular deposits of IgG and C3 along the GBM. Analysis of IgG subclasses showed predominant deposition of IgG1 and IgG4, unlike typical lupus nephritis in which there is predominant deposition of IgG1, IgG2, IgG3, and C1q. Electron microscopy identified numerous large electron-dense deposits (EDD of various types in the subepithelial region of the GBM, but there were no EDD localized in the mesangium or subendothelium. Based on these findings, MGN was considered to be closely related to MCTD in this patient.\n[Prevalencia de anticuerpos contra Brucella sp. En donantes del banco de sangre de un hospital de Lima](http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1726-46342007000400013&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAbel Ortega\n2007-10-01\nFull Text Available El Per\u00fa es un pa\u00eds end\u00e9mico de Brucelosis, por lo que existe el riesgo de transmisi\u00f3n a trav\u00e9s de sangre donada por no ser parte del tamizaje regular que realizan los bancos de sangre. Para conocer la prevalencia de anticuerpos contra Brucella en donantes del banco de sangre del Hospital Edgardo Rebagliati Martins, se analiz\u00f3 1003 muestras de suero. La prueba tamiz fue Rosa de Bengala (RB; las muestras positivas fueron evaluadas por las pruebas de aglutinaci\u00f3n en tubo (AT y 2-Mercaptoetanol (2-ME. Dos donantes fueron positivos a RB, confirmados por AT y 2-ME, se encontr\u00f3 una prevalencia de 0,20% (IC99%: 0,01-0,92. Se demostr\u00f3 la presencia de donantes portadores de anticuerpos contra Brucella con posible Brucelosis activa, evidenci\u00e1ndose la posibilidad de transmisi\u00f3n de esta infecci\u00f3n. Se debe realizar mayores estudios con la finalidad de conocer la realidad de otros bancos de sangre.\n[Japanese encephalitis can trigger anti-N-methyl-D-aspartate receptor encephalitis.](https://www.ncbi.nlm.nih.gov/pubmed/28470592)\nMa, Jiannan; Zhang, Ting; Jiang, Li\n2017-06-01\nJapanese encephalitis (JE) is usually a monophasic disease; however, in rare cases, patients with JE may have an early relapse after a partial recovery, giving rise to a biphasic pattern for the disease. In this study, we report three pediatric cases in which post-JE relapse was characterized by movement disorder and/or behavioral problems, and was related to anti-N-methyl-D-aspartate receptor (NMDAR) immunoglobulin G (IgG). Serum and cerebrospinal fluid were examined for anti-NMDAR IgG in three patients who had confirmed JE and then developed relapsing symptoms which were similar to those of anti-NMDAR encephalitis. The main symptoms of the two young children were choreoathetosis, irritability, and sleep disorder; while for the teenager, agitation, mutism, rigidity, and sleep disorder were the main symptoms. Samples of cerebrospinal fluid from all patients were positive for anti-NMDAR IgG, and all patients gradually improved with immunotherapy. Testing for NMDAR antibodies is highly recommend in patients with JE, especially those with a relapsing syndrome involving movement disorder and/or behavioral problems, as these patients may benefit from immunotherapy.\n[Prevalencia de anticuerpos contra Trypanosoma cruzi en donadores de sangre del IMSS, Orizaba, Veracruz, M\u00e9xico](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0036-36342006000100004) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nRamos-Ligonio Angel\n2006-01-01\nFull Text Available OBJETIVO: Determinar la prevalencia de anticuerpos contra Trypanosoma cruzi en donadores del Hospital General Regional del Instituto Mexicano del Seguro Social (IMSS en la ciudad de Orizaba, Veracruz. MATERIAL Y M\u00c9TODOS: Se examinaron muestras de donadores del banco de sangre del Hospital General Regional (HGRO del IMSS para la b\u00fasqueda de antiT. cruzi por ELISA, Western blot e IFI, utilizando una prote\u00edna recombinante (MBP::Hsp70 y un extracto crudo de epimastigotes. Las muestras fueron obtenidas entre los meses de octubre de 2001 a enero de 2002. RESULTADOS: Los 420 donadores de sangre analizados fueron seronegativos para HBV, HCV, BrA, VDRL y HIV. Despu\u00e9s del tamizaje de los 420 donadores, se identificaron dos individuos seropositivos por las pruebas de ELISA, Western blot e IFI, con una seroprevalencia de 0.48%. CONCLUSIONES: En este estudio se muestran evidencias de seropositividad para T. cruzi en donadores de sangre del HGRO, lo que sugiere la existencia de riesgo de contaminaci\u00f3n por transfusi\u00f3n sangu\u00ednea. Por tal motivo, es necesario aplicar programas para el tamizaje serol\u00f3gico a trav\u00e9s de t\u00e9cnicas inmunol\u00f3gicas con alta sensibilidad y especificidad.\n[Cerebrospinal fluid anti-Epstein-Barr virus specific oligoclonal IgM and IgG bands in patients with clinically isolated and Guillain-Barr\u00e9 syndrome.](https://www.ncbi.nlm.nih.gov/pubmed/27878471)\nFerraro, Diana; Galli, Veronica; Simone, Anna Maria; Bedin, Roberta; Vitetta, Francesca; Merelli, Elisa; Nichelli, Paolo Frigio; Sola, Patrizia\n2017-04-01\nEpstein-Barr virus (EBV) has been implicated in multiple sclerosis (MS) pathogenesis. We aimed to assess the frequency of EBV-specific IgG and IgM oligoclonal bands (OCB) in cerebrospinal fluid (CSF) of 50 patients with clinically isolated syndrome (CIS) and in 27 controls with Guillain-Barr\u00e9 syndrome (GBS). Furthermore, we assessed correlations between the presence of OCB and CIS patients' CSF, MRI, and clinical variables. There was no difference in the proportion of CIS and GB patients with positivity for anti-EBV-specific IgG/IgM OCB. There were no correlations between OCB and analyzed variables, nor were they predictive of a higher disability at 3 years.\n[Interleukin-7 (IL-7) enhances class switching to IgE and IgG4 in the presence of T cells via IL-9 and sCD23.](https://www.ncbi.nlm.nih.gov/pubmed/9454766)\nJeannin, P; Delneste, Y; Lecoanet-Henchoz, S; Gretener, D; Bonnefoy, J Y\n1998-02-15\nInterleukin-7 (IL-7) is a B-cell growth factor produced by both bone marrow stroma cells and follicular dendritic cells (FDCs) located in primary lymphoid follicles and germinal centers. In this study, we have evaluated the role of IL-7 on human Ig class switching. IL-7 was added to peripheral blood mononuclear cells (PBMCs) or tonsillar B cells in the absence or presence of IL-4 and/or anti-CD40 monoclonal antibody (MoAb). Alone, IL-7 did not affect Ig production by PBMCs or by anti-CD40 MoAb-stimulated B cells. Rather, IL-7 potentiated IL-4-induced IgE and IgG4 production by PBMCs. In parallel, IgG3 production was also enhanced but to a lesser extent, whereas the production of the other isotypes was unaltered. The activity of IL-2, IL-9, or IL-15, which share usage of the common gamma chain for signaling, was also assessed. IL-9, like IL-7, potentiated mainly IgE and IgG4 production by IL-4-stimulated PBMCs. IL-15, in contrast, was ineffective, whereas IL-2 enhanced the production of all isotypes. More precisely, IL-7 potentiation of IgE and IgG4 production required the presence of T cells and was accompanied by an increase of the expression of two soluble molecules favoring preferentially IgE and IgG4 synthesis: CD23 (sCD23) and IL-9. Moreover, neutralizing anti-CD23 and anti-IL-9 antibodies partly inhibited the increase of IgE synthesis induced by IL-7. Thus, IL-7 produced locally in the germinal centers by FDCs may interact with T cells and potentiate human IgE and IgG4 switching by favoring IL-9 and sCD23 production.\n[Control externo de la calidad del diagn\u00f3stico serol\u00f3gico del dengue en laboratorios de pa\u00edses de las Am\u00e9ricas, 1996-2001 Quality control of the serological diagnosis of dengue in laboratories throughout the Americas, 1996-2001](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892003001100001) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMar\u00eda G. Guzm\u00e1n\n2003-12-01\nFull Text Available OBJETIVO: Dar a conocer los resultados de cuatro controles externos de la calidad del diagn\u00f3stico serol\u00f3gico del dengue realizados en la Regi\u00f3n de las Am\u00e9ricas en el per\u00edodo de 1996- 2001 y presentar los resultados obtenidos por los laboratorios participantes. M\u00c9TODOS: Se realizaron controles externos de la calidad del diagn\u00f3stico serol\u00f3gico del dengue en 1996-1997, 1998-1999, 1999-2000 y 2000-2001. Paneles compuestos por 20 sueros (12 de estos positivos a anticuerpos IgM contra el dengue fueron enviados a laboratorios de la Regi\u00f3n para que participaran en los controles realizados. Los sueros de los paneles eran negativos a anticuerpos contra el virus de la inmunodeficiencia humana y el virus de la hepatitis C, as\u00ed como al ant\u00edgeno de superficie de la hepatitis B, y fueron almacenados a -20 \u00b0C hasta su env\u00edo en refrigeraci\u00f3n a los laboratorios participantes. La presencia de anticuerpos IgM se determin\u00f3 mediante un ensayo inmunoenzim\u00e1tico (ELISA de captura, mientras que el t\u00edtulo de anticuerpos IgG se determin\u00f3 por inhibici\u00f3n de la hemoaglutinaci\u00f3n o ELISA de IgG. Los resultados de la determinaci\u00f3n de anticuerpos IgM contra el dengue que no coincid\u00edan con los del centro de referencia se consideraron discordantes. El t\u00edtulo de anticuerpos IgG se consider\u00f3 discordante cuando los resultados difirieron en dos diluciones o m\u00e1s con respecto al resultado del centro de referencia. RESULTADOS: Un total de 27 laboratorios recibi\u00f3 59 paneles de sueros de 1996 a 2001, y se recibieron los resultados del an\u00e1lisis de 54 de esos paneles (91,5%. De 1 080 sueros (20 X 54, 95,6% coincidieron con el laboratorio de referencia en cuanto a los resultados de la detecci\u00f3n de anticuerpos IgM contra el dengue. Adem\u00e1s, en 47 paneles (87% la coincidencia con el laboratorio de referencia se observ\u00f3 en 90% de las muestras del panel o m\u00e1s. De los 27 paneles para los cuales se recibieron los resultados de los t\u00edtulos de anticuerpos IgG contra el\n[Characterization of the anti-factor VIII immunoglobulin profile in patients with hemophilia A by use of a fluorescence-based immunoassay](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4383171)\nBoylan, Brian; Rice, Anne S.; Dunn, Amy L.; Tarantino, Michael D.; Brettler, Doreen B.; Barrett, John C.; Miller, Connie H.\n2015-01-01\nSummary Background The development of neutralizing antibodies, referred to as inhibitors, against factor VIII (FVIII) is a major complication associated with FVIII infusion therapy for the treatment of hemophilia A (HA). Previous studies have shown that a subset of HA patients and a low percentage of healthy individuals harbor non-neutralizing anti-FVIII antibodies that do not elicit the clinical manifestations associated with inhibitor development. Objective Assess HA patients' anti-FVIII antibody profiles as potential predictors of clinical outcomes. Methods A fluorescence immunoassay (FLI) was used to detect anti-FVIII antibodies in 491 samples from 371 HA patients. Results Assessments of antibody profiles showed that the presence of anti-FVIII IgG1, IgG2, or IgG4 correlated qualitatively and quantitatively with the presence of a FVIII inhibitor as reported by the Nijmegen-Bethesda assay (NBA). Forty-eight patients with a negative inhibitor history contributed serial samples to the study, including seven patients who had negative NBA titers initially and later converted to NBA-positive. The FLI detected anti-FVIII IgG1 in five of those seven patients prior to their conversion to NBA-positive. Five of 15 serial-sample patients who had a negative inhibitor history and a positive anti-FVIII IgG1 later developed an inhibitor, compared to 2 of 33 patients with a negative inhibitor history without anti-FVIII IgG1. Conclusions These data provide a rationale for future studies designed both to monitor the dynamics of anti-FVIII antibody profiles in HA patients as a potential predictor of future inhibitor development and to assess the value of the anti-FVIII FLI as a supplement to traditional inhibitor testing. PMID:25354263\n[IgG4-Related Sclerosing Cholangitis.](https://www.ncbi.nlm.nih.gov/pubmed/27466792)\nNakazawa, Takahiro; Shimizu, Shuya; Naitoh, Itaru\n2016-08-01\nMore men than women develop immunoglobulin G4-related sclerosing cholangitis (IgG4-SC). Age at clinical onset is significantly older in patients with IgG4-SC. Patients with IgG4-SC appear similar to those with cholangiocarcinoma and primary sclerosing cholangitis (PSC). The association between IgG4-SC and autoimmune pancreatitis (AIP) is useful for the diagnosis of IgG4-SC. However, some IgG4-SC cases are isolated from AIP and are difficult to diagnose. The authors focus on three distinct features of IgG4-SC. First, diffuse inflammation induces a longer stenosis on cholangiography in contrast to the short stenosis of patients with PSC. Second, fibroinflammatory involvement is observed mainly in the stroma of the bile duct wall, whereas the bile duct epithelium is intact. Third, steroid therapy results in remarkable improvement. Although the prognosis of patients with IgG4-SC is good, some cases have developed portal hypertension and liver cirrhosis during their clinical course. Further study is needed to elucidate the long-term outcomes and mechanism of IgG4-SC. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.\n[DEFF Research Database (Denmark)](http://forskningsbasen.deff.dk/?lang=eng)\nDetlefsen, S; Kl\u00f6ppel, G\n2016-01-01\ninfiltrate, 2) storiform fibrosis and 3) obliterative phlebitis. The diagnosis is further supported by immunohistochemical demonstration of an increased infiltration of IgG4-positive plasma cells and an elevated IgG4/IgG ratio. The morphological criteria of IgG4-RD are in most cases detectable in biopsies...\n[On the role of IgG4 in inflammatory conditions: lessons for IgG4-related disease](https://www.narcis.nl/publication/RecordID/oai%3Apure.amc.nl%3Apublications%2F13865e81-407c-41d6-b2d7-cc42a1ab79dc/uquery/IGG4/id/19/Language/EN)\nTrampert, David C.; Hubers, Lowiek M.; van de Graaf, Stan F. J.; Beuers, Ulrich\n2017-01-01\nThe pathophysiology of immunoglobulin G4-related disease (IgG4-RD) and its most common manifestations, IgG4-associated (sclerosing) cholangitis and autoimmune pancreatitis, remains largely unknown, but IgG4 is presumably involved. IgG4 is a promiscuous antibody, which could be directly pathogenic,\n[A Comparative Analysis of Serum IgG4 Levels in Patients With IgG4-Related Disease and Other Disorders.](https://www.ncbi.nlm.nih.gov/pubmed/28918831)\nWang, Li; Chu, Xinmin; Ma, Yan; Zhang, Min; Wang, Xue; Jin, Li; Tan, Zhen; Li, Xiangpei; Li, Xiaomei\n2017-09-01\nElevated serum IgG4 levels are an important hallmark for diagnosing IgG4-related disease (IgG4-RD) but can also be found and reported in other diseases. The present study intended to compare the serum IgG4 levels in both IgG4-RD and non-IgG4-RD and determine the serum IgG4 levels in patients with IgG4-RD before and after glucocorticoid therapy. The study included 323 patients from Anhui Medical University Affiliated Provincial Hospital (China) and was conducted from July 2014-January 2016. A total of 25 patients were eventually diagnosed as having IgG4-RD, according to the IgG4-RD diagnostic criteria. Our study also included 108 patients with connective tissue disease, 94 patients with pancreatic lesions, 66 patients with bile duct lesions, 13 patients with carcinoma of the duodenal papilla and 20 control participants. The assay for serum IgG4 detection was peformed using the nephelometric method. Elevated levels of serum IgG4 (>1.35g/L) were detected in all patients with IgG4-RD, and reduced levels of serum IgG4 (IgG4-RD. The serum IgG4 level in patients with IgG4-RD after glucocorticoid therapy was significantly lower than that before glucocorticoid therapy (t = 2.426, P = 0.04). High levels of IgG4 were observed in IgG4-RD. However, a diagnosis of IgG4 disease can not only be dependent on the detection of elevated serum IgG4 levels but also may need clinical manifestations, serology, histopathology and other comprehensive information for verification. Copyright \u00a9 2017 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.\n[Human anti-luteinizing hormone-releasing hormone antibodies in patients treated with synthetic luteinizing hormone-releasing hormone](https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=17068271) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nMeakin, J.L.; Keogh, E.J.; Martin, C.E.\n1985-01-01\nOne hundred sixty-three patients who were given synthetic LH-RH therapeutically underwent monitoring of serum IgG anti-LH-RH antibodies. Five of the patients showed specific binding to antibodies. Development of anti-LH-RH antibodies was not limited to those patients with a congenital deficiency of LH-RH. Urticarial responses occurred in four patients, only one of whom had IgG antibodies. Patients who had IgG antibodies or an urticarial response underwent monitoring of their serum IgE anti-LH-RH antibodies, but none had a positive binding response. The refractory state which has been reported in patients in whom similar antibodies to LH-RH develop was not invariably observed among these patients\n[Histopathological Diagnostic Value of the IgG4+/IgG+ Ratio of Plasmacytic Infiltration for IgG4-Related Diseases](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4553963)\nDeng, Chuiwen; Li, Wenli; Chen, Si; Zhang, Wen; Li, Jing; Hu, Chaojun; Wen, Xiaoting; Zhang, Fengchun; Li, Yongzhe\n2015-01-01\nAbstract This article aims to perform a meta-analysis to evaluate the diagnostic value of the immunoglobulin G (IgG)4+/IgG+ ratio of plasmacytic infiltration for IgG4-related diseases. Four databases\u2014EMBASE, ISI Web of Knowledge, PubMed, and the Cochrane Library\u2014were systematically searched. Approximately 200 participants from several studies were included in this research. STATA 11.2 software (Stata Corporation, College Station, TX) and Meta-DiSc 1.4 (Unit of Clinical Biostatistics, Ramon y Cajal Hospital, Madrid, Spain) were used to perform the meta-analysis. Nine studies were included in the meta-analysis. The pooled diagnostic odds ratio was 18.94 [95% confidence interval (CI), 2.89\u2013124.30]. The sensitivity was 58.80% (95% CI, 50.90\u201366.30) and the specificity was 90.20% (95% CI, 81.20\u201395.80). The positive and negative likelihood ratios were 3.12 (95% CI, 1.07\u20139.16) and 0.26 (95% CI, 0.09\u20130.70), respectively. The area under the curve of the summary receiver-operating characteristic was 0.88. To conclude, the IgG4+/IgG+ ratio of plasmacytic infiltration is modestly effective in diagnosing IgG-related disease. PMID:25738476\n[Detection of anti-dsDNA by IgG ELISA test using two different sources of antigens: calf thymus versus E.coli](http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/12830.pdf&manuscript_id=12830) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMohammadi M\n2009-04-01\nFull Text Available \"nBackground: Anti-dsDNA antibodies frequently found in the sera Systemic Lupus Erythematosus patients, particularly in active disease stage. Nowadays exploit different eukaryotic and prokaryotic dsDNA as antigen source and different reagents as binder. The aim of this study to compared two dsDNA different sources and tow different kinds of reagents for binder in ELISA test. \"nMethods: In this study bacterial genomic DNA from E.coli (ATCC 25922 and genomic DNA from calf thymus extracted with high purity and were used as antigens for IgG anti-dsDNA detection by ELISA. To coat dsDNA in microtiter wells, tow different kinds of reagents including methylated -BSA and poly-l-lysine (for pre-coating are used. Sera from systemic lupus erythematosus patients and from normal blood donors are used to assess sensitivity and specificity of our ELISA test in compared with IF test and commercial kits. \"nResults: Our results displayed pre-coating of microtiter plates with methylated -BSA reduce nonspecific binding reaction and the relative sensitivity and specificity of ELISA increased when calf thymus DNA is employed as antigenic source in compared with IF test and commercial kits 80%, 88% and 100%, 98% respectively, but when E.coli DNA is used 73%, 69% and 85%, 79%, respectively. \"nConclusion: The genomic DNA from calf thymus is a potentially useful source of antigen for detection of anti-dsDNA by ELISA. Also the use of methylatted- BSA could have an effective role in reducing of nonspecific binding reactions.\n[Increased IgG4-Positive Plasma Cells in Granulomatosis with Polyangiitis: A Diagnostic Pitfall of IgG4-Related Disease](http://dx.doi.org/10.1155/2012/121702) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nSing Yun Chang\n2012-01-01\nFull Text Available Granulomatosis with polyangiitis (Wegener\u2019s (GPA may mimic IgG4-related disease (IgG4-RD on histologic examination of some biopsies, especially those from head and neck sites. IgG4 immunostain is often performed in this context for differential diagnosis with IgG4-RD. However, the prevalence of IgG4+ cells in GPA has not been explored. We examined the IgG4+ cells in 26 cases confirmed as GPA by a thorough clinical and pathologic assessment. Twenty-six biopsies consisted of 14 sinonasal/oral cavity/nasopharynx, 7 orbit/periorbital, 3 lung/pleura, 1 iliac fossa/kidney, and 1 dura specimens. Eight of 26 (31% biopsies revealed increased IgG4+ cells (>30/HPF and >40% in IgG4+/IgG+ ratio. The IgG4+ cells and IgG4+/IgG+ ratio ranged 37\u2013137/hpf and 44\u201383%, respectively. Eight biopsies with increased IgG4+ cells were from sinonasal (n=4 or orbital/periorbital (n=4 sites. In conclusion, increased IgG4+ cells are not uncommonly seen in sinonasal or orbital/periorbital biopsies of GPA, which could pose as a diagnostic pitfall.\n[Measurement of IgG antibodies to house dust mite and grass pollen by a solid-phase radioimmunoassay](https://www.osti.gov/etdeweb/biblio/5340871) [Energy Technology Data Exchange (ETDEWEB)](https://www.etde.org/etdeweb/fieldedsearch.jsp)\nDelespesse, G; Debisschop, M J; Flament, J [Hopital Saint Pierre, Louvain (Belgium). Lab. de Recherches de la Clinique Medicale\n1979-09-01\nA solid-phase radioimmunoassay was used to measure specific IgG antibodies to either Dermatophagoides pteronyssinus (DPT) or grass pollens. Radiolabelled protein A from Staphylococcus aureus (SpA) was used to determine the IgG antibodies attached to the microtubes. The binding of IgG from either normal or allergic sera to DPT-coated tubes was antigen specific and mediated by the Fab fragment of the immunoglobulin. IgG antibodies from non-allergic serum competed with IgE antibodies to DPT. IgE antibodies did not significantly interfere with the assay. Indeed heating a reaginic serum resulted in a striking reduction of the (/sup 125/I) anti- IgE binding to allergen-coated tubes without modifying the (/sup 125/I)-SpA binding. Furthermore, filtration of a reaginic serum through Sephacryl S-200 separated a peak of IgE antibodies. The solid phase method was more sensitive than a double-antibody technique employing the same DPT extract as labelled antigen. Non-allergic subjects had less IgG antibodies to DPT or grass pollens than allergic patients. In untreated patients, there was a good correlation between levels of IgG and IgE antibodies to grass pollens but not to DPT. Patients hyposensitized to house dust mite had on the average three times more specific IgG antibodies than untreated cases. (author).\n[Measurement of IgG antibodies to house dust mite and grass pollen by a solid-phase radioimmunoassay](https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=11505213) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nDelespesse, G.; Debisschop, M.J.; Flament, J.\n1979-01-01\nA solid-phase radioimmunoassay was used to measure specific IgG antibodies to either Dermatophagoides pteronyssinus (DPT) or grass pollens. Radiolabelled protein A from Staphylococcus aureus (SpA) was used to determine the IgG antibodies attached to the microtubes. The binding of IgG from either normal or allergic sera to DPT-coated tubes was antigen specific and mediated by the Fab fragment of the immunoglobulin. IgG antibodies from non-allergic serum competed with IgE antibodies to DPT. IgE antibodies did not significantly interfere with the assay. Indeed heating a reaginic serum resulted in a striking reduction of the ( 125 I) anti- IgE binding to allergen-coated tubes without modifying the ( 125 I)-SpA binding. Furthermore, filtration of a reaginic serum through Sephacryl S-200 separated a peak of IgE antibodies. The solid phase method was more sensitive than a double-antibody technique employing the same DPT extract as labelled antigen. Non-allergic subjects had less IgG antibodies to DPT or grass pollens than allergic patients. In untreated patients, there was a good correlation between levels of IgG and IgE antibodies to grass pollens but not to DPT. Patients hyposensitized to house dust mite had on the average three times more specific IgG antibodies than untreated cases. (author)\n[Anti-leukemic activity and tolerability of anti-human CD47 monoclonal antibodies](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=5386341)\nPietsch, E C; Dong, J; Cardoso, R; Zhang, X; Chin, D; Hawkins, R; Dinh, T; Zhou, M; Strake, B; Feng, P-H; Rocca, M; Santos, C Dos; Shan, X; Danet-Desnoyers, G; Shi, F; Kaiser, E; Millar, H J; Fenton, S; Swanson, R; Nemeth, J A; Attar, R M\n2017-01-01\nCD47, a broadly expressed cell surface protein, inhibits cell phagocytosis via interaction with phagocyte-expressed SIRP\u03b1. A variety of hematological malignancies demonstrate elevated CD47 expression, suggesting that CD47 may mediate immune escape. We discovered three unique CD47-SIRP\u03b1 blocking anti-CD47 monoclonal antibodies (mAbs) with low nano-molar affinity to human and cynomolgus monkey CD47, and no hemagglutination and platelet aggregation activity. To characterize the anti-cancer activity elicited by blocking CD47, the mAbs were cloned into effector function silent and competent Fc backbones. Effector function competent mAbs demonstrated potent activity in vitro and in vivo, while effector function silent mAbs demonstrated minimal activity, indicating that blocking CD47 only leads to a therapeutic effect in the presence of Fc effector function. A non-human primate study revealed that the effector function competent mAb IgG1 C47B222-(CHO) decreased red blood cells (RBC), hematocrit and hemoglobin by >40% at 1 mg/kg, whereas the effector function silent mAb IgG2\u03c3 C47B222-(CHO) had minimal impact on RBC indices at 1 and 10 mg/kg. Taken together, our findings suggest that targeting CD47 is an attractive therapeutic anti-cancer approach. However, the anti-cancer activity observed with anti-CD47 mAbs is Fc effector dependent as are the side effects observed on RBC indices. PMID:28234345\n[Enhancement of antibody-dependent cell-mediated cytotoxicity by endowing IgG with Fc\u03b1RI (CD89) binding.](https://www.ncbi.nlm.nih.gov/pubmed/25970007)\nBorrok, M Jack; Luheshi, Nadia M; Beyaz, Nurten; Davies, Gareth C; Legg, James W; Wu, Herren; Dall'Acqua, William F; Tsui, Ping\n2015-01-01\nFc effector functions such as antibody-dependent cell-mediated cytotoxicity (ADCC) and antibody-dependent cell-mediated phagocytosis (ADCP) are crucial to the efficacy of many antibody therapeutics. In addition to IgG, antibodies of the IgA isotype can also promote cell killing through engagement of myeloid lineage cells via interactions between the IgA-Fc and Fc\u03b1RI (CD89). Herein, we describe a unique, tandem IgG1/IgA2 antibody format in the context of a trastuzumab variable domain that exhibits enhanced ADCC and ADCP capabilities. The IgG1/IgA2 tandem Fc format retains IgG1 Fc\u03b3R binding as well as FcRn-mediated serum persistence, yet is augmented with myeloid cell-mediated effector functions via Fc\u03b1RI/IgA Fc interactions. In this work, we demonstrate anti-human epidermal growth factor receptor-2 antibodies with the unique tandem IgG1/IgA2 Fc can better recruit and engage cytotoxic polymorphonuclear (PMN) cells than either the parental IgG1 or IgA2. Pharmacokinetics of IgG1/IgA2 in BALB/c mice are similar to the parental IgG, and far surpass the poor serum persistence of IgA2. The IgG1/IgA2 format is expressed at similar levels and with similar thermal stability to IgG1, and can be purified via standard protein A chromatography. The tandem IgG1/IgA2 format could potentially augment IgG-based immunotherapeutics with enhanced PMN-mediated cytotoxicity while avoiding many of the problems associated with developing IgAs.\n[Validation of high throughput screening of human sera for detection of anti-PA IgG by Enzyme-Linked Immunosorbent Assay (ELISA) as an emergency response to an anthrax incident](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=5737902)\nSemenova, Vera A.; Steward-Clark, Evelene; Maniatis, Panagiotis; Epperson, Monica; Sabnis, Amit; Schiffer, Jarad\n2017-01-01\nTo improve surge testing capability for a response to a release of Bacillus anthracis, the CDC anti-Protective Antigen (PA) IgG Enzyme-Linked Immunosorbent Assay (ELISA) was re-designed into a high throughput screening format. The following assay performance parameters were evaluated: goodness of fit (measured as the mean reference standard r2), accuracy (measured as percent error), precision (measured as coefficient of variance (CV)), lower limit of detection (LLOD), lower limit of quantification (LLOQ), dilutional linearity, diagnostic sensitivity (DSN) and diagnostic specificity (DSP). The paired sets of data for each sample were evaluated by Concordance Correlation Coefficient (CCC) analysis. The goodness of fit was 0.999; percent error between the expected and observed concentration for each sample ranged from \u22124.6% to 14.4%. The coefficient of variance ranged from 9.0% to 21.2%. The assay LLOQ was 2.6 \u03bcg/mL. The regression analysis results for dilutional linearity data were r2 = 0.952, slope = 1.02 and intercept = \u22120.03. CCC between assays was 0.974 for the median concentration of serum samples. The accuracy and precision components of CCC were 0.997 and 0.977, respectively. This high throughput screening assay is precise, accurate, sensitive and specific. Anti-PA IgG concentrations determined using two different assays proved high levels of agreement. The method will improve surge testing capability 18-fold from 4 to 72 sera per assay plate. PMID:27814939\n[Anti-Platelet Factor 4/Heparin Antibody Formation Occurs Endogenously and at Unexpected High Frequency in Polycythemia Vera](http://dx.doi.org/10.1155/2017/9876819) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nSara C. Meyer\n2017-01-01\nFull Text Available Background. Myeloproliferative neoplasms (MPN encounter thromboses due to multiple known risk factors. Heparin-induced thrombocytopenia (HIT is a thrombotic syndrome mediated by anti-platelet factor 4 (PF4/heparin antibodies with undetermined significance for thrombosis in MPN. We hypothesized that anti-PF4/heparin Ab might occur in MPN and promote thrombosis. Methods. Anti-PF4/heparin antibodies were analyzed in 127 MPN patients including 76 PV and 51 ET. Screening, validation testing, and isotype testing of anti-PF4/heparin Ab were correlated with disease characteristics. Results. Anti-PF4/heparin antibodies were detected in 21% of PV and 12% of ET versus 0.3\u20133% in heparin-exposed patients. Validation testing confirmed anti-PF4/heparin immunoglobulins in 15% of PV and 10% of ET. Isotype testing detected 9.2% IgG and 5.3% IgM in PV and exclusively IgM in ET. IgG-positive PV patients encountered thromboses in 57.1% suggesting anti-PF4/heparin IgG may contribute to higher risk for thrombosis in MPN. Overall, 45% of PV patients experienced thromboses with 11.8% positive for anti-PF4/heparin IgG versus 7.1% in PV without thrombosis. Conclusion. Anti-PF4/heparin antibodies occur endogenously and more frequently in MPN than upon heparin exposure. Thrombotic risk increases in anti-PF4/heparin IgG-positive PV reflecting potential implications and calling for larger, confirmatory cohorts. Anti-PF4/heparin IgG should be assessed upon thrombosis in PV to facilitate avoidance of heparin in anti-PF4/heparin IgG-positive PV.\n[Obtenci\u00f3n y caracterizaci\u00f3n de un anticuerpo espec\u00edfico contra la hormona luteinizante humana](http://www.revistabiomedica.org/index.php/biomedica/article/view/922) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAdriana Uma\u00f1a\n1996-12-01\nFull Text Available En el presente trabajo se describe la obtenci\u00f3n del anticuerpo policlonal espec\u00edfico contra la hormona luteinizante humana (HL. La hormona fue purificada a partir de una fracci\u00f3n rica en glicoprote\u00ednas, obtenida de hip\u00f3fisis humanas, siguiendo el m\u00e9todo desarrollado previamente en el proyecto basado en diferencias de solubilidad y constante diel\u00e9ctrica entre las diferentes prote\u00ednas. El antisuero espec\u00edfico se obtuvo por inoculaci\u00f3n del ant\u00edgeno en conejos raza Nueva Zelanda y su producci\u00f3n controlada valorando el t\u00edtulo por RIA. La caracterizaci\u00f3n parcial del antisuero se realiz\u00f3 mediante la determinaci\u00f3n del t\u00edtulo \u00f3ptimo, afinidad, especificidad y su aplicabilidad para la cuantificaci\u00f3n en t\u00e9rminos de curva est\u00e1ndar y control de calidad, en comparaci\u00f3n con un antisuero de referencia internacional. Los resultados indicaron que el anticuerpo obtenido puede emplearse en la cuantificaci\u00f3n de HL por RIA.\nMarketkar, Shivali; LeGolvan, Mark\n2017-04-03\nIgG4 aortitis is one of the entities seen in the spectrum of IgG4-related disease (IgG4-RD). It is characterized by serologic (elevated serum IgG4) and histologic features including a lymphoplasmacytic infiltrate with increased numbers of IgG4-positive plasma cells, storiform fibrosis and obliterative phlebitis. Some studies have described a correlation between infections and IgG4 aortitis. We describe a patient with an aneurysm of the infrarenal descending abdominal aorta with features of IgG4-RD, as well as culture evidence of Streptococcus sanguis. [Full article available at http://rimed.org/rimedicaljournal-2017-04.asp].\n[Relative stabilities of IgG1 and IgG4 Fab domains: Influence of the light\u2013heavy interchain disulfide bond architecture](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3631360)\nHeads, James T; Adams, Ralph; D'Hooghe, Lena E; Page, Matt J T; Humphreys, David P; Popplewell, Andrew G; Lawson, Alastair D; Henry, Alistair J\n2012-01-01\nThe stability of therapeutic antibodies is a prime pharmaceutical concern. In this work we examined thermal stability differences between human IgG1 and IgG4 Fab domains containing the same variable regions using the thermofluor assay. It was found that the IgG1 Fab domain is up to 11\u00b0C more stable than the IgG4 Fab domain containing the same variable region. We investigated the cause of this difference with the aim of developing a molecule with the enhanced stability of the IgG1 Fab and the biological properties of an IgG4 Fc. We found that replacing the seven residues, which differ between IgG1 CH1 and IgG4 CH1 domains, while retaining the native IgG1 light-heavy interchain disulfide (L\u2013H) bond, did not affect thermal stability. Introducing the IgG1 type L\u2013H interchain disulfide bond (DSB) into the IgG4 Fab resulted in an increase in thermal stability to levels observed in the IgG1 Fab with the same variable region. Conversely, replacement of the IgG1 L\u2013H interchain DSB with the IgG4 type L\u2013H interchain DSB reduced the thermal stability. We utilized the increased stability of the IgG1 Fab and designed a hybrid antibody with an IgG1 CH1 linked to an IgG4 Fc via an IgG1 hinge. This construct has the expected biophysical properties of both the IgG4 Fc and IgG1 Fab domains and may therefore be a pharmaceutically relevant format. PMID:22761163\n[IgG4-related spinal pachymeningitis.](https://www.ncbi.nlm.nih.gov/pubmed/26567899)\nLu, Zhang; Tongxi, Liu; Jie, Luo; Yujuan, Jiao; Wei, Jiang; Xia, Liu; Yumin, Zheng; Xin, Lu\n2016-06-01\nThe aim of this study is to study the clinical, laboratory, imaging pathology, and prognosis features of IgG4-related spinal pachymeningitis. We worked with a 55-year-old man suffering from IgG4-related spinal pachymeningitis who had the most widespread lesion in his dura mater. We also review previous related studies and discuss the clinical characteristics of this rare disease. In total, eight IgG4-related spinal pachymeningitis patients have been reported in the literature since 2009. They were mostly male patients, 51.7 \u00b1 11.9 years old on average. Cervical and thoracic vertebrae were the most common sites for lesions. The most prominent symptom was varying numbness and weakness of the limbs and/or body associated with spinal cord compression. There was one patient (1/5) with elevated serum IgG4 levels and three patients (3/3) with increased cerebrospinal fluid (CSF) IgG4 index. Positive histopathologic findings are the strongest basis for a diagnosis. All the patients with IgG4-related spinal pachymeningitis responded well to glucocorticoid therapy. IgG4-related spinal pachymeningitis is an orphan disease that mainly occurs in cervical and thoracic vertebrae. Older males are the most susceptible group. Serum IgG4 levels were consistently normal in these cases, so analysis of CSF for IgG4 production (IgG4 index) could become a useful tool. Pathological findings remain the gold standard for diagnosis. Most patients responded favorably to glucocorticoid treatment.\n[Anti-Taenia solium metacestode IgG antibodies in serum samples from inhabitants of a central-western region of Brazil](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0036-46652006000100011) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nOliveira Heliana B. de\n2006-01-01\nFull Text Available A total of 354 serum samples from inhabitants who frequent the Clinical Laboratory in Catal\u00e3o, Goi\u00e1s, in the central-western region of Brazil, were collected from June to August, 2002. The samples were evaluated by indirect immunofluorescence antibody tests and an enzyme linked immunosorbent assay in order to detect anti-Taenia solium metacestode IgG antibodies. Reactive and inconclusive samples were tested by Western blotting (WB. Considering WB as a confirmation, the frequency of antibodies in the serum samples of the above population was 11.3% (CI 5.09 - 17.51. The immunodominant bands most frequently recognized in WB were 64-68 kDa (97.5% and 47-52 kDa (80%. The percentage of seropositivity to cysticercosis was significantly higher for individuals residing in areas without sewage systems (p < 0.0001. In conclusion, the results indicate a probable endemic situation of cysticercosis in this population. These results reinforce the urgent need for control and prevention measures to be taken by the local public health services.\n[Detecci\u00f3n de anticuerpos circulantes en donantes de sangre en M\u00e9xico Detection of antibodies present in blood donors in Mexico](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892009001000011) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJos\u00e9 J. Serrano Machuca\n2009-10-01\nFull Text Available OBJETIVO: Detectar anticuerpos circulantes contra seis infecciones transmisibles por sangre en donantes de una instituci\u00f3n de seguridad social en Quer\u00e9taro, M\u00e9xico. M\u00c9TODO: Se realiz\u00f3 un estudio transversal descriptivo retrospectivo con datos del Banco de Sangre del Hospital General Regional No. 1, del Instituto Mexicano del Seguro Social (IMSS. Se registraron 6 929 donantes, entre los cuales se identific\u00f3 a los diagnosticados con cualquier anticuerpo circulante contra brucelosis, enfermedad de Chagas, hepatitis B, hepatitis C, s\u00edfilis y VIH. Los casos identificados con cualquiera de estas infecciones se analizaron seg\u00fan edad, g\u00e9nero, estado civil, escolaridad, lugar de residencia y n\u00famero de donaciones. Para estimar la prevalencia total se dividi\u00f3 el n\u00famero de personas identificadas con cualquiera de los anticuerpos circulantes por el total de donantes, y luego por cada una de las diferentes infecciones. RESULTADOS: De los 6 929 donantes, 144 fueron detectados con alg\u00fan tipo de anticuerpo circulante de las seis infecciones potencialmente transmisibles por sangre, lo cual da una prevalencia total de 2,07% (0-4,4. Las prevalencias m\u00e1s altas por tipo de anticuerpo circulante correspondieron a la hepatitis C, con 0,721% (IC 95%, 0,522-0,920, y a la enfermedad de Chagas, con 0,649% (IC 95%, 0,460-0,838. CONCLUSI\u00d3N: La identificaci\u00f3n de la prevalencia de donantes de sangre con anticuerpos circulantes de alguna de estas seis infecciones potencialmente transmisibles por v\u00eda sangu\u00ednea permite establecer un perfil epidemiol\u00f3gico propio del banco de sangre del Hospital General Regional No. 1. La enfermedad de Chagas se presenta como emergente, dando pauta a dirigir los esfuerzos para su control.OBJECTIVE: To detect antibodies to six potentially blood-borne infections in blood donors at a social security institute in Quer\u00e9taro, Mexico. METHODS: A cross-sectional, retrospective, descriptive study was performed using data from the blood\n[ROLE OF PREEXISTING VIRUS-SPECIFIC IgG IN PRIMARY DISEASE AND IN REINFECTION WITH RESPIRATORY SYNCYTIAL VIRUS](http://iimmun.ru/iimm/article/view/107) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nV. Z. Krivitskaya\n2012-01-01\nFull Text Available Abstract. The aim of the study is evaluation of links between presence in blood of specific pre-existing IgG to respiratory-syncytial virus (RSV, clinical course of RSV infection and character specific to RSV humoral immune response in patients of different ages. The antibodies were detected by ELISA using whole RS virus or synthetic peptides corresponded to the selected determinants of the envelope RSV proteins. It was shown that RS specific maternal IgG antibodies passively transferred to babies in utero can circulate in the blood up to 10 months of life. The analysis of paired sera of 45 babies in the age of 1\u201310 months revealed firstly that presence of maternal IgG specific antibodies to the conservative B-cell immunogenic determinants of the F-protein (amino acids 221\u2013232 and/or the G-protein (amino acids 152\u2013164 and 184\u2013198 is coupled with more high morbidity of primary RSV infection (89% versus 56%, p = 0.023, and also with more high frequency of complicated by bronchus obstruction course of the disease (81% versus 20%, \u0440 = 0.001 in compare with babies who were serologically negative to the maternal determinants specific antibodies. The correlation analysis has shown that the high presence of maternal determinant-specific IgG in the blood in babies till 10 months of life is associated in the case of primary infection with disbalance of humoral anti-viral immune response: intensive synthesis of serum RSV IgA. This is evidence of complicated course of infection with simultaneous suppression of response to RSV specific IgG. As opposed to the primary RSV infection in patients older than 3 years (n = 121 it was not detected links between anamnestic determinant-specific IgG synthesized by own immune system as the results of previous disease episodes and synthesis of anti-RSV IgG, IgM, IgE and IgA in RSV re-infections. In the contrast to babies in more older patients the feedback connection between level of pre-existing determinant\n[Presence of anti-Toxoplasma antibodies in humans and their cats in the urban zone of Guadalajara](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86821999000500003) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nGalv\u00e1n Ram\u00edrez Mar\u00eda de la Luz\n1999-01-01\nFull Text Available Cats are the definitive hosts of Toxoplasma gondii. Infected cats excrete oocysts in their feces, infecting humans and other animals. The objective of the present study was to determine the presence of anti-Toxoplasma antibodies in cat owners and their pets, and determine if there was a relationship between Toxoplasma infection and humans who live with infected cats. IgG anti-Toxoplasma antibodies in sera of 59 cat owners were determined by enzyme-linked immunosorbent assay (ELISA, in 24 sera from their cats, IgG, IgM, and IgA antibodies were found using Burney's ELISA. Thirty-eight (64% of 59 cat owners were positive to IgG anti-Toxoplasma. Seropositivity for cats was 70.8% IgG, 8.3% IgM, and 62.5% IgA. Cohabitation with cats infected by T. gondii, feeding with leftovers or raw viscera, and lack of control over how their feces were handled are risk factors conducive for humans to become infected by T. gondii.\n[[IgG4 immunohistochemistry in Riedle thyroiditis].](https://www.ncbi.nlm.nih.gov/pubmed/28297756)\nWang, S; Luo, Y F; Cao, J L; Zhang, H; Shi, X H; Liang, Z Y; Feng, R E\n2017-03-08\nObjective: To observe the histopathological changes and immunohistochemical expression of IgG4 in Riedle thyroiditis (RT) and to study the relationship between RT and IgG4-related diseases (IgG4-RD). Methods: A total of 5 RT patients were collected from the Department of Pathology, Peking Union Medical College Hospital during April 2012 to August 2014. The clinical and immunohistochemical features were analyzed in the 5 patients. Histopathologic analysis was performed on hematoxylin and eosin-stained sections. Results: There were one male and four female patients, aged 52 to 78 years (median 59 years). Five cases were characterized by multiple nodules of thyroid, which increased year by year. All patients were found to have surrounding tissue compression symptoms and signs. Two female patients were found to have hypothyroidism. The serum concentration of IgG was elevated in 2 cases, and the serum concentration of IgG was not tested before operation in the remaining patients. By ultrasound, all presented as low echo or medium low echo. Strong echo occasionally appeared in hypoechoic nodules. Microscopically, fibrous tissue hyperplasia was infiltrated with varying numbers of lymphocytes and plasma cells. The occlusion of phlebitis was found in 4 cases and eosinophils were found in 3 cases. IgG4 counts and IgG4/IgG ratios in 5 cases were 20/HPF, 16%; 60/HPF, 82%; 22/HPF, 28%; 400/HPF, 266% and 33/HPF, 71%, respectively. Conclusions: With the similar pathological manifestations between RT and IgG4-RD, immunohistochemical staining shows that the number of IgG4 positive plasma cells and IgG4/IgG ratio of RT are increased in varying degrees. Some cases meet the diagnostic criteria of IgG4-RD, and speculate that some cases of RT belong to IgG4-RD.\n[Malaria resistance genes are associated with the levels of IgG subclasses directed against Plasmodium falciparum blood-stage antigens in Burkina Faso](http://www.malariajournal.com/content/11/1/308) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAfridi Sarwat\n2012-09-01\nFull Text Available Abstract Background HBB, IL4, IL12, TNF, LTA, NCR3 and FCGR2A polymorphisms have been associated with malaria resistance in humans, whereas cytophilic immunoglobulin G (IgG antibodies are thought to play a critical role in immune protection against asexual blood stages of the parasite. Furthermore, HBB, IL4, TNF, and FCGR2A have been associated with both malaria resistance and IgG levels. This suggests that some malaria resistance genes influence the levels of IgG subclass antibodies. Methods In this study, the effect of HBB, IL4, IL12, TNF, LTA, NCR3 and FCGR2A polymorphisms on the levels of IgG responses against Plasmodium falciparum blood-stage extract was investigated in 220 individuals living in Burkina Faso. The Pearson\u2019s correlation coefficient among IgG subclasses was determined. A family-based approach was used to assess the association of polymorphisms with anti-P. falciparum IgG, IgG1, IgG2, IgG3 and IgG4 levels. Results After applying a multiple test correction, several polymorphisms were associated with IgG subclass or IgG levels. There was an association of i haemoglobin C with IgG levels; ii the Fc\u03b3RIIa H/R131 with IgG2 and IgG3 levels; iii TNF-863 with IgG3 levels; iv TNF-857 with IgG levels; and, v TNF1304 with IgG3, IgG4, and IgG levels. Conclusion Taken together, the results support the hypothesis that some polymorphisms affect malaria resistance through their effect on the acquired immune response, and pave the way towards further comprehension of genetic control of an individual\u2019s humoral response against malaria.\n[A quantitative ELISA procedure for the measurement of membrane-bound platelet-associated IgG (PAIgG).](https://www.ncbi.nlm.nih.gov/pubmed/3976569)\nLynch, D M; Lynch, J M; Howe, S E\n1985-03-01\nA quantitative ELISA assay for the measurement of in vivo bound platelet-associated IgG (PAIgG) using intact patient platelets is presented. The assay requires quantitation and standardization of the number of platelets bound to microtiter plate wells and an absorbance curve using quantitated IgG standards. Platelet-bound IgG was measured using an F(ab')2 peroxidase labeled anti-human IgG and o-phenylenediamine dihydrochloride (OPD) as the substrate. Using this assay, PAIgG for normal individuals was 2.8 +/- 1.6 fg/platelet (mean +/- 1 SD; n = 30). Increased levels were found in 28 of 30 patients with clinical autoimmune thrombocytopenia (ATP) with a range of 7.0-80 fg/platelet. Normal PAIgG levels were found in 26 of 30 patients with nonimmune thrombocytopenia. In the sample population studied, the PAIgG assay showed a sensitivity of 93%, specificity of 90%, a positive predictive value of 0.90, and a negative predictive value of 0.93. The procedure is highly reproducible (CV = 6.8%) and useful in evaluating patients with suspected immune mediated thrombocytopenia.\n[Toxocara seroprevalence in children from a subtropical city in Argentina Prevalencia de anticuerpos anti Toxocara en ni\u00f1os de una ciudad subtropical de Argentina](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0036-46652000000400010) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJos\u00e9 Mario ALONSO\n2000-08-01\nFull Text Available Most studies from Argentina have focused on toxocariasis as an environmental problem of big cities, and there are no available data about children infection from small or middle-sized cities. In order to assess the prevalence of anti-Toxocara antibodies in infantile population, 206 children from Resistencia, of both sexes, aged 1-14 years old were studied by Elisa testing with E/S T. canis L2 antigens. Hematological parameters and immunoglobulin levels were determined; five days' stool samples were studied and epidemiological data were obtained by means of a questionnaire to parents. Results showed that 73% of the children had one or more dogs living at home, 57% reported geophagia and 37.9% were positive for Toxocara serology, but there was no significant difference in prevalence neither for boys and girls, nor concerning age. An increased risk of infection was observed in age groups 5-6 and 7-8 for boys, and in age groups 3-4 and 5-6 for girls.La mayor\u00eda de los estudios realizados en Argentina, han enfocado a la Toxocariosis como un problema medioambiental propio de las grandes ciudades y no existen datos acerca de esta infecci\u00f3n entre los ni\u00f1os de ciudades medianas o peque\u00f1as. A fin de determinar la prevalencia de anticuerpos anti-Toxocara en la poblaci\u00f3n infantil de la ciudad de Resistencia, se estudiaron 206 ni\u00f1os de ambos sexos, con edades comprendidas entre los 1-14 a\u00f1os, mediante el test de Elisa, empleando ant\u00edgenos E/S de larva L2 de Toxocara canis. Tambi\u00e9n se evaluaron los niveles de inmunoglobulinas s\u00e9ricas y los par\u00e1metros hematol\u00f3gicos; se efectuaron an\u00e1lisis coproparasitol\u00f3gico seriados en heces de 5 d\u00edas y se recolect\u00f3 informaci\u00f3n epidemiol\u00f3gica mediante cuestionario a los padres. Los resultados obtenidos se\u00f1alan que el 73% de los ni\u00f1os ten\u00edan uno o mas perros viviendo en la casa, que el 57% ten\u00edan antecedentes de geofagia y que el 37.9% ten\u00edan serolog\u00eda positiva para Toxocara, aunque no hubo diferencias\n[Cholangiocarcinoma with respect to IgG4 Reaction](http://dx.doi.org/10.1155/2014/803876) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nKenichi Harada\n2014-01-01\nFull Text Available IgG4 reactions marked by infiltration of IgG4-positive plasma cells in affected organs occur in cancer patients and in patients with IgG4-related diseases. Extrahepatic cholangiocarcinomas including gall bladder cancer are often accompanied by significant IgG4 reactions; these reactions show a negative correlation with CD8-positive cytotoxic T cells, suggesting that the evasion of immune surveillance is associated with cytotoxic T cells. The regulatory cytokine IL-10 may induce IgG4-positive plasma cell differentiation or promote B cell switching to IgG4 in the presence of IL-4. Cholangiocarcinoma cells may function as nonprofessional antigen presenting cells that indirectly induce IgG4 reactions via the IL-10-producing cells and/or these may act as Foxp3-positive and IL-10-producing cells that directly induce IgG4 reactions. Moreover, IgG4-related disease is a high-risk factor for cancer development; IgG4-related sclerosing cholangitis (IgG4-SC cases associated with cholangiocarcinoma or its precursor lesion biliary intraepithelial neoplasia (BilIN have been reported. IgG4-positive cell infiltration is an important finding of IgG4-SC but is not a histological hallmark of IgG4-SC. For the diagnosis of IgG4-SC, its differentiation from cholangiocarcinoma remains important.\n[Factors associated with seropositivity for anti-Toxoplasma gondiiantibodies in pregnant women of Londrina, Paran\u00e1, Brazil](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762009000200036) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nFMR Lopes\n2009-03-01\nFull Text Available The aim of this study was to evaluate associations between seropositivity for IgG and IgM anti-Toxoplasma gondii antibodies and socio-economic and environmental variables in pregnant women of Londrina, state of Paran\u00e1, Brazil. We interviewed 492 pregnant women, each of whom answered an epidemiological questionnaire, and collected blood samples for measurement of IgG and IgM anti-T. gondii antibodies by chemiluminescence. A confirmatory diagnosis of acute infection was made by an IgG avidity test. Titres of specific IgG anti-T. gondii were obtained by IFAT. Seropositivity for IgG anti-T. gondii antibodies was observed in 242 women (49.2% and, of these, six pregnant women (1.2% showed seropositivity for IgM. Age group, level of education, per capita income, presence of a cat in the house and a habit of eating green vegetables were all factors associated with a greater chance of infection with T. gondii. This study showed that 250 (50.8% pregnant women were susceptible to T. gondii and considered to be at high risk for toxoplasmosis during pregnancy. Based on the results obtained, is critical to establish a program of health surveillance for toxoplasmosis, in order to contribute to diagnosis and early treatment during the prenatal period. It is also necessary to introduce measures to prevent the Toxoplasma infection in seronegative pregnant women.\n[Affinity Maturation of an Anti-V Antigen IgG Expressed In Situ Via Adenovirus Gene Delivery Confers Enhanced Protection Against Yersinia pestis Challenge](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3784998)\nVan Blarcom, Thomas J.; Sofer-Podesta, Carolina; Ang, John; Boyer, Julie L.; Crystal, Ronald G.; Georgiou, George\n2013-01-01\nGenetic transfer of neutralizing antibodies has been shown to confer strong and persistent protection against bacterial and viral infectious agents. While it is well established that for many exogenous neutralizing antibodies increased antigen affinity correlates with protection, the effect of antigen affinity on antibodies produced in situ following adenoviral gene transfer has not been examined. The mouse IgG2b monoclonal antibody 2C12.4 recognizes the Yersinia pestis Type III secretion apparatus protein LcrV (V antigen) and confers protection in mice when administered as an IgG intraperitoneally or, following genetic immunization with engineered, replication-defective serotype 5 human adenovirus (Ad) 1. 2C12.4 was expressed as a scFv fragment in E. coli and was shown to display a KD=3.5 nM by surface plasmon resonance (SPR) analysis. The 2C12.4 scFv was subjected to random mutagenesis and variants with increased affinity were isolated by flow cytometry using the Anchored Periplasmic Expression (APEx) bacterial display system. After a single round of mutagenesis, variants displaying up to 35-fold lower KD values (H8, KD=100 pM) were isolated. The variable domains of the H8 scFv were used to replace those of the parental 2C12.4 IgG encoded in the Ad vector, Ad\u03b1V giving rise to Ad\u03b1V.H8. The two adenoviral vectors resulted in similar titers of anti-V antigen antibodies 3 days post-immunization with 109, 1010 or 1011 particle units. Following intranasal challenge with 363 LD50Y. pestis CO92, 54% of the mice immunized with 1010 pu of Ad\u03b1V.H8 survived at the 14 day end point compared to only 15% survivors for the group immunized with Ad\u03b1V expressing the lower affinity 2C12.4 (Pgenetic transfer may confer increased protection not only for Y. pestis challenge but possibly for other pathogens. PMID:20393511\n[Overview of IgG4 - Related Disease.](https://www.ncbi.nlm.nih.gov/pubmed/29362594)\nOpri\u0163\u0103, R; Opri\u0163\u0103, B; Berceanu, D; Diaconescu, I B\n2017-01-01\nRationale (hypothesis): IgG4-related disease (IgG4-RD) is a pathological entity recently recognized by the medical world that can affect any organ or system. However, there is insufficient data about this disease in medical literature. Aim (objective): A more extensive clarification of the IgG4 molecule, the diversified aspects of IgG4-related disease, and the response of this disease to treatment, will provide a crucial understanding of the immune system and other diseases now known to be associated with IgG4. The MEDLINE online medical database was used, and, after a comprehensive review of medical articles regarding IgG4-RD, published after 2003, using the search words \"IgG4- related disease\" and \"IgG4 molecule\", we have described the clinical, pathological and therapeutic features of IgG4-RD, as well as the presence of the IgG4 molecule in the evolution, diagnosis and management of this syndrome. We characterized the potential disease mechanisms and discussed early observations related to treatment. Given the response to immunosuppressive therapy, it is hypothesized that IgG4-related disease is most likely an autoimmune disease. Therefore, IgG4-related disease is a fibro-inflammatory condition that can affect any organ and can lead to the formation of pseudotumoral lesions requiring differential diagnosis with various malignancies. Positive diagnostic criteria are histopathological and require at least two features out of the following three: dense limphoplasmocitary infiltrate, storiform fibrosis, obliterative phlebitis.\n[[Hashimoto's thyroiditis(chronic thyroiditis), IgG4-related thyroiditis].](https://www.ncbi.nlm.nih.gov/pubmed/23214065)\nItoh, Mitsuyasu\n2012-11-01\nHashimoto's thyroiditis emerges in patients who have genetic preponderance such as SNPs of CTLA-4 and risk factors such as excess intake of iodine, pregnancy or postpartum period, and smoking. Such risk factors also affect the entire clinical course. One of the major outcomes in Hashimoto's thyroiditis appears to be increased in cardio-vascular risks through subclinical hypothyroidism and concomitant metabolic syndrome, but in most cases, treatment with L-T4 has little effects on cardio-vascular benefit or quality of life. The pregnant women also have risks for obstetric complications and postpartum thyroid dysfunction. The women who have anti-TPO antibodies, type 1 diabetes, or previous history of post-partum thyroid dysfunction are recommended to be measured their TSH. It is noteworthy that Hashimoto's thyroiditis is sometimes complicated with encephalopathy, papillary carcinoma, or IgG4-related thyroiditis. IgG4-related thyroiditis is partly similar but partly discerned from a variant of Hashimoto's thyroiditis. The pathogenetic roles of this variant on autoimmune-based thyroiditis remain unclear.\n[Potential of Murine IgG1 and Human IgG4 to Inhibit the Classical Complement and Fc\u03b3 Receptor Activation Pathways](http://journal.frontiersin.org/article/10.3389/fimmu.2018.00958/full) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nGina-Maria Lilienthal\n2018-05-01\nFull Text Available IgG antibodies (Abs mediate their effector functions through the interaction with Fc\u03b3 receptors (Fc\u03b3Rs and the complement factors. The main IgG-mediated complement activation pathway is induced through the binding of complement C1q to IgG Abs. This interaction is dependent on antigen-dependent hexamer formation of human IgG1 and IgG3 to increase the affinity for the six-headed C1q molecule. By contrast, human IgG4 fails to bind to C1q. Instead, it has been suggested that human IgG4 can block IgG1 and IgG3 hexamerization required for their binding to C1q and activating the complement. Here, we show that murine IgG1, which functionally resembles human IgG4 by not interacting with C1q, inhibits the binding of IgG2a, IgG2b, and IgG3 to C1q in vitro, and suppresses IgG2a-mediated complement activation in a hemolytic assay in an antigen-dependent and IgG subclass-specific manner. From this perspective, we discuss the potential of murine IgG1 and human IgG4 to block the complement activation as well as suppressive effects of sialylated IgG subclass Abs on Fc\u03b3R-mediated immune cell activation. Accumulating evidence suggests that both mechanisms seem to be responsible for preventing uncontrolled IgG (autoAb-induced inflammation in mice and humans. Distinct IgG subclass distributions and functionally opposite IgG Fc glycosylation patterns might explain different outcomes of IgG-mediated immune responses and provide new therapeutic options through the induction, enrichment, or application of antigen-specific sialylated human IgG4 to prevent complement and Fc\u03b3R activation as well.\n[Analysis of IgG4-positive clones in affected organs of IgG4-related disease.](https://www.ncbi.nlm.nih.gov/pubmed/26943245)\nKakuchi, Yasushi; Yamada, Kazunori; Ito, Kiyoaki; Hara, Satoshi; Fujii, Hiroshi; Yamagishi, Masakazu; Kawano, Mitsuhiro\n2016-11-01\nWe investigated class switch reaction (CSR) in affected organs and evaluated whether the same or genetically related clones exist in IgG4-RD. We studied three patients with IgG4-RD. Total cellular RNA was extracted from salivary glands and peripheral blood and lung tissue. Activation-induced cytidine deaminase (AID) and immunoglobulin heavy chain third complementarity determining region (IgVH-CDR3) of IgM and IgG4 were detected by reverse transcription polymerase chain reaction (RT-PCR). We analyzed the clonal relationship of infiltrating IgG4-positive cells, as compared with IgM. We determined the existence of common clones among organs and patients. AID was expressed in salivary glands of all patients and lung tissue in one. Closely related IgVH-CDR3 sequences in infiltrating IgG4-positive cells were detected in salivary glands and lung tissue. Identical IgVH-CDR3 sequence between IgM and IgG4 in salivary glands was detected in one patient, indicating CSR in salivary glands. Identical IgVH-CDR3 sequences of IgG4-positive cells were detected between salivary glands and peripheral blood in two patients. Four identical sequences of IgVH-CDR3 existed between patients. Interestingly, one of the four sequences was detected in all patients. Our results demonstrate the existence of common antigen(s) shared by patients with IgG4-RD.\n[Anti-Toxoplasma gondii antibodies in patients with beta-hemoglobinopathies: the first report in the Americas.](https://www.ncbi.nlm.nih.gov/pubmed/28615064)\nFerreira, Marina Neves; Bonini-Domingos, Claudia Regina; Fonseca Estev\u00e3o, Isabeth; de Castro Lobo, Clarice Lopes; Souza Carrocini, Gisele Cristina; Silveira-Carvalho, Aparecida Perp\u00e9tuo; Ricci, Oct\u00e1vio; de Mattos, Luiz Carlos; Brand\u00e3o de Mattos, Cinara C\u00e1ssia\n2017-06-14\nIn Brazil, there have been no previous studies of Toxoplasma gondii infection in sickle cell anemia patients and carriers of severe forms of beta-thalassemia. This study evaluated T. gondii infection in patients with beta-hemoglobinopathies. A total of 158 samples, 77 (48.7%) men and 81 (51.3%) women, were evaluated. Three groups were formed: G1 (85 patients with sickle cell disease); G2 (11 patients with homozygous beta-thalassemia; G3 (62 patients with heterozygous beta-thalassemia). ELISA was employed to identify anti-T. gondii IgM and IgG antibodies, and molecular analysis was performed to determine beta-hemoglobin mutations. Fisher's exact test was used to compare frequencies of anti-T. gondii IgM and IgG antibodies in respect to gender and age. Anti-T. gondii IgG antibodies were found in 43.5% of individuals in G1, 18.1% in G2 and 50% in G3. All samples from G1 and G2 were seronegative for anti-T. gondii IgM antibodies, but 3.2% from G3 were seropositive. Considering anti-T. gondii IgG antibodies, no statistical significant differences were found between these groups nor in seroprevalence between genders within each group. Despite this, comparisons of the mean ages between G1, G2 and G3 were statistically significant (G2 vs. G1: p value = 0.0001; G3 vs. G1: p-value <0.0001; G3 vs. G2: p-value = 0.0001). A comparison by age of patients with sickle cell anemia showed a trend of lower risk of infection among younger individuals. Therefore, this study demonstrates that T. gondii infection occurs in patients with beta-thalassemia and sickle cell anemia in Brazil as seen by the presence of anti-T. gondii IgM and IgG antibodies.\n[A radiolabeled antiglobulin assay to identify human cervical mucus immunoglobulin (Ig) A and IgG antisperm antibodies](https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=21019057) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nHaas, G.G. Jr.; D'Cruz, O.J.\n1989-01-01\nAntisperm immunoglobulin (Ig) A and IgG antibodies in human cervical mucus (CM) were identified by a radiolabeled antiglobulin assay. Cervical mucus samples from fertile and infertile women were exposed to a 1:3,200 dilution of 2-mercaptoethanol (2-ME), and 5 micrograms of the solubilized CM protein were assayed for the presence of IgA and IgG antisperm and anti-Candida activity by the radiolabeled antiglobulin assay. Purified human secretory IgA and IgG exposed to 2-ME retained the molecular integrity and functional activity of the untreated antibody molecules. CM aliquots collected after high-performance liquid chromatography (HPLC) fractionation were assessed for antisperm antibody activity; antisperm antibody activity was retained in the appropriate IgA or IgG CM fractions. The incidence of CM antisperm antibodies was minimally affected when the radiolabeled antiglobulin assay was performed with a motile sperm population. Approximately 70% of the CM IgA antisperm antibodies were of the IgA1 subclass; CM IgG was primarily of the IgG4 subclass. When Candida antigen was substituted for sperm in the radiolabeled antiglobulin assay, the CM antisperm antibodies were found to be exclusively sperm-specific. These data indicate that the radiolabeled antiglobulin assay using 2-ME to extract CM antibodies is a specific method for the assay of antisperm antibodies in CM\n[Encefalitis por anticuerpos contra el receptor de NMDA: experiencia con seis pacientes pedi\u00e1tricos. Potencial eficacia del metotrexato](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4819071)\nBravo-Oro, Antonio; Abud-Mendoza, Carlos; Quezada-Corona, Arturo; Dalmau, Josep; Campos-Guevara, Ver\u00f3nica\n2016-01-01\nIntroducci\u00f3n La encefalitis por anticuerpos contra el receptor de N-metil-D-aspartato (NMDA) es una entidad cada vez m\u00e1s diagnosticada en edad pedi\u00e1trica. A diferencia de los adultos, en muchos casos no se asocia a tumores y las manifestaciones iniciales en ni\u00f1os m\u00e1s frecuentes son crisis convulsivas y trastornos del movimiento, mientras que en los adultos predominan las alteraciones psiqui\u00e1tricas. Casos cl\u00ednicos Presentamos seis casos pedi\u00e1tricos confirmados con anticuerpos contra la subunidad NR1 del receptor de NMDA en suero y l\u00edquido cefalorraqu\u00eddeo. Cinco de los casos comenzaron con crisis convulsivas como manifestaci\u00f3n cl\u00ednica inicial antes de desarrollar el cuadro cl\u00e1sico de esta entidad. En todos los casos se utilizaron esteroides como primera l\u00ednea de tratamiento, con los que s\u00f3lo se observ\u00f3 control de las manifestaciones en uno, por lo que el resto de los pacientes requiri\u00f3 inmunomoduladores de segunda l\u00ednea. Todos los pacientes recibieron metotrexato como tratamiento inmunomodulador para evitar reca\u00eddas y la evoluci\u00f3n fue a la mejor\u00eda en todos ellos. Conclusiones En nuestra serie de pacientes con encefalitis por anticuerpos contra el receptor de NMDA, ninguno se asoci\u00f3 a tumores. Todos los casos recibieron metotrexato por lo menos durante un a\u00f1o, no observamos eventos adversos cl\u00ednicos ni por laboratorio, ni hubo secuelas neurol\u00f3gicas ni reca\u00eddas durante el tratamiento. Aunque es una serie peque\u00f1a y es deseable incrementar el n\u00famero y tiempo de evoluci\u00f3n, consideramos el metotrexato una excelente alternativa como tratamiento inmunomodulador para esta patolog\u00eda. PMID:24150952\n[Detecci\u00f3n de anticuerpos antiplasmodium por ELISA en donantes de sangre](http://www.revistabiomedica.org/index.php/biomedica/article/view/1829) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nPatricia Olaya de Morales\n1982-06-01\nFull Text Available La malaria, una enfermedad transmitida por mosquitos del genero anopheles, puede ser inducida a trav\u00e9s de transfusiones de sangre infectada con alguna de las especies de Plasmodium que afectan al hombre. Con el objeto de determinar el riesgo potencial de infecci\u00f3n inducida por transfusiones, se analizaron durante 9 meses y mediante la t\u00e9cnica de E.L.I.S.A., las muestras de suero tomadas a los donantes de sangre del Hospital Militar Central de Bogot\u00e1. El 8.6 por mil de las 3114 muestras analizadas, resultaron positivas para anticuerpos antimal\u00e1ricos y durante el tiempo del estudio fueron detectados 3 casos de malaria inducida por transfusiones.\n[Validation of high throughput screening of human sera for detection of anti-PA IgG by Enzyme-Linked Immunosorbent Assay (ELISA) as an emergency response to an anthrax incident.](https://www.ncbi.nlm.nih.gov/pubmed/27814939)\nSemenova, Vera A; Steward-Clark, Evelene; Maniatis, Panagiotis; Epperson, Monica; Sabnis, Amit; Schiffer, Jarad\n2017-01-01\nTo improve surge testing capability for a response to a release of Bacillus anthracis, the CDC anti-Protective Antigen (PA) IgG Enzyme-Linked Immunosorbent Assay (ELISA) was re-designed into a high throughput screening format. The following assay performance parameters were evaluated: goodness of fit (measured as the mean reference standard r 2 ), accuracy (measured as percent error), precision (measured as coefficient of variance (CV)), lower limit of detection (LLOD), lower limit of quantification (LLOQ), dilutional linearity, diagnostic sensitivity (DSN) and diagnostic specificity (DSP). The paired sets of data for each sample were evaluated by Concordance Correlation Coefficient (CCC) analysis. The goodness of fit was 0.999; percent error between the expected and observed concentration for each sample ranged from -4.6% to 14.4%. The coefficient of variance ranged from 9.0% to 21.2%. The assay LLOQ was 2.6 \u03bcg/mL. The regression analysis results for dilutional linearity data were r 2 = 0.952, slope = 1.02 and intercept = -0.03. CCC between assays was 0.974 for the median concentration of serum samples. The accuracy and precision components of CCC were 0.997 and 0.977, respectively. This high throughput screening assay is precise, accurate, sensitive and specific. Anti-PA IgG concentrations determined using two different assays proved high levels of agreement. The method will improve surge testing capability 18-fold from 4 to 72 sera per assay plate. Published by Elsevier Ltd.\n[Evolution of anti-Trypanosoma cruzi antibody production in patients with chronic Chagas disease: Correlation between antibody titers and development of cardiac disease severity.](http://europepmc.org/articles/PMC5536389?pdf=render) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nIngebourg Georg\n2017-07-01\nFull Text Available Chagas disease is one of the most important endemic infections in Latin America affecting around 6-7 million people. About 30-50% of patients develop the cardiac form of the disease, which can lead to severe cardiac dysfunction and death. In this scenario, the identification of immunological markers of disease progression would be a valuable tool for early treatment and reduction of death rates. In this observational study, the production of anti-Trypanosoma cruzi antibodies through a retrospective longitudinal follow-up in chronic Chagas disease patients\u00b4 cohort and its correlation with disease progression and heart commitment was evaluated. Strong inverse correlation (\u03c1 = -0.6375, p = 0.0005 between anti-T. cruzi IgG1 titers and left ventricular ejection fraction (LVEF in chronic Chagas cardiomyopathy (CCC patients were observed after disease progression. Elevated levels of anti-T. cruzi IgG3 titers were detected in all T. cruzi-infected patients, indicating a lack of correlation of this IgG isotype with disease progression. Furthermore, low levels of anti-T. cruzi IgG2, IgG4, and IgA were detected in all patients through the follow-up. Although without statistical significance anti-T. cruzi IgE tends to be more reactive in patients with the indeterminate form (IND of the disease (p = 0.0637. As this study was conducted in patients with many years of chronic disease no anti-T. cruzi IgM was detected. Taken together, these results indicate that the levels of anti-T. cruzi IgG1 could be considered to seek for promising biomarkers to predict the severity of chronic Chagas disease cardiomyopathy.\n[Prophylactic anti-D preparations display variable decreases in Fc-fucosylation of anti-D.](https://www.narcis.nl/publication/RecordID/oai%3Aresearch.vu.nl%3Apublications%2F936fdae0-ed7c-478c-a5c8-a30cfc16b929/uquery/Anti%20AND%20D/id/2/Language/EN)\nKapur, R.; Della Valle, L.; Verhagen, O.J.; Hipgrave Ederveen, A.; Ligthart, P.; de Haas, M.; Kumpel, B.; Wuhrer, M.; van der Schoot, C.E.; Vidarsson, G.\n2015-01-01\nBackground RhIG is obtained from hyperimmunized healthy anti-D donors (HIDs) boosted with D+ red blood cells (RBCs). One hypothesis for its mechanism of action is fast clearance of opsonized D+ RBCs through Fc\u03b3 receptor (Fc\u03b3R)III. Levels of immunoglobulin (Ig)G Fc-fucosylation influence interactions\n[Prophylactic anti-D preparations display variable decreases in Fc-fucosylation of anti-D](https://www.narcis.nl/publication/RecordID/oai%3Apure.amc.nl%3Apublications%2F32426ac4-2370-4751-a491-844c78fee98e/uquery/Anti%20AND%20D/id/9/Language/EN)\nKapur, Rick; Della Valle, Luciana; Verhagen, Onno J. H. M.; Hipgrave Ederveen, Agnes; Ligthart, Peter; de Haas, Masja; Kumpel, Belinda; Wuhrer, Manfred; van der Schoot, C. Ellen; Vidarsson, Gestur\n2015-01-01\nRhIG is obtained from hyperimmunized healthy anti-D donors (HIDs) boosted with D+ red blood cells (RBCs). One hypothesis for its mechanism of action is fast clearance of opsonized D+ RBCs through Fc\u03b3 receptor (Fc\u03b3R)III. Levels of immunoglobulin (Ig)G Fc-fucosylation influence interactions with\n[Immunochemical characteristics of IgG4 antibodies](https://www.narcis.nl/publication/RecordID/oai%3Apure.amc.nl%3Apublications%2F777ff21f-0a48-423b-a1b6-16ee9246b8ae/uquery/IGG4/id/4/Language/EN)\nvan der Zee, J. S.; Aalberse, R. C.\n1988-01-01\nAlthough a small part of the IgG4 subclass probably can bind to basophils (and mast cells), IgG4 antibodies usually do not behave as anaphylactic antibodies. Therefore, detection of IgG4 antibodies in serum is not a suitable in vitro assay for IgG-S-TS activity. Furthermore, differences between IgG4\n[DETECTION OF HUMAN ANTI-ZIKA VIRUS IgG BY ELISA USING AN ANTIGEN FROM in vitro INFECTED VERO CELLS: PRELIMINARY RESULTS](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0036-46652016005000270&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nLaura Masami SUMITA\nFull Text Available SUMMARY Zika virus (ZKV infection is a huge public health problem in Brazil because of the increased incidence of microcephaly in neonates from infected mothers. Detection of specific IgG antibodies in maternal serum samples constitutes an important approach for diagnosing ZKV infection and evaluating its relationship with neonatal microcephaly. However, as there is no serological test produced in Brazil to detect IgM and IgG antibodies against ZKV, we sought to examine specific IgG in serum samples from patients or suspected mothers to detect previous infection and to test for specificity with regard to flaviviral infections occurring in the same area. Brazilian Zika virus native antigens were obtained from infected Vero cell layers or free virions in the culture medium and then used in ELISA. We tested sera from eight ZKV RNA-diagnosed infected patients (ZKVR, seven neonates with microcephaly and their mothers after delivery (MM, 140 dengue virus IgM-positive (DM and IgG (DG-positive patients, and 100 yellow fever (YF-vaccinated patients. According to the ELISA, ZKVR samples were mostly positive (7/8, and all the MM serum samples were positive for ZKV IgG (7/7. In contrast, cross-reactions for dengue or yellow fever-vaccinated patients were observed, including DM (48/95, DG (10/45 or YF (3/100 serum samples; however, these cross-reactions exhibited low antigen avidity so that 6 M urea largely removed this cross-reactivity, with only a few cross-reacting samples remaining (8/140. ELISA based on extracted virions was much more specific, with all ZKVR (8/8 and MM sera being positive for ZKV IgG (7/7 and only borderline cross-reactivity found for DM (6/95, DG (3/45 or YF (4/100-vaccinated serum samples. This technique (ELISA can identify specific IgG in ZKV-infected patients and may be helpful in diagnosing congenital infetions after maternal RNA virus clearance or in epidemiological studies.\n[Does the Maternal Serum IgG Level during Pregnancy in Primary Antibody Deficiency Influence the IgG Level in the Newborn?](http://dx.doi.org/10.1155/2015/286380) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nVasantha Nagendran\n2015-01-01\nFull Text Available Purpose. To find out if the serum IgG level in the newborn baby was affected by low maternal serum IgG during pregnancy in two newly diagnosed primary antibody deficient patients. Method. Infant cord blood IgG level was compared with maternal IgG level in 2 mothers with newly diagnosed primary antibody deficiency, who declined replacement IgG treatment during pregnancy. Results. Both mothers delivered healthy babies with normal IgG levels at birth. Conclusions. The normal IgG levels and sound health in these 2 babies in spite of low maternal IgG throughout pregnancy raise interesting discussion points about maternofoetal immunoglobulin transport mechanisms in primary antibody deficiency.\nAalberse, Rob C.; Schuurman, Janine\n2002-01-01\nImmunoglobulin G4 (IgG4) antibodies have been known for some time to be functionally monovalent. Recently, the structural basis for this monovalency has been elucidated: the in vivo exchange of IgG half-molecules (one H-plus one L-chain) among IgG4. This process results in bispecific antibodies that\n[Prognostic value of anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma (NPC)](http://www.etde.org/etdeweb/details.jsp?query_id=1&page=0&osti_id=657245) [Energy Technology Data Exchange (ETDEWEB)](https://www.etde.org/etdeweb/fieldedsearch.jsp)\nLiu, Mu-Tai; Yeh, Chi-Yuan [Chang-Hua Christian Hospital, Chang-Hua (Taiwan, Province of China)\n1998-03-01\nEighty patients with histological diagnoses of nasopharyngeal cancer (NPC) were referred to Chang-Hua Christian Hospital for curative radiotherapy from 1985 to 1995. A mean dose of 7,020 cGy in 39 fractions was delivered to the primary tumor using a telecobalt-60 unit or 6-10 MV X-ray linear accelerator. Pre- and postradiotherapy serum levels of anti-Epstein-Barr virus (EBV)/VCA IgG and IgA were determined for all patients using the indirect immunoperoxidase assay. Multivariate analysis was done to determine which factors affected the patients` treatment outcome and survival. Five patients were excluded from this study due to incomplete radiotherapy, leaving 75 patients eligible for analysis. Overall local control was 77.3%, with a mean disease-free interval of 19.7 months. Factors affecting local control included radiation dose and pretreatment anti-EBV/VCA IgG titer. The overall 5-year actuarial survival for the 75 patients was 75%, with a median survival of 129.5 months. The 5-year actuarial survival rates for stage I+II, III, and IV patients were 90%, 40%, and 45%, respectively. Prognostic factors for survival included tumor histological type and pretreatment anti-EBV/VCA IgA titer, while prognostic factors for local control included total radiation dose received and pretreatment anti-EBV/VCA IgG titer. We found that there was a significant difference in the geometric mean titer of anti-EBV/VCA IgA antibodies before and after radiotherapy. Prognostic factors affecting NPC patients` actuarial survival included tumor histology and pretreatment IgA titer, while prognostic factors for local control of NPC included total radiation dose received and pretreatment IgG titer. (K.H.)\n[Prognostic value of anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma (NPC)](https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=29059509) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nLiu, Mu-Tai; Yeh, Chi-Yuan\n1998-01-01\nEighty patients with histological diagnoses of nasopharyngeal cancer (NPC) were referred to Chang-Hua Christian Hospital for curative radiotherapy from 1985 to 1995. A mean dose of 7,020 cGy in 39 fractions was delivered to the primary tumor using a telecobalt-60 unit or 6-10 MV X-ray linear accelerator. Pre- and postradiotherapy serum levels of anti-Epstein-Barr virus (EBV)/VCA IgG and IgA were determined for all patients using the indirect immunoperoxidase assay. Multivariate analysis was done to determine which factors affected the patients' treatment outcome and survival. Five patients were excluded from this study due to incomplete radiotherapy, leaving 75 patients eligible for analysis. Overall local control was 77.3%, with a mean disease-free interval of 19.7 months. Factors affecting local control included radiation dose and pretreatment anti-EBV/VCA IgG titer. The overall 5-year actuarial survival for the 75 patients was 75%, with a median survival of 129.5 months. The 5-year actuarial survival rates for stage I+II, III, and IV patients were 90%, 40%, and 45%, respectively. Prognostic factors for survival included tumor histological type and pretreatment anti-EBV/VCA IgA titer, while prognostic factors for local control included total radiation dose received and pretreatment anti-EBV/VCA IgG titer. We found that there was a significant difference in the geometric mean titer of anti-EBV/VCA IgA antibodies before and after radiotherapy. Prognostic factors affecting NPC patients' actuarial survival included tumor histology and pretreatment IgA titer, while prognostic factors for local control of NPC included total radiation dose received and pretreatment IgG titer. (K.H.)\n[Epidemiolog\u00eda de la enfermedad de Chagas en el municipio Andr\u00e9s Eloy Blanco, Lara, Venezuela: infestaci\u00f3n triatom\u00ednica y seroprevalencia en humanos](https://www.openaire.eu/search/publication?articleId=od______3056::692149d58b95d40db6faba3a453e8c9d)\nRodr\u00edguez-Bonfante,Claudina; Amaro,Aned; Garc\u00eda,Mar\u00eda; Mej\u00edas Wohlert,Ligia Elena; Guillen,Pamela; Antonio Garc\u00eda,Rafael; \u00c1lvarez,Naysan; D\u00edaz,Marialejandra; C\u00e1rdenas,Elsys; Castillo,Silvia; Bonfante-Garrido,Rafael; Bonfante-Cabarcas,Rafael\n2007-01-01\nSe realiz\u00f3 un despistaje serol\u00f3gico y recolecci\u00f3n de vectores en cuatro comunidades rurales del municipio Andr\u00e9s Eloy Blanco, Estado Lara, Venezuela. La muestra fue escogida en forma sistem\u00e1tica y aleatoria basada en conglomerados familiares. Se muestrearon 869 habitantes para determinar anticuerpos anti-Trypanosoma cruzi y anti-Leishmania sp. por inmunofluorescencia indirecta, aceptando como positivo diluciones > a 1:32 para anticuerpos anti-T. cruzi no reactivos para ant\u00edgenos de Leishmania...\n[Prevalence of Cytomegalovirus IgG Antibodies among Pregnant Women Visiting Antenatal Clinic, LAUTECH Teaching Hospital in Osogbo, Osun State, Nigeria.](https://www.ncbi.nlm.nih.gov/pubmed/26745015)\nAkende, Oluwatosin; Akanbi, Olusola Anuoluwapo; Oluremi, Adeolu Sunday; Okonko, Iheanyi Omezuruike; Opaleye, Oluyinka Oladele\n2016-01-01\nCytomegalovirus (CMV) is one of the predominant viral infections that lead to congenital diseases and teratogenic risks during the perinatal stage. There is paucity of seroepidemiological data on anti-CMV IgG antibody in pregnant women in Osogbo, Osun State, Nigeria. This study was aimed at determining the seroprevalence of Cytomegalovirus IgG antibody among pregnant women visiting antenatal clinic, LAUTECH Teaching Hospital, Osogbo, Nigeria. One hundred and seventy-four sera from the pregnant women were screened by Enzyme linked Immunosorbent Assay (ELISA) for cytomegalovirus (CMV) IgG antibody. Data analysis was done using SPSS software. In this study, 105 of the 174 pregnant women were seropositive for CMV IgG antibodies giving an antibody prevalence of 60%. There was no association found between CMV IgG seropositivity and the subjects' demographic characteristics, however, the 60.0% prevalence of CMV-IgG antibody observed amongst pregnant women in this study demands for vaccines and regular testing for the presence of CMV and its related risk factors in antenatal clinic.\n[Procedimientos para la detecci\u00f3n e identificaci\u00f3n de anticuerpos eritrocitarios](https://www.openaire.eu/search/publication?articleId=od_______623::23fcc096a7073841256cbf6b42306aa2)\nAlfonso Vald\u00e9s , Yalile; Bencomo Hern\u00e1ndez, Antonio\n2001-01-01\nEn Inmunohematolog\u00eda se ha desarrollado una amplia gama de procederes de detecci\u00f3n e identificaci\u00f3n de anticuerpos eritrocitarios in vitro, por lo cual se realiza una revisi\u00f3n de t\u00e9cnicas y m\u00e9todos empleados con este objetivo, como son el m\u00e9todo que utiliza eritrocitos pretratados con enzimas proteol\u00edticas y las t\u00e9cnicas de Polibreno, que utiliza soluci\u00f3n de baja fuerza i\u00f3nica (LISS), la de antiglobulina indirecta, la de aglutinaci\u00f3n en gel, la inhibici\u00f3n de la aglutinaci\u00f3n, la hem\u00f3lisis y la...\n[Desarrollo de una t\u00e9cnica de inmunoelectrotransferencia \"Westernblot\" para la detecci\u00f3n de anticuerpos contra componentes prote\u00ednicos de Salmonella Typhi](http://www.revistabiomedica.org/index.php/biomedica/article/view/1989) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMiguel Guzm\u00e1n Urrego\n1990-12-01\nFull Text Available Desde su desarrollo la lnmunoelectrotransferencia (INMET ha sido una herramienta \u00fatil en biolog\u00eda molecular as\u00ed como tambi\u00e9n en el diagn\u00f3stico de diferentes enfermedades infecciosas. Tradicionalniente la demostraci\u00f3n de anticuerpos contra Salmonella typhi, se ha enfocado hacia la detecci\u00f3n de aquellos, que se producen contra lipopolisac\u00e1ridos, especialmente los que se relacionan con el ant\u00edgeno som\u00e1tico \"0\". Pero pocos trabajos, se han realizado para la detecci\u00f3n de anticuerpos contra otros ant\u00edgenos tales como prote\u00ednas protoplasm\u00e1ticas. Este trabajo intenta demostrar si tales anticuerpos se producen en conejos inmunizados experimentalmente, as\u00ed como tambi\u00e9n en voluntarios vacunados contra la fiebre Tifoidea con lavacuna oral (cepa Ty21a. El ant\u00edgeno preparado y purificado a partir de una cepa de Salmonella typhi, fue suspendido en una soluci\u00f3n tamp\u00f3n y sonicado para obtener sus productos celulares; de esta manera y con la adecuada concentraci\u00f3n de prote\u00ednas fue separado en gel de poliacrilamida en sus diferentes fracciones antig\u00e9nicas y luego transferidos a membranas de nitrocelulosa en donde por medio de reacci\u00f3n inmunoenzim\u00e1tica, se visualiz\u00f3 la banda caracter\u00edstica, al poner en contacto la membrana con el antisuero hiperinmune obtenido en conejos (Modelo Experimental y el suero de voluntarios antes y despu\u00e9s de la inmunizaci\u00f3n (Modelo Humano. La banda visualizada correspondi\u00f3 a un peso aproximado de 38.000 kd. Trece de los voluntarios (32.5%, presentaron esta misma banda antes de la inmunizaci\u00f3n, la cual, aunque m\u00e1s tenue, represent\u00f3 un complejo ant\u00edgeno-anticuerpo, lo cual, induce a pensar en un posible contacto con el microorganismo en el pasado. La posibilidad de la reacci\u00f3n cruzada se descart\u00f3 realizando el mismo procedimiento con lisados de Escherichia coli.\n[Serodiagnosis of Toxoplasmosis: The effect of measurement of IgG avidity in pregnant women in Rabat in Morocco.](https://www.ncbi.nlm.nih.gov/pubmed/28433574)\nLaboudi, Majda; Sadak, Abderrahim\n2017-08-01\nThe diagnosis of Toxoplasmosis in pregnant women during the early first trimester of pregnancy is very important for preventing congenital infection of the fetus; it will not only prevent the risk of transmitting the infection to the fetus but it will also enable to give these women a preventive treatment. In this study, the avidity test was performed on pregnant women during their first prenatal visit at the National Institute of Hygiene in Rabat, Morocco. One hundred and twenty-eight sera samples were collected from 128 pregnant women between August 2015 and June 2016; these women were chosen retrospectively and were in their first four months of pregnancy. The samples were screened using the specific anti-Toxoplasma IgG and IgM antibodies and were subjected to an IgG avidity test. After the serological screening, only 54 women (42.4%) were tested positive for IgG antibodies and five women (3.9%) were tested positive for both anti-Toxoplasma IgG and IgM antibodies. Four IgM-negative women had low-avidity antibodies. However, none of the IgG-avidity test had detected low-avidity antibodies in the five IgM-positive women; three women (60%) had high-avidity antibodies, indicating that the infection was acquired in the distant past. The avidity test is a helpful tool to exclude a recently acquired toxoplasmosis infection within IgM-positive serum samples in pregnant women during their first trimester of pregnancy. Thus, allowing to perform an appropriate therapeutic intervention. Copyright \u00a9 2017 Elsevier B.V. All rights reserved.\n[Multinuclear NMR study of the structure of the Fv fragment of anti-dansyl mouse IgG2a antibody](http://www.etde.org/etdeweb/details.jsp?query_id=1&page=0&osti_id=5025656) [Energy Technology Data Exchange (ETDEWEB)](https://www.etde.org/etdeweb/fieldedsearch.jsp)\nTakahashi, Hideo; Odaka, Asano; Matsunaga, Chigusa; Kato, Koichi; Shimada, Ichio; Arata, Yoji (Univ. of Tokyo (Japan)); Kawaminami, Shunro (Kao Corp., Tochigi (Japan))\n1991-07-02\nA multinuclear NMR study is reported of Fv, which is a minimum antigen-binding unit of immunoglobulin. Fv has been prepared by clostripain digestion of a mouse anti-dansyl IgG2a monoclonal antibody that lacks the entire C{sub H}1 domain. A variety of Fv analogues labeled with {sup 2}H in the aromatic rings and with {sup 13}C and/or {sup 15}N in the peptide bonds have been prepared and used for multinuclear NMR analyses of Fv spectra of Fv sensitively reflect the antigen binding and can be used along with {sup 1}H and {sup 13}C spectral data for the structural analyses of antigen-antibody interactions. Hydrogen-deuterium exchange of the amide protons has been folowed in the absence and presence of DNS-Lys by using the {sup 1}H-{sup 15}N shift correlation spectra. Use of the {beta}-shift observed for the carbonyl carbon resonances has also been helpful in following the hydrogen-deuterium exchange. On the basis of the NMR data obtained, the static and dynamic structure of the Fv fragment in the absence and presence of DNS-Lys has been discussed.\n[Multinuclear NMR study of the structure of the Fv fragment of anti-dansyl mouse IgG2a antibody](https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=23011255) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nTakahashi, Hideo; Odaka, Asano; Matsunaga, Chigusa; Kato, Koichi; Shimada, Ichio; Arata, Yoji; Kawaminami, Shunro\n1991-01-01\nA multinuclear NMR study is reported of Fv, which is a minimum antigen-binding unit of immunoglobulin. Fv has been prepared by clostripain digestion of a mouse anti-dansyl IgG2a monoclonal antibody that lacks the entire C H 1 domain. A variety of Fv analogues labeled with 2 H in the aromatic rings and with 13 C and/or 15 N in the peptide bonds have been prepared and used for multinuclear NMR analyses of Fv spectra of Fv sensitively reflect the antigen binding and can be used along with 1 H and 13 C spectral data for the structural analyses of antigen-antibody interactions. Hydrogen-deuterium exchange of the amide protons has been folowed in the absence and presence of DNS-Lys by using the 1 H- 15 N shift correlation spectra. Use of the \u03b2-shift observed for the carbonyl carbon resonances has also been helpful in following the hydrogen-deuterium exchange. On the basis of the NMR data obtained, the static and dynamic structure of the Fv fragment in the absence and presence of DNS-Lys has been discussed\n[Estandarizaci\u00f3n de una prueba de ELISA para detectar anticuerpos IgE en pacientes con equinococosis quistica y su utilidad en el diagn\u00f3stico y seguimiento de pacientes tratados con albendazol: reporte preliminar](http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1025-55832012000100007&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nHerman Vild\u00f3zola\n2012-01-01\nFull Text Available Objetivos: Determinar las diluciones y concentraciones optimas de una prueba de ELISA para detectar anticuerpos IgE, as\u00ed como su sensibilidad, esp\u00e9cificidad y valor predictivo en pacientes con equinococosis quistica. Analizar si los niveles de anticuerpos IgE especificos se correlacionan con la respuesta al tratamiento m\u00e9dico con albendazol en un periodo mayor a un a\u00f1o de finalizado el tratamiento. Dise\u00f1o: Estudio cuasiexperimental con grupo control. Instituci\u00f3n: Instituto de Medicina Tropical Daniel A. Carri\u00f3n, Facultad de Medicina, UNMSM, Lima, Per\u00fa. Material de estudio: Prueba de ELISA para anticuerpo IgE. Intervenciones: Estandarizacion de la prueba de ELISA para anticuerpo IgE y dise\u00f1o preexperimento con preprueba y posprueba en un solo grupo, para evaluar su valor en el diagn\u00f3stico y seguimiento postratamiento de pacientes con quiste hidatidico hepatico tratados con albendazol. Para la estandarizacion de la prueba de ELISA, se utiliz\u00f3 suero de cinco pacientes con diagn\u00f3stico cl\u00ednico de equinococosis quistica, y la sensibilidad y especificidad de la prueba se us\u00f3 suero de 30 pacientes aparentemente sanos. Para determinar las reacciones cruzadas, se utiliz\u00f3 16 muestras de suero de pacientes con otras helmintiasis (ascariasis, strongiloidiasis, toxocariosis, trichuriasis, himenolepiasis, cisticercosis y teniasis. Para el diagn\u00f3stico y seguimiento postratamiento de equinocococosis qu\u00edstica, se utiliz\u00f3 el suero de 17 pacientes. Principales medidas de resultados: Sensibilidad y especificidad de prueba estandarizada de ELISA para detectar anticuerpos IgE. Resultados: La prueba estandarizada de ELISA para detectar anticuerpos IgE tuvo una sensibilidad de 95,6% y una especificidad de 100%. En los pacientes con quiste hidat\u00eddico hep\u00e1tico considerados curados, uniformemente disminuyeron los niveles de anticuerpo tipo IgE hasta la negativizaci\u00f3n. Se obtuvo elevaci\u00f3n de los niveles de IgE en los pacientes que presentaron\n[Prevalencia de anticuerpos antitrepon\u00e9micos y caracter\u00edsticas sociodemogr\u00e1ficas de la poblaci\u00f3n mexicana adulta en el a\u00f1o 2000 Anti-Treponema pallidum seroprevalence and sociodemographic characteristics in Mexican adult population, 2000](http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342007000900013) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nCarlos J Conde-Gonz\u00e1lez\n2007-01-01\nFull Text Available OBJETIVO: Determinar la frecuencia de anticuerpos antitrepon\u00e9micos en mexicanos adultos de ambos sexos y las caracter\u00edsticas de la poblaci\u00f3n relacionadas con la infecci\u00f3n sifil\u00edtica. MATERIAL Y M\u00c9TODOS: Se analizaron para anti-Treponema pallidum 12 010 sueros seleccionados de forma aleatoria de la Encuesta Nacional de Salud 2000, con aplicaci\u00f3n de un algoritmo conformado por t\u00e9cnicas serol\u00f3gicas trepon\u00e9micas y no trepon\u00e9micas, de tamizaje y confirmatorias, y se realiz\u00f3 un an\u00e1lisis estad\u00edstico para identificar los factores vinculados con la seropositividad. RESULTADOS: La seroprevalencia de anticuerpos antitrepon\u00e9micos fue de 3.1% (IC95% 2.5-3.7. Las caracter\u00edsticas relacionadas de modo significativo con la exposici\u00f3n a la infecci\u00f3n fueron la mayor edad (RM 3.3, sexo masculino (RM 1.3, residencia en la regi\u00f3n geogr\u00e1fica sur del pa\u00eds (RM 1.7, vivir en uni\u00f3n libre (RM 2.7 o ser viudo (RM 1.8, inicio de relaciones sexuales a edad temprana (RM 6.3 y, en las mujeres en particular, se identific\u00f3 el antecedente de mortinatos (RM 1.8 y el informe de falta de uso del cond\u00f3n como m\u00e9todo anticonceptivo (RM 14.1. CONCLUSIONES: Los hallazgos del estudio demuestran que la magnitud del antecedente de la infecci\u00f3n por el treponema en la poblaci\u00f3n mexicana adulta es considerablemente mayor respecto del que permite calcular la notificaci\u00f3n oficial de casos de la enfermedad. Como sucede con otras infecciones de transmisi\u00f3n sexual, aspectos sociodemogr\u00e1ficos, de g\u00e9nero y las pr\u00e1cticas sexuales no seguras incrementan la transmisi\u00f3n del agente etiol\u00f3gico. En M\u00e9xico existe la necesidad de reforzar la vigilancia de la infecci\u00f3n sifil\u00edtica a trav\u00e9s de un diagn\u00f3stico oportuno y eficaz de los casos, m\u00e1s su adecuado tratamiento, para coadyuvar al control del padecimiento.OBJECTIVE: To measure for the first time in a population based study the prevalence of antibodies against Treponema pallidum among the Mexican adult population and\n[Polymyositis with elevated serum IgG4 levels and abundant IgG4+ plasma cell infiltration: A case report and literature review.](https://www.ncbi.nlm.nih.gov/pubmed/29310344)\nAnan, Ryusuke; Akiyama, Mitsuhiro; Kaneko, Yuko; Kikuchi, Jun; Suzuki, Kazuko; Matsubara, Shiro; Takeuchi, Tsutomu\n2017-12-01\nPolymyositis (PM) is a type of autoimmune, inflammatory myopathy. IgG4-related disease (IgG4-RD) is a recently recognized disease entity characterized by elevated serum IgG4 levels and IgG4 plasma-cell infiltration of various organs. However, several reports have described cases of other diseases that present with those features, suggesting the importance of careful differential diagnosis. Herein, we report the first case of PM with elevated serum IgG4 levels and IgG4 plasma cells in the muscles, mimicking IgG4-RD.A 73-year-old woman visited our hospital because of proximal muscle weakness of both thighs. Her blood test showed high levels of serum creatinine kinase, aldolase, and IgG4. Magnetic resonance imaging of the thighs showed muscle edema. Needle electromyography showed findings typical of myositis. Histological analysis of her left quadriceps revealed infiltration of IgG4 plasma cells as well as CD8 T cells. Scattered necrotic and regenerating muscle fibers with no specific findings for IgG4-RD (storiform fibrosis and obliterative phlebitis) were typical for PM. We diagnosed her condition as PM and treated her with 40 mg/day of prednisolone that decreased levels of muscle enzymes and improved muscle weakness. Our case indicated that PM could present with high serum IgG4 levels and IgG4 plasma-cell infiltration, mimicking IgG4-RD. Although the mechanism of IgG4 elevation in such PM is unclear, our case highlights the necessity to recognize that high serum IgG4 levels and IgG4 plasma-cell infiltration in organs are not specific for IgG4-RD.\n[Epstein-Barr virus-infected cells in IgG4-related lymphadenopathy with comparison with extranodal IgG4-related disease.](https://www.ncbi.nlm.nih.gov/pubmed/24705309)\nTakeuchi, Mai; Sato, Yasuharu; Yasui, Hiroshi; Ozawa, Hiroaki; Ohno, Kyotaro; Takata, Katsuyoshi; Gion, Yuka; Orita, Yorihisa; Tachibana, Tomoyasu; Itoh, Tomoo; Asano, Naoko; Nakamura, Shigeo; Swerdlow, Steven H; Yoshino, Tadashi\n2014-07-01\nIgG4-related lymphadenopathy with increased numbers of Epstein-Barr virus (EBV)-infected cells has been reported but not fully described. We analyzed 31 cases of IgG4-related lymphadenopathy and 24 cases of extranodal IgG4-related diseases for their possible relationship with EBV. Other types of reactive lymph nodes (22) and angioimmunoblastic T-cell lymphoma (AITL) (10) were also studied for comparison. EBV-encoded RNA (EBER) in situ hybridization revealed EBER(+) cells in 18 of 31 cases (58%) of IgG4-related lymphadenopathy. Increased EBER(+) cells were found in only 4 of 22 (18.1%) non-IgG4-related reactive lymphoid hyperplasia in patients of a similar age (P=0.002) and in only 5 of 24 (21%) extranodal IgG4-related biopsies (P=0.006). Interestingly, all patients with EBER(+) progressively transformed germinal center-type IgG4-related lymphadenopathy had systemic lymphadenopathy and/or extranodal involvement. AITL also is associated with EBV, and IgG4-related lymphadenopathy sometimes mimics the morphology of AITL; however, the number of IgG4(+) cells in AITL was significantly less than that in IgG4-related lymphadenopathy (Pdisease; however, there was not a significant difference between the EBER(+) and EBER(-) cases. In conclusion, the presence of increased numbers of EBV-infected cells in IgG4-related lymphadenopathy, compared with other reactive lymphadenopathy or extranodal IgG4-related disease, suggests that there may be a relationship at least between nodal IgG4-related disease and EBV. It is important to avoid overdiagnosing these cases as malignant lymphomas or EBV-related lymphoproliferative disorders.\n[Chronic cat allergen exposure induces a TH2 cell-dependent IgG4 response related to low sensitization.](https://www.ncbi.nlm.nih.gov/pubmed/26371841)\nRenand, Amedee; Archila, Luis D; McGinty, John; Wambre, Erik; Robinson, David; Hales, Belinda J; Thomas, Wayne R; Kwok, William W\n2015-12-01\nIn human subjects, allergen tolerance has been observed after high-dose allergen exposure or after completed allergen immunotherapy, which is related to the accumulation of anti-inflammatory IgG4. However, the specific T-cell response that leads to IgG4 induction during chronic allergen exposure remains poorly understood. We sought to evaluate the relationship between cat allergen-specific T-cell frequency, cat allergen-specific IgE and IgG4 titers, and clinical status in adults with cat allergy with and without cat ownership and the cellular mechanism by which IgG4 is produced. Fel d 1-, Fel d 4-, Fel d 7-, and Fel d 8-specific T-cell responses were characterized by CD154 expression after antigen stimulation. In allergic subjects without cat ownership, the frequency of cat allergen (Fel d 1 and Fel d 4)-specific TH2 (sTH2) cells correlates with higher IgE levels and is linked to asthma. Paradoxically, we observed that subjects with cat allergy and chronic cat exposure maintain a high frequency of sTH2 cells, which correlates with higher IgG4 levels and low sensitization. B cells from allergic, but not nonallergic subjects, are able to produce IgG4 after cognate interactions with sTH2 clones and Fel d 1 peptide or the Fel d 1 recombinant protein. These experiments suggest that (1) allergen-experienced B cells with the capacity to produce IgG4 are present in allergic subjects and (2) cat allergen exposure induces an IgG4 response in a TH2 cell-dependent manner. Thus IgG4 accumulation could be mediated by chronic activation of the TH2 response, which in turn drives desensitization. Copyright \u00a9 2015 American Academy of Allergy, Asthma & Immunology. All rights reserved.\n[Pathological manifestations in lymphatic filariasis correlate with lack of inhibitory properties of IgG4 antibodies on IgE-activated granulocytes.](https://www.ncbi.nlm.nih.gov/pubmed/28742098)\nProdjinotho, Ulrich F; von Horn, Charlotte; Debrah, Alex Y; Batsa Debrah, Linda; Albers, Anna; Layland, Laura E; Hoerauf, Achim; Adjobimey, Tomabu\n2017-07-01\nHelminth parasites are known to be efficient modulators of their host's immune system. To guarantee their own survival, they induce alongside the classical Th2 a strong regulatory response with high levels of anti-inflammatory cytokines and elevated plasma levels of IgG4. This particular antibody was shown in different models to exhibit immunosuppressive properties. How IgG4 affects the etiopathology of lymphatic filariasis (LF) is however not well characterized. Here we investigate the impact of plasma and affinity-purified IgG/IgG4 fractions from endemic normals (EN) and LF infected pathology patients (CP), asymptomatic microfilaraemic (Mf+) and amicrofilaraemic (Mf-) individuals on IgE/IL3 activated granulocytes. The activation and degranulation states were investigated by monitoring the expression of CD63/HLADR and the release of granule contents (neutrophil elastase (NE), eosinophil cationic protein (ECP) and histamine) respectively by flow cytometry and ELISA. We could show that the activation of granulocytes was inhibited in the presence of plasma from EN and Mf+ individuals whereas those of Mf- and CP presented no effect. This inhibitory capacity was impaired upon depletion of IgG in Mf+ individuals but persisted in IgG-depleted plasma from EN, where it strongly correlated with the expression of IgA. In addition, IgA-depleted fractions failed to suppress granulocyte activation. Strikingly, affinity-purified IgG4 antibodies from EN, Mf+ and Mf- individuals bound granulocytes and inhibited activation and the release of ECP, NE and histamine. In contrast, IgG4 from CP could not bind granulocytes and presented no suppressive capacity. Reduction of both the affinity to, and the suppressive properties of anti-inflammatory IgG4 on granulocytes was reached only when Fc\u03b3RI and II were blocked simultaneously. These data indicate that IgG4 antibodies from Mf+, Mf- and EN, in contrast to those of CP, natively exhibit Fc\u03b3RI/II-dependent suppressive properties on\n[An Adult Case of Recurrent Guillain-Barr\u00e9 Syndrome with Anti-galactocerebroside Antibodies](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=5827325)\nTakahashi, Hisashi; Kimura, Tadashi; Yuki, Natsuko; Yoshioka, Akira\n2017-01-01\nA 79-year-old woman with a history of Guillain-Barr\u00e9 syndrome (GBS) developed somnolence and tetraparesis after pneumonia. Based on clinical and laboratory findings, she was diagnosed with complications of acute inflammatory demyelinating polyneuropathy (AIDP) and acute disseminated encephalomyelitis (ADEM). Anti-galactocerebroside (Gal-C) IgG antibodies were detected in her serum. Cases of recurrent GBS in patients who are positive for this antibody are extremely rare. The anti-Gal-C IgG antibodies likely played an important role in the pathogenesis of the AIDP and ADEM. PMID:29093388\n[Frequency of anti-Chlamydia trachomatis antibodies in infertile women referred to Tabriz Al-Zahra hospital](http://www.ssu.ac.ir/ijrm/index.php/ijrm/article/view/2310/pdf) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMahtab Sattari\n2017-08-01\nFull Text Available Background: Infertility is one of the major issues in society and its incidence is estimated to be almost 10-15%. Chlamydia trachomatis (C. trachomatis is an important cause of sexually transmitted diseases leading to infertility. Objective: This study was designed to determine the frequency of anti-C. trachomatis antibodies in infertile women at Al-zahra hospital, Tabriz, Iran. Materials and Methods: In this cross-sectional study, the blood samples were collected randomly from 184 infertile women (case group and 100 pregnant women (control group. The frequency of specific IgG and IgM anti-C. trachomatis antibodies were evaluated using ELISA method. Results: The frequency of IgG anti-C. trachomatis antibody in the control and case groups was 18% and 35.88%, respectively. IgM anti-C. trachomatis antibody was found in 2% of controls and 5.44% of infertile women. Our results showed the significant differences between the case and control groups in anti-C. trachomatis antibodies (IgG, p=0.035 and IgM, p=0.004. Also, no significant relation was seen between the frequency of anti-C. trachomatis antibodies and age, location, and tubal factor infertility in our two study groups. Conclusion: According to high frequency of antibody anti-C. trachomatis among infertile women in competition to the control group, evaluation and treatment of Chlamydia infections is necessary in these patients\n[Prevalencia de anticuerpos para Trypanosoma cruzi en caninos de dos municipios end\u00e9micos de Boyac\u00e1](http://revistas.unicordoba.edu.co/revistamvz/mvz-171/V17N1A15.pdf) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nDiego Manrique Abril\n2012-04-01\nFull Text Available Objetivo. evaluar la prevalencia de anticuerpos anti Trypanosoma cruzi (T. cruzi en una muestra de caninos dom\u00e9sticos residentes en dos municipios end\u00e9micos. Materiales y m\u00e9todos. Se tomaron muestras s\u00e9ricas de 20 caninos procedentes de hogares donde residen mujeres gestantes seropositivas y 40 perros habitantes de hogares de mujeres gestantes seronegativas en Miraflores y Moniquira, Boyac\u00e1. El an\u00e1lisis se realiz\u00f3 mediante prueba diagn\u00f3stica r\u00e1pida dipstick de InBios. Resultados. Se encontr\u00f3 prevalencia del 16.7% en Moniquir\u00e1 y del 13.3% Miraflores respectivamente con una prevalencia general del 15% en los dos municipios. Se hall\u00f3 riesgo 3 veces mayor de que ocurra la infecci\u00f3n en caninos, en los hogares donde residen gestantes seropositivas; adem\u00e1s la infestaci\u00f3n por pulgas y garrapatas en el animal, h\u00e1bitat cercano a la vivienda, se relacionan con mayor seropositividad en el canino. Conclusiones. La raza, el sexo, la presencia de aves en la casa y al examen cl\u00ednico general son considerados factores pron\u00f3sticos en en la infecci\u00f3n por Trypanosoma cruzi en caninos. Como factores protectores se identific\u00f3 la desparasitaci\u00f3n y vacunaci\u00f3n de los animales.\n[Establishment of a serum IgG4 cut-off value for the differential diagnosis of IgG4-related disease in Chinese population.](https://www.ncbi.nlm.nih.gov/pubmed/26565780)\nLi, Ping; Chen, Hua; Deng, Chuiwen; Wu, Ziyan; Lin, Wei; Zeng, Xiaofeng; Zhang, Wen; Zhang, Fengchun; Li, Yongzhe\n2016-07-01\nThis study was performed to better know diagnosis associated with serum IgG4 concentration, and to explore the possibility for development of a serum IgG4 for IgG4-related disease (IgG4-RD) in Chinese populations. We studied retrospectively 497 IgG4 serum subclass measurements from Peking Union Medical College Hospital during the four-year period, including 242 IgG4-RD, 130 other diseases and 125 healthy individuals. Serum IgG4 concentrations were significantly higher in IgG4-RD than in other pathologies (1662.9 \u00b1 3760.9 mg/L, p IgG4 level between other pathologies group and healthy individuals (p = 0.075). Among the 242 IgG4-RD patients analyzed, serum IgG4 concentrations were normal in 46 patients (19.0%). We found 32 patients (24.6%) with elevated serum IgG4 levels among the 130 patients who suffered from other pathologies. There were seven (5.6%) with serum IgG4 over 1350 mg/L in healthy individuals. The ROC curve analysis revealed that the optimal sensitivity and specificity were 80.0% and 88.2%, respectively, at the concentration of 1575 mg/L for Chinese patients. Our study demonstrated that serum IgG4 elevation was not specific of IgG4-RD. Further studies are needed to define the sensibility and specificity of IgG4 values for the diagnosis of IgG4-RD.\n[Current Concept of IgG4-Related Disease.](https://www.ncbi.nlm.nih.gov/pubmed/28091932)\nOkazaki, Kazuichi; Umehara, Hisanori\n2017-01-01\nIgG4-related disease (IgG4-RD) is a fibroinflammatory disease of unknown etiology, which is characterized by a tendency to form tumefactive lesions, increased serum levels of IgG4, and massive infiltration of IgG4-positive plasma cells with storiform fibrosis and/or obliterative phlebitis. Patients with IgG4-RD have frequently multiorgan involvements such as the pancreas, biliary tree, salivary glands, periorbital tissues, kidneys, lungs, lymph nodes, and retroperitoneum. IgG4-RD mainly affects middle-aged to elderly men except for involvement in lachrymal and salivary glands, so-called Mikulicz's disease. The clinical manifestations of IgG4-RD depend on individually involved organs and respond well to steroid, but the prognosis still remains unclear. Some patients develop serious complications such as obstructive jaundice due to hepatic, gallbladder, or pancreatic lesions; hydronephrosis due to retroperitoneal fibrosis; or respiratory symptoms due to pulmonary lesions. Nomenclatures of individual organ manifestation of IgG4-RD have been internationally consented.\n[Clinical features of IgG4-related rhinosinusitis.](https://www.ncbi.nlm.nih.gov/pubmed/28575786)\nHanaoka, Machiko; Kammisawa, Terumi; Koizumi, Satomi; Kuruma, Sawako; Chiba, Kazuro; Kikuyama, Masataka; Shirakura, Satoshi; Sugimoto, Taro; Hishima, Tsunekazu\n2017-09-01\nIgG4-related disease is a systemic disease that affects various organs of the body. Aim of this study is to elucidate the clinical characteristics of IgG4-related rhinosinusitis. Clinical features, laboratory findings, radiological and endoscopic findings, associated disease, treatment and prognosis were retrospectively examined in 10 patients with IgG4-related rhinosinusitis. The age was 59.1\u00b111.3 years old and male-to-female ratio was 1:1. The chief nasal complaints were hyposmia (n=4), nasal obstruction (n=3), and nothing (n=3). Serum IgG4 levels were elevated in all patients and the value was 740.4\u00b1472.4mg/dl. Other IgG4-related diseases were associated in all 10 patients, including IgG4-related sialadenitis (n=6), IgG4-related dacryoadenitis (n=5), and autoimmune pancreatitis (n=5). Imaging findings on CT/MRI were obstruction of the way of elimination (n=10), thickening of the sinus mucous membrane (n=10), and fluid in the sinus (n=6). All of the cases had bilateral findings. Nasal endoscopic findings were chiefly deviated nasal septum (n=5), polyps (n=4), edema of the mucous membrane (n=3). Histologically, abundant infiltration of IgG4 positive plasma cell and lymphocyte and an elevated IgG4+/IgG+ cell ration was detected in all 8 patients and 5 patients, respectively. Endoscopic sinus surgery was performed in 8 patients. Eight patients were treated with steroid therapy for other associated IgG4-related diseases. Symptoms improved in all 6 patients after an initial treatment (endoscopic surgery (n=5) and steroids (n=1)), but one patient suffered relapse. IgG4-related rhinosinusitis is a distinct entity of IgG4-related disease, and is associated in patients with multiple IgG4-related diseases. Copyright \u00a9 2017 Medical University of Bialystok. Published by Elsevier B.V. All rights reserved.\n[Seroprevalence of Anti-Toxoplasma gondii Antibodies Among Lebanese Pregnant Women.](https://www.ncbi.nlm.nih.gov/pubmed/29064352)\nNahouli, Hasan; El Arnaout, Nour; Chalhoub, Elias; Anastadiadis, Elie; El Hajj, Hiba\n2017-12-01\nToxoplasma gondii, the causative agent of toxoplasmosis, is a zoonotic obligate intracellular protozoan parasite responsible for the infection of almost one-third of the world's population. T. gondii is particularly threatening for primo-infected pregnant women and may lead, following vertical transplacental transmission, to spontaneous abortion, miscarriage, or severe manifestations in the newborn. The aim of this study was to provide an updated estimate of the seroprevalence of anti-T. gondii antibodies among a group of Lebanese pregnant women and its seroconversion rate. This is a retrospective cohort study, in which medical records of 11,000 pregnant women were screened. These women visited a private Obstetrics and Gynecology clinic located in Beirut, the capital of Lebanon, during the period of January 1994 till September 2015. Serological results of anti-T. gondii immunoglobulin G (IgG) and immunoglobulin M (IgM) results of 2456 Lebanese pregnant women who fulfilled the inclusion criteria were included in the analysis. Seropositivity and seroconversion rates for women with repeated tests were reported according to age and area of residence. The overall anti-T. gondii IgG and IgM seropositivity among 2456 Lebanese pregnant women was 82.6% and 1.8% respectively. The highest IgG seropositivity is among the age group of 35-44 years (87.81%) and at the governorate of \"Mount Lebanon\" (82.95%). Sixty-four seroconversions were detected and two abortions due to T. gondii infection during pregnancy were recorded. The seroprevalence of anti-T. gondii IgG among the screened pregnant women in Lebanon is the highest in the Arab region. These results highlight the importance of running a national sample survey to estimate the real potential burden of this infection and its impact on maternal and fetal health.\n[Nivel de corte de los ELISAs para cuantificaci\u00f3n de anticuerpos inducidos por la vacuna antimeningoc\u00f3cica VA-MENGOC-BC](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2001000200002&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nRolando Ochoa\n2001-06-01\nFull Text Available Para medir el grado de protecci\u00f3n inducido por vacunas antimeningoc\u00f3cicas se ha establecido el Ensayo Bactericida en Suero (EBS y se perfeccionan otros ensayos inmunobiol\u00f3gicos, sin embargo, es necesario contar con pruebas sencillas como el ELISA, capaz de evaluar un gran n\u00famero de muestras. Se estim\u00f3 el nivel de corte de los ELISAs para la cuantificaci\u00f3n de IgG humana contra los ant\u00edgenos de VA-MENGOC-BC, vacuna antimeningoc\u00f3cica compuesta por ves\u00edculas proteicas de membrana externa de meningococo B y polisac\u00e1rido capsular de meningococo C, con respecto a un panel de muestras de suero de lactantes, caracterizado por Ensayo Bactericida en Sangre Total (EBST. Los valores correspondientes a la m\u00e1xima sensibilidad y especificidad fueron respectivamente; 2 \u03bcg/mL y 12 \u03bcg/mL para antipolisac\u00e1rido C, y 1000 U/mL y 7000 U/mL para antiprote\u00ednas de membrana externa. La mayor coincidencia se obtuvo con 6 \u03bcg/mL y 2500 U/mL. Se evalu\u00f3 otro panel de muestras de suero de adolescentes entre 14 y 18 a\u00f1os, por ELISA y EBS para Neisseria meningitidis serogrupos B y C, alcanz\u00e1ndose una buena concordancia. Doce a\u00f1os despu\u00e9s de la inmunizaci\u00f3n con VA-MENGOC-BC persiste una importante concentraci\u00f3n de anticuerpos contra los ant\u00edgenos vacunales en los sueros estudiados.\n[Detection of IgG1 and IgG4 subtypes reactive against potato apyrase in schistosomiasis patients](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762010000400004) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nPriscila de Faria-Pinto\n2010-07-01\nFull Text Available In this paper, we showed for the first time that the conserved domains within Schistosoma mansoni ATP diphosphohydrolase isoforms, shared with potato apyrase, possess epitopes for the IgG1 and IgG4 subtypes, as 24 (80% of the 30 schistosomiasis patients were seropositive for this vegetable protein. The analyses for each patient cured (n = 14 after treatment (AT with praziquantel revealed variable IgG1 and IgG4 reactivity against potato apyrase. Different antigenic epitopes shared between the vegetable and parasite proteins could be involved in susceptibility or resistance to S. mansoni AT with praziquantel and these possibilities should be explored.\n[Hemolytic disease of the fetus and newborn caused by anti-E](http://www.ajts.org/article.asp?issn=0973-6247;year=2013;volume=7;issue=1;spage=84;epage=85;aulast=Usman) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAdiyyatu Sa\u2032idu Usman\n2013-01-01\nFull Text Available Objective: Maternal allo-antibody production is stimulated when fetal red blood cells are positive for an antigen absent on the mother\u2032s red cells. The maternal IgG antibodies produced will pass through the placenta and attack fetal red cells carrying the corresponding antigen. Allo-immune hemolytic disease of the fetus and newborn caused by anti-E rarely occurs. Case summary: We report two cases of anti-E hemolytic diseases in neonates. One of the neonates had severe hemolysis presenting with severe anemia, thrombocytopenia, and conjugated hyperbilirubinemia, while the other had moderate anemia and unconjugated hyperbilrubinemia. Although both the neonates were treated by phototherapy and intravenous immunoglobulin, one of them received double volume exchange transfusion. Conclusion: There appeared to be an increase in the occurrence of hemolytic disease of the fetus and newborn caused by Rh antibodies other than anti-D. In this case report, both patients presented with anemia and hyperbilirubinemia but were successfully treated, with a favorable outcome.\n[IgG4-related kidney disease \u2013 an update](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4318645)\nKawano, Mitsuhiro; Saeki, Takako\n2015-01-01\nPurpose of review IgG4-related disease (IgG4-RD) is a recently recognized systemic inflammatory disorder that can affect most organs/tissues such as sarcoidosis. The kidney is a frequently affected organ with tubulointerstitial nephritis (TIN), the representative lesion of IgG4-RD. This review focuses on the latest knowledge of IgG4-related kidney disease (IgG4-RKD). Recent findings A wide range of renal manifestations of IgG4-RD, that is TIN, membranous glomerulonephritis (MGN) and other glomerular lesions, and pyelitis, are collectively referred to as IgG4-RKD. Clinically, decreased renal function, or characteristic imaging findings such as multiple low-density lesions on contrast-enhanced computed tomography or diffuse thickening of the renal pelvic wall, are typical presenting features. Although a rapid response to corticosteroid therapy is a very important feature of IgG4-TIN, in cases in which renal function is moderately to severely decreased before therapy, only partial recovery of renal function is obtained. Summary TIN with characteristic imaging findings is a typical manifestation of IgG4-RKD in the interstitium, while MGN is a representative manifestation of the glomerular lesions. Although IgG4 is a central feature of IgG4-RD, the recent discovery of IgG4-negative IgG4-RD raises questions about the causative role of the IgG4 molecule in this context. PMID:25594543\n[Intrathoracic Manifestations of IgG4-Related Disease](http://pulmonarychronicles.com/index.php/pulmonarychronicles/article/view/324) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nSian Yik Lim\n2016-10-01\nFull Text Available Intrathoracic involvement with IgG4-related disease (IgG4-RD is frequently overlooked in IgG4-related disease patients. In this article we review the intrathoracic findings of IgG4-RD which are variable and protean. IgG4-related disease has been reported to affect the lung parenchyma, pleura, mediastinal/hilar lymph nodes, vasculature, and pericardium within the thorax. Mediastinal and hilar lymphadenopathy is the most common intrathoracic manifestation of IgG4-RD. Four main patterns of pulmonary disease have been described, including the solid nodular type, the bronchovascular type, the alveolar interstitial type, and the round shaped ground glass type. When feasible, a biopsy should be obtained to confirm the diagnosis. Most lesions show characteristic pathologic findings of IgG4-RD: dense lymphoplasmacytic infiltrate, storiform fibrosis, and obliterative phlebitis. While this helps establish the diagnosis, the interpretation of pathology findings in the clinical context is key in making an accurate diagnosis. Mimickers of IgG4-RD should be ruled out, before making a diagnosis. The intrathoracic findings of IgG4-RD can be treated effectively with prednisone, but may require additional immunosuppressive therapies, including rituximab.\n[Value of serum IgG4 in the diagnosis of IgG4-related disease and in differentiation from rheumatic diseases and other diseases.](https://www.ncbi.nlm.nih.gov/pubmed/21953287)\nYamamoto, Motohisa; Tabeya, Tetsuya; Naishiro, Yasuyoshi; Yajima, Hidetaka; Ishigami, Keisuke; Shimizu, Yui; Obara, Mikiko; Suzuki, Chisako; Yamashita, Kentaro; Yamamoto, Hiroyuki; Hayashi, Toshiaki; Sasaki, Shigeru; Sugaya, Toshiaki; Ishida, Tadao; Takano, Ken-Ichi; Himi, Tetsuo; Suzuki, Yasuo; Nishimoto, Norihiro; Honda, Saho; Takahashi, Hiroki; Imai, Kohzoh; Shinomura, Yasuhisa\n2012-06-01\nIgG4-related disease (IgG4-RD) is a novel disease entity that includes Mikulicz's disease, autoimmune pancreatitis (AIP), and many other conditions. It is characterized by elevated serum IgG4 levels and abundant IgG4-bearing plasmacyte infiltration of involved organs. We postulated that high levels of serum IgG4 would comprise a useful diagnostic tool, but little information is available about IgG4 in conditions other than IgG4-RD, including rheumatic diseases. Several reports have described cutoff values for serum IgG4 when diagnosing IgG4-RD, but these studies mostly used 135 mg/dL in AIP to differentiate from pancreatic cancer instead of rheumatic and other common diseases. There is no evidence for a cutoff serum IgG4 level of 135 mg/dL for rheumatic diseases and common diseases that are often complicated with rheumatic diseases. The aim of this work was to re-evaluate the usual cutoff serum IgG4 value in AIP (135 mg/dL) that is used to diagnose whole IgG4-RD in the setting of a rheumatic clinic by measuring serum IgG4 levels in IgG4-RD and various disorders. We therefore constructed ROC curves of serum IgG4 levels in 418 patients who attended Sapporo Medical University Hospital due to IgG4-RD and various rheumatic and common disorders. The optimal cut-off value of serum IgG4 for a diagnosis of IgG4-RD was 144 mg/dL, and the sensitivity and specificity were 95.10 and 90.76%, respectively. Levels of serum IgG4 were elevated in IgG4-RD, Churg-Strauss syndrome, multicentric Castleman's disease, eosinophilic disorders, and in some patients with rheumatoid arthritis, systemic sclerosis, chronic hepatitis, and liver cirrhosis. The usual cut-off value of 135 mg/dL in AIP is useful for diagnosing whole IgG4-RD, but high levels of serum IgG4 are sometimes observed in not only IgG4-RD but also other rheumatic and common diseases.\n[Increase in serum concentrations of IgG2 and IgG4 by selenium supplementation in children with Down's syndrome.](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1793096)\nAnner\u00e9n, G; Magnusson, C G; Nordvall, S L\n1990-01-01\nIn a previous study on children with Down's syndrome a reduced rate of infections was reported by their parents after the children had received six months' treatment with selenium supplements. In the present study the concentrations of the four IgG subclasses were measured in 29 of these children in samples of serum obtained before and immediately after the period of supplementation and one year after it had finished. Selenium had a significant augmentative effect on the serum concentrations of IgG2 and IgG4, but not of IgG1 and IgG3. This effect was not related to age, as among children over the age of 6 years the serum concentrations of IgG2 and IgG4 had decreased significantly one year after the treatment had been stopped. This study suggests that selenium has an immunoregulatory effect, which might be of importance in both basic research and clinical practice. PMID:2148668\n[Research on antibodies anti toxoplasma gondii in intraocular fluids (Aqueous and vitreous humor) from patients with ocular toxoplasmosis, in the City of Bel\u00e9m, Par\u00e1 State](https://www.openaire.eu/search/publication?articleId=dedup_wf_001::2675424db6a3d1362f5d296fbc4e7f16)\nCarmo, Ediclei Lima do; Almeida, Edmundo Frota; Bichara, Cl\u00e9a Nazar\u00e9; P\u00f3voa, Marinete Marins\n2005-01-01\nFoi realizada pesquisa de anticorpos IgG, IgM e IgA anti-Toxoplasma gondii no soro e fluidos intra-oculares (humor aquoso e v\u00edtreo) de pacientes com toxoplasmose ocular. A partir dos resultados obtidos verificou-se que anticorpos IgG e IgA intraocular anti-Toxoplasma gondii podem vir a ser importantes marcadores no diagn\u00f3stico de toxoplasmose ocular.Tests were performed for antibodies IgG, IgM and IgA anti-Toxoplasma gondii antibodies in serum and intraocular fluids (Aqueous and vitreous humo...\n[Comprehensive Analysis of the Therapeutic IgG4 Antibody Pembrolizumab: Hinge Modification Blocks Half Molecule Exchange In Vitro and In Vivo.](https://www.ncbi.nlm.nih.gov/pubmed/26308749)\nYang, Xiaoyu; Wang, Fengqiang; Zhang, Ying; Wang, Larry; Antonenko, Svetlana; Zhang, Shuli; Zhang, Yi Wei; Tabrizifard, Mohammad; Ermakov, Grigori; Wiswell, Derek; Beaumont, Maribel; Liu, Liming; Richardson, Daisy; Shameem, Mohammed; Ambrogelly, Alexandre\n2015-12-01\nIgG4 antibodies are evolving as an important class of cancer immunotherapies. However, human IgG4 can undergo Fab arm (half molecule) exchange with other IgG4 molecules in vivo. The hinge modification by a point mutation (S228P) prevents half molecule exchange of IgG4. However, the experimental confirmation is still expected by regulatory agencies. Here, we report for the first time the extensive analysis of half molecule exchange for a hinge-modified therapeutic IgG4 molecule, pembrolizumab (Keytruda) targeting programmed death 1 (PD1) receptor that was approved for advanced melanoma. Studies were performed in buffer or human serum using multiple exchange partners including natalizumab (Tysabri) and human IgG4 pool. Formation of bispecific antibodies was monitored by fluorescence resonance energy transfer, exchange with Fc fragments, mixed mode chromatography, immunoassays, and liquid chromatography-mass spectrometry. The half molecule exchange was also examined in vivo in SCID (severe combined immunodeficiency) mice. Both in vitro and in vivo results indicate that the hinge modification in pembrolizumab prevented half molecule exchange, whereas the unmodified counterpart anti-PD1 wt showed active exchange activity with other IgG4 antibodies or self-exchange activity with its own molecules. Our work, as an example expected for meeting regulatory requirements, contributes to establish without ambiguity that hinge-modified IgG4 antibodies are suitable for biotherapeutic applications. \u00a9 2015 Wiley Periodicals, Inc. and the American Pharmacists Association.\n[\u201cInclonals\u201d: IgGs and IgG-enzyme fusion proteins produced in an E. coli expression-refolding system](https://www.openaire.eu/search/publication?articleId=od_______908::7729499f9eb5962ca55df26d4b38c7eb)\nHakim, Rahely; Benhar, Itai\n2009-01-01\nFull-length antibodies and antibodies that ferry a cargo to target cells are desired biopharmaceuticals. We describe the production of full-length IgGs and IgG-toxin fusion proteins in E. coli. In the presented examples of anti CD30 and anti EGF-receptor antibodies, the antibody heavy and light chains or toxin fusions thereof were expressed in separate bacterial cultures, where they accumulated as insoluble inclusion bodies. Following refolding and purification, high yields (up to 50 mg/L of ...\n[La inmunocromatograf\u00eda para el diagn\u00f3stico de la infecci\u00f3n por Taenia solium en Mesocricetus auratus mediante la detecci\u00f3n de coproant\u00edgenos*](http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1726-46342001000200002&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nHermes Escalante A\n2001-07-01\nFull Text Available Objetivo: Evaluar la t\u00e9cnica de inmunocromatograf\u00eda para el diagn\u00f3stico de la infecci\u00f3n por Taenia solium en Mesocricetus auratus \"h\u00e1msters\" mediante la detecci\u00f3n de coproant\u00edgenos. Materiales y m\u00e9todos: Se produjo en Oryctolagus cunniculus \"conejo\" IgG anti-ant\u00edgenos de excreci\u00f3n/secreci\u00f3n (ES de T. solium y en Capra hircus \"cabra\" IgG anti-IgG de conejo. Parte de las IgG anti-ant\u00edgenos ES de T. solium fue conjugado con oro coloidal. La inmunocromatograf\u00eda se llev\u00f3 a cabo utilizando tiras de nitrocelulosa en las cu\u00e1les se fij\u00f3 dos bandas con anticuerpos de captura; en la primera, las IgG anti-ant\u00edgenos ES de T. solium (banda de prueba, y en la segunda las IgG anti-IgG de conejo (banda control. La t\u00e9cnica fue evaluada con un \"pool\" de tres muestras de medio de cultivo con ant\u00edgenos ES de T. solium, Hymenolepis nana, Dyphillobotrium pacificum y de larvas de Anisakis simplex, as\u00ed como con un \"pool\" de tres muestras fecales de h\u00e1msters no parasitados, de parasitados por H. nana y de siete muestras fecales de h\u00e1msters parasitados por T. Solium. Resultados: La inmunocromatograf\u00eda permiti\u00f3 detectar ant\u00edgenos de T. solium en muestras de medio de cultivo con ant\u00edgenos ES espec\u00edficas y en heces de h\u00e1msters parasitados por T. solium mediante la coloraci\u00f3n de la banda de prueba, siendo negativo cuando se utiliz\u00f3 medios con ES de otros helmintos y sin ant\u00edgenos, as\u00ed como con muestras de heces de h\u00e1msters infectados por otros par\u00e1sitos y de no parasitados. En todas las tiras usadas se observ\u00f3 coloraci\u00f3n de la banda control. Conclusi\u00f3n: La t\u00e9cnica de inmunocromatograf\u00eda es capaz de detectar ant\u00edgenos de T. solium, tanto en medio de cultivo como en heces de h\u00e1msters, faltando evaluar la sensibilidad y la especificidad con muestras fecales humanas para el diagn\u00f3stico de la teniosis mediante la detecci\u00f3n de coproant\u00edgenos.\n[IgG4-Related Disease: A Multispecialty Condition](http://dx.doi.org/10.1155/2014/723493) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nIuri Us\u00eada Santana\n2014-01-01\nFull Text Available IgG4-related disease (IgG4-RD is a recently recognized group of conditions, characterized by tumor-like swelling of involved organs, lymphoplasmacytic infiltrate rich in IgG4-positive plasma cells, variable degrees of fibrosis, and elevated serum IgG4 concentrations. Currently IgG4-RD is recognized as a systemic condition that can affect several organs and tissues. Herein we report the case of a 34-year-old male patient who was admitted to our hospital with diffuse abdominal pain, weight loss, and painful stiffness in his neck. He had a history of tumoral mass of the left maxillary region, right palpebral ptosis with protrusion of the eyeball, and chronic dry cough for about 6 years. Laboratory tests revealed polyclonal hypergammaglobulinemia and increased serum IgG4 levels. Immunohistochemical staining of the maxillary biopsy was compatible with IgG4-RD. He had an excellent response to corticosteroid therapy. This case highlights that IgG4-RD should be included in the differential diagnosis with multisystem diseases.\n[ELISA indireto para detec\u00e7\u00e3o de Ig G anti-v\u00edrus da doen\u00e7a de newcastle em soro de codorna](https://www.openaire.eu/search/publication?articleId=od______3056::aa3edf723f330bc1432b8373ec9772da)\nDaniela Duarte de Oliveira\n2004-01-01\nForam desenvolvidos e comparados dois ELISAs para detec\u00e7\u00e3o de IgG de codorna (Coturnix coturnix jap\u00f4nica) contra o v\u00edrus da doen\u00e7a de Newcastle (VDN). Um deles utilizando anticorpo secund\u00e1rio de camundongo anti-IgG de codorna e o outro, conjugado anti-IgG de galinha. Para a produ\u00e7\u00e3o de anticorpo secund\u00e1rio (IgG de camundongo anti-IgG de codorna), m\u00e9todos de purifica\u00e7\u00e3o de IgG de codorna foram avaliados utilizando 30 amostras de soros e gemas de ovos de codornas, confirmados posteriormente por...\n[Binding-site analysis of opioid receptors using monoclonal anti-idiotypic antibodies](https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=21093687) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nConroy, W.G.\n1988-01-01\nStructural relatedness between the variable region of anti-ligand antibodies and opioid binding sites allowed the generation of anti-idiotypic antibodies which recognized opioid receptors. The IgG 3 k antibodies which bound to opioid receptors were obtained when an anti-morphine antiserum was the idiotype. Both antibodies bound to opioid receptors, but only one of these blocked the binding of [ 3 H]naloxone. The antibody which did not inhibit the binding of [ 3 H]naloxone was itself displaced from the receptor by opioid ligands. The unique binding properties displayed by this antibody indicated that anti-idiotypic antibodies are not always a perfect image of the original ligand, and therefore may be more useful than typical ligands as probes for the receptor. An auto-anti-idiotypic technique was successfully used to obtain anti-opioid receptor antibodies. Another IgG 3 k antibody that blocked the binding of [ 3 H]naloxone to rat brain opioid receptors was obtained when a mouse was immunized with naloxone conjugated to bovine serum albumin. These data confirmed that an idiotype-anti-idiotype network which can generate an anti-receptor antibody normally functions when an opioid ligand is introduced into an animal in an immunogenic form\n[IgG4-Associated Cholangitis--A Mimic of PSC](https://www.narcis.nl/publication/RecordID/oai%3Apure.amc.nl%3Apublications%2Fc4c158b3-fc61-4aed-a47a-2f13c89c5371/uquery/basel%20AND%20iii/id/19/Language/EN)\nBeuers, Ulrich; Hubers, Lowiek M.; Doorenspleet, Marieke; Maillette de Buy Wenniger, Lucas; Klarenbeek, Paul L.; Boonstra, Kirsten; Ponsioen, Cyriel; Rauws, Erik; de Vries, Niek\n2015-01-01\nIgG4-associated cholangitis (IAC) is an inflammatory disorder of the biliary tract representing a major manifestation of IgG4-related disease (IgG4-RD) often with elevation of serum IgG4 levels, infiltration of IgG4+ plasma cells in the affected tissue and good response to immunosuppressive\n[TREATMENT OF IgG4-RELATED DISEASE](http://rsp.ima-press.net/rsp/article/view/2233) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nE. V. Sokol\n2016-01-01\nFull Text Available IgG4-related disease (IgG4-RD is a fibroinflammatory condition characterized by the occurrence of tumor-like foci in different organs with a unique histological pattern (moir\u043e-like fibrosis, obvious lymphoplasmacytic infiltration with large numbers of IgG4+ plasma cells, and obliterating phlebitis and elevated serum IgG4 levels in the majority of patients. Its first-line therapy is glucocorticoids at a starting dose of 0.6 mg/kg/day (equivalent to prednisolone; however, this treatment entails a great number of adverse events and high recurrence rates. The paper provides a review of today's literature on the treatment of IgG4-RD; particular emphasis is laid on the description of therapy with glucocorticoids and rituximab.\n[Diagnosis of IgG4-related sclerosing cholangitis](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3837265)\nNakazawa, Takahiro; Naitoh, Itaru; Hayashi, Kazuki; Miyabe, Katsuyuki; Simizu, Shuya; Joh, Takashi\n2013-01-01\nIgG4-related sclerosing cholangitis (IgG4-SC) is often associated with autoimmune pancreatitis. However, the diffuse cholangiographic abnormalities observed in IgG4-SC may resemble those observed in primary sclerosing cholangitis (PSC), and the presence of segmental stenosis suggests cholangiocarcinoma (CC). IgG4-SC responds well to steroid therapy, whereas PSC is only effectively treated with liver transplantation and CC requires surgical intervention. Since IgG4-SC was first described, it has become a third distinct clinical entity of sclerosing cholangitis. The aim of this review was to introduce the diagnostic methods for IgG4-SC. IgG4-SC should be carefully diagnosed based on a combination of characteristic clinical, serological, morphological, and histopathological features after cholangiographic classification and targeting of a disease for differential diagnosis. When intrapancreatic stenosis is detected, pancreatic cancer or CC should be ruled out. If multiple intrahepatic stenoses are evident, PSC should be distinguished on the basis of cholangiographic findings and liver biopsy with IgG4 immunostaining. Associated inflammatory bowel disease is suggestive of PSC. If stenosis is demonstrated in the hepatic hilar region, CC should be discriminated by ultrasonography, intraductal ultrasonography, bile duct biopsy, and a higher cutoff serum IgG4 level of 182 mg/dL. PMID:24282356\n[Papel de los anticuerpos antiplaquetarios en la infecci\u00f3n viral: una revisi\u00f3n sistem\u00e1tica de la literatura](http://www.revistabiomedica.org/index.php/biomedica/article/view/334) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nYenny M. Montenegro-Medina\n2011-04-01\nConclusiones. Aunque la aparici\u00f3n de anticuerpos antiplaquetarios no se considera el \u00fanico mecanismo que explica la trombocitopenia desarrollada en las infecciones virales mencionadas, de acuerdo con la literatura cient\u00edfica disponible, su presencia se asocia con la gravedad de la trombocitopenia y con potenciales implicaciones cl\u00ednicas en los pacientes.\n[Secondary IgG responses to type III pneumococcal polysaccharide. II. Different cellular requirements for induction and elicitation.](https://www.ncbi.nlm.nih.gov/pubmed/3609)\nBraley-Mullen, H\n1976-04-01\nMice primed with a thymus- (T) dependent form of Type III pneumococcal polysaccharide (S3), i.e., S3 coupled to erythrocytes (S3-RBC) produce S3-specific IgG antibody after secondary challenge with either S3 or S3-RBC. The production of IgG antibody by mice challenged with S3 was shown to be T independent since secondary responses were enhanced when mice were treated with anti-lymphocyte serum (ALS) at the time of secondary challenge with S3 and T-depleted spleen cells responded as well as unfractionated spleen cells to S3 in an adoptive transfer system. Secondary S3-specific IgG responses in mice challenged with S3-RBC were shown to be T dependent by the same criteria. The results obtained by using S3 as the antigen indicate that IgG-producing B cells (B lambda cells) can recognize and respond to antigen in the absence of helper T cells. On the other hand, T cells were required for the induction of S3-specific memory B lambda cells since mice depleted of T cells by treatment with ALS at the time of priming with S3-RBC failed to produce S3-specific IgG antibody after secondary challenge with either S3-specific IgG antibody after secondary chall-nge with either S3 or S3rbc. Since RBC-specific memory cells were induced in T-deprived mice the results suggest that T cell regulation of IgG antibody production may vary for different antigens.\n[IgG4-related Disease of the Genitourinary Tract](http://www.scopemed.org/fulltextpdf.php?mno=49298) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMukul K. Divatia\n2014-02-01\nFull Text Available IgG4-related disease (IgG4-RD is a recently established albeit well recognized fibro-inflammatory condition with distinctive features including a characteristic histopathological appearance; a propensity to develop tumefactive lesions in multiple body sites; and oft elevated serum IgG4 levels. The consensus statement on IgG-4 RD equips practicing pathologists with a set of working guidelines for the diagnosis of pathologic lesions identified in a host of different organ system affected with this disease. The diagnosis of IgG4-RD requires the combined presence of the characteristic histopathological appearance and increased numbers of IgG4-positive plasma cells. The essential histopathological features include a dense lymphoplasmacytic infiltrate, a storiform pattern of fibrosis, and obliterative phlebitis. Tissue IgG4-positive plasma cell counts and IgG4: IgG ratios are significant ancillary aids in establishing the diagnosis. The spectrum of IgG4-RD continues to expand and involve multiple body sites. The genitourinary system comprising of the kidneys, ureters, urinary bladder, urethra, prostate gland, testes and penis is one of the multiple organ systems to be affected by IgG4-RD. This review describes the clinical and histopathologic patterns of involvement of the genitourinary system by IgG4-RD, in association with serologic and radiological features. [J Interdiscipl Histopathol 2014; 2(1.000: 3-18\n[IgG4 antibodies in Egyptian patients with schistosomiasis](https://www.narcis.nl/publication/RecordID/oai%3Apure.amc.nl%3Apublications%2F13424964-ebbe-482f-a2c6-ce172a767cdc/uquery/IGG4/id/9/Language/EN)\nIskander, R.; Das, P. K.; Aalberse, R. C.\n1981-01-01\nSerum immunoglobulins were determined in 40 Egyptian patients with schistosomiasis. In addition to the well-established elevation in total IgE, a striking imbalance in the IgG subclass levels was found: IgG3 and IgG4 levels were markedly elevated, whereas IgG2 levels were normal. The IgG4 level did\nMaillette de Buy Wenniger, Lucas J.; Doorenspleet, Marieke E.; Verheij, Joanne; de Vries, Niek; Beuers, Ulrich\n2013-01-01\nThe diagnosis IgG4-related disease (IgG4-RD) is often difficult to make. The clinical spectrum is diverse, with a variety of organ systems that may be affected simultaneously or sequentially. Patients often present with symptoms that mimic a malignant disease, for example, symptoms compatible with a\n[IgG4-Associated Cholangitis Can Mimic Hilar Cholangiocarcinoma.](https://www.ncbi.nlm.nih.gov/pubmed/26033685)\nZaydfudim, Victor M; Wang, Andrew Y; de Lange, Eduard E; Zhao, Zimin; Moskaluk, Christopher A; Bauer, Todd W; Adams, Reid B\n2015-07-01\nIgG4-associated cholangitis can mimic hilar cholangiocarcinoma. Previously reported patients with IgG4-associated cholangitis mimicking cholangiocarcinoma had elevated serum IgG4 levels and long-segment biliary strictures. However, in the absence of other diagnostic criteria for malignancy, IgG4-associated cholangitis should remain a consideration among patients with normal serum IgG4 and a hilar mass suspicious for cholangiocarcinoma. The presence of a hilar mass and a malignant-appearing biliary stricture in two patients with normal serum IgG4 prompted further evaluation and subsequent concomitant liver and bile duct resection and reconstruction. The diagnosis of IgG4-associated cholangitis was established during the pathologic evaluation of the resected specimens. IgG4-associated cholangitis is a known imitator of hilar cholangiocarcinoma and should be considered in the differential diagnosis even among serologically IgG4-negative patients with a hilar mass prior to operative resection.\n[Isolated Mass-Forming IgG4-Related Cholangitis as an Initial Clinical Presentation of Systemic IgG4-Related Disease](http://www.jpatholtm.org/upload/pdf/jptm-2015-12-01.pdf) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nSeokhwi Kim\n2016-07-01\nFull Text Available IgG4-related disease (IgG4-RD may involve multiple organs. Although it usually presents as diffuse organ involvement, localized mass-forming lesions have been occasionally encountered in pancreas. However, the same pattern has been seldom reported in biliary tract. A 61-year-old male showed a hilar bile duct mass with multiple enlarged lymph nodes in imaging studies and he underwent trisectionectomy under impression of cholangiocarcinoma. Gross examination revealed a mass-like lesion around hilar bile duct. Histopathologically, dense lymphoplasmacytic infiltration and storiform fibrosis were identified without evidence of malignancy. Immunohistochemical stain demonstrated rich IgG4-positive plasma cell infiltration. Follow-up imaging studies disclosed multiple enlarged lymph nodes with involvement of pancreas and perisplenic soft tissue. The lesions have been significantly reduced after steroid treatment, which suggests multi-organ involvement of systemic IgG4-RD. Here, we report an unusual localized mass-forming IgG4-related cholangitis as an initial presentation of IgG4-RD, which was biliary manifestation of systemic IgG4-related autoimmune disease.\n[Evaluation of Immunity and Seropositivity of IgG Antibodies to Canine Parvoviruses in Vaccinated and Unvaccinated Dogs in Abeokuta, Nigeria.](https://www.ncbi.nlm.nih.gov/pubmed/25891124)\nBabalola, E T; Ijaopo, O K; Okonko, I O\n2016-01-01\nCanine Parvovirus (CPV) is a very contagious and virulent viral disease affecting domestic dogs all over the world causing high morbidity and mortality in dogs, especially puppies. This study aimed at determining the seropositivity of IgG antibodies against CPV in vaccinated and unvaccinated dogs and to evaluate the immune status of dogs presented in Abeokuta. Forty-eight dogs were enrolled in this study. These dogs were presented at random for treatment, routine checkup, and vaccination at the State Veterinary Hospital and Veterinary Teaching Hospital all in Abeokuta. All the dogs were fully maintained under domestic setting. Selection for study was done based on thorough examination of the dogs and their medical records. The clients were informed of the nature of the investigation. Blood samples were collected and analyzed for anti-CPV-IgG. In principle, protective immunity correlates with high antibody titers and this was determined using a commercially available immunocomb\u00ae test kit for anti-CPV IgG antibody. Of 48 dogs sampled, 38 (79.2%) had high level of anti-CPV antibody titer and 10 (20.8%) had low level of anti-CPV antibody titer. Twenty six (54.2%) were males while 22 (45.8%) were females. Forty-five (93.75%) dogs were exotic breeds while 3 (6.25%) dogs were mongrels. Thirty (62.5%) of the dogs were less than one year old and the age range of all dogs sampled was between 7 weeks and 7 years. There was no significant difference (P > 0.05) between sex and the level of immunity but significant differences (P canine parvovirus among dogs in Abeokuta, Nigeria. Of all variables evaluated, ages of dogs, breeds and post-vaccination period were the main correlates of the level of immunity to CPV. This study also showed agreement with previous studies in the diagnostic value of using the immunoblot ELISA assay for the rapid detection of anti-CPV IgG antibody.\n[Estudio del perfil de anticuerpos contra Helicobacter pylori producidos por pacientes con diferentes patolog\u00edas gastroduodenales](https://revistas.unal.edu.co/index.php/actabiol/article/view/27376) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nOlga Mar\u00eda Berm\u00fadez\n2004-07-01\nde la subclase 1 en los pacientes con gastritis atr\u00f3fica y adenocarcinoma g\u00e1strico, indica que la presencia de anticuerpos hacia esta prote\u00edna podr\u00eda ser usada como un marcador de c\u00e1ncer, mientras que el estudio del reconocimiento de los dem\u00e1s ant\u00edgenos principales (70 kDa, 90 kDA y VacA puede convertirse en una herramienta de importante valor para la caracterizaci\u00f3n de cada enfermedad.\n[Prevalencia de anticuerpos contra leptospira en poblaci\u00f3n urbana humana y canina del departamento del tolima](https://www.openaire.eu/search/publication?articleId=od______1326::76be0d14a3f1f02e02e0548376e95e2b)\nRomero, Marlyn H.; S\u00e1nchez, Jorge A.; Hayek, Linda C.\n2012-01-01\nObjetivo Determinar la seroprevalencia de anticuerpos contra Leptospira sp. y los serovares dominantes, en poblaci\u00f3n urbana humana y canina de tres municipios del departamento del Tolima, Colombia. Materiales y M\u00e9todos Se realiz\u00f3 un estudio epidemiol\u00f3gico trasversal con selecci\u00f3n de sujetos por conveniencia en 62 barrios. Se obtuvieron muestras de 850 personas.y 850 caninos durante los meses de junio, julio y agosto de 2007, las cuales fueron procesadas utilizando la prueba de microaglutinaci...\n[The autoimmune IgG4 -associated endocrine pathology](https://endojournals.ru/index.php/omet/article/view/9350) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMarina Yu. Yukina\n2017-11-01\nFull Text Available Immunoglobulin G4-associated diseases (IgG4-AD arethe group of chronic progressive autoimmune fibro-inflammatory pathology of various organs and tissues, characterized by their enlargement and abundant infiltration of immunoglobulin G4-positive plasma cells, as well as an increase in the level of serum immunoglobulin G4 (IgG4.In most patients, the disease is characterized by a mild course.However, there is evidence of a high incidence of malignancies in patients with IgG4-AD.Among endocrine IgG4-associated pathologies, pancreatitis with outcome in diabetes mellitus, hypophysitis and thyroiditis are described. Laboratory examination usually reveals an increased level of IgG4. However, the concentration of IgG4 could not be used as the only diagnostic criterion.The possibility of plasmablastsdetermining as a marker of the disease is discussed.Among the imaging techniques CT, MRI and 18F-FDG-PET/CT are used.However, the most informative method of diagnosis is biopsy. Randomized clinical trials to determine clear recommendations for the treatment of IgG4-AD were not conducted.In most cases, glucocorticoids are prescribed, and immunosuppressive therapy is sometimes used.According to the results of recent studies, the genetically engineered drug rituximab is relatively effective in inducing remission of the disease.Given the high recurrence rate and the risk of malignancy, patients with IgG4-AD require careful long-term follow-up. Thus, the review describes the clinical manifestations of IgG4-AD, examines the possibilities of their diagnosis and presents the existing methods of treatment.However, given the fact that IgG4-AD became a separate group of autoimmune pathology less than 20 years ago, there are insufficient data on these diseases. Researches related to epidemiology, pathophysiology, diagnosis and effective treatment of IgG4-AD are actual.\n[Comparative studies on Fc receptors for IgG on resting and activated T lymphocytes](https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=17054664) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nHueckel, C.; Jensen, H.L.; Rychly, J.; Sandor, M.; Erdei, A.; Gergely, J.\n1986-01-01\nFc-receptors for IgG (Fc\u03b3R) on resting (i.e. freshly prepared) and mitogen (Con A) or alloantigen-activated mouse spleen T cells were compared using binding of different markers such as 125 I-labelled immune complexes, 125 I-labelled anti Fc\u03b3R monoclonal antibody, FITC-labelled aggr. IgG and sheep erythrocytes covered with specific antibody (EA rosetting). C3b receptors were detected by rosetting with sheep erythrocytes covered with antibody and complement (EAC rosetting). The electrophoretic mobility of the cells without or after binding of aggr. IgG was also tested. Differences between resting and activated T cells were found: (1) After activation of T cells by mitogen or alloantigen, a proportion of Fc\u03b3R-positive cells increased two to four times. (2) Fc\u03b3R number per Fc\u03b3R-positive cell seemed to be higher on activated then on resting cells. (3) Fc\u03b3R-positive resting cells did not shed their Fc\u03b3R upon incubation at 4 0 C followed by incubation at 37 0 C, but Fc\u03b3R-positive activated cells shed a remarkable proportion of their Fc\u03b3R on the same conditions. (4) Binding of aggr. IgG caused a decrease of electrophoretic mobility of activated but not resting cells. (5) Fc\u03b3R-positive resting cells were also C3b receptor-positive, whereas Fc\u03b3R-positive activated cells had no detectable C3b receptors. (author)\n[Seroprevalencia de Hantavirus, Rickettsia y Chikungunya en poblaci\u00f3n ind\u00edgena del municipio de Tuch\u00edn, C\u00f3rdoba](http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0123-93922015000200005&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nSamia Barrera\nFull Text Available Introducci\u00f3n: La vigilancia de las enfermedades transmitidas por vectores es importante para establecer medidas de control en salud p\u00fablica. Las poblaciones ind\u00edgenas de C\u00f3rdoba viven en condiciones geoclim\u00e1ticas que favorecen la presencia de vectores que podr\u00edan permitir la diseminaci\u00f3n y aparici\u00f3n de hantavirosis, rickettsiosis y fiebre por el virus Chikungunya. Objetivo: Establecer la seroprevalencia de Hantavirus, Rickettsia sp. y Chikungunya en la poblaci\u00f3n ind\u00edgena de Tuch\u00edn, C\u00f3rdoba. Materiales y m\u00e9todos: Se realiz\u00f3 un estudio descriptivo de corte transversal en 190 individuos del resguardo ind\u00edgena del municipio de Tuch\u00edn; el muestreo fue realizado entre agosto y diciembre del 2012. La detecci\u00f3n de anticuerpos IgG contra Hantavirus se llev\u00f3 a cabo con la prueba IgG DxSelectTM (Focus Technologies, EL1600G, California, EE. UU., anticuerpos IgG contra Rickettsia sp. se determinaron por inmunofluorescencia indirecta y se realiz\u00f3 detecci\u00f3n de anticuerpos IgG contra el virus Chikungunya mediante ELISA de captura (Nova-Tec, inmunodiagnostica GmbH, CHIG0590, Alemania. Resultados: De 190 sueros analizados, el 5,2% (10/190 fueron positivos para Rickettsia sp. del grupo de la fiebre manchada, para Hantavirus 7 de 87 (8% fueron positivos y no se encontraron positivos para Chikungunya. No se encontraron diferencias significativas (p = 0,05 entre los seropositivos de Hantavirus y Rickettsia sp. para las variables g\u00e9nero, edad y ocupaci\u00f3n. Conclusiones: Los hallazgos demuestran exposici\u00f3n previa a Rickettsia sp. y a Hantavirus en la poblaci\u00f3n ind\u00edgena de Tuch\u00edn. Los resultados pueden ser \u00fatiles para establecer una alerta sobre estas fiebres hemorr\u00e1gicas. Aunque no se hallaron seropositivos para Chikungunya, este fue el primer trabajo de vigilancia epidemiol\u00f3gica realizado en Colombia sobre este virus.\n[Sphingosine-1-phosphate (S1P) enhances glomerular endothelial cells activation mediated by anti-myeloperoxidase antibody-positive IgG.](https://www.ncbi.nlm.nih.gov/pubmed/29168342)\nSun, Xiao-Jing; Chen, Min; Zhao, Ming-Hui\n2018-03-01\nCumulating evidences suggested an important role of sphingosine-1-phosphate (S1P) and its receptors in regulating endothelial barrier integrity. Our previous study revealed that the circulating S1P levels and renal expression of S1PRs correlated with disease activity and renal damage in patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). This study investigated the role of S1P and its receptors in myeloperoxidase (MPO)-ANCA-positive IgG-mediated glomerular endothelial cell (GEnC) activation. The effect of S1P on morphological alteration of GEnCs in the presence of MPO-ANCA-positive IgG was observed. Permeability assay was performed to determine endothelial monolayer activation in quantity. Both membrane-bound and soluble ICAM-1 and VCAM-1 levels were measured. Furthermore, antagonists and/or agonists of various S1PRs were employed to determine the role of different S1PRs. S1P enhanced MPO-ANCA-positive IgG-induced disruption of tight junction and disorganization of cytoskeleton in GEnCs. S1P induced further increase in monolayer permeability of GEnC monolayers in the presence of MPO-ANCA-positive IgG. S1P enhanced MPO-ANCA-positive IgG-induced membrane-bound and soluble ICAM-1/VCAM-1 up-regulation of GEnCs. Soluble ICAM-1 levels in the supernatants of GEnCs stimulated by S1P and MPO-ANCA-positive IgG increased upon pre-incubation of S1PR1 antagonist, while pre-incubation of GEnCs with the S1PR1 agonist down-regulated sICAM-1 level. Blocking S1PR2-4 reduced sICAM-1 levels in the supernatants of GEnCs stimulated by S1P and MPO-ANCA-positive IgG. Pre-incubation with S1PR5 agonist could increase sICAM-1 level in the supernatants of GEnC stimulated by S1P and MPO-ANCA-positive IgG. S1P can enhance MPO-ANCA-positive IgG-mediated GEnC activation through S1PR2-5. \u00a9 2017 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.\n[Frequency of antibodies class IgG anti-Rickettsia rickettsii in horses of Universidade Federal Rural do Rio de Janeiro, Serop\u00e9dica campus](http://rbmv.org/index.php/BJVM/article/view/358) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMatheus Dias Cordeiro\n2015-03-01\nFull Text Available ABSTRACT. Cordeiro M.D., Raia V.A., Valim J.R.A., Castro G.N.S., Souza C.E. & Fonseca A.H. [Frequency of antibodies class IgG anti-Rickettsia rickettsii in horses of Universidade Federal Rural do Rio de Janeiro, Serop\u00e9dica campus.] Frequ\u00eancia de anticorpos da classe IgG anti-Rickettsia rickettsii em equinos na Universidade Federal Rural do Rio de Janeiro, Campus Serop\u00e9dica. Revista Brasileira de Medicina Veterin\u00e1ria, 37(1:78-82, 2015. Departamento de Epidemiologia e Sa\u00fade P\u00fablica, Instituto de Veterin\u00e1ria, Universidade Federal Rural do Rio de Janeiro, Campus Serop\u00e9dica, BR 465, Km7, Serop\u00e9dica, RJ 23890-000, Brasil. E-mail: adivaldo@ufrrj.br The aim of this study was to verify, through the indirect immunofluorescence assay (IFA, the frequency of anti-Rickettsia rickettsii antibodies in horses at Universidade Federal Rural do Rio de Janeiro (UFRRJ Serop\u00e9dica campus, state of Rio de Janeiro. We analyzed serum samples from 42 horses from Department of Breeding Equine of UFRRJ. All samples were tested using fixed slides with antigens for R. rickettsii, Rickettsia rhipicephali and Rickettsia parkeri. We observed an overall prevalence of Rickettsia spp. 83.33% (35/42. For the agent R. rickettsii revealed a prevalence of 66.67% (28/42, still being categorized in titers of 1:64 (19/28 and 1:128 (9/28. Nine of the 28 positives horses for R. rickettsii (21.43% were no reactive to other agents, with titers 1:64 (8/9 and 1:128 (1/9. The only tick species found parasitizing horses on the campus of UFRRJ during the collection period were Amblyomma cajennense and Dermacentor nitens. The UFRRJ presents an environment that provides a ideal epidemiological niche for the permanence of Rickettsia bacteria. The high prevalence found in this study indicates that attention to epidemiological agent of Brazilian Spotted Fever in the study area is of utmost importance. The aim of this study was to verify, through the indirect immunofluorescence assay (IFA, the\n[Anti-interleukin-1 alpha autoantibodies in humans: Characterization, isotype distribution, and receptor-binding inhibition--higher frequency in Schnitzler's syndrome (urticaria and macroglobulinemia)](https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=23021930) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nSaurat, J.H.; Schifferli, J.; Steiger, G.; Dayer, J.M.; Didierjean, L.\n1991-01-01\nSince autoantibodies (Abs) to cytokines may modify their biologic activities, high-affinity binding factors for interleukin-1 alpha (IL-1 alpha BF) were characterized in human sera. IL-1 alpha BF was identified as IgG (1) by sucrose density-gradient centrifugation followed by immunodiffusion autoradiography, (2) by ligand-blotting method, (3) by ligand binding to affinity-immobilized serum IgG, and (4) by IgG affinity purification followed by sucrose density-gradient centrifugation. IL-1 alpha binding activity resided in the F(ab)2 fragment. The apparent equilibrium constant was in the range of IgG found after immunization with conventional antigens (i.e., 10(-9) to 10(-10) mol/L). Anti-IL-1 alpha IgG auto-Abs represented only an extremely small fraction of total IgG (less than 1/10(-5)). Some sera with IL-1 alpha BF and purified IgG thereof were able to inhibit by 96% to 98% the binding of human recombinant IL-1 alpha to its receptor on murine thymoma EL4-6.1 cells, whereas other sera did not. When 125I-labeled anti-IL-1 alpha IgG complexes were injected into rats, they prolonged the plasma half-life of 125I-labeled IL-1 alpha several fold and altered its tissue distribution. The predominant class was IgG (12/19), mainly IgG4 (9/19), but in five of the sera, anti-IL-1 alpha IgA was also detected. In a screening of 271 sera, IL-1 alpha BF was detected in 17/98 normal subjects and was not more frequent in several control groups of patients, except in patients with Schnitzler's syndrome (fever, chronic urticaria, bone pain, and monoclonal IgM paraprotein) (6/9; p less than 0.005). The pathologic significance of these auto-Abs remains to be determined\n[IgG4-related disease in autoimmune lymphoproliferative syndrome.](https://www.ncbi.nlm.nih.gov/pubmed/28478106)\nvan de Ven, Annick A J M; Seidl, Maximilian; Drendel, Vanessa; Schmitt-Graeff, Annette; Voll, Reinhard E; Rensing-Ehl, Anne; Speckmann, Carsten; Ehl, Stephan; Warnatz, Klaus; Kollert, Florian\n2017-07-01\nA patient with autoimmune lymphoproliferative disorder (ALPS) developed IgG4-related disease. In retrospect, he had high levels of serum IgG4 for several years prior to presenting with IgG4-related pancreatitis. These high IgG4 levels were masked by hypergammaglobulinemia, a common feature of ALPS. We next screened 18 ALPS patients; four of them displayed increased levels of IgG4. Hence, IgG4-related disease should be considered in ALPS patients, especially in those manifesting lymphocytic organ infiltration or excessive hypergammaglobulinaemia. Screening of IgG4-related disease patients for ALPS-associated mutations would provide further information on whether this disease could be a late-onset atypical presentation of ALPS. Copyright \u00a9 2017 Elsevier Inc. All rights reserved.\n[The Histopathology of IgG4-Related Disease.](https://www.ncbi.nlm.nih.gov/pubmed/27848036)\nAvincsal, Mehmet Ozgur; Zen, Yoh\n2017-01-01\nIgG4-related disease is a multi-organ immune-mediated chronic fibroinflammatory condition characterized by elevated serum IgG4 concentrations, tumefaction, and tissue infiltration by IgG4-positive plasma cells. The exact etiology of IgG4-related disease remains unclear with no known role of the IgG4 molecule itself being identified. Although the pancreas and salivary glands are the main organs affected, the involvement of other organs has also been reported. This multi-organ disease mimics a large number of malignant, infectious, and inflammatory disorders; therefore, a prompt differential diagnosis is important for selecting the right therapeutic strategy. Early steroid therapy assists in preventing tissue fibrosis, parenchymal extinction, and severe functional impairments in the affected organs. The definitive and prompt diagnosis of IgG4-related disease requires both histopathological confirmation and clinicopathological correlations. A histopathological examination is mandatory to exclude neoplastic or inflammatory conditions that mimic IgG4-related disease. The histological changes that occur are basically similar in any organ manifestation, with several site-specific findings being recognized. This chapter summarizes general rules for the pathological examination of IgG4-related disease, as well as the histopathological features and differential diagnoses of major organ manifestations.\n[Seroprevalence of Toxoplasma gondii IgG antibody in HIV/AIDS-infected individuals in Maputo, Mozambique](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-89102013000500890&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAb\u00edlio Domingos\n2013-10-01\nFull Text Available OBJECTIVE To analyze the prevalence of IgG antibodies to Toxoplasma gondii in patients infected with HIV/AIDS and the association of demographic and social variables. METHODS Descriptive cross-sectional study that included the analysis of sociodemographic data and laboratory findings of 200 patients infected with HIV/AIDS treated in a laboratory unit in Maputo, Mozambique, in 2010. Individual data for all participants were collected with a self-administered questionnaire. Plasma samples were tested for IgG testing of anti- T. gondii using hemagglutination for the analysis of antibodies. RESULTS The seroprevalence of IgG anti- T. gondii was 46.0% (95%CI 39.2;52.9, 39.3% (95%CI 29.5;50.0 in men and 50.9% (95%CI 41.9;59.8 in women, with no difference between sex (OR 1.30; 95%CI 0.95;1.77; p = 0.12. Ages ranged from 10 to 60 years, with a higher prevalence of infection in older age groups, but with no significant difference between them. Regularly consuming cattle meat (OR 1.74; 95%CI 1.04;2.89, p = 0.05, breeding cats/dogs (OR 6.18; 95%CI 3.60;10.62, p < 0.000 and having regular contact with soil (OR 3.38; 95%CI 2.19;5.21; p < 0.000 were significantly associated with risk of latent infection. CONCLUSIONS Toxoplasmosis is an infection with high prevalence in Mozambique. Cultural and behavioral aspects increase the risk. Toxoplasmosis can be responsible in our environment by the great burden of morbidity and mortality associated with meningoencephalic injuries in patients with HIV/AIDS.\n[Radiometric immunosorbent assay for the detection of anti-hormone-binding protein antibodies](https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=17082380) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nPierce, E.A.; Dame, M.C.; DeLuca, H.F.\n1986-01-01\nA radiometric immunosorbent assay (RISA) for the detection of monoclonal antibodies to hormone-binding proteins has been developed. The assay involves incubating hybridoma supernatants in microtiter wells that have been coated with goat anti-mouse IgG antibodies. Any mouse IgG in the test supernatant is thus specifically retained in the wells. Radioactive ligand-binding protein complexes are then incubated in the wells. The presence of anti-binding protein antibodies in the supernatant is indicated by specific retention of radioactive ligand-binding protein complexes in the wells. Crude antigen preparations, such as tissue homogenates, can be used to detect antibodies. The assay is capable of detecting antibody at concentrations 20 ng/ml (approx. 100 pM IgG). The RISA has been used successfully to screen for monoclonal antibodies to the intracellular receptor for 1,25-dihydroxyvitamin D 3 and should be useful for the detection of antibodies to ligand-binding proteins in general\n[Effect of antenatal parasitic infections on anti-vaccine IgG levels in children: a prospective birth cohort study in Kenya.](http://europepmc.org/articles/PMC4295886?pdf=render) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nIndu Malhotra\n2015-01-01\nFull Text Available Parasitic infections are prevalent among pregnant women in sub-Saharan Africa. We investigated whether prenatal exposure to malaria and/or helminths affects the pattern of infant immune responses to standard vaccinations against Haemophilus influenzae (Hib, diphtheria (DT, hepatitis B (Hep B and tetanus toxoid (TT.450 Kenyan women were tested for malaria, schistosomiasis, lymphatic filariasis (LF, and intestinal helminths during pregnancy. After three standard vaccinations at 6, 10 and 14 weeks, their newborns were followed biannually to age 36 months and tested for absolute levels of IgG against Hib, DT, Hep B, and TT at each time point. Newborns' cord blood (CB lymphocyte responses to malaria blood-stage antigens, soluble Schistosoma haematobium worm antigen (SWAP, and filaria antigen (BMA were also assessed. Three immunophenotype categories were compared: i tolerant (those having Plasmodium-, Schistosoma-, or Wuchereria-infected mothers but lacking respective Th1/Th2-type recall responses at birth to malaria antigens, SWAP, or BMA; ii sensitized (those with infected/uninfected mothers and detectable Th1/Th2-type CB recall response to respective parasite antigen; or iii unexposed (no evidence of maternal infection or CB recall response. Overall, 78.9% of mothers were infected with LF (44.7%, schistosomiasis (32.4%, malaria (27.6% or hookworm (33.8%. Antenatal maternal malaria, LF, and hookworm were independently associated with significantly lower Hib-specific IgG. Presence of multiple maternal infections was associated with lower infant IgG levels against Hib and DT antigens post-vaccination. Post-vaccination IgG levels were also significantly associated with immunophenotype: malaria-tolerized infants had reduced response to DT, whereas filaria-tolerized infants showed reduced response to Hib.There is an impaired ability to develop IgG antibody responses to key protective antigens of Hib and diphtheria in infants of mothers infected with\n[IgG4 subclass antibodies impair antitumor immunity in melanoma](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3613918)\nKaragiannis, Panagiotis; Gilbert, Amy E.; Josephs, Debra H.; Ali, Niwa; Dodev, Tihomir; Saul, Louise; Correa, Isabel; Roberts, Luke; Beddowes, Emma; Koers, Alexander; Hobbs, Carl; Ferreira, Silvia; Geh, Jenny L.C.; Healy, Ciaran; Harries, Mark; Acland, Katharine M.; Blower, Philip J.; Mitchell, Tracey; Fear, David J.; Spicer, James F.; Lacy, Katie E.; Nestle, Frank O.; Karagiannis, Sophia N.\n2013-01-01\nHost-induced antibodies and their contributions to cancer inflammation are largely unexplored. IgG4 subclass antibodies are present in IL-10\u2013driven Th2 immune responses in some inflammatory conditions. Since Th2-biased inflammation is a hallmark of tumor microenvironments, we investigated the presence and functional implications of IgG4 in malignant melanoma. Consistent with Th2 inflammation, CD22+ B cells and IgG4+-infiltrating cells accumulated in tumors, and IL-10, IL-4, and tumor-reactive IgG4 were expressed in situ. When compared with B cells from patient lymph nodes and blood, tumor-associated B cells were polarized to produce IgG4. Secreted B cells increased VEGF and IgG4, and tumor cells enhanced IL-10 secretion in cocultures. Unlike IgG1, an engineered tumor antigen-specific IgG4 was ineffective in triggering effector cell\u2013mediated tumor killing in vitro. Antigen-specific and nonspecific IgG4 inhibited IgG1-mediated tumoricidal functions. IgG4 blockade was mediated through reduction of Fc\u03b3RI activation. Additionally, IgG4 significantly impaired the potency of tumoricidal IgG1 in a human melanoma xenograft mouse model. Furthermore, serum IgG4 was inversely correlated with patient survival. These findings suggest that IgG4 promoted by tumor-induced Th2-biased inflammation may restrict effector cell functions against tumors, providing a previously unexplored aspect of tumor-induced immune escape and a basis for biomarker development and patient-specific therapeutic approaches. PMID:23454746\n[IgG4-Related Disease of Bilateral Temporal Bones.](https://www.ncbi.nlm.nih.gov/pubmed/27729479)\nLi, Lilun; Ward, Bryan; Cocks, Margaret; Kheradmand, Amir; Francis, Howard W\n2017-03-01\nIgG4-related disease (IgG4-RD) is an idiopathic inflammatory condition that causes pseudotumor formation in single or multiple organs, including those of the head and neck. Temporal bone involvement is rare, with only 3 cases of unilateral temporal bone IgG4-RD described in the literature. We report the first known case of IgG4-RD of bilateral temporal bones and describe its clinical presentation, diagnosis, and treatment. The patient was a 52-year-old man with latent tuberculosis (TB) who presented with a 10-year history of bilateral profound hearing loss and vestibular dysfunction. Computed tomography and magnetic resonance imaging demonstrated bilateral labyrinthine destruction with invasion of the posterior fossa. Immunoglobulin level testing showed elevated total serum IgG levels with normal IgG4 levels. Bilateral mastoidectomies were performed, with biopsy samples demonstrating IgG4 staining with IgG4-positive plasma cells up to 40/HPF (high power field) on the right and 20/HPF on the left, consistent with bilateral IgG4-RD. IgG4-RD of bilateral temporal bones presents with chronic and progressive bilateral hearing loss and vestibular dysfunction. Clinical presentation and radiologic findings are nonspecific, and definitive diagnosis must be made with histopathology and immunostaining. Corticosteroids are therapeutic, but surgical resection may be necessary for temporal bone IgG4-RD to improve long-term remission.\n[Riedel's thyroiditis association with IgG4-related disease.](https://www.ncbi.nlm.nih.gov/pubmed/27647429)\nStan, Marius N; Sonawane, Vikram; Sebo, Thomas J; Thapa, Prabin; Bahn, Rebecca S\n2017-03-01\nIgG4-positive (+) plasma cells have been reported in both Riedel's thyroiditis (RT) and Hashimoto's thyroiditis (HT). These cells are the hallmark of IgG4-related disease (IgG4-RD). We sought to determine whether RT is part of IgG4-RD spectrum. This was a case-control study performed at a tertiary medical centre. We included RT cases from the period 1958 to 2008 that had sufficient paraffin-embedded tissue for IgG4 immunostaining. Controls were patients with HT, age and gender matched, with similar pathology criteria. The main outcome measures were the intensity of the IgG4 staining and the clinical and histological correlates with IgG4-RD. Six pairs of RT and HT were analysed. The mean age was 44\u00b77 years. In both groups, 5/6 cases had positive IgG4 staining. The mean number of IgG4 + cells/ HPF, normalized to the degree of inflammation, was 3\u00b72 \u00b1 3\u00b70 SD (RT) vs 0\u00b79 \u00b1 0\u00b77 (HT), P = 0\u00b715, for fibrotic areas and 2\u00b71 \u00b1 2\u00b73 SD vs 1\u00b70 \u00b1 0\u00b78 (P = 0\u00b739) for areas with lymphoid aggregates. We found the number of IgG4 + cells in RT to be inversely correlated with the duration of disease (P = 0\u00b7046). Three RT cases had associated comorbidities from the IgG4-RD spectrum while none of the HT cases had such conditions. Riedel's thyroiditis is a component of IgG4-RD with the density of the IgG4 + lymphocytic infiltrate being time dependent. In this small study, we did not identify differences in IgG4 infiltration between RT and HT, minimizing the utility of this marker in RT diagnosis. \u00a9 2016 John Wiley & Sons Ltd.\n[Analysis of Tn antigenicity with a panel of new IgM and IgG1 monoclonal antibodies raised against leukemic cells](http://www.forskningsdatabasen.dk/en/catalog/194511669) [DEFF Research Database (Denmark)](http://forskningsbasen.deff.dk/?lang=eng)\nBlixt, Klas Ola; Lavrova, Olga I; Mazurov, Dmitriy V\n2012-01-01\nantigenicity remain poorly understood. As a consequence, a broad variety of anti-Tn monoclonal antibodies (mAbs) have been generated. To further investigate the nature and complexity of the Tn antigen, we generated seven different anti-Tn mAbs of IgM and IgG classes raised against human Jurkat T cells, which...... are Tn-positive due to the low activity of T-synthase and mutation in specific chaperone Cosmc. The binding analysis of anti-Tn mAbs with the array of synthetic saccharides, glycopeptides and O-glycoproteins revealed unexpected differences in specificities of anti-Tn mAbs. IgM mAbs bound the terminal Gal...\n[Pathomorphological characteristic of IgG4-related diseases](http://pat.zsmu.edu.ua/article/view/81051/78227) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nO. O. Dyadyk\n2016-08-01\nFull Text Available IgG4-related diseases are a relatively new group of diseases of unknown etiology which are characterized by the development of fibrosis of organs with the presence of big amounts of IgG4-positive plasma-cells in the area of the lesions and increased levels of IgG4 in serum. The organs that may be affected are pancreas, salivary gland, and others, clinical cases of kidney damage are described as well. Renal involvement in IgG4-related diseases most often occurs on the type of tubulointerstitial nephritis, with the further development of acute or chronic kidney injury. The clinic may be represented by the pseudotumor of kidney, renal tissue heterogeneity on the results of CT-studies; acute or chronic renal disease; combination with other organ damage (autoimmune pancreatitis, sclerosing cholangitis, sclerosing lymphoplasmacytic cholecystitis, colitis, sialadenitis, retroperitoneal fibrosis, etc.. Laboratory findings include an increased level of IgG4 in the blood serum, hypocomplementemia, eosinophilia. Histologically, there is interstitial inflammation with many plasma cells, interstitial fibrosis, tubular atrophy, thickening of the tubular basement membrane, some cases are a type of membranous glomerulonephritis. The aim of the study is to identify the patients with IgG4-related diseases with renal impairment and widening the pathological database of such patients with renal impairment to determine the classification criteria of this pathological condition. Materials and methods will include the deceased kidney screening, screening of patients with autoimmune and allergic diseases, nephrological patients screening with the lifetime biopsy (in some cases \u2013 repeat biopsy with chronic or acute kidney impairment. There will be clinical and pathological comparison in kidney damage and other diseases with the development of criteria for the classification of lesions in the presence of IgG4-positive substrates and further development of practical\n[In vitro study of protein release from AFCo1 and implications in mucosal immunisation](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2012000200003&lng=es&nrm=iso) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJos\u00e9 Ra\u00fal Dopico\n2012-04-01\nFull Text Available Los anticuerpos aviares (IgY presentan algunas ventajas con relaci\u00f3n a los anticuerpos IgG de mam\u00edferos, debido a su f\u00e1cil obtenci\u00f3n y purificaci\u00f3n y su bajo costo de producci\u00f3n. El objetivo de este trabajo fue estudiar la factibilidad de acoplar anticuerpos IgY a part\u00edculas de poliestireno y evaluar su desempe\u00f1o en ensayos de l\u00e1tex-aglutinaci\u00f3n en l\u00e1mina. Para este prop\u00f3sito se utiliz\u00f3 como modelo la detecci\u00f3n del ant\u00edgeno de superficie de la hepatitis B (HBsAg. Gallinas Leghorn se inmunizaron con el ingrediente farmac\u00e9utico activo que se utiliza en la elaboraci\u00f3n de la vacuna recombinante cubana Heberbiovac-HB. Los anticuerpos obtenidos se purificaron y emplearon en la preparaci\u00f3n de reactivos de l\u00e1tex-aglutinaci\u00f3n (0,8 \u00b5m para la detecci\u00f3n del HBsAg, los cuales se evaluaron con 50 muestras de suero frente a un reactivo comercial similar. Los resultados se evaluaron de satisfactorios. Se demostr\u00f3 la factibilidad de acoplar anticuerpos aviares a part\u00edculas de l\u00e1tex y se abre una perspectiva al empleo de este tipo de ensayo para el diagn\u00f3stico r\u00e1pido de diversas enfermedades.\n[Development of an IgG4-RD Responder Index](http://dx.doi.org/10.1155/2012/259408) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMollie N. Carruthers\n2012-01-01\nFull Text Available IgG4-related disease (IgG4-RD is a multiorgan inflammatory disease in which diverse organ manifestations are linked by common histopathological and immunohistochemical features. Prospective studies of IgG4-RD patients are required to clarify the natural history, long-term prognosis, and treatment approaches in this recently recognized condition. Patients with IgG4-RD have different organ manifestations and are followed by multiple specialties. Divergent approaches to the assessment of patients can complicate the interpretation of studies, emphasizing the critical need for validated outcome measures, particularly assessments of disease activity and response to treatment. We developed a prototype IgG4-RD Responder Index (IgG4-RD RI based on the approach used in the development of the Birmingham Vasculitis Activity Score for Wegener\u2019s granulomatosis (BVAS/WG. The IgG4-RD RI was refined by members of the International IgG4-RD Symposium Organizing Committee in a paper case exercise. The revised instrument was applied retrospectively to fifteen IgG4-RD patients at our institution. Those scores were compared to physician\u2019s global assessment scale for the same visits. This paper describes the philosophy and goals of the IgG4-RD RI, the steps in the development of this instrument to date, and future plans for validation of this instrument as an outcome measure.\n[Influenza virus neutralizing antibodies and IgG isotype profiles after immunization of mice with influenza A subunit vaccine using various adjuvants](https://www.narcis.nl/publication/RecordID/oai%3Apure.rug.nl%3Apublications%2F3bc35d9e-bdb3-4d3e-bd25-90b2258510c5/uquery/influenza/id/10/Language/EN)\nBenne, CA; Harmsen, M; vanderGraaff, W; Verheul, AFM; Snippe, H; Kraaijeveld, CA\nThe influence of various adjuvants on the development of influenza virus neutralizing antibodies and distribution of anti-influenza virus IgG isotypes after immunization of mice with influenza A (H3N2) subunit vaccine was investigated. Serum titres of influenza virus neutralizing antibodies and\n[The Clinical and Immunologic Features of Patients With Combined Anti-GBM Disease and Castleman Disease.](https://www.ncbi.nlm.nih.gov/pubmed/29510921)\nGu, Qiu-Hua; Jia, Xiao-Yu; Hu, Shui-Yi; Wang, Su-Xia; Zou, Wan-Zhong; Cui, Zhao; Zhao, Ming-Hui\n2018-06-01\nPatients with both anti-glomerular basement membrane (anti-GBM) disease and Castleman disease have been rarely reported. In this study, we report 3 patients with this combination. They had immunologic features similar to patients with classic anti-GBM disease. Sera from the 3 patients recognized the noncollagenous (NC) domain of the \u03b13 chain of type IV collagen (\u03b13(IV)NC1) and its 2 major epitopes, EA and EB. All 4 immunogloblin G (IgG) subclasses against \u03b13(IV)NC1 were detectable, with predominance of IgG1. In one patient with lymph node biopsy specimens available, sporadic plasma cells producing \u03b13(IV)NC1-IgG were found, suggesting a causal relationship between the 2 diseases. One patient, who achieved remission with antibody clearance and normalization of serum creatinine and interleukin 6 concentrations after plasma exchange and 3 cycles of chemotherapy, experienced recurrence of anti-GBM antibodies and an increase in interleukin 6 concentration after chemotherapy discontinuation because of adverse effects, but both returned to normal after another cycle of chemotherapy. This clinical course and the pathologic findings support the hypothesis that the Castleman disease-associated tumor cells are the source of the anti-GBM autoantibodies. Copyright \u00a9 2018 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.\n[Impact of child malnutrition on the specific anti-Plasmodium falciparum antibody response](http://www.malariajournal.com/content/8/1/116) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nFillol Florie\n2009-06-01\nFull Text Available Abstract Background In sub-Saharan Africa, preschool children represent the population most vulnerable to malaria and malnutrition. It is widely recognized that malnutrition compromises the immune function, resulting in higher risk of infection. However, very few studies have investigated the relationship between malaria, malnutrition and specific immunity. In the present study, the anti-Plasmodium falciparum IgG antibody (Ab response was evaluated in children according to the type of malnutrition. Methods Anthropometric assessment and blood sample collection were carried out during a cross-sectional survey including rural Senegalese preschool children. This cross-sectional survey was conducted in July 2003 at the onset of the rainy season. Malnutrition was defined as stunting (height-for-age P. falciparum whole extracts (schizont antigens was assessed by ELISA in sera of the included children. Results Both the prevalence of anti-malarial immune responders and specific IgG Ab levels were significantly lower in malnourished children than in controls. Depending on the type of malnutrition, wasted children and stunted children presented a lower specific IgG Ab response than their respective controls, but this difference was significant only in stunted children (P = 0.026. This down-regulation of the specific Ab response seemed to be explained by severely stunted children (HAZ \u2264 -2.5 compared to their controls (P = 0.03, while no significant difference was observed in mildly stunted children (-2.5 P. falciparum Ab response appeared to be independent of the intensity of infection. Conclusion Child malnutrition, and particularly stunting, may down-regulate the anti-P. falciparum Ab response, both in terms of prevalence of immune responders and specific IgG Ab levels. This study provides further evidence for the influence of malnutrition on the specific anti-malarial immune response and points to the importance of taking into account child\n[IgG4-related Disease and the Liver.](https://www.ncbi.nlm.nih.gov/pubmed/28506361)\nChen, Jonathan H; Deshpande, Vikram\n2017-06-01\nPathologists are likely to encounter IgG4-related disease in several organ systems. This article focuses on helping pathologists diagnose IgG4-related disease in the hepatobiliary system. Missing the diagnosis can result in unnecessary organ damage and/or unnecessary surgical and cancer therapy. In the liver, tumefactive lesion(s) involving the bile ducts with storiform fibrosis and an IgG4-enriched lymphoplasmacytic infiltrate are highly concerning for IgG4-related disease. The recent identification of oligoclonal populations of T cells and B cells in IgG4-related disease may lead to molecular tests, new therapeutics, and a greater mechanistic understanding of the disease. Copyright \u00a9 2017 Elsevier Inc. All rights reserved.\n[Preval\u00eancia de anticorpos IgG antiparvov\u00edrus B19 em gestantes durante o atendimento pr\u00e9-natal e casos de hidropisia fetal n\u00e3o imune atribu\u00eddos ao parvov\u00edrus B19, na Cidade do Rio de Janeiro Anti-parvovirus B19 IgG antibody prevalence in pregnant women during antenatal follow-up and cases of non-immune hydropsis fetalis due to parvovirus B19, in the City of Rio de Janeiro](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822006000500009) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAndr\u00e9 Ricardo Araujo da Silva\n2006-10-01\nFull Text Available Com o objetivo de medir a preval\u00eancia de anticorpos IgG contra o parvov\u00edrus B19 em gestantes com at\u00e9 24 semanas de idade gestacional e detectar a ocorr\u00eancia de casos de hidropisia fetal n\u00e3o-imune atribu\u00eddos a esse v\u00edrus, coletamos 249 amostras de soro em uma maternidade de refer\u00eancia na cidade do Rio de Janeiro, entre junho de 2003 e mar\u00e7o de 2005. As gestantes foram acompanhadas at\u00e9 o termo da gesta\u00e7\u00e3o, sendo detectados 17 casos de hidropisia fetal. Quatro casos foram atribu\u00eddos ao parvov\u00edrus B19 e dois destes ocorreram em gestantes residentes na zona oeste da cidade, em fevereiro de 2005. Resultados positivos para anticorpos IgG antiparvov\u00edrus B19 foram encontrados em 172 (71,6% gestantes (IC 95% 65,5-77,7%, sendo esta preval\u00eancia de anticorpos compar\u00e1vel \u00e0 encontrada em outras cidades brasileiras. A \u00fanica vari\u00e1vel associada com aquisi\u00e7\u00e3o pr\u00e9via de anticorpos IgG foi n\u00famero de gesta\u00e7\u00f5es anteriores maior que um(p= 0,02, IC 95% 0,36-0,94.With the aim of measuring the prevalence of anti-parvovirus B19 IgG antibodies during pregnancy up to 24 weeks of gestation and detecting cases of nonimmune hydrops fetalis, 249 sera from pregnant women attending a reference hospital in Rio de Janeiro city, from June 2003 to November 2004 were collected. They were followed-up until the end of pregnancy, with 17 cases of fetal hydrops detected. Four cases were caused by parvovirus B19 and two of them occurred in pregnant women living in the western zone of the city, during February 2005. Anti-parvovirus B19 IgG antibodies were found in 172 (71.6% pregnant women (CI 95% 65.5%-77.7%; this antibody prevalence is similar to results found for others Brazilian cities. The only variable associated with previous acquisition of IgG antibodies to parvovirus B19 was number of pregnancies greater than one (p= 0.02, CI 95% 0.36-0.94.\n[[Analysis of epitopes and function of anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sj\u00f6gren's syndrome].](https://www.ncbi.nlm.nih.gov/pubmed/20818151)\nTsuboi, Hiroto; Matsuo, Naomi; Iizuka, Mana; Nakamura, Yumi; Matsumoto, Isao; Sumida, Takayuki\n2010-01-01\nSj\u00f6gren's syndrome (SS) is an autoimmune disease that affects exocrine glands including salivary and lacrimal glands. It is characterized by lymphocytic infiltration into exocrine glands, leading to dry mouth and eyes. A number of auto-antibodies, such as anti-SS-A and SS-B antibodies, are detected in patients with SS. However, no SS-specific pathologic auto-antibodies have yet been found in this condition. M3 muscarinic acetylcholine receptor (M3R) plays a crucial role in the secretion of saliva from salivary glands. It is reported that some patients with SS carried inhibitory auto-antibodies against M3R. To clarify the epitopes and function of anti-M3R antibodies in SS, we examined antibodies to the extracellular domains (N terminal region, the first, second, and third extracellular loop) of M3R by ELISA using synthesized peptide antigens encoding these domains in 42 SS and 42 healthy controls (HC). Titers and positivity of anti-M3R antibodies to every extracellular domain of M3R were significantly higher in SS than in HC. For functional analysis, human salivary gland (HSG) cells were pre-cultured with IgG from anti-M3R antibodies positive SS, negative SS, and HC. HSG cells were stimulated with cevimeline hydrochloride and intracellular calcium concentration ([Ca(2+)](i)) was measured. IgG from anti-M3R antibodies to the second loop positive SS inhibited the increase of [Ca(2+)](i), but IgG from antibodies to the N terminal or the first loop positive SS enhanced it, while IgG from antibodies to the third loop positive SS showed no effect on [Ca(2+)](i) as well as IgG from anti-M3R antibodies negative SS and HC. These findings indicated the presence of several B cell epitopes on M3R in SS and effect of anti-M3R antibodies on the salivary secretion might differ with these epitopes.\n[Fibrosis pulmonar asociada a vasculitis con anticuerpos anticitoplasm\u00e1ticos positivos](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802012000400012&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMarcelo Fern\u00e1ndez Casares\n2012-08-01\nFull Text Available Las complicaciones pulmonares m\u00e1s conocidas de las vasculitis con anticuerpos anticitoplasm\u00e1ticos de los neutr\u00f3filos (ANCA positivos (VAA, son la hemorragia alveolar, los granulomas y la estenosis de la v\u00eda a\u00e9rea. En los \u00faltimos a\u00f1os han aparecido algunos informes aislados que muestran la asociaci\u00f3n con fibrosis pulmonar (FP, sugiriendo que \u00e9sta ser\u00eda otra complicaci\u00f3n de las VAA. En este trabajo informamos dos casos con dicha asociaci\u00f3n describiendo sus caracter\u00edsticas cl\u00ednicas, tomogr\u00e1ficas e inmunol\u00f3gicas. Dado que en la asociaci\u00f3n de FP y VAA notificada en los \u00faltimos a\u00f1os, la FP puede ser su primera manifestaci\u00f3n, podr\u00eda ser necesaria la b\u00fasqueda de ANCA en pacientes con FP, como causa de la misma y por el posible desarrollo posterior de vasculitis.\n[Two competitive enzyme immunoassays for the detection of IgG class antibodies to hepatitis a antigen](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86821991000200003) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nClaudia Lamarca Vitral\n1991-06-01\nFull Text Available Two competitive enzyme immunoassays (EIA techniques were developed: in the first (COMP-1, test sera were added together with HAV antigen on anti-HAV IgG-coated wells followed by an anti-HA VHRP conjugate; in the second (COMP-2, test sera and anti-HA VHRP conjugate competed for HAV epitopes previously adsorbed to anti-HA V IgG-coated wells. Both procedures used tetramethylbenzidine (TMB as a substrate. Both competitive tests were shown to be reproducible and suitable for routine diagnosis and research purposes.Foram desenvolvidos dois ensaios imunoenzim\u00e1ticos (EIA competitivos: no primeiro (COMP-1 colocou-se numa placa sensibilizada com anti-HAVIgG as amostras teste juntamente como ant\u00edgeno HA Vea seguir o conjugado anti-HA VHRP; no segundo (COMP-2, as amostras teste e o conjugado anti-HAV HRP competem pelos epitopos do ant\u00edgeno HAV previamente absorvido na placa sensibilizada do anti-HAV IgG. O substrato utilizado foi tetrametilbenzidina (TMB. Ambas as t\u00e9cnicas mostraram ser produt\u00edveis e aplic\u00e1veis para fins de diagn\u00f3stico e pesquisa.\n[IgG4-RELATED DISEASE. CLINICAL NOTES](http://rsp.ima-press.net/rsp/article/view/1679) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nVladimir Ivanovich Vasilyev\n2013-01-01\nFull Text Available IgG4-related diseases are a new nosological entity that encompasses a few previously known diseases. IgG4-related systemic disease is diagnosed if two or more affected organs are detected. This group of diseases has two similar signs: serological (elevated serum IgG4 subclass concentrations and histological (organ and tissue infiltration from plasmo-cytes secreting IgG4, and eosinophils, and the development of fibrosclerosis and phlebitis obliterans. The paper describes two cases. In one case, a multisystemic disease was observed virtually at its onset whereas in the other this lesion was diagnosed several years after the natural course of the disease.\n[Total lymphoid irradiation reduces IgG autoantibody production and enhances specific antibody responses in NZB/NZW F1 mice](http://www.etde.org/etdeweb/details.jsp?query_id=1&page=0&osti_id=5596714) [Energy Technology Data Exchange (ETDEWEB)](https://www.etde.org/etdeweb/fieldedsearch.jsp)\nFarinas, M.C.; Strober, S.\n1989-07-01\nThymus-independent primary antibody responses were studied in young and old (9 months) untreated and TLI-treated NZB/NZW and BALB/c mice. Untreated old NZB/NZW mice had a low primary response to Brucella abortus (BA) as compared to that of young NZB/NZW and BALB/c mice. However, TLI treatment resulted in a 130-fold increase in the IgG anti-BA primary antibody response at day 21 postimmunization, achieving similar levels to those of young NZB/NZW or nonautoimmune BALB/c mice. Anti-TNP responses to trinitrophenylated BA or Ficoll were masked by high background levels of anti-TNP antibodies. Despite the increase in the anti-BA response, spontaneous immunoglobulin secretion and autoantibody levels were markedly decreased after TLI in old NZB/NZW mice.\n[Total lymphoid irradiation reduces IgG autoantibody production and enhances specific antibody responses in NZB/NZW F1 mice](https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=21005906) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nFarinas, M.C.; Strober, S.\n1989-01-01\nThymus-independent primary antibody responses were studied in young and old (9 months) untreated and TLI-treated NZB/NZW and BALB/c mice. Untreated old NZB/NZW mice had a low primary response to Brucella abortus (BA) as compared to that of young NZB/NZW and BALB/c mice. However, TLI treatment resulted in a 130-fold increase in the IgG anti-BA primary antibody response at day 21 postimmunization, achieving similar levels to those of young NZB/NZW or nonautoimmune BALB/c mice. Anti-TNP responses to trinitrophenylated BA or Ficoll were masked by high background levels of anti-TNP antibodies. Despite the increase in the anti-BA response, spontaneous immunoglobulin secretion and autoantibody levels were markedly decreased after TLI in old NZB/NZW mice\n[Evaluation of antigen detection and polymerase chain reaction for diagnosis of amoebic liver abscess in patients on anti-amoebic treatment](http://www.biomedcentral.com/1756-0500/5/416) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJaiswal Virendra\n2012-08-01\nFull Text Available Abstract Background Diagnosis of amoebic liver abscess (ALA in patients on anti-amoebic drugs is difficult. There is scanty data on this issue using Entamoeba histolytica (E. histolytica lectin antigen and polymerase chain reaction (PCR. We studied utility of lectin antigen, PCR, and IgG antibody in diagnosis of liver abscess in patients on anti-amoebic treatment. Liver aspirate of 200 patients, of which 170 had anti-amoebic drug prior to drainage, was tested for E. histolytica lectin antigen by (ELISA, PCR, bacterial culture, and serum IgG antibody by (ELISA. Classification of abscesses was based on result of anti-amoebic IgG antibody and bacterial culture, E. histolytica PCR and bacterial culture, and E. histolytica lectin antigen and bacterial culture. Findings Using anti-amoebic IgG antibody and bacterial culture, 136/200 (68.0% were classified as ALA, 12/200 (6.0% as pyogenic liver abscess (PLA, 29/200 (14.5% as mixed infection, and 23/200 (11.5% remained unclassified. Using amoebic PCR and bacterial culture 151/200 (75.5% were classified as ALA, 25/200 (12.5% as PLA, 16/200 (8.0% as mixed infection, and 8/200 (4.0% remained unclassified. With E. histolytica lectin antigen and bacterial culture, 22/200 (11.0% patients were classified as ALA, 39/200 (19.5% as PLA, 2/200 (1.0% as mixed infection, and 137/200 (68.5% remained unclassified. Conclusions E. histolytica lectin antigen was not suitable for classification of ALA patients who had prior anti-amoebic treatment. However, PCR may be used as alternative test to anti-amoebic antibody in diagnosis of ALA.\n[Seroprevalance Anti-Toxoplasma gondii antibodies in children and adolescents with tourette syndrome/chronic motor or vocal tic disorder: A case-control study.](https://www.ncbi.nlm.nih.gov/pubmed/29554545)\nAkaltun, \u0130smail; Kara, Tayfun; Sertan Kara, Soner; Ayayd\u0131n, Hamza\n2018-05-01\nToxoplasma gondii infection may be associated with psychiatric disorders due to its neurological effects. The purpose of this study was to investigate the relation between tic disorders in children and adolescents and Anti-Toxoplasma IgG. 43 children diagnosed with Tourette's syndrome(TS) and 87 with chronic motor or vocal tic disorder(CMVTD), and 130 healthy volunteers, all aged 7-18, were enrolled. Anti-Toxoplasma IgG antibody levels obtained from blood specimens were investigated. Toxoplasma IgG positivity was determined in 16(37.2%) of the patients with TS, in 27(31%) of those with CMVTD and in 12(9.2%) members of the control group. Anti-Toxoplasma gondii antibody positivity was 5.827-fold higher in subjects with TS and 4.425-fold higher in subjects with CMVTD compared to the control group. Correlation was determined between a diagnosis of TS or CMVTD and Anti-Toxoplasma gondii antibodies. We think that it will be useful for the neuropsychiatric process associated with Anti-Toxoplasma gondii antibodies to be clarified. Copyright \u00a9 2018 Elsevier B.V. All rights reserved.\n[Generaci\u00f3n de anticuerpos policlonales para la detecci\u00f3n de la variante genot\u00edpica GIII de PVY, en cultivos de tomate de \u00e1rbol y papa de Colombia](https://revistas.unal.edu.co/index.php/biotecnologia/article/view/32886) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nYuliana Gallo Garc\u00eda\n2012-01-01\nFull Text Available T\u00edtulo en ingles: Generation of policlonal antibodies for detection of the PVY genotypic variant GIII in tamarillo and potato crops from Colombia Resumen: El potyvirus PVY es uno de los agentes causales m\u00e1s frecuentemente asociados a problemas virales en cultivos de papa y tomate de \u00e1rbol en Colombia. Dada la importancia econ\u00f3mica de las enfermedades causadas por PVY y a la necesidad de generar material de siembra certificado por su sanidad viral, es fundamental la generaci\u00f3n de herramientas de diagn\u00f3stico que permitan la detecci\u00f3n temprana de este virus. En este trabajo se reporta la obtenci\u00f3n de anticuerpos policlonales espec\u00edficos, \u00fatiles para la detecci\u00f3n del genotipo III de PVY (GIII, una de las tres variantes que recientemente han sido reportadas en cultivos de papa y tomate de \u00e1rbol de la regi\u00f3n Andina de Colombia. Como ant\u00edgeno, se utiliz\u00f3 un p\u00e9ptido sint\u00e9tico dise\u00f1ado a partir de la regi\u00f3n variable del extremo N-terminal del gen de la c\u00e1pside viral. La sensibilidad de los anticuerpos fue evaluada mediante pruebas de ELISA y dot-blot utilizando p\u00e9ptidos sint\u00e9ticos. Se realiz\u00f3 una prueba piloto para validar el uso de los anticuerpos a partir de plantas sintom\u00e1ticas y asintom\u00e1ticas obtenidas de una regi\u00f3n donde confluyen cultivos de ambas solan\u00e1ceas, encontr\u00e1ndose que los anticuerpos generados ofrecen mayores niveles de detecci\u00f3n que los anticuerpos comerciales com\u00fanmente utilizados para detectar los serotipos PVY-O,C y PVY-N de este virus. Palabras clave: anticuerpos policlonales; ELISA; potyvirus; RT-PCR; virus Y de la papa Abstract: PVY is one of the potyvirus more frequently associated with viral infections in tomato and tamarillo crops in Colombia. Due to the economic impact of PVY and the need to certify seeds as virus-free it is important to develop diagnostic tools that allow its premature detection. In this work, the obtention of antibodies detecting the genotype III of PVY is reported. This genotype\n[IgG4-Related Perineural Disease](http://dx.doi.org/10.1155/2012/401890) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nDai Inoue\n2012-01-01\nFull Text Available Aims. To elucidate characteristics of IgG4-related disease involving the peripheral nervous system. Methods. Retrospective review of 106 patients with IgG4-related disease identified 21 peripheral nerve lesions in 7 patients. Clinicopathological and radiological features were examined. Results. Peripheral nerve lesions were commonly identified in orbital or paravertebral area, involving orbital (=9, optic (=4, spinal (=7, and great auricular nerves (=1. The predominant radiological feature was a distinct perineural soft tissue mass, ranging 8 to 30 mm in diameter. Histologically, the epineurium was preferentially involved by massive lymphoplasmacytic infiltration rich in IgG4+ plasma cells. All lesions were neurologically asymptomatic and steroid-responsive at the first presentation, but one recurrent lesion around the optic nerve caused failing vision. Conclusion. IgG4-related disease of the peripheral nervous system is characterized by orbital or paravertebral localization, perineural mass formation, and rare neurologic symptoms. The term \u201cIgG4-related perineural disease\u201d seems appropriate to describe this entity.\n[CARACTERIZACI\u00d3N DE IGYS ANTI-LECTINA DE Salvia bogotensis Y SU APLICACI\u00d3N EN ESTUDIOS CITOQU\u00cdMICOS PARA LA DETECCI\u00d3N DEL ANT\u00cdGENO TN](http://www.revistas.unal.edu.co/index.php/rcolquim/article/view/13491) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nNohora Vega\n2010-02-01\nFull Text Available Las inmunoglobulinas aisladas de la yema de huevo (IgY son muy utilizadas actualmente en diversos campos de las ciencias biol\u00f3gicas, dadas sus ventajas frente a las IgG s\u00e9ricas de mam\u00edferos. En un trabajo previo establecimos las condiciones de obtenci\u00f3n de IgY dirigidas contra la lectinas de Salvia bogotensis; su utilizaci\u00f3n en estudios inmunocitoqu\u00edmicos requiere conocer sus principales caracter\u00edsticas moleculares y las condiciones para la interacci\u00f3n IgY-lectina. La lectina de Salvia bogotensis (SBoL reconoce espec\u00edficamente el ant\u00edgeno Tn, marcador tumoral en muchos tipos de c\u00e1ncer, pero se requieren herramientas adicionales para evidenciar esta interacci\u00f3n a nivel celular. Dada la disponibilidad de IgY anti-lectina de S. bogotensis, se realiz\u00f3 este trabajo con el objeto de caracterizar molecularmente estas IgY y evaluar su utilizaci\u00f3n en estudios inmunocitoqu\u00edmicos para la detecci\u00f3n del ant\u00edgeno Tn en c\u00e9lulas tumorales. A las IgY purificadas se les determin\u00f3 su punto isoel\u00e9ctrico, peso molecular y contenido de carbohidratos. Para establecer la especificidad de interacci\u00f3n IgY-SBoL se obtuvieron lectinas hom\u00f3logas y heter\u00f3logas y se ensayaron por ELLSA. La detecci\u00f3n del ant\u00edgeno Tn en las l\u00edneas celulares MCF-7 y HeLa con la lectina y las IgYs marcadas con biotina o peroxidasa se realiz\u00f3 por CELISA e inmunocitoqu\u00edmica. Los resultados mostraron que los anticuerpos IgY anti-SBoL son una herramienta de una alta sensibilidad para los ensayos de reconocimiento espec\u00edfico del ant\u00edgeno Tn.\n[Estimation of polyclonal IgG4 hybrids in normal human serum.](https://www.ncbi.nlm.nih.gov/pubmed/24512211)\nYoung, Elizabeth; Lock, Emma; Ward, Douglas G; Cook, Alexander; Harding, Stephen; Wallis, Gregg L F\n2014-07-01\nThe in vivo or in vitro formation of IgG4 hybrid molecules, wherein the immunoglobulins have exchanged half molecules, has previously been reported under experimental conditions. Here we estimate the incidence of polyclonal IgG4 hybrids in normal human serum and comment on the existence of IgG4 molecules with different immunoglobulin light chains. Polyclonal IgG4 was purified from pooled or individual donor human sera and sequentially fractionated using light-chain affinity and size exclusion chromatography. Fractions were analysed by SDS-PAGE, immunoblotting, ELISA, immunodiffusion and matrix-assisted laser-desorption mass spectrometry. Polyclonal IgG4 purified from normal serum contained IgG4\u03ba, IgG4\u03bb and IgG4\u03ba/\u03bb molecules. Size exclusion chromatography showed that IgG4 was principally present in monomeric form (150 000 MW). SDS-PAGE, immunoblotting and ELISA showed the purity of the three IgG4 samples. Immunodiffusion, light-chain sandwich ELISA and mass spectrometry demonstrated that both \u03ba and \u03bb light chains were present on only the IgG4\u03ba/\u03bb molecules. The amounts of IgG4\u03ba/\u03bb hybrid molecules ranged from 21 to 33% from the five sera analysed. Based on the molecular weight these molecules were formed of two IgG4 heavy chains plus one \u03ba and one \u03bb light chain. Polyclonal IgG (IgG4-depleted) was similarly fractionated according to light-chain specificity. No evidence of hybrid IgG \u03ba/\u03bb antibodies was observed. These results indicate that hybrid IgG4\u03ba/\u03bb antibodies compose a substantial portion of IgG4 from normal human serum. \u00a9 2014 John Wiley & Sons Ltd.\n[Anti-natural octyl disaccharide-leprosy IDRI diagnostic (NDO-LID) antibodies as indicators of leprosy reactions and neuritis.](https://www.ncbi.nlm.nih.gov/pubmed/28633333)\nSerrano-Coll, H\u00e9ctor; Mu\u00f1oz, M\u00f3nica; Camilo Beltr\u00e1n, Juan; Duthie, Malcolm S; Cardona-Castro, Nora\n2017-03-01\nLeprosy is a complex infectious and neurological disease caused by Mycobacterium leprae. Nerve damage is related to immunological hypersensitivity responses known as leprosy reactions (LRs). Diagnostic tools to predict LRs are not available. We hypothesized that natural octyl disaccharide-leprosy IDRI diagnostic (NDO-LID) would be helpful as an indicator of LRs and neuritis. To assess the utility of NDO-LID in indicating reactions, ELISA were used to detect specific antibodies in serum samples from 80 Colombian leprosy patients (40 with and 40 without history of LRs). Responses were detected using a range of detection reagents detecting IgG, IgM or both isotypes. Patients with a history of LRs had an increased seropositivity rate for anti-NDO-LID antibodies compared to patients without (anti-NDO-LID protein A [p=0.02], IgG anti-NDO-LID [p=0.01] and IgM anti-NDO-LID [p=0.01]). Further analyses of patients with a history of LRs indicated that both seropositivity rate and magnitude of responses were elevated among patients with neuritis versus those without neuritis (anti-NDO-LID protein A [p=0.03], IgG anti-NDO-LID [p=0.001] and IgM anti-NDO-LID [p=0.06]). Our data indicate that testing for serum anti-NDO-LID antibodies can be a useful screen to identify patients at risk of developing LRs and neuritis. \u00a9 The Author 2017. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.\n[IgG4-associated sclerosing cholangitis masquerading as hilar cholangiocarcinoma.](https://www.ncbi.nlm.nih.gov/pubmed/27439915)\nYadav, Kamal Sunder; Sali, Priyanka Akhilesh; Mansukhani, Verushka M; Shah, Rajiv; Jagannath, P\n2016-07-01\nIgG4-sclerosing cholangitis (IgG4-SC) commonly presents with type 1 autoimmune pancreatitis. Isolated IgG4-SC is rare. Differentiating IgG4-SC from cholangiocarcinoma preoperatively is challenging due to overlapping radio-clinical manifestations and difficult preoperative histology. We present three cases preoperatively diagnosed and surgically treated as hilar cholangiocarcinoma. First and second cases presented with cholangiocarcinoma with portal vein involvement and third with a malignant-appearing hilar stricture. On histopathology, IgG4-SC was diagnosed in the first two cases. Third patient had raised serum IgG4, and histopathology was inconclusive for IgG4-SC and negative for malignancy. However, she responded to steroid therapy.\n[Serologic aspects of IgG4 antibodies. II. IgG4 antibodies form small, nonprecipitating immune complexes due to functional monovalency](https://www.narcis.nl/publication/RecordID/oai%3Apure.amc.nl%3Apublications%2F175567bd-83c0-43d8-a9f0-8d3b4183748d/uquery/IGG4/id/10/Language/EN)\nvan der Zee, J. S.; van Swieten, P.; Aalberse, R. C.\n1986-01-01\nHuman IgG4 antibodies directed against phospholipase A, the P1 antigen from Dermatophago\u00efdes pteronyssinus extracts, and cat albumin were found unable to cross-link antigen. Previously, it was demonstrated that IgG4 antibodies, in contrast to IgG1 antibodies, did not cross-link Sepharose-bound\n[HMGB1/anti-HMGB1 antibodies define a molecular signature of early stages of HIV-Associated Neurocognitive Isorders (HAND](http://www.sciencedirect.com/science/article/pii/S2405844016310027) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMarie-Lise Gougeon\n2017-02-01\nConclusion: We report that brain injury in chronically HIV-infected patients on stable HAART is strongly associated with persistent CNS inflammation, which is correlated with increased levels of HMGB1 and anti-HMGB1 IgG in the CSF. Moreover, we identified circulating anti-HMGB1 IgG as a very early biomarker of neurological impairment in patients without HAND. These results might have important implication for the identification of patients who are at high risk of developing neurological disorders.\n[Rendimiento diagn\u00f3stico del Western Blot para detectar simult\u00e1neamente anticuerpos en pacientes con cisticercosis, hidatidosis y fascioliasis humana](http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1726-46342016000400003&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nKelly Davelois\nFull Text Available Objetivo. Determinar el rendimiento diagn\u00f3stico de la t\u00e9cnica de Western Blot para detectar simult\u00e1neamente anticuerpos en pacientes con cisticercosis, hidatidosis y fascioliasis humana. Materiales y m\u00e9todos. Estudio transversal de evaluaci\u00f3n de prueba diagn\u00f3stica. Se obtuvieron los ant\u00edgenos de excreci\u00f3n-secreci\u00f3n de las larvas de Taenia solium, quistes de Echinococcus granulosus; y la forma adulta de Fasciola hep\u00e1tica; que luego fueron separados electrofor\u00e9ticamente en geles de poliacrilamida individuales, transferidos y fijados a una membrana de nitrocelulosa para ser enfrentados con sueros de pacientes con las tres parasitosis. La sensibilidad de la t\u00e9cnica se evalu\u00f3 empleando 300 sueros individuales, 60 pools de dos parasitosis y 20 pools de tres parasitosis y la especificidad con 75 sueros de pacientes con otras parasitosis, 10 de pacientes con otras enfermedades y 15 sueros de personas no parasitadas. Resultados. La t\u00e9cnica reconoci\u00f3 trece glicoprote\u00ednas (GP: GP 35, 31, 24, 23, 18, 17, 14 y 13 kDa para cisticercosis, GP 8,16 y 21 kDa para hidatidosis y GP: 17 y 23 kDa para fascioliasis. La prueba detect\u00f3 la presencia de anticuerpos alcanzando una sensibilidad de 96% (IC95%: 94,62-98,54% en la detecci\u00f3n de una o las trece bandas, una especificidad de 100% (IC95%: 99,50 - 100,00%; individualmente, se tuvo una sensibilidad para cisticercosis de 97% (IC95%: 93,16-100%, para hidatidosis de 94% (IC95%: 88,85-99,15% y para fascioliasis de 96% (IC95%: 91,66-100%. Conclusiones. La prueba de Western blot es eficaz en la detecci\u00f3n, simultanea de anticuerpos en pacientes con cisticercosis, hidatidosis y fascioliasis humana, y puede ser utilizada como prueba de descarte o confirmatoria en zonas end\u00e9micas.\n[Evaluation of treatment of colostrum-deprived kittens with equine IgG.](https://www.ncbi.nlm.nih.gov/pubmed/12926587)\nCrawford, P Cynda; Hanel, Rita M; Levy, Julie K\n2003-08-01\nTo evaluate equine IgG as a treatment for kittens with failure of passive transfer of immunity (FPT). 13 specific pathogen-free queens and their 77 kittens. Kittens were randomized at birth into 9 treatment groups. One group contained colostrum-fed (nursing) kittens; the other groups contained colostrum-deprived kittens that were administered supplemental feline or equine IgG PO or SC during the first 12 hours after birth. Blood samples were collected at serial time points from birth to 56 days of age for determination of serum IgG concentrations. The capacity of equine IgG to opsonize bacteria for phagocytosis by feline neutrophils was determined via flow cytometry. Kittens that received feline or equine IgG SC had significantly higher serum IgG concentrations than those of kittens that received the supplements PO. In kittens that were administered supplemental IgG SC, serum IgG concentrations were considered adequate for protection against infection. The half-life of IgG in kittens treated with equine IgG was shorter than that in kittens treated with feline IgG. Feline IgG significantly enhanced the phagocytosis of bacteria by feline neutrophils, but equine IgG did not. Serum concentrations of equine IgG that are considered protective against infection are easily attained in kittens, but the failure of these antibodies to promote bacterial phagocytosis in vitro suggests that equine IgG may be an inappropriate treatment for FPT in kittens.\n[Anticuerpos anti LKM-1 y crioglobulinemia en hepatitis cr\u00f3nica autoinmune y por virus C de la hepatitis](https://www.openaire.eu/search/publication?articleId=od______3056::1a79f01de7e1b0b7153c7e091d9fb45a)\nJir\u00f3n V,M. Isabel; Ardiles S,Adriana; Parra B,M Adriana; Orellana V,Juana\n2000-01-01\nBackground: Anti liver kidney microsome antibodies (LKM-1) have been recently incorporated to the study and classification of chronic autoimmune hepatitis (HC-A1). The presence of anti LKM-1 antibodies and essential cryoglobulinemia is frequent in virus C associated chronic hepatitis (HC-VC). Aim: To study the frequency of anti LKM-1 antibodies and cryoglobulin levels in patients with HC-AI, HC-VC and cryptogenic cirrhosis. Patients and methods: Forty two patients were studied. Nineteen adult...\n[Detection of IgG against Toxocara in Sera of Employees of Meat Industry](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4614015)\nAlvarado-Esquivel, Cosme; Hern\u00e1ndez-Tinoco, Jes\u00fas; S\u00e1nchez-Anguiano, Luis Francisco; Ramos-Nev\u00e1rez, Agar; Cerrillo-Soto, Sandra Margarita; Guido-Arreola, Carlos Alberto; Saenz-Soto, Leandro\n2015-01-01\nContact with raw meat could represent a risk for Toxocara infection. We assessed the association of Toxocara infection with an occupation of meat worker though a case-control seroprevalence study of 124 meat workers and 248 subjects without this occupation. Sera of participants was analyzed for the presence of anti-Toxocara IgG antibodies. One (0.8%) of the 124 meat workers, and 5 (2.0%) of the 248 controls were positive for anti-Toxocara IgG antibodies (OR=0.39; 95% CI: 0.04-3.41; P=0.66). The seropositive meat worker was a male aged 28 years old, without vision impairment. None of the work characteristics i.e. frequency of contact with raw meat, use of safety practices, history of splashes at face with blood or raw meat, and injuries with sharp material at work was associated with Toxocara exposure. Seroprevalence of Toxocara infection was significantly higher (P=0.04) in meat workers with consumption of boar meat (1/6: 16.7%) than in those without this consumption (0/117: 0%). We conclude that meat workers do not have a higher risk for Toxocara infection than subjects without this occupation do. The 2% seroprevalence of Toxocara infection found in control subjects might suggest a low seroprevalence of this infection among people with other occupations in Durango City. However, additional case-control studies with larger sample sizes to confirm our results are needed. PMID:26508909\n[Neuron-derived IgG protects neurons from complement-dependent cytotoxicity.](https://www.ncbi.nlm.nih.gov/pubmed/23979841)\nZhang, Jie; Niu, Na; Li, Bingjie; McNutt, Michael A\n2013-12-01\nPassive immunity of the nervous system has traditionally been thought to be predominantly due to the blood-brain barrier. This concept must now be revisited based on the existence of neuron-derived IgG. The conventional concept is that IgG is produced solely by mature B lymphocytes, but it has now been found to be synthesized by murine and human neurons. However, the function of this endogenous IgG is poorly understood. In this study, we confirm IgG production by rat cortical neurons at the protein and mRNA levels, with 69.0 \u00b1 5.8% of cortical neurons IgG-positive. Injury to primary-culture neurons was induced by complement leading to increases in IgG production. Blockage of neuron-derived IgG resulted in more neuronal death and early apoptosis in the presence of complement. In addition, Fc\u03b3RI was found in microglia and astrocytes. Expression of Fc\u03b3R I in microglia was increased by exposure to neuron-derived IgG. Release of NO from microglia triggered by complement was attenuated by neuron-derived IgG, and this attenuation could be reversed by IgG neutralization. These data demonstrate that neuron-derived IgG is protective of neurons against injury induced by complement and microglial activation. IgG appears to play an important role in maintaining the stability of the nervous system.\n[Gingivitis y Anticuerpos Anticitoplasm\u00e1ticos de Neutr\u00f3filos en ni\u00f1os y adolescentes con leucemia](https://www.openaire.eu/search/publication?articleId=od_______624::ce651ccf57067dd29ac62e372aa6c46f)\nViera, Ninoska T.; Rojas de Morales, Thais; Navas, Rita M.; Zambrano, Olga R.; Paz de Gudi\u00f1o, Mercedes\n2004-01-01\nIntroducci\u00f3n: Las enfermedades sist\u00e9micas pueden originar y exacerbar alteraciones en el periodonto. Se ha demostrado la presencia de Anticuerpos Anticitoplasm\u00e1ticos de neutr\u00f3filos (ANCA) en pacientes con enfermedad periodontal destructiva y con enfermedades sist\u00e9micas. Objetivo: Determinar la relaci\u00f3n entre gingivitis y los ANCA en ni\u00f1os y adolescentes con leucemia que asistieron al Servicio Aut\u00f3nomo Hospital Universitario de Maracaibo y a la Fundaci\u00f3n del Hospital de Especialidades Pedi\u00e1tri...\n[Immunology of IgG4-related disease](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4516435)\nDella-Torre, E; Lanzillotta, M; Doglioni, C\n2015-01-01\nImmunoglobulin G4-related disease (IgG4-RD) is a fibroinflammatory condition that derives its name from the characteristic finding of abundant IgG4+ plasma cells in affected tissues, as well as the presence of elevated serum IgG4 concentrations in many patients. In contrast to fibrotic disorders, such as systemic sclerosis or idiopathic pulmonary fibrosis in which the tissues fibrosis has remained largely intractable to treatment, many IgG4-RD patients appear to have a condition in which the collagen deposition is reversible. The mechanisms underlying this peculiar feature remain unknown, but the remarkable efficacy of B cell depletion in these patients supports an important pathogenic role of B cell/T cell collaboration. In particular, aberrant T helper type 2 (Th2)/regulatory T cells sustained by putative autoreactive B cells have been proposed to drive collagen deposition through the production of profibrotic cytokines, but definitive demonstrations of this hypothesis are lacking. Indeed, a number of unsolved questions need to be addressed in order to fully understand the pathogenesis of IgG4-RD. These include the identification of an antigenic trigger(s), the implications (if any) of IgG4 antibodies for pathophysiology and the precise immunological mechanisms leading to fibrosis. Recent investigations have also raised the possibility that innate immunity might precede adaptive immunity, thus further complicating the pathological scenario. Here, we aim to review the most recent insights on the immunology of IgG4-RD, focusing on the relative contribution of innate and adaptive immune responses to the full pathological phenotype of this fibrotic condition. Clinical, histological and therapeutic features are also addressed. PMID:25865251\n[A case of proteinase 3 anti-neutrophil cytoplasmic antibody (PR3-ANCA positive/IgG4-related lung disease](http://www.sciencedirect.com/science/article/pii/S2213007116302192) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nHirokazu Touge\n2017-01-01\nFull Text Available IgG4-related lung disease (IgG4-RLD is a rare and chronic progressive autoimmune disease. We report a case of IgG4-related inflammatory pseudo-tumor of the lung that was seropositive for proteinase 3 anti-neutrophil cytoplasmic antibody (PR3-ANCA. A 61-year-old male had a mass lesion in the right lower lung field in chest X-ray. Transbronchial lung biopsy resulted in a pathological diagnosis of IgG4-RLD. The condition was improved by hormonal therapy.\n[Value of the detection of anti-HBc by radioimmunological assay in liver disease](https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=14795914) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nNoly, J.C.; Sepetjan, M.; Chevallier, P.; Trepo, C.\n1983-01-01\nDetection of anti-HBc by radioimmunossay was carried out on 1365 sera obtained from 947 liver disease patients. Anti-HBc always confirmed HBV infection in patients with HBs antigenemia. By contrast in the absence of detectable HBs Ag or anti-HBs, anti-HBc often becomes the only serological clue suggesting evidence of recent or ongoing HBV infection. Since anti-HBc may persist for prolonged period of time following acute HB infection only distinction between the IgG and IgM classes of anti-HBc may help to distinguish between persistant or past infection [fr\n[Identification of conformational epitopes for human IgG on Chemotaxis inhibitory protein of Staphylococcus aureus](http://www.biomedcentral.com/1471-2172/10/13) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nFurebring Christina\n2009-03-01\nFull Text Available Abstract Background The Chemotaxis inhibitory protein of Staphylococcus aureus (CHIPS blocks the Complement fragment C5a receptor (C5aR and formylated peptide receptor (FPR and is thereby a potent inhibitor of neutrophil chemotaxis and activation of inflammatory responses. The majority of the healthy human population has antibodies against CHIPS that have been shown to interfere with its function in vitro. The aim of this study was to define potential epitopes for human antibodies on the CHIPS surface. We also initiate the process to identify a mutated CHIPS molecule that is not efficiently recognized by preformed anti-CHIPS antibodies and retains anti-inflammatory activity. Results In this paper, we panned peptide displaying phage libraries against a pool of CHIPS specific affinity-purified polyclonal human IgG. The selected peptides could be divided into two groups of sequences. The first group was the most dominant with 36 of the 48 sequenced clones represented. Binding to human affinity-purified IgG was verified by ELISA for a selection of peptide sequences in phage format. For further analysis, one peptide was chemically synthesized and antibodies affinity-purified on this peptide were found to bind the CHIPS molecule as studied by ELISA and Surface Plasmon Resonance. Furthermore, seven potential conformational epitopes responsible for antibody recognition were identified by mapping phage selected peptide sequences on the CHIPS surface as defined in the NMR structure of the recombinant CHIPS31\u2013121 protein. Mapped epitopes were verified by in vitro mutational analysis of the CHIPS molecule. Single mutations introduced in the proposed antibody epitopes were shown to decrease antibody binding to CHIPS. The biological function in terms of C5aR signaling was studied by flow cytometry. A few mutations were shown to affect this biological function as well as the antibody binding. Conclusion Conformational epitopes recognized by human antibodies\n[Exposici\u00f3n a Estreptococo del grupo B en mujeres mexicanas en edad reproductiva Serologic evidence of high exposure to Group B streptococci (Streptococcus agalactiae in Mexican women of reproductive age](http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342002000100007) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nGerardo Palacios-Saucedo\n2002-01-01\nFull Text Available Objetivo. Evaluar la seroprevalencia de la infecci\u00f3n por Estreptococo del grupo B (EGB en una muestra representativa de mujeres en edad reproductiva de la Rep\u00fablica Mexicana. Material y m\u00e9todos. Se estudi\u00f3 una muestra representativa de sueros de la poblaci\u00f3n femenina mexicana de 15 a 40 a\u00f1os de edad, de todos los niveles socioecon\u00f3micos. La muestra fue seleccionada del Banco Nacional de Sueros por muestreo aleatorio simple por computadora. Los sueros se obtuvieron durante la \u00faltima encuesta seroepidemiol\u00f3gica nacional realizada en 1987 y 1988. Los ensayos para la estandarizaci\u00f3n y la evaluaci\u00f3n de la seroprevalencia se llevaron a cabo en el Hospital de Pediatr\u00eda del Centro M\u00e9dico Nacional Siglo XXI, del Instituto Mexicano del Seguro Social (IMSS entre enero y noviembre de 1995. Se midieron anticuerpos IgG antipolisac\u00e1rido de grupo de EGB usando un ensayo inmunoenzim\u00e1tico (ELISA estandarizado y validado en el laboratorio, utilizando un ant\u00edgeno espec\u00edfico de grupo, producido y purificado a partir de la cepa de referencia de EGB 110. Resultados. Se estudi\u00f3 un total de 2 669 muestras de suero, de las cuales 2 405 fueron positivas para la presencia de anticuerpos IgG contra el ant\u00edgeno de grupo de EGB. Esto corresponde a una seroprevalencia de 90.2 %. No hubo diferencia en los porcentajes de seropositividad por grupos de edad ni por entidades federativas. Conclusiones. Se detect\u00f3 una elevada prevalencia de anticuerpos contra el ant\u00edgeno de grupo del EGB. Los resultados de este estudio sugieren que existe una elevada exposici\u00f3n de las mujeres mexicanas j\u00f3venes a este microrganismo.Objective. To assess the prevalence of IgG antibodies against Group B streptococci (GBS among women of reproductive age in Mexico. Material and Methods. Serum specimens were drawn from 15 to 40 year-old women, representative of all regions and socioeconomic levels of the country. The sample was randomly selected from Banco Nacional de Sueros (National\n[Anticuerpos monoclonales contra la Gonadotropina Corionica Humana (HCG y su empleo en el diagn\u00f3stico precoz del embarazo.](http://infociencia.idict.cu/index.php/infociencia/article/view/302) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nTorres E\n2006-03-01\nFull Text Available Se describe la obtenci\u00f3n y caracterizaci\u00f3n de anticuerpos monoclonales contra la hormona gonadotropina cari\u00f3nica humana (HCG, seleccionados de la inmunizaci\u00f3n subcut\u00e1nea en ratones BALB/c. Se reporta tambi\u00e9n el desarrollo del sistema r\u00e1pido HeberFast Line\u00ae Embarazo, para la detecci\u00f3n de la hormona en muestras de orina, basado en los anticuerpos obtenidos y la tecnolog\u00eda del flujo lateral desarrollada en membranas de nitrocelulosa como soporte s\u00f3lido. El nivel de sensibilidad alcanzado con este sistema diagn\u00f3stico es de 20 UI/L de HCG en muestra de orina, y no se observ\u00f3 reactividad cruzada en analitos similares conteniendo concentraciones de las glicohormonas relacionadas; 1000 IU de LH, 5000 IU de FSH, y 1000 \u00b5IU de TSH respectivamente. Los estudios de estabilidad arrojaron, que el diagnosticador mantine las caracter\u00edsticas de funcionalidad por un tiempo de 15 meses a temperaturas entre 2 y 30 \u00baC, conformando este el tiempo de vigencia del sistema. De poseer en Farmacias, Consultorios M\u00e9dicos de la Familia y Hospital Gineco-Obst\u00e9tricos, un sistema r\u00e1pido y sencillo como el establecido en este trabajo, se pueden evitar todos los riesgos e inconvenientes que acarrean los procesos de interrupci\u00f3n del embarazo en la mujer.\n[IgG4-Related Autoimmune Prostatitis: Is It an Unusual or Underdiagnosed Manifestation of IgG4-Related Disease?](http://dx.doi.org/10.1155/2013/295472) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMar\u00eda T. Bourlon\n2013-01-01\nFull Text Available IgG4-related disease (IgG4-RD encompasses a wide range of extrapancreatic manifestations. Albeit some are relatively well known, others such as autoimmune prostatitis remain poorly described. We present a 61-year-old Latin-American male with autoimmune pancreatitis (AIP who presented with lower urinary tract symptoms (LUTS, normal prostate specific antigen (PSA test, and prostate enlargement attributed to benign prostatic hyperplasia (BPH. He underwent a transurethral resection of the prostate (TURP after which symptoms were resolved. On histopathology, prostatic stroma had a dense inflammatory infiltrate rich in plasma cells and lymphocytes; immunohistochemical morphometric assessment showed >10 IgG4-positive plasma cells/high power field (HPF. The diagnosis of IgG4-related prostatitis was postoperatively. We compared the patient characteristics with those of previous reports on Asian patients. Shared findings included prostate enlargement, LUTS (symptoms that can be confused with BPH, and PSA within normal limits or mild elevations. IgG4-related prostatitis is rarely considered as a preprocedural diagnosis, even in patients with evidence of IgG4-RD. Involved prostate zones include mainly central and transitional zones and less frequently the peripheral. Currently, there is insufficient data about the natural history and outcome. Whether steroids, transurethral resection, or both are the treatment of choice needs to be elucidated.\n[Characteristics of enzyme-linked immunosorbent assay for detection of IgG antibodies specific to \u0421hlamydia trachomatis heat shock protein (HSP-60](http://ukrbiochemjournal.org/wp-content/uploads/2017/01/Galkin_1_17.pdf) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nO. Yu. Galkin\n2017-02-01\nFull Text Available The goal of this work was to study sensitivity and specificity of the developed ELISA set for the identification of IgG antibodies against Chlamydia trachomatis HSP-60 (using biotinylated tyramine-based signal amplification system. The study was conducted using a panel of characterized sera, as well as two reference ELISA sets of similar purpose. According to the results of ELISA informative value parameters, the ELISA we have developed showed the highest specificity and sensitivity parameters (no false negative or false positive results were registered. In 4 out of 15 intralaboratory panel serum samples initially identified as negative, anti-HSP-60 IgG-antibodies test result in reference ELISA sets upon dilution changed from negative to positive. The nature of titration curves of false negative sera and commercial monoclonal antibodies \u041057-\u04129 against C. trachomatis HSP-60 after incubation for 24 h was indicative of the presence of anti-idiotypic antibodies in these samples. Upon sera dilution, idiotypic-anti-idiotypic complexes dissociated, which caused the change of test result. High informative value of the developed ELISA set for identification of IgG antibodies against C. trachomatis HSP-60 has been proven. Anti-idiotypic antibodies possessing C. trachomatis anti-HSP-60 activity and being one of the causes of false negative results of the relevant ELISA-based tests have been identified in blood sera of individuals infected with chlamydial genitourinary infection agents.\n[Fluorescent IgG fusion proteins made in E. coli](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3355479)\nLuria, Yael; Raichlin, Dina; Benhar, Itai\n2012-01-01\nAntibodies are among the most powerful tools in biological and biomedical research and are presently the fastest growing category of new bio-pharmaceutics. The most common format of antibody applied for therapeutic, diagnostic and analytical purposes is the IgG format. For medical applications, recombinant IgGs are made in cultured mammalian cells in a process that is too expensive to be considered for producing antibodies for diagnostic and analytical purposes. Therefore, for such purposes, mouse monoclonal antibodies or polyclonal sera from immunized animals are used. While looking for an easier and more rapid way to prepare full-length IgGs for therapeutic purposes, we recently developed and reported an expression and purification protocol for full-length IgGs, and IgG-based fusion proteins in E. coli, called \u201cInclonals.\u201d By applying the Inclonals technology, we could generate full-length IgGs that are genetically fused to toxins. The aim of the study described herein was to evaluate the possibility of applying the \u201cInclonals\u201d technology for preparing IgG-fluorophore fusion proteins. We found that IgG fused to the green fluorescent proteins enhanced GFP (EGFP) while maintaining functionality in binding, lost most of its fluorescence during the refolding process. In contrast, we found that green fluorescent Superfolder GFP (SFGFP)-fused IgG and red fluorescent mCherry-fused IgG were functional in antigen binding and maintained fluorescence intensity. In addition, we found that we can link several SFGFPs in tandem to each IgG, with fluorescence intensity increasing accordingly. Fluorescent IgGs made in E. coli may become attractive alternatives to monoclonal or polyclonal fluorescent antibodies derived from animals. PMID:22531449\n[Dynamics evaluation of total IgG, IgG1 and IgG2a in the serum of mice immunized with radioattenuated paracoccidioides brasiliensis yeast cells](https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=38111809) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nMartins, Estefania M.N.; Andrade, Antero S.R.; Reis, Bernardo S.; Goes, Alfredo M.\n2007-01-01\nParacoccidioides brasiliensis is the fungus agent of paracoccidioidomycosis, a deep-seated systemic infection of humans. Up to the moment no vaccine has still been reported. The potential of gamma radiation for pathogens attenuation and vaccine development was explored in this work. In our laboratory we developed radioattenuated yeast cells of P. brasiliensis and the aim of the present work was to evaluate the antibody production dynamics in mice immunized with this cells. Were analyzed the IgG antibodies titers as well as the type of response by analyzing the IgG1 and IgG2a antibody pattern in the course of infection. The mice were divided in two groups that were immunized one time and two times respectively. The mice infected with the virulent P. brasiliensis showed a high level of antibody production while the infection with the radioattenuated yeast did not significantly change the antibody level. The level of IgG raised in both immunized groups after the challenge. In the group immunized one time was not observed a significant difference between the levels of both subclasses when compared with the control. After the challenge of the group immunized two times the IgG2a levels increased significantly when analyzed 90 days post challenge. We concluded that a pattern related to the disease control was apparent in the group submitted to two immunizations. The mice had not developed a totally polarized pattern of TH1/TH2 response but a trend to a TH1 response was evident. (author)\n[Dynamics evaluation of total IgG, IgG1 and IgG2a in the serum of mice immunized with radioattenuated paracoccidioides brasiliensis yeast cells](http://www.etde.org/etdeweb/details.jsp?query_id=1&page=0&osti_id=20963824) [Energy Technology Data Exchange (ETDEWEB)](https://www.etde.org/etdeweb/fieldedsearch.jsp)\nMartins, Estefania M.N.; Andrade, Antero S.R. [Centro de Desenvolvimento da Tecnologia Nuclear (CDTN/CNEN-MG), Belo Horizonte, MG (Brazil)]. E-mail: estefaniabio@yahoo.com.br; antero@cdtn.br; Reis, Bernardo S.; Goes, Alfredo M. [Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG (Brazil). Dept. de Bioquimica e Imunologia]. E-mail: brsgarbi@mono.icb.ufmg.br; goes@mono.icb.ufmg.br\n2007-07-01\nParacoccidioides brasiliensis is the fungus agent of paracoccidioidomycosis, a deep-seated systemic infection of humans. Up to the moment no vaccine has still been reported. The potential of gamma radiation for pathogens attenuation and vaccine development was explored in this work. In our laboratory we developed radioattenuated yeast cells of P. brasiliensis and the aim of the present work was to evaluate the antibody production dynamics in mice immunized with this cells. Were analyzed the IgG antibodies titers as well as the type of response by analyzing the IgG1 and IgG2a antibody pattern in the course of infection. The mice were divided in two groups that were immunized one time and two times respectively. The mice infected with the virulent P. brasiliensis showed a high level of antibody production while the infection with the radioattenuated yeast did not significantly change the antibody level. The level of IgG raised in both immunized groups after the challenge. In the group immunized one time was not observed a significant difference between the levels of both subclasses when compared with the control. After the challenge of the group immunized two times the IgG2a levels increased significantly when analyzed 90 days post challenge. We concluded that a pattern related to the disease control was apparent in the group submitted to two immunizations. The mice had not developed a totally polarized pattern of TH1/TH2 response but a trend to a TH1 response was evident. (author)\n[Diagnostic value of anti-annexin A5 antibodies in seropositive versus seronegative antiphospholipid syndrome patients](http://www.sciencedirect.com/science/article/pii/S1110116417300881) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nGihan Omar\n2018-04-01\nFull Text Available Background: Current laboratory criteria for antiphospholipid syndrome (APS classification recommend testing positive for antiphospholipid (aPL antibodies. However, there appears to be a subset of patients with classical APS manifestations who test negative. Aim of the work: To analyze the potential clinical usefulness of testing for anti-annexin A5 antibodies in patients with APS and to study the effectiveness of testing for non-criteria aPLs in an attempt to increase the diagnostic yield, particularly in seronegative APS. Patients and methods: 60 APS patients were divided into two groups; 30 seropositive (SP-APS (group I and 30 age and sex matched seronegative (sN-APS testing negative for aPL antibodies. Serum assay for detection of isotypes of anti-annexin A5 antibodies (IgG and IgM were conducted. Results: The mean age of the patients was 32.9 \u00b1 5.8 years, female:male 57:3 and disease duration in SP-APS versus sN-APS (10.17 \u00b1 4.9 years versus 9.6 \u00b1 5.5 years respectively. Secondary APS was present in 16(53.3% patients in group I compared to 3(10% in group II (p < 0.0001. The mean anti-AnxA5 IgG level was 10.7 \u00b1 5.6 U/ml and IgM was 11.2 \u00b1 7.1 U/ml and were comparable between the 2 groups. The obstetric and thrombotic morbidity had no significant differences between SP and sN-APS. The IgG and IgM levels significantly correlated with the pregnancy morbidity, venous and arterial thrombosis events and showed reasonable sensitivities in their prediction (IgG:71.2%,72.8% and 75.8%; IgM: 68%,67.8% and 71.4% respectively and specificities (IgG:75.9%,77.8% and 81.5%; IgM: 70.9%,73.1% and 73.7% respectively. Conclusion: anti-annexinA5 antibodies are promising for detecting obstetric and thrombotic morbidity in both SP- and sN-APS patients. Keywords: Antiphospholipid syndrome, Seropositive APS (SP-APS, Seronegative APS (sN-APS, Anti-annexin A5 antibodies\n[IgG2 immunodeficiency: association to pediatric patients with bacterial meningoencephalitis Inmunodeficiencia de IgG2: asociaci\u00f3n en pacientes pedi\u00e1tricos con meningoencefalitis bacterianas](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2000000100021) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nXIOMARA ESCOBAR-P\u00c9REZ\n2000-03-01\nFull Text Available An IgG subclass deficiency is often associated with bacterial infections. We studied four pediatric patients suffering from meningoencephalitis, two of them due to Streptococcus pneumoniae and two due to Haemophilus influenzae type b. Simultaneous diagnostic serum and cerebrospinal fluid samples were taken during income. The four subclasses of IgG and albumin were quantified in both biologic fluids by radial immunodiffusion. Very low levels of seric IgG2 with non detectable cerebrospinal fluid IgG2 were found in the patients. No intrathecal IgG subclass synthesis was found in two patients. One patient with S. pneumoniae had IgG3 intrathecal synthesis. Intrathecal IgG1, IgG3 and IgG4 synthesis was found in one patient suffering from H. influenzae according with reibergrams. Substitutive therapy with intravenous gammaglobulin was given to the patients as part of the treatment.Las deficiencias por subclases de IgG se asocian frecuentemente con infecciones de origen bacteriano. Se estudian cuatro pacientes en edad pedi\u00e1trica con meningoencefalitis, dos de ellos a Streptococcus pneumoniae y dos a Haemophilus influenzae tipo b. Se toman muestras simult\u00e1neas diagn\u00f3sticas de suero y l\u00edquido cefalorraqu\u00eddeo en el momento del ingreso. Se cuantificaron las cuatro sublclases de IgG y alb\u00famina en ambos l\u00edquidos biol\u00f3gicos por inmunodifusi\u00f3n radial. Se encontr\u00f3 que los pacientes presentaban cifras muy disminuidas de IgG2 s\u00e9rico y ningun exhibia IgG2 en el l\u00edquido cefalorraqu\u00eddeo. Dos pacientes no sintetizaron ninguna subclase de IgG intratecalmente. Un paciente con S. pneumoniae sintetiz\u00f3 IgG3 intratecal. Uno de los pacientes con meningoencefalitis a H. influenzae sintetiz\u00f3 IgG1, IgG3 e IgG4 intratecalmente de acuerdo com el reibergrama. Estos pacientes recibieron terapia substitutiva com gammaglobulina intravenosa como parte de la medicaci\u00f3n.\n[Detecci\u00f3n de anticuerpos contra los ant\u00edgenos de diferenciaci\u00f3n tumoral proteinasa 3 (PR3 y mieloperoxidasa (MPO en la leucemia promieloc\u00edtica Detection of antibodies to antigens of proteinase 3 (PR3 tumor differentiations and myeloperoxidase (MPO in cases of promyelocytic leukemia](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-02892010000200004) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAda A. Arce Hern\u00e1ndez\n2010-08-01\nFull Text Available La leucemia promieloc\u00edtica (LPM subtipo M3 representa del 5-15 % en la clasificaci\u00f3n FAB de las leucemias mieloides agudas (LMA. Est\u00e1 asociada con caracter\u00edsticas gen\u00e9ticas \u00fanicas que incluyen la translocaci\u00f3n rec\u00edproca t(15;17(q22;q12. El mecanismo por el que ocurre la t(15;17 no se conoce. Las leucemias de estirpe mieloide expresan diversos ant\u00edgenos de diferenciaci\u00f3n tumoral como son la proteinasa 3 (PR 3 y la mieloperoxidasa (MPO que se encuentran sobreexpresados en el promielocito. Se plantea que participan en la maduraci\u00f3n y en la regulaci\u00f3n de la divisi\u00f3n celular. Existe poca informaci\u00f3n acerca de la respuesta inmune de pacientes con LPM dirigida contra las c\u00e9lulas tumorales. En nuestro trabajo se detect\u00f3 la presencia de anticuerpos contra los ant\u00edgenos de diferenciaci\u00f3n tumoral PR3 y MPO en diferentes fases del tratamiento de la enfermedad, mediante inmunofluorescencia indirecta. Los anticuerpos anti PR3 y anti MPO se detectaron en aquellos pacientes sin tratar y en fase de inducci\u00f3n, no as\u00ed en la consolidaci\u00f3n y mantenimiento, de ah\u00ed su posible utilidad como marcadores de diferenciaci\u00f3n celular.ABSTRACT Promyelocytic leukemia (PML subtype M3 represents the 5-15 % in the FAB classification of acute myeloid leukemias (AML. It is associated with the unique genetic features including the reciprocal t-translocation (15;17 (q22;q12. The mechanism of t is unknown. The myeloid leukemias express different tumoral differentiation antigens such as the proteinase 3 (PR 3 and myeloperoxidase (MPO which are over-expressed in promyelocyte. It is involved in maturation and regulation of cell division. There is scarce information on the immune response of patients with PLM against tumor cells. In our paper we detected presence of antibodies to RP3 and MPO tumor differentiation antigens in different phases of disease treatment by indirect immunofluorescence. Anti-MPO and anti-PR3 antibodies were detected in those patients without\n[Change of Serum IgG4 in Patients with Ocular Adnexal Marginal Zone B Cell Lymphoma Associated with IgG4-Related Ophthalmic Disease After Treatment.](https://www.ncbi.nlm.nih.gov/pubmed/28514197)\nWu, Yuan-Hung; Wang, Lei-Chi; Yen, Sang-Hue; Yu, Wei-Kuang; Kao, Shu-Ching; Kau, Hui-Chuan; Tsai, Chieh-Chih; Liu, Catherine Jui-Ling\n2017-09-01\nTo investigate the change of serum IgG4 concentrations correlated with clinical evolution in patients with ocular adnexal marginal zone B cell lymphoma associated with IgG4-related ophthalmic disease (IgG4-ROD). Three consecutive patients with histopathologically confirmed ocular adnexal marginal zone B cell lymphoma associated with IgG4-ROD were evaluated. Two patients received radiotherapy and 1 patient received steroid therapy. Treatment outcome was evaluated by clinical symptoms, radiologic examination, and change of serum IgG4 level in these patients. All patients had elevated serum IgG4 before treatment (462, 338, and 780 mg/dL respectively.) The 2 patients who received radiotherapy achieved complete remission and the serum IgG4 decreased to 345 and 92 mg/dL, respectively. The patient who underwent systemic steroid achieved partial remission and the serum IgG4 decrease to 161 mg/dL. Our study showed elevated serum IgG4 in all patients with ocular adnexal marginal zone B cell lymphoma associated with IgG4-ROD. In addition, the elevated serum IgG4 may decrease or keep stable after treatment, accompanied by improvement in clinical symptoms and reduction of lesions.\n[Proteolysis breaks tolerance toward intact \u03b1345(IV) collagen, eliciting novel anti-GBM autoantibodies specific for \u03b1345NC1 hexamers](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3563930)\nOlaru, Florina; Wang, Xu-Ping; Luo, Wentian; Ge, Linna; Miner, Jeffrey H; Kleinau, Sandra; Geiger, Xochiquetzal J.; Wasiluk, Andrew; Heidet, Laurence; Kitching, A. Richard; Borza, Dorin-Bogdan\n2012-01-01\nGoodpasture disease is an autoimmune kidney disease mediated by autoAbs against NC1 monomers of \u03b13(IV) collagen that bind to the glomerular basement membrane (GBM), usually causing rapidly progressive glomerulonephritis. We identified a novel type of human IgG4-restricted anti-GBM autoAbs associated with mild non-progressive glomerulonephritis, which specifically targeted \u03b1345NC1 hexamers but not \u03b13NC1 monomers. The mechanisms eliciting these anti-GBM autoAbs were investigated in mouse models recapitulating this phenotype. Wild type and Fc\u03b3RIIB\u2212/\u2212 mice immunized with autologous murine GBM NC1 hexamers produced mouse IgG1-restricted autoAbs specific for \u03b1345NC1 hexamers, which bound to the GBM in vivo but did not cause glomerulonephritis. In these mice, intact collagen IV from murine GBM was not immunogenic. However, in Col4a3\u2212/\u2212 Alport mice, both intact collagen IV and NC1 hexamers from murine GBM elicited IgG antibodies specific for \u03b13\u03b14\u03b15NC1 hexamers, which were not subclass restricted. As heterologous antigen in COL4A3-humanized mice, murine GBM NC1 hexamers elicited mouse IgG1, IgG2a and IgG2b autoAbs specific for \u03b1345NC1 hexamers and induced anti-GBM Ab glomerulonephritis. These findings indicate that tolerance toward autologous intact \u03b13\u03b14\u03b15(IV) collagen is established in hosts expressing this antigen, even though autoreactive B cells specific for \u03b1345NC1 hexamers are not purged from their repertoire. Proteolysis selectively breaches this tolerance by generating autoimmunogenic \u03b13\u03b14\u03b15NC1 hexamers. This provides a mechanism eliciting autoAbs specific for \u03b1345NC1 hexamers, which are restricted to non-inflammatory IgG subclasses and non-nephritogenic. In Alport syndrome, lack of tolerance toward \u03b13\u03b14\u03b15(IV) collagen promotes production of alloantibodies to \u03b1345NC1 hexamers, including pro-inflammatory IgG subclasses which mediate post-transplant anti-GBM nephritis. PMID:23303673\n[IgG4-related disease in the eye and ocular adnexa.](https://www.ncbi.nlm.nih.gov/pubmed/28858963)\nDerzko-Dzulynsky, Larissa\n2017-11-01\nIgG4-related disease is a multi-organ fibro-inflammatory disease with characteristic histopathology showing lymphoplasmacytic infiltration, increased IgG4+ plasma cells and elevated IgG4/IgG ratios (>40%). The lacrimal gland is the most common ocular site of involvement. Scleritis and intraocular involvement in IgG4-related ophthalmic disease (IgG4-ROD) have recently been reported. The purpose of this review is to describe orbital and intraocular IgG4-ROD with a focus on publications since 2016. Case reports of scleritis and uveitis in IgG4-ROD have been described since 2012. Systemic prednisone is recommended as the first-line treatment, but immunosuppressive therapy may be required for steroid-sparing or in steroid-resistant cases. High rates of systemic IgG4-RD involvement exist in patients with bilateral IgG4-ROD or if the lacrimal gland is involved. Rituximab is the most specific immune targeted therapy available with high rates of remission. IgG4-ROD is an emerging cause of scleritis and uveitis and should be considered in any patient with multisystem inflammatory disease. New targeted immune therapies may improve outcomes and lead to clinical remission.\n[Gingivitis y Anticuerpos Anticitoplasm\u00e1ticos de Neutr\u00f3filos en ni\u00f1os y adolescentes con leucemia](https://www.openaire.eu/search/publication?articleId=od______2079::fa24e04c25c7fc4be9b0e39e67722b80)\nViera, Ninoska; Rojas de Morales, Thais; Navas, Rita; Zambrano, Olga; Paz de Gudi\u00f1o, Mercedes\n2004-01-01\nIntroducci\u00f3n: Las enfermedades sist\u00e9micas pueden originar y exacerbar alteraciones en el periodonto. Se ha demostrado la presencia de Anticuerpos Anticitoplasm\u00e1ticos de neutr\u00f3fi los (ANCA) en pacientes con enfermedad periodontal destructiva y con enfermedades sist\u00e9micas. Objetivo: Determinar la re la ci\u00f3n entre gingivitis y los ANCA en ni\u00f1os y ado les cen tes con leucemia que asistieron al Servicio Aut\u00f3nomo Hospital Uni ver si ta rio de Maracaibo y a la Fundaci\u00f3n del Hosp...\n[A solid phase micro-radioimmunoassay to detect minute amounts of Ig class specific anti-viral antibody in a mouse model system](https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=7222183) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nCharlton, D.; Blandford, G.; Toronto Univ., Ontario\n1975-01-01\nA simple and rapid micro-radioimmunoassay was developed to detect and quantitate class specific mouse anti-sendai virus antibodies. Two different 125 I-labelled indicator systems were studied. After incubation of test serum with antigen one system used 125 I-rabbit anti-mouse IgG (RIA 1) and the second employed rabbit anti-mouse IgG, IgA or IgM followed by 125 I-sheep anti-rabbit immunoglobulin reagent (RIA 2). The RIA 2 method was adopted for routine use as it was more sensitive, gave better discrimination between sample and back-ground counts and eliminated the need for several labelled rabbit anti-mouse Ig class specific antisera. The technique was found to be about 100 times more sensitive than conventional HI tests, specific, reliable and economical of reagents and time\n[Frecuencia de anticuerpos contra el virus C de la hepatitis en pacientes con cirrosis hep\u00e1tica en Yucat\u00e1n, M\u00e9xico Frequency of antibodies against the hepatitis C virus in patients with hepatic cirrhosis in Yucatan, Mexico](http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342003000500003) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nRen\u00e1n A G\u00f3ngora-Biachi\n2003-10-01\nFull Text Available OBJETIVO: En este estudio reportamos la prevalencia de anticuerpos contra el virus C de la hepatitis (Ac-VCH en un grupo de pacientes con cirrosis hep\u00e1tica (CH. MATERIAL Y M\u00c9TODOS: Se hizo un estudio prospectivo, transversal y descriptivo, de marzo de 1998 a mayo de 1999. Se estudiaron a 153 pacientes (117 (76% hombres y 36 (24% mujeres con diagn\u00f3stico de CH, que eran atendidos en el Hospital General Agust\u00edn O' Horan y en el Centro de Investigaciones Regionales Doctor Hideyo Noguchi, en la ciudad de M\u00e9rida, Yucat\u00e1n, M\u00e9xico. Se aplic\u00f3 un cuestionario con datos cl\u00ednico-epidemiol\u00f3gicos y se determin\u00f3 la presencia de Ac-VCH (ELISA de 2\u00aa generaci\u00f3n y RIBA-2 para confirmar el diagn\u00f3stico a cada paciente. Se determin\u00f3 tambi\u00e9n el ant\u00edgeno de superficie de la hepatitis B (AgsHB y anticuerpos contra el ant\u00edgeno central de la hepatitis B (Anti-HBc mediante el m\u00e9todo de ELISA. La presencia de Ac-VCH fue relacionada con las variables epidemiol\u00f3gicas de los sujetos. La prevalencia de anti-HCV y la frecuencia de caracter\u00edsticas se compararon entre los pacientes positivos y negativos con las pruebas de c\u00b2 y exacta de Fisher. RESULTADOS: El 32% de los pacientes con CH (35/117 (30% hombres y 14/36 (39% mujeres fueron positivos para los Ac-VCH. El alcoholismo estuvo presente en todos los hombres serorreactivos y en ninguna de las mujeres positivas (pOBJECTIVE: To report the prevalence of antibodies against the hepatitis C virus (anti-HCV in a group of patients with hepatic cirrhosis (HC. MATERIAL AND METHODS: A prospective transversal and descriptive study was carried out from March 1998 to May 1999. Study subjects were 153 patients; 117 (76% male and 36 (24% female, diagnosed with HC. They were attended at the General Hospital Agust\u00edn O' Horan and at Regional Research Center Doctor Hideyo Noguchi, in Merida, Yucatan, Mexico. A clinical-epidemiologic questionnaire completed by interview was used for data collection. Anti-HCV were detected\n[Modulation of immune response to Lol p I by pretreatment with anti-idiotypic antibody is not restricted to the idiotypic expression.](https://www.ncbi.nlm.nih.gov/pubmed/7514517)\nBoutin, Y; H\u00e9bert, J\n1994-05-01\nTo study the role of anti-idiotypic antibodies in the regulation of the immune response to Lol p I (the major allergenic component of rye grass pollen), we have recently generated a panel of three MoAbs directed against distinct epitopes of Lolp I and an anti-idiotypic MoAb directed against the idiotype borne by one of the anti-Lol p I MoAbs (290A-167). The effects of pretreatment with this anti-idiotypic MoAb in BALB/c mice before immunization with the antigen have been examined. The anti-idiotypic MoAb or unrelated MoAb were given weekly for 8 weeks intraperitoneally. Mice then received the antigen (2 micrograms) adsorbed with alum (2 mg) at weeks 9, 11 and 13. Serum anti-Lol p I antibodies (IgG or IgE) and specific idiotypic responses were measured. Anti-Lol p I IgG antibodies could be detected before immunization with Lol p I only in mice pretreated with anti-idiotypic MoAb. Immunization with Lol p I induced an anti-Lol p I IgG response in both groups, but this response was higher in mice that received anti-idiotypic MoAb. Similar profiles were seen for specific IgE antibodies and idiotypic responses. Surprisingly, idiotypes borne by other anti-Lol p I MoAbs (539A-6 and 348A-6) had also been enhanced after pretreatment with the anti-290A-167 MoAb. These observations suggested that the pretreatment with this anti-idiotypic MoAb modulates not only the expression of the respective idiotype, but also affects other idiotype responses.\n[Therapeutic IgG4 antibodies engage in Fab-arm exchange with endogenous human IgG4 in vivo](https://www.narcis.nl/publication/RecordID/oai%3Apure.rug.nl%3Apublications%2F2c4cac1c-90ee-4d2d-ac5b-a5845842b60a/uquery/IGG4/id/5/Language/EN)\nLabrijn, Aran F.; Buijsse, Antonio Ortiz; van den Bremer, Ewald T. J.; Verwilligen, Annemiek Y. W.; Bleeker, Wim K.; Thorpe, Susan J.; Killestein, Joep; Polman, Chris H.; Aalberse, Rob C.; Schuurman, Janine; van de Winkel, Jan G. J.; Parren, Paul W. H. I.\nTwo humanized IgG4 antibodies, natalizumab and gemtuzumab, are approved for human use, and several others, like TGN1412, are or have been in clinical development. Although IgG4 antibodies can dynamically exchange half-molecules(1), Fab-arm exchange with therapeutic antibodies has not been\n[Therapeutic IgG4 antibodies engage in Fab-arm exchange with endogenous human IgG4 in vivo](https://www.narcis.nl/publication/RecordID/oai%3Apure.amc.nl%3Apublications%2F31f2c492-38cf-47bc-9d90-27ca5ae9df98/uquery/IGG4/id/7/Language/EN)\nLabrijn, Aran F.; Buijsse, Antonio Ortiz; van den Bremer, Ewald T. J.; Verwilligen, Annemiek Y. W.; Bleeker, Wim K.; Thorpe, Susan J.; Killestein, Joep; Polman, Chris H.; Aalberse, Rob C.; Schuurman, Janine; van de Winkel, Jan G. J.; Parren, Paul W. H. I.\n2009-01-01\nTwo humanized IgG4 antibodies, natalizumab and gemtuzumab, are approved for human use, and several others, like TGN1412, are or have been in clinical development. Although IgG4 antibodies can dynamically exchange half-molecules, Fab-arm exchange with therapeutic antibodies has not been demonstrated\n[Generaci\u00f3n de anticuerpos policlonales para la detecci\u00f3n de la variante genot\u00edpica GIII de PVY, en cultivos de tomate de \u00e1rbol y papa de Colombia](http://www.revistas.unal.edu.co/index.php/biotecnologia/article/view/32886) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nYuliana Gallo Garc\u00eda\n2012-04-01\nFull Text Available Normal 0 21 false false false ES-CO X-NONE X-NONE MicrosoftInternetExplorer4 T\u00edtulo en ingles: Generation of policlonal antibodies for detection of the PVY genotypic variant GIII in tamarillo and potato crops from Colombia Resumen: El potyvirus PVY es uno de los agentes causales m\u00e1s frecuentemente asociados a problemas virales en cultivos de papa y tomate de \u00e1rbol en Colombia. Dada la importancia econ\u00f3mica de las enfermedades causadas por PVY y a la necesidad de generar material de siembra certificado por su sanidad viral, es fundamental la generaci\u00f3n de herramientas de diagn\u00f3stico que permitan la detecci\u00f3n temprana de este virus. En este trabajo se reporta la obtenci\u00f3n de anticuerpos policlonales espec\u00edficos, \u00fatiles para la detecci\u00f3n del genotipo III de PVY (GIII, una de las tres variantes que recientemente han sido reportadas en cultivos de papa y tomate de \u00e1rbol de la regi\u00f3n Andina de Colombia. Como ant\u00edgeno, se utiliz\u00f3 un p\u00e9ptido sint\u00e9tico dise\u00f1ado a partir de la regi\u00f3n variable del extremo N-terminal del gen de la c\u00e1pside viral. La sensibilidad de los anticuerpos fue evaluada mediante pruebas de ELISA y dot-blot utilizando p\u00e9ptidos sint\u00e9ticos. Se realiz\u00f3 una prueba piloto para validar el uso de los anticuerpos a partir de plantas sintom\u00e1ticas y asintom\u00e1ticas obtenidas de una regi\u00f3n donde confluyen cultivos de ambas solan\u00e1ceas, encontr\u00e1ndose que los anticuerpos generados ofrecen mayores niveles de detecci\u00f3n que los anticuerpos comerciales com\u00fanmente utilizados para detectar los serotipos PVY-O,C y PVY-N de este virus. Palabras clave: anticuerpos policlonales; ELISA; potyvirus; RT-PCR; virus Y de la papa Abstract: PVY is one of the potyvirus more frequently associated with viral infections in tomato and tamarillo crops in Colombia. Due to the economic impact of PVY and the need to certify seeds as virus-free it is important to develop diagnostic tools that allow its premature detection. In this work, the\n[Orbital Pseudotumor: Uncommon Initial Presentation of IgG4-Related Disease](http://dx.doi.org/10.1155/2015/324365) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nTeresa Carbone\n2015-01-01\nFull Text Available IgG4-related disease (IgG4-RD encompasses a group of fibroinflammatory conditions recognized in recent times. The main clinical features include variable degrees of tissue fibrosis, tumorlike expansions, perivascular lymphocytic infiltration rich in IgG4-positive plasma cells, and elevated serum IgG4. A case has been reported of an elderly patient with an unexplained unilateral exophthalmia; biopsy was performed and revealed lymphocytic infiltration, suggesting IgG4-RD. High serum levels of IgG4, in association with a good response to steroid therapy and to the exclusion of other diagnoses, confirmed the hypothesis of orbital pseudotumor by IgG4-RD.\n[Elevated IgG4 serum levels in patients with cystic fibrosis.](https://www.ncbi.nlm.nih.gov/pubmed/28922375)\nClerc, Axelle; Reynaud, Quitterie; Durupt, St\u00e9phane; Chapuis-Cellier, Colette; Nov\u00e9-Josserand, Rapha\u00eble; Durieu, Isabelle; Lega, Jean Christophe\n2017-01-01\nSerum immunoglobulin (Ig) G4 elevation has been associated with several pathological conditions other than IgG4-related disease (IgG4-RD). In cystic fibrosis (CF), an elevation of specific IgG4 has been associated with colonization and infection by Pseudomonas aeruginosa. IgG4 elevation may be a marker of chronic infection or inflammatory stimulation. The aim of this study was to explore the prevalence of elevated IgG4 levels in CF and its correlation with the major clinical and microbiological features found in CF patients. In a cross-sectional study, we analyzed data from a large cohort of adult CF patients attending the CF center of Lyon University Hospital. An elevated IgG4 level was defined as being above the cut-off value of 135 mg/dL. One hundred and sixty-five CF patients were analyzed. An IgG4 elevation was detected in 43 patients (26%). Compared with the control group (\u2264 135 mg/dL), high IgG4 patients exhibited a greater prevalence of Staphylococcus aureus colonization and higher IgG, IgG1, IgG2 and IgE levels. No significant differences were observed in terms of pulmonary function, colonization with Pseudomonas aeruginosa, or the annual rate of bronchial exacerbations. An elevated IgG4 serum level was frequently detected in adult CF patients and did not appear to be associated with poor lung function. We suggest that IgG4 elevation is a marker of the activation of tolerance. Its clinical significance remains to be demonstrated.\n[ENFERMEDAD DE NEWCASTLE EN AVES DE TRASPATIO DEL EJE CAFETERO COLOMBIANO](http://apps.unicordoba.edu.co/revistas/revistamvz/mvz-142/v14n2a6.pdf) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMarlyn Romero P\n2009-08-01\nFull Text Available Objetivo. Evaluar la circulaci\u00f3n del virus de la enfermedad de Newcastle (ENC en aves de traspatio de siete municipios del eje cafetero por medio de la t\u00e9cnica ELISA. Materiales y m\u00e9todos. Fueron encuestados 465 predios para evaluar las normas de bioseguridad de las aves de traspatio de los municipios de Armenia, Circasia, Quimbaya, Montenegro, Filandia, Calarc\u00e1 y La Tebaida del Departamento del Quind\u00edo. Se analizaron 662 muestras de suero para detectar anticuerpos IgG contra el virus de la ENC por ELISA. Resultados. La seroprevalencia de la ENC en la poblaci\u00f3n de aves evaluada fue del 30.7%.(203/662, que corresponde al 38.5% de los predios encuestados. No se encontr\u00f3 asociaci\u00f3n entre la especie y la seroreactividad (p=0.21, ni entre la distribuci\u00f3n de los anticuerpos por grupos productivos y la edad (p>0.05. Los predios de traspatio son manejados de forma extensiva, albergan en las mismas instalaciones aves de diferentes especies y edades en el 64.3% (299/465, con edades en intervalos entre tres meses y cinco a\u00f1os. Fueron detectadas malas pr\u00e1cticas de manejo de la gallinaza y la mortalidad, sin encontrar asociaci\u00f3n estad\u00edsticamente significativa entre las variables evaluadas y la presencia de anticuerpos anti-virus de ENC (p>0.05. Conclusiones. Es necesario el establecimiento de planes adecuados de vacunaci\u00f3n de las aves de traspatio, la vigilancia epidemiol\u00f3gica activa, la observaci\u00f3n de los casos sospechosos, sin dejar de lado la educaci\u00f3n y capacitaci\u00f3n, sobre el adecuado manejo de los animales, dirigida a los propietarios de las aves como medidas de control de la enfermedad.\n[Utility of Serum IgG4 Levels in a Multiethnic Population.](https://www.ncbi.nlm.nih.gov/pubmed/29289265)\nQi, Ruyu; Chen, Luke Y C; Park, Sujin; Irvine, Robert; Seidman, Michael A; Kelsall, John T; Collins, David; Yin, Vivian; Slack, Graham W; Mattman, Andre; Lam, Eric; Carruthers, Mollie N\n2018-01-01\nIgG4-related disease (IgG4-RD) is a recently recognized condition defined by characteristic histopathologic findings in affected organs. Serum IgG4 concentration is often but not always elevated. The sensitivity and specificity of serum IgG4 vary greatly across studies and has been anecdotally associated to ethnicity. Our study was conducted to investigate the difference in serum IgG4 levels between Asian and non-Asian patients with IgG4-RD. This is a single-center retrospective study of 26 Asian and 10 non-Asian patients with histologically confirmed IgG4-RD. Serum IgG4 levels, clinical features and other laboratory findings were compared between the 2 groups, 31 Asian and 11 non-Asian patients with non-IgG4-RD rheumatic diseases were randomly identified to evaluate test characteristics of serum IgG4 measurement. Median serum IgG4 at time of diagnosis was significantly higher in Asian (median = 11.2g/L, interquartile range: 4.6-19.7) than non-Asian patients (median = 2.9g/L, interquartile range: 0.7-5.4, P = 0.0094), as well as the median serum IgG and total protein. Asian patients had more eosinophilia and polyclonal hypergammaglobulinemia than non-Asian patients (P = 0.016 and 0.001, respectively). Test sensitivity was higher in Asian (96%) than non-Asian patients (67%), whereas test specificity was higher in non-Asian patients (91% versus 71%). Asian patients with IgG4-RD have more exuberant serum IgG4, IgG and polyclonal hypergammaglobulinemia than non-Asian patients; the mechanism of this difference requires further study. These findings have significant clinical importance and must be accounted for in the diagnostic workup of patients in multiethnic settings. Copyright \u00a9 2018 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.\n[Use of anti-Aedes aegypti salivary extract antibody concentration to correlate risk of vector exposure and dengue transmission risk in Colombia.](http://europepmc.org/articles/PMC3846924?pdf=render) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nBerlin Londono-Renteria\nFull Text Available Norte de Santander is a region in Colombia with a high incidence of dengue virus (DENV. In this study, we examined the serum concentration of anti-Aedes salivary gland extract (SGE antibodies as a biomarker of DENV infection and transmission, and assessed the duration of anti-SGE antibody concentration after exposure to the vector ceased. We also determined whether SGE antibody concentration could differentiate between positive and negative DENV infected individuals and whether there are differences in exposure for each DENV serotype. We observed a significant decrease in the concentration of IgG antibodies at least 40 days after returning to an \"Ae. aegypti-free\" area. In addition, we found significantly higher anti-SGE IgG concentrations in DENV positive patients with some difference in exposure to mosquito bites among DENV serotypes. We conclude that the concentration of IgG antibodies against SGE is an accurate indicator of risk of dengue virus transmission and disease presence.\n[Anti-Phospholipid Syndrome In Nigeria: Report Of Five Cases ...](https://www.ajol.info/index.php/eamj/article/view/46942) [African Journals Online (AJOL)](http://www.ajol.info/index.php)\nFive cases of secondary anti-phospholipid syndrome (APS) are presented and literature reviewed. Pregnancy loss was the most common presentation but neurologic manifestations are also seen. IgG ACA was more commonly seen than IgM ACA. Although APS has been infrequently reported in black Africans, ...\n[POLYCLONAL ANTIBODIES TO DETECT THE CP-RT PROTEIN OF Potato Mop-Top VIRUS ANTICUERPOS POLICLONALES PARA LA DETECCI\u00d3N DE LA PROTE\u00cdNA CP-RT DEL Potato Mop-Top VIRUS](http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0304-28472012000200011) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nDerly Andrade Molina\n2012-06-01\nFull Text Available Abstract. Potato mop-top virus (PMTV causes an important re-emerging disease in potato crops in Colombia due to the increased incidence of its protozoan vector Spongospora subterranea f.sp. subterranea (Sss, the causing agent of Powdery scab disease. For an accurate detection of PMTV it is recommended to combine different diagnostic tests and evaluate multiple samples per plant or tissue. In order to increase the number of available tools for detection of PMTV, antibodies targeting the RT domain of the CP-RT protein were developed in this work. Sequencing of the RT domain from the colombian strain R25 was achieved and using bioinformatic analysis, a potential antigenic region was identified. A peptide mimicking the antigenic region was inoculated in rabbits for the production of polyclonal antibodies. The antibodies were tested by ELISA using Nicotiana benthamiana bait-plants infected with Sss cystosori and potato plants collected in La Uni\u00f3n (Antioquia. The validity of serological tests was confirmed by RT-PCR. A complete sequence of the RT domain and 441 nt of the CP gene were obtained. Phylogenetic analysis identified strain R25 as closely associated to the PMTV lineage distributed worldwide. A total of 19.26 mg of anti-CP-RT polyclonal antibodies useful in detecting PMTV in infected plants were obtained. As CP-RT is involved in transmission of PMTV by Sss, these antibodies will be useful for supporting not only diagnostic programs but also basic and epidemiologic studies aimed at understanding interactions between PMTV and Sss.Resumen. El Potato mop-top virus (PMTV es uno de los virus re-emergentes en los cultivos de papa de Colombia, como resultado del aumento de la incidencia de su vector natural, el protozoo Spongospora subterranea f.sp. mamarinm@unal.edu.co (Sss, agente causal de la Sarna polvosa de la papa. Para la detecci\u00f3n del virus se recomienda la realizaci\u00f3n simult\u00e1nea de diferentes pruebas, as\u00ed como la evaluaci\u00f3n de m\n[Development and characterization of highly informative ELISA for the detection of IgG and IgA antibodies to \u0421hlamydia trachomatis](http://ukrbiochemjournal.org/wp-content/uploads/2018/04/Galkin_3_18.pdf) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nO. Yu. Galkin\n2018-04-01\nFull Text Available The goal of this work was developing of highly informative an enzyme-linked immunosorbent assay (ELISA for the detection of IgG and IgA antibodies against to Chlamydia trachomatis, as well as comparative characterization of developed assay using standardized control materials. The study was conducted using: monoclonal antibodies (McAbs to human IgA and IgG; recombinant Ch. trachomatis proteins \u2013 Pgp3, major outer membrane protein (MOMP; two panels of characterized sera and four reference ELISA kits. The study of immunochemical activity of peroxidase conjugates of McAbs was performed in comparison with conjugates of commercial analogues: anti-IgG McAb 2A11 and anti-IgA McAb AD3. About half of the conjugates from the received McAbs panel were more active compared to the reference antibody conjugates. It was quite justified to use the conjugates of antibodies that interact with different antigenic determinants. When IgG antibodies were detected to MOMP, it was justified 1.14-1.56 times more; when IgA antibodies were detected to MOMP, it was justified 1.16-1.37 times more. ELISA for detecting IgG/IgA antibodies to MOMP and Pgp3 of Ch. trachomatis were evaluated using appropriately described serum panels OCO-42-28-313-00 and OCO-42-28-314-00. Comparative studies of the developed ELISA for the detection of IgG and IgA antibodies to the MOMP and Pgp3 of Ch. trachomatis showed their prominent advantage over the commercial analogues, which more clearly demonstrates the difference in the ratio of average values of optical density of positive and negative samples of the described panel of sera: this indicator for commercial kits was 1.36-3.59 times less.\n[IgG4 immunostaining and its implications in orbital inflammatory disease.](http://europepmc.org/articles/PMC4193851?pdf=render) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAmanda J Wong\nFull Text Available OBJECTIVE: IgG4-related disease is an emerging clinical entity which frequently involves tissue within the orbit. In order to appreciate the implications of IgG4 immunostaining, we analyzed gene expression and the prevalence of IgG4- immunostaining among subjects with orbital inflammatory diseases. METHODS: We organized an international consortium to collect orbital biopsies from 108 subjects including 22 with no known orbital disease, 42 with nonspecific orbital inflammatory disease (NSOI, 26 with thyroid eye disease (TED, 12 with sarcoidosis, and 6 with granulomatosis with polyangiitis (GPA. Lacrimal gland and orbital adipose tissue biopsies were immunostained for IgG4 or IgG secreting plasma cells. RNA transcripts were quantified by Affymetrix arrays. RESULTS: None of the healthy controls or subjects with TED had substantial IgG4 staining. Among the 63 others, the prevalence of significant IgG4-immunostaining ranged from 11 to 39% depending on the definition for significant. IgG4 staining was detectable in the majority of tissues from subjects with GPA and less commonly in tissue from subjects with sarcoidosis or NSOI. The detection of IgG4+ cells correlated with inflammation in the lacrimal gland based on histology. IgG4 staining tissue expressed an increase in transcripts associated with inflammation, especially B cell-related genes. Functional annotation analysis confirmed this. CONCLUSION: IgG4+ plasma cells are common in orbital tissue from patients with sarcoidosis, GPA, or NSOI. Even using the low threshold of 10 IgG4+ cells/high powered field, IgG4 staining correlates with increased inflammation in the lacrimal gland based on histology and gene expression.\n[IgG4 Immunostaining and Its Implications in Orbital Inflammatory Disease](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4193851)\nWong, Amanda J.; Planck, Stephen R.; Choi, Dongseok; Harrington, Christina A.; Troxell, Megan L.; Houghton, Donald C.; Stauffer, Patrick; Wilson, David J.; Grossniklaus, Hans E.; Dailey, Roger A.; Ng, John D.; Steele, Eric A.; Harris, Gerald J.; Czyz, Craig; Foster, Jill A.; White, Valerie A.; Dolman, Peter J.; Kazim, Michael; Patel, Payal J.; Edward, Deepak P.; Katan, Hind al; Hussain, Hailah al; Selva, Dinesh; Yeatts, R. Patrick; Korn, Bobby S.; Kikkawa, Don O.; Rosenbaum, James T.\n2014-01-01\nObjective IgG4-related disease is an emerging clinical entity which frequently involves tissue within the orbit. In order to appreciate the implications of IgG4 immunostaining, we analyzed gene expression and the prevalence of IgG4- immunostaining among subjects with orbital inflammatory diseases. Methods We organized an international consortium to collect orbital biopsies from 108 subjects including 22 with no known orbital disease, 42 with nonspecific orbital inflammatory disease (NSOI), 26 with thyroid eye disease (TED), 12 with sarcoidosis, and 6 with granulomatosis with polyangiitis (GPA). Lacrimal gland and orbital adipose tissue biopsies were immunostained for IgG4 or IgG secreting plasma cells. RNA transcripts were quantified by Affymetrix arrays. Results None of the healthy controls or subjects with TED had substantial IgG4 staining. Among the 63 others, the prevalence of significant IgG4-immunostaining ranged from 11 to 39% depending on the definition for significant. IgG4 staining was detectable in the majority of tissues from subjects with GPA and less commonly in tissue from subjects with sarcoidosis or NSOI. The detection of IgG4+ cells correlated with inflammation in the lacrimal gland based on histology. IgG4 staining tissue expressed an increase in transcripts associated with inflammation, especially B cell-related genes. Functional annotation analysis confirmed this. Conclusion IgG4+ plasma cells are common in orbital tissue from patients with sarcoidosis, GPA, or NSOI. Even using the low threshold of 10 IgG4+ cells/high powered field, IgG4 staining correlates with increased inflammation in the lacrimal gland based on histology and gene expression. PMID:25303270\n[Aplicaciones terap\u00e9uticas de las inmunoglobulinas humanas en Pediatr\u00eda](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75312013000200010&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAmauri L\u00e1zaro Noda Albelo\nFull Text Available En la actualidad existen diversos productos farmac\u00e9uticos constituidos por inmunoglobulinas (fundamentalmente IgG, purificadas por diversos m\u00e9todos, lo que implica que pueden ser administradas por diversas v\u00edas (intramuscular, intravenosa y subcut\u00e1nea. Estos productos tienen un amplio espectro de indicaciones en diversas enfermedades. Las inmunoglobulinas son los efectores finales de la respuesta inmune humoral, por lo que sus indicaciones fundamentales incluyen la terapia de reemplazo en enfermedades que cursan con d\u00e9ficit en la producci\u00f3n de anticuerpos, las situaciones en que se necesita de manera inmediata la presencia de anticuerpos neutralizantes, como en las terapias posexposici\u00f3n, y en enfermedades que cursan con disrregulaci\u00f3n de la respuesta inmune.\n[Pesquisa de anticorpos anti Toxoplasma gondii em fluidos intra-oculares (humor v\u00edtreo e humor aquoso) de pacientes com toxoplasmose ocular, na cidade de Bel\u00e9m, PA](https://www.openaire.eu/search/publication?articleId=dedup_wf_001::f1c3d2017035d932c048ed2543a72a4d)\nCarmo,Ediclei Lima do; Almeida,Edmundo Frota; Bichara,Cl\u00e9a Nazar\u00e9; P\u00f3voa,Marinete Marins\n2005-01-01\nFoi realizada pesquisa de anticorpos IgG, IgM e IgA anti-Toxoplasma gondii no soro e fluidos intra-oculares (humor aquoso e v\u00edtreo) de pacientes com toxoplasmose ocular. A partir dos resultados obtidos verificou-se que anticorpos IgG e IgA intraocular anti-Toxoplasma gondii podem vir a ser importantes marcadores no diagn\u00f3stico de toxoplasmose ocular.\n[Short communication: Anti-HIV-1 envelope immunoglobulin Gs in blood and cervicovaginal samples of Beninese commercial sex workers.](https://www.ncbi.nlm.nih.gov/pubmed/25354025)\nBatraville, Laurie-Anne; Richard, Jonathan; Veillette, Maxime; Labb\u00e9, Annie-Claude; Alary, Michel; Gu\u00e9dou, Fernand; Kaufmann, Daniel E; Poudrier, Johanne; Finzi, Andr\u00e9s; Roger, Michel\n2014-11-01\nCharacterization of the immune correlates of protection against HIV infection is crucial for the development of preventive strategies. This study examined HIV-1 envelope (Env) glycoproteins, specifically immunoglobulin G (IgG), in systemic and mucosal compartments of female Beninese commercial sex workers (CSWs). Samples of 23 HIV-1-positive and 20 highly exposed HIV-1-seronegative (HESN) CSWs were studied. HIV-1 Env-specific IgG detection in sera and cervicovaginal lavages (CVLs) from the study population was done by cell-based ELISA. The HIV neutralizing activity was evaluated with a neutralization assay. The HIV-1-specific antibody-dependent cellular cytotoxicity (ADCC) response of the cohort was measured with a FACS-based assay evaluating the ADCC-mediated elimination of gp120-coated target cells. No anti-HIV-1 Env-specific IgG neutralizing or ADCC activities were detected in samples from HESN CSWs. Samples from HIV-1-infected CSWs presented ADCC activity in both sera and CVLs. Anti-Env IgG from sera and CVLs from HIV-1-infected CSWs preferentially recognized Env in its CD4-bound conformation. HIV-1-infected CSWs have ADCC-mediating IgG that preferentially recognizes Env in its CD4-bound conformation at the mucosal site.\n[Increased IgG4 responses to multiple food and animal antigens indicate a polyclonal expansion and differentiation of pre-existing B cells in IgG4-related disease](https://www.narcis.nl/publication/RecordID/oai%3Apure.amc.nl%3Apublications%2Fc41fb903-9bc6-4cd8-a1eb-bd7fe0aa4955/uquery/IGG4/id/13/Language/EN)\nCulver, Emma L.; Vermeulen, Ellen; Makuch, Mateusz; van Leeuwen, Astrid; Sadler, Ross; Cargill, Tamsin; Klenerman, Paul; Aalberse, Rob C.; van Ham, S. Marieke; Barnes, Eleanor; Rispens, Theo\n2015-01-01\nIgG4-related disease (IgG4-RD) is a systemic fibroinflammatory condition, characterised by an elevated serum IgG4 concentration and abundant IgG4-positive plasma cells in the involved organs. An important question is whether the elevated IgG4 response is causal or a reflection of immune-regulatory\n[Neisseria meningitidis Group A IgG1 and IgG2 Subclass Immune Response in African Children Aged 12\u201323 Months Following Meningococcal Vaccination](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4639486)\nHolme, Daniel; Findlow, Helen; Sow, Samba O.; Idoko, Olubukola T.; Preziosi, Marie-Pierre; Carlone, George; Plikaytis, Brian D.; Borrow, Ray\n2015-01-01\nBackground. A group A meningococcal conjugate vaccine, PsA-TT, was licensed in 2010 and was previously studied in a phase 2 clinical trial to evaluate its safety and immunogenicity in African children 12\u201323 months of age. Methods. Subjects received either PsA-TT; meningococcal group A, C, W, Y polysaccharide vaccine (PsACWY); or Haemophilus influenzae type b conjugate vaccine (Hib-TT). Forty weeks following primary vaccination, the 3 groups were further randomized to receive either PsA-TT, one-fifth dose of PsACWY, or Hib-TT. Group A\u2013specific immunoglobulin G (IgG) subclass response was characterized using an enzyme-linked immunosorbent assay. Results. The predominant IgG subclass response, regardless of vaccine, was IgG1. One month following primary vaccination, the geometric mean concentrations (GMCs) of IgG1 and IgG2 in the PsA-TT group were 21.73 \u00b5g/mL and 6.27 \u00b5g/mL, whereas in the PsACWY group the mean GMCs were 2.01 \u00b5g/mL and 0.97 \u00b5g/mL, respectively (P Group A\u2013specific IgG1 and IgG2 GMCs remained greater in the PsA-TT group than in the PsACWY group 40 weeks following primary vaccination (P vaccines. Conclusions. Vaccination of African children aged 12\u201324 months with either PsA-TT or PsACWY elicited a predominantly IgG1 response. The IgG1:IgG2 mean ratio decreased following successive vaccination with PsACWY, indicating a shift toward IgG2, suggestive of the T-cell\u2013independent immune response commonly associated with polysaccharide antigens. Clinical Trials Registration. SRCTN78147026. PMID:26553689\n[Technetium-99m labeling anti-amastigote polyclonal antibodies of Leishmania amazonensis](https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=33047325) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nAraujo, J.G.V.C.; Toledo, V.P.C.P.; Guimaraes, T.M.P.D.; Bernardo-Filho, M.; Simal, C.J.R.; Mota, L.G.; Diniz, S.O.F.; Cardoso, V.N.\n2002-01-01\nAnti-amastigote polyclonal antibody (IgG) was incubated with solutions of stannous chloride and sodium borohidride. After that, 3.7 MBq of technetium-99m ( 99m Tc) was added. A labeling yield of the antibody about 84% was obtained. After filtration of 99m Tc-IgG, the radiochemical purity increased from 84 to 95%. The labeling of IgG with 99m Tc did not modify the immunoreactivity of the antibody, since it was able to identify in vitro and in vivo the specific antigen of Leishmania amazonensis\n[Mechanisms of anti-D action in the prevention of hemolytic disease of the fetus and newborn: what can we learn from rodent models?](https://www.ncbi.nlm.nih.gov/pubmed/19730101)\nBrinc, Davor; Denomme, Gregory A; Lazarus, Alan H\n2009-11-01\nHemolytic disease of the fetus and newborn can be effectively prevented by administration of anti-D to the mother. In this setting, the IgG purified from the plasma of D-alloimmunized donors prevents the maternal immune response to D-positive red blood cells (RBC). Several monoclonal anti-D antibodies have recently been developed for potential use in the setting of hemolytic disease of the fetus and newborn; the functional assays used to assess the potential success of these antibodies have often assumed antigen clearance as the predominant mechanism of anti-D. Unfortunately, the in-vivo success of these monoclonal antibodies has thus far been limited. A similar inhibitory effect of IgG has been observed in animal models with a vast array of different antigens, referred to as antibody-mediated immune suppression (AMIS). Here, studies of AMIS are reviewed and the relevance of these findings for anti-D-mediated immunoprophylaxis is discussed. In animal models of AMIS, IgG-mediated antigen clearance was not sufficient for prevention of the antibody response to RBC. Furthermore, anti-RBC IgG inhibited B-cell priming to foreign RBC, but failed to prevent a T-cell response and immunological memory. The applicability of AMIS models for determining the true mechanism of anti-D, though uncertain, may nevertheless provide knowledge as to potential mechanisms of action of anti-RBC antibodies.\n[Recurrent Mastoiditis Mimics IgG4 Related Disease: A Potential Diagnostic Pitfall.](https://www.ncbi.nlm.nih.gov/pubmed/27091207)\nDeshpande, Vikram; Zane, Nicolas A; Kraft, Stefan; Stone, John H; Faquin, William C\n2016-09-01\nIgG4-related disease (IgG4-RD) is a recently recognized entity that causes progressive fibrosis and formation of mass lesions. IgG4-RD can be diagnosed histologically by its hallmarks of storiform fibrosis, prominent lymphoplasmacytic infiltrate, and obliterative phlebitis, accompanied by the infiltration of excessive numbers of IgG4-positive plasma cells as well as elevations in serum IgG4 concentrations. A recent publication reported a case of IgG4-RD in the mastoid sinus, representing a new anatomic location for this disease. We report two additional cases of IgG4-RD occurring in the mastoid and causing clinical mastoiditis. The presenting symptoms were varied-tinnitus, hearing loss, and cranial nerve palsies. All three cases showed a dense lymphoplasmacytic infiltrate, storiform type fibrosis as well as elevated numbers of IgG4 positive plasma cells. The three patients responded to immunosuppressive therapy that included steroids and Rituximab. We further investigated 162 consecutive mastoiditis cases at our institution in order to determine the frequency of IgG4-RD as a previously unrecognized cause of mastoiditis. Within this latter cohort we identified nine cases of mastoiditis that had two of the histologic features of IgG4-RD, specifically storiform fibrosis and a dense lymphoplasmacytic infiltrate. Two of these cases showed >50 IgG4-positive plasma cells per high-power field with IgG4-IgG ratio of >40 %, thus fulfilling histological criteria for IgG4-RD. However, both were due to severe acute or chronic infection. In conclusion, we reaffirm IgG4 related mastoiditis as a distinct but uncommon cause of recurrent mastoiditis. The diagnosis of IgG4-related mastoiditis should be rendered with caution, and only after the exclusion of potential mimickers, particularly infection.\n[Inhibition of complement activation by IgG4 antibodies](https://www.narcis.nl/publication/RecordID/oai%3Apure.amc.nl%3Apublications%2Fa5b791d1-fc1e-4000-8be5-cbb3eeb27064/uquery/bee%20AND%20keeping/id/1/Language/EN)\nvan der Zee, J. S.; van Swieten, P.; Aalberse, R. C.\n1986-01-01\nProlonged exposure to antigens may result in high IgG4 antibody titres as was shown in a previous paper (Aalberse et al., 1983b). In novice bee keepers, a shift in the IgG1/IgG4 ratio of the response against phospholipase-A (PLA; a major component of bee venom) occurred. This resulted in an\n[Estandarizaci\u00f3n en Colombia de una prueba ELISA para la evaluaci\u00f3n de los niveles s\u00e9ricos de anticuerpos IgG contra diez serotipos de Streptococcus pneumoniae](http://www.revistabiomedica.org/index.php/biomedica/article/view/393) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nLuc\u00eda Carolina Leal-Esteban\n2012-03-01\nConclusi\u00f3n. Esta prueba ELISA cuantifica de forma confiable los niveles de IgG s\u00e9rica contra diez serotipos de S. pneumoniae y, de acuerdo con los resultados obtenidos en individuos sanos de nuestra poblaci\u00f3n, en este trabajo se validan los par\u00e1metros internacionales para considerar adecuada la respuesta a la vacuna 23-valente contra este microorganismo. DOI: http://dx.doi.org/10.7705/biomedica.v32i1.393\n[Hybrid IgG4/IgG4 Fc antibodies form upon 'Fab-arm' exchange as demonstrated by SDS-PAGE or size-exclusion chromatography](https://www.narcis.nl/publication/RecordID/oai%3Apure.amc.nl%3Apublications%2F1c395e4a-20f1-4d19-a7df-68ef91d10bf8/uquery/sds%20AND%20page/id/10/Language/EN)\nRispens, Theo; den Bleker, Tamara H.; Aalberse, Rob C.\n2010-01-01\nHuman IgG4 antibodies are dynamic molecules that in vivo exchange half-molecules to become bispecific antibodies. Here we show that IgG4 antibodies and IgG4 Fc fragments similarly exchange resulting in hybrid antibodies (a single Fab + Fc) with a molecular weight of ca. 100 kDa. These antibodies can\n[Sudan ebolavirus long recovered survivors produce GP-specific Abs that are of the IgG1 subclass and preferentially bind Fc\u03b3RI.](https://www.ncbi.nlm.nih.gov/pubmed/28729706)\nRadinsky, Olga; Edri, Avishay; Brusilovsky, Michael; Fedida-Metula, Shlomit; Sobarzo, Ariel; Gershoni-Yahalom, Orly; Lutwama, Julius; Dye, John; Lobel, Leslie; Porgador, Angel\n2017-07-20\nEbolavirus is a highly lethal pathogen, causing a severe hemorrhagic disease with a high fatality rate. To better understand immune correlates of protection by virus specific IgG, we investigated the evolution of the Fc\u03b3 receptors (Fc\u03b3Rs)-activating capabilities of antiviral IgG in serum samples of long recovered survivors. To this end, longitudinal serum samples from survivors of Sudan ebolavirus (SUDV) infection, studied over years, were examined for the presence of Ebola-GP specific IgG subclasses, and for their binding to Fc\u03b3Rs. We developed a cell-based reporter system to quantitate pathogen-specific antibody binding to Fc\u03b3RIIIA, Fc\u03b3RIIA, Fc\u03b3RIIB and Fc\u03b3RI. With this system, we demonstrate that anti-GP-specific stimulation of the Fc\u03b3RI reporter by survivors' sera was substantially high one year after acute infection, with a slight reduction in activity over a decade post infection. We further demonstrate that GP-specific IgG1 is by far the seroprevalent subclass that retained and even enhanced its presence in the sera, over ten years post infection; the prevalence of other GP-specific IgG subclasses was considerably reduced over time. In accordance, GP-specific Fc\u03b3RI reporter response and GP-specific total IgG1 subclass correlated in the studied group of Ebola survivors. These observations are important for further informing Ebola vaccine and therapeutic development.\n[Structural characterization of the Man5 glycoform of human IgG3 Fc](http://www.etde.org/etdeweb/details.jsp?query_id=1&page=0&osti_id=1400303) [Energy Technology Data Exchange (ETDEWEB)](https://www.etde.org/etdeweb/fieldedsearch.jsp)\nShah, Ishan S.; Lovell, Scott; Mehzabeen, Nurjahan; Battaile, Kevin P.; Tolbert, Thomas J. (Kansas); (HWMRI)\n2017-12-01\nImmunoglobulin G (IgG) consists of four subclasses in humans: IgG1, IgG2, IgG3 and IgG4, which are highly conserved but have unique differences that result in subclass-specific effector functions. Though IgG1 is the most extensively studied IgG subclass, study of other subclasses is important to understand overall immune function and for development of new therapeutics. When compared to IgG1, IgG3 exhibits a similar binding profile to Fc\u03b3 receptors and stronger activation of complement. All IgG subclasses are glycosylated at N297, which is required for Fc\u03b3 receptor and C1q complement binding as well as maintaining optimal Fc conformation. We have determined the crystal structure of homogenously glycosylated human IgG3 Fc with a GlcNAc2Man5 (Man5) high mannose glycoform at 1.8 \u00c5 resolution and compared its structural features with published structures from the other IgG subclasses. Although the overall structure of IgG3 Fc is similar to that of other subclasses, some structural perturbations based on sequence differences were revealed. For instance, the presence of R435 in IgG3 (and H435 in the other IgG subclasses) has been implicated to result in IgG3-specific properties related to binding to protein A, protein G and the neonatal Fc receptor (FcRn). The IgG3 Fc structure helps to explain some of these differences. Additionally, protein-glycan contacts observed in the crystal structure appear to correlate with IgG3 affinity for Fc\u03b3 receptors as shown by binding studies with IgG3 Fc glycoforms. Finally, this IgG3 Fc structure provides a template for further studies aimed at engineering the Fc for specific gain of function.\n[Factores de riesgo asociados a la seroprevalencia de anticuerpos a Neospora caninum en ganado lechero de Aguascalientes, M\u00e9xico](https://www.openaire.eu/search/publication?articleId=doajarticles::8cb3ca76e3a2e594a6c9b2d93fadfea1)\nRoc\u00edo Conzuelo Sierra; Leticia Medina-Esparza; Miguel Ramos Parra; Zeferino Garc\u00eda-V\u00e1zquez; Carlos Cruz-V\u00e1zquez\n2011-01-01\nEl objetivo del presente trabajo fue identificar potenciales factores de riesgo, incluyendo laposible presencia de contaminaci\u00f3n del agua de bebida con ooquistes del par\u00e1sito, asociados con la seroprevalencia de anticuerpos a N. caninum en hatos lecheros de Aguascalientes, M\u00e9xico. Se tomaron muestras de suero sangu\u00edneo de 150 vacas, mismas que fueron analizadas por la t\u00e9cnica de ELISA, se detect\u00f3 la presencia de ADN de N. caninum en el agua de bebida mediante una prueba de PCR anidada, y se a...\n[Invasive cervical cancer accompanied by IgG4-related disease.](https://www.ncbi.nlm.nih.gov/pubmed/27238361)\nMizuno, Rin; Yamanishi, Yukio; Uda, Satoko; Terashima, Tsuyoshi; Higashi, Tatsuya; Higuchi, Toshihiro\n2016-09-01\nIgG4-related disease (IgG4-RD) is a systemic disease that affects multiple organs and generates nodules or thickening. Discriminating these diseases from malignancy is important because glucocorticoid treatment is effective for patients with IgG4-RD. Coexistence of IgG4-RD with various malignant diseases has been reported, but there are few reports with regard to gynecologic malignant diseases. We encountered a case of invasive cervical cancer stage IIB accompanied by IgG4-RD. The patient was a 46-year-old woman. On pelvic magnetic resonance imaging, fluorodeoxyglucose-positron emission tomography and computed tomography, systemic multiple lymph node swelling was seen, including in the neck and the mediastinum in addition to uterine cervix. Diagnosis (and hence, appropriate treatment choice) was achieved on pathology of the submandibular gland and uterus, and analysis of serum IgG4. IgG4-RD should be suspected in patients presenting with malignancy and unusual multiple lymph node swelling. \u00a9 2016 Japan Society of Obstetrics and Gynecology.\n[Anti-soluble liver antigen (SLA) antibodies in chronic HCV infection.](https://www.ncbi.nlm.nih.gov/pubmed/15497455)\nVitozzi, Susana; Lapierre, Pascal; Djilali-Saiah, Idriss; Marceau, Gabriel; Beland, Kathie; Alvarez, Fernando\n2004-05-01\nHepatitis C infection is associated with autoimmune disorders, such as the production of autoantibodies. Anti-LKM1 and anti-LC1, immunomarkers of type 2 autoimmune hepatitis, have been previously associated with a HCV infection. Anti-Soluble-Liver-Antigen autoantibodies (SLA) are specifically associated with type 1 and type 2 autoimmune hepatitis and more closely related to patients who relapse after steroid therapy. The recent molecular cloning of the soluble liver antigen provides the opportunity to develop more specific tests for the detection of antibodies against it. The aim of this work is to characterize anti-soluble-liver autoantibodies in sera from patients chronically infected by HCV. A recombinant cDNA from activated Jurkat cells coding for the full length tRNP(Ser)Sec/SLA antigen was obtained. ELISA, Western Blot and immunoprecipitation tests were developed and used to search for linear and conformational epitopes recognized by anti-SLA antibodies in sera from patients chronically infected by HCV. Anti-soluble liver antigen antibodies were found in sera from 10.4% of HCV-infected patients. The prevalence was significantly increased to 27% when anti-LKM1 was also present. Most anti-SLA reactivity was directed against conformational epitopes on the antigen. The means titers by ELISA were lower than those obtained in type 2 AIH. The result of autoantibody isotyping showed a subclass restriction to IgG1 and also IgG4. This study shows the presence of anti-SLA antibodies in approximately 10% of HCV infected patients. The prevalence of SLA autoantibodies in HCV infected patients increases when LKM1 autoantibodies are also present. The relationship between the prevalence of this characteristic autoimmune hepatitis autoantibody and the implication of an autoimmune phenomenon in the liver injury of patients chronically infected by HCV needs further investigation.\n[IgG4-Seronegative Autoimmune Pancreatitis and Sclerosing Cholangitis](http://dx.doi.org/10.1155/2015/591360) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAllon Kahn\n2015-01-01\nFull Text Available IgG4-related disease is a relatively novel clinical entity whose gastrointestinal manifestations include type 1 autoimmune pancreatitis (AIP and IgG4-associated sclerosing cholangitis. The presence of elevated serum IgG4 is suggestive but not essential for the diagnosis of type 1 AIP and is a pervasive feature of the proposed diagnostic criteria. The differential diagnosis of type 1 AIP includes malignant conditions, emphasizing the importance of a deliberate, comprehensive evaluation. Management of patients with a suggestive clinical presentation, but without serum IgG4 elevation, is difficult. Here we present three cases of IgG4-seronegative AIP and sclerosing cholangitis that responded to empiric steroid therapy and discuss approach considerations. These cases demonstrate the value of meticulous application of existing diagnostic algorithms to achieve a clinical diagnosis and avoid surgical intervention.\n[Human placenta: relative content of antibodies of different classes and subclasses (IgG1-IgG4) containing lambda- and kappa-light chains and chimeric lambda-kappa-immunoglobulins.](https://www.ncbi.nlm.nih.gov/pubmed/25644595)\nLekchnov, Evgenii A; Sedykh, Sergey E; Dmitrenok, Pavel S; Buneva, Valentina N; Nevinsky, Georgy A\n2015-06-01\nThe specific organ placenta is much more than a filter: it is an organ that protects, feeds and regulates the growth of the embryo. Affinity chromatography, ELISA, SDS-PAGE and matrix-assisted laser desorption ionization mass spectrometry were used. Using 10 intact human placentas deprived of blood, a quantitative analysis of average relative content [% of total immunoglobulins (Igs)] was carried out for the first time: (92.7), IgA (2.4), IgM (2.5), kappa-antibodies (51.4), lambda-antibodies (48.6), IgG1 (47.0), IgG2 (39.5), IgG3 (8.8) and IgG4 (4.3). It was shown for the first time that placenta contains sIgA (2.5%). In the classic paradigm, Igs represent products of clonal B-cell populations, each producing antibodies recognizing a single antigen. There is a common belief that IgGs in mammalian biological fluids are monovalent molecules having stable structures and two identical antigen-binding sites. However, similarly to human milk Igs, placenta antibodies undergo extensive half-molecule exchange and the IgG pool consists of 43.5 \u00b1 15.0% kappa-kappa-IgGs and 41.6 \u00b1 17.0% lambda-lambda-IgGs, while 15.0 \u00b1 4.0% of the IgGs contained both kappa- and lambda-light chains. Kappa-kappa-IgGs and lambda-lambda-IgGs contained, respectively (%): IgG1 (47.7 and 34.4), IgG2 (36.3 and 44.5), IgG3 (7.4 and 11.8) and IgG4 (7.5 and 9.1), while chimeric kappa-lambda-IgGs consisted of (%): 43.5 IgG1, 41.0 IgG2, 5.6 IgG3 and 7.9 IgG4. Our data are indicative of the possibility of half-molecule exchange between placenta IgGs of various subclasses, raised against different antigens, which explains a very well-known polyspecificity and cross-reactivity of different human IgGs. \u00a9 The Japanese Society for Immunology. 2015. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.\n[IgG isotypic antibodies to crude Plasmodium falciparum blood-stage ...](https://www.ajol.info/index.php/ahs/article/viewFile/152531/142119) [African Journals Online (AJOL)](http://www.ajol.info/index.php)\nMethods: Levels of IgG (IgG1-IgG4) and IgM to crude P. falciparum blood stage antigen ... dosage influenced P. falciparum-specific isotypic antibody responses to blood stage .... exposed Swedish donors. ..... with adverse pregnancy outcomes.", "language": null, "image": null, "pagetype": null, "links": ["#", "//worldwidescience.org/index.html", "//worldwidescience.org/about.html", "//worldwidescience.org/news.html", "//worldwidescience.org/wws", "//worldwidescience.org/contact.html", "//worldwidescience.org/sitemap.html", "//worldwidescience.org/help.html", "#", "#", "#", "#", "#", "#", "http://www.revistabiomedica.org/index.php/biomedica/article/view/2070", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802006000600003", "https://doaj.org/search#.V6PA8bgrK70", "http://www.iatreia.udea.edu.co/index.php/iatreia/article/view/235", "https://doaj.org/search#.V6PA8bgrK70", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-02892001000200008", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0036-36342003000500002", "https://doaj.org/search#.V6PA8bgrK70", "http://www.revistabiomedica.org/index.php/biomedica/article/view/2530", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1726-46342000000100007&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "http://www.iatreia.udea.edu.co/index.php/iatreia/article/view/432", "https://doaj.org/search#.V6PA8bgrK70", "http://www.revistabiomedica.org/index.php/biomedica/article/view/1103", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1025-55832011000300006&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342003000500002", "https://doaj.org/search#.V6PA8bgrK70", "http://revistas.unicordoba.edu.co/revistamvz/mvz-172/V17N2A9.pdf", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342008000500008", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0036-36342002000300008", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/27632931", "https://www.science.gov/", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49891999000600018", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=od_______615::52a083a2b18f5d5c56245c2510ac2485", "https://www.openaire.eu/search/advanced/publications", "http://erevistas.saber.ula.ve/index.php/biomedicina/article/view/4282", "https://doaj.org/search#.V6PA8bgrK70", "http://journal.frontiersin.org/article/10.3389/fimmu.2018.00129/full", "https://doaj.org/search#.V6PA8bgrK70", "http://www.redalyc.org/articulo.oa?id=265628982002", "https://doaj.org/search#.V6PA8bgrK70", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802012000200007&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/23228149", "https://www.science.gov/", "http://www.virologyj.com/content/9/1/304", "https://doaj.org/search#.V6PA8bgrK70", "http://scielo.sld.cu/pdf/vac/v16n1/vac02107.pdf", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2011000400003", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=dedup_wf_001::3612f80d59bde955697dc80f0bf5300f", "https://www.openaire.eu/search/advanced/publications", "https://www.openaire.eu/search/publication?articleId=od______1404::3275170fdd830f23aae3cf86adb62970", "https://www.openaire.eu/search/advanced/publications", "http://www.revistabiomedica.org/index.php/biomedica/article/view/122", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0325-75412007000100012", "https://doaj.org/search#.V6PA8bgrK70", "http://www.forskningsdatabasen.dk/en/catalog/2270631557", "http://forskningsbasen.deff.dk/?lang=eng", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-02891999000100007", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2011000200008", "https://doaj.org/search#.V6PA8bgrK70", "http://www.dovepress.com/anti-metallothionein-igg-and-levels-of-metallothionein-in-autistic-chi-a2771", "https://doaj.org/search#.V6PA8bgrK70", "http://dx.doi.org/10.1155/2015/638129", "https://doaj.org/search#.V6PA8bgrK70", "https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=22008682", "http://inis.iaea.org/search/", "http://www.revistabiomedica.org/index.php/biomedica/article/view/3249", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/26359685", "https://www.science.gov/", "http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802013000100004&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/18613460", "https://www.science.gov/", "http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802012000100005&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "https://www.openaire.eu/search/publication?articleId=od______2008::22ca84354c29c39b3f3d5cb83a7a1406", "https://www.openaire.eu/search/advanced/publications", "https://www.narcis.nl/publication/RecordID/oai%3Apure.amc.nl%3Apublications%2F48a483d2-20f5-41a4-bdbc-e0050cb2260f/uquery/IGG4/id/11/Language/EN", "http://www.narcis.nl", "https://www.ncbi.nlm.nih.gov/pubmed/22262223", "https://www.science.gov/", "https://www.narcis.nl/publication/RecordID/oai%3Adare.uva.nl%3Apublications%2F3837baea-3cdc-4e16-bca8-b1a34dbb2dd1/uquery/IGG4/id/14/Language/EN", "http://www.narcis.nl", "https://www.narcis.nl/publication/RecordID/oai%3Aresearch.vu.nl%3Apublications%2Fb459fa62-5e69-4def-ae46-031d7c7ae690/uquery/IGG4/id/12/Language/EN", "http://www.narcis.nl", "http://www.revistabiomedica.org/index.php/biomedica/article/view/855", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/27896569", "https://www.science.gov/", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3101880", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/23070898", "https://www.science.gov/", "https://www.narcis.nl/publication/RecordID/oai%3Apure.amc.nl%3Apublications%2Ff03cd7ea-1870-4be3-a9f1-c8ec0eb4b84b/uquery/fab/id/6/Language/EN", "http://www.narcis.nl", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3003908", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/23695895", "https://www.science.gov/", "https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=12605221", "http://inis.iaea.org/search/", "http://www.iaea.org/inis/collection/NCLCollectionStore/_Public/26/040/26040665.pdf?r=1", "http://inis.iaea.org/search/", "https://www.ncbi.nlm.nih.gov/pubmed/28514287", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/29506084", "https://www.science.gov/", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3848062", "https://www.science.gov/", "http://journals.mui.ac.ir/jrms/article/view/342", "https://doaj.org/search#.V6PA8bgrK70", "https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=30043931", "http://inis.iaea.org/search/", "http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802004000300006", "https://doaj.org/search#.V6PA8bgrK70", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "http://europepmc.org/articles/PMC3561451?pdf=render", "https://doaj.org/search#.V6PA8bgrK70", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4099331", "https://www.science.gov/", "http://e-cmh.org/upload/pdf/cmh-20-162.pdf", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/28721101", "https://www.science.gov/", "http://jmb.tums.ac.ir/index.php/jmb/article/view/113", "https://doaj.org/search#.V6PA8bgrK70", "http://www.sciencedirect.com/science/article/pii/S0120563313700226", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=od_______619::61023da14b4f2a8c5ae1017a254ceac1", "https://www.openaire.eu/search/advanced/publications", "http://www.revistabiomedica.org/index.php/biomedica/article/view/221", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0325-75412007000300010&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0036-46652001000300007", "https://doaj.org/search#.V6PA8bgrK70", "http://www.id-press.eu/mjms/article/view/321", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/17898552", "https://www.science.gov/", "https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=15030919", "http://inis.iaea.org/search/", "http://journal.frontiersin.org/Journal/10.3389/fimmu.2016.00493/full", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/29776608", "https://www.science.gov/", "http://www.revistabiomedica.org/index.php/biomedica/article/view/1941", "https://doaj.org/search#.V6PA8bgrK70", "http://www.revistabiomedica.org/index.php/biomedica/article/view/1077", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802009000600002", "https://doaj.org/search#.V6PA8bgrK70", "http://www.forskningsdatabasen.dk/en/catalog/5787441", "http://forskningsbasen.deff.dk/?lang=eng", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4997596", "https://www.science.gov/", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "http://www.iaea.org/inis/collection/NCLCollectionStore/_Public/30/018/30018792.pdf?r=1", "http://inis.iaea.org/search/", "https://www.ncbi.nlm.nih.gov/pubmed/27275238", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/29689714", "https://www.science.gov/", "https://www.openaire.eu/search/publication?articleId=od_______612::4450a66f555dc64f379f8e241722c40b", "https://www.openaire.eu/search/advanced/publications", "https://www.ncbi.nlm.nih.gov/pubmed/11665655", "https://www.science.gov/", "http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1726-46342007000400004&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/16848548", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/24179992", "https://www.science.gov/", "https://www.narcis.nl/publication/RecordID/oai%3Apure.amc.nl%3Apublications%2F87c26126-c5e9-4525-ad23-1f452ebb923c/uquery/Anti%20AND%20D/id/15/Language/EN", "http://www.narcis.nl", "http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342002000300008", "https://doaj.org/search#.V6PA8bgrK70", "https://www.osti.gov/etdeweb/biblio/38160", "https://www.etde.org/etdeweb/fieldedsearch.jsp", "http://www.iatreia.udea.edu.co/index.php/iatreia/article/view/474", "https://doaj.org/search#.V6PA8bgrK70", "https://www.narcis.nl/publication/RecordID/oai%3Apure.rug.nl%3Apublications%2F7c0cedcf-64d0-4052-b30a-f29b12972020/uquery/Anti%20AND%20D/id/10/Language/EN", "http://www.narcis.nl", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-09352018000100001&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "http://www.iatreia.udea.edu.co/index.php/iatreia/article/view/416", "https://doaj.org/search#.V6PA8bgrK70", "http://www.biomedcentral.com/1756-0500/5/167", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0036-46652002000400002", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2004000600019", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822005000200002", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/29651290", "https://www.science.gov/", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "http://journal.frontiersin.org/article/10.3389/fimmu.2018.00619/full", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=doajarticles::d3bf614135a7f7442b07d75548a47a39", "https://www.openaire.eu/search/advanced/publications", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4485911", "https://www.science.gov/", "https://www.openaire.eu/search/publication?articleId=doajarticles::f9d4081bcecc5ee2b2eb8e294952e14b", "https://www.openaire.eu/search/advanced/publications", "https://www.ncbi.nlm.nih.gov/pubmed/21214298", "https://www.science.gov/", "https://www.openaire.eu/search/publication?articleId=od______3056::b03ef0f759c9125d7ce04f0845b57faf", "https://www.openaire.eu/search/advanced/publications", "http://www.forskningsdatabasen.dk/en/catalog/2290412631", "http://forskningsbasen.deff.dk/?lang=eng", "https://www.ncbi.nlm.nih.gov/pubmed/27536208", "https://www.science.gov/", "http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802007000200006", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/26415367", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/18968430", "https://www.science.gov/", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-29612011000400010", "https://doaj.org/search#.V6PA8bgrK70", "http://europepmc.org/articles/PMC2894072?pdf=render", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/8756029", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/24630869", "https://www.science.gov/", "http://cienciaspecuarias.inifap.gob.mx/index.php/Pecuarias/article/view/4439/3731", "https://doaj.org/search#.V6PA8bgrK70", "http://europepmc.org/articles/PMC4900587?pdf=render", "https://doaj.org/search#.V6PA8bgrK70", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4900587", "https://www.science.gov/", "http://ojs.actapediatrica.org.mx/index.php/APM/article/view/1206", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0325-75412007000300010", "https://doaj.org/search#.V6PA8bgrK70", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802012000200007", "https://doaj.org/search#.V6PA8bgrK70", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-29532004000300002", "https://doaj.org/search#.V6PA8bgrK70", "http://www.revistabiomedica.org/index.php/biomedica/article/view/637", "https://doaj.org/search#.V6PA8bgrK70", "https://pubs.er.usgs.gov/publication/70188105", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/27318181", "https://www.science.gov/", "http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0465-546X2014000300002&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802005000400006", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/26837241", "https://www.science.gov/", "https://www.openaire.eu/search/publication?articleId=doajarticles::44d691368bbcc6a8f4eda7e7887fe263", "https://www.openaire.eu/search/advanced/publications", "http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802013000200004&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "http://www.revistabiomedica.org/index.php/biomedica/article/view/1994", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342003001100014", "https://doaj.org/search#.V6PA8bgrK70", "http://www.revistabiomedica.org/index.php/biomedica/article/view/1340", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302003000400037", "https://doaj.org/search#.V6PA8bgrK70", "http://www.revistabiomedica.org/index.php/biomedica/article/view/1116", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1676-24442003000200003", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=doajarticles::ae92c86cab8f4fc5b2100e8cd33b961b", "https://www.openaire.eu/search/advanced/publications", "http://respiratory-research.com/content/12/1/42", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342006000300006", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/19301204", "https://www.science.gov/", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "http://www.iaea.org/inis/collection/NCLCollectionStore/_Public/14/760/14760433.pdf?r=1", "http://inis.iaea.org/search/", "http://www.forskningsdatabasen.dk/en/catalog/37483831", "http://forskningsbasen.deff.dk/?lang=eng", "https://www.ncbi.nlm.nih.gov/pubmed/26497518", "https://www.science.gov/", "http://www.revistabiomedica.org/index.php/biomedica/article/view/1372", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02761989000200017", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/27377454", "https://www.science.gov/", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2015000300001&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "http://www.revistabiomedica.org/index.php/biomedica/article/view/1035", "https://doaj.org/search#.V6PA8bgrK70", "http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=7902106&query_hl=17", "http://forskningsbasen.deff.dk/?lang=eng", "https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=21090354", "http://inis.iaea.org/search/", "https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=41019450", "http://inis.iaea.org/search/", "https://www.openaire.eu/search/publication?articleId=od_______908::13dff595dd525dd45a41f85372234426", "https://www.openaire.eu/search/advanced/publications", "http://journals.tbzmed.ac.ir/PDF/APB/Manuscript/APB-3-333.pdf", "https://doaj.org/search#.V6PA8bgrK70", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3848219", "https://www.science.gov/", "http://www.redalyc.org/articulo.oa?id=43211940006", "https://doaj.org/search#.V6PA8bgrK70", "http://europepmc.org/articles/PMC3988235?pdf=render", "https://doaj.org/search#.V6PA8bgrK70", "https://www.osti.gov/etdeweb/biblio/6015448", "https://www.etde.org/etdeweb/fieldedsearch.jsp", "https://www.ncbi.nlm.nih.gov/pubmed/22366632", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/22543621", "https://www.science.gov/", "http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0123-93922006000300006", "https://doaj.org/search#.V6PA8bgrK70", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "http://www.revistabiomedica.org/index.php/biomedica/article/view/1990", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342007000300006", "https://doaj.org/search#.V6PA8bgrK70", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4663111", "https://www.science.gov/", "https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=12635302", "http://inis.iaea.org/search/", "https://www.ncbi.nlm.nih.gov/pubmed/6235283", "https://www.science.gov/", "http://revistas.unicordoba.edu.co/revistamvz/mvz-173/V17N3A4.pdf", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/28597369", "https://www.science.gov/", "http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802003000500004", "https://doaj.org/search#.V6PA8bgrK70", "http://www.jpatholtm.org/upload/pdf/jptm-2015-11-09.pdf", "https://doaj.org/search#.V6PA8bgrK70", "https://docs.google.com/folder/d/0B_IdlsctkRrxU0kxWVFQa05MNEU/edit?usp=sharing&pli=1&docId=0B_IdlsctkRrxb1BnVTZCdWoxRUE", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ajol.info/index.php/ajb/article/viewFile/98691/87955", "http://www.ajol.info/index.php", "http://aprendeenlinea.udea.edu.co/revistas/index.php/fnsp/article/view/22372", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0120-56332013000100007", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/25101933", "https://www.science.gov/", "http://dx.doi.org/10.1007/s00604-010-0442-x", "http://inis.iaea.org/search/", "https://www.ncbi.nlm.nih.gov/pubmed/28351925", "https://www.science.gov/", "https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=22083446", "http://inis.iaea.org/search/", "https://www.osti.gov/etdeweb/biblio/6151459", "https://www.etde.org/etdeweb/fieldedsearch.jsp", "https://www.openaire.eu/search/publication?articleId=dedup_wf_001::4d5fda784fc5e06c9e2cbd6f95d27536", "https://www.openaire.eu/search/advanced/publications", "http://www.ijdr.in/article.asp?issn=0970-9290;year=2012;volume=23;issue=5;spage=694;epage=695;aulast=Krishnaswamy", "https://doaj.org/search#.V6PA8bgrK70", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "https://www.openaire.eu/search/publication?articleId=od______1739::212bba95176d5b7bc815ccd4e2cd2691", "https://www.openaire.eu/search/advanced/publications", "http://www.redalyc.org/articulo.oa?id=265619698008", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/19624737", "https://www.science.gov/", "http://www.revistabiomedica.org/index.php/biomedica/article/view/1112", "https://doaj.org/search#.V6PA8bgrK70", "http://dx.doi.org/10.1155/2015/834749", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/1086786", "https://www.science.gov/", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2013000300006&lng=es&nrm=iso", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/26851295", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/28197739", "https://www.science.gov/", "https://fsl-bsf.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1LSwMxEB7EIurJJz5hbp5WY7rdbKEUat1VD4rFFr2VPGVBs2C3oB787Sa7qyteekuGIWRgMjP5mAdAm56S4J9NkIwJTWJm2lEou0oyFZ-HJnLaxKQLMjwsOZm0k6fwbuRLY35qxGovEDRQRpkKxf-0T_IunhH29eDbbrtw3-l6azBK0vt1WLVvsuKvchtLC5luwFYzxhadKZ_7xSYsabsN2dDnepdAFeYGOd66_7fGlAvMbJE7wqMfW4slwp59aoU3z1c4sEUmcvWBLs7ES-3Rf-d3sCf6F3nhE8rnr70z0feEcf6eWb_ZgZM0GQ-vg99LTmspq_7W01owRndh2eZW7wESE0sXr1AWRyaMuIo7HcWpCIUgXU4p2QdcdNrBYpZDWGtwhiNoGfcO9DGsmNlLIGbmG3lDjUI", "http://science-libraries.canada.ca/eng/national-science-library/", "http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1025-55832012000100008&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/9000670", "https://www.science.gov/", "http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802012000400012", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/26964842", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/25234110", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/24252165", "https://www.science.gov/", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892003001100001&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/28239472", "https://www.science.gov/", "https://www.openaire.eu/search/publication?articleId=od_______621::7e1633db2080f63743041c74da64c51d", "https://www.openaire.eu/search/advanced/publications", "https://www.ncbi.nlm.nih.gov/pubmed/26907324", "https://www.science.gov/", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=23078827", "http://inis.iaea.org/search/", "https://www.ncbi.nlm.nih.gov/pubmed/27466793", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/10415009", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/27864697", "https://www.science.gov/", "http://www.mdpi.com/1996-1944/7/9/6843", "https://doaj.org/search#.V6PA8bgrK70", "https://www.dovepress.com/serum-total-igg-and-igg4-levels-in-thyroid-eye-disease-peer-reviewed-article-IMCRJ", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/28987046", "https://www.science.gov/", "https://www.ajol.info/index.php/ajcem/article/download/83865/73873", "http://www.ajol.info/index.php", "https://www.ncbi.nlm.nih.gov/pubmed/28686149", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/9463082", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/28363116", "https://www.science.gov/", "https://www.frontiersin.org/article/10.3389/fimmu.2018.01183/full", "https://doaj.org/search#.V6PA8bgrK70", "http://www.dtic.mil/docs/citations/AD0729303", "https://www.science.gov/", "https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=11505226", "http://inis.iaea.org/search/", "http://www.jgid.org/article.asp?issn=0974-777X;year=2009;volume=1;issue=1;spage=29;epage=32;aulast=Jain", "https://doaj.org/search#.V6PA8bgrK70", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2006000200001&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "http://dx.doi.org/10.1155/2012/580814", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/25568323", "https://www.science.gov/", "https://www.openaire.eu/search/publication?articleId=dedup_wf_001::b4ea5f20b024ce1dfdc886c43b84f379", "https://www.openaire.eu/search/advanced/publications", "https://www.narcis.nl/publication/RecordID/oai%3Apure.amc.nl%3Apublications%2F1973c654-54d7-4cfe-99d0-cb51a458d45b/uquery/IGG4/id/1/Language/EN", "http://www.narcis.nl", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2013005000002", "https://doaj.org/search#.V6PA8bgrK70", "http://www.forskningsdatabasen.dk/en/catalog/19729781", "http://forskningsbasen.deff.dk/?lang=eng", "https://www.ncbi.nlm.nih.gov/pubmed/22064712", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/27494183", "https://www.science.gov/", "http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1726-46342002000100002&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "http://europepmc.org/articles/PMC3256135?pdf=render", "https://doaj.org/search#.V6PA8bgrK70", "http://www.lenus.ie/hse/handle/10147/237978", "http://www.lenus.ie/hse/", "https://www.ncbi.nlm.nih.gov/pubmed/24052007", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/21078423", "https://www.science.gov/", "https://www.openaire.eu/search/publication?articleId=dedup_wf_001::b07c5dbd73c0494ecf79b52780895500", "https://www.openaire.eu/search/advanced/publications", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1678-91992009000400008", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/25583986", "https://www.science.gov/", "http://www.iaea.org/inis/collection/NCLCollectionStore/_Public/21/079/21079400.pdf?r=1", "http://inis.iaea.org/search/", "https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=14750542", "http://inis.iaea.org/search/", "http://dx.doi.org/10.1155/2012/472376", "https://doaj.org/search#.V6PA8bgrK70", "http://europepmc.org/articles/PMC4416882?pdf=render", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/25522313", "https://www.science.gov/", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2006000300004&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=dedup_wf_001::71df4eb03637b7a393f035af520d2ce6", "https://www.openaire.eu/search/advanced/publications", "http://www.etde.org/etdeweb/details.jsp?query_id=1&page=0&osti_id=6444152", "https://www.etde.org/etdeweb/fieldedsearch.jsp", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "https://www.ncbi.nlm.nih.gov/pubmed/28606325", "https://www.science.gov/", "http://www.veterinaryworld.org/Vol.10/January-2017/15.pdf", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/29719659", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/28461116", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/26617921", "https://www.science.gov/", "http://revistaseletronicas.pucrs.br/ojs/index.php/scientiamedica/article/viewFile/1636/1899", "https://doaj.org/search#.V6PA8bgrK70", "http://www.narcis.nl/publication/RecordID/oai%3Adspace.library.uu.nl%3A1874%2F341294/uquery/Omalizumab/id/16/Language/EN", "http://www.narcis.nl", "http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0325-75412006000200007", "https://doaj.org/search#.V6PA8bgrK70", "http://www.dovepress.com/necrotizing-rpgn-with-linear-anti-igg-deposits-in-a-patient-with-histo-peer-reviewed-article-IJNRD", "https://doaj.org/search#.V6PA8bgrK70", "https://www.osti.gov/etdeweb/biblio/5733965", "https://www.etde.org/etdeweb/fieldedsearch.jsp", "https://www.ncbi.nlm.nih.gov/pubmed/25474510", "https://www.science.gov/", "http://www.etde.org/etdeweb/details.jsp?query_id=1&page=0&osti_id=5503835", "https://www.etde.org/etdeweb/fieldedsearch.jsp", "http://dx.doi.org/10.1016/j.yexcr.2012.09.001", "http://inis.iaea.org/search/", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2001000300003&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0036-36342003000500003", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1726-46342003000400004&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "http://www.sciencedirect.com/science/article/pii/S0120563317301936", "https://doaj.org/search#.V6PA8bgrK70", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-02892001000300008", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/20008198", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/29428821", "https://www.science.gov/", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "https://www.ncbi.nlm.nih.gov/pubmed/28284385", "https://www.science.gov/", "https://www.journalhealthsciences.com/index.php/UDES/article/view/80", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0041-87812003000600006", "https://doaj.org/search#.V6PA8bgrK70", "http://www.forskningsdatabasen.dk/en/catalog/2393860578", "http://forskningsbasen.deff.dk/?lang=eng", "https://www.ncbi.nlm.nih.gov/pubmed/28881485", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/18666325", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/24884481", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/26223472", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/26972314", "https://www.science.gov/", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892006000700005", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=dedup_wf_001::1673f4284151b71a02e4b2ae2806ae97", "https://www.openaire.eu/search/advanced/publications", "https://www.ncbi.nlm.nih.gov/pubmed/24030741", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/24329006", "https://www.science.gov/", "http://www.forskningsdatabasen.dk/en/catalog/185167140", "http://forskningsbasen.deff.dk/?lang=eng", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842003000400004", "https://doaj.org/search#.V6PA8bgrK70", "http://www.etde.org/etdeweb/details.jsp?query_id=1&page=0&osti_id=22209429", "https://www.etde.org/etdeweb/fieldedsearch.jsp", "http://adsabs.harvard.edu/abs/2013JNR....15.1964L", "https://www.science.gov/", "http://dx.doi.org/10.1007/s11051-013-1964-z", "http://inis.iaea.org/search/", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=5839796", "https://www.science.gov/", "http://www.malariajournal.com/content/8/1/286", "https://doaj.org/search#.V6PA8bgrK70", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "https://www.ncbi.nlm.nih.gov/pubmed/3309063", "https://www.science.gov/", "http://www.etde.org/etdeweb/details.jsp?query_id=1&page=0&osti_id=22212621", "https://www.etde.org/etdeweb/fieldedsearch.jsp", "https://www.ncbi.nlm.nih.gov/pubmed/27438709", "https://www.science.gov/", "http://europepmc.org/articles/PMC4270775?pdf=render", "https://doaj.org/search#.V6PA8bgrK70", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2009000300002&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/29629396", "https://www.science.gov/", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4401680", "https://www.science.gov/", "http://adsabs.harvard.edu/abs/2010cosp...38.3536P", "https://www.science.gov/", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762012000300008&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-09352007000500040", "https://doaj.org/search#.V6PA8bgrK70", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4616795", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/27125474", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/24730215", "https://www.science.gov/", "http://www.eurjmedres.com/content/16/9/385", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/28319486", "https://www.science.gov/", "https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=8346974", "http://inis.iaea.org/search/", "http://europepmc.org/articles/PMC2566810?pdf=render", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892000001100001", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/27068526", "https://www.science.gov/", "http://jdt.tums.ac.ir/index.php/jdt/article/view/1177", "https://doaj.org/search#.V6PA8bgrK70", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "http://www.sciencedirect.com/science/article/pii/S2214330017300809", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1726-46342007000400013&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/28470592", "https://www.science.gov/", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0036-36342006000100004", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/27878471", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/9454766", "https://www.science.gov/", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892003001100001", "https://doaj.org/search#.V6PA8bgrK70", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4383171", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/27466792", "https://www.science.gov/", "http://www.forskningsdatabasen.dk/en/catalog/2306502410", "http://forskningsbasen.deff.dk/?lang=eng", "https://www.narcis.nl/publication/RecordID/oai%3Apure.amc.nl%3Apublications%2F13865e81-407c-41d6-b2d7-cc42a1ab79dc/uquery/IGG4/id/19/Language/EN", "http://www.narcis.nl", "https://www.ncbi.nlm.nih.gov/pubmed/28918831", "https://www.science.gov/", "https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=17068271", "http://inis.iaea.org/search/", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4553963", "https://www.science.gov/", "http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/12830.pdf&manuscript_id=12830", "https://doaj.org/search#.V6PA8bgrK70", "http://dx.doi.org/10.1155/2012/121702", "https://doaj.org/search#.V6PA8bgrK70", "https://www.osti.gov/etdeweb/biblio/5340871", "https://www.etde.org/etdeweb/fieldedsearch.jsp", "https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=11505213", "http://inis.iaea.org/search/", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=5386341", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/25970007", "https://www.science.gov/", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=5737902", "https://www.science.gov/", "http://dx.doi.org/10.1155/2017/9876819", "https://doaj.org/search#.V6PA8bgrK70", "http://www.revistabiomedica.org/index.php/biomedica/article/view/922", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/28375417", "https://www.science.gov/", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3631360", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/26567899", "https://www.science.gov/", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0036-46652006000100011", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892009001000011", "https://doaj.org/search#.V6PA8bgrK70", "http://iimmun.ru/iimm/article/view/107", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86821999000500003", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/28297756", "https://www.science.gov/", "http://www.malariajournal.com/content/11/1/308", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/3976569", "https://www.science.gov/", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0036-46652000000400010", "https://doaj.org/search#.V6PA8bgrK70", "http://dx.doi.org/10.1155/2014/803876", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762009000200036", "https://doaj.org/search#.V6PA8bgrK70", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3784998", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/29362594", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/23214065", "https://www.science.gov/", "http://journal.frontiersin.org/article/10.3389/fimmu.2018.00958/full", "https://doaj.org/search#.V6PA8bgrK70", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "https://www.ncbi.nlm.nih.gov/pubmed/26943245", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/28615064", "https://www.science.gov/", "https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=21019057", "http://inis.iaea.org/search/", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4819071", "https://www.science.gov/", "http://www.revistabiomedica.org/index.php/biomedica/article/view/1829", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/27814939", "https://www.science.gov/", "http://europepmc.org/articles/PMC5536389?pdf=render", "https://doaj.org/search#.V6PA8bgrK70", "https://www.narcis.nl/publication/RecordID/oai%3Aresearch.vu.nl%3Apublications%2F936fdae0-ed7c-478c-a5c8-a30cfc16b929/uquery/Anti%20AND%20D/id/2/Language/EN", "http://www.narcis.nl", "https://www.narcis.nl/publication/RecordID/oai%3Apure.amc.nl%3Apublications%2F32426ac4-2370-4751-a491-844c78fee98e/uquery/Anti%20AND%20D/id/9/Language/EN", "http://www.narcis.nl", "https://www.narcis.nl/publication/RecordID/oai%3Apure.amc.nl%3Apublications%2F777ff21f-0a48-423b-a1b6-16ee9246b8ae/uquery/IGG4/id/4/Language/EN", "http://www.narcis.nl", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0036-46652016005000270&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "http://dx.doi.org/10.1155/2015/286380", "https://doaj.org/search#.V6PA8bgrK70", "https://www.narcis.nl/publication/RecordID/oai%3Apure.amc.nl%3Apublications%2F4e1fdc33-67bb-4872-a42f-78ebdc28a264/uquery/IGG4/id/16/Language/EN", "http://www.narcis.nl", "http://www.etde.org/etdeweb/details.jsp?query_id=1&page=0&osti_id=657245", "https://www.etde.org/etdeweb/fieldedsearch.jsp", "https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=29059509", "http://inis.iaea.org/search/", "https://www.openaire.eu/search/publication?articleId=od______3056::692149d58b95d40db6faba3a453e8c9d", "https://www.openaire.eu/search/advanced/publications", "https://www.ncbi.nlm.nih.gov/pubmed/26745015", "https://www.science.gov/", "https://www.openaire.eu/search/publication?articleId=od_______623::23fcc096a7073841256cbf6b42306aa2", "https://www.openaire.eu/search/advanced/publications", "http://www.revistabiomedica.org/index.php/biomedica/article/view/1989", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/28433574", "https://www.science.gov/", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "http://www.etde.org/etdeweb/details.jsp?query_id=1&page=0&osti_id=5025656", "https://www.etde.org/etdeweb/fieldedsearch.jsp", "https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=23011255", "http://inis.iaea.org/search/", "http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1025-55832012000100007&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342007000900013", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/29310344", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/24705309", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/26371841", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/28742098", "https://www.science.gov/", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=5827325", "https://www.science.gov/", "http://www.ssu.ac.ir/ijrm/index.php/ijrm/article/view/2310/pdf", "https://doaj.org/search#.V6PA8bgrK70", "http://revistas.unicordoba.edu.co/revistamvz/mvz-171/V17N1A15.pdf", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/26565780", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/28091932", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/28575786", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/29064352", "https://www.science.gov/", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2001000200002&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762010000400004", "https://doaj.org/search#.V6PA8bgrK70", "http://www.ajts.org/article.asp?issn=0973-6247;year=2013;volume=7;issue=1;spage=84;epage=85;aulast=Usman", "https://doaj.org/search#.V6PA8bgrK70", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4318645", "https://www.science.gov/", "http://pulmonarychronicles.com/index.php/pulmonarychronicles/article/view/324", "https://doaj.org/search#.V6PA8bgrK70", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "https://www.ncbi.nlm.nih.gov/pubmed/21953287", "https://www.science.gov/", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1793096", "https://www.science.gov/", "https://www.openaire.eu/search/publication?articleId=dedup_wf_001::2675424db6a3d1362f5d296fbc4e7f16", "https://www.openaire.eu/search/advanced/publications", "https://www.ncbi.nlm.nih.gov/pubmed/26308749", "https://www.science.gov/", "https://www.openaire.eu/search/publication?articleId=od_______908::7729499f9eb5962ca55df26d4b38c7eb", "https://www.openaire.eu/search/advanced/publications", "http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1726-46342001000200002&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "http://dx.doi.org/10.1155/2014/723493", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=od______3056::aa3edf723f330bc1432b8373ec9772da", "https://www.openaire.eu/search/advanced/publications", "https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=21093687", "http://inis.iaea.org/search/", "https://www.narcis.nl/publication/RecordID/oai%3Apure.amc.nl%3Apublications%2Fc4c158b3-fc61-4aed-a47a-2f13c89c5371/uquery/basel%20AND%20iii/id/19/Language/EN", "http://www.narcis.nl", "http://rsp.ima-press.net/rsp/article/view/2233", "https://doaj.org/search#.V6PA8bgrK70", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3837265", "https://www.science.gov/", "http://www.revistabiomedica.org/index.php/biomedica/article/view/334", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/3609", "https://www.science.gov/", "http://www.scopemed.org/fulltextpdf.php?mno=49298", "https://doaj.org/search#.V6PA8bgrK70", "https://www.narcis.nl/publication/RecordID/oai%3Apure.amc.nl%3Apublications%2F13424964-ebbe-482f-a2c6-ce172a767cdc/uquery/IGG4/id/9/Language/EN", "http://www.narcis.nl", "https://www.narcis.nl/publication/RecordID/oai%3Apure.amc.nl%3Apublications%2Ff5c86ac7-c1a4-441d-848d-ef43a548764e/uquery/past%20AND%20year%20AND%20papers/id/8/Language/EN", "http://www.narcis.nl", "https://www.ncbi.nlm.nih.gov/pubmed/26033685", "https://www.science.gov/", "http://www.jpatholtm.org/upload/pdf/jptm-2015-12-01.pdf", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/25891124", "https://www.science.gov/", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "https://revistas.unal.edu.co/index.php/actabiol/article/view/27376", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=od______1326::76be0d14a3f1f02e02e0548376e95e2b", "https://www.openaire.eu/search/advanced/publications", "https://endojournals.ru/index.php/omet/article/view/9350", "https://doaj.org/search#.V6PA8bgrK70", "https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=17054664", "http://inis.iaea.org/search/", "http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0123-93922015000200005&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/29168342", "https://www.science.gov/", "http://rbmv.org/index.php/BJVM/article/view/358", "https://doaj.org/search#.V6PA8bgrK70", "https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=23021930", "http://inis.iaea.org/search/", "https://www.ncbi.nlm.nih.gov/pubmed/28478106", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/27848036", "https://www.science.gov/", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-89102013000500890&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=17082380", "http://inis.iaea.org/search/", "http://europepmc.org/articles/PMC4295886?pdf=render", "https://doaj.org/search#.V6PA8bgrK70", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3613918", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/27729479", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/27647429", "https://www.science.gov/", "http://www.forskningsdatabasen.dk/en/catalog/194511669", "http://forskningsbasen.deff.dk/?lang=eng", "http://pat.zsmu.edu.ua/article/view/81051/78227", "https://doaj.org/search#.V6PA8bgrK70", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2012000200003&lng=es&nrm=iso", "https://doaj.org/search#.V6PA8bgrK70", "http://dx.doi.org/10.1155/2012/259408", "https://doaj.org/search#.V6PA8bgrK70", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "https://www.narcis.nl/publication/RecordID/oai%3Apure.rug.nl%3Apublications%2F3bc35d9e-bdb3-4d3e-bd25-90b2258510c5/uquery/influenza/id/10/Language/EN", "http://www.narcis.nl", "https://www.ncbi.nlm.nih.gov/pubmed/29510921", "https://www.science.gov/", "http://www.malariajournal.com/content/8/1/116", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/28506361", "https://www.science.gov/", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822006000500009", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/20818151", "https://www.science.gov/", "http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802012000400012&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86821991000200003", "https://doaj.org/search#.V6PA8bgrK70", "http://rsp.ima-press.net/rsp/article/view/1679", "https://doaj.org/search#.V6PA8bgrK70", "http://www.etde.org/etdeweb/details.jsp?query_id=1&page=0&osti_id=5596714", "https://www.etde.org/etdeweb/fieldedsearch.jsp", "https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=21005906", "http://inis.iaea.org/search/", "http://www.biomedcentral.com/1756-0500/5/416", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/29554545", "https://www.science.gov/", "https://revistas.unal.edu.co/index.php/biotecnologia/article/view/32886", "https://doaj.org/search#.V6PA8bgrK70", "http://dx.doi.org/10.1155/2012/401890", "https://doaj.org/search#.V6PA8bgrK70", "http://www.revistas.unal.edu.co/index.php/rcolquim/article/view/13491", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/24512211", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/28633333", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/27439915", "https://www.science.gov/", "https://www.narcis.nl/publication/RecordID/oai%3Apure.amc.nl%3Apublications%2F175567bd-83c0-43d8-a9f0-8d3b4183748d/uquery/IGG4/id/10/Language/EN", "http://www.narcis.nl", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "http://www.sciencedirect.com/science/article/pii/S2405844016310027", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1726-46342016000400003&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/12926587", "https://www.science.gov/", "https://www.openaire.eu/search/publication?articleId=od______3056::1a79f01de7e1b0b7153c7e091d9fb45a", "https://www.openaire.eu/search/advanced/publications", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4614015", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/23979841", "https://www.science.gov/", "https://www.openaire.eu/search/publication?articleId=od_______624::ce651ccf57067dd29ac62e372aa6c46f", "https://www.openaire.eu/search/advanced/publications", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4516435", "https://www.science.gov/", "http://www.sciencedirect.com/science/article/pii/S2213007116302192", "https://doaj.org/search#.V6PA8bgrK70", "https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=14795914", "http://inis.iaea.org/search/", "http://www.biomedcentral.com/1471-2172/10/13", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342002000100007", "https://doaj.org/search#.V6PA8bgrK70", "http://infociencia.idict.cu/index.php/infociencia/article/view/302", "https://doaj.org/search#.V6PA8bgrK70", "http://dx.doi.org/10.1155/2013/295472", "https://doaj.org/search#.V6PA8bgrK70", "http://ukrbiochemjournal.org/wp-content/uploads/2017/01/Galkin_1_17.pdf", "https://doaj.org/search#.V6PA8bgrK70", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3355479", "https://www.science.gov/", "https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=38111809", "http://inis.iaea.org/search/", "http://www.etde.org/etdeweb/details.jsp?query_id=1&page=0&osti_id=20963824", "https://www.etde.org/etdeweb/fieldedsearch.jsp", "http://www.sciencedirect.com/science/article/pii/S1110116417300881", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2000000100021", "https://doaj.org/search#.V6PA8bgrK70", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-02892010000200004", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/28514197", "https://www.science.gov/", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3563930", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/28858963", "https://www.science.gov/", "https://www.openaire.eu/search/publication?articleId=od______2079::fa24e04c25c7fc4be9b0e39e67722b80", "https://www.openaire.eu/search/advanced/publications", "https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=7222183", "http://inis.iaea.org/search/", "http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342003000500003", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/7514517", "https://www.science.gov/", "https://www.narcis.nl/publication/RecordID/oai%3Apure.rug.nl%3Apublications%2F2c4cac1c-90ee-4d2d-ac5b-a5845842b60a/uquery/IGG4/id/5/Language/EN", "http://www.narcis.nl", "https://www.narcis.nl/publication/RecordID/oai%3Apure.amc.nl%3Apublications%2F31f2c492-38cf-47bc-9d90-27ca5ae9df98/uquery/IGG4/id/7/Language/EN", "http://www.narcis.nl", "http://www.revistas.unal.edu.co/index.php/biotecnologia/article/view/32886", "https://doaj.org/search#.V6PA8bgrK70", "http://dx.doi.org/10.1155/2015/324365", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/28922375", "https://www.science.gov/", "http://apps.unicordoba.edu.co/revistas/revistamvz/mvz-142/v14n2a6.pdf", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/29289265", "https://www.science.gov/", "http://europepmc.org/articles/PMC3846924?pdf=render", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ajol.info/index.php/eamj/article/view/46942", "http://www.ajol.info/index.php", "http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0304-28472012000200011", "https://doaj.org/search#.V6PA8bgrK70", "http://ukrbiochemjournal.org/wp-content/uploads/2018/04/Galkin_3_18.pdf", "https://doaj.org/search#.V6PA8bgrK70", "http://europepmc.org/articles/PMC4193851?pdf=render", "https://doaj.org/search#.V6PA8bgrK70", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4193851", "https://www.science.gov/", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75312013000200010&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=dedup_wf_001::f1c3d2017035d932c048ed2543a72a4d", "https://www.openaire.eu/search/advanced/publications", "https://www.ncbi.nlm.nih.gov/pubmed/25354025", "https://www.science.gov/", "https://www.narcis.nl/publication/RecordID/oai%3Apure.amc.nl%3Apublications%2Fc41fb903-9bc6-4cd8-a1eb-bd7fe0aa4955/uquery/IGG4/id/13/Language/EN", "http://www.narcis.nl", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4639486", "https://www.science.gov/", "https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=33047325", "http://inis.iaea.org/search/", "https://www.ncbi.nlm.nih.gov/pubmed/19730101", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/27091207", "https://www.science.gov/", "https://www.narcis.nl/publication/RecordID/oai%3Apure.amc.nl%3Apublications%2Fa5b791d1-fc1e-4000-8be5-cbb3eeb27064/uquery/bee%20AND%20keeping/id/1/Language/EN", "http://www.narcis.nl", "http://www.revistabiomedica.org/index.php/biomedica/article/view/393", "https://doaj.org/search#.V6PA8bgrK70", "https://www.narcis.nl/publication/RecordID/oai%3Apure.amc.nl%3Apublications%2F1c395e4a-20f1-4d19-a7df-68ef91d10bf8/uquery/sds%20AND%20page/id/10/Language/EN", "http://www.narcis.nl", "https://www.ncbi.nlm.nih.gov/pubmed/28729706", "https://www.science.gov/", "http://www.etde.org/etdeweb/details.jsp?query_id=1&page=0&osti_id=1400303", "https://www.etde.org/etdeweb/fieldedsearch.jsp", "https://www.openaire.eu/search/publication?articleId=doajarticles::8cb3ca76e3a2e594a6c9b2d93fadfea1", "https://www.openaire.eu/search/advanced/publications", "https://www.ncbi.nlm.nih.gov/pubmed/27238361", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/15497455", "https://www.science.gov/", "http://dx.doi.org/10.1155/2015/591360", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/25644595", "https://www.science.gov/", "https://www.ajol.info/index.php/ahs/article/viewFile/152531/142119", "http://www.ajol.info/index.php", "#", "#", "#", "#", "#", "#", "http://worldwidescience.org/disclaimer.html", null, "http://www.science.gov", "http://worldwidescience.org"]}